Compound ID,Uniprot ID,Compound Name,Standard inchi key,Max Phase,Target Pref Name,Gene Names,Target Class,Wild type or mutant,Mutation information,PubMed ID,End Point Standard Type,End Point Standard Relation,End Point Standard Value,End Point Standard Units,Endpoint Mode of Action,Assay Format,Assay Type,Assay Sub Type,Inhibitor Type,Detection Technology,Compound concentration value,Compound concentration value units,Substrate type,Substrate Type Standard Relation,Substrate Type Standard Value,Substrate Type Standard Units,Assay cell line,Assay Description,Activity Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation Comments,Assay ID,DTC Tid,DTC Activity ID,DTC Molregno,Record ID,DTC Document ID
CHEMBL10,P20309,SB-203580,CDMGBJANTYXAIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484111,DTCC00132413,2089752,46191
CHEMBL10,P20309,SB-203580,CDMGBJANTYXAIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484112,DTCC00132413,2089752,46191
CHEMBL1006,P20309,AMIFOSTINE,JKOQGQFVAUAYPM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291231,DTCC00224760,898282,46191
CHEMBL1006,P20309,AMIFOSTINE,JKOQGQFVAUAYPM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291232,DTCC00224760,898282,46191
CHEMBL1009,P20309,LEVODOPA,WTDRDQBEARUVNC-LURJTMIESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425193,DTCC00224903,1351112,46191
CHEMBL1009,P20309,LEVODOPA,WTDRDQBEARUVNC-LURJTMIESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425194,DTCC00224903,1351112,46191
CHEMBL101,P20309,PHENYLBUTAZONE,VYMDGNCVAMGZFE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400148,DTCC00142582,217583,46191
CHEMBL101,P20309,PHENYLBUTAZONE,VYMDGNCVAMGZFE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400149,DTCC00142582,217583,46191
CHEMBL101168,P20309,1-AMINOBENZOTRIAZOLE,JCXKHYLLVKZPKE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302826,DTCC01742000,2057641,46191
CHEMBL101168,P20309,1-AMINOBENZOTRIAZOLE,JCXKHYLLVKZPKE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302827,DTCC01742000,2057641,46191
CHEMBL1016,P20309,CANDESARTAN,HTQMVQVXFRQIKW-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7270400,DTCC00228418,413969,46191
CHEMBL1016,P20309,CANDESARTAN,HTQMVQVXFRQIKW-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7270401,DTCC00228418,413969,46191
CHEMBL101740,P20309,CIDOXEPIN,ODQWQRRAPPTVAG-BOPFTXTBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,52,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14758918,DTCC00106776,2107070,68567
CHEMBL101740,P20309,CIDOXEPIN,ODQWQRRAPPTVAG-BOPFTXTBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,52,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14759567,DTCC00106776,2107070,68567
CHEMBL1020,P20309,TOLMETIN,UPSPUYADGBWSHF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7472719,DTCC00229841,477924,46191
CHEMBL1020,P20309,TOLMETIN,UPSPUYADGBWSHF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7472720,DTCC00229841,477924,46191
CHEMBL1024,P20309,IFOSFAMIDE,HOMGKSMUEGBAAB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7308701,DTCC00230672,703982,46191
CHEMBL1024,P20309,IFOSFAMIDE,HOMGKSMUEGBAAB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7308702,DTCC00230672,703982,46191
CHEMBL10272,P20309,BENZETIMIDE,LQQIVYSCPWCSSD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,<,1,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455668,DTCC00137829,726896,31823
CHEMBL10272,P20309,BENZETIMIDE,LQQIVYSCPWCSSD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455667,DTCC00137829,726895,31823
CHEMBL103,P20309,PROGESTERONE,RJKFOVLPORLFTN-LEKSSAKUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374847,DTCC00142899,1092348,46191
CHEMBL103,P20309,PROGESTERONE,RJKFOVLPORLFTN-LEKSSAKUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374848,DTCC00142899,1092348,46191
CHEMBL10309,P20309,,KIBLABCMQPRMIQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,<,1,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455665,DTCC00137862,726893,31823
CHEMBL10309,P20309,,KIBLABCMQPRMIQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455664,DTCC00137862,726892,31823
CHEMBL104,P20309,CLOTRIMAZOLE,VNFPBHJOKIVQEB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,9928,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356675,DTCC00143452,1960074,46191
CHEMBL104,P20309,CLOTRIMAZOLE,VNFPBHJOKIVQEB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,2104,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356676,DTCC00143452,1960074,46191
CHEMBL1042,P20309,CHOLECALCIFEROL,QYSXJUFSXHHAJI-YRZJJWOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7353932,DTCC00235252,1992802,46191
CHEMBL1042,P20309,CHOLECALCIFEROL,QYSXJUFSXHHAJI-YRZJJWOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7353933,DTCC00235252,1992802,46191
CHEMBL104210,P20309,,WMIQSPDXASFBFO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,457.09,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1604090,DTCC00274324,237689,16818
CHEMBL104332,P20309,,RAVGDLZWTLVAPH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,676.08,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1606517,DTCC00274628,1500359,16818
CHEMBL104574,P20309,,RNEMFGJTTJMEDD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,1380.38,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1606522,DTCC00274976,1947469,16818
CHEMBL1046,P20309,AMINOCAPROIC ACID,SLXKOJJOQWFEFD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299487,DTCC00237384,574618,46191
CHEMBL1046,P20309,AMINOCAPROIC ACID,SLXKOJJOQWFEFD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299488,DTCC00237384,574618,46191
CHEMBL104693,P20309,,COXRSODPRFBGSM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,100,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1638247,DTCC00274452,173278,16818
CHEMBL104700,P20309,,SCDKHPSUXHBJDJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478133,DTCC00272114,931177,48255
CHEMBL104803,P20309,,LEYDLUKDXKBMCP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,3090.3,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1628130,DTCC00274750,1947467,16818
CHEMBL104804,P20309,,ZNDQFSMTECRSAH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,2041.74,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1617926,DTCC00274751,1818372,16818
CHEMBL105,P20309,MITOMYCIN,NWIBSHFKIJFRCO-WUDYKRTCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430649,DTCC00143504,542580,46191
CHEMBL105,P20309,MITOMYCIN,NWIBSHFKIJFRCO-WUDYKRTCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430650,DTCC00143504,542580,46191
CHEMBL105122,P20309,,BLBSVEUIBHKGSO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,229.09,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1634436,DTCC00274610,76375,16818
CHEMBL105148,P20309,,OUVBYPZNWMJZAC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,91.2,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1607687,DTCC00274948,530297,16818
CHEMBL105160,P20309,,PUYDWHDEVFRQHJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,281.84,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1619195,DTCC00274323,1532750,16818
CHEMBL1054,P20309,TRICHLORMETHIAZIDE,LMJSLTNSBFUCMU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449082,DTCC00242621,2025646,46191
CHEMBL1054,P20309,TRICHLORMETHIAZIDE,LMJSLTNSBFUCMU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449083,DTCC00242621,2025646,46191
CHEMBL1055,P20309,CHLORTHALIDONE,JIVPVXMEBJLZRO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7345345,DTCC00242796,1798406,46191
CHEMBL1055,P20309,CHLORTHALIDONE,JIVPVXMEBJLZRO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7345346,DTCC00242796,1798406,46191
CHEMBL105593,P20309,,QVRAVHDSUQELII-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,5128.61,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1617921,DTCC00274319,1914852,16818
CHEMBL105674,P20309,,BRKQBHOIDPLFHE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,2754.23,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1626937,DTCC00274320,723967,16818
CHEMBL105945,P20309,,IBWCPVIKXQCSIK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,398.11,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1619190,DTCC00274657,1468029,16818
CHEMBL106,P20309,FLUCONAZOLE,RFHAOTPXVQNOHP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7303315,DTCC00143630,51470,46191
CHEMBL106,P20309,FLUCONAZOLE,RFHAOTPXVQNOHP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7303316,DTCC00143630,51470,46191
CHEMBL1062,P20309,HYDROXYPROGESTERONE,DBPWSSGDRRHUNT-CEGNMAFCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7315035,DTCC00245885,1092342,46191
CHEMBL1062,P20309,HYDROXYPROGESTERONE,DBPWSSGDRRHUNT-CEGNMAFCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7315036,DTCC00245885,1092342,46191
CHEMBL106218,P20309,,LSMMQGJPNNFZFL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,218.78,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1608905,DTCC00274422,1947468,16818
CHEMBL106219,P20309,,GCMYOOAJYOMGJH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,50.12,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1600058,DTCC00274423,1403707,16818
CHEMBL106224,P20309,,QHLINTGFIHRERO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,70.79,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1610198,DTCC00274502,723969,16818
CHEMBL106259,P20309,,KBGAIKLFNZYVGJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,15488.17,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1623054,DTCC00274752,1532749,16818
CHEMBL1064,P20309,SIMVASTATIN,RYMZZMVNJRMUDD-HGQWONQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7482226,DTCC00246331,217585,46191
CHEMBL1064,P20309,SIMVASTATIN,RYMZZMVNJRMUDD-HGQWONQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7482227,DTCC00246331,217585,46191
CHEMBL1065,P20309,METHYSERGIDE,KPJZHOPZRAFDTN-ZRGWGRIASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7406835,DTCC00246366,1124452,46191
CHEMBL1065,P20309,METHYSERGIDE,KPJZHOPZRAFDTN-ZRGWGRIASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7406836,DTCC00246366,1124452,46191
CHEMBL106505,P20309,,XVFUETUXJMLJLC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,1023.29,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1636824,DTCC00274661,433739,16818
CHEMBL1068,P20309,OXCARBAZEPINE,CTRLABGOLIVAIY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391002,DTCC00246694,1285880,46191
CHEMBL1068,P20309,OXCARBAZEPINE,CTRLABGOLIVAIY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391003,DTCC00246694,1285880,46191
CHEMBL1069,P20309,VALSARTAN,ACWBQPMHZXGDFX-QFIPXVFZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445710,DTCC00246716,1992811,46191
CHEMBL1069,P20309,VALSARTAN,ACWBQPMHZXGDFX-QFIPXVFZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445711,DTCC00246716,1992811,46191
CHEMBL107,P20309,COLCHICINE,IAKHMKGGTNLKSZ-INIZCTEOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7348123,DTCC00144185,153441,46191
CHEMBL107,P20309,COLCHICINE,IAKHMKGGTNLKSZ-INIZCTEOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7348124,DTCC00144185,153441,46191
CHEMBL1070,P20309,NABUMETONE,BLXXJMDCKKHMKV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7426575,DTCC00246857,1992808,46191
CHEMBL1070,P20309,NABUMETONE,BLXXJMDCKKHMKV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7426576,DTCC00246857,1992808,46191
CHEMBL1071,P20309,OXAPROZIN,OFPXSFXSNFPTHF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7386690,DTCC00246868,1092346,46191
CHEMBL1071,P20309,OXAPROZIN,OFPXSFXSNFPTHF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7386691,DTCC00246868,1092346,46191
CHEMBL1073,P20309,GLIPIZIDE,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327403,DTCC00246919,1285876,46191
CHEMBL1073,P20309,GLIPIZIDE,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327404,DTCC00246919,1285876,46191
CHEMBL107444,P20309,,IFGIZQGZVWYBFG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,912.01,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1628125,DTCC00274766,982408,16818
CHEMBL1076211,P20309,TOLPERISONE,FSKFPVLPFLJRQB-UHFFFAOYSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7481422,DTCC00627461,315671,46191
CHEMBL1076211,P20309,TOLPERISONE,FSKFPVLPFLJRQB-UHFFFAOYSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7481423,DTCC00627461,315671,46191
CHEMBL1076586,P20309,,APHXKHUFVKITGC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232497,DTCC00628883,1395765,37887
CHEMBL107679,P20309,,QTRFYRFDHGEFHT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,263.03,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1620539,DTCC00274767,1980414,16818
CHEMBL107680,P20309,,OYHIKVPEGKDTOV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,25703.96,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1602665,DTCC00274768,1435658,16818
CHEMBL1077,P20309,BROMFENAC,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7261725,DTCC00247634,930077,46191
CHEMBL1077,P20309,BROMFENAC,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7261726,DTCC00247634,930077,46191
CHEMBL1079079,P20309,,WGIPGQAPFNVWIX-XXFZXMJFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19767206,INHIBITION,<,50,%,,,,,,,,,,,,,,Displacement of [3H]QNB from Muscarinic acetylcholine receptor M3 at 10 uM by scintillation counting,,Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.,Bioorg. Med. Chem. Lett.,2009,19,21,"Donohue SR, Varnäs K, Jia Z, Gulyás B, Pike VW, Halldin C",,619817,DTCT0023280,3267824,DTCC00632772,857661,37697
CHEMBL108,P20309,CARBAMAZEPINE,FFGPTBGBLSHEPO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7263514,DTCC00144764,249939,46191
CHEMBL108,P20309,CARBAMAZEPINE,FFGPTBGBLSHEPO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7263515,DTCC00144764,249939,46191
CHEMBL1080155,P20309,,UPQNBHKMICCAIA-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232500,DTCC00628951,360780,37887
CHEMBL1080389,P20309,,MESZSUFNQDICOD-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232505,DTCC00629139,845782,37887
CHEMBL1080556,P20309,,ZMAZHOAGBMLOSO-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232506,DTCC00629140,1972518,37887
CHEMBL1080735,P20309,,CZUGKEKGXKWONC-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232507,DTCC00629141,1557015,37887
CHEMBL1080755,P20309,,MIJPHKXHAZCAQK-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232510,DTCC00629203,1428131,37887
CHEMBL1080907,P20309,,LADSERODBYZUAW-FQEVSTJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232508,DTCC00629142,619263,37887
CHEMBL1080926,P20309,,KFUNLUIORXHBPH-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232511,DTCC00629204,68682,37887
CHEMBL1081212,P20309,,WGTCBXOFOSMWEQ-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232504,DTCC00629053,1746137,37887
CHEMBL1081254,P20309,,ZALZZXXESRJJEH-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232509,DTCC00629202,1524928,37887
CHEMBL1081648,P20309,,YNLYAYGRKYOTBJ-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232498,DTCC00628885,133282,37887
CHEMBL1081649,P20309,,YNLYAYGRKYOTBJ-LJQANCHMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232499,DTCC00628886,1298076,37887
CHEMBL1082,P20309,AMOXICILLIN,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286162,DTCC00250356,51444,46191
CHEMBL1082,P20309,AMOXICILLIN,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286163,DTCC00250356,51444,46191
CHEMBL1082209,P20309,,MYYHPWVXRPLYMD-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232501,DTCC00629050,1428125,37887
CHEMBL1082210,P20309,,LGKIWGDJKNJYMG-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232502,DTCC00629051,1717622,37887
CHEMBL1082211,P20309,,GGUUYQBMWBFCFQ-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20137933,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,2010,20,5,"Yu M, Lizarzaburu M, Beckmann H, Connors R, Dai K, Haller K, Li C, Liang L, Lindstrom M, Ma J, Motani A, Wanska M, Zhang A, Li L, Medina JC",,615846,DTCT0023280,3232503,DTCC00629052,68680,37887
CHEMBL1082365,P20309,,MVPPAPVWAOWBNM-RBZFPXEDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,5011.87,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351616,DTCC00647214,1245019,39114
CHEMBL1082723,P20309,NITD609,CKLPLPZSUQEDRT-WPCRTTGESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20813948,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human recombinant muscarinic M3 receptor,,"Spiroindolones, a potent compound class for the treatment of malaria.",Science,2010,329,5996,"Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, González-Páez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT",,658568,DTCT0023280,3467845,DTCC00031143,1686650,40818
CHEMBL1083002,P20309,,XRFSBFDSFFGNLO-GOEBONIOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,10000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351604,DTCC00647156,80525,39114
CHEMBL1083003,P20309,,JGFRSSUKDACYEW-CXAGYDPISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,10000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351607,DTCC00647157,2049558,39114
CHEMBL1083108,P20309,,FYHNYIIANJTURE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483611,IC50,=,1000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,"2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.",Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635570,DTCT0023280,3354912,DTCC00647014,437862,39128
CHEMBL1083203,P20309,VU0366369,JCOKRGWZMBZKFO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20156687,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Potentiation of muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization up to 30 uM after 1 hr by FLIPR assay,Not Active,"Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAM.",Bioorg. Med. Chem. Lett.,2010,20,6,"Bridges TM, Phillip Kennedy J, Noetzel MJ, Breininger ML, Gentry PR, Jeffrey Conn P, Lindsley CW",,614481,DTCT0023280,3225181,DTCC00030625,1972551,38134
CHEMBL1083203,P20309,VU0366369,JCOKRGWZMBZKFO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23562060,EC50,>,30000,NM,,,,,,,,,,,,,,Positive allosteric modulation of human muscarinic M3 receptor,,"Discovery of ML326: The first sub-micromolar, selective M5 PAM.",Bioorg. Med. Chem. Lett.,2013,23,10,"Gentry PR, Bridges TM, Lamsal A, Vinson PN, Smith E, Chase P, Hodder PS, Engers JL, Niswender CM, Scott Daniels J, Jeffrey Conn P, Wood MR, Lindsley CW",,960034,DTCT0023280,12436495,DTCC00030625,1995531,54522
CHEMBL1083317,P20309,,WBOODGFYHYTNPC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,10000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351610,DTCC00647158,437863,39114
CHEMBL1083402,P20309,,XLNXEIMQNXKDGM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,19.95,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351577,DTCC00646999,209464,39114
CHEMBL1083403,P20309,,SFXHRHJZVXBMCV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351580,DTCC00647000,1439768,39114
CHEMBL1083404,P20309,,NAKZMBCUNDKEPL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,1258.93,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351583,DTCC00647001,2081681,39114
CHEMBL1083618,P20309,,MNXZAZYAHAQZFK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,3162.28,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351594,DTCC00647072,921882,39114
CHEMBL1083723,P20309,,CWSRXZGMHUIVTH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483611,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium level by FLIPR assay,Not Active,"2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.",Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635562,DTCT0023280,3354936,DTCC00646951,921881,39128
CHEMBL1083723,P20309,,CWSRXZGMHUIVTH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483611,IC50,=,251.19,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,"2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.",Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635570,DTCT0023280,3354908,DTCC00646951,921881,39128
CHEMBL1083911,P20309,,ZDSQJKATGRXWKZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,EC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351499,DTCC00647502,80532,39114
CHEMBL1083911,P20309,,ZDSQJKATGRXWKZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483611,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium level by FLIPR assay,Not Active,"2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.",Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635562,DTCT0023280,3354928,DTCC00647502,80528,39128
CHEMBL1083911,P20309,,ZDSQJKATGRXWKZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483611,EC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,"2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.",Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635570,DTCT0023280,3354810,DTCC00647502,80528,39128
CHEMBL1083925,P20309,,ARRNZUHFFUCBML-DZGCQCFKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium level by FLIPR assay,Not Active,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635224,DTCT0023280,3351631,DTCC00647070,889965,39114
CHEMBL1083925,P20309,,ARRNZUHFFUCBML-DZGCQCFKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,39.81,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351588,DTCC00647070,889965,39114
CHEMBL1083926,P20309,,ARRNZUHFFUCBML-ZFWWWQNUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,2511.89,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351591,DTCC00647071,241804,39114
CHEMBL1084804,P20309,,HQIXQFFDDIVACN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,125.89,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351567,DTCC00646933,1245014,39114
CHEMBL1084805,P20309,,UPEZSWRDIKOCFA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,PIC50,=,70,,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351570,DTCC00646934,566617,39114
CHEMBL1084850,P20309,,XFNFSPCSZMPISP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,2,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351552,DTCC00646856,1536874,39114
CHEMBL1084851,P20309,,SGNIBEHDIDGYPB-XVNBXDOJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,12.59,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351555,DTCC00646857,469592,39114
CHEMBL1084941,P20309,VU0365137,FZOKIVAOPLLMAV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20156687,ACTIVITY,=,25,%,,cell_based,,,,,,,,,,,CHO,Potentiation of muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization at 30 uM after 1 hr by FLIPR assay relative to acetylcholine,,"Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAM.",Bioorg. Med. Chem. Lett.,2010,20,6,"Bridges TM, Phillip Kennedy J, Noetzel MJ, Breininger ML, Gentry PR, Jeffrey Conn P, Lindsley CW",,614479,DTCT0023280,3225187,DTCC00030633,1717647,38134
CHEMBL1084941,P20309,VU0365137,FZOKIVAOPLLMAV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,2710,NM,,cell_based,,,,,,,,,,,PAM,PUBCHEM_BIOASSAY: Discovery of novel allosteric modulators of the M1 muscarinic receptor: PAM Calcium Assay Dose-Response with M3. Measurement of intracellular Ca2+ using Fluo-4 dye in CHO-K1 cells stably transfected with human M3 (Class of assay: confirmatory) ,Active,PUBCHEM BIOASSAY DATA SET,,,,,,,688283,DTCT0023280,4578456,DTCC00030633,1731643,33038
CHEMBL1084993,P20309,,COFVSAVKXZLUQG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483611,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium level by FLIPR assay,Not Active,"2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.",Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635562,DTCT0023280,3354940,DTCC00647087,1886831,39128
CHEMBL1084993,P20309,,COFVSAVKXZLUQG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483611,IC50,=,1258.93,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,"2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.",Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635570,DTCT0023280,3354916,DTCC00647087,1886831,39128
CHEMBL108545,P20309,METHYL SALICYLATE,OSWPMRLSEDHDFF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7419673,DTCC00280235,1705877,46191
CHEMBL108545,P20309,METHYL SALICYLATE,OSWPMRLSEDHDFF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7419674,DTCC00280235,1705877,46191
CHEMBL1085507,P20309,,HGCIAEDEQLOQDG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483611,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium level by FLIPR assay,Not Active,"2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.",Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635562,DTCT0023280,3354932,DTCC00647661,1277546,39128
CHEMBL1085507,P20309,,HGCIAEDEQLOQDG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483611,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,"2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR.",Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Foley JJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635570,DTCT0023280,3354904,DTCC00647661,1277546,39128
CHEMBL1085556,P20309,,KOWTVWBNPHVWND-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,1995.26,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351563,DTCC00646931,209463,39114
CHEMBL1085985,P20309,,QZHQGKPLHXJZRJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20483599,IC50,=,1258.93,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human muscarinic M3 receptor expressed in CHO cells,,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,2010,20,12,"Budzik B, Garzya V, Shi D, Walker G, Lauchart Y, Lucas AJ, Rivero RA, Langmead CJ, Watson J, Wu Z, Forbes IT, Jin J",,635228,DTCT0023280,3351613,DTCC00647159,112723,39114
CHEMBL1087,P20309,MEPIVACAINE,INWLQCZOYSRPNW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434290,DTCC00254348,1416035,46191
CHEMBL1087,P20309,MEPIVACAINE,INWLQCZOYSRPNW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434291,DTCC00254348,1416035,46191
CHEMBL1088,P20309,MESORIDAZINE,SLVMESMUVMCQIY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,90,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14733831,DTCC00254367,2105060,68417
CHEMBL1088775,P20309,,QVPKHRFTCWCWIQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297962,DTCC00637590,1854471,38385
CHEMBL1089,P20309,PHENELZINE,RMUCZJUITONUFY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374277,DTCC00254379,1188072,46191
CHEMBL1089,P20309,PHENELZINE,RMUCZJUITONUFY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374278,DTCC00254379,1188072,46191
CHEMBL1089453,P20309,,GFKUETCHMIRCOJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297961,DTCC00637523,1148766,38385
CHEMBL108947,P20309,DOTHIEPIN,PHTUQLWOUWZIMZ-BOPFTXTBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,38,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14758759,DTCC00278250,2111355,68567
CHEMBL1089771,P20309,,JZQVHVWLVCTLJZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297967,DTCC00637659,1244893,38385
CHEMBL109,P20309,VALPROIC ACID,NIJJYAXOARWZEE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443996,DTCC00144879,413980,46191
CHEMBL109,P20309,VALPROIC ACID,NIJJYAXOARWZEE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443997,DTCC00144879,413980,46191
CHEMBL1090094,P20309,,QKFHNOPORKWPCI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,=,3700,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297210,DTCC00634449,360852,38256
CHEMBL1090095,P20309,,BAQPYTMHDYMJTL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297211,DTCC00634450,1842913,38256
CHEMBL1090096,P20309,,SQRJOOHMAHJJTB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,=,4300,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297212,DTCC00634451,1874981,38256
CHEMBL1090097,P20309,,JQRLKSBFNGHMGT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,=,4200,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297213,DTCC00634452,101004,38256
CHEMBL1090103,P20309,,HCOCVIIDJMDWEZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297968,DTCC00637660,1083850,38385
CHEMBL1090104,P20309,,OHQQYIMZEFQMQZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297969,DTCC00637661,177139,38385
CHEMBL1090105,P20309,,NGHJNYKOMAXVNF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297970,DTCC00637662,502141,38385
CHEMBL1090106,P20309,,PJHLWBWESJUHAG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297971,DTCC00637663,1504412,38385
CHEMBL1090759,P20309,,ICPCKPPISUAYOH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,EC80,=,10000,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization at 10 uM,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625124,DTCT0023280,3297246,DTCC00634527,328253,38256
CHEMBL1090759,P20309,,ICPCKPPISUAYOH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297214,DTCC00634527,328253,38256
CHEMBL1091236,P20309,,CIJKWWGOTUIBJB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297977,DTCC00637816,1886718,38385
CHEMBL1091237,P20309,,HHIKSUGMZSRONC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297978,DTCC00637817,372693,38385
CHEMBL1091392,P20309,,YOOATANIHWAWIC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297965,DTCC00124978,1536753,38385
CHEMBL1091548,P20309,,SDCDPMVLBHJOLH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297992,DTCC00636916,986449,38385
CHEMBL1091611,P20309,,UOPFFROOWNZTBH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297991,DTCC00637955,39075,38385
CHEMBL1091967,P20309,,VTNZEILTURARBQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297982,DTCC00637884,340130,38385
CHEMBL1091968,P20309,,WIWJJEQYHCZEJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297983,DTCC00637885,1665828,38385
CHEMBL1092,P20309,TRIHEXYPHENIDYL HYDROCHLORIDE,QDWJJTJNXAKQKD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,26.3,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,522576,DTCC00256401,1849758,2697
CHEMBL1092430,P20309,,WXJVRYWRJJUUAM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297981,DTCC00637820,1601205,38385
CHEMBL1092460,P20309,,WKPWPQPLJKMEQY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,=,5600,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297207,DTCC00635604,1039407,38256
CHEMBL1092461,P20309,,UPEXLJSFWIFHBM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297208,DTCC00635605,1778155,38256
CHEMBL1092849,P20309,,MVRPGBDUYQGYFE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297963,DTCC00637591,2049449,38385
CHEMBL1092987,P20309,,STVHKOSRRHWCDH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297972,DTCC00637719,1918754,38385
CHEMBL1092988,P20309,,XWXOZNSDTJGFSF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297973,DTCC00637720,1342804,38385
CHEMBL1092989,P20309,,LZGUJTKKQCIPJG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297974,DTCC00637721,1148770,38385
CHEMBL1093022,P20309,,BZOZCYUAJYUGMM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297990,DTCC00637954,824810,38385
CHEMBL1093126,P20309,,ZLGFFOIACZAPJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297964,DTCC00637592,209362,38385
CHEMBL1093127,P20309,,ZZGUJHFBBMPAKM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297966,DTCC00637593,1083848,38385
CHEMBL1093224,P20309,,QVVGDJPNAHSEMW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297975,DTCC00637722,1179671,38385
CHEMBL1093238,P20309,,ILHDWRROLWPCJE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297976,DTCC00637723,469477,38385
CHEMBL1093482,P20309,,FLAPGGIPKPXUDP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297987,DTCC00637951,1407804,38385
CHEMBL1093483,P20309,,XYGZCUVDNQIUGP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297988,DTCC00637952,1310237,38385
CHEMBL1093538,P20309,,VXFLYKWETSEHQD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297979,DTCC00637818,1633540,38385
CHEMBL1093539,P20309,,NUTZYNZCZPEGHK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297980,DTCC00637819,372694,38385
CHEMBL1093775,P20309,,DBPDHFWBWJNZSI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297209,DTCC00634448,1200417,38256
CHEMBL1093810,P20309,,PNBINKNETGHVFJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297989,DTCC00637953,1342808,38385
CHEMBL1093894,P20309,,DDBOMNKUQLLIBU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297984,DTCC00637886,1211892,38385
CHEMBL1093895,P20309,,QQMHKRBBNSTPEB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297985,DTCC00637887,889858,38385
CHEMBL1093896,P20309,,VXVFFFFZJJDWBG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297986,DTCC00637888,1886719,38385
CHEMBL1093933,P20309,,HIFXMAOMJYCUPQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297215,DTCC00634528,1428183,38256
CHEMBL1094003,P20309,,JFBTWUTWFGXZLY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,=,820,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297206,DTCC00635603,1006994,38256
CHEMBL1094208,P20309,"1-(2,3-DICHLOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",SGKVPHOMCZNDPT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631440,DTCT0023280,3337733,DTCC00642251,1232809,38666
CHEMBL1094209,P20309,,HOMRLSWXGFQYGM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631440,DTCT0023280,3337729,DTCC00642252,1746259,38666
CHEMBL1094231,P20309,"1-(3-CHLORO-4-FLUOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",DAXGWLCLIPNRDH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631440,DTCT0023280,3337730,DTCC00642205,133424,38666
CHEMBL1094514,P20309,,FQPJRGDRIOAJCS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631440,DTCT0023280,3337732,DTCC00642303,683992,38666
CHEMBL1095699,P20309,AZASERINE,MZZGOOYMKKIOOX-VKHMYHEASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259581,DTCC00644151,1960073,46191
CHEMBL1095699,P20309,AZASERINE,MZZGOOYMKKIOOX-VKHMYHEASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259582,DTCC00644151,1960073,46191
CHEMBL1096467,P20309,,DXRCWRDHBIVBIS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20427184,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010,20,10,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631440,DTCT0023280,3337731,DTCC00642302,1746261,38666
CHEMBL1098230,P20309,,PQPVHIHIJVIEQG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20384344,KI,>,1000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.,J. Med. Chem.,2010,53,9,"Ishikawa M, Shinei R, Yokoyama F, Yamauchi M, Oyama M, Okuma K, Nagayama T, Kato K, Kakui N, Sato Y",,630139,DTCT0023280,3336758,DTCC00641534,631300,38886
CHEMBL11,P20309,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,60,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14755641,DTCC00132703,2110621,68567
CHEMBL1101,P20309,BIPERIDEN,YSXKPIUOCJLQIE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,3.9,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14736891,DTCC00257029,2106123,68417
CHEMBL1103,P20309,FURAZOLIDONE,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7318599,DTCC00257236,1512809,46191
CHEMBL1103,P20309,FURAZOLIDONE,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7318600,DTCC00257236,1512809,46191
CHEMBL1105,P20309,6-METHOXY-2-NAPHTHYLACETIC ACID,PHJFLPMVEFKEPL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7280998,DTCC00257334,1830683,46191
CHEMBL1105,P20309,6-METHOXY-2-NAPHTHYLACETIC ACID,PHJFLPMVEFKEPL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7280999,DTCC00257334,1830683,46191
CHEMBL110691,P20309,CHLORMADINONE ACETATE,QMBJSIBWORFWQT-DFXBJWIESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7353847,DTCC00283843,217574,46191
CHEMBL110691,P20309,CHLORMADINONE ACETATE,QMBJSIBWORFWQT-DFXBJWIESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7353848,DTCC00283843,217574,46191
CHEMBL1108,P20309,DROPERIDOL,RMEDXOLNCUSCGS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7334429,DTCC00258432,542573,46191
CHEMBL1108,P20309,DROPERIDOL,RMEDXOLNCUSCGS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7334430,DTCC00258432,542573,46191
CHEMBL11081,P20309,,HWYHDWGGACRVEH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,48,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1135652,DTCC00139125,2035170,10523
CHEMBL11081,P20309,,HWYHDWGGACRVEH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,88.8,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1135653,DTCC00139125,2035170,10523
CHEMBL1109,P20309,SULFAPHENAZOLE,QWCJHSGMANYXCW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7471885,DTCC00258904,1544901,46191
CHEMBL1109,P20309,SULFAPHENAZOLE,QWCJHSGMANYXCW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7471886,DTCC00258904,1544901,46191
CHEMBL1110,P20309,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288589,DTCC00258915,1318437,46191
CHEMBL1110,P20309,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288590,DTCC00258915,1318437,46191
CHEMBL1112,P20309,ARIPIPRAZOLE,CEUORZQYGODEFX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,4677,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14756437,DTCC00106550,2110885,68826
CHEMBL1112,P20309,ARIPIPRAZOLE,CEUORZQYGODEFX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12784105,KI,=,4680,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14756438,DTCC00106550,2110875,69826
CHEMBL1112,P20309,ARIPIPRAZOLE,CEUORZQYGODEFX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329745,DTCT0023280,13584609,DTCC00106550,1580612,39761
CHEMBL1113,P20309,AMOXAPINE,QWGDMFLQWFTERH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,1781,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283227,DTCC00260398,1059327,46191
CHEMBL1113,P20309,AMOXAPINE,QWGDMFLQWFTERH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,378,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283228,DTCC00260398,1059327,46191
CHEMBL111639,P20309,FLUOROCARAZOLOL,QHLGXPUIUKSADT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11512051,KI,=,1590,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14736654,DTCC00281815,2106040,69642
CHEMBL111639,P20309,FLUOROCARAZOLOL,QHLGXPUIUKSADT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11512051,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14736655,DTCC00281815,2106040,69642
CHEMBL1117,P20309,IDARUBICIN,XDXDZDZNSLXDNA-TZNDIEGXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327841,DTCC00263156,153444,46191
CHEMBL1117,P20309,IDARUBICIN,XDXDZDZNSLXDNA-TZNDIEGXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327842,DTCC00263156,153444,46191
CHEMBL1118,P20309,DESVENLAFAXINE,KYYIDSXMWOZKMP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16675639,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14739351,DTCC00265702,2107016,69000
CHEMBL111861,P20309,CORTISONE,LPYXTAPPNYMYOP-XDBTXSBWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7361038,DTCC00283836,671786,46191
CHEMBL111861,P20309,CORTISONE,LPYXTAPPNYMYOP-XDBTXSBWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7361039,DTCC00283836,671786,46191
CHEMBL112,P20309,ACETAMINOPHEN,RZVAJINKPMORJF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7300429,DTCC00145865,1544892,46191
CHEMBL112,P20309,ACETAMINOPHEN,RZVAJINKPMORJF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7300430,DTCC00145865,1544892,46191
CHEMBL1123,P20309,DICYCLOMINE,CURUTKGFNZGFSE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,4.38,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7350933,DTCC00269590,1798408,46191
CHEMBL1123,P20309,DICYCLOMINE,CURUTKGFNZGFSE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.927,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7350934,DTCC00269590,1798408,46191
CHEMBL113,P20309,CAFFEINE,RYYVLZVUVIJVGH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7264837,DTCC00145890,51450,46191
CHEMBL113,P20309,CAFFEINE,RYYVLZVUVIJVGH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7264838,DTCC00145890,51450,46191
CHEMBL1130,P20309,DOXIFLURIDINE,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7317331,DTCC00272346,1124449,46191
CHEMBL1130,P20309,DOXIFLURIDINE,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7317332,DTCC00272346,1124449,46191
CHEMBL114,P20309,SAQUINAVIR,QWAXKHKRTORLEM-UGJKXSETSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475493,DTCC00146405,703985,46191
CHEMBL114,P20309,SAQUINAVIR,QWAXKHKRTORLEM-UGJKXSETSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475494,DTCC00146405,703985,46191
CHEMBL1140,P20309,NIACINAMIDE,DFPAKSUCGFBDDF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392588,DTCC00277524,800582,46191
CHEMBL1140,P20309,NIACINAMIDE,DFPAKSUCGFBDDF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392589,DTCC00277524,800582,46191
CHEMBL1144,P20309,PRAVASTATIN,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378920,DTCC00280505,413976,46191
CHEMBL1144,P20309,PRAVASTATIN,TUZYXOIXSAXUGO-PZAWKZKUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378921,DTCC00280505,413976,46191
CHEMBL1148,P20309,TORSEMIDE,NGBFQHCMQULJNZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7455391,DTCC00281790,1830692,46191
CHEMBL1148,P20309,TORSEMIDE,NGBFQHCMQULJNZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7455392,DTCC00281790,1830692,46191
CHEMBL1149,P20309,LEVOCARNITINE,PHIQHXFUZVPYII-ZCFIWIBFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420919,DTCC00283052,51485,46191
CHEMBL1149,P20309,LEVOCARNITINE,PHIQHXFUZVPYII-ZCFIWIBFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420920,DTCC00283052,51485,46191
CHEMBL115,P20309,INDINAVIR,CBVCZFGXHXORBI-PXQQMZJSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7426627,DTCC00146406,51478,46191
CHEMBL115,P20309,INDINAVIR,CBVCZFGXHXORBI-PXQQMZJSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7426628,DTCC00146406,51478,46191
CHEMBL115769,P20309,RWJ-68354,ADQZGIYHFQQPRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466641,DTCC01742367,2057653,46191
CHEMBL115769,P20309,RWJ-68354,ADQZGIYHFQQPRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466642,DTCC01742367,2057653,46191
CHEMBL1159650,P20309,CLOBETASOL PROPIONATE,CBGUOGMQLZIXBE-XGQKBEPLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7352183,DTCC00648029,703979,46191
CHEMBL1159650,P20309,CLOBETASOL PROPIONATE,CBGUOGMQLZIXBE-XGQKBEPLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7352184,DTCC00648029,703979,46191
CHEMBL116,P20309,AMPRENAVIR,YMARZQAQMVYCKC-OEMFJLHTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296972,DTCC00146541,833155,46191
CHEMBL116,P20309,AMPRENAVIR,YMARZQAQMVYCKC-OEMFJLHTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296973,DTCC00146541,833155,46191
CHEMBL1160977,P20309,,TXZJWJKTYUNDIE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,457.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1631668,DTCC00649063,1403963,15558
CHEMBL1160977,P20309,,TXZJWJKTYUNDIE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,521.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1602529,DTCC00649063,1403965,15558
CHEMBL1160977,P20309,,TXZJWJKTYUNDIE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,630.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1610065,DTCC00649063,1403964,15558
CHEMBL1162,P20309,NORETHINDRONE,VIKNJXKGJWUCNN-XGXHKTLJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7384193,DTCC00288264,510305,46191
CHEMBL1162,P20309,NORETHINDRONE,VIKNJXKGJWUCNN-XGXHKTLJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7384194,DTCC00288264,510305,46191
CHEMBL1162116,P20309,,MAGHIFWNWZHPQG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13679167,KI,=,109.65,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14739094,DTCC00649922,2106912,68421
CHEMBL116590,P20309,,GIJXKZJWITVLHI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,1.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14744555,DTCC00292530,2108760,68417
CHEMBL116601,P20309,,VBJUABDIUTZBTD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,918,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1622976,DTCC00297023,336270,15558
CHEMBL1167,P20309,SPECTINOMYCIN,UNFWWIHTNXNPBV-WXKVUWSESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7482370,DTCC00289197,249944,46191
CHEMBL1167,P20309,SPECTINOMYCIN,UNFWWIHTNXNPBV-WXKVUWSESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7482371,DTCC00289197,249944,46191
CHEMBL1168,P20309,RAMIPRIL,HDACQVRGBOVJII-JBDAPHQKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483640,DTCC00289284,1765979,46191
CHEMBL1168,P20309,RAMIPRIL,HDACQVRGBOVJII-JBDAPHQKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483641,DTCC00289284,1765979,46191
CHEMBL1169,P20309,AMINOSALICYLIC ACID,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288807,DTCC00290367,671785,46191
CHEMBL1169,P20309,AMINOSALICYLIC ACID,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288808,DTCC00290367,671785,46191
CHEMBL1171434,P20309,,XVOYSCVBGLVSOL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14737617,DTCC00655109,2106368,69159
CHEMBL1172,P20309,DESLORATADINE,JAUOIFJMECXRGI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,446,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7359357,DTCC00291020,1674143,46191
CHEMBL1172,P20309,DESLORATADINE,JAUOIFJMECXRGI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,95,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7359358,DTCC00291020,1674143,46191
CHEMBL117405,P20309,S(-)-PINDOLOL,JZQKKSLKJUAGIC-NSHDSACASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7289038,DTCC01742455,1992798,46191
CHEMBL117405,P20309,S(-)-PINDOLOL,JZQKKSLKJUAGIC-NSHDSACASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7289039,DTCC01742455,1992798,46191
CHEMBL1177,P20309,PEMOLINE,NRNCYVBFPDDJNE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7393332,DTCC00292515,1576126,46191
CHEMBL1177,P20309,PEMOLINE,NRNCYVBFPDDJNE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7393333,DTCC00292515,1576126,46191
CHEMBL118,P20309,CELECOXIB,RZEKVGVHFLEQIL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355774,DTCC01738574,51454,46191
CHEMBL118,P20309,CELECOXIB,RZEKVGVHFLEQIL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355775,DTCC01738574,51454,46191
CHEMBL1180284,P20309,,MVGKVQYNQPRWCV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,IC50,=,5524,NM,,cell_based,,,,,,,,,,,,Binding affinity to human M3 muscarinic receptor expressed in cell membranes by radioligand binding assay,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936422,DTCT0023280,11761567,DTCC00659275,1462534,53451
CHEMBL1180285,P20309,,VQMYCZUUGWZZTK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,IC50,=,88,NM,,cell_based,,,,,,,,,,,,Binding affinity to human M3 muscarinic receptor expressed in cell membranes by radioligand binding assay,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936422,DTCT0023280,11761566,DTCC00659276,363254,53451
CHEMBL1180343,P20309,,ZPASGLGRGIEHTG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,IC50,=,52496,NM,,cell_based,,,,,,,,,,,,Binding affinity to human M3 muscarinic receptor expressed in cell membranes by radioligand binding assay,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936422,DTCT0023280,11761568,DTCC00659336,71014,53451
CHEMBL1180343,P20309,,ZPASGLGRGIEHTG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,1370,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936173,DTCT0023280,11759530,DTCC00659336,71014,53451
CHEMBL118241,P20309,,NMBIPAUSMWERKN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,675.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1601114,DTCC00296801,853792,15558
CHEMBL1182657,P20309,TIOTROPIUM,LERNTVKEWCAPOY-USXSHJJOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.0316,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126129,DTCC00661559,1076091,62168
CHEMBL1182657,P20309,TIOTROPIUM,LERNTVKEWCAPOY-USXSHJJOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,>,22.87,HR,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573408,DTCC00661559,1077556,63971
CHEMBL1184,P20309,ACETYLCHOLINE CHLORIDE,JUGOREOARAHOCO-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,ACTIVITY,=,16,/S,,cell_based,,,,,,,,,,,HEK293,Agonist activity at M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as rate constant at 100 uM to 1 mM by FRET method,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723359,DTCT0023280,5123004,DTCC00294982,361493,43500
CHEMBL1184,P20309,ACETYLCHOLINE CHLORIDE,JUGOREOARAHOCO-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,EC50,=,220,NM,,cell_based,,,,,,,,,,,HEK293,Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723353,DTCT0023280,5122981,DTCC00294982,361493,43500
CHEMBL1184,P20309,ACETYLCHOLINE CHLORIDE,JUGOREOARAHOCO-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,TIME,=,62.4,MS,,cell_based,,,,,,,,,,,HEK293,Agonist activity at M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as half-maximal activation time at 100 uM to 1 mM by FRET method,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723356,DTCT0023280,5122993,DTCC00294982,361493,43500
CHEMBL1185,P20309,ZOLMITRIPTAN,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7658443,P[A50],<,4.5,,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3 using rabbit saphenous vein assay.,,Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties.,J. Med. Chem.,1995,38,18,"Glen RC, Martin GR, Hill AP, Hyde RM, Woollard PM, Salmon JA, Buckingham J, Robertson AD",,138840,DTCT0023280,369345,DTCC00295192,205474,13218
CHEMBL118553,P20309,,FBXWZYGGXYSJHT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,24861.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1617804,DTCC00297025,1014977,15558
CHEMBL1187846,P20309,SCOPOLAMINE,STECJAGHUSJQJN-ODICJLLRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,6.5,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936173,DTCT0023280,11759531,DTCC00666582,1591753,53451
CHEMBL1189234,P20309,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,336,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11474389,DTCC00667938,1780157,51935
CHEMBL1189234,P20309,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,336,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12601231,DTCC00667938,1780916,55935
CHEMBL1191,P20309,SULFAMETHIZOLE,VACCAVUAMIDAGB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458740,DTCC00301538,1577010,46191
CHEMBL1191,P20309,SULFAMETHIZOLE,VACCAVUAMIDAGB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458741,DTCC00301538,1577010,46191
CHEMBL1191560,P20309,,OMADIDFKVYFXIO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,243,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417725,DTCC00670190,525282,54418
CHEMBL119385,P20309,VX-745,VEPKQEUBKLEPRA-UHFFFAOYSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447694,DTCC00293200,1092352,46191
CHEMBL119385,P20309,VX-745,VEPKQEUBKLEPRA-UHFFFAOYSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447695,DTCC00293200,1092352,46191
CHEMBL1194,P20309,PRILOCAINE,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404858,DTCC00305352,898295,46191
CHEMBL1194,P20309,PRILOCAINE,MVFGUOIZUNYYSO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404859,DTCC00305352,898295,46191
CHEMBL119443,P20309,ERGONOVINE,WVVSZNPYNCNODU-XTQGRXLLSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7328245,DTCC00295305,1798410,46191
CHEMBL119443,P20309,ERGONOVINE,WVVSZNPYNCNODU-XTQGRXLLSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7328246,DTCC00295305,1798410,46191
CHEMBL1196,P20309,PROPARACAINE,KCLANYCVBBTKTO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7394324,DTCC00305570,1927021,46191
CHEMBL1196,P20309,PROPARACAINE,KCLANYCVBBTKTO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7394325,DTCC00305570,1927021,46191
CHEMBL1198,P20309,PRAMOXINE,DQKXQSGTHWVTAD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374628,DTCC00305773,1674146,46191
CHEMBL1198,P20309,PRAMOXINE,DQKXQSGTHWVTAD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374629,DTCC00305773,1674146,46191
CHEMBL12,P20309,DIAZEPAM,AAOVKJBEBIDNHE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7363750,DTCC00132806,51463,46191
CHEMBL12,P20309,DIAZEPAM,AAOVKJBEBIDNHE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7363751,DTCC00132806,51463,46191
CHEMBL1200391,P20309,TROMETHAMINE,LENZDBCJOHFCAS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7451070,DTCC00678381,1092351,46191
CHEMBL1200391,P20309,TROMETHAMINE,LENZDBCJOHFCAS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7451071,DTCC00678381,1092351,46191
CHEMBL1200396,P20309,BUPIVACAINE HYDROCHLORIDE,SIEYLFHKZGLBNX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258897,DTCC00678386,1155677,46191
CHEMBL1200396,P20309,BUPIVACAINE HYDROCHLORIDE,SIEYLFHKZGLBNX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258898,DTCC00678386,1155677,46191
CHEMBL1200406,P20309,DIMENHYDRINATE,NFLLKCVHYJRNRH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,447,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7366211,DTCC00678394,736259,46191
CHEMBL1200406,P20309,DIMENHYDRINATE,NFLLKCVHYJRNRH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,95,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7366212,DTCC00678394,736259,46191
CHEMBL1200431,P20309,GADOPENTETATE DIMEGLUMINE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331445,DTCC00678414,1544899,46191
CHEMBL1200431,P20309,GADOPENTETATE DIMEGLUMINE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331446,DTCC00678414,1544899,46191
CHEMBL1200528,P20309,CHROMIC CHLORIDE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371348,DTCC00678493,1447878,46191
CHEMBL1200528,P20309,CHROMIC CHLORIDE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371349,DTCC00678493,1447878,46191
CHEMBL1200545,P20309,DIFLORASONE DIACETATE,BOBLHFUVNSFZPJ-JOYXJVLSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7366130,DTCC00678506,1734055,46191
CHEMBL1200545,P20309,DIFLORASONE DIACETATE,BOBLHFUVNSFZPJ-JOYXJVLSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7366131,DTCC00678506,1734055,46191
CHEMBL1200558,P20309,BACITRACIN,CLKOFPXJLQSYAH-ABRJDSQDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258132,DTCC00678469,1734054,46191
CHEMBL1200558,P20309,BACITRACIN,CLKOFPXJLQSYAH-ABRJDSQDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258133,DTCC00678469,1734054,46191
CHEMBL1200559,P20309,LACTIC ACID,JVTAAEKCZFNVCJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437729,DTCC00678516,1124450,46191
CHEMBL1200559,P20309,LACTIC ACID,JVTAAEKCZFNVCJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437730,DTCC00678516,1124450,46191
CHEMBL1200585,P20309,OXYMETHOLONE,ICMWWNHDUZJFDW-DHODBPELSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7380238,DTCC00678533,1577006,46191
CHEMBL1200585,P20309,OXYMETHOLONE,ICMWWNHDUZJFDW-DHODBPELSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7380239,DTCC00678533,1577006,46191
CHEMBL1200600,P20309,FLUOROMETHOLONE,FAOZLTXFLGPHNG-KNAQIMQKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7316283,DTCC00678548,1027053,46191
CHEMBL1200600,P20309,FLUOROMETHOLONE,FAOZLTXFLGPHNG-KNAQIMQKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7316284,DTCC00678548,1027053,46191
CHEMBL1200604,P20309,TROPICAMIDE,BGDKAVGWHJFAGW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,142,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7452933,DTCC00678551,1416038,46191
CHEMBL1200604,P20309,TROPICAMIDE,BGDKAVGWHJFAGW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,30,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7452934,DTCC00678551,1416038,46191
CHEMBL1200623,P20309,ETHYLESTRENOL,AOXRBFRFYPMWLR-XGXHKTLJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7317909,DTCC00678568,1544897,46191
CHEMBL1200623,P20309,ETHYLESTRENOL,AOXRBFRFYPMWLR-XGXHKTLJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7317910,DTCC00678568,1544897,46191
CHEMBL1200624,P20309,ETHYNODIOL DIACETATE,ONKUMRGIYFNPJW-KIEAKMPYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7322143,DTCC00678569,88628,46191
CHEMBL1200624,P20309,ETHYNODIOL DIACETATE,ONKUMRGIYFNPJW-KIEAKMPYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7322144,DTCC00678569,88628,46191
CHEMBL1200629,P20309,VECURONIUM BROMIDE,VEPSYABRBFXYIB-PWXDFCLTSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449445,DTCC00678574,703989,46191
CHEMBL1200629,P20309,VECURONIUM BROMIDE,VEPSYABRBFXYIB-PWXDFCLTSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449446,DTCC00678574,703989,46191
CHEMBL1200633,P20309,IVERMECTIN,SPBDXSGPUHCETR-JFUDTMANSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,6062.6,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416309,DTCC00678578,606970,46191
CHEMBL1200633,P20309,IVERMECTIN,SPBDXSGPUHCETR-JFUDTMANSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1285,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416310,DTCC00678578,606970,46191
CHEMBL1200656,P20309,NATAMYCIN,NCXMLFZGDNKEPB-FFPOYIOWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383011,DTCC00678594,1351116,46191
CHEMBL1200656,P20309,NATAMYCIN,NCXMLFZGDNKEPB-FFPOYIOWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383012,DTCC00678594,1351116,46191
CHEMBL1200679,P20309,ZINC CHLORIDE,JIAARYAFYJHUJI-UHFFFAOYSA-L,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7450602,DTCC00678612,315674,46191
CHEMBL1200679,P20309,ZINC CHLORIDE,JIAARYAFYJHUJI-UHFFFAOYSA-L,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7450603,DTCC00678612,315674,46191
CHEMBL1200693,P20309,MANGANESE CHLORIDE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434085,DTCC00678623,671789,46191
CHEMBL1200693,P20309,MANGANESE CHLORIDE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434086,DTCC00678623,671789,46191
CHEMBL1200709,P20309,CROTAMITON,DNTGGZPQPQTDQF-XBXARRHUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7343984,DTCC00678636,1188066,46191
CHEMBL1200709,P20309,CROTAMITON,DNTGGZPQPQTDQF-XBXARRHUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7343985,DTCC00678636,1188066,46191
CHEMBL1200748,P20309,CARBIDOPA,QTAOMKOIBXZKND-PPHPATTJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479729,DTCC00678662,606973,46191
CHEMBL1200748,P20309,CARBIDOPA,QTAOMKOIBXZKND-PPHPATTJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479730,DTCC00678662,606973,46191
CHEMBL120080,P20309,,JXFMNHZWZPYJBA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,86.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1617770,DTCC00107411,1112627,15558
CHEMBL1200803,P20309,SOLIFENACIN SUCCINATE,RXZMMZZRUPYENV-VROPFNGYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,130.8,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964100,DTCC00678711,476771,44627
CHEMBL1200845,P20309,HALCINONIDE,MUQNGPZZQDCDFT-JNQJZLCISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331916,DTCC00678745,1765972,46191
CHEMBL1200845,P20309,HALCINONIDE,MUQNGPZZQDCDFT-JNQJZLCISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331917,DTCC00678745,1765972,46191
CHEMBL1200862,P20309,METYROSINE,NHTGHBARYWONDQ-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7432624,DTCC00678758,88631,46191
CHEMBL1200862,P20309,METYROSINE,NHTGHBARYWONDQ-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7432625,DTCC00678758,88631,46191
CHEMBL1200993,P20309,GALLAMINE TRIETHIODIDE,REEUVFCVXKWOFE-UHFFFAOYSA-K,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7305879,DTCC00678870,381013,46191
CHEMBL1200993,P20309,GALLAMINE TRIETHIODIDE,REEUVFCVXKWOFE-UHFFFAOYSA-K,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7307895,DTCC00678870,381013,46191
CHEMBL1201,P20309,THIOTHIXENE,GFBKORZTTCHDGY-UWVJOHFNSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,1600,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14735522,DTCC00107669,2105676,68417
CHEMBL1201010,P20309,FLUDROCORTISONE ACETATE,SYWHXTATXSMDSB-GSLJADNHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7316187,DTCC00678884,381011,46191
CHEMBL1201010,P20309,FLUDROCORTISONE ACETATE,SYWHXTATXSMDSB-GSLJADNHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7316188,DTCC00678884,381011,46191
CHEMBL1201012,P20309,FLURANDRENOLIDE,POPFMWWJOGLOIF-XWCQMRHXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331307,DTCC00678886,381012,46191
CHEMBL1201012,P20309,FLURANDRENOLIDE,POPFMWWJOGLOIF-XWCQMRHXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331308,DTCC00678886,381012,46191
CHEMBL1201024,P20309,METHSCOPOLAMINE BROMIDE,CXYRUNPLKGGUJF-XKTSLVMZSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,1.13,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411021,DTCC00678896,1059334,46191
CHEMBL1201024,P20309,METHSCOPOLAMINE BROMIDE,CXYRUNPLKGGUJF-XKTSLVMZSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.239,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411022,DTCC00678896,1059334,46191
CHEMBL1201027,P20309,GLYCOPYRROLATE BROMIDE,VPNYRYCIDCJBOM-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605545,DTCC00678898,469998,42029
CHEMBL120109,P20309,,LQHWLESHMQULFK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,5523.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1603885,DTCC00297433,1306309,15558
CHEMBL1201117,P20309,METHOCARBAMOL,GNXFOGHNGIVQEH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7432390,DTCC00678968,800581,46191
CHEMBL1201117,P20309,METHOCARBAMOL,GNXFOGHNGIVQEH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7432391,DTCC00678968,800581,46191
CHEMBL1201139,P20309,MEGESTROL ACETATE,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412835,DTCC00678986,639582,46191
CHEMBL1201139,P20309,MEGESTROL ACETATE,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412836,DTCC00678986,639582,46191
CHEMBL1201146,P20309,NORETHINDRONE ACETATE,IMONTRJLAWHYGT-ZCPXKWAGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388549,DTCC00678989,703984,46191
CHEMBL1201146,P20309,NORETHINDRONE ACETATE,IMONTRJLAWHYGT-ZCPXKWAGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388550,DTCC00678989,703984,46191
CHEMBL1201151,P20309,MESTRANOL,IMSSROKUHAOUJS-MJCUULBUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412948,DTCC00678994,542579,46191
CHEMBL1201151,P20309,MESTRANOL,IMSSROKUHAOUJS-MJCUULBUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412949,DTCC00678994,542579,46191
CHEMBL120119,P20309,,NHSMMNPCZQYXDK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,88.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1630632,DTCC00297376,368944,15558
CHEMBL1201193,P20309,LEVOBUPIVACAINE,LEBVLXFERQHONN-INIZCTEOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416636,DTCC00679027,282998,46191
CHEMBL1201193,P20309,LEVOBUPIVACAINE,LEBVLXFERQHONN-INIZCTEOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416637,DTCC00679027,282998,46191
CHEMBL1201195,P20309,CEFMETAZOLE,SNBUBQHDYVFSQF-HIFRSBDPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7347181,DTCC00679029,833158,46191
CHEMBL1201195,P20309,CEFMETAZOLE,SNBUBQHDYVFSQF-HIFRSBDPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7347182,DTCC00679029,833158,46191
CHEMBL1201203,P20309,BENZTROPINE,GIJXKZJWITVLHI-PMOLBWCYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,1.29,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276995,DTCC00679037,1609543,46191
CHEMBL1201203,P20309,BENZTROPINE,GIJXKZJWITVLHI-PMOLBWCYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.272,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276996,DTCC00679037,1609543,46191
CHEMBL1201207,P20309,BETAMETHASONE PHOSPHORIC ACID,VQODGRNSFPNSQE-DVTGEIKXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,6429,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7280081,DTCC00679040,444634,46191
CHEMBL1201207,P20309,BETAMETHASONE PHOSPHORIC ACID,VQODGRNSFPNSQE-DVTGEIKXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1363,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7280082,DTCC00679040,444634,46191
CHEMBL1201216,P20309,DAPIPRAZOLE,RFWZESUMWJKKRN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7342164,DTCC00679045,1544895,46191
CHEMBL1201216,P20309,DAPIPRAZOLE,RFWZESUMWJKKRN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7342165,DTCC00679045,1544895,46191
CHEMBL1201220,P20309,DIATRIZOIC ACID,YVPYQUNUQOZFHG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7359455,DTCC00679049,444639,46191
CHEMBL1201220,P20309,DIATRIZOIC ACID,YVPYQUNUQOZFHG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7359456,DTCC00679049,444639,46191
CHEMBL1201237,P20309,LEVOBUNOLOL,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412272,DTCC00679063,736261,46191
CHEMBL1201237,P20309,LEVOBUNOLOL,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412273,DTCC00679063,736261,46191
CHEMBL1201325,P20309,HEXOCYCLIUM,ZRYHPQCHHOKSMD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2704370,KI,=,1.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14735661,DTCC00679118,2105724,68413
CHEMBL1201335,P20309,GLYCOPYRROLATE,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542763,DTCC00679124,1512932,46625
CHEMBL1201335,P20309,GLYCOPYRROLATE,ANGKOCUUWGHLCE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.126,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940976,DTCC00679124,1495635,56408
CHEMBL1201346,P20309,BALSALAZID,IPOKCKJONYRRHP-FMQUCBEESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7263992,DTCC00679132,1512805,46191
CHEMBL1201346,P20309,BALSALAZID,IPOKCKJONYRRHP-FMQUCBEESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7263993,DTCC00679132,1512805,46191
CHEMBL120135,P20309,,WCEJBLSHLNKAQO-OALUTQOASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,2551.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1608737,DTCC00297225,1818632,15558
CHEMBL1201353,P20309,DEXCHLORPHENIRAMINE,SOYKEARSMXGVTM-HNNXBMFYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,2579,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7337929,DTCC00679137,185552,46191
CHEMBL1201353,P20309,DEXCHLORPHENIRAMINE,SOYKEARSMXGVTM-HNNXBMFYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,547,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7337930,DTCC00679137,185552,46191
CHEMBL1201356,P20309,METHYLERGONOVINE,UNBRKDKAWYKMIV-QWQRMKEZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7428238,DTCC00679140,1124451,46191
CHEMBL1201356,P20309,METHYLERGONOVINE,UNBRKDKAWYKMIV-QWQRMKEZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7428239,DTCC00679140,1124451,46191
CHEMBL1201469,P20309,GRAMICIDIN,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327543,DTCC00679278,217579,46191
CHEMBL1201469,P20309,GRAMICIDIN,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327544,DTCC00679278,217579,46191
CHEMBL1201631,P20309,INSULIN HUMAN,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7435171,DTCC00679306,1798411,46191
CHEMBL1201631,P20309,INSULIN HUMAN,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7435172,DTCC00679306,1798411,46191
CHEMBL1202034,P20309,,VEYWVHLDJDNQIN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1102658,DTCC00679608,551950,10523
CHEMBL1202034,P20309,,VEYWVHLDJDNQIN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,51.7,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1102659,DTCC00679608,551950,10523
CHEMBL1202035,P20309,,QPRZNGPPFRJATN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1114709,DTCC00125738,6407,10523
CHEMBL1202035,P20309,,QPRZNGPPFRJATN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,17.4,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1114710,DTCC00125738,6407,10523
CHEMBL1202036,P20309,,WLUAMISZKHMBJK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1121742,DTCC00679609,810001,10523
CHEMBL1202036,P20309,,WLUAMISZKHMBJK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,32.1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1121743,DTCC00679609,810001,10523
CHEMBL1202037,P20309,,NFWKPBRVJWDIDO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1115833,DTCC00679610,1262737,10523
CHEMBL1202037,P20309,,NFWKPBRVJWDIDO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,39.2,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1115834,DTCC00679610,1262737,10523
CHEMBL1202038,P20309,,YBCMKMUYQYPEIG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1094848,DTCC00679611,390593,10523
CHEMBL1202038,P20309,,YBCMKMUYQYPEIG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,39.1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1094849,DTCC00679611,390593,10523
CHEMBL1202039,P20309,,IFSAWRPGVYDBAF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1104055,DTCC00679612,1004223,10523
CHEMBL1202039,P20309,,IFSAWRPGVYDBAF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,25,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1104056,DTCC00679612,1004223,10523
CHEMBL1202040,P20309,,HRULKRUVBYERLE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1102666,DTCC00679613,971644,10523
CHEMBL1202040,P20309,,HRULKRUVBYERLE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,28,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1102668,DTCC00679613,971644,10523
CHEMBL1202041,P20309,,QGINZTFBZKWTOY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1115825,DTCC00679614,1229853,10523
CHEMBL1202041,P20309,,QGINZTFBZKWTOY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,45.1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1115826,DTCC00679614,1229853,10523
CHEMBL1202042,P20309,,WWLSFLODAROTHV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1131913,DTCC00679615,1327842,10523
CHEMBL1202042,P20309,,WWLSFLODAROTHV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,17.3,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1131914,DTCC00679615,1327842,10523
CHEMBL1202043,P20309,,GILYLJWBFGKOQY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1134447,DTCC00679616,65795,10523
CHEMBL1202043,P20309,,GILYLJWBFGKOQY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,67.4,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1134448,DTCC00679616,65795,10523
CHEMBL1202044,P20309,,ZLIVXFOQDMVKDX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,14,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1102654,DTCC00679617,259466,10523
CHEMBL1202044,P20309,,ZLIVXFOQDMVKDX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,15.6,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1102655,DTCC00679617,259466,10523
CHEMBL1202045,P20309,,UQXNRBVKNLNFEC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1131917,DTCC00679618,1904442,10523
CHEMBL1202045,P20309,,UQXNRBVKNLNFEC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,32.1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1131918,DTCC00679618,1904442,10523
CHEMBL1202046,P20309,,VCVLQEYNUAPQOU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,8,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1114705,DTCC00679619,584094,10523
CHEMBL1202046,P20309,,VCVLQEYNUAPQOU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,12.5,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1114706,DTCC00679619,584094,10523
CHEMBL1202047,P20309,,BARXMQDZXPGLJQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1130517,DTCC00679620,2035171,10523
CHEMBL1202047,P20309,,BARXMQDZXPGLJQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,40,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1130518,DTCC00679620,2035171,10523
CHEMBL1202048,P20309,,NTTSCLHTHGXRAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1121746,DTCC00679621,1715034,10523
CHEMBL1202048,P20309,,NTTSCLHTHGXRAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,81.4,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1121747,DTCC00679621,1715034,10523
CHEMBL1202049,P20309,,LRWPRUCYZWUCQU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1135648,DTCC00679622,1522175,10523
CHEMBL1202049,P20309,,LRWPRUCYZWUCQU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,30.3,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1135649,DTCC00679622,1522175,10523
CHEMBL1202050,P20309,,QZOQJAAEBCONEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1106992,DTCC00679623,745635,10523
CHEMBL1202050,P20309,,QZOQJAAEBCONEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,29.4,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1106993,DTCC00679623,745635,10523
CHEMBL1202051,P20309,,HXNNQZXFSQHEPZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1113585,DTCC00679624,616412,10523
CHEMBL1202051,P20309,,HXNNQZXFSQHEPZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,59.1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1113586,DTCC00679624,616412,10523
CHEMBL1202052,P20309,,GLAHQGOSHONWMZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1133164,DTCC00679625,907926,10523
CHEMBL1202052,P20309,,GLAHQGOSHONWMZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,92.1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1133165,DTCC00679625,907926,10523
CHEMBL1202053,P20309,,YFXXMARWRIXSQZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1115829,DTCC00679626,1969713,10523
CHEMBL1202053,P20309,,YFXXMARWRIXSQZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,24.6,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1115830,DTCC00679626,1969713,10523
CHEMBL1202054,P20309,,KUNDKPWRJUXNFL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,3,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1098983,DTCC00679627,875335,10523
CHEMBL1202054,P20309,,KUNDKPWRJUXNFL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,52.6,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1098984,DTCC00679627,875335,10523
CHEMBL1202055,P20309,,PQRAZYKDVNDLGH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1102662,DTCC00679628,162906,10523
CHEMBL1202055,P20309,,PQRAZYKDVNDLGH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,37.5,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1102663,DTCC00679628,162906,10523
CHEMBL1202056,P20309,,YVAWJGQPPKGLCT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1124117,DTCC00679629,1904441,10523
CHEMBL1202056,P20309,,YVAWJGQPPKGLCT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,59.1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1124118,DTCC00679629,1904441,10523
CHEMBL1202057,P20309,,HDXVUCMTXSGDIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,8,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1113581,DTCC00679630,1651302,10523
CHEMBL1202057,P20309,,HDXVUCMTXSGDIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,40,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1113582,DTCC00679630,1651302,10523
CHEMBL1202058,P20309,,BZRFXAHRSLPWPO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,4,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1115821,DTCC00679631,1101753,10523
CHEMBL1202058,P20309,,BZRFXAHRSLPWPO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,55,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1115822,DTCC00679631,1101753,10523
CHEMBL1202126,P20309,,VPOIQGBLZNQEAW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1104046,DTCC00679690,777718,10523
CHEMBL1202126,P20309,,VPOIQGBLZNQEAW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,34.4,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1104047,DTCC00679690,777718,10523
CHEMBL1202127,P20309,,XDGWCQMIBCSEGC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1117232,DTCC00679691,745634,10523
CHEMBL1202127,P20309,,XDGWCQMIBCSEGC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,55.9,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1117233,DTCC00679691,745634,10523
CHEMBL1202129,P20309,,XANUSWVCRWJZCK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1108267,DTCC00679692,681063,10523
CHEMBL1202129,P20309,,XANUSWVCRWJZCK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,18.1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1108268,DTCC00679692,681063,10523
CHEMBL1202130,P20309,,PZJQQYHNEAPSNT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1124113,DTCC00679693,1457326,10523
CHEMBL1202130,P20309,,PZJQQYHNEAPSNT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,20,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1124114,DTCC00679693,1457326,10523
CHEMBL1202131,P20309,,KQTHRQNXIAFOTM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1131921,DTCC00679694,1619108,10523
CHEMBL1202131,P20309,,KQTHRQNXIAFOTM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,81.9,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1131922,DTCC00679694,1619108,10523
CHEMBL1202132,P20309,,SHYDUDJYCGLWEA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1104051,DTCC00679695,1489955,10523
CHEMBL1202132,P20309,,SHYDUDJYCGLWEA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,65,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1104052,DTCC00679695,1489955,10523
CHEMBL1202133,P20309,,BAKHDMNQKYCQGY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,7,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1120109,DTCC00679696,65796,10523
CHEMBL1202133,P20309,,BAKHDMNQKYCQGY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,47,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1120110,DTCC00679696,65796,10523
CHEMBL1202134,P20309,,LUAZXZFLXZINKC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1112284,DTCC00679697,1969712,10523
CHEMBL1202134,P20309,,LUAZXZFLXZINKC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,93.7,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1112285,DTCC00679697,1969712,10523
CHEMBL1202135,P20309,,RVMYAJQLIWLBQN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,7,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1105557,DTCC00679698,1229854,10523
CHEMBL1202135,P20309,,RVMYAJQLIWLBQN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,70.5,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1105558,DTCC00679698,1229854,10523
CHEMBL1202136,P20309,,RPPYGXHLUOHSKA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,7,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1096176,DTCC00679699,1840126,10523
CHEMBL1202136,P20309,,RPPYGXHLUOHSKA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,40.5,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1096177,DTCC00679699,1840126,10523
CHEMBL1202233,P20309,N-PROPARGYL STRYCHNINE BROMIDE,CXNWEZOBKOYOJV-YRDDRJARSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.5,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1342826,DTCC00031632,336607,15566
CHEMBL1202233,P20309,N-PROPARGYL STRYCHNINE BROMIDE,CXNWEZOBKOYOJV-YRDDRJARSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.7,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1342825,DTCC00031632,336607,15566
CHEMBL1202233,P20309,N-PROPARGYL STRYCHNINE BROMIDE,CXNWEZOBKOYOJV-YRDDRJARSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,<,0.2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1342835,DTCC00031632,336607,15566
CHEMBL1202233,P20309,N-PROPARGYL STRYCHNINE BROMIDE,CXNWEZOBKOYOJV-YRDDRJARSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1342831,DTCC00031632,336607,15566
CHEMBL1202234,P20309,N-PHENYLETHYL STRYCHNINE BROMIDE,BLDWBPZYUVTXRR-DBYHAXBSSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.6,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,460853,DTCC00031633,821195,15566
CHEMBL1202234,P20309,N-PHENYLETHYL STRYCHNINE BROMIDE,BLDWBPZYUVTXRR-DBYHAXBSSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.8,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1364239,DTCC00031633,821195,15566
CHEMBL1202234,P20309,N-PHENYLETHYL STRYCHNINE BROMIDE,BLDWBPZYUVTXRR-DBYHAXBSSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,<,0.2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,460872,DTCC00031633,821195,15566
CHEMBL1202234,P20309,N-PHENYLETHYL STRYCHNINE BROMIDE,BLDWBPZYUVTXRR-DBYHAXBSSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,460860,DTCC00031633,821195,15566
CHEMBL120329,P20309,,NGRKDWCQMJUMCO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,684,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1634352,DTCC00297427,1014979,15558
CHEMBL120472,P20309,,VDIWFPRSPJKJSW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,114.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1599960,DTCC00297100,1403966,15558
CHEMBL120539,P20309,,ZRBMWKJNKBFNDY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,6874.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1607552,DTCC00296859,982658,15558
CHEMBL120581,P20309,,SEMNLRZWRZTWOX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,257.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1603897,DTCC00297378,1500623,15558
CHEMBL120599,P20309,,OODYHGDZYKNGBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,529.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1638093,DTCC00297068,1144906,15558
CHEMBL1208572,P20309,SALINOMYCIN,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466770,DTCC00685596,1641853,46191
CHEMBL1208572,P20309,SALINOMYCIN,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466771,DTCC00685596,1641853,46191
CHEMBL12089,P20309,BERBERINE CHLORIDE,VKJGBAJNNALVAV-UHFFFAOYSA-M,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259928,DTCC00140102,1416025,46191
CHEMBL12089,P20309,BERBERINE CHLORIDE,VKJGBAJNNALVAV-UHFFFAOYSA-M,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259929,DTCC00140102,1416025,46191
CHEMBL120963,P20309,,OSKAUUHELWXKCH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,5051.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1620402,DTCC00297492,530533,15558
CHEMBL120972,P20309,,LOZFSJRXJHXNTK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1600.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1625406,DTCC00297449,1597456,15558
CHEMBL12098,P20309,SCH-211803,VMJKUCKTXMESQR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,700,NM,,,,,,,,,,,,,,Binding affinity to human M3 muscarinic receptor,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936428,DTCT0023280,11761586,DTCC00140426,2007708,53451
CHEMBL121,P20309,ROSIGLITAZONE,YASAKCUCGLMORW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483876,DTCC00148715,51506,46191
CHEMBL121,P20309,ROSIGLITAZONE,YASAKCUCGLMORW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483877,DTCC00148715,51506,46191
CHEMBL1210154,P20309,,CQUWKHKELQQYRI-KGENOOAVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20591666,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells,,A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.,Bioorg. Med. Chem. Lett.,2010,20,15,"Gattinoni S, Simone CD, Dallavalle S, Fezza F, Nannei R, Battista N, Minetti P, Quattrociocchi G, Caprioli A, Borsini F, Cabri W, Penco S, Merlini L, Maccarrone M",,643621,DTCT0023280,3413144,DTCC00686944,241890,39814
CHEMBL121059,P20309,,FNNCHHONWUGPND-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,201.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1612526,DTCC00297292,853790,15558
CHEMBL121298,P20309,,FTKPFUBMQMNNCK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,14309.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1619067,DTCC00297331,1112628,15558
CHEMBL121299,P20309,,JAGXFYHNAMPDLO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1218.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1631718,DTCC00297332,1694121,15558
CHEMBL12131,P20309,CLOSANTEL,JMPFSEBWVLAJKM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7354398,DTCC00140760,1674142,46191
CHEMBL12131,P20309,CLOSANTEL,JMPFSEBWVLAJKM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7354399,DTCC00140760,1674142,46191
CHEMBL121385,P20309,,MYOPWBZSPUGXNA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,2801.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1611312,DTCC00297182,205508,15558
CHEMBL1214185,P20309,ROXITHROMYCIN,RXZBMPWDPOLZGW-XMRMVWPWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462249,DTCC00688811,2057652,46191
CHEMBL1214185,P20309,ROXITHROMYCIN,RXZBMPWDPOLZGW-XMRMVWPWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462250,DTCC00688811,2057652,46191
CHEMBL121476,P20309,,QYNGEGPYZQDJLR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1095.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1617765,DTCC00297487,1564967,15558
CHEMBL121520,P20309,,OQVSETKVPVIQRS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,155.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1619072,DTCC00297102,1533001,15558
CHEMBL121552,P20309,,XDJKUYGHZCAUNE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,844.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1610053,DTCC00297591,950340,15558
CHEMBL1219,P20309,RABEPRAZOLE,YREYEVIYCVEVJK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475031,DTCC00316485,574625,46191
CHEMBL1219,P20309,RABEPRAZOLE,YREYEVIYCVEVJK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475032,DTCC00316485,574625,46191
CHEMBL122,P20309,ROFECOXIB,RZJQGNCSTQAWON-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479610,DTCC00150159,1830689,46191
CHEMBL122,P20309,ROFECOXIB,RZJQGNCSTQAWON-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479611,DTCC00150159,1830689,46191
CHEMBL1220,P20309,TINIDAZOLE,HJLSLZFTEKNLFI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7485537,DTCC00316820,1318449,46191
CHEMBL1220,P20309,TINIDAZOLE,HJLSLZFTEKNLFI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7485538,DTCC00316820,1318449,46191
CHEMBL1221,P20309,SULCONAZOLE,AFNXATANNDIXLG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,3404,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462988,DTCC00317729,1830690,46191
CHEMBL1221,P20309,SULCONAZOLE,AFNXATANNDIXLG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,721,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462989,DTCC00317729,1830690,46191
CHEMBL1221512,P20309,L-744832,PGOKBMWPBDRDGN-IBXSQZDTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416395,DTCC00031822,1927016,46191
CHEMBL1221512,P20309,L-744832,PGOKBMWPBDRDGN-IBXSQZDTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416396,DTCC00031822,1927016,46191
CHEMBL122353,P20309,,GEYMYSIKLOWDOD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,2312.2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1621670,DTCC00297329,1850784,15558
CHEMBL122354,P20309,,ULGGYRALEGWDES-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,349,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1628017,DTCC00297379,1532998,15558
CHEMBL1223753,P20309,,XGJTUORNDQJFHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,2511.89,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448767,DTCC00692485,2049713,40459
CHEMBL1223753,P20309,,XGJTUORNDQJFHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,2511.89,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as intracellular calcium mobilization after 10 to 15 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2010,1,6,,,849489,DTCT0023280,11347745,DTCC00692485,2039746,50717
CHEMBL1223753,P20309,,XGJTUORNDQJFHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INTRINSIC ACTIVITY,=,58,%,,cell_based,,,,,,,,,,,CHO,Intrinsic activity at human muscarinic M3 receptor expressed in CHO cells assessed as intracellular calcium mobilization after 10 to 15 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2010,1,6,,,849499,DTCT0023280,11347783,DTCC00692485,2039746,50717
CHEMBL1223754,P20309,,PXORDJUYHQIUMZ-RXAXNXDRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,79.43,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448772,DTCC00692486,890117,40459
CHEMBL1223803,P20309,,QSURXDMYUKWSGE-SAIGFBBZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,63.1,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448777,DTCC00692534,502415,40459
CHEMBL1223804,P20309,,CSORRUCUIASAPJ-JKIUYZKVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,125.89,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448782,DTCC00692535,760447,40459
CHEMBL1223805,P20309,,ZCMNJNNUKNOUAH-XYWHTSSQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448787,DTCC00692536,145360,40459
CHEMBL1223806,P20309,,JUTLWWKUPLIXDQ-CYWCHRQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,1995.26,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448792,DTCC00692537,241974,40459
CHEMBL1223807,P20309,,CGXQSGGPBGLGOJ-CYWCHRQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,>,15848.93,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448797,DTCC00692538,2081861,40459
CHEMBL1223860,P20309,,OFKIADWOPUKZHM-VVOJOOEHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,794.33,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448802,DTCC00692591,1179942,40459
CHEMBL1223861,P20309,,XSDXQFXBUOFSAB-VVOJOOEHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,1995.26,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448807,DTCC00692592,307674,40459
CHEMBL1223862,P20309,,VBAJEBMVDLIJME-VVOJOOEHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,1584.89,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448812,DTCC00692593,112864,40459
CHEMBL1223863,P20309,,APAQNVIEKCXJMH-LBZQVFOQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,2511.89,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3448817,DTCC00692594,1886987,40459
CHEMBL1223864,P20309,,GBZSJPUHVOXXGF-VVOJOOEHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,1258.93,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3449530,DTCC00692595,274830,40459
CHEMBL1223938,P20309,,KCCWJPIIEYKCRC-RXAXNXDRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,398.11,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3449535,DTCC00692669,405949,40459
CHEMBL1223939,P20309,,QVMLFGHAVILTTL-RXAXNXDRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,3162.28,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3449540,DTCC00692670,1439946,40459
CHEMBL1223940,P20309,,XEBWPMWXHPVINJ-UILWBTOOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,630.96,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3449545,DTCC00692671,1439947,40459
CHEMBL1223941,P20309,,GCEVFXMRGSNNRI-UILWBTOOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20709550,EC50,=,3981.07,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR assay,,"The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.",Bioorg. Med. Chem. Lett.,2010,20,18,"Johnson DJ, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F",,652865,DTCT0023280,3449550,DTCC00692672,1408068,40459
CHEMBL1224034,P20309,,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20692833,INHIBITION,=,20.6,%,,,,,,,,,,,,,,Displacement of [3H]QNB from human muscarinic M3 receptor at 10 uM,,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,2010,20,18,"Kwon YJ, Saubern S, Macdonald JM, Huang XP, Setola V, Roth BL",,652375,DTCT0023280,3449430,DTCC00692765,716520,40427
CHEMBL1224382,P20309,,ZLRRLSAVNUFCQT-LBPRGKRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20724153,INHIBITION,<,20,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 10 uM,,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010,20,18,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654142,DTCT0023280,3446683,DTCC00693087,695956,40497
CHEMBL1230333,P20309,,VYTXLSQVYGNWLV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7298819,DTCC00693927,2089742,46191
CHEMBL1230333,P20309,,VYTXLSQVYGNWLV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7298820,DTCC00693927,2089742,46191
CHEMBL1230813,P20309,ALFADEX,HFHDHCJBZVLPGP-RWMJIURBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291139,DTCC00693991,1155676,46191
CHEMBL1230813,P20309,ALFADEX,HFHDHCJBZVLPGP-RWMJIURBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291140,DTCC00693991,1155676,46191
CHEMBL123099,P20309,,WWXXBKMUWRZJRN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,52495.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1626782,DTCC00297518,1753933,15558
CHEMBL1231,P20309,OXYBUTYNIN,XIQVNETUBQGFHX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,1.3,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879405,DTCC00321776,531822,10048
CHEMBL1231,P20309,OXYBUTYNIN,XIQVNETUBQGFHX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,0.78,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164148,DTCC00321776,520908,23149
CHEMBL1231,P20309,OXYBUTYNIN,XIQVNETUBQGFHX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,1.51,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512618,DTCC00321776,543684,48454
CHEMBL1231,P20309,OXYBUTYNIN,XIQVNETUBQGFHX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,2.71,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7403928,DTCC00321776,542581,46191
CHEMBL1231,P20309,OXYBUTYNIN,XIQVNETUBQGFHX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.574,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7403929,DTCC00321776,542581,46191
CHEMBL1231107,P20309,CYROMAZINE,LVQDKIWDGQRHTE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7344061,DTCC00694021,1027050,46191
CHEMBL1231107,P20309,CYROMAZINE,LVQDKIWDGQRHTE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7344062,DTCC00694021,1027050,46191
CHEMBL1231530,P20309,BETAMIPRON,CWXYHOHYCJXYFQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7260037,DTCC00694066,1830684,46191
CHEMBL1231530,P20309,BETAMIPRON,CWXYHOHYCJXYFQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7260038,DTCC00694066,1830684,46191
CHEMBL123198,P20309,,UQLPHQTVCDGSMN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,871.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1633074,DTCC00297517,368943,15558
CHEMBL123292,P20309,CYCLOHEXIMIDE,YPHMISFOHDHNIV-FSZOTQKASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356877,DTCC00297204,477915,46191
CHEMBL123292,P20309,CYCLOHEXIMIDE,YPHMISFOHDHNIV-FSZOTQKASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356878,DTCC00297204,477915,46191
CHEMBL1235242,P20309,,XWHHYOYVRVGJJY-QMMMGPOBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283858,DTCC00694481,413967,46191
CHEMBL1235242,P20309,,XWHHYOYVRVGJJY-QMMMGPOBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283859,DTCC00694481,413967,46191
CHEMBL1236282,P20309,THIAMPHENICOL,OTVAEFIXJLOWRX-NXEZZACHSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7474578,DTCC00694596,1894975,46191
CHEMBL1236282,P20309,THIAMPHENICOL,OTVAEFIXJLOWRX-NXEZZACHSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7474579,DTCC00694596,1894975,46191
CHEMBL1237,P20309,LISINOPRIL,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416768,DTCC00323141,88630,46191
CHEMBL1237,P20309,LISINOPRIL,RLAWWYSOJDYHDC-BZSNNMDCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416769,DTCC00323141,88630,46191
CHEMBL1237044,P20309,TRAMADOL,TVYLLZQTGLZFBW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466313,DTCC00694678,381017,46191
CHEMBL1237044,P20309,TRAMADOL,TVYLLZQTGLZFBW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466314,DTCC00694678,381017,46191
CHEMBL1237174,P20309,HYDRAZINE,OAKJQQAXSVQMHS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331980,DTCC00126200,639581,46191
CHEMBL1237174,P20309,HYDRAZINE,OAKJQQAXSVQMHS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331981,DTCC00126200,639581,46191
CHEMBL124173,P20309,,DIINCAPSZJSTCD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1491,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1601119,DTCC00297520,1564968,15558
CHEMBL1242923,P20309,,FLGSUSWMWSZVMP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,EMAX,=,1,%,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as increase of acetylcholine-induced calcium flux at 10 uM by FLIPR assay relative to acetylcholine,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659448,DTCT0023280,3460752,DTCC00697046,1200707,40772
CHEMBL1242923,P20309,,FLGSUSWMWSZVMP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,KI,=,7000,NM,,cell_based,,,,,,,,,,,BHK-21,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659456,DTCT0023280,3460786,DTCC00697046,1200707,40772
CHEMBL1242923,P20309,,FLGSUSWMWSZVMP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,KI,>=,1000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659575,DTCT0023280,3460886,DTCC00697046,1200707,40772
CHEMBL1242950,P20309,AC-42,ANTKBACNWQHQJE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,EMAX,=,6,%,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as increase of acetylcholine-induced calcium flux at 10 uM by FLIPR assay relative to acetylcholine,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659448,DTCT0023280,3460753,DTCC00032233,1972874,40772
CHEMBL1242950,P20309,AC-42,ANTKBACNWQHQJE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,KI,=,2800,NM,,cell_based,,,,,,,,,,,BHK-21,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659456,DTCT0023280,3460788,DTCC00032233,1972874,40772
CHEMBL1242950,P20309,AC-42,ANTKBACNWQHQJE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,KI,>=,1000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659575,DTCT0023280,3460888,DTCC00032233,1972874,40772
CHEMBL1242979,P20309,,XGOZHCNNVCVDJO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,EMAX,=,7,%,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as increase of acetylcholine-induced calcium flux at 10 uM by FLIPR assay relative to acetylcholine,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659448,DTCT0023280,3460756,DTCC00697100,1265910,40772
CHEMBL1243,P20309,SULFABENZAMIDE,PBCZLFBEBARBBI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7467372,DTCC00325694,217587,46191
CHEMBL1243,P20309,SULFABENZAMIDE,PBCZLFBEBARBBI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7467373,DTCC00325694,217587,46191
CHEMBL1243010,P20309,,PQBNTIOMKCBFPA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,EMAX,=,0,%,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as increase of acetylcholine-induced calcium flux at 10 uM by FLIPR assay relative to acetylcholine,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659448,DTCT0023280,3460757,DTCC00697129,1525314,40772
CHEMBL1255785,P20309,MUSCARINE CHLORIDE,WUFRNEJYZWHXLC-CTERPIQNSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,ACTIVITY,=,15,/S,,cell_based,,,,,,,,,,,HEK293,Agonist activity at M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as rate constant at 100 uM to 1 mM by FRET method,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723359,DTCT0023280,5123007,DTCC00699469,101582,43500
CHEMBL1255785,P20309,MUSCARINE CHLORIDE,WUFRNEJYZWHXLC-CTERPIQNSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,EC50,=,1000,NM,,cell_based,,,,,,,,,,,HEK293,Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723353,DTCT0023280,5122984,DTCC00699469,101582,43500
CHEMBL1255785,P20309,MUSCARINE CHLORIDE,WUFRNEJYZWHXLC-CTERPIQNSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,TIME,=,66.8,MS,,cell_based,,,,,,,,,,,HEK293,Agonist activity at M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as half-maximal activation time at 100 uM to 1 mM by FRET method,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723356,DTCT0023280,5122996,DTCC00699469,101582,43500
CHEMBL1255834,P20309,BW-723C86,ALFGDCNSEBJYSP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8788493,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14732976,DTCC00032296,2104804,68805
CHEMBL1255834,P20309,BW-723C86,ALFGDCNSEBJYSP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276071,DTCC00032296,1124446,46191
CHEMBL1255834,P20309,BW-723C86,ALFGDCNSEBJYSP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276072,DTCC00032296,1124446,46191
CHEMBL1255837,P20309,DIHYDROERGOCRISTINE MESYLATE,SPXACGZWWVIDGR-SPZWACKZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7353285,DTCC00699500,1447881,46191
CHEMBL1255837,P20309,DIHYDROERGOCRISTINE MESYLATE,SPXACGZWWVIDGR-SPZWACKZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7353286,DTCC00699500,1447881,46191
CHEMBL1255901,P20309,HUPERZINE A,ZRJBHWIHUMBLCN-HZRLMBICSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323392,DTCC00699536,930079,46191
CHEMBL1255901,P20309,HUPERZINE A,ZRJBHWIHUMBLCN-HZRLMBICSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323393,DTCC00699536,930079,46191
CHEMBL1256017,P20309,ARCAINE SULFATE,RWTGFMPOODRXIM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7265111,DTCC00699626,994589,46191
CHEMBL1256017,P20309,ARCAINE SULFATE,RWTGFMPOODRXIM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7265112,DTCC00699626,994589,46191
CHEMBL1257741,P20309,,QULRUOVLZAHRKQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20801651,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulation of muscarinic M3 receptor expressed in CHO cells assessed as potentiation of acetylcholine-induced intracellular calcium mobilization at 30 uM after 1 hr by FLIPR assay relative to acetylcholine,Not Active,Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,19,"Bridges TM, Kennedy JP, Hopkins CR, Conn PJ, Lindsley CW",,664700,DTCT0023280,3531441,DTCC00700936,760543,41125
CHEMBL1257975,P20309,,RUQIIZGSRSUFTC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20801651,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulation of muscarinic M3 receptor expressed in CHO cells assessed as potentiation of acetylcholine-induced intracellular calcium mobilization at 30 uM after 1 hr by FLIPR assay relative to acetylcholine,Not Active,Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,19,"Bridges TM, Kennedy JP, Hopkins CR, Conn PJ, Lindsley CW",,664700,DTCT0023280,3531445,DTCC00701164,1952005,41125
CHEMBL1257975,P20309,,RUQIIZGSRSUFTC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23562060,EC50,>,30000,NM,,,,,,,,,,,,,,Positive allosteric modulation of human muscarinic M3 receptor,,"Discovery of ML326: The first sub-micromolar, selective M5 PAM.",Bioorg. Med. Chem. Lett.,2013,23,10,"Gentry PR, Bridges TM, Lamsal A, Vinson PN, Smith E, Chase P, Hodder PS, Engers JL, Niswender CM, Scott Daniels J, Jeffrey Conn P, Wood MR, Lindsley CW",,960034,DTCT0023280,12436496,DTCC00701164,1962841,54522
CHEMBL1258223,P20309,,WKWADEWWLCVVLF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20812727,KI,=,823,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010,53,19,"Xu R, Hong J, Morse CL, Pike VW",,664964,DTCT0023280,3532977,DTCC00701398,1168405,41144
CHEMBL1258452,P20309,,DZZIAERGLDKTBT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20812727,KI,=,1095,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010,53,19,"Xu R, Hong J, Morse CL, Pike VW",,664964,DTCT0023280,3533021,DTCC00701623,716604,41144
CHEMBL1258614,P20309,,IUEKKZWRWOFGRT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664306,DTCT0023280,3527804,DTCC00701782,911256,41064
CHEMBL1258671,P20309,,WLHFUBIRAHRPHA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20812727,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010,53,19,"Xu R, Hong J, Morse CL, Pike VW",,664964,DTCT0023280,3533065,DTCC00701836,911257,41144
CHEMBL12587,P20309,MUSCARINE,UQOFGTXDASPNLL-XHNCKOQMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,INHIBITION,=,28,%,,cell_based,,,,,,,,,,,CHO,Inhibition of binding of [3H]- quinuclidinyl benzilate to Muscarinic acetylcholine receptor M3 in membranes of CHO cells at 100 uM compound concentration,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138590,DTCT0023280,614127,DTCC00141393,3904,15779
CHEMBL12587,P20309,MUSCARINE,UQOFGTXDASPNLL-XHNCKOQMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,,,,cell_based,,,,,,,,,,,CHO,The binding affinity was measured as inhibition of binding of [3H]- oxotremorine-M to Muscarinic acetylcholine receptor M3 in membranes of CHO cells,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138708,DTCT0023280,614128,DTCC00141393,3904,15779
CHEMBL1258722,P20309,,FZPKLZHGBRKKCP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664306,DTCT0023280,3527768,DTCC00701888,2038361,41064
CHEMBL1258723,P20309,,LHSWZGXDIPQNGE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664306,DTCT0023280,3527868,DTCC00701889,14439,41064
CHEMBL1258843,P20309,,VHENJOBTWCOIPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20727749,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010,20,19,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664306,DTCT0023280,3527901,DTCC00702004,1265966,41064
CHEMBL1261,P20309,CITRIC ACID,KRKNYBCHXYNGOX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356408,DTCC00331493,1609544,46191
CHEMBL1261,P20309,CITRIC ACID,KRKNYBCHXYNGOX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356409,DTCC00331493,1609544,46191
CHEMBL1262,P20309,OXICONAZOLE,QRJJEGAJXVEBNE-HKOYGPOVSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,4531,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7399606,DTCC00332757,1059336,46191
CHEMBL1262,P20309,OXICONAZOLE,QRJJEGAJXVEBNE-HKOYGPOVSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,960.4,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7399607,DTCC00332757,1059336,46191
CHEMBL127,P20309,MEROPENEM,DMJNNHOOLUXYBV-PQTSNVLCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7438526,DTCC00154030,51487,46191
CHEMBL127,P20309,MEROPENEM,DMJNNHOOLUXYBV-PQTSNVLCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7438527,DTCC00154030,51487,46191
CHEMBL12713,P20309,SERTINDOLE,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,2692,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14757886,DTCC00141218,2111180,68826
CHEMBL127273,P20309,PIPERTRAMINE,HECAWZFPXYNICY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11708906,KI,=,422,NM,,cell_based,,,,,,,,,,,CHO-K1,Affinity for human M3 cloned muscarinic receptor subtype expressed in CHO-K1 cells,,"Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activators.",J. Med. Chem.,2001,44,24,"Melchiorre C, Bolognesi ML, Budriesi R, Ghelardini C, Chiarini A, Minarini A, Rosini M, Tumiatti V, Wade EJ",,138697,DTCT0023280,1581711,DTCC00310771,659872,16447
CHEMBL127273,P20309,PIPERTRAMINE,HECAWZFPXYNICY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Allosteric modulation of Homo sapiens (human) recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of carbachol-induced [35S]GTPgammaS binding,Active,,Med Chem Res,2004,13,1,,,931716,DTCT0023280,11737262,DTCC00310771,674072,51595
CHEMBL127273,P20309,PIPERTRAMINE,HECAWZFPXYNICY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to Homo sapiens (human) recombinant muscarinic M3 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding,Not Active,,Med Chem Res,2004,13,1,,,931834,DTCT0023280,11737272,DTCC00310771,674072,51595
CHEMBL127516,P20309,BUTAMBEN,IUWVALYLNVXWKX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7270306,DTCC00306410,381006,46191
CHEMBL127516,P20309,BUTAMBEN,IUWVALYLNVXWKX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7270307,DTCC00306410,381006,46191
CHEMBL1276308,P20309,MIFEPRISTONE,VKHAHZOOUSRJNA-GCNJZUOMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7419808,DTCC00706050,120974,46191
CHEMBL1276308,P20309,MIFEPRISTONE,VKHAHZOOUSRJNA-GCNJZUOMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7419809,DTCC00706050,120974,46191
CHEMBL1278088,P20309,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20931963,IC50,>,1000,NM,,,,,,,,,,,,,,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010,53,21,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684916,DTCT0023280,3586977,DTCC00707742,716661,41871
CHEMBL128,P20309,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7480705,DTCC00154636,671796,46191
CHEMBL128,P20309,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7480706,DTCC00154636,671796,46191
CHEMBL1282,P20309,IMIQUIMOD,DOUYETYNHWVLEO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306543,DTCC00339893,1927015,46191
CHEMBL1282,P20309,IMIQUIMOD,DOUYETYNHWVLEO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306544,DTCC00339893,1927015,46191
CHEMBL128365,P20309,ARECAIDINE PROPARGYL ESTER,SPHRJZBOFYIKMC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,=,851.14,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904204,DTCC00310540,2035763,20440
CHEMBL12856,P20309,INAMRINONE,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299771,DTCC00141434,1447876,46191
CHEMBL12856,P20309,INAMRINONE,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299772,DTCC00141434,1447876,46191
CHEMBL128786,P20309,,JGUYPHCIIOXIMF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11708906,REDUCTION,=,12,%,,cell_based,,,,,,,,,,,CHO-K1,Affinity for human M3 cloned muscarinic receptor subtype expressed in CHO-K1 cells at a concentration of 10 uM,,"Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activators.",J. Med. Chem.,2001,44,24,"Melchiorre C, Bolognesi ML, Budriesi R, Ghelardini C, Chiarini A, Minarini A, Rosini M, Tumiatti V, Wade EJ",,138718,DTCT0023280,1583202,DTCC00310538,950502,16447
CHEMBL1289,P20309,HALOPROGIN,CTETYYAZBPJBHE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306307,DTCC00108442,1512810,46191
CHEMBL1289,P20309,HALOPROGIN,CTETYYAZBPJBHE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306308,DTCC00108442,1512810,46191
CHEMBL1289081,P20309,,ZQTMZGRHYCEEOE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,63.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605558,DTCC00708985,954523,42029
CHEMBL1289082,P20309,,MYUNUPXWDYZLKP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,63.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605559,DTCC00708986,631731,42029
CHEMBL1289201,P20309,,XUEHBXCPZIUJTD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,100,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605560,DTCC00709107,1408279,42029
CHEMBL1289202,P20309,,SLIFLCGOQYVBQV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,125.89,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605561,DTCC00709108,1440147,42029
CHEMBL1289314,P20309,,GLQAZINVOQYMEQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,199.53,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605562,DTCC00709215,469990,42029
CHEMBL1289315,P20309,,HZQKLJHETYZKDH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,398.11,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605563,DTCC00709216,1822866,42029
CHEMBL1289432,P20309,,XXNYHJSXWIIHAO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,398.11,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605564,DTCC00709330,1887147,42029
CHEMBL1289433,P20309,,AQIDBTIRISFWQF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,>,1000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605565,DTCC00709331,469991,42029
CHEMBL1289544,P20309,,GJEWYBFMWZEOCF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,158.49,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605566,DTCC00709443,1698333,42029
CHEMBL1289545,P20309,,ALYOAWZYSZLYLO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,10,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605567,DTCC00709444,1245415,42029
CHEMBL1289626,P20309,WMS-1410,KKLZGWQBNXJWGZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20965739,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]N-Methyl-scopolamine from muscarinic M3 receptor at 1 to 3 uM,Not Active,"Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.",Bioorg. Med. Chem.,2010,18,22,"Tewes B, Frehland B, Schepmann D, Schmidtke KU, Winckler T, Wünsch B",,686773,DTCT0023280,3613330,DTCC00032749,40842,41994
CHEMBL1289653,P20309,,KWUNZCGOPMIGFE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,1.26,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605568,DTCC00709550,1116809,42029
CHEMBL1289654,P20309,,LYQGZYIUMYUMCO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,7.94,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605569,DTCC00709551,1051619,42029
CHEMBL1289758,P20309,,HNJOKNBVVXSFPS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605570,DTCC00709656,113052,42029
CHEMBL1289759,P20309,,BAXUYIMBZSDPGM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,>,1000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605571,DTCC00709657,1634021,42029
CHEMBL1289865,P20309,,WBBYBFVZVFEOLK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605572,DTCC00709759,696143,42029
CHEMBL1289866,P20309,,MGWLEIOWCHHXGB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,3.98,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605573,DTCC00709760,1116811,42029
CHEMBL1289982,P20309,,WJZLXGFMQGCPSN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,19.95,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605574,DTCC00709875,1666264,42029
CHEMBL1289983,P20309,,GPARJKKXMHOXEG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605575,DTCC00709876,534726,42029
CHEMBL129,P20309,ZIDOVUDINE,HBOMLICNUCNMMY-XLPZGREQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7446873,DTCC00154782,51517,46191
CHEMBL129,P20309,ZIDOVUDINE,HBOMLICNUCNMMY-XLPZGREQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7446874,DTCC00154782,51517,46191
CHEMBL1290077,P20309,,BWSIBMJVLHAOKJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,398.11,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605576,DTCC00709971,373162,42029
CHEMBL1290078,P20309,,FXYMZHCQKFWAQZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,>,1000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605577,DTCC00709972,1727682,42029
CHEMBL1290183,P20309,,RTOVDRRASKFSTF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,100,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605548,DTCC00126799,1310723,42029
CHEMBL1290184,P20309,,BOXHESMXGWQKOM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,100,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605549,DTCC00710071,1343287,42029
CHEMBL1290185,P20309,,PXZBMRRYQSNJHN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,>,1000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605578,DTCC00710072,1472523,42029
CHEMBL1290294,P20309,,KSKQPQJGZKKGHN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,125.89,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605550,DTCC00710181,922257,42029
CHEMBL1290295,P20309,,VMVVEALWGMZVMD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,>,1000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605551,DTCC00710182,307878,42029
CHEMBL1290409,P20309,,XNMKWEUDGCIMSJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,>,1000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605552,DTCC00710294,1790414,42029
CHEMBL1290410,P20309,,KWDRCVJZNGJVMU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,316.23,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605553,DTCC00710295,792746,42029
CHEMBL1290519,P20309,,QULIURHFTHMXNP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells at 1 uM after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687870,DTCT0023280,3605974,DTCC00710404,1019207,42029
CHEMBL1290520,P20309,,YIWYYFDCFJXRTE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells at 1 uM after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687870,DTCT0023280,3605975,DTCC00710405,728439,42029
CHEMBL1290634,P20309,,OOLRDYUDZYBWFI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,794.33,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605554,DTCC00710518,663849,42029
CHEMBL1290635,P20309,,KQSBDHSJXORWPF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,251.19,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605555,DTCC00710519,1952107,42029
CHEMBL1290752,P20309,,HLYKZUHDUDNXQM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,31.62,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605556,DTCC00710630,1952112,42029
CHEMBL1290753,P20309,,DVFSAKUPFCXDBO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,50.12,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605557,DTCC00710631,792748,42029
CHEMBL12948,P20309,SEMUSTINE,FVLVBPDQNARYJU-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466879,DTCC00141274,1318442,46191
CHEMBL12948,P20309,SEMUSTINE,FVLVBPDQNARYJU-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466880,DTCC00141274,1318442,46191
CHEMBL129680,P20309,,UIUZIOPTAVDIIT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11708906,REDUCTION,=,17,%,,cell_based,,,,,,,,,,,CHO-K1,Affinity for human M3 cloned muscarinic receptor subtype expressed in CHO-K1 cells at a concentration of 10 uM,,"Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activators.",J. Med. Chem.,2001,44,24,"Melchiorre C, Bolognesi ML, Budriesi R, Ghelardini C, Chiarini A, Minarini A, Rosini M, Tumiatti V, Wade EJ",,138718,DTCT0023280,1568422,DTCC00310541,1662133,16447
CHEMBL1297,P20309,FENOPROFEN,RDJGLLICXDHJDY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7307447,DTCC00343797,1830685,46191
CHEMBL1297,P20309,FENOPROFEN,RDJGLLICXDHJDY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7307448,DTCC00343797,1830685,46191
CHEMBL13,P20309,METOPROLOL,IUBSYMUCCVWXPE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7419768,DTCC00132868,1798412,46191
CHEMBL13,P20309,METOPROLOL,IUBSYMUCCVWXPE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7419769,DTCC00132868,1798412,46191
CHEMBL130,P20309,CHLORAMPHENICOL,WIIZWVCIJKGZOK-RKDXNWHRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7347278,DTCC00154805,51455,46191
CHEMBL130,P20309,CHLORAMPHENICOL,WIIZWVCIJKGZOK-RKDXNWHRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7347279,DTCC00154805,51455,46191
CHEMBL13030,P20309,,STECJAGHUSJQJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,0.44,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14739166,DTCC00141761,2106946,68417
CHEMBL1306,P20309,TERCONAZOLE,BLSQLHNBWJLIBQ-OZXSUGGESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,14537,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7474479,DTCC00347547,1830691,46191
CHEMBL1306,P20309,TERCONAZOLE,BLSQLHNBWJLIBQ-OZXSUGGESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,3081,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7474480,DTCC00347547,1830691,46191
CHEMBL1308,P20309,FOMEPIZOLE,RIKMMFOAQPJVMX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286802,DTCC00348807,1862712,46191
CHEMBL1308,P20309,FOMEPIZOLE,RIKMMFOAQPJVMX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286803,DTCC00348807,1862712,46191
CHEMBL130835,P20309,PIPERTRAMINE AMIDE,UWKMFEOQWPCWLU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11708906,KI,=,97.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Affinity for human M3 cloned muscarinic receptor subtype expressed in CHO-K1 cells,,"Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activators.",J. Med. Chem.,2001,44,24,"Melchiorre C, Bolognesi ML, Budriesi R, Ghelardini C, Chiarini A, Minarini A, Rosini M, Tumiatti V, Wade EJ",,138697,DTCT0023280,1563816,DTCC00310217,1723785,16447
CHEMBL130835,P20309,PIPERTRAMINE AMIDE,UWKMFEOQWPCWLU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Allosteric modulation of Homo sapiens (human) recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of carbachol-induced [35S]GTPgammaS binding,Active,,Med Chem Res,2004,13,1,,,931716,DTCT0023280,11737261,DTCC00310217,1736350,51595
CHEMBL130835,P20309,PIPERTRAMINE AMIDE,UWKMFEOQWPCWLU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to Homo sapiens (human) recombinant muscarinic M3 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding,Not Active,,Med Chem Res,2004,13,1,,,931834,DTCT0023280,11737271,DTCC00310217,1736350,51595
CHEMBL131,P20309,PREDNISOLONE,OIGNJSKKLXVSLS-VWUMJDOOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391898,DTCC00154827,1734061,46191
CHEMBL131,P20309,PREDNISOLONE,OIGNJSKKLXVSLS-VWUMJDOOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391899,DTCC00154827,1734061,46191
CHEMBL131428,P20309,ALVAMELINE,RNMOMKCRCIRYCZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EFFICACY,<,20,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay relative to acetylcholine,,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517987,DTCT0023280,14545934,DTCC00313039,431620,63681
CHEMBL1319362,P20309,HOMATROPINE HYDROBROMIDE,DWSGTFTVBLXELC-RDYJJYPNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,76,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319139,DTCC00729363,1027054,46191
CHEMBL1319362,P20309,HOMATROPINE HYDROBROMIDE,DWSGTFTVBLXELC-RDYJJYPNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,16,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319140,DTCC00729363,1027054,46191
CHEMBL13209,P20309,NITRAZEPAM,KJONHKAYOJNZEC-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396990,DTCC00141996,477919,46191
CHEMBL13209,P20309,NITRAZEPAM,KJONHKAYOJNZEC-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396991,DTCC00141996,477919,46191
CHEMBL1321,P20309,PROCARBAZINE,CPTBDICYNRMXFX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400647,DTCC00352822,671792,46191
CHEMBL1321,P20309,PROCARBAZINE,CPTBDICYNRMXFX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400648,DTCC00352822,671792,46191
CHEMBL1321154,P20309,ROXARSONE,XMVJITFPVVRMHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457878,DTCC00731018,542582,46191
CHEMBL1321154,P20309,ROXARSONE,XMVJITFPVVRMHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457879,DTCC00731018,542582,46191
CHEMBL1323615,P20309,,HFXCUJLZEIBVQQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,10000,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late-stage radioligand binding dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): PDSP screen Ki. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1792, AID1796, AID1823, AID2532, AID2538, AID2539, AID2541, AID2545, AID2556, AID2664, AID2752, AID2773, AID434992, AID434993, AID434997, AID435002, AID435009, AID435013, AID463255, AID488778, AID504381, AID504410] Panel member name: Muscarinic receptor M3",inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,737616,DTCT0023280,5403308,DTCC00733300,992395,33038
CHEMBL132698,P20309,,IQCCZGULZZAZRT-JMJMLWOWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9435896,IC50,=,2200,NM,,,,,,,,,,,,,,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",,"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,1997,40,26,"Bromidge SM, Brown F, Cassidy F, Clark MS, Dabbs S, Hadley MS, Hawkins J, Loudon JM, Naylor CB, Orlek BS, Riley GJ",,138586,DTCT0023280,1345990,DTCC00318013,1468498,14467
CHEMBL1333512,P20309,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE",UTGQNNCQYDRXCH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7422303,DTCC00742601,1155682,46191
CHEMBL1333512,P20309,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE",UTGQNNCQYDRXCH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7422304,DTCC00742601,1155682,46191
CHEMBL13341,P20309,NIMETAZEPAM,GWUSZQUVEVMBPI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7384078,DTCC00141962,606971,46191
CHEMBL13341,P20309,NIMETAZEPAM,GWUSZQUVEVMBPI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7384079,DTCC00141962,606971,46191
CHEMBL13378,P20309,"(R,S)-AMPA",UUDAMDVQRQNNHZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286380,DTCC00141891,1220272,46191
CHEMBL13378,P20309,"(R,S)-AMPA",UUDAMDVQRQNNHZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286381,DTCC00141891,1220272,46191
CHEMBL134,P20309,CLONIDINE,GJSURZIOUXUGAL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7341554,DTCC00155022,51459,46191
CHEMBL134,P20309,CLONIDINE,GJSURZIOUXUGAL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7341555,DTCC00155022,51459,46191
CHEMBL134342,P20309,LIPOIC ACID,AGBQKNBQESQNJD-SSDOTTSWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487454,DTCC00318217,1220281,46191
CHEMBL134342,P20309,LIPOIC ACID,AGBQKNBQESQNJD-SSDOTTSWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487455,DTCC00318217,1220281,46191
CHEMBL1346,P20309,DARIFENACIN,HXGBXQDTNZMWGS-RUZDIDTESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11303071,KI,=,0.84,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14743878,DTCC00374164,2108547,68460
CHEMBL1346,P20309,DARIFENACIN,HXGBXQDTNZMWGS-RUZDIDTESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,0.84,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1610162,DTCC00374164,1469215,11844
CHEMBL1346,P20309,DARIFENACIN,HXGBXQDTNZMWGS-RUZDIDTESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,1.3,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879404,DTCC00374164,1469600,10048
CHEMBL1346,P20309,DARIFENACIN,HXGBXQDTNZMWGS-RUZDIDTESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126128,DTCC00374164,1464271,62168
CHEMBL134641,P20309,SABCOMELINE,IQWCBYSUUOFOMF-QTLFRQQHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9435896,IC50,=,60,NM,,,,,,,,,,,,,,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",,"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,1997,40,26,"Bromidge SM, Brown F, Cassidy F, Clark MS, Dabbs S, Hadley MS, Hawkins J, Loudon JM, Naylor CB, Orlek BS, Riley GJ",,138586,DTCT0023280,1326991,DTCC00317926,2045965,14467
CHEMBL134641,P20309,SABCOMELINE,IQWCBYSUUOFOMF-QTLFRQQHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,=,117,NM,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545931,DTCC00317926,2043375,63681
CHEMBL134641,P20309,SABCOMELINE,IQWCBYSUUOFOMF-QTLFRQQHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EFFICACY,=,28.3,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay relative to acetylcholine,,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517987,DTCT0023280,14545935,DTCC00317926,2043375,63681
CHEMBL1349,P20309,VALACYCLOVIR,HDOVUKNUBWVHOX-QMMMGPOBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7453046,DTCC00378678,930089,46191
CHEMBL1349,P20309,VALACYCLOVIR,HDOVUKNUBWVHOX-QMMMGPOBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7453047,DTCC00378678,930089,46191
CHEMBL135,P20309,ESTRADIOL,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7265760,DTCC00155036,51448,46191
CHEMBL135,P20309,ESTRADIOL,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7265761,DTCC00155036,51448,46191
CHEMBL1351,P20309,CARBOPLATIN,OLESAACUTLOWQZ-UHFFFAOYSA-L,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355682,DTCC00380917,1480344,46191
CHEMBL1351,P20309,CARBOPLATIN,OLESAACUTLOWQZ-UHFFFAOYSA-L,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355683,DTCC00380917,1480344,46191
CHEMBL135328,P20309,,COFRKLYXCWVCKM-WGRRCAOGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9435896,IC50,=,1200,NM,,,,,,,,,,,,,,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",,"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,1997,40,26,"Bromidge SM, Brown F, Cassidy F, Clark MS, Dabbs S, Hadley MS, Hawkins J, Loudon JM, Naylor CB, Orlek BS, Riley GJ",,138586,DTCT0023280,1352862,DTCC00317423,1468499,14467
CHEMBL135645,P20309,,WJIDIDMJHVMZSA-FMIVXFBMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9435896,IC50,=,28,NM,,,,,,,,,,,,,,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB)radioligand in human cloned Muscarinic acetylcholine receptor M3",,"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,1997,40,26,"Bromidge SM, Brown F, Cassidy F, Clark MS, Dabbs S, Hadley MS, Hawkins J, Loudon JM, Naylor CB, Orlek BS, Riley GJ",,138587,DTCT0023280,1364664,DTCC00318014,1112870,14467
CHEMBL1357815,P20309,,RUYRNYRGPSAXTK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21194936,ACTIVITY,,,,,,,,,,,,,,,,,Orthosteric binding affinity to M3 receptor at 10 uM by radioligand binding assay,Not Active,"Discovery and optimization of a novel, selective and brain penetrant M(1) positive allosteric modulator (PAM): The development of ML169, an MLPCN probe.",Bioorg. Med. Chem. Lett.,2011,21,9,"Reid PR, Bridges TM, Sheffler DJ, Cho HP, Lewis LM, Days E, Daniels JS, Jones CK, Niswender CM, Weaver CD, Conn PJ, Lindsley CW, Wood MR",,745298,DTCT0023280,5940374,DTCC00765108,1622765,44108
CHEMBL136027,P20309,,JETRJUTXVVSGTR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,ACTIVITY,=,50,%,,cell_based,,,,,,,,,,,A9,Ability to stimulate biochemical responses in cell lines expressing muscarinic A9 L receptor sub types,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138565,DTCT0023280,842654,DTCC00317760,1807227,17526
CHEMBL136027,P20309,,JETRJUTXVVSGTR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,EC50,=,2.51189E+12,NM,,cell_based,,,,,,,,,,,A9,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138825,DTCT0023280,842653,DTCC00317760,1807227,17526
CHEMBL136027,P20309,,JETRJUTXVVSGTR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,KI,=,79.43,NM,,cell_based,,,,,,,,,,,A9,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138831,DTCT0023280,842652,DTCC00317760,1807227,17526
CHEMBL136045,P20309,N-CYCLOHEXYLMETHYL STRYCHNINE IODIDE,LUKZBVLMTSSIFN-OPZGMFQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1341587,DTCC01743352,1208475,15566
CHEMBL136045,P20309,N-CYCLOHEXYLMETHYL STRYCHNINE IODIDE,LUKZBVLMTSSIFN-OPZGMFQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.1,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1341588,DTCC01743352,1208475,15566
CHEMBL136045,P20309,N-CYCLOHEXYLMETHYL STRYCHNINE IODIDE,LUKZBVLMTSSIFN-OPZGMFQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,<,0.2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1341595,DTCC01743352,1208475,15566
CHEMBL136045,P20309,N-CYCLOHEXYLMETHYL STRYCHNINE IODIDE,LUKZBVLMTSSIFN-OPZGMFQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1341593,DTCC01743352,1208475,15566
CHEMBL136478,P20309,SODIUM NITROPRUSSIDE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7460526,DTCC00320064,1155687,46191
CHEMBL136478,P20309,SODIUM NITROPRUSSIDE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7460527,DTCC00320064,1155687,46191
CHEMBL1365675,P20309,AMITRAZ,QXAITBQSYVNQDR-ZIOPAAQOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7295392,DTCC00772476,1027047,46191
CHEMBL1365675,P20309,AMITRAZ,QXAITBQSYVNQDR-ZIOPAAQOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7295393,DTCC00772476,1027047,46191
CHEMBL1366,P20309,AURANOFIN,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273683,DTCC00388917,833156,46191
CHEMBL1366,P20309,AURANOFIN,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273684,DTCC00388917,833156,46191
CHEMBL1367424,P20309,,RDAMITSUPFEENV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,76960,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist NMS competition at M3. (Class of assay: confirmatory) [Related pubchem assays: 1488 (Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist Confirmation Assay), 626 (Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist Primary Screen)]",Inconclusive,PUBCHEM BIOASSAY DATA SET,,,,,,,688684,DTCT0023280,4800308,DTCC00774106,2054775,33038
CHEMBL137,P20309,METRONIDAZOLE,VAOCPAMSLUNLGC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7424046,DTCC00155250,51489,46191
CHEMBL137,P20309,METRONIDAZOLE,VAOCPAMSLUNLGC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7424047,DTCC00155250,51489,46191
CHEMBL1370,P20309,BUDESONIDE,VOVIALXJUBGFJZ-KWVAZRHASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7275959,DTCC00392952,898284,46191
CHEMBL1370,P20309,BUDESONIDE,VOVIALXJUBGFJZ-KWVAZRHASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7275960,DTCC00392952,898284,46191
CHEMBL1370561,P20309,AMINOPHYLLINE,FQPFAHBPWDRTLU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283050,DTCC00777070,1383772,46191
CHEMBL1370561,P20309,AMINOPHYLLINE,FQPFAHBPWDRTLU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283051,DTCC00777070,1383772,46191
CHEMBL1371,P20309,CHLORZOXAZONE,TZFWDZFKRBELIQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349625,DTCC00394427,1992801,46191
CHEMBL1371,P20309,CHLORZOXAZONE,TZFWDZFKRBELIQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349626,DTCC00394427,1992801,46191
CHEMBL1371125,P20309,BENZO[E]PYRENE,TXVHTIQJNYSSKO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7265678,DTCC00777599,2025635,46191
CHEMBL1371125,P20309,BENZO[E]PYRENE,TXVHTIQJNYSSKO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7265679,DTCC00777599,2025635,46191
CHEMBL1371937,P20309,PANTHENOL,SNPLKNRPJHDVJA-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7397523,DTCC00778371,1059337,46191
CHEMBL1371937,P20309,PANTHENOL,SNPLKNRPJHDVJA-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7397524,DTCC00778371,1059337,46191
CHEMBL1372,P20309,OXIGLUTATIONE,YPZRWBKMTBYPTK-BJDJZHNGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331683,DTCC00395874,898290,46191
CHEMBL1372,P20309,OXIGLUTATIONE,YPZRWBKMTBYPTK-BJDJZHNGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331684,DTCC00395874,898290,46191
CHEMBL1373,P20309,MODAFINIL,YFGHCGITMMYXAQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7413592,DTCC00396162,1512812,46191
CHEMBL1373,P20309,MODAFINIL,YFGHCGITMMYXAQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7413593,DTCC00396162,1512812,46191
CHEMBL137384,P20309,,COFRKLYXCWVCKM-JZGIUJARSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9435896,IC50,=,380,NM,,,,,,,,,,,,,,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",,"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,1997,40,26,"Bromidge SM, Brown F, Cassidy F, Clark MS, Dabbs S, Hadley MS, Hawkins J, Loudon JM, Naylor CB, Orlek BS, Riley GJ",,138586,DTCT0023280,1324335,DTCC00318155,173741,14467
CHEMBL137837,P20309,,JCBFKEORAXPJSU-CLYFSWBMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.5,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1324017,DTCC00322740,1241263,15566
CHEMBL137837,P20309,,JCBFKEORAXPJSU-CLYFSWBMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.6,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1324018,DTCC00322740,1241263,15566
CHEMBL137837,P20309,,JCBFKEORAXPJSU-CLYFSWBMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1324025,DTCC00322740,1241263,15566
CHEMBL137837,P20309,,JCBFKEORAXPJSU-CLYFSWBMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1324030,DTCC00322740,1241263,15566
CHEMBL1381098,P20309,1-NAPHTHYLISOTHIOCYANATE,JBDOSUUXMYMWQH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7285126,DTCC00786869,866013,46191
CHEMBL1381098,P20309,1-NAPHTHYLISOTHIOCYANATE,JBDOSUUXMYMWQH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7285127,DTCC00786869,866013,46191
CHEMBL1382,P20309,TOLTERODINE,OOGJQPCLVADCPB-HXUWFJFHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,3.2,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879406,DTCC00400338,435303,10048
CHEMBL1382,P20309,TOLTERODINE,OOGJQPCLVADCPB-HXUWFJFHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18042383,KI,=,3.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells,,Design and synthesis of a fluorescent muscarinic antagonist.,Bioorg. Med. Chem. Lett.,2008,18,2,"Jones LH, Randall A, Napier C, Trevethick M, Sreckovic S, Watson J",,468831,DTCT0023280,2294391,DTCC00400338,439494,11705
CHEMBL1382,P20309,TOLTERODINE,OOGJQPCLVADCPB-HXUWFJFHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,3.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939458,DTCC00400338,443510,44387
CHEMBL1382,P20309,TOLTERODINE,OOGJQPCLVADCPB-HXUWFJFHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,<,15,MIN,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939460,DTCC00400338,443510,44387
CHEMBL1382,P20309,TOLTERODINE,OOGJQPCLVADCPB-HXUWFJFHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21863888,KI,=,3.6,NM,,,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human M3 receptor,,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771725,DTCT0023280,6112787,DTCC00400338,443793,46044
CHEMBL1384,P20309,KANAMYCIN,SBUJHOSQTJFQJX-NOAMYHISSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420598,DTCC00402979,51482,46191
CHEMBL1384,P20309,KANAMYCIN,SBUJHOSQTJFQJX-NOAMYHISSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420599,DTCC00402979,51482,46191
CHEMBL1385840,P20309,ERGOCORNINE,UJYGDMFEEDNVBF-OGGGUQDZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323942,DTCC00791188,444641,46191
CHEMBL1385840,P20309,ERGOCORNINE,UJYGDMFEEDNVBF-OGGGUQDZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323943,DTCC00791188,444641,46191
CHEMBL138585,P20309,,ADTDBAKUQAKBGZ-VXJIXCKJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,<,3.9,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1333210,DTCC00322191,1565272,15566
CHEMBL138585,P20309,,ADTDBAKUQAKBGZ-VXJIXCKJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.9,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1333211,DTCC00322191,1565272,15566
CHEMBL138585,P20309,,ADTDBAKUQAKBGZ-VXJIXCKJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1333220,DTCC00322191,1565272,15566
CHEMBL138585,P20309,,ADTDBAKUQAKBGZ-VXJIXCKJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1333216,DTCC00322191,1565272,15566
CHEMBL1386,P20309,TRANSPLATIN,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7448978,DTCC00405544,315673,46191
CHEMBL1386,P20309,TRANSPLATIN,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7448979,DTCC00405544,315673,46191
CHEMBL138617,P20309,,QRKXNMQJQQZNCY-GMLMXPDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,<,4.4,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1363063,DTCC00322518,595260,15566
CHEMBL138617,P20309,,QRKXNMQJQQZNCY-GMLMXPDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.5,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1362509,DTCC00322518,595260,15566
CHEMBL138617,P20309,,QRKXNMQJQQZNCY-GMLMXPDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1363072,DTCC00322518,595260,15566
CHEMBL138617,P20309,,QRKXNMQJQQZNCY-GMLMXPDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1363068,DTCC00322518,595260,15566
CHEMBL1388,P20309,MONOBENZONE,VYQNWZOUAUKGHI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7417919,DTCC00405603,833163,46191
CHEMBL1388,P20309,MONOBENZONE,VYQNWZOUAUKGHI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7417920,DTCC00405603,833163,46191
CHEMBL138903,P20309,,GUZRLBNFMNLPRF-OPZGMFQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,<,5.2,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1330543,DTCC00322623,31590,15566
CHEMBL138903,P20309,,GUZRLBNFMNLPRF-OPZGMFQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,5.3,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1330544,DTCC00322623,31590,15566
CHEMBL138903,P20309,,GUZRLBNFMNLPRF-OPZGMFQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1330553,DTCC00322623,31590,15566
CHEMBL138903,P20309,,GUZRLBNFMNLPRF-OPZGMFQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1330549,DTCC00322623,31590,15566
CHEMBL139,P20309,DICLOFENAC,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7342381,DTCC00156996,1220275,46191
CHEMBL139,P20309,DICLOFENAC,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7342382,DTCC00156996,1220275,46191
CHEMBL1393,P20309,SPIRONOLACTONE,LXMSZDCAJNLERA-ZHYRCANASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454175,DTCC00405635,1512816,46191
CHEMBL1393,P20309,SPIRONOLACTONE,LXMSZDCAJNLERA-ZHYRCANASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454176,DTCC00405635,1512816,46191
CHEMBL1395,P20309,METHYLTESTOSTERONE,GCKMFJBGXUYNAG-HLXURNFRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7295910,DTCC00405823,1798403,46191
CHEMBL1395,P20309,METHYLTESTOSTERONE,GCKMFJBGXUYNAG-HLXURNFRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7295911,DTCC00405823,1798403,46191
CHEMBL139677,P20309,N-CHLOROMETHYL BRUCINE CHLORIDE,GCEPQLWZBVGLQN-CQIPDZJVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.3,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,366600,DTCC01743355,1597777,15566
CHEMBL139677,P20309,N-CHLOROMETHYL BRUCINE CHLORIDE,GCEPQLWZBVGLQN-CQIPDZJVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.7,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,366597,DTCC01743355,1597777,15566
CHEMBL139677,P20309,N-CHLOROMETHYL BRUCINE CHLORIDE,GCEPQLWZBVGLQN-CQIPDZJVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.2,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,366616,DTCC01743355,1597777,15566
CHEMBL139677,P20309,N-CHLOROMETHYL BRUCINE CHLORIDE,GCEPQLWZBVGLQN-CQIPDZJVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,>,0.2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,366641,DTCC01743355,1597777,15566
CHEMBL139835,P20309,CYPROTERONE ACETATE,UWFYSQMTEOIJJG-FDTZYFLXSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7339766,DTCC00327558,153442,46191
CHEMBL139835,P20309,CYPROTERONE ACETATE,UWFYSQMTEOIJJG-FDTZYFLXSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7339767,DTCC00327558,153442,46191
CHEMBL1399,P20309,ANASTROZOLE,YBBLVLTVTVSKRW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7284810,DTCC00413581,1992800,46191
CHEMBL1399,P20309,ANASTROZOLE,YBBLVLTVTVSKRW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7284811,DTCC00413581,1992800,46191
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,70,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1036440,DTCC00132960,1852580,8985
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7783150,EC50,=,1800,NM,,,,,,,,,,,,,,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),,Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors.,J. Med. Chem.,1995,38,12,"Bräuner-Osborne H, Ebert B, Brann MR, Falch E, Krogsgaard-Larsen P",,138582,DTCT0023280,919846,DTCC00132960,1838571,13059
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9435896,IC50,=,9100,NM,,,,,,,,,,,,,,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",,"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,1997,40,26,"Bromidge SM, Brown F, Cassidy F, Clark MS, Dabbs S, Hadley MS, Hawkins J, Loudon JM, Naylor CB, Orlek BS, Riley GJ",,138586,DTCT0023280,1325752,DTCC00132960,1851015,14467
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9622546,INHIBITION,=,16,%,,cell_based,,,,,,,,,,,CHO,Percentage Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,,6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.,J. Med. Chem.,1998,41,12,"Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW",,138723,DTCT0023280,1615393,DTCC00132960,1849811,14670
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,ED50,=,100,NM,,cell_based,,,,,,,,,,,NIH3T3,Amplification of transfected NIH3T3 cells was measured in Muscarinic acetylcholine receptor M3 required to produce half maximal effect,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138583,DTCT0023280,1610360,DTCC00132960,1838826,14722
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,ED50,=,2500,NM,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M3 values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol.,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138584,DTCT0023280,1610346,DTCC00132960,1838826,14722
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,STIMULATION,=,100,%,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M3. values are the maximal response obtained from the compound tested at 100 uM normalized to the effects of carbachol.,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138720,DTCT0023280,1610347,DTCC00132960,1838826,14722
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,880,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS radioligand using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139673,DTCT0023280,532132,DTCC00132960,1849757,2697
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,INHIBITION,=,4,%,,cell_based,,,,,,,,,,,CHO,Inhibition of binding of [3H]- quinuclidinyl benzilate to Muscarinic acetylcholine receptor M3 in membranes of CHO cells at 100 uM compound concentration,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138590,DTCT0023280,591961,DTCC00132960,1838814,15779
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,591962,DTCC00132960,1838814,15779
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12747793,KI,=,20000,NM,,,,,,,,,,,,,,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,,C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.,J. Med. Chem.,2003,46,11,"Kim MG, Bodor ET, Wang C, Harden TK, Kohn H",,138704,DTCT0023280,1072794,DTCC00132960,1849938,17326
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,ACTIVITY,=,350,%,,cell_based,,,,,,,,,,,A9,Ability to stimulate biochemical responses in cell lines expressing muscarinic A9 L receptor sub types,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138565,DTCT0023280,841457,DTCC00132960,1839668,17526
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,EC50,=,5.01187E+13,NM,,cell_based,,,,,,,,,,,A9,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138825,DTCT0023280,841456,DTCC00132960,1839668,17526
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,KI,=,6309.57,NM,,cell_based,,,,,,,,,,,A9,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138831,DTCT0023280,841455,DTCC00132960,1839668,17526
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,=,43651.58,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904077,DTCC00132960,1840771,20440
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,EC50,=,1819.7,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432435,DTCT0023280,2061465,DTCC00132960,1841083,22396
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,INTRINSIC ACTIVITY,=,1,,,cell_based,,,,,,,,,,,CHO,Intrinsic activity at muscarinic M3 receptor expressed in CHO cells assessed as ratio of agonist activity to activity of carbachol,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432440,DTCT0023280,2061464,DTCC00132960,1841083,22396
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,EC50,=,5011.87,NM,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001127,DTCC00132960,1852323,21638
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,6309.57,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,1999293,DTCC00132960,1852323,21638
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18077164,KI,=,43651.58,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,,"Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.",Bioorg. Med. Chem. Lett.,2008,18,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Buccioni M, Nesi M, Matucci R",,461882,DTCT0023280,2278181,DTCC00132960,1841480,25106
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,43651.58,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649045,DTCC00132960,1853023,31191
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,43651.58,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164338,DTCC00132960,1854277,36765
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,ACTIVITY,=,15.9,/S,,cell_based,,,,,,,,,,,HEK293,Agonist activity at M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as rate constant at 100 uM to 1 mM by FRET method,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723359,DTCT0023280,5123005,DTCC00132960,1843485,43500
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,EC50,=,1900,NM,,cell_based,,,,,,,,,,,HEK293,Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723353,DTCT0023280,5122982,DTCC00132960,1843485,43500
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,TIME,=,62.7,MS,,cell_based,,,,,,,,,,,HEK293,Agonist activity at M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as half-maximal activation time at 100 uM to 1 mM by FRET method,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723356,DTCT0023280,5122994,DTCC00132960,1843485,43500
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22329602,EC50,=,15000,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human M3 receptor in HEK293 cells assessed as induction of calcium response by fluorescence assay,,Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.,J. Med. Chem.,2012,55,5,"Daval SB, Valant C, Bonnet D, Kellenberger E, Hibert M, Galzi JL, Ilien B",,882205,DTCT0023280,11472215,DTCC00132960,1864605,51872
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24980056,KI,=,43651.58,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,,"Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.",Bioorg. Med. Chem. Lett.,2014,24,15,"Del Bello F, Bonifazi A, Quaglia W, Mazzolari A, Barocelli E, Bertoni S, Matucci R, Nesi M, Piergentili A, Vistoli G",,1459949,DTCT0023280,13906704,DTCC00132960,1866846,60777
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,100,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88022,DTCT0023280,744624,DTCC00132960,1851556,316
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,10600,NM,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity in SK-N-SH neuroblastoma cells expressing human muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88157,DTCT0023280,744625,DTCC00132960,1851556,316
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259114,DTCC00132960,1862714,46191
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259115,DTCC00132960,1862714,46191
CHEMBL14,P20309,CARBACHOL,AIXAANGOTKPUOY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,PI,=,100,%,,cell_based,,,,,,,,,,,CHO,Ability to stimulate inositol phosphate(PI) accumulation in CHO cells expressing human m3 receptor (max. concentration. 100 uM),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,139790,DTCT0023280,1483456,DTCC00132960,1851388,1549
CHEMBL140076,P20309,N-ALLYL BRUCINE IODIDE,AONOIOROLLXNKA-NZKWEKDOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.5,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1331770,DTCC01743364,788824,15566
CHEMBL140076,P20309,N-ALLYL BRUCINE IODIDE,AONOIOROLLXNKA-NZKWEKDOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.8,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1331769,DTCC01743364,788824,15566
CHEMBL140076,P20309,N-ALLYL BRUCINE IODIDE,AONOIOROLLXNKA-NZKWEKDOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1331777,DTCC01743364,788824,15566
CHEMBL140076,P20309,N-ALLYL BRUCINE IODIDE,AONOIOROLLXNKA-NZKWEKDOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1331782,DTCC01743364,788824,15566
CHEMBL1400945,P20309,PREGNENOLONE CARBONITRILE ,VSBHRRMYCDQLJF-ZDNYCOCVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400502,DTCC00805254,1220279,46191
CHEMBL1400945,P20309,PREGNENOLONE CARBONITRILE ,VSBHRRMYCDQLJF-ZDNYCOCVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400503,DTCC00805254,1220279,46191
CHEMBL1403281,P20309,ERGOCRYPTINE,YDOTUXAWKBPQJW-NSLWYYNWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293833,DTCC00807428,381005,46191
CHEMBL1403281,P20309,ERGOCRYPTINE,YDOTUXAWKBPQJW-NSLWYYNWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293834,DTCC00807428,381005,46191
CHEMBL1405,P20309,ESTRONE,DNXHEGUUPJUMQT-CBZIJGRNSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7317794,DTCC00418600,606969,46191
CHEMBL1405,P20309,ESTRONE,DNXHEGUUPJUMQT-CBZIJGRNSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7317795,DTCC00418600,606969,46191
CHEMBL14053,P20309,TRICHLOROACETIC ACID,YNJBWRMUSHSURL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7450947,DTCC00143400,444644,46191
CHEMBL14053,P20309,TRICHLOROACETIC ACID,YNJBWRMUSHSURL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7450948,DTCC00143400,444644,46191
CHEMBL14060,P20309,PHENOL,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387259,DTCC00143418,413974,46191
CHEMBL14060,P20309,PHENOL,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387260,DTCC00143418,413974,46191
CHEMBL141,P20309,LAMIVUDINE,JTEGQNOMFQHVDC-NKWVEPMBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407838,DTCC00160169,51484,46191
CHEMBL141,P20309,LAMIVUDINE,JTEGQNOMFQHVDC-NKWVEPMBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407839,DTCC00160169,51484,46191
CHEMBL1411979,P20309,METHAPYRILENE,HNJJXZKZRAWDPF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7423816,DTCC00815629,153445,46191
CHEMBL1411979,P20309,METHAPYRILENE,HNJJXZKZRAWDPF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7423817,DTCC00815629,153445,46191
CHEMBL1413,P20309,CICLOPIROX,SCKYRAXSEDYPSA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7341214,DTCC00427786,1416026,46191
CHEMBL1413,P20309,CICLOPIROX,SCKYRAXSEDYPSA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7341215,DTCC00427786,1416026,46191
CHEMBL141343,P20309,U-78517F,KPZQRBACZSLMPH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447456,DTCC01743360,671797,46191
CHEMBL141343,P20309,U-78517F,KPZQRBACZSLMPH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447457,DTCC01743360,671797,46191
CHEMBL141736,P20309,,ABXGTNGUHIUIPP-HWHTXHROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.5,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,366476,DTCC00322596,336606,15566
CHEMBL141736,P20309,,ABXGTNGUHIUIPP-HWHTXHROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,5,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1360518,DTCC00322596,336606,15566
CHEMBL141736,P20309,,ABXGTNGUHIUIPP-HWHTXHROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,<,0.2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,366495,DTCC00322596,336606,15566
CHEMBL141736,P20309,,ABXGTNGUHIUIPP-HWHTXHROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,366484,DTCC00322596,336606,15566
CHEMBL1419,P20309,SIBUTRAMINE,UNAANXDKBXWMLN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7473533,DTCC00432414,1765981,46191
CHEMBL1419,P20309,SIBUTRAMINE,UNAANXDKBXWMLN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7473534,DTCC00432414,1765981,46191
CHEMBL14192,P20309,BENZYLIMIDAZOLE,KKKDZZRICRFGSD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283528,DTCC00143373,381004,46191
CHEMBL14192,P20309,BENZYLIMIDAZOLE,KKKDZZRICRFGSD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283529,DTCC00143373,381004,46191
CHEMBL1423,P20309,PIMOZIDE,YVUQSNJEYSNKRX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,1955,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14732532,DTCC00436871,2103623,68826
CHEMBL1424807,P20309,,UDQMXYJSNNCRAS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23517028,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation after 15 mins by Alphascreen Surefire assay,Not Active,Biophysical fragment screening of the ß1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.,J. Med. Chem.,2013,56,9,"Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M",,944378,DTCT0023280,11811016,DTCC00827471,447207,54118
CHEMBL1424807,P20309,,UDQMXYJSNNCRAS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23517028,KI,>,19952.62,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]-NMS from recombinant muscarinic M3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by liquid scintillation counting analysis,,Biophysical fragment screening of the ß1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.,J. Med. Chem.,2013,56,9,"Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M",,944382,DTCT0023280,11811055,DTCC00827471,447207,54118
CHEMBL1425,P20309,MERCAPTOPURINE,GLVAUDGFNGKCSF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7300315,DTCC00110799,51440,46191
CHEMBL1425,P20309,MERCAPTOPURINE,GLVAUDGFNGKCSF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7300316,DTCC00110799,51440,46191
CHEMBL1428,P20309,NIMODIPINE,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388433,DTCC00437760,930083,46191
CHEMBL1428,P20309,NIMODIPINE,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388434,DTCC00437760,930083,46191
CHEMBL1430,P20309,PENICILLAMINE,VVNCNSJFMMFHPL-VKHMYHEASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401984,DTCC00441311,898294,46191
CHEMBL1430,P20309,PENICILLAMINE,VVNCNSJFMMFHPL-VKHMYHEASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401985,DTCC00441311,898294,46191
CHEMBL1431,P20309,METFORMIN,XZWYZXLIPXDOLR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421557,DTCC00441526,1318443,46191
CHEMBL1431,P20309,METFORMIN,XZWYZXLIPXDOLR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421558,DTCC00441526,1318443,46191
CHEMBL143228,P20309,,UGYPGJCVNPPUPE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,1.1,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573389,DTCC00326036,1142428,63971
CHEMBL143228,P20309,,UGYPGJCVNPPUPE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,,,,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,Not Determined,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573399,DTCC00326036,1142428,63971
CHEMBL1433,P20309,DOXYCYCLINE,JBIWCJUYHHGXTC-AKNGSSGZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330168,DTCC00443319,381009,46191
CHEMBL1433,P20309,DOXYCYCLINE,JBIWCJUYHHGXTC-AKNGSSGZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330169,DTCC00443319,381009,46191
CHEMBL143469,P20309,,INEDRTXKDAPQKU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,2.88,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13965496,DTCC00326299,934122,60063
CHEMBL14376,P20309,ILOPERIDONE,XMXHEBAFVSFQEX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11750183,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14732035,DTCC00143788,2104585,69484
CHEMBL1440,P20309,TETRACYCLINE,OFVLGDICTFRJMM-WESIUVDSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457073,DTCC00445351,51511,46191
CHEMBL1440,P20309,TETRACYCLINE,OFVLGDICTFRJMM-WESIUVDSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457074,DTCC00445351,51511,46191
CHEMBL1444,P20309,LETROZOLE,HPJKCIUCZWXJDR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433623,DTCC00445802,1285878,46191
CHEMBL1444,P20309,LETROZOLE,HPJKCIUCZWXJDR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433624,DTCC00445802,1285878,46191
CHEMBL1447,P20309,LINCOMYCIN,OJMMVQQUTAEWLP-KIDUDLJLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408103,DTCC00448831,1059331,46191
CHEMBL1447,P20309,LINCOMYCIN,OJMMVQQUTAEWLP-KIDUDLJLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408104,DTCC00448831,1059331,46191
CHEMBL1451,P20309,TRIAMCINOLONE,GFNANZIMVAIWHM-OBYCQNJPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442048,DTCC00451754,1512818,46191
CHEMBL1451,P20309,TRIAMCINOLONE,GFNANZIMVAIWHM-OBYCQNJPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442049,DTCC00451754,1512818,46191
CHEMBL1454,P20309,LEVAMISOLE,HLFSDGLLUJUHTE-SNVBAGLBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407973,DTCC00454681,1927017,46191
CHEMBL1454,P20309,LEVAMISOLE,HLFSDGLLUJUHTE-SNVBAGLBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407974,DTCC00454681,1927017,46191
CHEMBL1454946,P20309,FLUBENDAZOLE,CPEUVMUXAHMANV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7333149,DTCC00855742,51469,46191
CHEMBL1454946,P20309,FLUBENDAZOLE,CPEUVMUXAHMANV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7333150,DTCC00855742,51469,46191
CHEMBL1455,P20309,ALTRETAMINE,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7282925,DTCC00455954,800569,46191
CHEMBL1455,P20309,ALTRETAMINE,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7282926,DTCC00455954,800569,46191
CHEMBL1455766,P20309,,JEJWQCTZDAJWOX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24690494,KI,<,1000,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor (unknown origin),,Antagonists of the kappa opioid receptor.,Bioorg. Med. Chem. Lett.,2014,24,9,"Urbano M, Guerrero M, Rosen H, Roberts E",,1352902,DTCT0023280,13690243,DTCC00856520,1677898,58670
CHEMBL1456,P20309,MYCOPHENOLATE MOFETIL,RTGDFNSFWBGLEC-SYZQJQIISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434990,DTCC00456082,477918,46191
CHEMBL1456,P20309,MYCOPHENOLATE MOFETIL,RTGDFNSFWBGLEC-SYZQJQIISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434991,DTCC00456082,477918,46191
CHEMBL1458880,P20309,CADMIUM DICHLORIDE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258996,DTCC00859394,800572,46191
CHEMBL1458880,P20309,CADMIUM DICHLORIDE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258997,DTCC00859394,800572,46191
CHEMBL1459098,P20309,,CCNNNCNYEOXXMF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24164599,IC50,>,30000,NM,,cell_based,,,,,,,,,,,,Negative allosteric modulation of human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization incubated for 150 secs prior to acetylcholine induction by Fluo-4 AM staining-based fluorescence assay,,"Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).",J. Med. Chem.,2013,56,22,"Gentry PR, Kokubo M, Bridges TM, Kett NR, Harp JM, Cho HP, Smith E, Chase P, Hodder PS, Niswender CM, Daniels JS, Conn PJ, Wood MR, Lindsley CW",,1284793,DTCT0023280,12988111,DTCC00859592,707039,56851
CHEMBL145913,P20309,,SRNHSTWHMJIPBN-NLFFAJNJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,5.4,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1375717,DTCC00334901,77067,16058
CHEMBL1460,P20309,DIDANOSINE,BXZVVICBKDXVGW-NKWVEPMBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355229,DTCC00459811,348398,46191
CHEMBL1460,P20309,DIDANOSINE,BXZVVICBKDXVGW-NKWVEPMBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355230,DTCC00459811,348398,46191
CHEMBL146249,P20309,,MXMXMYWNGBMDEJ-IMSXRSKXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,11,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1370511,DTCC00333925,1468698,16058
CHEMBL146291,P20309,,RMIVAAULYORDDZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,93,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1390624,DTCC00334673,402212,16058
CHEMBL1463,P20309,FLUCYTOSINE,XRECTZIEBJDKEO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7307589,DTCC00462514,1674145,46191
CHEMBL1463,P20309,FLUCYTOSINE,XRECTZIEBJDKEO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7307590,DTCC00462514,1674145,46191
CHEMBL146307,P20309,,PQLJILRFRUEHRW-GJZUVCINSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,21,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1394331,DTCC00334984,1786542,16058
CHEMBL146351,P20309,,KYYKFSMOYWOWFU-RDPSFJRHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,16,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1373068,DTCC00333926,1724089,16058
CHEMBL146359,P20309,,OBBYKKSLZDOMNB-BWKNWUBXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,18,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1378180,DTCC00335178,1883361,16058
CHEMBL1464,P20309,WARFARIN,PJVWKTKQMONHTI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449551,DTCC00462727,2089753,46191
CHEMBL1464,P20309,WARFARIN,PJVWKTKQMONHTI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449552,DTCC00462727,2089753,46191
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,0.316,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362678,DTCC00864052,1523608,26143
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,2.07,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2911773,DTCC00864052,1536032,35090
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,KI,=,0.83,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581966,DTCT0023280,2910997,DTCC00864052,1536032,35090
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.19,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504631,DTCC00864052,1544931,46208
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.213,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776524,DTCT0023280,7504740,DTCC00864052,1544931,46208
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.29,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776521,DTCT0023280,7504624,DTCC00864052,1544931,46208
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,PKB,,,,,,,,,,,,,,,,,Antagonist activity at M3 receptor in human bronchial ring assessed as inhibition of electrically field-stimulated contractile response after 4 hrs,Not Determined,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776581,DTCT0023280,7504764,DTCC00864052,1544931,46208
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,0.0733,HR,,,,,,,,,,,,,,Displacement of radioligand from M3 receptor assessed as dissociation half life,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776591,DTCT0023280,7504797,DTCC00864052,1544931,46208
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,0.197,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 24 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776525,DTCT0023280,7504746,DTCC00864052,1544931,46208
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,0.283,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504610,DTCC00864052,1544931,46208
CHEMBL1464005,P20309,IPRATROPIUM BROMIDE,LHLMOSXCXGLMMN-WDTICOSOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,1.7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057453,DTCC00864052,1529060,58648
CHEMBL146464,P20309,,CJDXHNZNBXVNIP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,2.5,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1366529,DTCC00334967,627908,16058
CHEMBL146567,P20309,,ZHLYDKYZZGUNHA-GJZUVCINSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,2,NM,,cell_based,,,,,,,,,,,CHO,Ability to inhibit binding of [3H]NMS was determined by receptor binding assay using membranes from chinese hamster ovary (CHO) cells expressing cloned Muscarinic acetylcholine receptor M3,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,87678,DTCT0023280,1399319,DTCC00334581,205976,16058
CHEMBL1466,P20309,DICUMAROL,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7346664,DTCC00462777,1480345,46191
CHEMBL1466,P20309,DICUMAROL,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7346665,DTCC00462777,1480345,46191
CHEMBL1467,P20309,ALLOPURINOL,OFCNXPDARWKPPY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7282836,DTCC00463996,51443,46191
CHEMBL1467,P20309,ALLOPURINOL,OFCNXPDARWKPPY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7282837,DTCC00463996,51443,46191
CHEMBL147105,P20309,,MTBIBWFHYCAYTO-DVECYGJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,13,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1383291,DTCC00334527,563147,16058
CHEMBL1475,P20309,TRIOXSALEN,FMHHVULEAZTJMA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447341,DTCC00470391,153447,46191
CHEMBL1475,P20309,TRIOXSALEN,FMHHVULEAZTJMA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447342,DTCC00470391,153447,46191
CHEMBL147554,P20309,,DOPPWUHKJURUAH-GJZUVCINSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,17,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1375723,DTCC00335177,1694548,16058
CHEMBL147611,P20309,,HYOWZAANPMTHNJ-NLFFAJNJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,3.1,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1394344,DTCC00335149,595395,16058
CHEMBL147653,P20309,,KTCCCXMNJFFEIS-BWKNWUBXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,3.8,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1367807,DTCC00334645,1468699,16058
CHEMBL147672,P20309,,YKIZAJAMUKDIOU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,50,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1401828,DTCC00334472,1274134,16058
CHEMBL1476898,P20309,CADMIUM ACETATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279018,DTCC00876074,51449,46191
CHEMBL1476898,P20309,CADMIUM ACETATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279019,DTCC00876074,51449,46191
CHEMBL147695,P20309,,ZGVVXALTCVXMNS-XXBNENTESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,30,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1399326,DTCC00335122,756772,16058
CHEMBL1477,P20309,CERIVASTATIN,SEERZIQQUAZTOL-ANMDKAQQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7364398,DTCC00471235,736257,46191
CHEMBL1477,P20309,CERIVASTATIN,SEERZIQQUAZTOL-ANMDKAQQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7364399,DTCC00471235,736257,46191
CHEMBL147778,P20309,,HRBJAGYSTCJZLI-NLFFAJNJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,8.9,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1371816,DTCC00335095,854242,16058
CHEMBL1479,P20309,DANAZOL,POZRVZJJTULAOH-LHZXLZLDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,17747,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7367973,DTCC00472761,1512807,46191
CHEMBL1479,P20309,DANAZOL,POZRVZJJTULAOH-LHZXLZLDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,3762,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7367974,DTCC00472761,1512807,46191
CHEMBL1480,P20309,FELODIPINE,RZTAMFZIAATZDJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7326567,DTCC00472762,1894965,46191
CHEMBL1480,P20309,FELODIPINE,RZTAMFZIAATZDJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7326568,DTCC00472762,1894965,46191
CHEMBL1480987,P20309,CYCLANDELATE,WZHCOOQXZCIUNC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7348261,DTCC00879865,444638,46191
CHEMBL1480987,P20309,CYCLANDELATE,WZHCOOQXZCIUNC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7348262,DTCC00879865,444638,46191
CHEMBL1481,P20309,GLIMEPIRIDE,WIGIZIANZCJQQY-RUCARUNLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323097,DTCC00472763,1641848,46191
CHEMBL1481,P20309,GLIMEPIRIDE,WIGIZIANZCJQQY-RUCARUNLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323098,DTCC00472763,1641848,46191
CHEMBL148129,P20309,,OJFDFZDJBGCLLL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,12,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1390620,DTCC00334844,1047843,16058
CHEMBL1482157,P20309,,CKDRIMCQYYURDN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,59340,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist NMS competition at M3. (Class of assay: confirmatory) [Related pubchem assays: 1488 (Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist Confirmation Assay), 626 (Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist Primary Screen)]",Inconclusive,PUBCHEM BIOASSAY DATA SET,,,,,,,688684,DTCT0023280,4800311,DTCC00880935,85701,33038
CHEMBL1483,P20309,ALBENDAZOLE,HXHWSAZORRCQMX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296457,DTCC00474063,315661,46191
CHEMBL1483,P20309,ALBENDAZOLE,HXHWSAZORRCQMX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296458,DTCC00474063,315661,46191
CHEMBL148310,P20309,,KRCWDAGTDHZOFY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,220,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1393152,DTCC00334966,369371,16058
CHEMBL148328,P20309,,SQSAXGWIZUBYJD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,100,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1366538,DTCC00334904,1533438,16058
CHEMBL148404,P20309,,YPRMCONKNHLNEC-KOSHJBKYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,15,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1365314,DTCC00334349,173925,16058
CHEMBL148450,P20309,,LRYVHUGMUSRZRA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,5.9,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1391982,DTCC00334418,1786543,16058
CHEMBL148489,P20309,N-(3-PYRIDYLMETHYL)PYRROLIDINE,YFCWBKBNFCDPDF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478848,DTCC00339052,2026783,48255
CHEMBL1487,P20309,ATORVASTATIN,XUKUURHRXDUEBC-KAYWLYCHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7266636,DTCC00483650,1480343,46191
CHEMBL1487,P20309,ATORVASTATIN,XUKUURHRXDUEBC-KAYWLYCHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7266637,DTCC00483650,1480343,46191
CHEMBL1489,P20309,AZACITIDINE,NMUSYJAQQFHJEW-KVTDHHQDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276638,DTCC00484776,1416024,46191
CHEMBL1489,P20309,AZACITIDINE,NMUSYJAQQFHJEW-KVTDHHQDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276639,DTCC00484776,1416024,46191
CHEMBL1489254,P20309,TRIACETIN,URAYPUMNDPQOKB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440444,DTCC00887628,249945,46191
CHEMBL1489254,P20309,TRIACETIN,URAYPUMNDPQOKB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440445,DTCC00887628,249945,46191
CHEMBL1490,P20309,TRIHEXYPHENIDYL,HWHLPVGTWGOCJO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,6.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14742137,DTCC00112203,2107957,68417
CHEMBL1490,P20309,TRIHEXYPHENIDYL,HWHLPVGTWGOCJO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,2.45,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14742138,DTCC00112203,2107958,68416
CHEMBL1490,P20309,TRIHEXYPHENIDYL,HWHLPVGTWGOCJO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,1288.25,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14742139,DTCC00112203,2107958,68416
CHEMBL1490,P20309,TRIHEXYPHENIDYL,HWHLPVGTWGOCJO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,15,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442179,DTCC00112203,703988,46191
CHEMBL1490,P20309,TRIHEXYPHENIDYL,HWHLPVGTWGOCJO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,3.15,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442180,DTCC00112203,703988,46191
CHEMBL1491,P20309,AMLODIPINE,HTIQEAQVCYTUBX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299681,DTCC00112206,217573,46191
CHEMBL1491,P20309,AMLODIPINE,HTIQEAQVCYTUBX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299682,DTCC00112206,217573,46191
CHEMBL1493,P20309,FLAVOXATE,SPIUTQOUKAMGCX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7324540,DTCC00112214,1960075,46191
CHEMBL1493,P20309,FLAVOXATE,SPIUTQOUKAMGCX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7324541,DTCC00112214,1960075,46191
CHEMBL1493369,P20309,,MVMQESMQSYOVGV-OAHLLOKOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,138.04,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1002707,DTCC00891521,1469114,17703
CHEMBL149484,P20309,,WHFTUKDGFGFLCG-RLWLMLJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,3.5,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1386958,DTCC00334552,821325,16058
CHEMBL149486,P20309,,WOXZWDNEPKZBSN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,6.4,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1366534,DTCC00334419,983071,16058
CHEMBL149769,P20309,,OSKBHMKTWRTXFP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,17,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1393156,DTCC00334498,1241408,16058
CHEMBL1501,P20309,FLUOCINONIDE,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7307687,DTCC00485637,1253323,46191
CHEMBL1501,P20309,FLUOCINONIDE,WJOHZNCJWYWUJD-IUGZLZTKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7307688,DTCC00485637,1253323,46191
CHEMBL1502,P20309,PANTOPRAZOLE,IQPSEEYGBUAQFF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401862,DTCC00485677,1027057,46191
CHEMBL1502,P20309,PANTOPRAZOLE,IQPSEEYGBUAQFF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401863,DTCC00485677,1027057,46191
CHEMBL150219,P20309,,KYYKFSMOYWOWFU-YKSBVNFPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,6.2,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1383284,DTCC00335391,1597924,16058
CHEMBL1503,P20309,OMEPRAZOLE,SUBDBMMJDZJVOS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7399506,DTCC00485679,1609551,46191
CHEMBL1503,P20309,OMEPRAZOLE,SUBDBMMJDZJVOS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7399507,DTCC00485679,1609551,46191
CHEMBL1504,P20309,TRIAMCINOLONE ACETONIDE,YNDXUCZADRHECN-JNQJZLCISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443647,DTCC00485699,833165,46191
CHEMBL1504,P20309,TRIAMCINOLONE ACETONIDE,YNDXUCZADRHECN-JNQJZLCISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443648,DTCC00485699,833165,46191
CHEMBL1512,P20309,FLUNISOLIDE,XSFJVAJPIHIPKU-XWCQMRHXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7328958,DTCC00486813,703980,46191
CHEMBL1512,P20309,FLUNISOLIDE,XSFJVAJPIHIPKU-XWCQMRHXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7328959,DTCC00486813,703980,46191
CHEMBL1513,P20309,IRBESARTAN,YOSHYTLCDANDAN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416184,DTCC00486818,1609548,46191
CHEMBL1513,P20309,IRBESARTAN,YOSHYTLCDANDAN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416185,DTCC00486818,1609548,46191
CHEMBL1515,P20309,METHIMAZOLE,PMRYVIKBURPHAH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7428102,DTCC00486838,153446,46191
CHEMBL1515,P20309,METHIMAZOLE,PMRYVIKBURPHAH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7428103,DTCC00486838,153446,46191
CHEMBL1515611,P20309,BROMISOVALUM,CMCCHHWTTBEZNM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7267556,DTCC00912063,1220274,46191
CHEMBL1515611,P20309,BROMISOVALUM,CMCCHHWTTBEZNM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7267557,DTCC00912063,1220274,46191
CHEMBL1516176,P20309,,PDNJLMZEGXHSCU-VKHMYHEASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14742316,DTCC00912618,2108018,69159
CHEMBL1517,P20309,OXYTETRACYCLINE,IWVCMVBTMGNXQD-PXOLEDIWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388938,DTCC00486898,413973,46191
CHEMBL1517,P20309,OXYTETRACYCLINE,IWVCMVBTMGNXQD-PXOLEDIWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388939,DTCC00486898,413973,46191
CHEMBL1518,P20309,PROPYLTHIOURACIL,KNAHARQHSZJURB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7377132,DTCC00486945,348404,46191
CHEMBL1518,P20309,PROPYLTHIOURACIL,KNAHARQHSZJURB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7377133,DTCC00486945,348404,46191
CHEMBL151938,P20309,MILAMELINE,YMMXHEYLRHNXAB-RMKNXTFCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,=,58.6,%,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060850,DTCC00343278,966623,61603
CHEMBL1521,P20309,ZALEPLON,HUNXMJYCHXQEGX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443433,DTCC00487037,994596,46191
CHEMBL1521,P20309,ZALEPLON,HUNXMJYCHXQEGX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443434,DTCC00487037,994596,46191
CHEMBL15245,P20309,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7453283,DTCC00144859,88638,46191
CHEMBL15245,P20309,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7453284,DTCC00144859,88638,46191
CHEMBL1527608,P20309,DOXOFYLLINE,HWXIGFIVGWUZAO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7321570,DTCC00923329,88626,46191
CHEMBL1527608,P20309,DOXOFYLLINE,HWXIGFIVGWUZAO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7321571,DTCC00923329,88626,46191
CHEMBL1529,P20309,DIPHENIDOL HYDROCHLORIDE,AVZIYZHXZAYGJS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,8.91251E+14,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368137,DTCC00491244,1841660,26235
CHEMBL153062,P20309,4-NONYLPHENOL,IGFHQQFPSIBGKE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7289465,DTCC00341324,1609541,46191
CHEMBL153062,P20309,4-NONYLPHENOL,IGFHQQFPSIBGKE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7289466,DTCC00341324,1609541,46191
CHEMBL1531134,P20309,MELPERONE,DKMFBWQBDIGMHM-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14737950,DTCC00926655,2106476,68417
CHEMBL153479,P20309,AMBROXOL,JBDGDEWWOUBZPM-XYPYZODXSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288679,DTCC00342236,2057643,46191
CHEMBL153479,P20309,AMBROXOL,JBDGDEWWOUBZPM-XYPYZODXSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288680,DTCC00342236,2057643,46191
CHEMBL1535,P20309,HYDROXYCHLOROQUINE,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310736,DTCC00494467,1416033,46191
CHEMBL1535,P20309,HYDROXYCHLOROQUINE,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310737,DTCC00494467,1416033,46191
CHEMBL1535797,P20309,,YIWXEUIRYNIJHG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,12390,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist NMS competition at M3. (Class of assay: confirmatory) [Related pubchem assays: 1488 (Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist Confirmation Assay), 626 (Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist Primary Screen)]",Inconclusive,PUBCHEM BIOASSAY DATA SET,,,,,,,688684,DTCT0023280,4800310,DTCC00931027,1477394,33038
CHEMBL1536,P20309,ERGOCALCIFEROL,MECHNRXZTMCUDQ-RKHKHRCZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319700,DTCC00494790,348400,46191
CHEMBL1536,P20309,ERGOCALCIFEROL,MECHNRXZTMCUDQ-RKHKHRCZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319701,DTCC00494790,348400,46191
CHEMBL1537,P20309,AZLOCILLIN,JTWOMNBEOCYFNV-NFFDBFGFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7275188,DTCC00495073,1059328,46191
CHEMBL1537,P20309,AZLOCILLIN,JTWOMNBEOCYFNV-NFFDBFGFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7275189,DTCC00495073,1059328,46191
CHEMBL1539,P20309,SULFADOXINE,PJSFRIWCGOHTNF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7480468,DTCC00495107,1512817,46191
CHEMBL1539,P20309,SULFADOXINE,PJSFRIWCGOHTNF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7480469,DTCC00495107,1512817,46191
CHEMBL154,P20309,NAPROXEN,CMWTZPSULFXXJA-VIFPVBQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392472,DTCC00174165,1992809,46191
CHEMBL154,P20309,NAPROXEN,CMWTZPSULFXXJA-VIFPVBQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392473,DTCC00174165,1992809,46191
CHEMBL1540,P20309,PENCICLOVIR,JNTOCHDNEULJHD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7397645,DTCC00495142,1577007,46191
CHEMBL1540,P20309,PENCICLOVIR,JNTOCHDNEULJHD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7397646,DTCC00495142,1577007,46191
CHEMBL154111,P20309,SALSALATE,WVYADZUPLLSGPU-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7471131,DTCC00343795,1894974,46191
CHEMBL154111,P20309,SALSALATE,WVYADZUPLLSGPU-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7471132,DTCC00343795,1894974,46191
CHEMBL1542,P20309,AZATHIOPRINE,LMEKQMALGUDUQG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7266764,DTCC00495633,962447,46191
CHEMBL1542,P20309,AZATHIOPRINE,LMEKQMALGUDUQG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7266765,DTCC00495633,962447,46191
CHEMBL1544,P20309,LIOTHYRONINE,AUYYCJSJGJYCDS-LBPRGKRZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296002,DTCC00497321,1480341,46191
CHEMBL1544,P20309,LIOTHYRONINE,AUYYCJSJGJYCDS-LBPRGKRZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296003,DTCC00497321,1480341,46191
CHEMBL15511,P20309,ENROFLOXACIN,SPFYMRJSYKOXGV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7332428,DTCC00145113,1577005,46191
CHEMBL15511,P20309,ENROFLOXACIN,SPFYMRJSYKOXGV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7332429,DTCC00145113,1577005,46191
CHEMBL1554,P20309,DACTINOMYCIN,RJURFGZVJUQBHK-IIXSONLDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365620,DTCC00113195,2089745,46191
CHEMBL1554,P20309,DACTINOMYCIN,RJURFGZVJUQBHK-IIXSONLDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365621,DTCC00113195,2089745,46191
CHEMBL1559151,P20309,,XKJQVUIXSBOCPP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,360100,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist NMS competition at M3. (Class of assay: confirmatory) [Related pubchem assays: 1488 (Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist Confirmation Assay), 626 (Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist Primary Screen)]",Inconclusive,PUBCHEM BIOASSAY DATA SET,,,,,,,688684,DTCT0023280,4800309,DTCC00952613,1024084,33038
CHEMBL1559535,P20309,,LCRABWZMGNEZJV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23517028,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation after 15 mins by Alphascreen Surefire assay,Not Active,Biophysical fragment screening of the ß1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.,J. Med. Chem.,2013,56,9,"Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M",,944378,DTCT0023280,11811014,DTCC00952975,220252,54118
CHEMBL1559535,P20309,,LCRABWZMGNEZJV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23517028,KI,>,19952.62,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]-NMS from recombinant muscarinic M3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by liquid scintillation counting analysis,,Biophysical fragment screening of the ß1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.,J. Med. Chem.,2013,56,9,"Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M",,944382,DTCT0023280,11811053,DTCC00952975,220252,54118
CHEMBL1560,P20309,CAPTOPRIL,FAKRSMQSSFJEIM-RQJHMYQMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279132,DTCC00507377,1092341,46191
CHEMBL1560,P20309,CAPTOPRIL,FAKRSMQSSFJEIM-RQJHMYQMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279133,DTCC00507377,1092341,46191
CHEMBL156455,P20309,"1,1-DICHLOROETHENE",LGXVIGDEPROXKC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7287919,DTCC00349580,866014,46191
CHEMBL156455,P20309,"1,1-DICHLOROETHENE",LGXVIGDEPROXKC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7287920,DTCC00349580,866014,46191
CHEMBL1564753,P20309,,FPBRFRSODHILCO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21194936,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at M3 receptor,,"Discovery and optimization of a novel, selective and brain penetrant M(1) positive allosteric modulator (PAM): The development of ML169, an MLPCN probe.",Bioorg. Med. Chem. Lett.,2011,21,9,"Reid PR, Bridges TM, Sheffler DJ, Cho HP, Lewis LM, Days E, Daniels JS, Jones CK, Niswender CM, Weaver CD, Conn PJ, Lindsley CW, Wood MR",,745348,DTCT0023280,5940382,DTCC00957819,426960,44108
CHEMBL1566,P20309,ACARBOSE,XUFXOAAUWZOOIT-SXARVLRPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7289553,DTCC00510603,994587,46191
CHEMBL1566,P20309,ACARBOSE,XUFXOAAUWZOOIT-SXARVLRPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7289554,DTCC00510603,994587,46191
CHEMBL1566249,P20309,AMPIROXICAM,LSNWBKACGXCGAJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7294237,DTCC00959245,800570,46191
CHEMBL1566249,P20309,AMPIROXICAM,LSNWBKACGXCGAJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7294238,DTCC00959245,800570,46191
CHEMBL1566956,P20309,TROXIPIDE,YSIITVVESCNIPR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443886,DTCC00959918,283002,46191
CHEMBL1566956,P20309,TROXIPIDE,YSIITVVESCNIPR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443887,DTCC00959918,283002,46191
CHEMBL1567463,P20309,CHOLINE ALFOSCERATE,SUHOQUVVVLNYQR-MRVPVSSYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7362568,DTCC00960399,315662,46191
CHEMBL1567463,P20309,CHOLINE ALFOSCERATE,SUHOQUVVVLNYQR-MRVPVSSYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7362569,DTCC00960399,315662,46191
CHEMBL15675,P20309,,WRBQCJLTQVVWLA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9438027,IC50,=,9700,NM,,cell_based,,,,,,,,,,,CHO,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,,"Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.",J. Med. Chem.,1998,41,1,"Sauerberg P, Olesen PH, Sheardown MJ, Rimvall K, Thøgersen H, Shannon HE, Sawyer BD, Ward JS, Bymaster FP, DeLapp NW, Calligaro DO, Swedberg MD",,138982,DTCT0023280,1562867,DTCC00146080,517470,14608
CHEMBL1568,P20309,FLUDARABINE,HBUBKKRHXORPQB-FJFJXFQQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7311909,DTCC00513782,1894966,46191
CHEMBL1568,P20309,FLUDARABINE,HBUBKKRHXORPQB-FJFJXFQQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7311910,DTCC00513782,1894966,46191
CHEMBL157138,P20309,LISURIDE,BKRGVLQUQGGVSM-KBXCAEBGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421029,DTCC00350629,1447884,46191
CHEMBL157138,P20309,LISURIDE,BKRGVLQUQGGVSM-KBXCAEBGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421030,DTCC00350629,1447884,46191
CHEMBL1572,P20309,NETILMICIN,CIDUJQMULVCIBT-MQDUPKMGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379605,DTCC00514638,1734059,46191
CHEMBL1572,P20309,NETILMICIN,CIDUJQMULVCIBT-MQDUPKMGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379606,DTCC00514638,1734059,46191
CHEMBL157548,P20309,DANOFLOXACIN,QMLVECGLEOSESV-RYUDHWBXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7337834,DTCC00348763,1798407,46191
CHEMBL157548,P20309,DANOFLOXACIN,QMLVECGLEOSESV-RYUDHWBXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7337835,DTCC00348763,1798407,46191
CHEMBL15770,P20309,SULINDAC,MLKXDPUZXIRXEP-MFOYZWKCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458880,DTCC00145905,930088,46191
CHEMBL15770,P20309,SULINDAC,MLKXDPUZXIRXEP-MFOYZWKCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458881,DTCC00145905,930088,46191
CHEMBL158,P20309,AZTREONAM,WZPBZJONDBGPKJ-VEHQQRBSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7278148,DTCC00182933,510296,46191
CHEMBL158,P20309,AZTREONAM,WZPBZJONDBGPKJ-VEHQQRBSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7278149,DTCC00182933,510296,46191
CHEMBL1586,P20309,BECLOMETHASONE,NBMKJKDGKREAPL-DVTGEIKXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7272360,DTCC00514882,1188063,46191
CHEMBL1586,P20309,BECLOMETHASONE,NBMKJKDGKREAPL-DVTGEIKXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7272361,DTCC00514882,1188063,46191
CHEMBL159,P20309,VINBLASTINE,JXLYSJRDGCGARV-CFWMRBGOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440921,DTCC00190732,1577012,46191
CHEMBL159,P20309,VINBLASTINE,JXLYSJRDGCGARV-CFWMRBGOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440922,DTCC00190732,1577012,46191
CHEMBL1592,P20309,QUINAPRIL,JSDRRTOADPPCHY-HSQYWUDLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7377344,DTCC00515121,1705879,46191
CHEMBL1592,P20309,QUINAPRIL,JSDRRTOADPPCHY-HSQYWUDLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7377345,DTCC00515121,1705879,46191
CHEMBL15928,P20309,GR-127935,YDBCEBYHYKAFRX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8057272,KI,<,1000,NM,,,,,,,,,,,,,,Binding affinity against muscarinic M3 receptor,,"Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists.",J. Med. Chem.,1994,37,15,"Clitherow JW, Scopes DI, Skingle M, Jordan CC, Feniuk W, Campbell IB, Carter MC, Collington EW, Connor HE, Higgins GA",,138259,DTCT0023280,581496,DTCC00145820,1681941,12559
CHEMBL15928,P20309,GR-127935,YDBCEBYHYKAFRX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1846163,DTCC00145820,1695325,19805
CHEMBL15936,P20309,,RMTXTNQLNMQOTD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9438027,IC50,=,100000,NM,,cell_based,,,,,,,,,,,CHO,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,,"Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.",J. Med. Chem.,1998,41,1,"Sauerberg P, Olesen PH, Sheardown MJ, Rimvall K, Thøgersen H, Shannon HE, Sawyer BD, Ward JS, Bymaster FP, DeLapp NW, Calligaro DO, Swedberg MD",,138982,DTCT0023280,1578158,DTCC00146131,1616778,14608
CHEMBL15944,P20309,,SGQUZSYRIZOLFQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9438027,IC50,=,1600,NM,,cell_based,,,,,,,,,,,CHO,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,,"Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.",J. Med. Chem.,1998,41,1,"Sauerberg P, Olesen PH, Sheardown MJ, Rimvall K, Thøgersen H, Shannon HE, Sawyer BD, Ward JS, Bymaster FP, DeLapp NW, Calligaro DO, Swedberg MD",,138982,DTCT0023280,1583522,DTCC00146312,1934022,14608
CHEMBL1598608,P20309,AZASETRON,WUKZPHOXUVCQOR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7262527,DTCC00989336,1734053,46191
CHEMBL1598608,P20309,AZASETRON,WUKZPHOXUVCQOR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7263849,DTCC00989336,1734053,46191
CHEMBL16,P20309,PHENYTOIN,CXOFVDLJLONNDW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374389,DTCC00132980,51500,46191
CHEMBL16,P20309,PHENYTOIN,CXOFVDLJLONNDW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374390,DTCC00132980,51500,46191
CHEMBL160,P20309,CYCLOSPORINE,PMATZTZNYRCHOR-CGLBZJNRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365517,DTCC00191777,51461,46191
CHEMBL160,P20309,CYCLOSPORINE,PMATZTZNYRCHOR-CGLBZJNRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365518,DTCC00191777,51461,46191
CHEMBL1601669,P20309,ALFACALCIDOL,OFHCOWSQAMBJIW-AVJTYSNKSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302145,DTCC00992187,217572,46191
CHEMBL1601669,P20309,ALFACALCIDOL,OFHCOWSQAMBJIW-AVJTYSNKSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302146,DTCC00992187,217572,46191
CHEMBL1602658,P20309,,AAJHOEQMTSTUJP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25147929,EC50,>,30000,NM,,cell_based,,,,,,,,,,,,Activity at human muscarinic acetylcholine receptor subtype 3 expressed in CHO cells by calcium mobilization assay,,"Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380).",J. Med. Chem.,2014,57,18,"Gentry PR, Kokubo M, Bridges TM, Noetzel MJ, Cho HP, Lamsal A, Smith E, Chase P, Hodder PS, Niswender CM, Daniels JS, Conn PJ, Lindsley CW, Wood MR",,1457825,DTCT0023280,13953778,DTCC00993115,816821,59741
CHEMBL16068,P20309,BROMOBENZENE,QARVLSVVCXYDNA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7270208,DTCC00145980,2057646,46191
CHEMBL16068,P20309,BROMOBENZENE,QARVLSVVCXYDNA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7270209,DTCC00145980,2057646,46191
CHEMBL16073,P20309,PHENACETIN,CPJSUEIXXCENMM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404382,DTCC00145899,120977,46191
CHEMBL16073,P20309,PHENACETIN,CPJSUEIXXCENMM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404383,DTCC00145899,120977,46191
CHEMBL1612004,P20309,,VMPITZXILSNTON-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7382249,DTCC01001920,736263,46191
CHEMBL1612004,P20309,,VMPITZXILSNTON-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7382250,DTCC01001920,736263,46191
CHEMBL1614641,P20309,FLUNOXAPROFEN,ARPYQKTVRGFPIS-VIFPVBQESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7333250,DTCC01003541,510300,46191
CHEMBL1614641,P20309,FLUNOXAPROFEN,ARPYQKTVRGFPIS-VIFPVBQESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7333251,DTCC01003541,510300,46191
CHEMBL1614664,P20309,PSEUDOHYPERICIN,YXBUQQDFTYOHQI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14759175,DTCC01003548,2107269,69275
CHEMBL1614664,P20309,PSEUDOHYPERICIN,YXBUQQDFTYOHQI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14759824,DTCC01003548,2107269,69275
CHEMBL1615433,P20309,,OEXHQOGQTVQTAT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11303071,KI,=,0.51,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14735321,DTCC01003651,2105593,68460
CHEMBL1618305,P20309,NALOXONAZINE,AJPSBXJNFJCCBI-YOHUGVJRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411656,DTCC01006289,120976,46191
CHEMBL1618305,P20309,NALOXONAZINE,AJPSBXJNFJCCBI-YOHUGVJRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411657,DTCC01006289,120976,46191
CHEMBL1619,P20309,CLADRIBINE,PTOAARAWEBMLNO-KVQBGUIXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7367120,DTCC00525900,217575,46191
CHEMBL1619,P20309,CLADRIBINE,PTOAARAWEBMLNO-KVQBGUIXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7367121,DTCC00525900,217575,46191
CHEMBL1621597,P20309,IPRATROPIUM,OEXHQOGQTVQTAT-BHIXFJMTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,<,0.25,HR,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573407,DTCC01009446,528171,63971
CHEMBL1624037,P20309,,ZBSSIYGXZQZYDM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21930376,EC50,>,30000,NM,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant muscarinic M3 receptor by HTS cell based assay,,"Development of a highly selective, orally bioavailable and CNS penetrant M(1) agonist derived from the MLPCN probe ML071.",Bioorg. Med. Chem. Lett.,2011,21,21,"Lebois EP, Digby GJ, Sheffler DJ, Melancon BJ, Tarr JC, Cho HP, Miller NR, Morrison R, Bridges TM, Xiang Z, Scott Daniels J, Wood MR, Jeffrey Conn P, Lindsley CW",,788153,DTCT0023280,7525534,DTCC01011793,768521,46139
CHEMBL1624037,P20309,,ZBSSIYGXZQZYDM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,ACTIVITY,,,,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor by calcium mobilization assay,Not Active,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815541,DTCT0023280,10459157,DTCC01011793,769500,48012
CHEMBL1624037,P20309,,ZBSSIYGXZQZYDM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,EC50,,,,,,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor by calcium mobilization assay,Not Active,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815537,DTCT0023280,10455675,DTCC01011793,769500,48012
CHEMBL162477,P20309,,JTTPGMRULUVVEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1122908,DTCC00358485,584093,10523
CHEMBL162477,P20309,,JTTPGMRULUVVEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,6,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1122909,DTCC00358485,584093,10523
CHEMBL1626,P20309,CLEMASTINE,YNNUSGIPVFPVBX-NHCUHLMSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,39,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7339343,DTCC00527946,639576,46191
CHEMBL1626,P20309,CLEMASTINE,YNNUSGIPVFPVBX-NHCUHLMSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,8.25,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7339344,DTCC00527946,639576,46191
CHEMBL1627,P20309,,ZMOPTLXEYOVARP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18783208,ACTIVITY,<,50,%,,,,,,,,,,,,,,Displacement of [3H]QNB from human muscarinic M3 receptor at 10 uM,,Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function.,J. Med. Chem.,2008,51,19,"Lazarova N, Zoghbi SS, Hong J, Seneca N, Tuan E, Gladding RL, Liow JS, Taku A, Innis RB, Pike VW",,539331,DTCT0023280,2565787,DTCC00528903,2048118,31935
CHEMBL1628227,P20309,DOXEPIN,ODQWQRRAPPTVAG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,69,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349210,DTCC01015577,898288,46191
CHEMBL1628227,P20309,DOXEPIN,ODQWQRRAPPTVAG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,15,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349211,DTCC01015577,898288,46191
CHEMBL1629810,P20309,2-HYDROXYPROPYL-BETA-CYCLODEXTRIN,BIIFEDMBGOQTDO-USCPGHQQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7301580,DTCC00033243,510295,46191
CHEMBL1629810,P20309,2-HYDROXYPROPYL-BETA-CYCLODEXTRIN,BIIFEDMBGOQTDO-USCPGHQQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7301581,DTCC00033243,510295,46191
CHEMBL163,P20309,RITONAVIR,NCDNCNXCDXHOMX-XGKFQTDJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470867,DTCC00204116,51505,46191
CHEMBL163,P20309,RITONAVIR,NCDNCNXCDXHOMX-XGKFQTDJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470868,DTCC00204116,51505,46191
CHEMBL1630287,P20309,,SPJFAHGKPNJTEC-JGVFFNPUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20932609,ACTIVITY,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]quinuclidinyl benzylate from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,Synthesis of novel chiral ¿2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.,Eur. J. Med. Chem.,2010,45,12,"Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, De Micheli C",,696896,DTCT0023280,5023970,DTCC00127317,1460671,42205
CHEMBL1630288,P20309,,SPJFAHGKPNJTEC-YUMQZZPRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20932609,ACTIVITY,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]quinuclidinyl benzylate from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,Synthesis of novel chiral ¿2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.,Eur. J. Med. Chem.,2010,45,12,"Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, De Micheli C",,696896,DTCT0023280,5023971,DTCC00127318,716709,42205
CHEMBL1630289,P20309,,UPEAJKMAKIXYFZ-DTWKUNHWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20932609,ACTIVITY,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]quinuclidinyl benzylate from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,Synthesis of novel chiral ¿2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.,Eur. J. Med. Chem.,2010,45,12,"Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, De Micheli C",,696896,DTCT0023280,5023972,DTCC01016150,974974,42205
CHEMBL1630290,P20309,,BUAOTVHPQXTFOP-NTSWFWBYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20932609,ACTIVITY,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]quinuclidinyl benzylate from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,Synthesis of novel chiral ¿2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.,Eur. J. Med. Chem.,2010,45,12,"Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, De Micheli C",,696896,DTCT0023280,5023973,DTCC01016151,490923,42205
CHEMBL1630291,P20309,,HQIUWJQPBRHHAF-NKWVEPMBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20932609,ACTIVITY,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]quinuclidinyl benzylate from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,Synthesis of novel chiral ¿2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.,Eur. J. Med. Chem.,2010,45,12,"Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, De Micheli C",,696896,DTCT0023280,5023974,DTCC01016152,974975,42205
CHEMBL1630292,P20309,,IWHMHIGCZDANJP-NKWVEPMBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20932609,ACTIVITY,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]quinuclidinyl benzylate from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,Synthesis of novel chiral ¿2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.,Eur. J. Med. Chem.,2010,45,12,"Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, De Micheli C",,696896,DTCT0023280,5023975,DTCC01016153,230553,42205
CHEMBL1630293,P20309,,IWHMHIGCZDANJP-BQBZGAKWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20932609,ACTIVITY,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]quinuclidinyl benzylate from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,Synthesis of novel chiral ¿2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.,Eur. J. Med. Chem.,2010,45,12,"Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, De Micheli C",,696896,DTCT0023280,5023976,DTCC01016154,1654702,42205
CHEMBL1630294,P20309,,ZEDLJHYUUZMPBO-JGVFFNPUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20932609,ACTIVITY,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]quinuclidinyl benzylate from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,Synthesis of novel chiral ¿2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.,Eur. J. Med. Chem.,2010,45,12,"Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, De Micheli C",,696896,DTCT0023280,5023977,DTCC01016155,15118,42205
CHEMBL1630295,P20309,,LAUIYVZDKSCUAB-IUCAKERBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20932609,ACTIVITY,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]quinuclidinyl benzylate from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,Synthesis of novel chiral ¿2-isoxazoline derivatives related to ABT-418 and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.,Eur. J. Med. Chem.,2010,45,12,"Dallanoce C, Magrone P, Matera C, Lo Presti L, De Amici M, Riganti L, Clementi F, Gotti C, De Micheli C",,696896,DTCT0023280,5023978,DTCC01016156,1811022,42205
CHEMBL1630578,P20309,TIRILIZAD,RBKASMJPSJDQKY-RBFSKHHSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7455262,DTCC01016434,1798419,46191
CHEMBL1630578,P20309,TIRILIZAD,RBKASMJPSJDQKY-RBFSKHHSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7455263,DTCC01016434,1798419,46191
CHEMBL1630579,P20309,MYRTECAINE,BZRYYBWNOUALTQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7409362,DTCC01016435,1416036,46191
CHEMBL1630579,P20309,MYRTECAINE,BZRYYBWNOUALTQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7409363,DTCC01016435,1416036,46191
CHEMBL1632158,P20309,,RNXYMZNGMNWKMC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075638,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to muscarinic acetylcholine receptor M3,,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,2010,18,24,"Brudeli B, Moltzau LR, Andressen KW, Krobert KA, Klaveness J, Levy FO",,697211,DTCT0023280,5017462,DTCC01017945,1445751,42157
CHEMBL1632174,P20309,,ODMLUIATXKBXOW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075638,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to muscarinic acetylcholine receptor M3,,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,2010,18,24,"Brudeli B, Moltzau LR, Andressen KW, Krobert KA, Klaveness J, Levy FO",,697211,DTCT0023280,5017463,DTCC01017961,1185873,42157
CHEMBL164290,P20309,N-NITROSODIETHYLAMINE,WBNQDOYYEUMPFS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7413695,DTCC00108812,703983,46191
CHEMBL164290,P20309,N-NITROSODIETHYLAMINE,WBNQDOYYEUMPFS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7413696,DTCC00108812,703983,46191
CHEMBL1643,P20309,RIBAVIRIN,IWUCXVSUMQZMFG-AFCXAGJDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470747,DTCC00540588,217584,46191
CHEMBL1643,P20309,RIBAVIRIN,IWUCXVSUMQZMFG-AFCXAGJDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470748,DTCC00540588,217584,46191
CHEMBL1643899,P20309,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21146989,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700892,DTCT0023280,5036636,DTCC01020576,166198,42620
CHEMBL1643899,P20309,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601393,DTCC01020576,168448,55935
CHEMBL1643900,P20309,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21146989,KI,=,1395,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700893,DTCT0023280,5036576,DTCC01020577,942929,42620
CHEMBL1643900,P20309,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,1395,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598957,DTCC01020577,945255,55935
CHEMBL1643901,P20309,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21146989,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700892,DTCT0023280,5036698,DTCC01020578,1460729,42620
CHEMBL1643901,P20309,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601405,DTCC01020578,1463030,55935
CHEMBL1643902,P20309,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21146989,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011,21,1,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700892,DTCT0023280,5036730,DTCC01020579,619871,42620
CHEMBL1643902,P20309,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601401,DTCC01020579,622243,55935
CHEMBL1644612,P20309,,PQTKLDRCMUNDCS-IZZQQSIFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21112782,INHIBITION,<,60,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 10 uM,,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,2011,21,1,"Angus D, Bingham M, Buchanan D, Dunbar N, Gibson L, Goodwin R, Haunsø A, Houghton A, Huggett M, Morphy R, Napier S, Nimz O, Passmore J, Walker G",,700300,DTCT0023280,5049186,DTCC01021261,1654766,42542
CHEMBL165,P20309,RESVERATROL,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466387,DTCC00217176,930085,46191
CHEMBL165,P20309,RESVERATROL,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466388,DTCC00217176,930085,46191
CHEMBL1650,P20309,CORTISONE ACETATE,ITRJWOMZKQRYTA-RFZYENFJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365397,DTCC00542150,1705875,46191
CHEMBL1650,P20309,CORTISONE ACETATE,ITRJWOMZKQRYTA-RFZYENFJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365398,DTCC00542150,1705875,46191
CHEMBL1650844,P20309,,MEBYDATXPNEUSM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20875743,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 1 uM relative to control,,"Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships.",Bioorg. Med. Chem.,2010,18,21,"Hayashi S, Nakata E, Morita A, Mizuno K, Yamamura K, Kato A, Ohashi K",,714735,DTCT0023280,5075441,DTCC01023170,1137420,43117
CHEMBL1651208,P20309,,DWTYHCYVKJONSP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23009245,INHIBITION,=,-2,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human muscarinic M3 receptor at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012,55,22,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876190,DTCT0023280,11437747,DTCC01023515,317585,51586
CHEMBL1651219,P20309,,ZQBPXBADOJMCRU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23009245,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human muscarinic M3 receptor at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012,55,22,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876190,DTCT0023280,11437698,DTCC01023526,1675972,51586
CHEMBL1651906,P20309,STREPTOZOTOCIN,ZSJLQEPLLKMAKR-YDEIVXIUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7480350,DTCC01024120,1318448,46191
CHEMBL1651906,P20309,STREPTOZOTOCIN,ZSJLQEPLLKMAKR-YDEIVXIUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7480351,DTCC01024120,1318448,46191
CHEMBL165790,P20309,IPRIFLAVONE,SFBODOKJTYAUCM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407516,DTCC00358921,542578,46191
CHEMBL165790,P20309,IPRIFLAVONE,SFBODOKJTYAUCM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407517,DTCC00358921,542578,46191
CHEMBL1660,P20309,RIFAPENTINE,WDZCUPBHRAEYDL-GZAUEHORSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483767,DTCC00550275,930086,46191
CHEMBL1660,P20309,RIFAPENTINE,WDZCUPBHRAEYDL-GZAUEHORSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483768,DTCC00550275,930086,46191
CHEMBL166385,P20309,,KNYTYCPABXXTHV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,39.2,NM,,,,,,,,,,,,,,Tested in vitro for the binding affinity against muscarinic receptor subtype 3 (M3),,,Bioorg. Med. Chem. Lett.,1997,7,7,,,138255,DTCT0023280,1413403,DTCC00362082,1274493,2471
CHEMBL1668584,P20309,,YPVOSIDECMYMTD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21333408,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to Muscarinic M3 receptor at 10 uM by radioligand binding assay,Not Active,"2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2011,46,4,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Mitkin OD, Tkachenko SE, Kysil VM, Okun I",,740376,DTCT0023280,5907292,DTCC01025412,943137,44130
CHEMBL1669669,P20309,RO-5212773,KLFVWQCQUXXLOU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21237643,INHIBITION,=,-10,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells,,Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).,Bioorg. Med. Chem. Lett.,2011,21,4,"Stalder H, Hoener MC, Norcross RD",,716485,DTCT0023280,5105734,DTCC00033580,1557659,43309
CHEMBL1670,P20309,MITOTANE,JWBOIMRXGHLCPP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434902,DTCC00555980,2057649,46191
CHEMBL1670,P20309,MITOTANE,JWBOIMRXGHLCPP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434903,DTCC00555980,2057649,46191
CHEMBL167027,P20309,,MRQZZXHSUJAGCV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,1174.9,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1000328,DTCC00366911,1208990,17703
CHEMBL167223,P20309,,RPUXCIYWJSVFFV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,95.5,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,981193,DTCC00366910,1565806,17703
CHEMBL1672288,P20309,,LVXAMCKZCLWWTF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21207959,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.,J. Med. Chem.,2011,54,3,"Siméon FG, Wendahl MT, Pike VW",,718167,DTCT0023280,5116588,DTCC01026954,798550,43561
CHEMBL167438,P20309,,XUOXFNVMOHAQCW-MDZDMXLPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,3,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88024,DTCT0023280,747068,DTCC00364102,1436725,316
CHEMBL167438,P20309,,XUOXFNVMOHAQCW-MDZDMXLPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,,,,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor; ND=Not determined,Not Determined,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88158,DTCT0023280,747069,DTCC00364102,1436725,316
CHEMBL167593,P20309,AF-102A,WUTYZMFRCNBCHQ-HNHGDDPOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,0.8,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in forskolin-stimulated cAMP accumulation using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222746,DTCT0023280,1019574,DTCC00000291,519912,319
CHEMBL167593,P20309,AF-102A,WUTYZMFRCNBCHQ-HNHGDDPOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,10,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in phosphoinositides (PI) hydrolysis using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222891,DTCT0023280,1019572,DTCC00000291,519912,319
CHEMBL167593,P20309,AF-102A,WUTYZMFRCNBCHQ-HNHGDDPOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,11,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in Arachidonic acid (AA) release using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222745,DTCT0023280,1019573,DTCC00000291,519912,319
CHEMBL167593,P20309,AF-102A,WUTYZMFRCNBCHQ-HNHGDDPOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,86,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in intracellular calcium ion concentration ([Ca2+]i) using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222747,DTCT0023280,1019575,DTCC00000291,519912,319
CHEMBL1679,P20309,LEUCOVORIN,VVIAGPKUTFNRDU-ABLWVSNPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437864,DTCC00560549,1188068,46191
CHEMBL1679,P20309,LEUCOVORIN,VVIAGPKUTFNRDU-ABLWVSNPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437865,DTCC00560549,1188068,46191
CHEMBL167911,P20309,DICHLORVOS,OEBRKCOSUFCWJD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7338059,DTCC00362299,1544896,46191
CHEMBL167911,P20309,DICHLORVOS,OEBRKCOSUFCWJD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7338060,DTCC00362299,1544896,46191
CHEMBL168067,P20309,,HYJRTXSYDAFGJK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,0.52,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14737865,DTCC00360826,2106443,68416
CHEMBL168067,P20309,,HYJRTXSYDAFGJK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13679167,KI,=,0.68,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14737864,DTCC00360826,2106442,68421
CHEMBL168145,P20309,,PYTIEHIIMNFIHE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,33.5,NM,,,,,,,,,,,,,,Tested in vitro for the binding affinity against muscarinic receptor subtype 3 (M3),,,Bioorg. Med. Chem. Lett.,1997,7,7,,,138255,DTCT0023280,1420536,DTCC00362503,142074,2471
CHEMBL168149,P20309,,MBPOELUZVMXXFK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,79.1,NM,,,,,,,,,,,,,,Tested in vitro for the binding affinity against muscarinic receptor subtype 3 (M3),,,Bioorg. Med. Chem. Lett.,1997,7,7,,,138255,DTCT0023280,1426828,DTCC00361714,660513,2471
CHEMBL168223,P20309,,OATWUYJMZFPPQE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,134896.29,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,988164,DTCC00366953,109687,17703
CHEMBL1683351,P20309,,CACJJIUIFBOUQZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO-NFAT cells assessed as potentiation of acetylcholine-induced calcium flux at up to 100 uM after 1 hr by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2010,1,6,,,825856,DTCT0023280,10505904,DTCC01029336,995737,48445
CHEMBL1683351,P20309,,CACJJIUIFBOUQZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INHIBITION,,,,,cell_based,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor expressed in CHO-NFAT cells assessed as inhibition of acetylcholine-induced calcium flux at up to 100 uM after 1 hr by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2010,1,6,,,825859,DTCT0023280,10506529,DTCC01029336,995737,48445
CHEMBL1683908,P20309,,AGZCCVMWUZINGV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,46,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147809,DTCC01029891,16143,34812
CHEMBL1683909,P20309,,GMUZURIIVQVTEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,22,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147810,DTCC01029892,975125,34812
CHEMBL1683910,P20309,,SNSBQQKMJWPBHG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,55,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147811,DTCC01029893,619997,34812
CHEMBL1683911,P20309,,QMNIWLSHBOAIRC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,77,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147812,DTCC01029894,426820,34812
CHEMBL1683912,P20309,,VEZUYUPQRWMWRR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,17,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147813,DTCC01029895,1843501,34812
CHEMBL1683913,P20309,,OGGMZCFUDVJLKS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,14,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147814,DTCC01029896,749190,34812
CHEMBL1683914,P20309,,ZGIRHUKIUUZULV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,4.8,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147815,DTCC01029897,555458,34812
CHEMBL1683915,P20309,,DJJGUBUFSOKYKD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,5.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147816,DTCC01029898,1686927,34812
CHEMBL1683916,P20309,,ZNGFRXRQAQBPRI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147817,DTCC01029899,1907910,34812
CHEMBL1683917,P20309,,XAKZYHYSMQNRQN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,9.5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147818,DTCC01029900,1364115,34812
CHEMBL1683918,P20309,,NPPKYDWIWISSQR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,25,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147819,DTCC01029901,1940046,34812
CHEMBL1683919,P20309,,XXFMZCBWGTZGPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,48,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147820,DTCC01029902,263032,34812
CHEMBL1683920,P20309,,NPXZKPMDXMXGDW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,50,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147821,DTCC01029903,975126,34812
CHEMBL1683921,P20309,,FBJGCUBGHZNZIT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,67,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147822,DTCC01029904,1590004,34812
CHEMBL1683922,P20309,,UTIXCFWOKAICCG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,84,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147823,DTCC01029905,1331430,34812
CHEMBL1683923,P20309,,AANNUKSOCVVCRY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,98,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147824,DTCC01029906,1233404,34812
CHEMBL1683924,P20309,,ZFBIQOOTKQCTMV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,19,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147825,DTCC01029907,101610,34812
CHEMBL1683925,P20309,,QWGJSLGCLDLRCT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,0.53,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147826,DTCC01029908,749191,34812
CHEMBL1683926,P20309,,CPDOURDQZZGXQY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,1.8,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147827,DTCC01029909,1811167,34812
CHEMBL1683927,P20309,,AKXIVMUNQXHFIC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,0.75,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147828,DTCC01029910,198252,34812
CHEMBL1683928,P20309,,SJQCPEITVGUNOS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,1.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147829,DTCC01029911,652509,34812
CHEMBL1683929,P20309,,ZTPMTVFZFFNGGK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,2.5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147830,DTCC01029912,878907,34812
CHEMBL1683930,P20309,,ZGRDNSWDDZYGAP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,2.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147831,DTCC01029913,457850,34812
CHEMBL1683931,P20309,,SMJZXEGGFGRWAA-LJAQVGFWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,28,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147832,DTCC01029914,716864,34812
CHEMBL1683932,P20309,,KXDZFZWHYIWOHI-XIFFEERXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,0.74,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147833,DTCC01029915,716865,34812
CHEMBL1683933,P20309,,YCNOXWXLGBFFOF-UMSFTDKQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,0.32,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147834,DTCC01029916,1940047,34812
CHEMBL1683934,P20309,,NVEMUJANQDPDSC-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,0.01,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147835,DTCC01029917,943059,34812
CHEMBL1683934,P20309,,NVEMUJANQDPDSC-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.126,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126132,DTCC01029917,946486,62168
CHEMBL1683934,P20309,,NVEMUJANQDPDSC-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.82,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579666,DTCC01029917,945545,39463
CHEMBL1683935,P20309,,UBYLWRAVITWHBW-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,0.14,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147836,DTCC01029918,619998,34812
CHEMBL1683936,P20309,,DQCFXRWZNALQHV-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,0.14,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147837,DTCC01029919,555459,34812
CHEMBL1683938,P20309,,NVEMUJANQDPDSC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,0.18,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147839,DTCC01029920,911519,34812
CHEMBL1683939,P20309,,SKQQIRNICDPYHD-AMLLJQFGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,32,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147840,DTCC01029921,1460848,34812
CHEMBL1683940,P20309,,UPYWGAGJXOCCLN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,7.5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147841,DTCC01029922,1396512,34812
CHEMBL1683941,P20309,,OEMAFJPJPSVKLB-PIJVGCKKSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,140,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147842,DTCC01029923,1907911,34812
CHEMBL1683942,P20309,,URXYIXJBDQHQKL-NNROHFPBSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,4.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147843,DTCC01029924,1200984,34812
CHEMBL168421,P20309,,QWOUYGSZYVGPNZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,10,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in forskolin-stimulated cAMP accumulation using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222746,DTCT0023280,1029459,DTCC00365113,1165234,319
CHEMBL168421,P20309,,QWOUYGSZYVGPNZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,76,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in phosphoinositides (PI) hydrolysis using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222891,DTCT0023280,1029457,DTCC00365113,1165234,319
CHEMBL168421,P20309,,QWOUYGSZYVGPNZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,130,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in intracellular calcium ion concentration ([Ca2+]i) using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222747,DTCT0023280,1029460,DTCC00365113,1165234,319
CHEMBL168545,P20309,,FTLMHKNWSZNHPE-VAWYXSNFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,56,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88024,DTCT0023280,742197,DTCC00363757,369713,316
CHEMBL168545,P20309,,FTLMHKNWSZNHPE-VAWYXSNFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,9600,NM,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity in SK-N-SH neuroblastoma cells expressing human muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88157,DTCT0023280,742198,DTCC00363757,369713,316
CHEMBL168561,P20309,,BJBPIKGEGWKHQY-BUHFOSPRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,2,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88023,DTCT0023280,748261,DTCC00363665,434752,316
CHEMBL168561,P20309,,BJBPIKGEGWKHQY-BUHFOSPRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,,,,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor; ND=Not determined,Not Determined,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88158,DTCT0023280,748262,DTCC00363665,434752,316
CHEMBL1687,P20309,TUBOCURARINE CHLORIDE,MHXYWXHKLBMJKL-QBYKQQEBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356979,DTCC00570867,1253320,46191
CHEMBL1687,P20309,TUBOCURARINE CHLORIDE,MHXYWXHKLBMJKL-QBYKQQEBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356980,DTCC00570867,1253320,46191
CHEMBL168704,P20309,,SZXDNUASCUAYNA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,954.99,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1000404,DTCC00366951,951175,17703
CHEMBL168707,P20309,,LQOJFNRTYZDTBR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,501.19,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,992979,DTCC00366972,304534,17703
CHEMBL168815,P20309,CEVIMELINE,WUTYZMFRCNBCHQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24980056,KI,=,2570.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,,"Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.",Bioorg. Med. Chem. Lett.,2014,24,15,"Del Bello F, Bonifazi A, Quaglia W, Mazzolari A, Barocelli E, Bertoni S, Matucci R, Nesi M, Piergentili A, Vistoli G",,1459949,DTCT0023280,13906731,DTCC00363711,2029941,60777
CHEMBL169401,P20309,,GWWHCPBYLSKMJU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,575.44,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1012492,DTCC00367067,1372352,17703
CHEMBL169410,P20309,,VGPXROMBXGVRRS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,4,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in forskolin-stimulated cAMP accumulation using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222746,DTCT0023280,1024478,DTCC00365087,1165233,319
CHEMBL169410,P20309,,VGPXROMBXGVRRS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,84,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in phosphoinositides (PI) hydrolysis using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222891,DTCT0023280,1024476,DTCC00365087,1165233,319
CHEMBL169410,P20309,,VGPXROMBXGVRRS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,132,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in intracellular calcium ion concentration ([Ca2+]i) using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222747,DTCT0023280,1024479,DTCC00365087,1165233,319
CHEMBL169494,P20309,,APFCQQCNJNTQPE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,1548.82,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1002778,DTCC00367082,1981497,17703
CHEMBL169594,P20309,,SIOXJKJAYRUERS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,8128.31,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,984582,DTCC00367699,238799,17703
CHEMBL169680,P20309,,QLIVKGYZYOUCNK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,11748.98,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,985785,DTCC00367053,1533828,17703
CHEMBL1697694,P20309,AFLATOXIN,OQIQSTLJSLGHID-WNWIJWBNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291020,DTCC00127800,1092339,46191
CHEMBL1697694,P20309,AFLATOXIN,OQIQSTLJSLGHID-WNWIJWBNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291021,DTCC00127800,1092339,46191
CHEMBL170088,P20309,,BSSWNYCCQZRJSB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,630.96,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,995594,DTCC00367803,142113,17703
CHEMBL170221,P20309,,QOMMMTAFQPGRCW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,288.4,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,990397,DTCC00366581,1851592,17703
CHEMBL1702607,P20309,,ADVPTQAUNPRNPO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14733108,DTCC01037443,2104825,69159
CHEMBL17045,P20309,OTENZEPAD,UBRKDAVQCKZSPO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2704370,KI,=,838,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14747399,DTCC00147653,2106885,68413
CHEMBL17045,P20309,OTENZEPAD,UBRKDAVQCKZSPO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3272174,KI,=,820,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14747400,DTCC00147653,2106884,68415
CHEMBL17045,P20309,OTENZEPAD,UBRKDAVQCKZSPO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,2089,NM,,,,,,,,,,,,,,Binding affinity to human M3 muscarinic receptor,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936428,DTCT0023280,11761587,DTCC00147653,782942,53451
CHEMBL171102,P20309,,UFUQREONAQKXQA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,67.61,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1006247,DTCC00367808,531362,17703
CHEMBL171216,P20309,,DHRLTOSMTNHHKC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,741.31,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,993042,DTCC00367910,1501416,17703
CHEMBL1712923,P20309,IRSOGLADINE MALEATE,PJLVTVAIERNDEQ-BTJKTKAUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7424748,DTCC01047420,1894969,46191
CHEMBL1712923,P20309,IRSOGLADINE MALEATE,PJLVTVAIERNDEQ-BTJKTKAUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7424749,DTCC01047420,1894969,46191
CHEMBL1713967,P20309,,PSNVTEQUIAAEDR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24690494,KI,<,1000,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor (unknown origin),,Antagonists of the kappa opioid receptor.,Bioorg. Med. Chem. Lett.,2014,24,9,"Urbano M, Guerrero M, Rosen H, Roberts E",,1352902,DTCT0023280,13690244,DTCC01048423,546344,58670
CHEMBL17157,P20309,TERFENADINE,GUGOEEXESWIERI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7478813,DTCC00148306,510307,46191
CHEMBL17157,P20309,TERFENADINE,GUGOEEXESWIERI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7478814,DTCC00148306,510307,46191
CHEMBL172233,P20309,,YRDKYTTYDOWYLC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,707.95,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,998994,DTCC00367907,821713,17703
CHEMBL172234,P20309,,RRBBABSWMAZZDG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,8912.51,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,986960,DTCC00367908,1851591,17703
CHEMBL1724,P20309,MEPENZOLATE BROMIDE,JRRNZNSGDSFFIR-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24844758,KI,=,2.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3R expressed in CHOK1 cells after 2 hrs by scintillation counting analysis,,"Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities.",Bioorg. Med. Chem.,2014,22,13,"Yamashita Y, Tanaka K, Asano T, Yamakawa N, Kobayashi D, Ishihara T, Hanaya K, Shoji M, Sugai T, Wada M, Mashimo T, Fukunishi Y, Mizushima T",,1362504,DTCT0023280,13761439,DTCC00582503,784162,59448
CHEMBL1726,P20309,NISOLDIPINE,VKQFCGNPDRICFG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392695,DTCC00583129,1830687,46191
CHEMBL1726,P20309,NISOLDIPINE,VKQFCGNPDRICFG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392696,DTCC00583129,1830687,46191
CHEMBL1727,P20309,CEPHALEXIN,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7360096,DTCC00584128,444636,46191
CHEMBL1727,P20309,CEPHALEXIN,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7360097,DTCC00584128,444636,46191
CHEMBL1729,P20309,CISAPRIDE,DCSUBABJRXZOMT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7345571,DTCC00585645,315663,46191
CHEMBL1729,P20309,CISAPRIDE,DCSUBABJRXZOMT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7345572,DTCC00585645,315663,46191
CHEMBL1730,P20309,CEFOTAXIME,GPRBEKHLDVQUJE-QSWIMTSFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7351454,DTCC00585909,51453,46191
CHEMBL1730,P20309,CEFOTAXIME,GPRBEKHLDVQUJE-QSWIMTSFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7351455,DTCC00585909,51453,46191
CHEMBL1732,P20309,DIHYDROERGOTAMINE,LUZRJRNZXALNLM-JGRZULCMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7357599,DTCC00586321,381008,46191
CHEMBL1732,P20309,DIHYDROERGOTAMINE,LUZRJRNZXALNLM-JGRZULCMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7357600,DTCC00586321,381008,46191
CHEMBL1738699,P20309,,YVPGZQLRPAGKLA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant M3 receptor at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751928,DTCT0023280,5974991,DTCC01070772,735160,44781
CHEMBL174,P20309,AMPICILLIN,AVKUERGKIZMTKX-NJBDSQKTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291501,DTCC00385816,51446,46191
CHEMBL174,P20309,AMPICILLIN,AVKUERGKIZMTKX-NJBDSQKTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291502,DTCC00385816,51446,46191
CHEMBL1741,P20309,CLARITHROMYCIN,AGOYDEPGAOXOCK-KCBOHYOISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371522,DTCC00596664,1641846,46191
CHEMBL1741,P20309,CLARITHROMYCIN,AGOYDEPGAOXOCK-KCBOHYOISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371523,DTCC00596664,1641846,46191
CHEMBL1743259,P20309,ETOPERIDONE,IZBNNCFOBMGTQX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14736248,DTCC01074180,2105927,68567
CHEMBL1744448,P20309,BLEOMYCIN A2,LOLFAJUUOFBGSF-KYIYJVAASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7277197,DTCC00127875,898283,46191
CHEMBL1744448,P20309,BLEOMYCIN A2,LOLFAJUUOFBGSF-KYIYJVAASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7277198,DTCC00127875,898283,46191
CHEMBL1747,P20309,TOBRAMYCIN,NLVFBUXFDBBNBW-PBSUHMDJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7459579,DTCC00603485,1734066,46191
CHEMBL1747,P20309,TOBRAMYCIN,NLVFBUXFDBBNBW-PBSUHMDJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7459580,DTCC00603485,1734066,46191
CHEMBL175,P20309,DEXIBUPROFEN,HEFNNWSXXWATRW-JTQLQIEISA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7346527,DTCC00396784,1862715,46191
CHEMBL175,P20309,DEXIBUPROFEN,HEFNNWSXXWATRW-JTQLQIEISA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7346528,DTCC00396784,1862715,46191
CHEMBL1751,P20309,DIGOXIN,LTMHDMANZUZIPE-PUGKRICDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7348994,DTCC00607566,51464,46191
CHEMBL1751,P20309,DIGOXIN,LTMHDMANZUZIPE-PUGKRICDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7348995,DTCC00607566,51464,46191
CHEMBL1752,P20309,DYPHYLLINE,KSCFJBIXMNOVSH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7304584,DTCC00607571,2089746,46191
CHEMBL1752,P20309,DYPHYLLINE,KSCFJBIXMNOVSH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7304585,DTCC00607571,2089746,46191
CHEMBL1753,P20309,CLINDAMYCIN,KDLRVYVGXIQJDK-AWPVFWJPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7347909,DTCC00607595,898286,46191
CHEMBL1753,P20309,CLINDAMYCIN,KDLRVYVGXIQJDK-AWPVFWJPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7347910,DTCC00607595,898286,46191
CHEMBL1754,P20309,DOXAPRAM,XFDJYSQDBULQSI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7338488,DTCC00607599,1027051,46191
CHEMBL1754,P20309,DOXAPRAM,XFDJYSQDBULQSI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7338489,DTCC00607599,1027051,46191
CHEMBL1760,P20309,TERBUTALINE,XWTYSIMOBUGWOL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470128,DTCC00609006,542583,46191
CHEMBL1760,P20309,TERBUTALINE,XWTYSIMOBUGWOL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470129,DTCC00609006,542583,46191
CHEMBL1762,P20309,TOCAINIDE,BUJAGSGYPOAWEI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463987,DTCC00609197,1544903,46191
CHEMBL1762,P20309,TOCAINIDE,BUJAGSGYPOAWEI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463988,DTCC00609197,1544903,46191
CHEMBL1765683,P20309,,ZVRXOXFSMYJETP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21428406,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011,54,8,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743736,DTCT0023280,5918987,DTCC01078226,652599,44302
CHEMBL1765684,P20309,,VCKIDQVWSDVZCZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21428406,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011,54,8,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743736,DTCT0023280,5918988,DTCC01078227,975211,44302
CHEMBL1766,P20309,DESOXIMETASONE,VWVSBHGCDBMOOT-IIEHVVJPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7363643,DTCC00610116,348397,46191
CHEMBL1766,P20309,DESOXIMETASONE,VWVSBHGCDBMOOT-IIEHVVJPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7363644,DTCC00610116,348397,46191
CHEMBL177,P20309,AMIKACIN,LKCWBDHBTVXHDL-RMDFUYIESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293941,DTCC00409875,1253318,46191
CHEMBL177,P20309,AMIKACIN,LKCWBDHBTVXHDL-RMDFUYIESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293942,DTCC00409875,1253318,46191
CHEMBL1770373,P20309,PF-3246799,CZWQBSKNHUVZLI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21195614,IC50,=,300,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,"Pyrimido[4,5-d]azepines as potent and selective 5-HT(2C) receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence.",Bioorg. Med. Chem. Lett.,2011,21,9,"Andrews MD, Fish PV, Blagg J, Brabham TK, Brennan PE, Bridgeland A, Brown AD, Bungay PJ, Conlon KM, Edmunds NJ, Af Forselles K, Gibbons CP, Green MP, Hanton G, Holbrook M, Jessiman AS, McIntosh K, McMurray G, Nichols CL, Root JA, Storer RI, Sutton MR, Ward RV, Westbrook D, Whitlock GA",,744881,DTCT0023280,5933233,DTCC00033971,69510,44351
CHEMBL177040,P20309,,MVWIZZHMSROILD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,3.3,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1615241,DTCC00374670,821809,11844
CHEMBL1771,P20309,CLOPIDOGREL,GKTWGGQPFAXNFI-HNNXBMFYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7345839,DTCC00616891,639577,46191
CHEMBL1771,P20309,CLOPIDOGREL,GKTWGGQPFAXNFI-HNNXBMFYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7345840,DTCC00616891,639577,46191
CHEMBL1773074,P20309,,BBKNEJRUSCLTOC-GTZDIBSYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,0.765,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939434,DTCC01081657,1479185,44387
CHEMBL1773074,P20309,,BBKNEJRUSCLTOC-GTZDIBSYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,>,1200,MIN,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939403,DTCC01081657,1479185,44387
CHEMBL1773196,P20309,,HBGQOZREDFTVBJ-CHGHPAACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,0.091,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939428,DTCC01081590,1317270,44387
CHEMBL1773196,P20309,,HBGQOZREDFTVBJ-CHGHPAACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,=,355,MIN,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939455,DTCC01081590,1317270,44387
CHEMBL1773197,P20309,,DNVDKAWXAWHRBJ-HIJQYJRJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,0.276,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939429,DTCC01081591,248784,44387
CHEMBL1773197,P20309,,DNVDKAWXAWHRBJ-HIJQYJRJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,=,166,MIN,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939456,DTCC01081591,248784,44387
CHEMBL1773198,P20309,,LKCQOFXWGIJPPL-KPNPWFHDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,0.397,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939430,DTCC01081592,1732921,44387
CHEMBL1773198,P20309,,LKCQOFXWGIJPPL-KPNPWFHDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,=,135,MIN,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939457,DTCC01081592,1732921,44387
CHEMBL1773262,P20309,,NZHNIGYHUYTHPF-ZUKKLESISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,6.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939431,DTCC01081654,638487,44387
CHEMBL1773262,P20309,,NZHNIGYHUYTHPF-ZUKKLESISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,<,15,MIN,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939396,DTCC01081654,638487,44387
CHEMBL1773263,P20309,,BVIPNQBYJXNDMC-HIJQYJRJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,1.45,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939432,DTCC01081655,1543732,44387
CHEMBL1773263,P20309,,BVIPNQBYJXNDMC-HIJQYJRJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,,,,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,Not Determined,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939393,DTCC01081655,1543732,44387
CHEMBL1773264,P20309,,AFTLTCTXIJHBOV-RZLWBAEQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,0.634,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939433,DTCC01081656,1732922,44387
CHEMBL1773264,P20309,,AFTLTCTXIJHBOV-RZLWBAEQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,>,1200,MIN,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939402,DTCC01081656,1732922,44387
CHEMBL1773265,P20309,,DORKQDJVMZQKPG-ABJZOGFOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,4.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939435,DTCC01081658,897200,44387
CHEMBL1773265,P20309,,DORKQDJVMZQKPG-ABJZOGFOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,,,,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,Not Determined,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939394,DTCC01081658,897200,44387
CHEMBL1773266,P20309,,QFWQOMWVGRRQSE-VQOCUYOESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,0.99,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939436,DTCC01081659,1284745,44387
CHEMBL1773266,P20309,,QFWQOMWVGRRQSE-VQOCUYOESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,>,1200,MIN,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939404,DTCC01081659,1284745,44387
CHEMBL1773267,P20309,,TZASHOBYSUICIA-WGYIJZORSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,KI,=,0.305,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745281,DTCT0023280,5939437,DTCC01081660,281828,44387
CHEMBL1773267,P20309,,TZASHOBYSUICIA-WGYIJZORSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21075627,TIME,>,1200,MIN,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells assessed as time required to reach 50% of total [3H]NMS binding by dilution-offset methodology,,Inhalation by design: Dual pharmacology ß-2 agonists/M3 antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2011,21,9,"Jones LH, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, Fulton C, Hilton L, James K, Jones RM, Kenyon AS, Marshall S, Newman SD, Osborne R, Patel S, Selby MD, Stuart EF, Trevethick MA, Wright KN, Price DA",,745293,DTCT0023280,5939405,DTCC01081660,281828,44387
CHEMBL1773267,P20309,,TZASHOBYSUICIA-WGYIJZORSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,0.31,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573387,DTCC01081660,268216,63971
CHEMBL1773267,P20309,,TZASHOBYSUICIA-WGYIJZORSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,>,20,HR,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573397,DTCC01081660,268216,63971
CHEMBL177756,P20309,FLUORESCEIN,YKGGGCXBWXHKIZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7312003,DTCC00376005,1894967,46191
CHEMBL177756,P20309,FLUORESCEIN,YKGGGCXBWXHKIZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7312004,DTCC00376005,1894967,46191
CHEMBL1777826,P20309,,BDLKVZCRRROJRY-FQEVSTJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,1.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964084,DTCC01084632,2088610,44627
CHEMBL1777827,P20309,,NBAFBTBCPVIPLO-OCJYMVTRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.5,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964186,DTCC01084723,670628,44627
CHEMBL1779031,P20309,,IJIHPPHWXPHTRG-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,796.8,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964083,DTCC01084631,993470,44627
CHEMBL1779032,P20309,,KZJQTCGYGSMOSC-NRFANRHFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,3.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964085,DTCC01084633,379884,44627
CHEMBL1779033,P20309,,FJVQALKRJDSNIH-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964086,DTCC01084634,1317305,44627
CHEMBL1779034,P20309,,JZXJMFOSRNVGHQ-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964087,DTCC01084635,1673032,44627
CHEMBL1779035,P20309,,OJZRLJIPACRTSA-INIZCTEOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,71.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964088,DTCC01084636,1446727,44627
CHEMBL1779036,P20309,,LIAJJEHSFRHBLC-KRWDZBQOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,4.3,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964089,DTCC01084637,1154501,44627
CHEMBL1779037,P20309,,SRSDGJOKLMADHL-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,1.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964090,DTCC01084638,314550,44627
CHEMBL1779038,P20309,,QCTSRLYZXNHQPV-INIZCTEOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,659.3,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964091,DTCC01084639,961298,44627
CHEMBL1779039,P20309,,CRWJHTMQXCFORB-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,22.5,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964092,DTCC01084640,2088611,44627
CHEMBL1779040,P20309,,VRZIYMYSNOVVOK-KRWDZBQOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,5.9,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964093,DTCC01084641,476770,44627
CHEMBL1779041,P20309,,CZTMYBUHNDAZEH-INIZCTEOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,17.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964094,DTCC01084642,1543762,44627
CHEMBL1779042,P20309,,SNNFRAGGSGAUHH-NRFANRHFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,74.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964095,DTCC01084643,1350032,44627
CHEMBL1779043,P20309,,DUVRCCCAGVFLMM-FQEVSTJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,15,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964096,DTCC01084644,1186921,44627
CHEMBL1779044,P20309,,URDXFKMXLZZTRI-FQEVSTJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,2.4,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964097,DTCC01084645,702859,44627
CHEMBL1779045,P20309,,WRQCVLFZYUVEBT-NRFANRHFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,1.4,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964098,DTCC01084646,1123408,44627
CHEMBL1779046,P20309,TARAFENACIN,UXZDMXYRRQJIBJ-IBGZPJMESA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,1.5,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964099,DTCC01084647,799493,44627
CHEMBL1779047,P20309,YM-46303,ZUBLNWRGQSNWGQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964101,DTCC00034106,1284775,44627
CHEMBL1779048,P20309,,WTZBHTVFOKQBMQ-UEWQQYQFSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,17.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964181,DTCC01084648,1925854,44627
CHEMBL1779049,P20309,,PNWQOMABRMWDMF-LVKSKBLHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.3,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964182,DTCC01084649,347258,44627
CHEMBL1779058,P20309,,HJKLOGARPBXZTP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11474316,DTCC01084658,232067,51935
CHEMBL1779059,P20309,,QCBXRMVDVAHCPR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11474293,DTCC01084659,1365536,51935
CHEMBL1779060,P20309,,ZOAKYUHDXICZSY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11474268,DTCC01084660,1719581,51935
CHEMBL1779128,P20309,,MCGSMQKZGMDZFT-AEDYTTQKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964183,DTCC01084720,1925856,44627
CHEMBL1779129,P20309,,GDLWJBJOVTYAJR-GSEXTUOBSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964184,DTCC01084721,735122,44627
CHEMBL1779130,P20309,,IFLRXULRZIQGMB-YEXUYRPESA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,18.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964185,DTCC01084722,1673037,44627
CHEMBL1779131,P20309,,HSGQPXOPCPJENX-CCOWBORGSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.3,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964187,DTCC01084724,1479218,44627
CHEMBL1779132,P20309,,AJWNYCANTFUYEF-ZZNGFPBBSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964188,DTCC01084725,49731,44627
CHEMBL1779133,P20309,,RUMIBZGNGQBYPD-DSSKCDFUSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964189,DTCC01084726,1123413,44627
CHEMBL1779134,P20309,,DDOSKJZAVXHTNA-SUPQUVAKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,19,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964190,DTCC01084727,443544,44627
CHEMBL1779135,P20309,,ZEKWXBFSCSXDLQ-NRMJQQDLSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.8,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964191,DTCC01084728,1317308,44627
CHEMBL1779136,P20309,,FHESLQGDLROIOJ-SSVLGJNASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964192,DTCC01084729,831979,44627
CHEMBL1779137,P20309,,JZCRAMPGFZJPOE-ZZNGFPBBSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.8,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964193,DTCC01084730,1958867,44627
CHEMBL1779138,P20309,,QKWOYWROMVNAEX-QKIIOBKNSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.9,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964194,DTCC01084731,928938,44627
CHEMBL1779139,P20309,,QNJLKXCSRKQDKU-JQXPCOHGSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,1.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964195,DTCC01084732,2024482,44627
CHEMBL1779140,P20309,,CAKRLTNLKHYGIV-DFXIHDQSSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21524581,IC50,=,0.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2011,21,11,"Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H",,748300,DTCT0023280,5964196,DTCC01084733,605827,44627
CHEMBL178,P20309,DAUNORUBICIN,STQGQHZAVUOBTE-VGBVRHCVSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7346445,DTCC00413150,477916,46191
CHEMBL178,P20309,DAUNORUBICIN,STQGQHZAVUOBTE-VGBVRHCVSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7346446,DTCC00413150,477916,46191
CHEMBL1783889,P20309,,DSNALXIKDKGHLJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human M3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496631,DTCT0023280,14434859,DTCC01087435,1615288,62611
CHEMBL1784671,P20309,,NVCJMYLJSSPEKR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant M3 receptor at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751928,DTCT0023280,5974990,DTCC01088207,184448,44781
CHEMBL1784673,P20309,,CPOQTXKWWFQYCF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant M3 receptor at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751928,DTCT0023280,5974989,DTCC01088209,314586,44781
CHEMBL1784685,P20309,,APARPRRWRUIPGQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant M3 receptor at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751928,DTCT0023280,5974988,DTCC01088221,1764905,44781
CHEMBL1784694,P20309,,USRJTKDRTOTPRU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21570838,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human recombinant M3 receptor at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011,21,12,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751928,DTCT0023280,5974987,DTCC01088230,347293,44781
CHEMBL1790041,P20309,RANITIDINE,VMXUWOKSQNHOCA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487869,DTCC01089619,2025642,46191
CHEMBL1790041,P20309,RANITIDINE,VMXUWOKSQNHOCA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487870,DTCC01089619,2025642,46191
CHEMBL179166,P20309,SODIUM ORTHOVANAD,IHIXIJGXTJIKRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7464949,DTCC00382287,217586,46191
CHEMBL179166,P20309,SODIUM ORTHOVANAD,IHIXIJGXTJIKRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7464950,DTCC00382287,217586,46191
CHEMBL1794855,P20309,,RPZYOWNZYQHSLJ-SPIKMXEPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,15203136,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards human muscarinic acetylcholine receptor M3,,"(+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents.",Bioorg. Med. Chem. Lett.,2004,14,14,"Dukat M, Taroua M, Dahdouh A, Siripurapu U, Damaj MI, Martin BR, Glennon RA",,138698,DTCT0023280,1179887,DTCC01091119,1176028,6518
CHEMBL1800285,P20309,,RJTJRVASUFIDQM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21682298,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHONFAT cells assessed as increase in acetylcholine-induced calcium mobilization at 10 uM preincubated for 4 mins measured after 1 hr by FLIPR assay,Not Active,Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold.,J. Med. Chem.,2011,54,13,"Kuduk SD, Chang RK, Di Marco CN, Pitts DR, Greshock TJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT, Ray WJ",,757287,DTCT0023280,6022778,DTCC01094004,1058331,45174
CHEMBL1802360,P20309,,VNSQNNPGGZXQAN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,>,25118.86,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as intracellular calcium mobilization after 10 to 15 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2010,1,6,,,849489,DTCT0023280,11347750,DTCC01095922,912732,50717
CHEMBL181,P20309,DIAZOXIDE,GDLBFKVLRPITMI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368179,DTCC00110806,800574,46191
CHEMBL181,P20309,DIAZOXIDE,GDLBFKVLRPITMI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368180,DTCC00110806,800574,46191
CHEMBL182,P20309,GANCICLOVIR,IRSCQMHQWWYFCW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7316490,DTCC00437788,639580,46191
CHEMBL182,P20309,GANCICLOVIR,IRSCQMHQWWYFCW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7316491,DTCC00437788,639580,46191
CHEMBL1824777,P20309,,ZHHLHBNBIKLLJG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21788137,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767214,DTCT0023280,6091830,DTCC01106515,961498,45468
CHEMBL1824778,P20309,,LPAMOYXJLQSGRI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21788137,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767214,DTCT0023280,6091829,DTCC01106516,1058448,45468
CHEMBL1824784,P20309,,HXOMGUPFBWZKBK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21788137,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767214,DTCT0023280,6091828,DTCC01106522,638709,45468
CHEMBL1824785,P20309,,ZILQWXOKQUVSTI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21788137,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011,21,18,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767214,DTCT0023280,6091827,DTCC01106523,1640941,45468
CHEMBL1834184,P20309,,YNFDIGJKJPNFFD-SJORKVTESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21873051,INHIBITION,=,-6,%,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor at 10 uM by radioligand binding assay,,"Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.",Bioorg. Med. Chem. Lett.,2011,21,19,"Kley JT, Mack J, Hamilton B, Scheuerer S, Redemann N",,771400,DTCT0023280,6119832,DTCC01109702,1526121,46053
CHEMBL1834350,P20309,,XEWOFIPWWSYNAY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21866910,KI,=,10000,NM,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor,,"N'-(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT(6)R) Antagonists with Unique Structural Features.",J. Med. Chem.,2011,54,20,"van Loevezijn A, Venhorst J, Iwema Bakker WI, de Korte CG, de Looff W, Verhoog S, van Wees JW, van Hoeve M, van de Woestijne RP, van der Neut MA, Borst AJ, van Dongen MJ, de Bruin NM, Keizer HG, Kruse CG",,771228,DTCT0023280,6116223,DTCC01109859,1655306,46048
CHEMBL1835609,P20309,,UBQRACCCHXXOJB-ZOWNYOTGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21905669,INHIBITION,=,-6.8,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor at 10 uM by radioligand displacement assay,,Discovery of Isoxazole Analogues of Sazetidine-A as Selective a4ß2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression.,J. Med. Chem.,2011,54,20,"Liu J, Yu LF, Eaton JB, Caldarone B, Cavino K, Ruiz C, Terry M, Fedolak A, Wang D, Ghavami A, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,772138,DTCT0023280,6125238,DTCC01111063,1285033,46123
CHEMBL1836644,P20309,,DVDGHCLLWLHYLG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21863888,KI,=,49,NM,,,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human M3 receptor,,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771725,DTCT0023280,6112788,DTCC01112009,1479486,46044
CHEMBL1836645,P20309,,IUTQZHKFJYKMRH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21863888,KI,=,10,NM,,,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human M3 receptor,,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771725,DTCT0023280,6112789,DTCC01112010,1544021,46044
CHEMBL1836646,P20309,,ITXRGZRPRZJEGV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21863888,KI,=,2.5,NM,,,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human M3 receptor,,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771725,DTCT0023280,6112790,DTCC01112011,1058505,46044
CHEMBL1836647,P20309,,MWNIKTJZFRMVQT-UMSFTDKQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21863888,KI,=,2.2,NM,,,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human M3 receptor,,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771725,DTCT0023280,6112791,DTCC01112012,1797559,46044
CHEMBL1836647,P20309,,MWNIKTJZFRMVQT-UMSFTDKQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21863888,TIME,<,16,MIN,,,,,,,,,,,,,,Antagonist activity at human cloned M3 receptor assessed as time taken to reach 50% of total [3H]NMS for solvent treated membranes by dilution-offset method,,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,2011,54,19,"Osborne R, Clarke N, Glossop P, Kenyon A, Liu H, Patel S, Summerhill S, Jones LH",,771732,DTCT0023280,6112807,DTCC01112012,1797559,46044
CHEMBL184,P20309,ACYCLOVIR,MKUXAQIIEYXACX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288466,DTCC00438001,51442,46191
CHEMBL184,P20309,ACYCLOVIR,MKUXAQIIEYXACX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288467,DTCC00438001,51442,46191
CHEMBL184238,P20309,URB597,ROFVXGGUISEHAM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16352709,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14740667,DTCC00000860,2107472,69711
CHEMBL184618,P20309,NEOMYCIN,PGBHMTALBVVCIT-VCIWKGPPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7405436,DTCC00392052,1894971,46191
CHEMBL184618,P20309,NEOMYCIN,PGBHMTALBVVCIT-VCIWKGPPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7405437,DTCC00392052,1894971,46191
CHEMBL185,P20309,FLUOROURACIL,GHASVSINZRGABV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7320519,DTCC00440753,51471,46191
CHEMBL185,P20309,FLUOROURACIL,GHASVSINZRGABV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7320520,DTCC00440753,51471,46191
CHEMBL18701,P20309,RO-201724,PDMUULPVBYQBBK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475237,DTCC00149559,1674149,46191
CHEMBL18701,P20309,RO-201724,PDMUULPVBYQBBK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475238,DTCC00149559,1674149,46191
CHEMBL1873703,P20309,DIELDRIN,DFBKLUNHFCTMDC-PICURKEMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7359571,DTCC01123582,800575,46191
CHEMBL1873703,P20309,DIELDRIN,DFBKLUNHFCTMDC-PICURKEMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7359572,DTCC01123582,800575,46191
CHEMBL18797,P20309,SULINDAC SULFIDE,LFWHFZJPXXOYNR-MFOYZWKCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463264,DTCC00150119,994595,46191
CHEMBL18797,P20309,SULINDAC SULFIDE,LFWHFZJPXXOYNR-MFOYZWKCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463265,DTCC00150119,994595,46191
CHEMBL1885748,P20309,,JQSJAVBMIMDUFO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23642479,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM relative to control,,Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.,Bioorg. Med. Chem. Lett.,2013,23,12,"Coombs TC, Tanega C, Shen M, Wang JL, Auld DS, Gerritz SW, Schoenen FJ, Thomas CJ, Aubé J",,965699,DTCT0023280,12471663,DTCC01135294,545285,54833
CHEMBL188921,P20309,BUFLOMEDIL,OWYLAEYXIQKAOL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7278916,DTCC00395665,1188065,46191
CHEMBL188921,P20309,BUFLOMEDIL,OWYLAEYXIQKAOL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7278917,DTCC00395665,1188065,46191
CHEMBL189,P20309,MILRINONE,PZRHRDRVRGEVNW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7422067,DTCC00450749,930081,46191
CHEMBL189,P20309,MILRINONE,PZRHRDRVRGEVNW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7422068,DTCC00450749,930081,46191
CHEMBL189171,P20309,ACEMETACIN,FSQKKOOTNAMONP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7297672,DTCC00393990,800567,46191
CHEMBL189171,P20309,ACEMETACIN,FSQKKOOTNAMONP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7297673,DTCC00393990,800567,46191
CHEMBL189676,P20309,SURINABANT,HMXDWDSNPRNUKI-UHFFFAOYSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,15131245,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14758311,DTCC00396917,2111237,69827
CHEMBL190,P20309,THEOPHYLLINE,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7465848,DTCC00451755,413979,46191
CHEMBL190,P20309,THEOPHYLLINE,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7465849,DTCC00451755,413979,46191
CHEMBL19019,P20309,NALTREXONE,DQCKKXVULJGBQN-XFWGSAIBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7409491,DTCC00149948,88632,46191
CHEMBL19019,P20309,NALTREXONE,DQCKKXVULJGBQN-XFWGSAIBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7409492,DTCC00149948,88632,46191
CHEMBL1902627,P20309,CLORPRENALINE,SSMSBSWKLKKXGG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7350100,DTCC01151693,866018,46191
CHEMBL1902627,P20309,CLORPRENALINE,SSMSBSWKLKKXGG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7350101,DTCC01151693,866018,46191
CHEMBL1902981,P20309,EPERISONE,SQUNAWUMZGQQJD-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306884,DTCC01152035,348399,46191
CHEMBL1902981,P20309,EPERISONE,SQUNAWUMZGQQJD-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306885,DTCC01152035,348399,46191
CHEMBL1907864,P20309,,FXBXWJPMXQHOGD-VUAZUDAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,57,%,,,,,,,,,,,,,,Maximal response obtained for each drug normalized to effect of carbachol in Muscarinic acetylcholine receptor M3,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138571,DTCT0023280,1612869,DTCC01156699,712022,14722
CHEMBL1907864,P20309,,FXBXWJPMXQHOGD-VUAZUDAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,ED50,=,4568000,NM,,cell_based,,,,,,,,,,,NIH3T3,Amplification of transfected NIH3T3 cells was measured in Muscarinic acetylcholine receptor M3 required to produce half maximal effect,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138583,DTCT0023280,1612868,DTCC01156699,712022,14722
CHEMBL1907864,P20309,,FXBXWJPMXQHOGD-VUAZUDAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,STIMULATION,=,5.2,%,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M3 values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol.,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138719,DTCT0023280,1612864,DTCC01156699,712022,14722
CHEMBL1908355,P20309,TENIDAP,LXIKEPCNDFVJKC-QXMHVHEDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487264,DTCC01156858,1285881,46191
CHEMBL1908355,P20309,TENIDAP,LXIKEPCNDFVJKC-QXMHVHEDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487265,DTCC01156858,1285881,46191
CHEMBL1909048,P20309,,RBCUCXILXJXLTB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291574,DTCC00128929,444633,46191
CHEMBL1909048,P20309,,RBCUCXILXJXLTB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291575,DTCC00128929,444633,46191
CHEMBL1909049,P20309,,FSIWGHXVLYRBFQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7297147,DTCC00128930,930074,46191
CHEMBL1909049,P20309,,FSIWGHXVLYRBFQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7297148,DTCC00128930,930074,46191
CHEMBL1909050,P20309,,DLDAZIVPAOLETE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299896,DTCC01157054,413966,46191
CHEMBL1909050,P20309,,DLDAZIVPAOLETE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299897,DTCC01157054,413966,46191
CHEMBL1909051,P20309,,LUHHARLTABWBTO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7301687,DTCC01157055,1480342,46191
CHEMBL1909051,P20309,,LUHHARLTABWBTO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7301688,DTCC01157055,1480342,46191
CHEMBL1909054,P20309,CARBOXYMETHYLCELLULOSE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7360008,DTCC01157056,768475,46191
CHEMBL1909054,P20309,CARBOXYMETHYLCELLULOSE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7360009,DTCC01157056,768475,46191
CHEMBL1909055,P20309,COBALTOUS CHLORIDE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7369658,DTCC01157057,1992803,46191
CHEMBL1909055,P20309,COBALTOUS CHLORIDE,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7369659,DTCC01157057,1992803,46191
CHEMBL1909056,P20309,COBALT(II) ACETYLACETONATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7339548,DTCC01157058,736258,46191
CHEMBL1909056,P20309,COBALT(II) ACETYLACETONATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7339549,DTCC01157058,736258,46191
CHEMBL1909057,P20309,COPPER(II) OXIDE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356757,DTCC01157059,1318440,46191
CHEMBL1909057,P20309,COPPER(II) OXIDE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356758,DTCC01157059,1318440,46191
CHEMBL1909062,P20309,LEAD (II) ACETATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420788,DTCC01157060,1609549,46191
CHEMBL1909062,P20309,LEAD (II) ACETATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420789,DTCC01157060,1609549,46191
CHEMBL1909063,P20309,LEAD(IV) ACETATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425060,DTCC01157061,1765974,46191
CHEMBL1909063,P20309,LEAD(IV) ACETATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425061,DTCC01157061,1765974,46191
CHEMBL1909064,P20309,LIPOPOLYSACCHARIDE E. COLI O55:B5,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412410,DTCC01157062,898291,46191
CHEMBL1909064,P20309,LIPOPOLYSACCHARIDE E. COLI O55:B5,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412411,DTCC01157062,898291,46191
CHEMBL1909065,P20309,LYSERGOL,RWVUEZAROXKXRT-VQLSFVLHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425527,DTCC01157063,510303,46191
CHEMBL1909065,P20309,LYSERGOL,RWVUEZAROXKXRT-VQLSFVLHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425528,DTCC01157063,510303,46191
CHEMBL1909067,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412714,DTCC01157064,1734058,46191
CHEMBL1909067,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412715,DTCC01157064,1734058,46191
CHEMBL1909068,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7417068,DTCC01157065,1059333,46191
CHEMBL1909068,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7417069,DTCC01157065,1059333,46191
CHEMBL1909069,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421359,DTCC01157066,1253326,46191
CHEMBL1909069,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421360,DTCC01157066,1253326,46191
CHEMBL1909070,P20309,NAFENOPIN,XJGBDJOMWKAZJS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7435127,DTCC01157067,866020,46191
CHEMBL1909070,P20309,NAFENOPIN,XJGBDJOMWKAZJS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7435128,DTCC01157067,866020,46191
CHEMBL1909071,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7373621,DTCC01157068,1765978,46191
CHEMBL1909071,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7373622,DTCC01157068,1765978,46191
CHEMBL1909072,P20309,PIPAMAZINE,OSJJYEUEJRVVOD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395940,DTCC01157069,1927019,46191
CHEMBL1909072,P20309,PIPAMAZINE,OSJJYEUEJRVVOD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395941,DTCC01157069,1927019,46191
CHEMBL1909073,P20309,PIPERILATE ETHOBROMIDE,VPUGSHLBERYQGC-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,157,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404596,DTCC01157070,348403,46191
CHEMBL1909073,P20309,PIPERILATE ETHOBROMIDE,VPUGSHLBERYQGC-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,33,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404597,DTCC01157070,348403,46191
CHEMBL1909074,P20309,POLYVINYLPYRROLIDONE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400380,DTCC01157071,1059338,46191
CHEMBL1909074,P20309,POLYVINYLPYRROLIDONE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400381,DTCC01157071,1059338,46191
CHEMBL1909075,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7381699,DTCC01157072,606972,46191
CHEMBL1909075,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7381700,DTCC01157072,606972,46191
CHEMBL1909076,P20309,,RSTSYGXUDMJEFP-SECBINFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475355,DTCC01157073,1894973,46191
CHEMBL1909076,P20309,,RSTSYGXUDMJEFP-SECBINFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475356,DTCC01157073,1894973,46191
CHEMBL1909078,P20309,SODIUM ARSENITE,PTLRDCMBXHILCL-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7456191,DTCC01157074,1351117,46191
CHEMBL1909078,P20309,SODIUM ARSENITE,PTLRDCMBXHILCL-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7456192,DTCC01157074,1351117,46191
CHEMBL1909079,P20309,STANNOUS FLUORIDE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458483,DTCC01157075,671794,46191
CHEMBL1909079,P20309,STANNOUS FLUORIDE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458484,DTCC01157075,671794,46191
CHEMBL1909080,P20309,STRONTIUM CHLORIDE HEXAHYDRATE,AMGRXJSJSONEEG-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484611,DTCC01157076,1124455,46191
CHEMBL1909080,P20309,STRONTIUM CHLORIDE HEXAHYDRATE,AMGRXJSJSONEEG-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484612,DTCC01157076,1124455,46191
CHEMBL1909083,P20309,ZIRCONIUM(IV) CHLORIDE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7452474,DTCC01157077,120980,46191
CHEMBL1909083,P20309,ZIRCONIUM(IV) CHLORIDE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7452475,DTCC01157077,120980,46191
CHEMBL191,P20309,LOSARTAN,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408318,DTCC00475883,1705876,46191
CHEMBL191,P20309,LOSARTAN,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408319,DTCC00475883,1705876,46191
CHEMBL1910845,P20309,,XKGBDMVXPVMRSW-VWLOTQADSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,1.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776521,DTCT0023280,7504630,DTCC01158226,1416067,46208
CHEMBL1910845,P20309,,XKGBDMVXPVMRSW-VWLOTQADSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,2.4,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504637,DTCC01158226,1416067,46208
CHEMBL1910845,P20309,,XKGBDMVXPVMRSW-VWLOTQADSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,0.633,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504616,DTCC01158226,1416067,46208
CHEMBL1910846,P20309,,NYFXIMCEKNFZKB-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.25,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504636,DTCC01158227,1092388,46208
CHEMBL1910846,P20309,,NYFXIMCEKNFZKB-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,1.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776521,DTCT0023280,7504629,DTCC01158227,1092388,46208
CHEMBL1910846,P20309,,NYFXIMCEKNFZKB-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504615,DTCC01158227,1092388,46208
CHEMBL1910847,P20309,,NYFXIMCEKNFZKB-AREMUKBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,1.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504635,DTCC01158228,1766016,46208
CHEMBL1910847,P20309,,NYFXIMCEKNFZKB-AREMUKBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,6.4,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776521,DTCT0023280,7504628,DTCC01158228,1766016,46208
CHEMBL1910847,P20309,,NYFXIMCEKNFZKB-AREMUKBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504614,DTCC01158228,1766016,46208
CHEMBL1910848,P20309,,ZTUYXANCGWZAKE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.049,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504634,DTCC01158229,185583,46208
CHEMBL1910848,P20309,,ZTUYXANCGWZAKE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.11,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776521,DTCT0023280,7504627,DTCC01158229,185583,46208
CHEMBL1910848,P20309,,ZTUYXANCGWZAKE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,8.02,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504613,DTCC01158229,185583,46208
CHEMBL1910849,P20309,,JCZWHTSVKJZFOP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.27,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504633,DTCC01158230,1927051,46208
CHEMBL1910849,P20309,,JCZWHTSVKJZFOP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,3.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776521,DTCT0023280,7504626,DTCC01158230,1927051,46208
CHEMBL1910849,P20309,,JCZWHTSVKJZFOP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,17.5,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504612,DTCC01158230,1927051,46208
CHEMBL1910850,P20309,,OGDKFVQZFIMTCJ-AREMUKBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.201,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776524,DTCT0023280,7504735,DTCC01158231,1318481,46208
CHEMBL1910850,P20309,,OGDKFVQZFIMTCJ-AREMUKBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.51,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504644,DTCC01158231,1318481,46208
CHEMBL1910850,P20309,,OGDKFVQZFIMTCJ-AREMUKBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,PKB,=,8,,,,,,,,,,,,,,,Antagonist activity at M3 receptor in human bronchial ring assessed as inhibition of electrically field-stimulated contractile response after 4 hrs,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776581,DTCT0023280,7504759,DTCC01158231,1318481,46208
CHEMBL1910850,P20309,,OGDKFVQZFIMTCJ-AREMUKBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504654,DTCC01158231,1318481,46208
CHEMBL1910850,P20309,,OGDKFVQZFIMTCJ-AREMUKBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 24 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776525,DTCT0023280,7504741,DTCC01158231,1318481,46208
CHEMBL1910851,P20309,,OGDKFVQZFIMTCJ-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.18,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776524,DTCT0023280,7504736,DTCC01158232,1188102,46208
CHEMBL1910851,P20309,,OGDKFVQZFIMTCJ-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.21,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504645,DTCC01158232,1188102,46208
CHEMBL1910851,P20309,,OGDKFVQZFIMTCJ-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,PKB,=,9.3,,,,,,,,,,,,,,,Antagonist activity at M3 receptor in human bronchial ring assessed as inhibition of electrically field-stimulated contractile response after 4 hrs,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776581,DTCT0023280,7504760,DTCC01158232,1188102,46208
CHEMBL1910851,P20309,,OGDKFVQZFIMTCJ-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504655,DTCC01158232,1188102,46208
CHEMBL1910851,P20309,,OGDKFVQZFIMTCJ-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 24 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776525,DTCT0023280,7504742,DTCC01158232,1188102,46208
CHEMBL1910852,P20309,,NQHXUGVGTKIBRD-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.16,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504646,DTCC01158233,249969,46208
CHEMBL1910852,P20309,,NQHXUGVGTKIBRD-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,6.45,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504656,DTCC01158233,249969,46208
CHEMBL1910853,P20309,,DHVGGWOJZQLBEO-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.76,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504647,DTCC01158234,639612,46208
CHEMBL1910853,P20309,,DHVGGWOJZQLBEO-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,3.82,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504657,DTCC01158234,639612,46208
CHEMBL1910854,P20309,,RTYJOLZVELFOPY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,2.3,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504648,DTCC01158235,1766017,46208
CHEMBL1910854,P20309,,RTYJOLZVELFOPY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504658,DTCC01158235,1766017,46208
CHEMBL1910855,P20309,,ICYDCFVNJUZBHP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,11,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504649,DTCC01158236,1705900,46208
CHEMBL1910855,P20309,,ICYDCFVNJUZBHP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,,,,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,Not Determined,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504659,DTCC01158236,1705900,46208
CHEMBL1910856,P20309,PF-3635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.128,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776524,DTCT0023280,7504737,DTCC00040657,1124490,46208
CHEMBL1910856,P20309,PF-3635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504650,DTCC00040657,1124490,46208
CHEMBL1910856,P20309,PF-3635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,PKB,=,9.6,,,,,,,,,,,,,,,Antagonist activity at M3 receptor in human bronchial ring assessed as inhibition of electrically field-stimulated contractile response after 4 hrs,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776581,DTCT0023280,7504761,DTCC00040657,1124490,46208
CHEMBL1910856,P20309,PF-3635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,83.3,HR,,,,,,,,,,,,,,Displacement of radioligand from M3 receptor assessed as dissociation half life,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776591,DTCT0023280,7504787,DTCC00040657,1124490,46208
CHEMBL1910856,P20309,PF-3635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504660,DTCC00040657,1124490,46208
CHEMBL1910856,P20309,PF-3635659,WGOJWDWKHJHXSV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 24 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776525,DTCT0023280,7504743,DTCC00040657,1124490,46208
CHEMBL1910857,P20309,,LOLYQCAGADWETQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.18,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504651,DTCC01158237,1480381,46208
CHEMBL1910857,P20309,,LOLYQCAGADWETQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,20.67,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504661,DTCC01158237,1480381,46208
CHEMBL1910858,P20309,,TWXXXRKOWRJDCO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.73,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504653,DTCC01158238,1253355,46208
CHEMBL1910858,P20309,,TWXXXRKOWRJDCO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504662,DTCC01158238,1253355,46208
CHEMBL1910859,P20309,,NFWKXQRPNKZBHD-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,2,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504696,DTCC01158239,121004,46208
CHEMBL1910859,P20309,,NFWKXQRPNKZBHD-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,13.38,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504704,DTCC01158239,121004,46208
CHEMBL1910860,P20309,,HQOWLVGGFHIDSX-RUZDIDTESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.56,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504697,DTCC01158240,606998,46208
CHEMBL1910860,P20309,,HQOWLVGGFHIDSX-RUZDIDTESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504705,DTCC01158240,606998,46208
CHEMBL1910861,P20309,,QQOHGNCVYFJDMM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,1.9,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504698,DTCC01158241,768488,46208
CHEMBL1910861,P20309,,QQOHGNCVYFJDMM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,23.5,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504706,DTCC01158241,768488,46208
CHEMBL1910862,P20309,,GJPGEALJAYCYSF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.22,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504699,DTCC01158242,217617,46208
CHEMBL1910862,P20309,,GJPGEALJAYCYSF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,,,,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,Not Determined,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504707,DTCC01158242,217617,46208
CHEMBL1910863,P20309,,QEFYNFCZEAWDPT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504700,DTCC01158243,2089777,46208
CHEMBL1910863,P20309,,QEFYNFCZEAWDPT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,,,,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,Not Determined,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504708,DTCC01158243,2089777,46208
CHEMBL1910864,P20309,,JHFOPISWTBENTQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,7.3,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504701,DTCC01158244,704017,46208
CHEMBL1910864,P20309,,JHFOPISWTBENTQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,2.75,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504709,DTCC01158244,704017,46208
CHEMBL1910865,P20309,,TYQDNAMKCKQGHS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.163,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776524,DTCT0023280,7504738,DTCC01158245,994623,46208
CHEMBL1910865,P20309,,TYQDNAMKCKQGHS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.26,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504702,DTCC01158245,994623,46208
CHEMBL1910865,P20309,,TYQDNAMKCKQGHS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,PKB,=,8.8,,,,,,,,,,,,,,,Antagonist activity at M3 receptor in human bronchial ring assessed as inhibition of electrically field-stimulated contractile response after 4 hrs,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776581,DTCT0023280,7504762,DTCC01158245,994623,46208
CHEMBL1910865,P20309,,TYQDNAMKCKQGHS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,20.67,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504710,DTCC01158245,994623,46208
CHEMBL1910865,P20309,,TYQDNAMKCKQGHS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 24 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776525,DTCT0023280,7504744,DTCC01158245,994623,46208
CHEMBL1910866,P20309,,FYLDYFDWQWVALO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.71,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504703,DTCC01158246,1480382,46208
CHEMBL1910866,P20309,,FYLDYFDWQWVALO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504711,DTCC01158246,1480382,46208
CHEMBL1916224,P20309,,NYDGEZQQIMDHCY-QGZVFWFLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21930376,EC50,>,30000,NM,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant muscarinic M3 receptor by HTS cell based assay,,"Development of a highly selective, orally bioavailable and CNS penetrant M(1) agonist derived from the MLPCN probe ML071.",Bioorg. Med. Chem. Lett.,2011,21,21,"Lebois EP, Digby GJ, Sheffler DJ, Melancon BJ, Tarr JC, Cho HP, Miller NR, Morrison R, Bridges TM, Xiang Z, Scott Daniels J, Wood MR, Jeffrey Conn P, Lindsley CW",,788153,DTCT0023280,7525535,DTCC01161021,1577067,46139
CHEMBL1917204,P20309,CCG-50014,QUIIIYITNGOFEI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at human muscarinic M3 receptor expressed in HEK293T cells assessed as increase in carbachol-induced intracellular calcium level at 10 uM after 30 to 45 mins by fluorimetry,Active,,ACS Med. Chem. Lett.,2012,3,2,,,821038,DTCT0023280,10492696,DTCC00040770,705058,48262
CHEMBL192,P20309,SILDENAFIL,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7477907,DTCC00477686,639584,46191
CHEMBL192,P20309,SILDENAFIL,BNRNXUUZRGQAQC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7477908,DTCC00477686,639584,46191
CHEMBL19215,P20309,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20451398,ACTIVITY,=,3.8,NM,,,,,,,,,,,,,,Displacement of [3H]QNB from human cloned muscarinic M3 receptor,,Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.,Bioorg. Med. Chem.,2010,18,22,"Hooker JM, Kim SW, Reibel AT, Alexoff D, Xu Y, Shea C",,681162,DTCT0023280,3578681,DTCC00150357,296043,41784
CHEMBL19215,P20309,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7417272,DTCC00150357,315666,46191
CHEMBL19215,P20309,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7417273,DTCC00150357,315666,46191
CHEMBL1921802,P20309,,ZZAVQSJREUCADH-XUGYUHTKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542714,DTCC01162779,1641931,46625
CHEMBL1921904,P20309,,FNYFFCOCVNTJCD-NNMXADRKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542721,DTCC01162773,2025728,46625
CHEMBL1921905,P20309,,DYNJLEKGXRTDOQ-NNMXADRKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0316,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542720,DTCC01162774,1544994,46625
CHEMBL1921906,P20309,,HUYMQVAQICPEIT-XRFQPOIASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0398,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542719,DTCC01162775,478013,46625
CHEMBL1921907,P20309,,ZHBJNOSRXDDRLF-NNMXADRKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.0631,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542718,DTCC01162776,510389,46625
CHEMBL1921908,P20309,,KYZXOVOTLUIFDM-IPGWDNQVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.0501,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542717,DTCC00129121,1447970,46625
CHEMBL1921909,P20309,,DMTORAWXSSNLOO-TWWVWNITSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0631,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542716,DTCC01162777,1641930,46625
CHEMBL1921910,P20309,,VLWKCPPUBKYCEF-BQTUONFDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542715,DTCC01162778,574701,46625
CHEMBL1921911,P20309,,AIMRQTXCPBQWFD-FYQWWBFWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542712,DTCC01162780,833232,46625
CHEMBL1921912,P20309,,IINAHPOQUFMJIU-PMTRCUQQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,6.31,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542711,DTCC01162781,1674224,46625
CHEMBL1921913,P20309,,WGOSBZASWNBYTQ-UCMBYLDGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1.58,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542710,DTCC01162782,1285970,46625
CHEMBL1921914,P20309,,RKSCZVHQYFYRQE-FXIXRJGSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542709,DTCC01162783,1285971,46625
CHEMBL1921915,P20309,,ZDMIIYGPOIOKNJ-NNRFIJQCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0316,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542708,DTCC01162784,1512906,46625
CHEMBL1921916,P20309,,OZXJKDPJLLASGG-GFDKVKMOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0501,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542707,DTCC01162785,1862793,46625
CHEMBL1921917,P20309,,NZBUIVFAQJILBU-NGWQEONKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.0794,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542706,DTCC01162786,1544995,46625
CHEMBL1921918,P20309,,LDMUCNIFYVJOTG-YPAULADPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542705,DTCC01162787,1960145,46625
CHEMBL1921919,P20309,,DYBHRYASVPRHCT-KIKKPEDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.126,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542704,DTCC01162788,1512907,46625
CHEMBL1921920,P20309,,OSCMWRVJRBRUDD-ZMJBPPSBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,2.51,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542703,DTCC01162789,1027147,46625
CHEMBL1921921,P20309,,FKZXUTFIOSGCHU-NGWQEONKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.316,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542702,DTCC01162790,1027148,46625
CHEMBL1921922,P20309,,DCTDMLRUYBFRCL-KIKKPEDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1.26,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542701,DTCC01162791,1577090,46625
CHEMBL1921923,P20309,,JHOZGFQMXDYMCZ-TZVITEJDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542700,DTCC01162792,1188142,46625
CHEMBL1921924,P20309,,QUYWVXBALJRRMH-YAFCZHNFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.316,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542699,DTCC01162793,283079,46625
CHEMBL1921925,P20309,,YXJHGLMJLQLKDJ-WVOWOTBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.0631,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542698,DTCC01162794,1798494,46625
CHEMBL1921926,P20309,,VQHLGGYSUFMZNH-DWTCRTLWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.398,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542697,DTCC01162795,2089833,46625
CHEMBL1921927,P20309,,JKZTXAFKMWAXLC-QKZQWPARSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542695,DTCC01162796,1577091,46625
CHEMBL1921928,P20309,,ABIVXWKXMJCZMZ-LQXXZEARSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542694,DTCC01162797,994667,46625
CHEMBL1921929,P20309,,OBJDKIORAOGSLE-NAZCUKFVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.631,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542693,DTCC01162798,1253409,46625
CHEMBL1921930,P20309,,NOIIZVLZESZXLC-BNAAVTMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542692,DTCC01162799,574702,46625
CHEMBL1921931,P20309,,MKXOEYWYQYOBEQ-BNAAVTMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1.26,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542691,DTCC01162800,898366,46625
CHEMBL1921932,P20309,,KTGKJEWKNRXADV-SHZVQYQYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.316,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542690,DTCC01162801,2057705,46625
CHEMBL1921933,P20309,,QHUHABYGKGPQMQ-SHZVQYQYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542689,DTCC01162802,348490,46625
CHEMBL1921934,P20309,,FJOACQNMBCLIDI-PCUONRJLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542688,DTCC01162803,704067,46625
CHEMBL1921935,P20309,,YHGPEGHFOGAKHM-JRZMRVHDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.0631,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542687,DTCC01162804,1577092,46625
CHEMBL1921936,P20309,,MOQMSSOYEONBHV-SXBWKGCASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.631,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542686,DTCC01162805,1992894,46625
CHEMBL1921937,P20309,,SBXBQRYZOXPPSA-ATAXOEMKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.0794,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542685,DTCC01162806,348491,46625
CHEMBL1921938,P20309,,DVXMXOBIXWVEAN-GFDKVKMOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542684,DTCC01162807,1092441,46625
CHEMBL1921939,P20309,,RUOCWECVFHBXNS-QKZQWPARSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.501,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542683,DTCC01162808,768546,46625
CHEMBL1921940,P20309,,DYNQEVUMIFLEOX-WFMIRFNLSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542682,DTCC01162809,153535,46625
CHEMBL1921941,P20309,,WKMMKXONQAAZDT-JZXTWQBISA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.126,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542681,DTCC01162810,51738,46625
CHEMBL1921942,P20309,,FPVBKJOAXYOMGD-VWTNIKFJSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542680,DTCC01162811,1544996,46625
CHEMBL1921943,P20309,,VAEJXCRKXKTGOE-JREOFSSMSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542679,DTCC01162812,542657,46625
CHEMBL1921944,P20309,,FKEWCZKTNYQRTE-ZXZDCFMOSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542678,DTCC01162813,444709,46625
CHEMBL1921945,P20309,,VZNXMVGDWIFGPG-PDGMAZNTSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542677,DTCC01162814,1027149,46625
CHEMBL1921946,P20309,,BKNNXJKQQWVAHA-JSZRZZSISA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.126,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542676,DTCC01162815,607044,46625
CHEMBL1922048,P20309,,BDPZTHDWQYMKRB-JDSZFFLXSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1.26,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542675,DTCC01162917,283081,46625
CHEMBL1922049,P20309,,RIMUVXFPXPFFCV-JDSZFFLXSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542674,DTCC01162918,574704,46625
CHEMBL1922050,P20309,,HBESSADZMVANJT-JDSZFFLXSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542673,DTCC01162919,671862,46625
CHEMBL1922051,P20309,,FWGZCGKLVODFPY-ZKZAZUJQSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542672,DTCC01162920,1895063,46625
CHEMBL1922052,P20309,,STBUKKKWQRDACN-CALFJGIESA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542671,DTCC01162921,2025730,46625
CHEMBL1922053,P20309,,FNLYMMFDVOHLPL-UCZZCIKGSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542670,DTCC01162922,833233,46625
CHEMBL1922054,P20309,,BTNKJHBSKAVDTH-WMBYLGNXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542669,DTCC01162923,1351195,46625
CHEMBL1922055,P20309,,CUHHKRVQQVBABE-MHCCUNAPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542668,DTCC01162924,2089834,46625
CHEMBL1922056,P20309,,KBKMJOUMILUGRZ-DAUOMQBBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.316,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542667,DTCC01162925,121057,46625
CHEMBL1922057,P20309,,FMOVWGDUYITLGZ-VWTNIKFJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.398,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542666,DTCC01162926,1480436,46625
CHEMBL1922058,P20309,,NSUXHNATZRCPHE-VEERZVHFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542665,DTCC01162927,768548,46625
CHEMBL19224,P20309,PAPAVERINE,XQYZDYMELSJDRZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371806,DTCC00150178,1351115,46191
CHEMBL19224,P20309,PAPAVERINE,XQYZDYMELSJDRZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371807,DTCC00150178,1351115,46191
CHEMBL1922614,P20309,,UKQMQTGGUNTZKM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22029285,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 1 uM by ligand displacement assay,Not Active,"Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.",J. Med. Chem.,2011,54,23,"Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Tkachenko SE, Okun IM",,789968,DTCT0023280,7548709,DTCC01163436,1512917,46592
CHEMBL19236,P20309,MOXONIDINE,WPNJAUFVNXKLIM-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430735,DTCC00150160,1894970,46191
CHEMBL19236,P20309,MOXONIDINE,WPNJAUFVNXKLIM-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430736,DTCC00150160,1894970,46191
CHEMBL1924025,P20309,,RAWSDFNXZQJMDA-XRFQPOIASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542724,DTCC01164806,574718,46625
CHEMBL1924026,P20309,,DDYMHKDAECHERK-HUVSLODASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1.58,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542762,DTCC01164807,1059420,46625
CHEMBL1924027,P20309,,BSGBCJXYGLKSES-ZMBIFBSDSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.0316,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542761,DTCC01164808,542684,46625
CHEMBL1924028,P20309,,NVSYZLKDFATHHJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542747,DTCC01164809,898389,46625
CHEMBL1924029,P20309,,KBMILMUSFPMBSW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542746,DTCC01164810,1895076,46625
CHEMBL1924030,P20309,,WMBPTNZBPGXZAR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542745,DTCC01164811,833267,46625
CHEMBL1924031,P20309,,ZMXYDUSRRWUQKE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542744,DTCC01164812,1285999,46625
CHEMBL1924032,P20309,,VISHRZZLGOYWIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1.26,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542743,DTCC01164813,2057719,46625
CHEMBL1924033,P20309,,NIEKFDVEFLUMLQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542742,DTCC01164814,185645,46625
CHEMBL1924034,P20309,,QEBAODYBLVOGEJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,10,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542741,DTCC01164815,1383861,46625
CHEMBL1924035,P20309,,PHYCQDDAIMNIIQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,158.49,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542739,DTCC01164816,348511,46625
CHEMBL1924036,P20309,,JHSINHUWGNKNKA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542740,DTCC01164817,1188161,46625
CHEMBL1924037,P20309,,TXMQKSRNNXQQRH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,2.51,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542737,DTCC01164818,768563,46625
CHEMBL1924038,P20309,,FWPJONCBQIJIRI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542738,DTCC01164819,510423,46625
CHEMBL1924039,P20309,,BNDUWEJKIVVMAZ-LROBGIAVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542736,DTCC01164820,1447987,46625
CHEMBL1924040,P20309,,RVXKMYHNDBHDLD-SHZVQYQYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.0501,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542734,DTCC01164821,1960169,46625
CHEMBL1924041,P20309,,RVXKMYHNDBHDLD-ZOGAMXBRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542733,DTCC01164822,930187,46625
CHEMBL1924042,P20309,,ZXAIBYRKWLCJDI-KKHVISAVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542732,DTCC01164823,153559,46625
CHEMBL1924043,P20309,,RHTDCYORTDFEFL-WILGIRNMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,251.19,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542731,DTCC01164824,607069,46625
CHEMBL1924044,P20309,,LWLXUWUHMUVTCQ-UCWJKEELSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542730,DTCC01164825,1447988,46625
CHEMBL1924045,P20309,,FNBHAPOWAKDVPI-CYLKOEIPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,7.94,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542729,DTCC01164826,736348,46625
CHEMBL1924046,P20309,,UZEVBPRKTBGQEP-RJYCBYKVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.631,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542728,DTCC01164827,607070,46625
CHEMBL1924047,P20309,,DVEKJMIGSBNUCB-YXWZOGTMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542727,DTCC01164828,866115,46625
CHEMBL1924048,P20309,,BBIBFZJMAOWDKQ-FXIXRJGSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0501,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542726,DTCC01164829,315774,46625
CHEMBL1924049,P20309,,OMGBLXWNGZEFEP-NNMXADRKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,=,0.126,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542725,DTCC01164830,1027167,46625
CHEMBL1924050,P20309,,ACGBRZCIFNWBLV-NNMXADRKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0398,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542723,DTCC01164831,348512,46625
CHEMBL1924051,P20309,,MZAVVLWULQNHMR-XRFQPOIASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0501,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542722,DTCC01164832,1253432,46625
CHEMBL19299,P20309,LOXOPROFEN,YMBXTVYHTMGZDW-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416983,DTCC00151156,1960076,46191
CHEMBL19299,P20309,LOXOPROFEN,YMBXTVYHTMGZDW-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416984,DTCC00151156,1960076,46191
CHEMBL193,P20309,NIFEDIPINE,HYIMSNHJOBLJNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401218,DTCC00485676,51493,46191
CHEMBL193,P20309,NIFEDIPINE,HYIMSNHJOBLJNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401219,DTCC00485676,51493,46191
CHEMBL193482,P20309,ESTRIOL,PROQIPRRNZUXQM-ZXXIGWHRSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7313555,DTCC00405591,348401,46191
CHEMBL193482,P20309,ESTRIOL,PROQIPRRNZUXQM-ZXXIGWHRSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7313556,DTCC00405591,348401,46191
CHEMBL1939222,P20309,,HTSQRRQNKJNSLH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22191331,INHIBITION,=,-4,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM by radioligand displacement assay,,ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis.,J. Med. Chem.,2012,55,1,"Chen T, Benmohamed R, Kim J, Smith K, Amante D, Morimoto RI, Kirsch DR, Ferrante RJ, Silverman RB",,858146,DTCT0023280,11390363,DTCC01170899,931965,51183
CHEMBL1940125,P20309,,KZEVRYRKBGRMEZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22197142,IC50,>,30000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by fluorescence assay,,Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012.,Bioorg. Med. Chem. Lett.,2012,22,2,"Melancon BJ, Lamers AP, Bridges TM, Sulikowski GA, Utley TJ, Sheffler DJ, Noetzel MJ, Morrison RD, Scott Daniels J, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Wood MR",,797808,DTCT0023280,7594609,DTCC01171746,1876300,47107
CHEMBL194206,P20309,,AOENLUNXEDMDRT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1846052,DTCC00404620,531747,19805
CHEMBL1950351,P20309,,UCMNIYFDRVBMFV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22284817,ACTIVITY,<,50,%,,,,,,,,,,,,,,Activity at human M3 receptor at 10 uM,,¿-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration.,Bioorg. Med. Chem. Lett.,2012,22,4,"Cheng YX, Pourashraf M, Luo X, Srivastava S, Walpole C, Salois D, St-Onge S, Payza K, Lessard E, Yu XH, Tomaszewski MJ",,804091,DTCT0023280,7637700,DTCC01175791,1397355,47435
CHEMBL195437,P20309,4-OCTYLPHENOL,NTDQQZYCCIDJRK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,19004,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291994,DTCC00405592,1285870,46191
CHEMBL195437,P20309,4-OCTYLPHENOL,NTDQQZYCCIDJRK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,4028,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7291995,DTCC00405592,1285870,46191
CHEMBL1956107,P20309,,HGVUTNMCDMGTOE-WOVMCDHWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22175766,INHIBITION,=,85,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells at 10 uM after 60 mins,,"Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.",J. Med. Chem.,2012,55,2,"Annedi SC, Ramnauth J, Maddaford SP, Renton P, Rakhit S, Mladenova G, Dove P, Silverman S, Andrews JS, Felice MD, Porreca F",,806513,DTCT0023280,7652549,DTCC01177827,781958,47509
CHEMBL195927,P20309,,SYERHDJULLPKRY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1846141,DTCC00404634,435219,19805
CHEMBL196,P20309,ASCORBATE,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273497,DTCC00506386,282996,46191
CHEMBL196,P20309,ASCORBATE,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273498,DTCC00506386,282996,46191
CHEMBL196169,P20309,,PGAUZNVGTNAJSV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1859446,DTCC00407473,1340290,19805
CHEMBL196258,P20309,,PYUBHJHQYILWFE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16250647,INHIBITION,<,10,%,,,,,,,,,,,,,,Percent inhibition against Muscarinic acetylcholine receptor M3 at 1 uM,,"2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.",J. Med. Chem.,2005,48,22,"Minetti P, Tinti MO, Carminati P, Castorina M, Di Cesare MA, Di Serio S, Gallo G, Ghirardi O, Giorgi F, Giorgi L, Piersanti G, Bartoccini F, Tarzia G",,321772,DTCT0023280,1855374,DTCC00406824,1016173,19966
CHEMBL196370,P20309,,FBDANPRMCCLYRK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1859401,DTCC00407468,951602,19805
CHEMBL196598,P20309,,DZKYLEMMURXALW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1846098,DTCC00404626,77831,19805
CHEMBL197408,P20309,,WJYDVXOBGXFRGI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1846074,DTCC00404625,1566191,19805
CHEMBL197669,P20309,ST1535,CYYQMAWUIRPCNW-UHFFFAOYSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16250647,INHIBITION,<,10,%,,,,,,,,,,,,,,Percent inhibition against Muscarinic acetylcholine receptor M3 at 1 uM,,"2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.",J. Med. Chem.,2005,48,22,"Minetti P, Tinti MO, Carminati P, Castorina M, Di Cesare MA, Di Serio S, Gallo G, Ghirardi O, Giorgi F, Giorgi L, Piersanti G, Bartoccini F, Tarzia G",,321772,DTCT0023280,1855329,DTCC00406821,1048667,19966
CHEMBL197796,P20309,,BNXUKTBRYQQOIZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1846120,DTCC00404633,142509,19805
CHEMBL197973,P20309,,JGAVKZMDPWRTHU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,631,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879429,DTCC00411377,239283,10048
CHEMBL1983100,P20309,ESAPRAZOLE,RTFADALJKSFJDZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,=,87000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464586,DTCC01199373,1042080,54820
CHEMBL1987019,P20309,,RLUNJKJUFRFYJM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,691.83,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14743766,DTCC01203063,2108500,68416
CHEMBL198949,P20309,,DUFKTZBQJIHIAQ-VGZDNEPHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16198561,IC50,>,1000,NM,,,,,,,,,,,,,,Inhibition of human muscarinic receptor M3,,Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis.,Bioorg. Med. Chem. Lett.,2005,15,23,"Revesz L, Bollbuck B, Buhl T, Eder J, Esser R, Feifel R, Heng R, Hiestand P, Jachez-Demange B, Loetscher P, Sparrer H, Schlapbach A, Waelchli R",,325912,DTCT0023280,1867485,DTCC00408984,1501911,11231
CHEMBL199591,P20309,,LTTDHGFPRZVXKM-JOCHJYFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,1000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879423,DTCC00411514,1405296,10048
CHEMBL199821,P20309,,ROGNPHYAHLESSZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,2.5,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879432,DTCC00411323,1695402,10048
CHEMBL199981,P20309,,QZXIHFJVAQJVKZ-JOCHJYFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,7.9,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879427,DTCC00411343,337604,10048
CHEMBL2,P20309,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387604,DTCC00132268,1155685,46191
CHEMBL2,P20309,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387605,DTCC00132268,1155685,46191
CHEMBL20,P20309,ACETAZOLAMIDE,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7281112,DTCC00133144,51441,46191
CHEMBL20,P20309,ACETAZOLAMIDE,BZKPWHYZMXOIDC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7281113,DTCC00133144,51441,46191
CHEMBL200171,P20309,,ZGBSEJYQXDWFRF-FGZHOGPDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.25,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879414,DTCC00411648,693233,10048
CHEMBL200208,P20309,,WUMIJQZPHGJALC-QFIPXVFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,63,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879438,DTCC00411752,983950,10048
CHEMBL200209,P20309,,MMMQUSWLVGQDBX-XMMPIXPASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,100,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879426,DTCC00411453,1949027,10048
CHEMBL200210,P20309,,LLHFDYRCKMNGML-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,10,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879416,DTCC00411595,1631029,10048
CHEMBL200234,P20309,,YZKSXUIOKWQABW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23517028,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation after 15 mins by Alphascreen Surefire assay,Not Active,Biophysical fragment screening of the ß1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.,J. Med. Chem.,2013,56,9,"Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M",,944378,DTCT0023280,11811015,DTCC00409356,512959,54118
CHEMBL200234,P20309,,YZKSXUIOKWQABW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23517028,KI,>,19952.62,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]-NMS from recombinant muscarinic M3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by liquid scintillation counting analysis,,Biophysical fragment screening of the ß1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.,J. Med. Chem.,2013,56,9,"Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M",,944382,DTCT0023280,11811054,DTCC00409356,512959,54118
CHEMBL200319,P20309,,ZGBSEJYQXDWFRF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.4,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879415,DTCC00411596,2079065,10048
CHEMBL200321,P20309,,MGQGSHOWWMKMKS-HXUWFJFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of radioligand binding at human muscarinic M3 receptor at 10 uM,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327861,DTCT0023280,1880652,DTCC00411566,1437211,10048
CHEMBL200401,P20309,,LABGCBWSNGTBPM-GOSISDBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.08,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879420,DTCC00411476,304977,10048
CHEMBL200416,P20309,,DVSLSPWSCJLOGG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.63,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879431,DTCC00411334,919138,10048
CHEMBL200432,P20309,,VDLFTAVQHMFQHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.25,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879434,DTCC00411798,822222,10048
CHEMBL200566,P20309,,MFJMNDSAKGEJIM-JUERFOTFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,100,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879422,DTCC00411549,1048730,10048
CHEMBL200693,P20309,,VBKBVALDNMYEBZ-WTQRLHSKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.2,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879437,DTCC00411753,1146194,10048
CHEMBL200906,P20309,,OQMLSKSSPKAKJQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275071,ACTIVITY,=,0,%,,,,,,,,,,,,,,Percentage binding to muscarinic M3 at 10 uM,,A new chemical tool for exploring the physiological function of the PDE2 isozyme.,Bioorg. Med. Chem. Lett.,2006,16,2,"Chambers RJ, Abrams K, Garceau NY, Kamath AV, Manley CM, Lilley SC, Otte DA, Scott DO, Sheils AL, Tess DA, Vellekoop AS, Zhang Y, Lam KT",,327577,DTCT0023280,1878578,DTCC00411800,1393610,20142
CHEMBL200957,P20309,,MTAUYQIIHXMBJZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879433,DTCC00411799,789819,10048
CHEMBL2012728,P20309,,LTQWNQOQFFXHAJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22342142,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of M3 receptor at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012,22,6,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811289,DTCT0023280,10426534,DTCC01227134,427664,47711
CHEMBL2012737,P20309,,NFEVAAXMHCVVQF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22342142,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of M3 receptor at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012,22,6,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811289,DTCT0023280,10426533,DTCC01227143,620872,47711
CHEMBL201933,P20309,,NSEVJPOKAGLQCK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,1.3,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879412,DTCC00411655,206806,10048
CHEMBL2021476,P20309,,HRTBCTVVOSBTBF-XZHZQXPNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18595721,KI,=,44.67,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,,"Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.",Bioorg. Med. Chem.,2008,16,15,"Minarini A, Marucci G, Bellucci C, Giorgi G, Tumiatti V, Bolognesi ML, Matera R, Rosini M, Melchiorre C",,491020,DTCT0023280,2759487,DTCC01230258,1588508,30679
CHEMBL2021477,P20309,,HRTBCTVVOSBTBF-IXOXMDGESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18595721,KI,=,39.81,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,,"Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.",Bioorg. Med. Chem.,2008,16,15,"Minarini A, Marucci G, Bellucci C, Giorgi G, Tumiatti V, Bolognesi ML, Matera R, Rosini M, Melchiorre C",,491020,DTCT0023280,2759486,DTCC01230259,1524083,30679
CHEMBL2021478,P20309,,HRTBCTVVOSBTBF-ZZYOSWMOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18595721,KI,=,48.98,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,,"Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.",Bioorg. Med. Chem.,2008,16,15,"Minarini A, Marucci G, Bellucci C, Giorgi G, Tumiatti V, Bolognesi ML, Matera R, Rosini M, Melchiorre C",,491020,DTCT0023280,2759485,DTCC01230260,229196,30679
CHEMBL2021479,P20309,,HRTBCTVVOSBTBF-VSIGASKDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18595721,KI,=,40.74,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,,"Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.",Bioorg. Med. Chem.,2008,16,15,"Minarini A, Marucci G, Bellucci C, Giorgi G, Tumiatti V, Bolognesi ML, Matera R, Rosini M, Melchiorre C",,491020,DTCT0023280,2759484,DTCC01230261,359937,30679
CHEMBL2021993,P20309,,GGVKTRZGPZQDNC-MQZRBUFZSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461707,DTCC01230538,1448921,47954
CHEMBL2021993,P20309,,GGVKTRZGPZQDNC-MQZRBUFZSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,<,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461726,DTCC01230538,1448921,47954
CHEMBL2021994,P20309,,SWCCFIKQJPITSF-GLDYSVIMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461708,DTCC01230539,834288,47954
CHEMBL2021994,P20309,,SWCCFIKQJPITSF-GLDYSVIMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,<,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461727,DTCC01230539,834288,47954
CHEMBL2021995,P20309,,TYFHYJPZGXVGOE-APKPJTILSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461709,DTCC01230540,867078,47954
CHEMBL2021995,P20309,,TYFHYJPZGXVGOE-APKPJTILSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,<,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461728,DTCC01230540,867078,47954
CHEMBL2021996,P20309,,IHHSWQGTMZCYJY-PLBAHABXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461710,DTCC01230541,1831709,47954
CHEMBL2021996,P20309,,IHHSWQGTMZCYJY-PLBAHABXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,<,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461729,DTCC01230541,1831709,47954
CHEMBL2021997,P20309,,QUBBYGYZWPXUFL-BAYXQSOBSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461711,DTCC01230542,2090744,47954
CHEMBL2021997,P20309,,QUBBYGYZWPXUFL-BAYXQSOBSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.0398,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461730,DTCC01230542,2090744,47954
CHEMBL2021998,P20309,,NKNXKMRFPHQTBE-NDNKGBFRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461712,DTCC01230543,218615,47954
CHEMBL2021998,P20309,,NKNXKMRFPHQTBE-NDNKGBFRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.0794,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461731,DTCC01230543,218615,47954
CHEMBL202290,P20309,,OFDZVXVDBFZQTO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of radioligand binding at human muscarinic M3 receptor at 10 uM,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327861,DTCT0023280,1879419,DTCC00411477,239284,10048
CHEMBL2022960,P20309,,BWAKMLKESHKOHK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,ACTIVITY,=,19,%,,,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor at 30 uM by calcium mobilization assay relative to acetylcholine,,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815540,DTCT0023280,10458465,DTCC01231459,867095,48012
CHEMBL2022960,P20309,,BWAKMLKESHKOHK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,EC50,=,5900,NM,,,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor by calcium mobilization assay,,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815537,DTCT0023280,10458441,DTCC01231459,867095,48012
CHEMBL2023760,P20309,,XKRKFRNMCTYSTF-GLDYSVIMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461700,DTCC01232186,2026757,47954
CHEMBL2023760,P20309,,XKRKFRNMCTYSTF-GLDYSVIMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.0251,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461721,DTCC01232186,2026757,47954
CHEMBL2023761,P20309,,AINYDMAWYSRABK-SKOPMZHTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,=,26.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461701,DTCC01232187,543597,47954
CHEMBL2023762,P20309,,CCXOXKSAHHQWSK-IWFPPBCPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461702,DTCC01232188,1254417,47954
CHEMBL2023762,P20309,,CCXOXKSAHHQWSK-IWFPPBCPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,<,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461722,DTCC01232188,1254417,47954
CHEMBL2023763,P20309,,CCXOXKSAHHQWSK-LBHWNIOJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,=,32,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461703,DTCC01232189,218637,47954
CHEMBL2023764,P20309,,RUFDCRHFGITFQH-APKPJTILSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization incubated for 90 mins measured following 180 mins washout by FLIPR analysis,Active,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815854,DTCT0023280,10461741,DTCC01232190,1448933,47954
CHEMBL2023764,P20309,,RUFDCRHFGITFQH-APKPJTILSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461704,DTCC01232190,1448933,47954
CHEMBL2023764,P20309,,RUFDCRHFGITFQH-APKPJTILSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,<,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461723,DTCC01232190,1448933,47954
CHEMBL2023764,P20309,,RUFDCRHFGITFQH-APKPJTILSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KI,=,0.16,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from muscarinic acetylcholine M3 receptor expressed in CHO cell membrane,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815847,DTCT0023280,10461734,DTCC01232190,1448933,47954
CHEMBL2023764,P20309,,RUFDCRHFGITFQH-APKPJTILSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,PA2,,,,,,,,,,,,,,,,,Antagonist potency at human muscarinic acetylcholine M3 receptor in bronchos assessed as non competitive inhibition of carbachol-induced bronchoconstriction,Active,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815848,DTCT0023280,10461735,DTCC01232190,1448933,47954
CHEMBL2023764,P20309,,RUFDCRHFGITFQH-APKPJTILSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,TIME,>,600,MIN,,,,,,,,,,,,,,Antagonist activity at human muscarinic acetylcholine M3 receptor in bronchos assessed as time for 50% reversal of carbachol-induced bronchoconstriction to maximum relaxation at 10 nM,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815849,DTCT0023280,10461736,DTCC01232190,1448933,47954
CHEMBL2023765,P20309,,LLAKUMMDYFQHBD-WYHMBPENSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461705,DTCC01232191,511378,47954
CHEMBL2023765,P20309,,LLAKUMMDYFQHBD-WYHMBPENSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,<,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461724,DTCC01232191,511378,47954
CHEMBL2023766,P20309,,CKBPDZNBKMAPCI-WYHMBPENSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461706,DTCC01232192,511379,47954
CHEMBL2023766,P20309,,CKBPDZNBKMAPCI-WYHMBPENSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,<,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461725,DTCC01232192,511379,47954
CHEMBL2024087,P20309,,FQIJPHXWIONJLF-JKOKRWQUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22171543,INHIBITION,=,0,%,,,,,,,,,,,,,,Displacement of [3H]QNB from M3 receptor at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012,55,2,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815949,DTCT0023280,10457849,DTCC01232472,1365032,48063
CHEMBL2024089,P20309,,HGSHFGWWOPXUPH-WHOFXGATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22171543,INHIBITION,=,30.2,%,,,,,,,,,,,,,,Displacement of [3H]QNB from M3 receptor at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012,55,2,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815949,DTCT0023280,10457850,DTCC01232474,102538,48063
CHEMBL2024094,P20309,,NMIIKXFGCKOYRV-WHOFXGATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22171543,INHIBITION,=,9.6,%,,,,,,,,,,,,,,Displacement of [3H]QNB from M3 receptor at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012,55,2,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815949,DTCT0023280,10457851,DTCC01232479,1008460,48063
CHEMBL2024331,P20309,,AJSHPFXXSLQSKN-NEYBNPPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,ACTIVITY,=,36,%,,,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor at 30 uM by calcium mobilization assay relative to acetylcholine,,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815540,DTCT0023280,10458485,DTCC01232694,1799447,48012
CHEMBL2024331,P20309,,AJSHPFXXSLQSKN-NEYBNPPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,EC50,>,10000,NM,,,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor by calcium mobilization assay,,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815537,DTCT0023280,10458448,DTCC01232694,1799447,48012
CHEMBL2024332,P20309,,OHFJWWZZUQRDMV-NEYBNPPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,ACTIVITY,,,,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor by calcium mobilization assay,Not Active,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815541,DTCT0023280,10459158,DTCC01232695,1767024,48012
CHEMBL2024332,P20309,,OHFJWWZZUQRDMV-NEYBNPPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,EC50,,,,,,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor by calcium mobilization assay,Not Active,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815537,DTCT0023280,10455966,DTCC01232695,1767024,48012
CHEMBL2024407,P20309,,UPSHGSHERZLKSV-BJWYYQGGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,ACTIVITY,=,13,%,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor assessed as remaining activity measured as percentage of maximum response generated from 80% of saturating dose of ACh at 30 uM by calcium mobilization assay,,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815542,DTCT0023280,10458462,DTCC01232768,931155,48012
CHEMBL2024407,P20309,,UPSHGSHERZLKSV-BJWYYQGGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,IC50,>,10000,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor by calcium mobilization assay,,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815541,DTCT0023280,10458449,DTCC01232768,931155,48012
CHEMBL2024408,P20309,,UPSHGSHERZLKSV-OSYLJGHBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,EC50,,,,,,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor by calcium mobilization assay,Not Active,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815537,DTCT0023280,10456085,DTCC01232769,543604,48012
CHEMBL2024408,P20309,,UPSHGSHERZLKSV-OSYLJGHBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,IC50,,,,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor by calcium mobilization assay,Not Active,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815541,DTCT0023280,10459159,DTCC01232769,543604,48012
CHEMBL202729,P20309,,DLVRPVAAPVUMHJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,7.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914017,DTCC00419403,1340411,20612
CHEMBL2030622,P20309,,ITUMTGGIBOPIJQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10477998,DTCC01235111,1610661,48255
CHEMBL2030623,P20309,,HJOLMLNXMCFYQQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478039,DTCC01235112,382111,48255
CHEMBL2030624,P20309,,MFKYGKXYJBKSQN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478086,DTCC01235113,218663,48255
CHEMBL2030625,P20309,,JVHYCBRRZUMPEJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818154,DTCT0023280,10478186,DTCC01235114,53054,48255
CHEMBL2030626,P20309,,TWUZJTIHFYRNSV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,=,661,NM,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478202,DTCC01235115,1735130,48255
CHEMBL2030627,P20309,,JJTSIVODPMDGBG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10467007,DTCC01235116,1417143,48255
CHEMBL2030628,P20309,,URNOPSHFIGOPOJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478616,DTCC01235117,1221331,48255
CHEMBL2030629,P20309,,SRRZEMVAQOSBLB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478663,DTCC01235118,963513,48255
CHEMBL2030630,P20309,,LCBQDWKMNGEPLD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10472721,DTCC01235119,1961153,48255
CHEMBL2030631,P20309,N-BENZYLPYRROLIDINE,CWEGCQIIDCZZED-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478735,DTCC00041635,1993939,48255
CHEMBL2030632,P20309,N-(3-FLUOROBENZYL)PYRROLIDINE,PRKCBGIXZFUCEF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478773,DTCC00041636,1417144,48255
CHEMBL2030633,P20309,"N-(3,4-DIMETHOXYBENZYL)PYRROLIDINE",MIZXZRHARATZMK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10478820,DTCC00041637,801620,48255
CHEMBL2030634,P20309,N-(CYCLOHEXYLMETHYL)PYRROLIDINE,ADGIWWYGVBZYMC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818154,DTCT0023280,10479216,DTCC00041638,769521,48255
CHEMBL2030635,P20309,N-(2-PHENYLETHYL)PYRROLIDINE,KLUCWWVQVUXBSE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10479259,DTCC00041639,995674,48255
CHEMBL2030636,P20309,,PXBKRGXXBYALIH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10479303,DTCC00129963,1156787,48255
CHEMBL2030637,P20309,,VBKWQJLSFFFYLC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10479386,DTCC00129964,834331,48255
CHEMBL203124,P20309,,KHVDQCLELPNWCP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,501,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914048,DTCC00418596,1209501,20612
CHEMBL2031737,P20309,,GPZMWOXSIRVXQW-OAHLLOKOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22313227,KI,=,512,NM,,,,,,,,,,,,,,Binding affinity to human recombinant M3 receptor,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012,55,5,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818805,DTCT0023280,10474240,DTCC01236182,1106160,48153
CHEMBL2032049,P20309,,WAOZNBXSEVIAGX-MBOZVWFJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22542010,KI,>,2000,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition.,Bioorg. Med. Chem. Lett.,2012,22,11,"Mihalic JT, Fan P, Chen X, Chen X, Fu Y, Motani A, Liang L, Lindstrom M, Tang L, Chen JL, Jaen J, Dai K, Li L",,818588,DTCT0023280,10469512,DTCC01236483,284103,48184
CHEMBL203249,P20309,,KGGLWTNSVNKIRD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879407,DTCC00412032,1819979,10048
CHEMBL203266,P20309,TRIMETAZIDINE,UHWVSEOVJBQKBE-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443768,DTCC00417182,381018,46191
CHEMBL203266,P20309,TRIMETAZIDINE,UHWVSEOVJBQKBE-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7443769,DTCC00417182,381018,46191
CHEMBL2036273,P20309,,DZWCPJPFRNJGMB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22420844,INHIBITION,=,88,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM,,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,2012,55,7,"Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F",,820370,DTCT0023280,10484644,DTCC01238063,218701,48312
CHEMBL2036988,P20309,METHOXYNEPATAEFOLIN,VBXFGTHKNFHIFR-XXPYTPQDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22475308,INHIBITION,>,50,%,,,,,,,,,,,,,,Displacement of [3H]QNB from human muscarinic M3 receptor at 10 uM,,Bis-spirolabdane diterpenoids from Leonotis nepetaefolia.,J. Nat. Prod.,2012,75,4,"Li J, Fronczek FR, Ferreira D, Burandt CL, Setola V, Roth BL, Zjawiony JK",,821612,DTCT0023280,10489556,DTCC01238708,199168,48326
CHEMBL2036989,P20309,LEONOTININ,TYPXWADRUZBXSO-FHZWTMRJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22475308,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Bis-spirolabdane diterpenoids from Leonotis nepetaefolia.,J. Nat. Prod.,2012,75,4,"Li J, Fronczek FR, Ferreira D, Burandt CL, Setola V, Roth BL, Zjawiony JK",,821616,DTCT0023280,10490447,DTCC01238709,1234394,48326
CHEMBL2036990,P20309,,IARPMRDAHBVKSU-LHBFQHFASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22475308,INHIBITION,>,50,%,,,,,,,,,,,,,,Displacement of [3H]QNB from human muscarinic M3 receptor at 10 uM,,Bis-spirolabdane diterpenoids from Leonotis nepetaefolia.,J. Nat. Prod.,2012,75,4,"Li J, Fronczek FR, Ferreira D, Burandt CL, Setola V, Roth BL, Zjawiony JK",,821612,DTCT0023280,10490448,DTCC01238710,492040,48326
CHEMBL2037369,P20309,,NCTIMJFWDQCLDW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at human muscarinic M3 receptor expressed in HEK293T cells assessed as increase in carbachol-induced intracellular calcium level at 10 uM after 30 to 45 mins by fluorimetry,Not Active,,ACS Med. Chem. Lett.,2012,3,2,,,821038,DTCT0023280,10492698,DTCC01239090,1221383,48262
CHEMBL2042400,P20309,,LEGDVZOKNFCETQ-BAUSSPIASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,17782.79,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512631,DTCC01240773,218733,48454
CHEMBL2042401,P20309,,LEGDVZOKNFCETQ-DHTOPLTISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,81283.05,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512630,DTCC01240774,737371,48454
CHEMBL2042402,P20309,,RJZHSUUYVXVMCC-DTPOWOMPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,9772.37,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512629,DTCC01240775,769575,48454
CHEMBL2042403,P20309,,RJZHSUUYVXVMCC-DFQHDRSWSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,31622.78,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512628,DTCC01240776,53167,48454
CHEMBL2042404,P20309,,BKINEQWDKRMUEM-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,3.63,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512627,DTCC01240777,834387,48454
CHEMBL2042405,P20309,,BKINEQWDKRMUEM-FYZYNONXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,1.48,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512626,DTCC01240778,1352251,48454
CHEMBL2042406,P20309,,BKINEQWDKRMUEM-FSRHSHDFSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,61.66,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512625,DTCC01240779,1799513,48454
CHEMBL2042407,P20309,,JHYPVNXUOIYEEE-GZJHNZOKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,8912.51,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512624,DTCC01240780,640772,48454
CHEMBL2042551,P20309,,JHYPVNXUOIYEEE-FDOHDBATSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,21379.62,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512623,DTCC01240920,737372,48454
CHEMBL2042552,P20309,,BLGKQVFOHFETTH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,2.19,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512622,DTCC01240921,1156844,48454
CHEMBL2042553,P20309,,BLGKQVFOHFETTH-FERBBOLQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,1.51,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512621,DTCC01240922,995736,48454
CHEMBL2042554,P20309,,BLGKQVFOHFETTH-GMUIIQOCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,72.44,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512620,DTCC01240923,349607,48454
CHEMBL204353,P20309,,MGTADWHLHADAMM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,158,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914050,DTCC00419230,1631102,20612
CHEMBL204449,P20309,,LRQBXHMVEXEFBO-GFCCVEGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16263279,ACTIVITY,=,5,%,,,,,,,,,,,,,,Binding affinity to Muscarinic M3 receptor at 10 uM,,A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function.,Bioorg. Med. Chem. Lett.,2006,16,3,"Chambers RJ, Abrams K, Castleberry TA, Cheng JB, Fisher DA, Kamath AV, Marfat A, Nettleton DO, Pillar JD, Salter ED, Sheils AL, Shirley JT, Turner CR, Umland JP, Lam KT",,334455,DTCT0023280,1897155,DTCC00415662,908590,20371
CHEMBL204471,P20309,,GJVBNDHZSKKRIS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,251,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914037,DTCC00419387,1469691,20612
CHEMBL204777,P20309,,YDLRQTYCCOPFRW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,2512,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914022,DTCC00419466,984045,20612
CHEMBL205105,P20309,,UBDJPACUDUKNTI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,13,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914055,DTCC00418987,466974,20612
CHEMBL205140,P20309,,ZXGBUYYCGYRAJF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,790,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914049,DTCC00419238,1695488,20612
CHEMBL205482,P20309,,JKAXYRSCMQDECT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,79,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914021,DTCC00419741,1982023,20612
CHEMBL205582,P20309,,LAQMMOXBFGQUFY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,501,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914057,DTCC00418984,789880,20612
CHEMBL205596,P20309,CHOLIC ACID,BHQCQFFYRZLCQQ-OELDTZBJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7358266,DTCC00419527,1027049,46191
CHEMBL205596,P20309,CHOLIC ACID,BHQCQFFYRZLCQQ-OELDTZBJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7358267,DTCC00419527,1027049,46191
CHEMBL205654,P20309,UCB-101333-3,XMDRTFUFPOAGDR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,3.16,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptors,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345381,DTCT0023280,1914062,DTCC00001633,110232,20612
CHEMBL205654,P20309,UCB-101333-3,XMDRTFUFPOAGDR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,3.2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914043,DTCC00001633,110232,20612
CHEMBL205654,P20309,UCB-101333-3,XMDRTFUFPOAGDR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,3.16,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157817,DTCC00001633,108785,23370
CHEMBL205654,P20309,UCB-101333-3,XMDRTFUFPOAGDR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,3.2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157556,DTCC00001633,108785,23370
CHEMBL205654,P20309,UCB-101333-3,XMDRTFUFPOAGDR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18686943,KI,=,3.2,NM,,,,,,,,,,,,,,Antagonist activity at muscarinic M3 receptor,,Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.,J. Med. Chem.,2008,51,18,"Kodimuthali A, Jabaris SS, Pal M",,511386,DTCT0023280,2438053,DTCC00001633,99717,31041
CHEMBL205686,P20309,,JVMURZUCIBLXKW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,16,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914042,DTCC00419420,435372,20612
CHEMBL205737,P20309,,IQXLRDXEYGVGAX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,126,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914034,DTCC00419838,919206,20612
CHEMBL2057392,P20309,,MADRUEVBYJEFFT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22738637,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Activity at human M3 receptor expressed in CHO cells coexpressing Gqi5 assessed as effect on acetylcholine induced calcium mobilization up to 30 uM incubated for 144 secs prior to acetylcholine addition by Fluo-4-AM staining,Not Active,"Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor.",Bioorg. Med. Chem. Lett.,2012,22,15,"Salovich JM, Vinson PN, Sheffler DJ, Lamsal A, Utley TJ, Blobaum AL, Bridges TM, Le U, Jones CK, Wood MR, Daniels JS, Conn PJ, Niswender CM, Lindsley CW, Hopkins CR",,830302,DTCT0023280,10543735,DTCC01244422,879920,48755
CHEMBL2057417,P20309,,XNCQMFVABACABG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23177787,EC50,>,30000,NM,,cell_based,,,,,,,,,,,CHO-K1,Positive allosteric modulation of human muscarinic M3 receptor expressed in CHO-K1 cells assessed as leftward shift in acetylcholine response treated for 144 secs prior to acetylcholine addition measured for 5 mins by Fluo-4-AM based calcium mobilization assay,,"Discovery of a selective M4 positive allosteric modulator based on the 3-amino-thieno[2,3-b]pyridine-2-carboxamide scaffold: development of ML253, a potent and brain penetrant compound that is active in a preclinical model of schizophrenia.",Bioorg. Med. Chem. Lett.,2013,23,1,"Le U, Melancon BJ, Bridges TM, Vinson PN, Utley TJ, Lamsal A, Rodriguez AL, Venable D, Sheffler DJ, Jones CK, Blobaum AL, Wood MR, Daniels JS, Conn PJ, Niswender CM, Lindsley CW, Hopkins CR",,935574,DTCT0023280,11757872,DTCC01244447,1768175,53161
CHEMBL2057513,P20309,,GOKSDAYTCVNLDM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22749871,IC50,>,10000,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor assessed as inhibition of acetylcholine-induced calcium mobilization,,Development of novel M1 antagonist scaffolds through the continued optimization of the MLPCN probe ML012.,Bioorg. Med. Chem. Lett.,2012,22,15,"Melancon BJ, Utley TJ, Sevel C, Mattmann ME, Cheung YY, Bridges TM, Morrison RD, Sheffler DJ, Niswender CM, Daniels JS, Conn PJ, Lindsley CW, Wood MR",,830696,DTCT0023280,10548544,DTCC01244540,2026871,48776
CHEMBL2057776,P20309,,VORKZGMPBYXFTH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22749871,IC50,>,10000,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor assessed as inhibition of acetylcholine-induced calcium mobilization,,Development of novel M1 antagonist scaffolds through the continued optimization of the MLPCN probe ML012.,Bioorg. Med. Chem. Lett.,2012,22,15,"Melancon BJ, Utley TJ, Sevel C, Mattmann ME, Cheung YY, Bridges TM, Morrison RD, Sheffler DJ, Niswender CM, Daniels JS, Conn PJ, Lindsley CW, Wood MR",,830696,DTCT0023280,10548545,DTCC01244767,511505,48776
CHEMBL205797,P20309,,RFWRTNNKLHHJRZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells at 10 um,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345403,DTCT0023280,1914059,DTCC00419872,435373,20612
CHEMBL205840,P20309,,QKSJHXLMFBVDOO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,40,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914032,DTCC00419845,757747,20612
CHEMBL205841,P20309,,BFNPRFLHTXILPM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,79,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914031,DTCC00419846,887401,20612
CHEMBL205853,P20309,,XWQHYCHXAAQZQB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,79,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914012,DTCC00419040,725592,20612
CHEMBL205854,P20309,,IUQXHCUZLUWKGE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells at 10 um,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345403,DTCT0023280,1914058,DTCC00419041,1787507,20612
CHEMBL2059306,P20309,,AXDIUCNCCQGFAR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22677319,EC50,,,,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as calcium mobilization for 6 mins by Calcium4-based staining,Not Determined,Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential.,Bioorg. Med. Chem. Lett.,2012,22,15,"Sams AG, Larsen K, Mikkelsen GK, Hentzer M, Christoffersen CT, Jensen KG, Frederiksen K, Bang-Andersen B",,829280,DTCT0023280,10537504,DTCC01246249,608133,48886
CHEMBL2059306,P20309,,AXDIUCNCCQGFAR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22677319,EMAX,=,0,%,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as calcium mobilization atb 10 uM for 6 mins by Calcium4-based staining relative to acetylcholine,,Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential.,Bioorg. Med. Chem. Lett.,2012,22,15,"Sams AG, Larsen K, Mikkelsen GK, Hentzer M, Christoffersen CT, Jensen KG, Frederiksen K, Bang-Andersen B",,829279,DTCT0023280,10536765,DTCC01246249,608133,48886
CHEMBL205944,P20309,,SMDRRUNWBQSQOY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,50,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914053,DTCC00419223,1631101,20612
CHEMBL205976,P20309,,YZJQCFJGKQCYRK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,6.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914039,DTCC00419502,596334,20612
CHEMBL205992,P20309,,JBWCNOPGANKPFJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,32,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914052,DTCC00419228,1340410,20612
CHEMBL206087,P20309,,JADYFZLYBMTREE-TZMCWYRMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,398,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914026,DTCC00419434,337693,20612
CHEMBL206127,P20309,,XXABYSVRHXDZSD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,316,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914023,DTCC00110272,2014851,20612
CHEMBL206480,P20309,,AIDPXYQPEWPREA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,79,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914045,DTCC00419414,1755272,20612
CHEMBL206714,P20309,,FUYUTRKKJJBHKN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,25,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914030,DTCC00419786,1598870,20612
CHEMBL206753,P20309,,XLHQYBJELIZCHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,251,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914024,DTCC00419389,1695489,20612
CHEMBL206780,P20309,,RGTCYDPCTXELPL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,398,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914040,DTCC00419501,77998,20612
CHEMBL2068237,P20309,CISPLATIN,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349825,DTCC01249018,51458,46191
CHEMBL2068237,P20309,CISPLATIN,,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349826,DTCC01249018,51458,46191
CHEMBL206826,P20309,,ZOJHOUMTADYCPM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,100,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914018,DTCC00419439,435374,20612
CHEMBL207098,P20309,,KYIYAJAPKLUBQX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,398,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914020,DTCC00419803,1566335,20612
CHEMBL207287,P20309,,OAVVSQBKJRDNQT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,50,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914014,DTCC00419811,1534378,20612
CHEMBL20732,P20309,,JUJQGTXZIQGMJE-FYWRMAATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,14125.38,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1326462,DTCC00153893,807797,4821
CHEMBL207816,P20309,,IWBCYHIRISUDJH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,10,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914013,DTCC00419820,1275054,20612
CHEMBL2079587,P20309,STANOZOLOL,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7467256,DTCC01253362,930087,46191
CHEMBL2079587,P20309,STANOZOLOL,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7467257,DTCC01253362,930087,46191
CHEMBL208280,P20309,,JNJDNJHSLSAXOG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,16,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914054,DTCC00419076,1663392,20612
CHEMBL208299,P20309,,AYACAXMPYSGUQG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,316,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914036,DTCC00419794,1372931,20612
CHEMBL208300,P20309,,AJIDPCFITULIMR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,501,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914028,DTCC00419795,403206,20612
CHEMBL208335,P20309,,KSCAGWNABYAOMP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,10,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914016,DTCC00419753,1242403,20612
CHEMBL2087421,P20309,,TYDKAHFZLFMNQX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22369198,INHIBITION,=,8,%,,cell_based,,,,,,,,,,,,Inhibition of human M3 receptor at 5 uM by cell based assay,,From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.,J. Med. Chem.,2012,55,6,"Barth M, Bondoux M, Luccarini JM, Peyrou V, Dodey P, Pruneau D, Massardier C, Paquet JL",,841991,DTCT0023280,10599242,DTCC01254414,1578316,50456
CHEMBL20883,P20309,TEGAFUR,WFWLQNSHRPWKFK-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7474366,DTCC00152531,1027060,46191
CHEMBL20883,P20309,TEGAFUR,WFWLQNSHRPWKFK-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7474367,DTCC00152531,1027060,46191
CHEMBL2092735,P20309,,PUJOJSPRKCGQLP-WEDRDUODSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904080,DTCC00130869,876005,20440
CHEMBL2092736,P20309,,PUJOJSPRKCGQLP-BAIKKSGKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904078,DTCC00130870,584767,20440
CHEMBL2092737,P20309,,FXAMBWMILDAFOW-YDEXJTGXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904084,DTCC00130871,778355,20440
CHEMBL2092820,P20309,,PUJOJSPRKCGQLP-ILBPCHQASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904088,DTCC01256294,1134531,20440
CHEMBL2093081,P20309,,PUJOJSPRKCGQLP-LUQVCMFFSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904087,DTCC01256543,1715640,20440
CHEMBL2093082,P20309,,PUJOJSPRKCGQLP-DFGQEVQKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904079,DTCC01256544,1102416,20440
CHEMBL2093082,P20309,,PUJOJSPRKCGQLP-DFGQEVQKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904085,DTCC01256544,1102415,20440
CHEMBL2093082,P20309,,PUJOJSPRKCGQLP-DFGQEVQKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904086,DTCC01256544,1102414,20440
CHEMBL2093083,P20309,,FXAMBWMILDAFOW-NMSKTSORSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904083,DTCC01256545,260098,20440
CHEMBL2093084,P20309,,PUJOJSPRKCGQLP-VQSDNHQRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,=,33884.42,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904205,DTCC01256546,1872755,20440
CHEMBL21,P20309,SULFANILAMIDE,FDDDEECHVMSUSB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7467521,DTCC00133176,88635,46191
CHEMBL21,P20309,SULFANILAMIDE,FDDDEECHVMSUSB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7467522,DTCC00133176,88635,46191
CHEMBL2103747,P20309,ACONITINE,XFSBVAOIAHNAPC-FKHWODAVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7285670,DTCC00130938,671783,46191
CHEMBL2103747,P20309,ACONITINE,XFSBVAOIAHNAPC-FKHWODAVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7287002,DTCC00130938,671783,46191
CHEMBL2103774,P20309,TIBOLONE,WZDGZWOAQTVYBX-XOINTXKNSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7468230,DTCC01257131,1416037,46191
CHEMBL2103774,P20309,TIBOLONE,WZDGZWOAQTVYBX-XOINTXKNSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7468231,DTCC01257131,1416037,46191
CHEMBL2103803,P20309,DAROTROPIUM BROMIDE,CWRNUVNMUYSOFQ-XITXYIRHSA-M,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903774,DTCC01257154,1810125,35251
CHEMBL2103803,P20309,DAROTROPIUM BROMIDE,CWRNUVNMUYSOFQ-XITXYIRHSA-M,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903676,DTCC01257154,1810125,35251
CHEMBL2103803,P20309,DAROTROPIUM BROMIDE,CWRNUVNMUYSOFQ-XITXYIRHSA-M,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KD,=,0.02,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by measuring ratio of acetylcholine EC50 in presence and absence of compound by FLIPR assay,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581783,DTCT0023280,2903721,DTCC01257154,1810125,35251
CHEMBL2103803,P20309,DAROTROPIUM BROMIDE,CWRNUVNMUYSOFQ-XITXYIRHSA-M,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KI,=,0.0631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581785,DTCT0023280,2903703,DTCC01257154,1810125,35251
CHEMBL2103803,P20309,DAROTROPIUM BROMIDE,CWRNUVNMUYSOFQ-XITXYIRHSA-M,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969410,DTCC01257154,1811379,44786
CHEMBL2103803,P20309,DAROTROPIUM BROMIDE,CWRNUVNMUYSOFQ-XITXYIRHSA-M,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,0.02,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969445,DTCC01257154,1811379,44786
CHEMBL2103803,P20309,DAROTROPIUM BROMIDE,CWRNUVNMUYSOFQ-XITXYIRHSA-M,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,0.1,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor in human bronchus assessed as potency against carbachol-induced contraction,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750517,DTCT0023280,5969461,DTCC01257154,1811379,44786
CHEMBL2103803,P20309,DAROTROPIUM BROMIDE,CWRNUVNMUYSOFQ-XITXYIRHSA-M,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KI,=,0.06,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750516,DTCT0023280,5969460,DTCC01257154,1811379,44786
CHEMBL2103803,P20309,DAROTROPIUM BROMIDE,CWRNUVNMUYSOFQ-XITXYIRHSA-M,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,TIME,=,85,MIN,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor in human bronchus assessed as reversal time for 50% of carbachol-induced contraction to return to maximum relaxation at 10 nM,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750518,DTCT0023280,5969462,DTCC01257154,1811379,44786
CHEMBL2104153,P20309,CYAMEMAZINE,SLFGIOIONGJGRT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12527336,KI,=,32,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14738137,DTCC01257488,2106533,69666
CHEMBL2104850,P20309,RILAPINE,UJCYUJOQBXHJFH-ZBKNUEDVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,1400,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14730446,DTCC01258165,2104136,68417
CHEMBL2105617,P20309,AJMALINE,CJDRUOGAGYHKKD-FUIWMBJSSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293721,DTCC01258909,2089743,46191
CHEMBL2105617,P20309,AJMALINE,CJDRUOGAGYHKKD-FUIWMBJSSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293722,DTCC01258909,2089743,46191
CHEMBL210578,P20309,,CXQUOFVDYCOSEZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25070422,KI,,,,,,,,,,,,,,,,,Displacement of [3H]QNB from human muscarinic M3 receptor by liquid scintillation counting,Not Determined,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452253,DTCT0023280,13943029,DTCC00423474,578712,61087
CHEMBL2105807,P20309,MADURAMICIN,WQGJEAMPBSZCIF-HKSLRPGUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429811,DTCC01259078,898292,46191
CHEMBL2105807,P20309,MADURAMICIN,WQGJEAMPBSZCIF-HKSLRPGUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429812,DTCC01259078,898292,46191
CHEMBL2106399,P20309,KITASAMYCIN,IEMDOFXTVAPVLX-YWQHLDGFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412041,DTCC01259639,800579,46191
CHEMBL2106399,P20309,KITASAMYCIN,IEMDOFXTVAPVLX-YWQHLDGFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412042,DTCC01259639,800579,46191
CHEMBL2106570,P20309,METHYLBENACTYZIUM BROMIDE,DKMVJQCQTCLYIF-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,4.25,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417732,DTCC01259804,848413,54418
CHEMBL2107687,P20309,VALETHAMATE BROMIDE,CEJGGHKJHDHLAZ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,26,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442412,DTCC01260864,1512819,46191
CHEMBL2107687,P20309,VALETHAMATE BROMIDE,CEJGGHKJHDHLAZ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,5.59,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442413,DTCC01260864,1512819,46191
CHEMBL2107797,P20309,NORGESTREL,WWYNJERNGUHSAO-CULCCENASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7397107,DTCC01260973,1894972,46191
CHEMBL2107797,P20309,NORGESTREL,WWYNJERNGUHSAO-CULCCENASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7397108,DTCC01260973,1894972,46191
CHEMBL2110892,P20309,BIETAMIVERINE,JGTJANXYSNVLMQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,186,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417733,DTCC01263555,363476,54418
CHEMBL2111051,P20309,TALSACLIDINE,XVFJONKUSLSKSW-JTQLQIEISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,=,2696,NM,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545932,DTCC01263708,1465730,63681
CHEMBL2111051,P20309,TALSACLIDINE,XVFJONKUSLSKSW-JTQLQIEISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EFFICACY,=,26.1,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay relative to acetylcholine,,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517987,DTCT0023280,14545936,DTCC01263708,1465730,63681
CHEMBL2111540,P20309,,BFELQLHLUNQIHL-KHTLXAHUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,29.4,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1713495,DTCC01263943,1132350,3918
CHEMBL2112313,P20309,,UWAWUASXFCAUES-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,630.96,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1422076,DTCC01264657,2077195,5053
CHEMBL2112589,P20309,,OZCCPRJEWJXRBF-JUDYQFGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,315.4,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1636675,DTCC01264921,1597457,15558
CHEMBL2112955,P20309,,VWBQUAMKHIBZSG-JGCGQSQUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,0.31,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1605332,DTCC01265271,1274637,11844
CHEMBL2112956,P20309,,STUWFURQGSMWES-UUWRZZSWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,1,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1612684,DTCC01265272,1501530,11844
CHEMBL2112957,P20309,,UCBXWLPRAVDTBU-UZNICKRLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,0.25,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1606481,DTCC01265273,1469216,11844
CHEMBL2112958,P20309,,ZNXQAFLLESPBNZ-BYYXFNHRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,0.47,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1635653,DTCC01265274,174413,11844
CHEMBL2112959,P20309,,POGDAPYUQHRUOU-MGBGTMOVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,0.76,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1624187,DTCC01265275,757305,11844
CHEMBL2112961,P20309,,GVTZHKIAVNUTSV-GOJCVTOHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,2.2,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1608865,DTCC01265277,466488,11844
CHEMBL2114064,P20309,,UXBPYISKBNGZMG-VXPBITRUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,37.04,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1692831,DTCC01266042,1838592,3918
CHEMBL2114066,P20309,,BFELQLHLUNQIHL-LDCRUHPQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,,,,,,,,,,,,,,,,,The compound was tested for the binding affinity against Muscarinic acetylcholine receptor M3; not tested,Not Determined,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138713,DTCT0023280,1679857,DTCC01266044,193269,3918
CHEMBL2114067,P20309,,GTJOIOQFIDFYOI-PMERELPUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,27.8,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1712180,DTCC01266045,486082,3918
CHEMBL2114068,P20309,,OLZRBZLJTKELRL-SSEXGKCCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,0.13,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1679862,DTCC01266046,421734,3918
CHEMBL211501,P20309,ANTIMYCIN A,UIFFUZWRFRDZJC-SBOOETFBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259263,DTCC00428375,930076,46191
CHEMBL211501,P20309,ANTIMYCIN A,UIFFUZWRFRDZJC-SBOOETFBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259264,DTCC00428375,930076,46191
CHEMBL2115126,P20309,,UXBPYISKBNGZMG-VALFACCDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,58.8,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1681289,DTCC01266593,1617583,3918
CHEMBL2115127,P20309,,GTJOIOQFIDFYOI-SSEXGKCCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,20.1,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1708096,DTCC01266594,421733,3918
CHEMBL2115128,P20309,,OLZRBZLJTKELRL-PMERELPUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,0.38,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1692836,DTCC01266595,1681900,3918
CHEMBL211976,P20309,,KFVGSPFDTINYRJ-SXLOSVNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,2.8,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974304,DTCC00432379,1069802,21327
CHEMBL212141,P20309,,XNEGPONSGSBZSW-OCBJUFRSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,2.4,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974291,DTCC00432001,326122,21327
CHEMBL212282,P20309,,UMRGDBCMTHRMHK-VBAOBBRWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,12,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972915,DTCC00432239,2067689,21327
CHEMBL212530,P20309,,AJBNNKUOBSHORY-ZUPGYTDKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,59,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972907,DTCC00432052,1490694,21327
CHEMBL212530,P20309,,AJBNNKUOBSHORY-ZUPGYTDKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,170,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974226,DTCC00432052,1490694,21327
CHEMBL212645,P20309,,SSQJHXZOEJZLAK-IZNNDHRXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.51,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974290,DTCC00432003,681830,21327
CHEMBL21321,P20309,,OMYFTZZTQULVGM-LDADJPATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,1698.24,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1331488,DTCC00154351,1999969,4821
CHEMBL21328,P20309,,OPLKWFZZUZVAEU-GHRIWEEISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,72443.6,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1344038,DTCC00154193,1390965,4821
CHEMBL213709,P20309,,AOYBULVQHCLRGS-VATRIRCNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.92,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974295,DTCC00431565,876150,21327
CHEMBL214029,P20309,,AIZMFPJJDXEQKC-SXLOSVNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.48,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974298,DTCC00432276,617218,21327
CHEMBL214268,P20309,PHA-543613,IPKZCLGGYKRDES-ZDUSSCGKSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16821801,INHIBITION,=,33,%,,,,,,,,,,,,,,Inhibition of M3 receptor at 1 uM,,"Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.",J. Med. Chem.,2006,49,14,"Wishka DG, Walker DP, Yates KM, Reitz SC, Jia S, Myers JK, Olson KL, Jacobsen EJ, Wolfe ML, Groppi VE, Hanchar AJ, Thornburgh BA, Cortes-Burgos LA, Wong EH, Staton BA, Raub TJ, Higdon NR, Wall TM, Hurst RS, Walters RR, Hoffmann WE, Hajos M, Franklin S, Carey G, Gold LH, Cook KK, Sands SB, Zhao SX, Soglia JR, Kalgutkar AS, Arneric SP, Rogers BN",,369062,DTCT0023280,1951564,DTCC00427596,1134622,20998
CHEMBL214268,P20309,PHA-543613,IPKZCLGGYKRDES-ZDUSSCGKSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18490160,ACTIVITY,=,33,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]DAMP from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,"Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity.",Bioorg. Med. Chem. Lett.,2008,18,12,"Acker BA, Jacobsen EJ, Rogers BN, Wishka DG, Reitz SC, Piotrowski DW, Myers JK, Wolfe ML, Groppi VE, Thornburgh BA, Tinholt PM, Walters RR, Olson BA, Fitzgerald L, Staton BA, Raub TJ, Krause M, Li KS, Hoffmann WE, Hajos M, Hurst RS, Walker DP",,479261,DTCT0023280,2375380,DTCC00427596,1135467,26339
CHEMBL214270,P20309,,JIXRWGPDSPEFRX-VBAOBBRWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,88,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972905,DTCC00432050,1905230,21327
CHEMBL214270,P20309,,JIXRWGPDSPEFRX-VBAOBBRWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,29,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974225,DTCC00432050,1905230,21327
CHEMBL214342,P20309,,NPDFULBIQZLKSB-SXLOSVNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.51,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974296,DTCC00431564,940407,21327
CHEMBL214461,P20309,,AAAGJCMYVIZUAW-VBAOBBRWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,6,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972916,DTCC00432350,1296062,21327
CHEMBL214536,P20309,,SBDBHULTCVPFKP-VBAOBBRWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,6,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972918,DTCC00432352,908761,21327
CHEMBL214642,P20309,,IPLIEWKYFXHNMH-SLGZMBILSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,4.2,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974289,DTCC00432353,972440,21327
CHEMBL2146597,P20309,,VSWSLQBTTUYKSP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,3981.07,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as intracellular calcium mobilization after 10 to 15 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2010,1,6,,,849489,DTCT0023280,11347749,DTCC01282644,1008764,50717
CHEMBL2146597,P20309,,VSWSLQBTTUYKSP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INTRINSIC ACTIVITY,=,62,%,,cell_based,,,,,,,,,,,CHO,Intrinsic activity at human muscarinic M3 receptor expressed in CHO cells assessed as intracellular calcium mobilization after 10 to 15 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2010,1,6,,,849499,DTCT0023280,11347716,DTCC01282644,1008764,50717
CHEMBL2146598,P20309,,SHKKFEWDVRVDFL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as intracellular calcium mobilization after 10 to 15 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2010,1,6,,,849489,DTCT0023280,11347748,DTCC01282645,1812322,50717
CHEMBL2146599,P20309,,YTAGXFHCBLRULY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,3981.07,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as intracellular calcium mobilization after 10 to 15 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2010,1,6,,,849489,DTCT0023280,11347746,DTCC01282646,135174,50717
CHEMBL2146599,P20309,,YTAGXFHCBLRULY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INTRINSIC ACTIVITY,=,72,%,,cell_based,,,,,,,,,,,CHO,Intrinsic activity at human muscarinic M3 receptor expressed in CHO cells assessed as intracellular calcium mobilization after 10 to 15 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2010,1,6,,,849499,DTCT0023280,11347782,DTCC01282646,135174,50717
CHEMBL214723,P20309,,COMTUMBLKXMVJR-UHSPUVENSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,40,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972908,DTCC00432059,293524,21327
CHEMBL214898,P20309,,UPPZIKNLEDOKKO-PHAUOLPESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.19,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974292,DTCC00432000,1840925,21327
CHEMBL21508,P20309,,OBCGRJKQZYJHMU-SFQUDFHCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,27542.29,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1361406,DTCC00154257,775450,4821
CHEMBL21509,P20309,,GVOLYPPAXQIHQQ-JQIJEIRASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,21379.62,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1341346,DTCC00154258,1772914,4821
CHEMBL215180,P20309,,CNPFYHSXAKKLOF-SLGZMBILSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.3,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974305,DTCC00432275,131144,21327
CHEMBL215180,P20309,,CNPFYHSXAKKLOF-SLGZMBILSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.316,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974231,DTCC00432275,131144,21327
CHEMBL215180,P20309,,CNPFYHSXAKKLOF-SLGZMBILSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,0.3,NM,,,,,,,,,,,,,,Binding affinity to human M3 muscarinic receptor,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936428,DTCT0023280,11761585,DTCC00432275,135714,53451
CHEMBL215189,P20309,,XWZQPFIZAGITHQ-IZNNDHRXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.53,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974293,DTCC00431999,424170,21327
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9884068,KI,=,39.81,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14737850,DTCC00154255,2106436,69657
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,ACTIVITY,=,280,%,,cell_based,,,,,,,,,,,A9,Ability to stimulate biochemical responses in cell lines expressing muscarinic A9 L receptor sub types,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138565,DTCT0023280,831856,DTCC00154255,1229363,17526
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,EC50,=,3.98107E+13,NM,,cell_based,,,,,,,,,,,A9,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138825,DTCT0023280,831855,DTCC00154255,1229363,17526
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,KI,=,79.43,NM,,cell_based,,,,,,,,,,,A9,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138831,DTCT0023280,831854,DTCC00154255,1229363,17526
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,EC50,=,25118.86,NM,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001148,DTCC00154255,1242574,21638
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,79.43,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,2001096,DTCC00154255,1242574,21638
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,SMAX,=,80,%,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis relative to carbachol,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422705,DTCT0023280,2001177,DTCC00154255,1242574,21638
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,EC50,=,120,NM,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as increase of acetylcholine-induced calcium flux by FLIPR assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659446,DTCT0023280,3460750,DTCC00154255,1233017,40772
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,EMAX,=,54,%,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as increase of acetylcholine-induced calcium flux by FLIPR assay relative to acetylcholine,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659447,DTCT0023280,3460751,DTCC00154255,1233017,40772
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,KI,=,13,NM,,cell_based,,,,,,,,,,,BHK-21,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659456,DTCT0023280,3460787,DTCC00154255,1233017,40772
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,7.76,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961030,DTCC00154255,1257346,60063
CHEMBL21536,P20309,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EFFICACY,<,20,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay relative to acetylcholine,,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517987,DTCT0023280,14545937,DTCC00154255,1238464,63681
CHEMBL215894,P20309,,AFAZXESEAHMGAC-BMSWWXRLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,1.6,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974299,DTCC00432274,260223,21327
CHEMBL2164350,P20309,,QJFWBEXGRNKZIY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22738628,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor at 10 uM by radioligand binding assay,,Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.,Bioorg. Med. Chem. Lett.,2012,22,14,"Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF",,859828,DTCT0023280,11398995,DTCC01289819,19400,49664
CHEMBL2164354,P20309,,YUOLKUGHNOWKJF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22738628,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor at 10 uM by radioligand binding assay,,Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.,Bioorg. Med. Chem. Lett.,2012,22,14,"Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF",,859828,DTCT0023280,11398973,DTCC01289823,1494590,49664
CHEMBL2164905,P20309,,DKVRRZMTJBDMTP-HXUWFJFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23062550,IC50,>,1500,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor by calcium mobilization assay,,Synthesis and biological characterization of a series of novel diaryl amide M1 antagonists.,Bioorg. Med. Chem. Lett.,2012,22,22,"Poslusney MS, Sevel C, Utley TJ, Bridges TM, Morrison RD, Kett NR, Sheffler DJ, Niswender CM, Daniels JS, Conn PJ, Lindsley CW, Wood MR",,858566,DTCT0023280,11404458,DTCC01290328,1494596,51312
CHEMBL2165447,P20309,,KZONDTNPVHWVKU-NSHDSACASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EFFICACY,=,47.6,%,,,,,,,,,,,,,,Displacement of [3H]QNB from human recombinant muscarinic M3 receptor at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,880430,DTCT0023280,11471952,DTCC01290805,912917,51811
CHEMBL2165820,P20309,,OGZIQVTYHMBLMX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22335555,EC50,>,40000,NM,,cell_based,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor by cell based functional assay,,"1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.",J. Med. Chem.,2012,55,6,"Ramnauth J, Renton P, Dove P, Annedi SC, Speed J, Silverman S, Mladenova G, Maddaford SP, Zinghini S, Rakhit S, Andrews J, Lee DK, Zhang D, Porreca F",,859012,DTCT0023280,11392624,DTCC01291154,1780057,51191
CHEMBL2165820,P20309,,OGZIQVTYHMBLMX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22335555,INHIBITION,=,89,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM,,"1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.",J. Med. Chem.,2012,55,6,"Ramnauth J, Renton P, Dove P, Annedi SC, Speed J, Silverman S, Mladenova G, Maddaford SP, Zinghini S, Rakhit S, Andrews J, Lee DK, Zhang D, Porreca F",,859016,DTCT0023280,11392629,DTCC01291154,1780057,51191
CHEMBL216927,P20309,CDD-0304,KQHKTHFVDIBYJZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,ACTIVITY,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis relative to carbachol,Not Active,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422705,DTCT0023280,2001193,DTCC00002177,1177506,21638
CHEMBL216927,P20309,CDD-0304,KQHKTHFVDIBYJZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KD,=,158.49,NM,,,,,,,,,,,,,,Antagonist activity at human M3 receptor assessed as inhibition of carbachol binding,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422715,DTCT0023280,2001222,DTCC00002177,1177506,21638
CHEMBL216927,P20309,CDD-0304,KQHKTHFVDIBYJZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,25.12,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,2001093,DTCC00002177,1177506,21638
CHEMBL216927,P20309,CDD-0304,KQHKTHFVDIBYJZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,Not Determined,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001145,DTCC00002177,1177506,21638
CHEMBL216928,P20309,CDD-0313A,PUNXWODWMDLZDP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,ACTIVITY,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis relative to carbachol,Not Active,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422705,DTCT0023280,2001190,DTCC00002182,1114101,21638
CHEMBL216928,P20309,CDD-0313A,PUNXWODWMDLZDP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KD,=,158.49,NM,,,,,,,,,,,,,,Antagonist activity at human M3 receptor assessed as inhibition of carbachol binding,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422715,DTCT0023280,2001223,DTCC00002182,1114101,21638
CHEMBL216928,P20309,CDD-0313A,PUNXWODWMDLZDP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,316.23,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,2001090,DTCC00002182,1114101,21638
CHEMBL216928,P20309,CDD-0313A,PUNXWODWMDLZDP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,Not Determined,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001142,DTCC00002182,1114101,21638
CHEMBL216983,P20309,CDD-0300,ZSNOBCQCTZOWGP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,ACTIVITY,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis relative to carbachol,Not Active,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422705,DTCT0023280,2001191,DTCC00002181,757914,21638
CHEMBL216983,P20309,CDD-0300,ZSNOBCQCTZOWGP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,316.23,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,2001091,DTCC00002181,757914,21638
CHEMBL216983,P20309,CDD-0300,ZSNOBCQCTZOWGP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,Not Determined,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001143,DTCC00002181,757914,21638
CHEMBL21716,P20309,,VDRDKKLNMTZAMF-GHRIWEEISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,1737.8,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1336609,DTCC00154025,969396,4821
CHEMBL21731,P20309,MAPROTILINE,QSLMDECMDJKHMQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,473,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408418,DTCC00155108,1059332,46191
CHEMBL21731,P20309,MAPROTILINE,QSLMDECMDJKHMQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,100,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408419,DTCC00155108,1059332,46191
CHEMBL2177127,P20309,,IRMBVBDXXYXPEW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23098038,INHIBITION,<,20,%,,,,,,,,,,,,,,Inhibition of radioligand binding to muscarinic M3 receptor at 10 uM,,Identification of Small Molecule Inhibitors of Amyloid ß-Induced Neuronal Apoptosis Acting through the Imidazoline I(2) Receptor.,J. Med. Chem.,2012,55,22,"Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P",,878147,DTCT0023280,11425902,DTCC01296149,2027620,51656
CHEMBL2179392,P20309,,RJIRTFWCWLPHDK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23098038,INHIBITION,<,20,%,,,,,,,,,,,,,,Inhibition of radioligand binding to muscarinic M3 receptor at 10 uM,,Identification of Small Molecule Inhibitors of Amyloid ß-Induced Neuronal Apoptosis Acting through the Imidazoline I(2) Receptor.,J. Med. Chem.,2012,55,22,"Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P",,878147,DTCT0023280,11425882,DTCC01296145,900186,51656
CHEMBL2179395,P20309,,JXJCCQYPULQIKT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23098038,INHIBITION,<,20,%,,,,,,,,,,,,,,Inhibition of radioligand binding to muscarinic M3 receptor at 10 uM,,Identification of Small Molecule Inhibitors of Amyloid ß-Induced Neuronal Apoptosis Acting through the Imidazoline I(2) Receptor.,J. Med. Chem.,2012,55,22,"Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P",,878147,DTCT0023280,11425892,DTCC01296148,1385589,51656
CHEMBL218755,P20309,CDD-0311A,DMFXETUOWLUQID-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,ACTIVITY,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis relative to carbachol,Not Active,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422705,DTCT0023280,2001194,DTCC00002180,1081534,21638
CHEMBL218755,P20309,CDD-0311A,DMFXETUOWLUQID-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,251.19,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,2001094,DTCC00002180,1081534,21638
CHEMBL218755,P20309,CDD-0311A,DMFXETUOWLUQID-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,Not Determined,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001146,DTCC00002180,1081534,21638
CHEMBL219118,P20309,CDD-0316A,NWZNQDANKXXDFA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,ACTIVITY,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis relative to carbachol,Not Active,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422705,DTCT0023280,2001188,DTCC00002173,1242575,21638
CHEMBL219118,P20309,CDD-0316A,NWZNQDANKXXDFA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,199.53,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,2001088,DTCC00002173,1242575,21638
CHEMBL219118,P20309,CDD-0316A,NWZNQDANKXXDFA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,Not Determined,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001140,DTCC00002173,1242575,21638
CHEMBL219146,P20309,VINDESINE,HHJUWIANJFBDHT-KOTLKJBCSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7444117,DTCC00110817,833166,46191
CHEMBL219146,P20309,VINDESINE,HHJUWIANJFBDHT-KOTLKJBCSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7444118,DTCC00110817,833166,46191
CHEMBL21937,P20309,,CCJCVFDNMOHXKD-FYWRMAATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,61659.5,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1352156,DTCC00153920,1999968,4821
CHEMBL219786,P20309,,NIWWXHZNICDGMJ-NFQNBQCWSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,0.339,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025534,DTCC00442212,1230764,22057
CHEMBL219825,P20309,,DFCLHAWGKPEFIX-AABGKKOBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,1.45,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025537,DTCC00442163,1069912,22057
CHEMBL219916,P20309,DOMPERIDONE,FGXWKSZFVQUSTL-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368624,DTCC00437363,898287,46191
CHEMBL219916,P20309,DOMPERIDONE,FGXWKSZFVQUSTL-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368625,DTCC00437363,898287,46191
CHEMBL2203297,P20309,,HDQUUGXDIXAFND-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474992,DTCC01299648,1767801,51814
CHEMBL2203551,P20309,,JUWUZLUBIRHYMM-LBPRGKRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EFFICACY,=,12.2,%,,,,,,,,,,,,,,Displacement of [3H]QNB from human recombinant muscarinic M3 receptor at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012,3,12,,,880430,DTCT0023280,11472001,DTCC01298943,621402,51811
CHEMBL2203583,P20309,,FIDMKJAODKOWLB-ZCYQVOJMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474979,DTCC01298974,1417984,51814
CHEMBL2203584,P20309,,SKJFRZHCWXYAJO-ZCYQVOJMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474978,DTCC01298975,1800259,51814
CHEMBL2203585,P20309,,VPXSNNQNVYWAFZ-UPVQGACJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474977,DTCC01298976,512284,51814
CHEMBL2203586,P20309,,VPXSNNQNVYWAFZ-ISKFKSNPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474976,DTCC01298977,544444,51814
CHEMBL2203587,P20309,,LZDLTMOQGQYUGR-UFHPHHKVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474975,DTCC01298978,641572,51814
CHEMBL2203588,P20309,,JJZFKOWTNHBAIZ-LEAFIULHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474974,DTCC01298979,1320337,51814
CHEMBL2203589,P20309,,RNHAKLDOIWFCAG-AHWVRZQESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474973,DTCC01298980,479970,51814
CHEMBL2203713,P20309,,BLZNLOLTHDUEOL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22840695,IC50,=,4500,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.",Eur. J. Med. Chem.,2012,55,,"Annedi SC, Maddaford SP, Ramnauth J, Renton P, Rybak T, Silverman S, Rakhit S, Mladenova G, Dove P, Andrews JS, Zhang D, Porreca F",,882998,DTCT0023280,11458175,DTCC00131535,738126,51915
CHEMBL2203713,P20309,,BLZNLOLTHDUEOL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22840695,INHIBITION,=,86,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells at 10 uM after 60 mins,,"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.",Eur. J. Med. Chem.,2012,55,,"Annedi SC, Maddaford SP, Ramnauth J, Renton P, Rybak T, Silverman S, Rakhit S, Mladenova G, Dove P, Andrews JS, Zhang D, Porreca F",,882763,DTCT0023280,11459361,DTCC00131535,738126,51915
CHEMBL220393,P20309,,NIWWXHZNICDGMJ-SXWPHCFWSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,4.9,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025533,DTCC00442232,2036008,22057
CHEMBL2204275,P20309,,XXODCMADFJBDQF-AHWVRZQESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474972,DTCC01299635,1832563,51814
CHEMBL2204276,P20309,,FIBRBKFUNRMRFO-UPVQGACJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474971,DTCC01299636,2027662,51814
CHEMBL2204277,P20309,,FOQMVKNXEUJYCI-BDYUSTAISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474970,DTCC01299637,996534,51814
CHEMBL2204278,P20309,,LRIKGCLRMYSYQF-REWPJTCUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474969,DTCC01299638,1928933,51814
CHEMBL2204279,P20309,,OYASZMONHSVVKJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474968,DTCC01299639,155439,51814
CHEMBL2204280,P20309,,ODGUKNDCZNGAKR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474967,DTCC01299640,1546773,51814
CHEMBL2204281,P20309,,QACVLFQXGRITHV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474999,DTCC01299641,1320348,51814
CHEMBL2204282,P20309,,LVRHJZVCGDCHTR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474998,DTCC01299642,1385629,51814
CHEMBL2204283,P20309,,ASAKPTPDFNXOQN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474997,DTCC01299643,1417991,51814
CHEMBL2204284,P20309,,PQBDCCOMAUHYMR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474996,DTCC01299644,317621,51814
CHEMBL2204285,P20309,,PPSWWWJSXZKIER-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474995,DTCC01299645,641584,51814
CHEMBL2204286,P20309,,LSGPMLRAXGDHOO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474994,DTCC01299646,1735977,51814
CHEMBL2204287,P20309,,RVWAWUIQLFFGKP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474993,DTCC01299647,284932,51814
CHEMBL2204288,P20309,,VQOODHMEHSFDIY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474991,DTCC01299649,446531,51814
CHEMBL2204289,P20309,,SWXIQGTYEGYANE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474990,DTCC01299650,512289,51814
CHEMBL2204290,P20309,,GZCQUBZRWYUBQW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474989,DTCC01299651,317622,51814
CHEMBL2204291,P20309,,GHGAAXGCWQYTIR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474988,DTCC01299652,90551,51814
CHEMBL2204292,P20309,,XWBMKWRXWZAUNY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474987,DTCC01299653,1157642,51814
CHEMBL2204293,P20309,,BOKAJJSPBODAJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474986,DTCC01299654,932061,51814
CHEMBL2204294,P20309,,JXVLBLUZXYVJPZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474985,DTCC01299655,1864583,51814
CHEMBL2204295,P20309,,HTAQQEUOWQTSRS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474984,DTCC01299656,1707708,51814
CHEMBL2204296,P20309,,VYIAJFRXASNPLT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474983,DTCC01299657,1222196,51814
CHEMBL2204297,P20309,,ZJUBSMWYIJGFHD-URXFXBBRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474982,DTCC01299658,932062,51814
CHEMBL2204298,P20309,,LNHPUZJXWLAOPY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474981,DTCC01299659,1578959,51814
CHEMBL2204299,P20309,,BKXHYASUZZNKFX-GOTSBHOMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at muscarinic M3 receptor expressing in CHONFAT cells assessed as potentiation of acetylcholine-induced calcium mobilization preincubated for 4 mins and measured 4 mins after acetylcholine stimulation by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2012,3,12,,,880579,DTCT0023280,11474980,DTCC01299660,1962020,51814
CHEMBL220553,P20309,,CRTBVFNYYUEWDJ-NKWVEPMBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629553,DTCC00439938,416951,56353
CHEMBL2205811,P20309,,ZKOQRCXMSDAJIR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,1727,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472833,DTCC01301027,1267730,51935
CHEMBL2205812,P20309,,TWMXGXSGGIIQDM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,407,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472813,DTCC01301028,556858,51935
CHEMBL2205813,P20309,,FOTUXOOYRRRHFQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884049,DTCT0023280,11474484,DTCC01301029,1688236,51935
CHEMBL2205814,P20309,,KULMFBVVFDTVNX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884049,DTCT0023280,11474452,DTCC01301030,1623988,51935
CHEMBL2205815,P20309,,MYZBXDLMEOAPIJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472774,DTCC01301031,1876967,51935
CHEMBL2205816,P20309,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,209,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472750,DTCC01301032,880294,51935
CHEMBL2205816,P20309,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,209,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598963,DTCC01301032,881049,55935
CHEMBL2205817,P20309,,GFQHCUYWLHSGJR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,2268,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472740,DTCC01301033,912942,51935
CHEMBL2205818,P20309,,VTLZIWJSKWWYHL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472724,DTCC01301034,1106585,51935
CHEMBL2205819,P20309,,GOYQRMVWIWPDFU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11477202,DTCC01301035,1170086,51935
CHEMBL2205820,P20309,,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11422827,DTCC01301036,1559073,51935
CHEMBL2205820,P20309,,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12595271,DTCC01301036,1559919,55935
CHEMBL2205821,P20309,,DHQYUPWRESNGBC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11427463,DTCC01301037,362894,51935
CHEMBL2205822,P20309,,CUIQKJJPRAKRJM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11461543,DTCC01301038,1844780,51935
CHEMBL2205823,P20309,,WWXCWTRLUXMAHX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,360,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11474247,DTCC01301039,1780156,51935
CHEMBL2205824,P20309,,LIKZWSUAMNZHAE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884049,DTCT0023280,11475918,DTCC01301040,1688238,51935
CHEMBL2205825,P20309,,GYKFQDQFKGGVKD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,1225,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11474228,DTCC01301041,750568,51935
CHEMBL2205826,P20309,,TVDFWGUKMIRJAD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11474210,DTCC01301042,750569,51935
CHEMBL2205827,P20309,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,1728,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11473010,DTCC01301043,1812524,51935
CHEMBL2205827,P20309,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,1728,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598966,DTCC01301043,1813367,55935
CHEMBL2205828,P20309,,QUMVESOWCHBEEV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11450005,DTCC01301044,1234798,51935
CHEMBL2205829,P20309,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,1609,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472982,DTCC01301045,330310,51935
CHEMBL2205829,P20309,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,1609,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598961,DTCC01301045,331095,55935
CHEMBL2205830,P20309,,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472965,DTCC01301046,1494712,51935
CHEMBL2205830,P20309,,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598962,DTCC01301046,1495531,55935
CHEMBL2205831,P20309,,RRBNCHNWWUXYEM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472935,DTCC01301047,556859,51935
CHEMBL2205831,P20309,,RRBNCHNWWUXYEM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598960,DTCC01301047,557648,55935
CHEMBL2205832,P20309,,ZUHLFYHHSNMSRE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884049,DTCT0023280,11475816,DTCC01301048,589038,51935
CHEMBL2205833,P20309,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884049,DTCT0023280,11475778,DTCC01301049,2039955,51935
CHEMBL2205833,P20309,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601395,DTCC01301049,2040747,55935
CHEMBL2205834,P20309,,QFMGHZDEZHDVJJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472908,DTCC01301050,167654,51935
CHEMBL2205835,P20309,,FPHVMMXTLGSYHV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472879,DTCC01301051,1623989,51935
CHEMBL2205835,P20309,,FPHVMMXTLGSYHV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598965,DTCC01301051,1624817,55935
CHEMBL2205836,P20309,,PSBBAGWMKGXQRW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,=,543,NM,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11472853,DTCC01301052,1041425,51935
CHEMBL2206333,P20309,,SMZSZJJPCBPLCN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22329602,INHIBITION,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human M3 receptor in HEK293 cells assessed as inhibition of 20 uM carbachol induced calcium response at 10 uM by fluorescence assay,Not Active,Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.,J. Med. Chem.,2012,55,5,"Daval SB, Valant C, Bonnet D, Kellenberger E, Hibert M, Galzi JL, Ilien B",,882204,DTCT0023280,11472214,DTCC01301530,1320364,51872
CHEMBL2206334,P20309,,HJCOVULGUXGGSU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22329602,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human M3 receptor in HEK293 cells at 10 uM,Not Active,Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.,J. Med. Chem.,2012,55,5,"Daval SB, Valant C, Bonnet D, Kellenberger E, Hibert M, Galzi JL, Ilien B",,882207,DTCT0023280,11472217,DTCC01301531,932085,51872
CHEMBL2206335,P20309,,DXPBRIOEFRSDGR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22329602,INHIBITION,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human M3 receptor in HEK293 cells assessed as inhibition of 20 uM carbachol induced calcium response at 10 uM by fluorescence assay,Not Active,Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.,J. Med. Chem.,2012,55,5,"Daval SB, Valant C, Bonnet D, Kellenberger E, Hibert M, Galzi JL, Ilien B",,882204,DTCT0023280,11472213,DTCC01301532,1482293,51872
CHEMBL2206397,P20309,RO-4992479,NIRASHDWADNQJU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22795332,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human M3 receptor at 10 uM by CEREP assay,,Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.,Bioorg. Med. Chem. Lett.,2012,22,16,"Galley G, Stalder H, Goergler A, Hoener MC, Norcross RD",,881746,DTCT0023280,11478622,DTCC00045622,835169,51910
CHEMBL2206585,P20309,,HKRMWBKEZJIJNK-LJAQVGFWSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,197.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482534,DTCC01301779,1190078,52022
CHEMBL2206586,P20309,,NBHKBEGQNUWGRE-PMERELPUSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,<,5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482533,DTCC01301780,673722,52022
CHEMBL2206587,P20309,,ZQHBXNYECHRJKJ-NDEPHWFRSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,10.2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482532,DTCC01301781,1896898,52022
CHEMBL2206588,P20309,,VJTPWZBBLMLRGU-LJAQVGFWSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,50.2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481958,DTCC01301782,219563,52022
CHEMBL2206589,P20309,,HDUFNCWFVWHJPJ-HKBQPEDESA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,27.5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481957,DTCC01301783,1418012,52022
CHEMBL2206590,P20309,,WSIWFXPEBHBVCW-DHUJRADRSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,<,5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481956,DTCC01301784,738162,52022
CHEMBL2206591,P20309,,QAZOBYCWYDQBSG-REEGWEMXSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,<,5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481955,DTCC01301785,802493,52022
CHEMBL2206592,P20309,,ZXGVHVOAWOFUSH-PMERELPUSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,<,5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481954,DTCC01301786,608923,52022
CHEMBL2206593,P20309,,XSRZYTWQASJNFR-QHCPKHFHSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,>,3300,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481953,DTCC01301787,608924,52022
CHEMBL2206594,P20309,,RYMFOAUAWBJIBB-LJAQVGFWSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,392.4,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481952,DTCC01301788,1287837,52022
CHEMBL2206595,P20309,,IDQDYULTECQGBI-UMSFTDKQSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,51.9,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481951,DTCC01301789,900247,52022
CHEMBL2206596,P20309,,KCLCTPSCFVOYGG-DEOSSOPVSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,<,5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481950,DTCC01301790,1061237,52022
CHEMBL2206597,P20309,,XCBLMGUSEAEAND-PMERELPUSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,<,5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481949,DTCC01301791,1353057,52022
CHEMBL2206598,P20309,,YFPYHKSOTMFYSY-DEOSSOPVSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,<,5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11481948,DTCC01301792,415915,52022
CHEMBL2206599,P20309,,IRQNZOGGZGSWQD-SMCANUKXSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,45.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482549,DTCC01301793,1482296,52022
CHEMBL2206600,P20309,,LFSUTWJOQHTMTB-XIFFEERXSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,68.9,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482548,DTCC01301794,1832589,52022
CHEMBL2206601,P20309,,IKQNEBWRSMWPOA-NDEPHWFRSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,579.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482547,DTCC01301795,219564,52022
CHEMBL2206602,P20309,,AWAIMVZXXQUWMW-UMSFTDKQSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,70.4,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482546,DTCC01301796,54797,52022
CHEMBL2206603,P20309,,QUPJVYNMOIZXHG-NDEPHWFRSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,142.6,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482545,DTCC01301797,2091674,52022
CHEMBL2206604,P20309,,VIXVIRHYJPIXPC-PMERELPUSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,223.2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482544,DTCC01301798,90578,52022
CHEMBL2206605,P20309,,CCMKPZZOFUAWCG-WBCKFURZSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,82.2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482543,DTCC01301799,1800305,52022
CHEMBL2206606,P20309,,NTXIFNZVYVWYBG-JBVCSEDXSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,6.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482542,DTCC01301800,1061238,52022
CHEMBL2206607,P20309,,XBJVFFSOHGDXIL-PMERELPUSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,44.9,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482541,DTCC01301801,284958,52022
CHEMBL2206608,P20309,,ZCGQKZSNOODCBF-HKBQPEDESA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,33.4,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482540,DTCC01301802,1962040,52022
CHEMBL2206609,P20309,,OGASJMHZEUYYQJ-SANMLTNESA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,158.9,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482539,DTCC01301803,251926,52022
CHEMBL2206610,P20309,,CFOKNQFWJGSGNX-SANMLTNESA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,237,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482538,DTCC01301804,1643767,52022
CHEMBL2207175,P20309,,OAEFSBJQWFGYCK-LJAQVGFWSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,>,3300,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482537,DTCC01302368,1320371,52022
CHEMBL2207176,P20309,,ZRESSCFPNIPPGT-XIFFEERXSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,417.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482535,DTCC01302369,1928958,52022
CHEMBL2207177,P20309,,IRQNZOGGZGSWQD-VEEOACQBSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23099092,IC50,=,13.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups.,Bioorg. Med. Chem. Lett.,2012,22,23,"Jin Q, Davis RS, Bullion AM, Jin J, Wang Y, Widdowson KL, Palovich MR, Foley JJ, Schmidt DB, Buckley PT, Webb EF, Salmon M, Belmonte KE, Sarau HM, Busch-Petersen J",,886299,DTCT0023280,11482550,DTCC01302370,1061247,52022
CHEMBL22108,P20309,DIMETHINDENE,MVMQESMQSYOVGV-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,190.55,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1349285,DTCC00154081,1001935,4821
CHEMBL221400,P20309,,ZDNLCBVEWCZBLZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,4.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030897,DTCC00443224,1949353,22115
CHEMBL221401,P20309,,HWCBLDPYKRZMKJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,4.83,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030911,DTCC00443264,1307991,22115
CHEMBL221660,P20309,,PGOGWBOUZHXTME-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,1132,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030928,DTCC00443182,1534602,22115
CHEMBL221713,P20309,,VPDMCJAWFJFKGY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,152,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030935,DTCC00443262,629093,22115
CHEMBL221753,P20309,BENZETHONIUM CHLORIDE,UREZNYTWGJKWBI-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,383,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259856,DTCC00440345,120969,46191
CHEMBL221753,P20309,BENZETHONIUM CHLORIDE,UREZNYTWGJKWBI-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,81,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7259857,DTCC00440345,120969,46191
CHEMBL221775,P20309,,KVBKUXNXDGXGGR-GOWJNXQMSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,282,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030383,DTCC00443128,822540,22116
CHEMBL221829,P20309,,KSQLCEYEYYJZIW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,7.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030917,DTCC00443227,919470,22115
CHEMBL221885,P20309,,POWRDMFYCZXKPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells at 10 uM,,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429183,DTCT0023280,2031025,DTCC00443269,1275274,22115
CHEMBL221886,P20309,SISOMICIN,URWAJWIAIPFPJE-YFMIWBNJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7486446,DTCC00443300,703986,46191
CHEMBL221886,P20309,SISOMICIN,URWAJWIAIPFPJE-YFMIWBNJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7486447,DTCC00443300,703986,46191
CHEMBL2220427,P20309,ERYTHROMYCIN ESTOLATE,TYQXKHPOXXXCTP-CSLYCKPJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7304939,DTCC01305390,639579,46191
CHEMBL2220427,P20309,ERYTHROMYCIN ESTOLATE,TYQXKHPOXXXCTP-CSLYCKPJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7304940,DTCC01305390,639579,46191
CHEMBL2220442,P20309,FLUVASTATIN,FJLGEFLZQAZZCD-VAWYXSNFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310041,DTCC01305406,1059330,46191
CHEMBL2220442,P20309,FLUVASTATIN,FJLGEFLZQAZZCD-VAWYXSNFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310042,DTCC01305406,1059330,46191
CHEMBL222054,P20309,,JMSDQUDVBLZSMZ-PXWGLLCJSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,2.61,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030389,DTCC00443103,175053,22116
CHEMBL222090,P20309,,MJAZCYVGXMBABM-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,310,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030384,DTCC00443127,1209727,22116
CHEMBL222207,P20309,,ZEUMKUUXZQOHBM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,6.59,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030909,DTCC00443272,1631341,22115
CHEMBL222259,P20309,,NIWWXHZNICDGMJ-CCXMUWKTSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,0.912,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025531,DTCC00110978,843777,22057
CHEMBL222387,P20309,,KVCMZPILKHYETB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,0.96,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030896,DTCC00443225,403441,22115
CHEMBL222388,P20309,,XZLJEIBXFOYRCP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,2.37,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030918,DTCC00443226,855432,22115
CHEMBL222402,P20309,,KFMHNFUCCFKKRZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,923,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030934,DTCC00443270,305282,22115
CHEMBL222403,P20309,,MRELIADAHWJAPD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,4.54,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030910,DTCC00443271,1177570,22115
CHEMBL222423,P20309,,WYDDPFDEYBYHQA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells at 10 uM,,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429183,DTCT0023280,2031023,DTCC00443207,305283,22115
CHEMBL222424,P20309,,DLFIQCGXPLUMEB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,2.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030939,DTCC00443237,1209726,22115
CHEMBL222425,P20309,,FHBGWWMCNBBQMJ-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,612,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030203,DTCC00443108,1566544,22116
CHEMBL222426,P20309,,POYPWMLCUXGEFJ-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,507,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030381,DTCC00443136,272329,22116
CHEMBL222449,P20309,,XONNUPKRLWJHEZ-HSGLFRJESA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,3.01,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030360,DTCC00443095,1114150,22116
CHEMBL222450,P20309,,RCWPNVPTHVJCPA-WNEYBHKTSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,1.62,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030391,DTCC00443096,1469940,22116
CHEMBL222527,P20309,,WIQPTWADILJWQN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,354,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030932,DTCC00443278,532156,22115
CHEMBL22257,P20309,,LVUAGQQUWPYWRI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,680133,DTCC00156749,388203,17183
CHEMBL22257,P20309,,LVUAGQQUWPYWRI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.68,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,680128,DTCC00156749,388203,17183
CHEMBL22257,P20309,,LVUAGQQUWPYWRI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.19,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,680127,DTCC00156749,388203,17183
CHEMBL222634,P20309,,AFEXNFIIGBMTBH-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,9.11,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030437,DTCC00443066,435613,22116
CHEMBL222636,P20309,,LETHFKJQPLZEST-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,1.89,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030370,DTCC00443061,1405618,22116
CHEMBL222689,P20309,,ULSVQRMDLUIMAZ-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,153,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030386,DTCC00443121,693534,22116
CHEMBL222804,P20309,,OWTHNZCKZNYDHG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,7.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030919,DTCC00443221,1502261,22115
CHEMBL222860,P20309,,PAWBGCCWTWGZPD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,2.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030936,DTCC00443261,951933,22115
CHEMBL222863,P20309,OUABAIN,LPMXVESGRSUGHW-HBYQJFLCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7377982,DTCC00444362,1059335,46191
CHEMBL222863,P20309,OUABAIN,LPMXVESGRSUGHW-HBYQJFLCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7377983,DTCC00444362,1059335,46191
CHEMBL222874,P20309,,WGSZVRHYQKWPAG-HVQYUPJGSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,22.9,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030390,DTCC00443102,855433,22116
CHEMBL222916,P20309,,ZVKKBJJVVACKPK-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,541,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030367,DTCC00443073,1437525,22116
CHEMBL222917,P20309,,XEKBKFPFVCGCBX-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,356,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030366,DTCC00443074,1982234,22116
CHEMBL222975,P20309,,KVBKUXNXDGXGGR-SUHMBNCMSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,3158,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030382,DTCC00443135,1177571,22116
CHEMBL222976,P20309,,SNNSMXBTHSLXDC-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,6.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030373,DTCC00443164,919471,22116
CHEMBL223016,P20309,,GSDMGLIRMIERDF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,3.15,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030924,DTCC00443190,1469939,22115
CHEMBL223017,P20309,,XTFLNWJPCXKOPL-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,82,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030893,DTCC00443232,1049029,22115
CHEMBL223022,P20309,,RRHMCEJLGKCOGL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,1056,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030926,DTCC00443186,2015097,22115
CHEMBL223028,P20309,,IWVCFEIBBOTGAN-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,1.76,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030372,DTCC00443165,1949354,22116
CHEMBL223029,P20309,,UHYXERRLBRDGAY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,2185,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030877,DTCC00443193,1566542,22115
CHEMBL223030,P20309,,WXXBJLZSTINTDE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,2057,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030916,DTCC00443233,1916677,22115
CHEMBL223055,P20309,,JULMDUPZBRMFGS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,0.67,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030377,DTCC00443149,1787752,22116
CHEMBL223079,P20309,,PPZQHODYVASSTK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,6.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030912,DTCC00443257,1725275,22115
CHEMBL223186,P20309,,OBYYCKOMCLLSSD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,117,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030931,DTCC00443176,337922,22115
CHEMBL223187,P20309,,QGNPVKPZJQODAL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,1630,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030930,DTCC00443177,370534,22115
CHEMBL223188,P20309,,HEOLOYBLVYPIDH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,26.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030879,DTCC00443218,1695719,22115
CHEMBL223267,P20309,,SVBGOQXKSXKHJQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,2.57,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030937,DTCC00443254,661270,22115
CHEMBL223268,P20309,,INXPOROWIALBHJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells at 10 uM,,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429183,DTCT0023280,2031022,DTCC00443255,1566543,22115
CHEMBL223646,P20309,,XGZBYKQDOKYZIP-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Not Active,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030371,DTCC00443060,33997,22116
CHEMBL223668,P20309,,QTWQZQOULZVQSB-UOQVMRJOSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,0.75,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030362,DTCC00443088,207101,22116
CHEMBL223724,P20309,,CKBYLKDVYYBZOR-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,2065,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030378,DTCC00443148,1405617,22116
CHEMBL223925,P20309,,IYSLFQOZFGCFSX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,53.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030914,DTCC00443240,822539,22115
CHEMBL22397,P20309,,CHEDIRAZCBLFFH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; Activity range is 0.81-1.19,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138578,DTCT0023280,467101,DTCC00156659,1584181,17183
CHEMBL22397,P20309,,CHEDIRAZCBLFFH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.15,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,467087,DTCC00156659,1584181,17183
CHEMBL22397,P20309,,CHEDIRAZCBLFFH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.2,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,467086,DTCC00156659,1584181,17183
CHEMBL224783,P20309,,NBVYRBDIADJELP-ZGAORZAOSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,7.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030363,DTCC00443081,1884514,22116
CHEMBL224784,P20309,,QDZCUVUMJGPNOP-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,335,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030380,DTCC00443142,1787751,22116
CHEMBL224823,P20309,,YOZOYTTXAGJANI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells at 10 uM,,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429183,DTCT0023280,2031024,DTCC00443285,1373161,22115
CHEMBL224965,P20309,,LTWQRFZUJAVEAS-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,2535,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030387,DTCC00443115,1599088,22116
CHEMBL225074,P20309,,UUGHVUGONUOFJE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,8.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030921,DTCC00443214,1755527,22115
CHEMBL2252949,P20309,(-)-CAMPHOR,DSSYKIVIOFKYAU-OIBJUYFYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420673,DTCC01315138,510302,46191
CHEMBL2252949,P20309,(-)-CAMPHOR,DSSYKIVIOFKYAU-OIBJUYFYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420674,DTCC01315138,510302,46191
CHEMBL225387,P20309,,POWPGJYSOCFEPI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,16.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030880,DTCC00443212,1242627,22115
CHEMBL22587,P20309,ITRACONAZOLE,VHVPQPYKVGDNFY-ZPGVKDDISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411964,DTCC01738573,51481,46191
CHEMBL22587,P20309,ITRACONAZOLE,VHVPQPYKVGDNFY-ZPGVKDDISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411965,DTCC01738573,51481,46191
CHEMBL226335,P20309,RUTIN,IKGXIBQEEMLURG-NVPNHPEKSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14750352,DTCC00448737,2109891,69275
CHEMBL227378,P20309,,KUBKWLQZGDWVNE-RJUBDTSPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,EC50,=,50118.72,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432435,DTCT0023280,2061479,DTCC00111211,358831,22396
CHEMBL227378,P20309,,KUBKWLQZGDWVNE-RJUBDTSPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,INTRINSIC ACTIVITY,=,1,,,cell_based,,,,,,,,,,,CHO,Intrinsic activity at muscarinic M3 receptor expressed in CHO cells assessed as ratio of agonist activity to activity of carbachol,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432440,DTCT0023280,2061499,DTCC00111211,358831,22396
CHEMBL227378,P20309,,KUBKWLQZGDWVNE-RJUBDTSPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18077164,KI,=,36307.81,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,,"Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.",Bioorg. Med. Chem. Lett.,2008,18,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Buccioni M, Nesi M, Matucci R",,461882,DTCT0023280,2278185,DTCC00111211,359263,25106
CHEMBL227429,P20309,,KUBKWLQZGDWVNE-OZZZDHQUSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18077164,KI,=,23442.29,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,,"Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.",Bioorg. Med. Chem. Lett.,2008,18,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Buccioni M, Nesi M, Matucci R",,461882,DTCT0023280,2278183,DTCC00111209,1873473,25106
CHEMBL227934,P20309,STRYCHNINE,QMGVPVSNSZLJIA-FVWCLLPLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1333157,DTCC00448002,1080246,15566
CHEMBL227934,P20309,STRYCHNINE,QMGVPVSNSZLJIA-FVWCLLPLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.2,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1333156,DTCC00448002,1080246,15566
CHEMBL227934,P20309,STRYCHNINE,QMGVPVSNSZLJIA-FVWCLLPLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,<,0.2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1333166,DTCC00448002,1080246,15566
CHEMBL227934,P20309,STRYCHNINE,QMGVPVSNSZLJIA-FVWCLLPLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1333162,DTCC00448002,1080246,15566
CHEMBL227934,P20309,STRYCHNINE,QMGVPVSNSZLJIA-FVWCLLPLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454312,DTCC00448002,1092350,46191
CHEMBL227934,P20309,STRYCHNINE,QMGVPVSNSZLJIA-FVWCLLPLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454313,DTCC00448002,1092350,46191
CHEMBL228144,P20309,,KUBKWLQZGDWVNE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,EC50,=,275.42,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432435,DTCT0023280,2061481,DTCC00447747,1037469,22396
CHEMBL228144,P20309,,KUBKWLQZGDWVNE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,EC50,=,56234.13,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432435,DTCT0023280,2061478,DTCC00447747,1037470,22396
CHEMBL228144,P20309,,KUBKWLQZGDWVNE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,INTRINSIC ACTIVITY,=,1,,,cell_based,,,,,,,,,,,CHO,Intrinsic activity at muscarinic M3 receptor expressed in CHO cells assessed as ratio of agonist activity to activity of carbachol,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432440,DTCT0023280,2061498,DTCC00447747,1037470,22396
CHEMBL228144,P20309,,KUBKWLQZGDWVNE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,INTRINSIC ACTIVITY,>,1,,,cell_based,,,,,,,,,,,CHO,Intrinsic activity at muscarinic M3 receptor expressed in CHO cells assessed as ratio of agonist activity to activity of carbachol,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432440,DTCT0023280,2061501,DTCC00447747,1037469,22396
CHEMBL228144,P20309,,KUBKWLQZGDWVNE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18077164,KI,=,7585.78,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,,"Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.",Bioorg. Med. Chem. Lett.,2008,18,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Buccioni M, Nesi M, Matucci R",,461882,DTCT0023280,2278179,DTCC00447747,1037892,25106
CHEMBL228144,P20309,,KUBKWLQZGDWVNE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18077164,KI,=,35481.34,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,,"Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.",Bioorg. Med. Chem. Lett.,2008,18,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Buccioni M, Nesi M, Matucci R",,461882,DTCT0023280,2278184,DTCC00447747,1037898,25106
CHEMBL22899,P20309,,XMWWTIJWNHPXSJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,685064,DTCC00156750,451852,17183
CHEMBL22899,P20309,,XMWWTIJWNHPXSJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.83,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,685059,DTCC00156750,451852,17183
CHEMBL22899,P20309,,XMWWTIJWNHPXSJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.43,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,685058,DTCC00156750,451852,17183
CHEMBL229383,P20309,NYSTATIN,VQOXZBDYSJBXMA-VHFLTRTASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7377894,DTCC00451716,51495,46191
CHEMBL229383,P20309,NYSTATIN,VQOXZBDYSJBXMA-VHFLTRTASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7377895,DTCC00451716,51495,46191
CHEMBL229429,P20309,,WTLBLIGPXACYET-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17571866,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]QNB from muscarinic M3 receptor,,Synthesis and simple 18F-labeling of 3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with positron emission tomography.,J. Med. Chem.,2007,50,14,"Siméon FG, Brown AK, Zoghbi SS, Patterson VM, Innis RB, Pike VW",,439692,DTCT0023280,2110792,DTCC00452403,403579,22982
CHEMBL23,P20309,DILTIAZEM,HSUGRBWQSSZJOP-RTWAWAEBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7361894,DTCC00133282,866019,46191
CHEMBL23,P20309,DILTIAZEM,HSUGRBWQSSZJOP-RTWAWAEBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7361895,DTCC00133282,866019,46191
CHEMBL23037,P20309,,YANNOGLYWKJWIU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,692508,DTCC00157819,322936,17183
CHEMBL23037,P20309,,YANNOGLYWKJWIU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.88,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,692503,DTCC00157819,322936,17183
CHEMBL23037,P20309,,YANNOGLYWKJWIU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.55,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,692502,DTCC00157819,322936,17183
CHEMBL2306159,P20309,,LVAXIKIVPNIRLY-LRGKQRPYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903769,DTCC01334772,360427,35251
CHEMBL2306159,P20309,,LVAXIKIVPNIRLY-LRGKQRPYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,=,1059,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903681,DTCC01334772,360427,35251
CHEMBL2306159,P20309,,LVAXIKIVPNIRLY-LRGKQRPYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,1059,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969403,DTCC01334772,361731,44786
CHEMBL2307674,P20309,,RDSXSJQZTCPEAY-GXZPSDDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903772,DTCC01334788,1906866,35251
CHEMBL2307674,P20309,,RDSXSJQZTCPEAY-GXZPSDDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,=,1338,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903678,DTCC01334788,1906866,35251
CHEMBL2307674,P20309,,RDSXSJQZTCPEAY-GXZPSDDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,1338,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969400,DTCC01334788,1908099,44786
CHEMBL2308786,P20309,,ABFWCAYAWMISPA-YBULGZATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903765,DTCC01334805,1265205,35251
CHEMBL2308786,P20309,,ABFWCAYAWMISPA-YBULGZATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,=,839,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903685,DTCC01334805,1265205,35251
CHEMBL2308786,P20309,,ABFWCAYAWMISPA-YBULGZATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,839,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969409,DTCC01334805,1266520,44786
CHEMBL230951,P20309,L-HOMOCYSTEATE,VBOQYPQEPHKASR-VKHMYHEASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14730853,DTCC00002972,2104237,69159
CHEMBL2311547,P20309,,FWYPQEHHZLGOPK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936173,DTCT0023280,11759523,DTCC01335811,459665,53451
CHEMBL23116,P20309,,CGWRGBAOGWNYQF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,680121,DTCC00157274,937341,17183
CHEMBL23116,P20309,,CGWRGBAOGWNYQF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.08,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,680116,DTCC00157274,937341,17183
CHEMBL23116,P20309,,CGWRGBAOGWNYQF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.71,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,680115,DTCC00157274,937341,17183
CHEMBL2312346,P20309,,GYBGSRCFWGEOKR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936173,DTCT0023280,11759526,DTCC01335802,71013,53451
CHEMBL2312347,P20309,,KPAAMRKQCRIZJP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936173,DTCT0023280,11759525,DTCC01335803,1688570,53451
CHEMBL2312352,P20309,,MWFQIDNMZVEVKH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,4890,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936173,DTCT0023280,11759524,DTCC01335808,1106942,53451
CHEMBL2312361,P20309,,WEVVZJGQIWKFOJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,2840,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936173,DTCT0023280,11759527,DTCC01335818,557215,53451
CHEMBL2312376,P20309,,NVTIISFGYLGRFE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,31100,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936173,DTCT0023280,11759528,DTCC01335833,557216,53451
CHEMBL2312389,P20309,,ZQHWFHCBXAHFCX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,4070,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936173,DTCT0023280,11759529,DTCC01335846,363255,53451
CHEMBL2313377,P20309,,VIZLOCIWSKXQJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23177787,EC50,>,30000,NM,,cell_based,,,,,,,,,,,CHO-K1,Positive allosteric modulation of human muscarinic M3 receptor expressed in CHO-K1 cells assessed as leftward shift in acetylcholine response treated for 144 secs prior to acetylcholine addition measured for 5 mins by Fluo-4-AM based calcium mobilization assay,,"Discovery of a selective M4 positive allosteric modulator based on the 3-amino-thieno[2,3-b]pyridine-2-carboxamide scaffold: development of ML253, a potent and brain penetrant compound that is active in a preclinical model of schizophrenia.",Bioorg. Med. Chem. Lett.,2013,23,1,"Le U, Melancon BJ, Bridges TM, Vinson PN, Utley TJ, Lamsal A, Rodriguez AL, Venable D, Sheffler DJ, Jones CK, Blobaum AL, Wood MR, Daniels JS, Conn PJ, Niswender CM, Lindsley CW, Hopkins CR",,935574,DTCT0023280,11757873,DTCC01336824,1800648,53161
CHEMBL2315675,P20309,,UVNVDXZOLDWJKU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23200253,INHIBITION,,,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium response,Active,Further exploration of M1 allosteric agonists: subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism.,Bioorg. Med. Chem. Lett.,2013,23,1,"Sheffler DJ, Sevel C, Le U, Lovell KM, Tarr JC, Carrington SJ, Cho HP, Digby GJ, Niswender CM, Conn PJ, Hopkins CR, Wood MR, Lindsley CW",,937318,DTCT0023280,11770749,DTCC01339042,621802,53186
CHEMBL23165,P20309,,CAXMANIKZVDXRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,685052,DTCC00157278,257092,17183
CHEMBL23165,P20309,,CAXMANIKZVDXRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.2,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,685047,DTCC00157278,257092,17183
CHEMBL23165,P20309,,CAXMANIKZVDXRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.33,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,685046,DTCC00157278,257092,17183
CHEMBL232104,P20309,,BRIVIXLMMUIBJY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17606674,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 10 uM,Not Active,"Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.",Antimicrob. Agents Chemother.,2007,51,10,"Van Voorhis WC, Rivas KL, Bendale P, Nallan L, Hornéy C, Barrett LK, Bauer KD, Smart BP, Ankala S, Hucke O, Verlinde CL, Chakrabarti D, Strickland C, Yokoyama K, Buckner FS, Hamilton AD, Williams DK, Lombardo LJ, Floyd D, Gelb MH",,498962,DTCT0023280,2717301,DTCC00461356,1166865,34114
CHEMBL23213,P20309,,LCMPHCNGBOFIIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,338676,DTCC00157371,743428,17183
CHEMBL23213,P20309,,LCMPHCNGBOFIIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.69,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,467136,DTCC00157371,743428,17183
CHEMBL23213,P20309,,LCMPHCNGBOFIIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.78,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,467131,DTCC00157371,743428,17183
CHEMBL23215,P20309,,UKRRBWIMPSHZQA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; Activity range is 0.81-1.19,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138578,DTCT0023280,676225,DTCC00157179,679022,17183
CHEMBL23215,P20309,,UKRRBWIMPSHZQA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.39,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,676219,DTCC00157179,679022,17183
CHEMBL23215,P20309,,UKRRBWIMPSHZQA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.48,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,676220,DTCC00157179,679022,17183
CHEMBL232208,P20309,,FVUZIDRSHPEKLF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,40,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157560,DTCC00462732,2013441,23370
CHEMBL23230,P20309,,GCBGYFKVQRFTLA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,3,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; Activity range is 1.2-3,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138579,DTCT0023280,341859,DTCC00156456,1487662,17183
CHEMBL23230,P20309,,GCBGYFKVQRFTLA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.19,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,468817,DTCC00156456,1487662,17183
CHEMBL23230,P20309,,GCBGYFKVQRFTLA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.53,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,341851,DTCC00156456,1487662,17183
CHEMBL232416,P20309,,UZFSUYXDEBVIPE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,79,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157559,DTCC00462735,1435923,23370
CHEMBL232417,P20309,,WCKUPOIOQDQXOE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157557,DTCC00462737,1176038,23370
CHEMBL232419,P20309,,UWTHGZFFTNZQDZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,15.85,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157818,DTCC00462803,498474,23370
CHEMBL232419,P20309,,UWTHGZFFTNZQDZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,16,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157735,DTCC00462803,498474,23370
CHEMBL23249,P20309,,CGQGRCDXSPURIB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; Activity range is 0.81-1.19,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138578,DTCT0023280,672409,DTCC00157760,451850,17183
CHEMBL23249,P20309,,CGQGRCDXSPURIB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.12,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,672404,DTCC00157760,451850,17183
CHEMBL23249,P20309,,CGQGRCDXSPURIB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.13,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,672403,DTCC00157760,451850,17183
CHEMBL2326501,P20309,,KRCLPAGVJVBLJR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23237837,INHIBITION,=,35,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties.,Bioorg. Med. Chem. Lett.,2013,23,2,"Butini S, Gemma S, Brindisi M, Maramai S, Minetti P, Celona D, Napolitano R, Borsini F, Cabri W, Fezza F, Merlini L, Dallavalle S, Campiani G, Maccarrone M",,939802,DTCT0023280,11784474,DTCC01344807,1353507,53501
CHEMBL23280,P20309,,FDWLWYGRBKLFLR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,655293,DTCC00157314,485386,17183
CHEMBL23280,P20309,,FDWLWYGRBKLFLR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.78,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,655288,DTCC00157314,485386,17183
CHEMBL23280,P20309,,FDWLWYGRBKLFLR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.98,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,655287,DTCC00157314,485386,17183
CHEMBL232860,P20309,,CUUIZNGDJFGLAX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,20,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157567,DTCC00462719,1882892,23370
CHEMBL233198,P20309,,LAYPCPWQLOVMFU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,56,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164155,DTCC00464034,1684614,23149
CHEMBL233199,P20309,,NTVCTXKXWYXMHR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,23,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164153,DTCC00464037,520907,23149
CHEMBL233200,P20309,,QJZTYRBARUHAQD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,19,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164152,DTCC00464038,131417,23149
CHEMBL233201,P20309,,MMHVHROUFYSFCY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,6.8,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164140,DTCC00464052,1652394,23149
CHEMBL233202,P20309,,YTSWRFHHGNPXRN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,5.8,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164139,DTCC00464053,260467,23149
CHEMBL2335158,P20309,,LISGMSBYRAXPJH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23517028,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as stimulation of ERK1/2 phosphorylation after 15 mins by Alphascreen Surefire assay,Not Active,Biophysical fragment screening of the ß1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.,J. Med. Chem.,2013,56,9,"Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M",,944378,DTCT0023280,11811017,DTCC01348600,56308,54118
CHEMBL2335158,P20309,,LISGMSBYRAXPJH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23517028,KI,=,7943.28,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]-NMS from recombinant muscarinic M3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by liquid scintillation counting analysis,,Biophysical fragment screening of the ß1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.,J. Med. Chem.,2013,56,9,"Christopher JA, Brown J, Doré AS, Errey JC, Koglin M, Marshall FH, Myszka DG, Rich RL, Tate CG, Tehan B, Warne T, Congreve M",,944382,DTCT0023280,11811047,DTCC01348600,56308,54118
CHEMBL2335706,P20309,MARISTACHONE A,VGUIDVOAJKITDB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23268694,INHIBITION,,,,,,,,,,,,,,,,,Displacement of [3H]QNB from M3 receptor (unknown origin) at 10 uM,Not Active,Unprecedented Polyketides from a Marine Sponge-Associated Stachylidium sp.,J. Nat. Prod.,2013,76,3,"Almeida C, Eguereva E, Kehraus S, König GM",,942182,DTCT0023280,11820864,DTCC01349130,964975,53803
CHEMBL2336050,P20309,XANOMELINE TARTARIC ACID,SJSVWTMVMBGIHQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,85,%,,,,,,,,,,,,,,Agonist activity at M3 receptor (unknown origin) at 3 uM by calcium mobilization assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945487,DTCT0023280,11817204,DTCC01349473,1061920,53713
CHEMBL2336051,P20309,,RRTGKUQTNXZEPG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,2,%,,,,,,,,,,,,,,Agonist activity at M3 receptor (unknown origin) at 3 uM by calcium mobilization assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945487,DTCT0023280,11817203,DTCC01349474,1995438,53713
CHEMBL2336052,P20309,,XNMRJBAZODGLIG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,3,%,,,,,,,,,,,,,,Agonist activity at M3 receptor (unknown origin) at 3 uM by calcium mobilization assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945487,DTCT0023280,11817202,DTCC01349475,1126978,53713
CHEMBL2336053,P20309,,SKBHHBPGCAHMHQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,2,%,,,,,,,,,,,,,,Agonist activity at M3 receptor (unknown origin) at 3 uM by calcium mobilization assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945487,DTCT0023280,11817201,DTCC01349476,1386351,53713
CHEMBL2336054,P20309,,BPIMWCPHYBQONW-GOSISDBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,8,%,,,,,,,,,,,,,,Agonist activity at M3 receptor (unknown origin) at 3 uM by calcium mobilization assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945487,DTCT0023280,11817200,DTCC01349477,1321012,53713
CHEMBL2336055,P20309,,BPIMWCPHYBQONW-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,7,%,,,,,,,,,,,,,,Agonist activity at M3 receptor (unknown origin) at 3 uM by calcium mobilization assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945487,DTCT0023280,11817199,DTCC01349478,1579675,53713
CHEMBL2336055,P20309,,BPIMWCPHYBQONW-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,7,%,,cell_based,,,,,,,,,,,CHO,Partial agonist activity at human M3 receptor in CHO cells assessed as calcium mobilization at 3 uM after 60 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945478,DTCT0023280,11817162,DTCC01349478,1579675,53713
CHEMBL2336056,P20309,,XYJGESNOBLCYIX-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,2,%,,cell_based,,,,,,,,,,,CHO,Partial agonist activity at human M3 receptor in CHO cells assessed as calcium mobilization at 3 uM after 60 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945478,DTCT0023280,11817161,DTCC01349479,771005,53713
CHEMBL2336057,P20309,,UNDGBOSCPSZNOO-KRWDZBQOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,31,%,,cell_based,,,,,,,,,,,CHO,Partial agonist activity at human M3 receptor in CHO cells assessed as calcium mobilization at 3 uM after 60 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945478,DTCT0023280,11817160,DTCC01349480,997223,53713
CHEMBL2336058,P20309,,UVNKKPKCQPPWPY-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Partial agonist activity at human M3 receptor in CHO cells assessed as calcium mobilization at 3 uM after 60 mins by FLIPR assay,Not Determined,,ACS Med. Chem. Lett.,2013,4,2,,,945478,DTCT0023280,11817159,DTCC01349481,1061921,53713
CHEMBL2336059,P20309,,PNUNTGVSYVVWCT-FFGOWVMKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,=,7,%,,cell_based,,,,,,,,,,,CHO,Partial agonist activity at human M3 receptor in CHO cells assessed as calcium mobilization at 3 uM after 60 mins by FLIPR assay,,,ACS Med. Chem. Lett.,2013,4,2,,,945478,DTCT0023280,11817158,DTCC01349482,447217,53713
CHEMBL2336059,P20309,,PNUNTGVSYVVWCT-FFGOWVMKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Partial agonist activity at human M3 receptor in CHO cells assessed as calcium mobilization at 30 uM after 60 mins by FLIPR assay,Not Active,,ACS Med. Chem. Lett.,2013,4,2,,,945473,DTCT0023280,11817149,DTCC01349482,447217,53713
CHEMBL234099,P20309,,ZNEJOQYHVKBESN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,1.3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157570,DTCC00462707,173428,23370
CHEMBL23421,P20309,,RQBNPDOIQMFAEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; Activity range is 0.81-1.19,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138578,DTCT0023280,682506,DTCC00157708,1001954,17183
CHEMBL23421,P20309,,RQBNPDOIQMFAEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.16,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,682500,DTCC00157708,1001954,17183
CHEMBL23421,P20309,,RQBNPDOIQMFAEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.23,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,682501,DTCC00157708,1001954,17183
CHEMBL23422,P20309,,ZRZXULZYIXERFS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,>,3,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138576,DTCT0023280,657775,DTCC00157709,485385,17183
CHEMBL23422,P20309,,ZRZXULZYIXERFS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.89,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,657769,DTCC00157709,485385,17183
CHEMBL23422,P20309,,ZRZXULZYIXERFS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.47,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,657770,DTCC00157709,485385,17183
CHEMBL234252,P20309,,VHCDKYWUNQXVAJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,20,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164066,DTCC00464029,1970737,23149
CHEMBL234253,P20309,,PLQQFQYHSIBALT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,18,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164157,DTCC00464031,1361639,23149
CHEMBL234254,P20309,,SJUDKHLUHJDELT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,20,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164156,DTCC00464032,843932,23149
CHEMBL234255,P20309,,SDANSUYLLDYVEH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,IC50,>,100,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164150,DTCC00464041,1937479,23149
CHEMBL234256,P20309,,NXYSORJHLYHQML-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,IC50,>,100,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164149,DTCC00464042,99121,23149
CHEMBL234257,P20309,,FWARLZJUQIRKFD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,4.9,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164147,DTCC00464043,1490940,23149
CHEMBL234258,P20309,,VODYLGKYBHYDON-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,2.1,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164137,DTCC00111781,1937480,23149
CHEMBL234260,P20309,,XQEWLUVUJCPQTJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,IC50,>,100,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164132,DTCC00464055,1970739,23149
CHEMBL234438,P20309,,XRWFEGDYDKMREJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,2.5,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164145,DTCC00464046,293758,23149
CHEMBL234439,P20309,,YKESQPGCPVQXIU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,2.7,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164144,DTCC00464047,260466,23149
CHEMBL234440,P20309,,RXLCWZMWTUZMFM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,0.22,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164135,DTCC00111784,391687,23149
CHEMBL234926,P20309,ALLYL ALCOHOL,XXROGKLTLUQVRX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7285792,DTCC00463304,1992799,46191
CHEMBL234926,P20309,ALLYL ALCOHOL,XXROGKLTLUQVRX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7285793,DTCC00463304,1992799,46191
CHEMBL2355126,P20309,,GFBKORZTTCHDGY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14736829,DTCC01355759,2106101,68826
CHEMBL23614,P20309,,MENFGARWIHUEEE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,656582,DTCC00157145,1066608,17183
CHEMBL23614,P20309,,MENFGARWIHUEEE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.54,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,656577,DTCC00157145,1066608,17183
CHEMBL23614,P20309,,MENFGARWIHUEEE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.04,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,656576,DTCC00157145,1066608,17183
CHEMBL23620,P20309,,AENGNZMXXWOIGO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,<,0.2,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138576,DTCT0023280,683913,DTCC00157330,1358310,17183
CHEMBL23620,P20309,,AENGNZMXXWOIGO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,3.57,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,683908,DTCC00157330,1358310,17183
CHEMBL23620,P20309,,AENGNZMXXWOIGO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.45,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,683907,DTCC00157330,1358310,17183
CHEMBL2367892,P20309,TEICOPLANIN,DDTDNCYHLGRFBM-YZEKDTGTSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7478733,DTCC01364937,1734064,46191
CHEMBL2367892,P20309,TEICOPLANIN,DDTDNCYHLGRFBM-YZEKDTGTSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7478734,DTCC01364937,1734064,46191
CHEMBL23718,P20309,,DBKHNQOKLJGKHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; Activity range is 0.81-1.19,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138578,DTCT0023280,668671,DTCC00157276,646873,17183
CHEMBL23718,P20309,,DBKHNQOKLJGKHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.23,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,668665,DTCC00157276,646873,17183
CHEMBL23718,P20309,,DBKHNQOKLJGKHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.29,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,668666,DTCC00157276,646873,17183
CHEMBL23766,P20309,,HFKVLNRQLIUBQK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,370806,DTCC00156713,2064695,17183
CHEMBL23766,P20309,,HFKVLNRQLIUBQK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.37,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,666258,DTCC00156713,2064695,17183
CHEMBL23766,P20309,,HFKVLNRQLIUBQK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.06,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,666257,DTCC00156713,2064695,17183
CHEMBL2377261,P20309,,NHFIEMNGVIAFJO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,59,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417735,DTCC01373269,1462766,54418
CHEMBL2377262,P20309,,UNOFGQWDNLJPIO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,109,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417734,DTCC01373270,1333429,54418
CHEMBL2377267,P20309,,IEENUMOCDKBVGC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,6.55,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417731,DTCC01373275,977115,54418
CHEMBL2377268,P20309,,WUBQAMJWWIKNOF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,11.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417730,DTCC01373276,913552,54418
CHEMBL2377269,P20309,,KTWQAWSQSOISLN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,8.37,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417729,DTCC01373277,1366113,54418
CHEMBL2377383,P20309,,QBMKZMQZHBIKTJ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,0.543,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417726,DTCC01373392,2072353,54418
CHEMBL2377384,P20309,,ILFQGJPUOKTJFS-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,384,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417741,DTCC01373393,1009525,54418
CHEMBL2377385,P20309,,WMUOPJLADBOCIX-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,270,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417740,DTCC01373394,363477,54418
CHEMBL2377387,P20309,,BEJYISOPDBBZRK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,3.12,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417739,DTCC01373396,977119,54418
CHEMBL2377388,P20309,,MDXUMQALCQXJNR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,254,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417738,DTCC01373397,71223,54418
CHEMBL2377392,P20309,,YHOBTARVXRPKOX-ATNAJCNCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,5.97,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417736,DTCC01373401,1942144,54418
CHEMBL23800,P20309,,NBRWIZIJDNMSNB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; activity range is 0.81-1.19.,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138580,DTCT0023280,676237,DTCC00156607,1712968,17183
CHEMBL23800,P20309,,NBRWIZIJDNMSNB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.69,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,676231,DTCC00156607,1712968,17183
CHEMBL23800,P20309,,NBRWIZIJDNMSNB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.85,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,676232,DTCC00156607,1712968,17183
CHEMBL2381116,P20309,,KLJVDMAOKMSBQX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23535330,INHIBITION,=,10.1,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 2 ug/mL relative to control,,Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors.,Bioorg. Med. Chem. Lett.,2013,23,9,"Huang X, Cheng CC, Fischmann TO, Duca JS, Richards M, Tadikonda PK, Reddy PA, Zhao L, Arshad Siddiqui M, Parry D, Davis N, Seghezzi W, Wiswell D, Shipps GW",,959491,DTCT0023280,12441000,DTCC01374670,318350,54512
CHEMBL2381694,P20309,,LSQVHDRSPDDZCD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23562060,EC50,>,30000,NM,,,,,,,,,,,,,,Positive allosteric modulation of human muscarinic M3 receptor,,"Discovery of ML326: The first sub-micromolar, selective M5 PAM.",Bioorg. Med. Chem. Lett.,2013,23,10,"Gentry PR, Bridges TM, Lamsal A, Vinson PN, Smith E, Chase P, Hodder PS, Engers JL, Niswender CM, Scott Daniels J, Jeffrey Conn P, Wood MR, Lindsley CW",,960034,DTCT0023280,12436494,DTCC01375257,1676796,54522
CHEMBL238825,P20309,,GLWSGDKTCKSDDJ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,7386,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193392,DTCC00473747,553087,23951
CHEMBL239017,P20309,,AJENPBREDFYWBC-WLHGVMLRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193394,DTCC00473723,1684723,23951
CHEMBL239038,P20309,,HMOWQFSYVPAWFE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,1448,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193390,DTCC00473755,1491067,23951
CHEMBL2391147,P20309,,ZTGRWYMPQCQTHD-ONGXEEELSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23582449,INHIBITION,=,-7,%,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor at 10 uM by radioligand displacement assay relative to control,,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,2013,21,10,"Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M",,964381,DTCT0023280,12465405,DTCC01378839,220399,54817
CHEMBL23913,P20309,,NUTSQOAOSUIGTG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,668683,DTCC00157342,2113,17183
CHEMBL23913,P20309,,NUTSQOAOSUIGTG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.76,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,668678,DTCC00157342,2113,17183
CHEMBL23913,P20309,,NUTSQOAOSUIGTG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.21,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,668677,DTCC00157342,2113,17183
CHEMBL2391352,P20309,,SVDDGLLNLDJPMR-CQSZACIVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,>,100000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464578,DTCC01379044,783274,54820
CHEMBL2391353,P20309,,SVDDGLLNLDJPMR-AWEZNQCLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,=,57000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464577,DTCC01379045,232738,54820
CHEMBL2391356,P20309,,FFOHTSTWXWJGQR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,=,83000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464585,DTCC01379048,1624607,54820
CHEMBL2391357,P20309,,PPBAIQRIGSBMLY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,>,100000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464584,DTCC01379049,1720186,54820
CHEMBL2391366,P20309,,FLZQJCYTWHTBQZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,>,100000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464583,DTCC01379058,298312,54820
CHEMBL2391367,P20309,,XEHUMSSPPJBPTC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,>,100000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464582,DTCC01379059,1720188,54820
CHEMBL2391368,P20309,,KNJJOWALGUDOAQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,>,100000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464581,DTCC01379060,103662,54820
CHEMBL2391374,P20309,,JUOBOZOPQHCZHN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,>,100000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464580,DTCC01379066,1170684,54820
CHEMBL2391382,P20309,,QHHMXXCQXNRNIO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23601816,IC50,>,100000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,,Synthesis and biological evaluation of Esaprazole analogues showing s1 binding and neuroprotective properties in vitro.,Bioorg. Med. Chem.,2013,21,11,"Kelly NM, Wellejus A, Elbrønd-Bek H, Weidner MS, Jørgensen SH",,964798,DTCT0023280,12464579,DTCC01379074,1559733,54820
CHEMBL2391541,P20309,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23602445,KI,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human recombinant muscarinic M3 receptor expressed in CHO cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,964945,DTCT0023280,12464705,DTCC01379235,1386484,54821
CHEMBL2392692,P20309,,PVTFEAGMCGMRRS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23664879,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of human M3 receptor at 1 uM relative to control,,"Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.",Bioorg. Med. Chem. Lett.,2013,23,12,"Thalji RK, McAtee JJ, Belyanskaya S, Brandt M, Brown GD, Costell MH, Ding Y, Dodson JW, Eisennagel SH, Fries RE, Gross JW, Harpel MR, Holt DA, Israel DI, Jolivette LJ, Krosky D, Li H, Lu Q, Mandichak T, Roethke T, Schnackenberg CG, Schwartz B, Shewchuk LM, Xie W, Behm DJ, Douglas SA, Shaw AL, Marino JP",,965595,DTCT0023280,12464874,DTCC01380390,1353885,54882
CHEMBL239436,P20309,,VFCQKOHYXBHEEJ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,4740,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193387,DTCC00473786,1135076,23951
CHEMBL23945,P20309,,MEEHCMNYBLILPE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,686290,DTCC00157770,1455086,17183
CHEMBL23945,P20309,,MEEHCMNYBLILPE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.09,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,686285,DTCC00157770,1455086,17183
CHEMBL23945,P20309,,MEEHCMNYBLILPE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.64,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,686284,DTCC00157770,1455086,17183
CHEMBL23957,P20309,OXOTREMORINE METHIODIDE,VVLMSCJCXMBGDI-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,=,100,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1100270,DTCC00157455,1360565,10523
CHEMBL23957,P20309,OXOTREMORINE METHIODIDE,VVLMSCJCXMBGDI-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,52.1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1100271,DTCC00157455,1360565,10523
CHEMBL23957,P20309,OXOTREMORINE METHIODIDE,VVLMSCJCXMBGDI-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,ACTIVITY,=,15.5,/S,,cell_based,,,,,,,,,,,HEK293,Agonist activity at M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as rate constant at 100 uM to 1 mM by FRET method,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723359,DTCT0023280,5123006,DTCC00157455,1364092,43500
CHEMBL23957,P20309,OXOTREMORINE METHIODIDE,VVLMSCJCXMBGDI-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,EC50,=,1800,NM,,cell_based,,,,,,,,,,,HEK293,Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723353,DTCT0023280,5122983,DTCC00157455,1364092,43500
CHEMBL23957,P20309,OXOTREMORINE METHIODIDE,VVLMSCJCXMBGDI-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20716489,TIME,=,64.4,MS,,cell_based,,,,,,,,,,,HEK293,Agonist activity at M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as half-maximal activation time at 100 uM to 1 mM by FRET method,,"FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.",Bioorg. Med. Chem.,2011,19,3,"Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C",,723356,DTCT0023280,5122995,DTCC00157455,1364092,43500
CHEMBL239655,P20309,,UQZAVYSUPBKOKC-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,3995,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193393,DTCC00473741,1198789,23951
CHEMBL2397268,P20309,,JAKRIQWSQWQJHM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23627311,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of M3 receptor (unknown origin) at 5 uM by psychoactive drug screening programme assay,,Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.,J. Med. Chem.,2013,56,13,"Santangelo Freel RM, Ogden KK, Strong KL, Khatri A, Chepiga KM, Jensen HS, Traynelis SF, Liotta DC",,968896,DTCT0023280,12483466,DTCC01381880,1353904,54936
CHEMBL239866,P20309,,PBFSACOMFMTPRN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,3919,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193388,DTCC00473784,778850,23951
CHEMBL24,P20309,ATENOLOL,METKIMKYRPQLGS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7263723,DTCC00133283,574620,46191
CHEMBL24,P20309,ATENOLOL,METKIMKYRPQLGS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7263724,DTCC00133283,574620,46191
CHEMBL2407169,P20309,,FXSQQLNKTDEABY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,75,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 10 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973735,DTCT0023280,12518212,DTCC01385568,525405,55302
CHEMBL2407170,P20309,,LADAHLLZQWQIQI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,7,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 1 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973739,DTCT0023280,12518240,DTCC01385569,1748811,55302
CHEMBL2407170,P20309,,LADAHLLZQWQIQI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,11,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 10 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973735,DTCT0023280,12518211,DTCC01385569,1748811,55302
CHEMBL2407171,P20309,,BOMYBXNCZBOHBY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,8,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 1 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973739,DTCT0023280,12518239,DTCC01385570,848547,55302
CHEMBL2407171,P20309,,BOMYBXNCZBOHBY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,25,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 10 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973735,DTCT0023280,12518210,DTCC01385570,848547,55302
CHEMBL2407172,P20309,,QENKQKJYIYHKMN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,21,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 1 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973739,DTCT0023280,12518238,DTCC01385571,1430735,55302
CHEMBL2407172,P20309,,QENKQKJYIYHKMN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,36,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 10 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973735,DTCT0023280,12518209,DTCC01385571,1430735,55302
CHEMBL2407173,P20309,,IMKSIJGBYUNDJM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,4,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 1 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973739,DTCT0023280,12518237,DTCC01385572,1430736,55302
CHEMBL2407173,P20309,,IMKSIJGBYUNDJM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,21,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 10 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973735,DTCT0023280,12518208,DTCC01385572,1430736,55302
CHEMBL2407174,P20309,,YECILIXPPXYQHK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,2,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 1 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973739,DTCT0023280,12518236,DTCC01385573,945117,55302
CHEMBL2407174,P20309,,YECILIXPPXYQHK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,3,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 10 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973735,DTCT0023280,12518207,DTCC01385573,945117,55302
CHEMBL2407174,P20309,,YECILIXPPXYQHK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,=,2,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 1 uM by calcium mobilization assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447387,DTCT0023280,13918274,DTCC01385573,966496,60676
CHEMBL2407175,P20309,,AATNRUXRJQIOEV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,3,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 10 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973735,DTCT0023280,12518206,DTCC01385574,1009659,55302
CHEMBL2407175,P20309,,AATNRUXRJQIOEV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23816371,EFFICACY,=,6,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as calcium mobilization at 1 uM by FLIPR assay relative to control,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013,23,16,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973739,DTCT0023280,12518235,DTCC01385574,1009659,55302
CHEMBL241694,P20309,ETHISTERONE,CHNXZKVNWQUJIB-CEGNMAFCSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7305051,DTCC00474598,1674144,46191
CHEMBL241694,P20309,ETHISTERONE,CHNXZKVNWQUJIB-CEGNMAFCSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7305052,DTCC00474598,1674144,46191
CHEMBL242273,P20309,SAFROLE,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483991,DTCC00455925,315669,46191
CHEMBL242273,P20309,SAFROLE,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483992,DTCC00455925,315669,46191
CHEMBL242345,P20309,,JCBGAEQLPPOPDK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17276075,KI,=,213.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H] N-methyl-scopolamine chloride from human muscarinic receptor M3 expressed in CHO cells,,Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moieties.,Bioorg. Med. Chem.,2007,15,6,"Tumiatti V, Minarini A, Milelli A, Rosini M, Buccioni M, Marucci G, Ghelardini C, Bellucci C, Melchiorre C",,442040,DTCT0023280,2144877,DTCC00460288,391696,23213
CHEMBL242822,P20309,,LOFIKFNSIYDUDB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157565,DTCC00462721,1980614,23370
CHEMBL242823,P20309,,RQPBNUNWFPKAII-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,200,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157564,DTCC00462723,1208126,23370
CHEMBL2429890,P20309,,VGYQUDBPYFLBLJ-PTCVETCVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601390,DTCC01398005,1268545,55935
CHEMBL2432038,P20309,,OKCSFONJDXUZOU-CAUKCHDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601389,DTCC01398006,913793,55935
CHEMBL2432039,P20309,,CHZUEGVOEFMIJH-ZKRSMWHSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,466,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598954,DTCC01398007,1845582,55935
CHEMBL2432040,P20309,,MPBJQDFYALBXED-CAUKCHDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,1058,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598969,DTCC01398008,1139742,55935
CHEMBL2432041,P20309,,MSTPNDDVMWUDFF-CAUKCHDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,1782,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598968,DTCC01398009,71453,55935
CHEMBL2432042,P20309,,LNTMHZZRTAQEJQ-CPVTZQMHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601411,DTCC01398010,589816,55935
CHEMBL2432043,P20309,,LKFSLMWAVKMONG-KPCGFGSOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601410,DTCC01398011,2040745,55935
CHEMBL2432044,P20309,,IDXFKHDXIHNWAI-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601409,DTCC01398012,2040746,55935
CHEMBL2432045,P20309,,ZWCQZHOWEDKJBN-CAUKCHDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601394,DTCC01398013,1657028,55935
CHEMBL2432046,P20309,,KNBHNNRMMAKKFI-SEDVZXITSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601392,DTCC01398014,1009784,55935
CHEMBL2432047,P20309,,CNPQMMDLXZBMLB-KPCGFGSOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598959,DTCC01398015,1268546,55935
CHEMBL2432048,P20309,,KBAKPEFQDPCCTP-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,2155,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598958,DTCC01398016,1495532,55935
CHEMBL2432049,P20309,,DUZKXKAAUHDBQA-CAUKCHDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,2119,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598956,DTCC01398017,298486,55935
CHEMBL2432050,P20309,,SJWCMFMHVZULSJ-DKSPCFMDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598955,DTCC01398018,881050,55935
CHEMBL2432051,P20309,,CPLYGLAQLNAQOI-SEDVZXITSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601391,DTCC01398019,71454,55935
CHEMBL2432052,P20309,,SGFPDDMJMPKKTB-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601408,DTCC01398020,783458,55935
CHEMBL2432053,P20309,,DEOOAAFCKARVDM-CAUKCHDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601407,DTCC01398021,751332,55935
CHEMBL2432054,P20309,,QQUOSDRKLSIRED-DKSPCFMDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,=,1301,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598967,DTCC01398022,945256,55935
CHEMBL2432055,P20309,,VNGQWOKKSKAESQ-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601406,DTCC01398023,2040748,55935
CHEMBL2432056,P20309,,JHFKLSFCMAHSDK-LLOIJXFCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601404,DTCC01398024,103846,55935
CHEMBL2432057,P20309,,QHQJBDOHEUWLBB-CAUKCHDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601403,DTCC01398025,71455,55935
CHEMBL2432058,P20309,,MJOVYQVAQIHDSE-DKSPCFMDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601402,DTCC01398026,2008169,55935
CHEMBL2432059,P20309,,YLVXPEMITKSDOS-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601400,DTCC01398027,2008170,55935
CHEMBL2432060,P20309,,CKFQOWSPJPMWEK-IINHSQADSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601399,DTCC01398028,1235634,55935
CHEMBL2432061,P20309,,ZFZXJOHWFSRUAO-LLOIJXFCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601398,DTCC01398029,1720366,55935
CHEMBL2432062,P20309,,SSQDVMAIIMMISV-SEDVZXITSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601397,DTCC01398030,1780918,55935
CHEMBL2432063,P20309,,BMHWWKPJPARTBN-RAOGCBAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985315,DTCT0023280,12601396,DTCC01398031,331096,55935
CHEMBL2436555,P20309,,QFNMPNWOYBWECY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24035337,KI,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human recombinant muscarinic M3 receptor expressed in CHO cells after 90 mins by radioligand displacement assay,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013,23,21,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988240,DTCT0023280,12618296,DTCC01399574,71471,56006
CHEMBL24369,P20309,,SHORJVPMMAZEFL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1560441,KI,=,178,NM,,,,,,,,,,,,,,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,,"Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).",J. Med. Chem.,1992,35,7,"Leader H, Gordon RK, Baumgold J, Boyd VL, Newman AH, Smejkal RM, Chiang PK",,138701,DTCT0023280,665220,DTCC00158729,1114573,11861
CHEMBL243712,P20309,AMISULPRIDE,NTJOBXMMWNYJFB-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19337725,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14728318,DTCC00458164,2103595,69290
CHEMBL2440659,P20309,,AXVLPJHYYFHCHK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24074843,INHIBITION,>,35,%,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]-N-Methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO-K1 cells at 10 uM relative to control,,Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.,Bioorg. Med. Chem. Lett.,2013,23,21,"Felts AS, Rodriguez AL, Morrison RD, Venable DF, Manka JT, Bates BS, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA",,990327,DTCT0023280,12632842,DTCC01401025,1592232,56261
CHEMBL2441750,P20309,,SXGAHCLWFLASQB-LURJTMIESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629563,DTCC01402121,1580034,56353
CHEMBL2441751,P20309,,SXGAHCLWFLASQB-ZCFIWIBFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629562,DTCC01402122,901274,56353
CHEMBL2441752,P20309,,HPBPYAVNZRYWLD-ZETCQYMHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629561,DTCC01402123,1354099,56353
CHEMBL2441753,P20309,,HPBPYAVNZRYWLD-SSDOTTSWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629560,DTCC01402124,1833603,56353
CHEMBL2441754,P20309,,LIUNIAJFCDDQCI-YFKPBYRVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629559,DTCC01402125,771353,56353
CHEMBL2441755,P20309,,LIUNIAJFCDDQCI-RXMQYKEDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629558,DTCC01402126,1419036,56353
CHEMBL2441756,P20309,,OKUHBVWVMMKCTK-LURJTMIESA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629557,DTCC01402127,481033,56353
CHEMBL2441757,P20309,,OKUHBVWVMMKCTK-ZCFIWIBFSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629556,DTCC01402128,901275,56353
CHEMBL2441758,P20309,,JWNZFAVZLHKVEZ-LURJTMIESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629555,DTCC01402129,188411,56353
CHEMBL2441759,P20309,,KOSPIGBSYQUASP-ZETCQYMHSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629554,DTCC01402130,577618,56353
CHEMBL2441760,P20309,,UCARHSNNRIEHFG-BQBZGAKWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629551,DTCC01402131,1158691,56353
CHEMBL2441761,P20309,,UCARHSNNRIEHFG-RQJHMYQMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629550,DTCC01402132,1833604,56353
CHEMBL2442940,P20309,,INPPXFAIFVJMMD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24050790,INHIBITION,,,,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor at 10 uM by radioligand binding assay,Not Active,"Identification of a novel benzoxazolone derivative as a selective, orally active 18 kDa translocator protein (TSPO) ligand.",J. Med. Chem.,2013,56,20,"Fukaya T, Ishiyama T, Baba S, Masumoto S",,991157,DTCT0023280,12640935,DTCC01403311,103900,56238
CHEMBL24441,P20309,BETAHISTINE,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7274139,DTCC00159008,606968,46191
CHEMBL24441,P20309,BETAHISTINE,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7274140,DTCC00159008,606968,46191
CHEMBL2449003,P20309,ENDO-ATROPINE,RKUNBYITZUJHSG-VFSICIBPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24365159,KI,=,0.269,NM,,,,,,,,,,,,,,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283821,DTCT0023280,12984007,DTCC01404551,447718,56928
CHEMBL2449003,P20309,ENDO-ATROPINE,RKUNBYITZUJHSG-VFSICIBPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24365159,KI,=,0.27,NM,,,,,,,,,,,,,,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283821,DTCT0023280,12984041,DTCC01404551,447718,56928
CHEMBL244946,P20309,,WIHMMKGUBDZGEG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17867665,IC50,=,3162.28,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic receptor M3,,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,2007,50,21,"Micheli F, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A, Curcuruto O, Damiani F, Fabio RD, Donati D, Gentile G, Gribble A, Hamprecht D, Tedesco G, Terreni S, Tarsi L, Lightfoot A, Stemp G, Macdonald G, Smith A, Pecoraro M, Petrone M, Perini O, Piner J, Rossi T, Worby A, Pilla M, Valerio E, Griffante C, Mugnaini M, Wood M, Scott C, Andreoli M, Lacroix L, Schwarz A, Gozzi A, Bifone A, Ashby CR, Hagan JJ, Heidbreder C",,446402,DTCT0023280,2158151,DTCC00459015,1312948,23588
CHEMBL245137,P20309,,LULCHIOOZRNQCR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157563,DTCC00462728,108837,23370
CHEMBL245416,P20309,L-MIMOSINE,WZNJWVWKTVETCG-YFKPBYRVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7424946,DTCC00474857,2025639,46191
CHEMBL245416,P20309,L-MIMOSINE,WZNJWVWKTVETCG-YFKPBYRVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7424947,DTCC00474857,2025639,46191
CHEMBL246955,P20309,,XYYGFCDTBHAUSN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17127059,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity at muscarinic M3 receptor at 1 uM,Not Active,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,4,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453451,DTCT0023280,2219179,DTCC00477235,1361791,24220
CHEMBL24768,P20309,,XBYNQNZFRXGCJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; Activity range is 0.81-1.19,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138578,DTCT0023280,657763,DTCC00157302,1390992,17183
CHEMBL24768,P20309,,XBYNQNZFRXGCJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.27,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,657758,DTCC00157302,1390992,17183
CHEMBL24768,P20309,,XBYNQNZFRXGCJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.43,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,657757,DTCC00157302,1390992,17183
CHEMBL24769,P20309,,VETMSBQYQCVNTI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; Activity range is 0.81-1.19,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138578,DTCT0023280,337897,DTCC00157303,1066609,17183
CHEMBL24769,P20309,,VETMSBQYQCVNTI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.92,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,678689,DTCC00157303,1066609,17183
CHEMBL24769,P20309,,VETMSBQYQCVNTI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,6.05,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,678384,DTCC00157303,1066609,17183
CHEMBL24773,P20309,,WTFFYZGCISALRI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Activity at human muscarinic M3 receptor expressed in HEK293T cells assessed as increase in carbachol-induced intracellular calcium level at 10 uM after 30 to 45 mins by fluorimetry,Not Active,,ACS Med. Chem. Lett.,2012,3,2,,,821038,DTCT0023280,10492697,DTCC00158769,1642937,48262
CHEMBL248702,P20309,DEXFENFLURAMINE,DBGIVFWFUFKIQN-VIFPVBQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7342245,DTCC00487049,1351109,46191
CHEMBL248702,P20309,DEXFENFLURAMINE,DBGIVFWFUFKIQN-VIFPVBQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7342246,DTCC00487049,1351109,46191
CHEMBL24944,P20309,TRIBROMSALAN,KVSKGMLNBAPGKH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447214,DTCC00154630,1830693,46191
CHEMBL24944,P20309,TRIBROMSALAN,KVSKGMLNBAPGKH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447215,DTCC00154630,1830693,46191
CHEMBL25,P20309,ASPIRIN,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276454,DTCC00133284,51447,46191
CHEMBL25,P20309,ASPIRIN,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276455,DTCC00133284,51447,46191
CHEMBL250450,P20309,ISOQUERCETIN,OVSQVDMCBVZWGM-QSOFNFLRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14750929,DTCC00486067,2109951,69275
CHEMBL250699,P20309,A-803467,VHKBTPQDHDSBSP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17483457,IC50,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]4DAMP from muscarinic M3 receptor,,"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.",Proc. Natl. Acad. Sci. U.S.A.,2007,104,20,"Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, Thomas J, Liu D, Krambis M, Liu Y, McGaraughty S, Chu K, Roeloffs R, Zhong C, Mikusa JP, Hernandez G, Gauvin D, Wade C, Zhu C, Pai M, Scanio M, Shi L, Drizin I, Gregg R, Matulenko M, Hakeem A, Gross M, Johnson M, Marsh K, Wagoner PK, Sullivan JP, Faltynek CR, Krafte DS",,466555,DTCT0023280,2351648,DTCC00003813,310509,25480
CHEMBL251254,P20309,HYPEROSIDE,OVSQVDMCBVZWGM-DTGCRPNFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14748616,DTCC00487046,2109632,69275
CHEMBL252258,P20309,,IENZWNOPOBXYDA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18032038,KI,=,1200,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives.,Bioorg. Med. Chem. Lett.,2008,18,1,"Watson RJ, Allen DR, Birch HL, Chapman GA, Galvin FC, Jopling LA, Knight RL, Meier D, Oliver K, Meissner JW, Owen DA, Thomas EJ, Tremayne N, Williams SC",,461639,DTCT0023280,2276378,DTCC00487955,1555574,25082
CHEMBL252556,P20309,IDEBENONE,JGPMMRGNQUBGND-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7332108,DTCC00485000,185554,46191
CHEMBL252556,P20309,IDEBENONE,JGPMMRGNQUBGND-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7332109,DTCC00485000,185554,46191
CHEMBL252557,P20309,GLYCOLIC ACID,AEMRFAOFKBGASW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310445,DTCC00485664,962448,46191
CHEMBL252557,P20309,GLYCOLIC ACID,AEMRFAOFKBGASW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310446,DTCC00485664,962448,46191
CHEMBL253376,P20309,BROMHEXINE,OJGDCBLYJGHCIH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7264638,DTCC00112211,444635,46191
CHEMBL253376,P20309,BROMHEXINE,OJGDCBLYJGHCIH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7264639,DTCC00112211,444635,46191
CHEMBL254219,P20309,DIGITOXIN,WDJUZGPOPHTGOT-XUDUSOBPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7344722,DTCC00112296,994591,46191
CHEMBL254219,P20309,DIGITOXIN,WDJUZGPOPHTGOT-XUDUSOBPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7344723,DTCC00112296,994591,46191
CHEMBL254586,P20309,,HIEWUKRQZWTODT-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,3.63078E+15,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368188,DTCC00491202,973166,26235
CHEMBL255692,P20309,,AGLGNGYZLGAMMU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,2.63027E+12,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368180,DTCC00491000,779210,26235
CHEMBL256923,P20309,,WKQSRKXBSJVAPZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,5.7544E+14,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368178,DTCC00490963,1166669,26235
CHEMBL257174,P20309,,BTQDJTLGMUWWAS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,1.90546E+14,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368174,DTCC00490920,521368,26235
CHEMBL25719,P20309,GERANIOL,GLZPCOQZEFWAFX-JXMROGBWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314588,DTCC00159285,898289,46191
CHEMBL25719,P20309,GERANIOL,GLZPCOQZEFWAFX-JXMROGBWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314589,DTCC00159285,898289,46191
CHEMBL257431,P20309,,VZUVCAGXYLMFEC-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18042383,KI,=,30,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells,,Design and synthesis of a fluorescent muscarinic antagonist.,Bioorg. Med. Chem. Lett.,2008,18,2,"Jones LH, Randall A, Napier C, Trevethick M, Sreckovic S, Watson J",,468831,DTCT0023280,2294402,DTCC00501223,731058,11705
CHEMBL257547,P20309,,FJJZUKMINKWTNH-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,1.31826E+14,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368183,DTCC00491042,1744887,26235
CHEMBL257586,P20309,,ILZXXCKEBBEGOP-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,2.29087E+13,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368179,DTCC00491001,1555751,26235
CHEMBL257643,P20309,,HLNKJDYNEWLULB-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18042383,KI,=,24,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells,,Design and synthesis of a fluorescent muscarinic antagonist.,Bioorg. Med. Chem. Lett.,2008,18,2,"Jones LH, Randall A, Napier C, Trevethick M, Sreckovic S, Watson J",,468831,DTCT0023280,2294401,DTCC00501224,505258,11705
CHEMBL257704,P20309,EPLIVANSERIN,VAIOZOCLKVMIMN-PRJWTAEASA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,15999145,KI,=,2387,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14755029,DTCC00498890,2104430,69464
CHEMBL257804,P20309,,OSKIBTUMPHFWJH-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,2.75423E+14,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368173,DTCC00490918,811563,26235
CHEMBL257909,P20309,,LUJLISGGFLGFKZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18060777,INHIBITION,=,64,%,,,,,,,,,,,,,,Inhibition of muscarinic 3 receptor at 1 uM,,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008,18,1,"Ly KS, Letavic MA, Keith JM, Miller JM, Stocking EM, Barbier AJ, Bonaventure P, Lord B, Jiang X, Boggs JD, Dvorak L, Miller KL, Nepomuceno D, Wilson SJ, Carruthers NI",,463189,DTCT0023280,2296193,DTCC00501642,1555605,25227
CHEMBL258161,P20309,,WXNBHJKPRXJXST-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,1.34896E+14,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368186,DTCC00491127,779209,26235
CHEMBL258385,P20309,,JOZKTPSVXOGLJA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,1.51356E+15,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368187,DTCC00491164,1716417,26235
CHEMBL258959,P20309,,MMAOIAFUZKMAOY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,2.51,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362680,DTCC00492467,1296797,26143
CHEMBL26,P20309,SULPIRIDE,BGRJTUBHPOOWDU-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7476347,DTCC00133325,413978,46191
CHEMBL26,P20309,SULPIRIDE,BGRJTUBHPOOWDU-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7476348,DTCC00133325,413978,46191
CHEMBL260228,P20309,,XELSLLUJXUXNOB-RPBOFIJWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,2.51,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362682,DTCC00492469,455778,26143
CHEMBL260374,P20309,THIOPERAMIDE,QKDDJDBFONZGBW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8564266,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14729273,DTCC00494403,2103825,69351
CHEMBL262198,P20309,,BINQUROWAKHZJG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,100.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1610058,DTCC00297546,724203,15558
CHEMBL262303,P20309,,ZCJMFORCHMCSBO-GRTNUQQKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,4514.2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1615095,DTCC00297240,1500621,15558
CHEMBL262455,P20309,,FXBXWJPMXQHOGD-UVTIVQHFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,87,%,,,,,,,,,,,,,,Maximal response obtained for each drug normalized to effect of carbachol in Muscarinic acetylcholine receptor M3,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138571,DTCT0023280,1619417,DTCC00210291,808700,14722
CHEMBL262455,P20309,,FXBXWJPMXQHOGD-UVTIVQHFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,ED50,=,865,NM,,cell_based,,,,,,,,,,,NIH3T3,Amplification of transfected NIH3T3 cells was measured in Muscarinic acetylcholine receptor M3 required to produce half maximal effect,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138583,DTCT0023280,1619416,DTCC00210291,808700,14722
CHEMBL262455,P20309,,FXBXWJPMXQHOGD-UVTIVQHFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,STIMULATION,=,10.4,%,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M3 values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol.,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138719,DTCT0023280,1619409,DTCC00210291,808700,14722
CHEMBL26260,P20309,BETA-NAPHTHOFLAVONE,OUGIDAPQYNCXRA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7271184,DTCC00163498,1641845,46191
CHEMBL26260,P20309,BETA-NAPHTHOFLAVONE,OUGIDAPQYNCXRA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7271185,DTCC00163498,1641845,46191
CHEMBL262777,P20309,VANCOMYCIN,MYPYJXKWCTUITO-LYRMYLQWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447586,DTCC00189637,51514,46191
CHEMBL262777,P20309,VANCOMYCIN,MYPYJXKWCTUITO-LYRMYLQWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447587,DTCC00189637,51514,46191
CHEMBL263040,P20309,,DYVREFSXUJXDOE-KNQAVFIVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,76,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1457976,DTCC00221668,1681863,5621
CHEMBL263555,P20309,,BQIFXNSKBXZEIQ-CYFREDJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,15115380,KI,=,9089,NM,,,,,,,,,,,,,,Antagonistic activity against muscarinic M3 receptor,,"Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.",J. Med. Chem.,2004,47,10,"Tagat JR, McCombie SW, Nazareno D, Labroli MA, Xiao Y, Steensma RW, Strizki JM, Baroudy BM, Cox K, Lachowicz J, Varty G, Watkins R",,138699,DTCT0023280,980078,DTCC00236769,1617730,17809
CHEMBL264374,P20309,BEZAFIBRATE,IIBYAHWJQTYFKB-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7262967,DTCC00179544,249938,46191
CHEMBL264374,P20309,BEZAFIBRATE,IIBYAHWJQTYFKB-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7262968,DTCC00179544,249938,46191
CHEMBL264414,P20309,,OIVUQKJVYIDTLN-RPWUZVMVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362684,DTCC00492513,1744876,26143
CHEMBL264676,P20309,,XELSLLUJXUXNOB-JWQCQUIFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,0.316,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362683,DTCC00492514,1329382,26143
CHEMBL264747,P20309,,NGRQZBLQNGSLEN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,4800,NM,,,,,,,,,,,,,,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),,,Bioorg. Med. Chem. Lett.,1994,4,24,,,138254,DTCT0023280,854635,DTCC00261905,627065,1026
CHEMBL26503,P20309,,NSELTLNRXBZSCP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,685040,DTCC00157306,2064694,17183
CHEMBL26503,P20309,,NSELTLNRXBZSCP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,3.93,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,685035,DTCC00157306,2064694,17183
CHEMBL26503,P20309,,NSELTLNRXBZSCP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.56,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,685034,DTCC00157306,2064694,17183
CHEMBL26505,P20309,APROFENE,DIDYGLSKVUKRRP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1560441,KI,=,7.7,NM,,,,,,,,,,,,,,Antimuscarinic potency and subset specificity was characterised by inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,,"Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).",J. Med. Chem.,1992,35,7,"Leader H, Gordon RK, Baumgold J, Boyd VL, Newman AH, Smejkal RM, Chiang PK",,138700,DTCT0023280,659211,DTCC00158663,726265,11861
CHEMBL26505,P20309,APROFENE,DIDYGLSKVUKRRP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,7760,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417724,DTCC00158663,718828,54418
CHEMBL265256,P20309,TRIPITRAMINE,YUJOQEAGGUIMED-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7805774,KI,=,38.25,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14738073,DTCC00287645,2106510,69664
CHEMBL265256,P20309,TRIPITRAMINE,YUJOQEAGGUIMED-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,38.02,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1358965,DTCC00287645,1584156,4821
CHEMBL265256,P20309,TRIPITRAMINE,YUJOQEAGGUIMED-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18595721,KI,=,147.91,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,,"Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.",Bioorg. Med. Chem.,2008,16,15,"Minarini A, Marucci G, Bellucci C, Giorgi G, Tumiatti V, Bolognesi ML, Matera R, Rosini M, Melchiorre C",,491020,DTCT0023280,2759463,DTCC00287645,1595999,30679
CHEMBL267014,P20309,L-745870,OGJGQVFWEPNYSB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1246487,DTCC00134100,855981,4253
CHEMBL267044,P20309,LEVOSULPIRIDE,BGRJTUBHPOOWDU-NSHDSACASA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433753,DTCC00136073,1734057,46191
CHEMBL267044,P20309,LEVOSULPIRIDE,BGRJTUBHPOOWDU-NSHDSACASA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433754,DTCC00136073,1734057,46191
CHEMBL267345,P20309,AMPHOTERICIN B,APKFDSVGJQXUKY-INPOYWNPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288959,DTCC00139627,51445,46191
CHEMBL267345,P20309,AMPHOTERICIN B,APKFDSVGJQXUKY-INPOYWNPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288960,DTCC00139627,51445,46191
CHEMBL267648,P20309,PEFLOXACIN,FHFYDNQZQSQIAI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7389055,DTCC00141792,735393,46191
CHEMBL267648,P20309,PEFLOXACIN,FHFYDNQZQSQIAI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7389056,DTCC00141792,735393,46191
CHEMBL267744,P20309,TICRYNAFEN,AGHANLSBXUWXTB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7476969,DTCC00134562,1544902,46191
CHEMBL267744,P20309,TICRYNAFEN,AGHANLSBXUWXTB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7476970,DTCC00134562,1544902,46191
CHEMBL267894,P20309,AMOBARBITAL,VIROVYVQCGLCII-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302547,DTCC00134214,1092340,46191
CHEMBL267894,P20309,AMOBARBITAL,VIROVYVQCGLCII-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302548,DTCC00134214,1092340,46191
CHEMBL268175,P20309,,OHZDCLVTEMUSFX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,13000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1020609,DTCC00103432,855650,8985
CHEMBL268291,P20309,DIMETHYLFORMAMIDE,ZMXDDKWLCZADIW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7418025,DTCC00136577,1765977,46191
CHEMBL268291,P20309,DIMETHYLFORMAMIDE,ZMXDDKWLCZADIW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7418026,DTCC00136577,1765977,46191
CHEMBL268808,P20309,NORARECOLINE,DYPLDWLIOGXSSE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,300,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1051738,DTCC00132961,1852581,8985
CHEMBL269280,P20309,,WOYPOZFCHPWOPA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,16.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030923,DTCC00443206,1916676,22115
CHEMBL269706,P20309,,AQYXZOFAYAWXHY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,1600,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1040575,DTCC00132999,467442,8985
CHEMBL269732,P20309,TACROLIMUS,QJJXYPPXXYFBGM-LFZNUXCKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458969,DTCC00132983,1765982,46191
CHEMBL269732,P20309,TACROLIMUS,QJJXYPPXXYFBGM-LFZNUXCKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458970,DTCC00132983,1765982,46191
CHEMBL27,P20309,PROPRANOLOL,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26565745,EC50,>,5011.87,NM,,,,,,,,,,,,,,Agonist activity at human wild-type M3 receptor expressed in CHO-K1 cells assessed as calcium level by FDSS assay,,Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example.,J. Med. Chem.,2015,58,23,"Rombouts FJ, Tovar F, Austin N, Tresadern G, Trabanco AA.",,1539160,DTCT0023280,2900,DTCC00133355,534,65419
CHEMBL27,P20309,PROPRANOLOL,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26565745,IC50,>,5011.87,NM,,,,,,,,,,,,,,Antagonist activity at human wild-type M3 receptor expressed in CHO-K1 cells assessed as acetylcholine-induced calcium by FDSS assay,,Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example.,J. Med. Chem.,2015,58,23,"Rombouts FJ, Tovar F, Austin N, Tresadern G, Trabanco AA.",,1539137,DTCT0023280,2831,DTCC00133355,534,65419
CHEMBL27,P20309,PROPRANOLOL,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7402956,DTCC00133355,51503,46191
CHEMBL27,P20309,PROPRANOLOL,AQHHHDLHHXJYJD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7402957,DTCC00133355,51503,46191
CHEMBL270299,P20309,BAY-11-7085,VHKZGNPOHPFPER-ONNFQVAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7269558,DTCC00504714,1220273,46191
CHEMBL270299,P20309,BAY-11-7085,VHKZGNPOHPFPER-ONNFQVAWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7269559,DTCC00504714,1220273,46191
CHEMBL270595,P20309,,OXEFHEYEQUISKC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22607684,KI,,,,,,,,,,,,,,,,,Inhibition of M3 muscarinic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012,22,12,"Banister SD, Rendina LM, Kassiou M",,818109,DTCT0023280,10479339,DTCC00502273,1928089,48255
CHEMBL271108,P20309,,WHKGYJCRLQITBW-SWJBRDQASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18042383,KI,=,10.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells,,Design and synthesis of a fluorescent muscarinic antagonist.,Bioorg. Med. Chem. Lett.,2008,18,2,"Jones LH, Randall A, Napier C, Trevethick M, Sreckovic S, Watson J",,468831,DTCT0023280,2294400,DTCC00501174,439493,11705
CHEMBL271519,P20309,,PUIFCTVMZJJWPO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20202841,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine-induced calcium mobilization,,Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.,Bioorg. Med. Chem. Lett.,2010,20,7,"Miller NR, Daniels RN, Lee D, Conn PJ, Lindsley CW",,625132,DTCT0023280,3297205,DTCC00501171,1039406,38256
CHEMBL273348,P20309,TOSUFLOXACIN,WUWFMDMBOJLQIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7461923,DTCC00145035,2025645,46191
CHEMBL273348,P20309,TOSUFLOXACIN,WUWFMDMBOJLQIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7461924,DTCC00145035,2025645,46191
CHEMBL273586,P20309,,YIDUXCASAXKJEC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,100,NM,,,,,,,,,,,,,,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),,,Bioorg. Med. Chem. Lett.,1994,4,24,,,138254,DTCT0023280,849708,DTCC00261906,1629598,1026
CHEMBL274119,P20309,RACEMETHIONINE,FFEARJCKVFRZRR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14733408,DTCC00135493,2104905,69159
CHEMBL27507,P20309,ZAMIFENACIN,BDNFQGRSKSQXRI-XMMPIXPASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,organism_based,,,,,,,,,,,,Evaluated for the in vivo antagonistic activity against muscarinic M3 receptor; Active,Active,,Bioorg. Med. Chem. Lett.,1997,7,10,,,222728,DTCT0023280,1313841,DTCC00161817,1664117,2095
CHEMBL275104,P20309,,VMJSEWCRPGCNOF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,392,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193395,DTCC00135456,1937592,23951
CHEMBL275742,P20309,DEXPROPRANOLOL,AQHHHDLHHXJYJD-CQSZACIVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375215,DTCC00140656,1674148,46191
CHEMBL275742,P20309,DEXPROPRANOLOL,AQHHHDLHHXJYJD-CQSZACIVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375216,DTCC00140656,1674148,46191
CHEMBL27577,P20309,SALICYLAMIDE,SKZKKFZAGNVIMN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457995,DTCC00161342,185557,46191
CHEMBL27577,P20309,SALICYLAMIDE,SKZKKFZAGNVIMN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457996,DTCC00161342,185557,46191
CHEMBL275914,P20309,,ZKWQIRHRFKLAAQ-DWCFPWJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,74,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974220,DTCC00110598,1005011,21327
CHEMBL275914,P20309,,ZKWQIRHRFKLAAQ-DWCFPWJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,99,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974221,DTCC00110598,1005011,21327
CHEMBL27673,P20309,METHOCTRAMINE,RPMBYDYUVKEZJA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,213.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14740869,DTCC00167159,2107538,68416
CHEMBL27673,P20309,METHOCTRAMINE,RPMBYDYUVKEZJA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2704370,KI,=,118,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14740870,DTCC00167159,2107539,68413
CHEMBL27673,P20309,METHOCTRAMINE,RPMBYDYUVKEZJA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7805774,KI,=,277.32,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14740868,DTCC00167159,2107537,69664
CHEMBL27673,P20309,METHOCTRAMINE,RPMBYDYUVKEZJA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11708906,KI,=,277,NM,,cell_based,,,,,,,,,,,CHO-K1,Affinity for human M3 cloned muscarinic receptor subtype expressed in CHO-K1 cells,,"Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activators.",J. Med. Chem.,2001,44,24,"Melchiorre C, Bolognesi ML, Budriesi R, Ghelardini C, Chiarini A, Minarini A, Rosini M, Tumiatti V, Wade EJ",,138697,DTCT0023280,1598481,DTCC00167159,821044,16447
CHEMBL27673,P20309,METHOCTRAMINE,RPMBYDYUVKEZJA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17276075,KI,=,524.81,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H] N-methyl-scopolamine chloride from human muscarinic receptor M3 expressed in CHO cells,,Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moieties.,Bioorg. Med. Chem.,2007,15,6,"Tumiatti V, Minarini A, Milelli A, Rosini M, Buccioni M, Marucci G, Ghelardini C, Bellucci C, Melchiorre C",,442040,DTCT0023280,2144873,DTCC00167159,811071,23213
CHEMBL276832,P20309,HYDRALAZINE,RPTUSVTUFVMDQK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327709,DTCC00139551,1416032,46191
CHEMBL276832,P20309,HYDRALAZINE,RPTUSVTUFVMDQK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327710,DTCC00139551,1416032,46191
CHEMBL276955,P20309,,VNMYYRHSGSTCLY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; Activity range is 0.81-1.19,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138578,DTCT0023280,665117,DTCC00157300,743429,17183
CHEMBL276955,P20309,,VNMYYRHSGSTCLY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.52,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,665112,DTCC00157300,743429,17183
CHEMBL276955,P20309,,VNMYYRHSGSTCLY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.58,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,665111,DTCC00157300,743429,17183
CHEMBL277100,P20309,TEMAFLOXACIN,QKDHBVNJCZBTMR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483038,DTCC00145004,1124457,46191
CHEMBL277100,P20309,TEMAFLOXACIN,QKDHBVNJCZBTMR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483039,DTCC00145004,1124457,46191
CHEMBL277474,P20309,ANTIPYRINE,VEQOALNAAJBPNY-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7262204,DTCC00154395,509231,46191
CHEMBL277474,P20309,ANTIPYRINE,VEQOALNAAJBPNY-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7262205,DTCC00154395,509231,46191
CHEMBL277478,P20309,,LCQFWMFZOXYQKN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,467122,DTCC00156696,451851,17183
CHEMBL277478,P20309,,LCQFWMFZOXYQKN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.33,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,467110,DTCC00156696,451851,17183
CHEMBL277478,P20309,,LCQFWMFZOXYQKN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.63,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,467109,DTCC00156696,451851,17183
CHEMBL277642,P20309,HIMBACINE,FMPNFDSPHNUFOS-LPJDIUFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,333.6,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,521573,DTCC00155272,1078954,2697
CHEMBL277642,P20309,HIMBACINE,FMPNFDSPHNUFOS-LPJDIUFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,93.33,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1362828,DTCC00155272,1066574,4821
CHEMBL277642,P20309,HIMBACINE,FMPNFDSPHNUFOS-LPJDIUFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,93.33,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1376772,DTCC00155272,1078901,4936
CHEMBL277642,P20309,HIMBACINE,FMPNFDSPHNUFOS-LPJDIUFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,104.71,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1395326,DTCC00155272,1078902,4936
CHEMBL27769,P20309,STANOLONE,NVKAWKQGWWIWPM-ABEVXSGRSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462857,DTCC00161007,1318447,46191
CHEMBL27769,P20309,STANOLONE,NVKAWKQGWWIWPM-ABEVXSGRSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462858,DTCC00161007,1318447,46191
CHEMBL277916,P20309,,WKHXCSBUDSQAPB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,676260,DTCC00157818,290407,17183
CHEMBL277916,P20309,,WKHXCSBUDSQAPB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.86,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,676255,DTCC00157818,290407,17183
CHEMBL277916,P20309,,WKHXCSBUDSQAPB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.14,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,676254,DTCC00157818,290407,17183
CHEMBL278074,P20309,,USQJGTQEUASCDF-QGOAFFKASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,2089.3,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1328946,DTCC00154026,1551941,4821
CHEMBL278129,P20309,,JOXSTTNEVMTGKF-DTQAZKPQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,15135.61,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1362823,DTCC00153921,1162809,4821
CHEMBL278172,P20309,BENZOCAINE,BLFLLBZGZJTVJG-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7268465,DTCC00146075,88623,46191
CHEMBL278172,P20309,BENZOCAINE,BLFLLBZGZJTVJG-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7268466,DTCC00146075,88623,46191
CHEMBL279105,P20309,,ZFWDHAFFYWSZBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9438027,IC50,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,,"Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.",J. Med. Chem.,1998,41,1,"Sauerberg P, Olesen PH, Sheardown MJ, Rimvall K, Thøgersen H, Shannon HE, Sawyer BD, Ward JS, Bymaster FP, DeLapp NW, Calligaro DO, Swedberg MD",,138982,DTCT0023280,1587089,DTCC00146217,1805397,14608
CHEMBL279225,P20309,,QDIDITZTHXPBSB-JQIJEIRASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,63095.73,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1353585,DTCC00154167,1649053,4821
CHEMBL279453,P20309,AF-DX-384,MZDYABXXPZNUCT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,66.07,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14735821,DTCC01739107,2105775,68416
CHEMBL279453,P20309,AF-DX-384,MZDYABXXPZNUCT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,66.07,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1331503,DTCC01739107,1325436,4821
CHEMBL279520,P20309,,HHAOUXZZQFSSJV-FOWTUZBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,40738.03,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1349290,DTCC00154134,646844,4821
CHEMBL27979,P20309,"A-349,821",CFUHKRLMDNFZED-SFTDATJTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12657274,KI,=,1659.59,NM,,,,,,,,,,,,,,Binding affinity towards human muscarinic M3 receptor,,Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2003,13,7,"Faghih R, Dwight W, Pan JB, Fox GB, Krueger KM, Esbenshade TA, McVey JM, Marsh K, Bennani YL, Hancock AA",,138829,DTCT0023280,970133,DTCC00160807,711123,6248
CHEMBL280220,P20309,,GCLKZSBEVYSDDQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,229.09,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1624218,DTCC00274472,1753714,16818
CHEMBL280340,P20309,,BOKGVUFNDGIOAI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,681334,DTCC00156608,257093,17183
CHEMBL280340,P20309,,BOKGVUFNDGIOAI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.47,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,681329,DTCC00156608,257093,17183
CHEMBL280340,P20309,,BOKGVUFNDGIOAI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,6.03,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,681328,DTCC00156608,257093,17183
CHEMBL280552,P20309,,JGORYXHQZAIVNW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,686302,DTCC00157810,1741143,17183
CHEMBL280552,P20309,,JGORYXHQZAIVNW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.83,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,686297,DTCC00157810,1741143,17183
CHEMBL280552,P20309,,JGORYXHQZAIVNW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.92,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,686296,DTCC00157810,1741143,17183
CHEMBL280675,P20309,,SYYNGVQCTYOERQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at Muscarinic acetylcholine receptor M3; activity ranges is 0.2-0.8.,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138581,DTCT0023280,468478,DTCC00156697,581799,17183
CHEMBL280675,P20309,,SYYNGVQCTYOERQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.06,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,689778,DTCC00156697,581799,17183
CHEMBL280675,P20309,,SYYNGVQCTYOERQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.61,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,689532,DTCC00156697,581799,17183
CHEMBL280684,P20309,,ITTZJEYXTVMDSM-FOWTUZBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,10000,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1354952,DTCC00154209,937321,4821
CHEMBL28079,P20309,ZAPRINAST,REZGGXNDEMKIQB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445014,DTCC00165545,1862720,46191
CHEMBL28079,P20309,ZAPRINAST,REZGGXNDEMKIQB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445015,DTCC00165545,1862720,46191
CHEMBL280951,P20309,,WYGQAWOOBVONHO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,468587,DTCC00156693,1999995,17183
CHEMBL280951,P20309,,WYGQAWOOBVONHO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.9,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,468582,DTCC00156693,1999995,17183
CHEMBL280951,P20309,,WYGQAWOOBVONHO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.11,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,468581,DTCC00156693,1999995,17183
CHEMBL280998,P20309,CATECHOL,YCIMNLLNPGFGHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7342890,DTCC00161195,541717,46191
CHEMBL280998,P20309,CATECHOL,YCIMNLLNPGFGHC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7342891,DTCC00161195,541717,46191
CHEMBL28218,P20309,BROMPERIDOL,RKLNONIVDFXQRX-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,7140,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14740317,DTCC00161023,2107351,68417
CHEMBL282424,P20309,,OOKNJSVAHXTYKL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1223544,DTCC00165257,1373675,4253
CHEMBL282468,P20309,CHOLINE CHLORIDE,SGMZJAMFUVOLNK-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7366932,DTCC00159655,120971,46191
CHEMBL282468,P20309,CHOLINE CHLORIDE,SGMZJAMFUVOLNK-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7366933,DTCC00159655,120971,46191
CHEMBL282575,P20309,ESTRADIOL BENZOATE,UYIFTLBWAOGQBI-BZDYCCQFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7268533,DTCC00165062,1674141,46191
CHEMBL282575,P20309,ESTRADIOL BENZOATE,UYIFTLBWAOGQBI-BZDYCCQFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7268534,DTCC00165062,1674141,46191
CHEMBL282680,P20309,,ADNXJRWPXNPPPG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,468575,DTCC00156714,1681187,17183
CHEMBL282680,P20309,,ADNXJRWPXNPPPG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.75,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,691219,DTCC00156714,1681187,17183
CHEMBL282680,P20309,,ADNXJRWPXNPPPG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.06,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,691117,DTCC00156714,1681187,17183
CHEMBL282829,P20309,,FKHBXKAEVUTBRK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1246513,DTCC00165330,35152,4253
CHEMBL282874,P20309,,ACUBTKJTXUPFDJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,338699,DTCC00156645,128051,17183
CHEMBL282874,P20309,,ACUBTKJTXUPFDJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.56,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,338690,DTCC00156645,128051,17183
CHEMBL282874,P20309,,ACUBTKJTXUPFDJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.86,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,338688,DTCC00156645,128051,17183
CHEMBL283036,P20309,,BFQIOOYNLCWKIJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1245264,DTCC00165333,1535102,4253
CHEMBL283196,P20309,ALPHA-NAPHTHOFLAVONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296552,DTCC00163499,671784,46191
CHEMBL283196,P20309,ALPHA-NAPHTHOFLAVONE,VFMMPHCGEFXGIP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296553,DTCC00163499,671784,46191
CHEMBL283320,P20309,,IAVVJRZRDIWUJA-DTQAZKPQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,45708.82,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1353580,DTCC00154194,1423196,4821
CHEMBL283792,P20309,,CNTRLZBJBYDJRJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,686278,DTCC00157117,1616899,17183
CHEMBL283792,P20309,,CNTRLZBJBYDJRJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.64,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,686273,DTCC00157117,1616899,17183
CHEMBL283792,P20309,,CNTRLZBJBYDJRJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.88,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,686121,DTCC00157117,1616899,17183
CHEMBL284137,P20309,,HLBJQGCUNYZLFQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1560441,KI,=,4,NM,,,,,,,,,,,,,,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,,"Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).",J. Med. Chem.,1992,35,7,"Leader H, Gordon RK, Baumgold J, Boyd VL, Newman AH, Smejkal RM, Chiang PK",,138701,DTCT0023280,682681,DTCC00158499,1949834,11861
CHEMBL284994,P20309,"(1R,4S)-TRANS-SERTRALINE",VGKDLMBJGBXTGI-YVEFUNNKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,1300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14731530,DTCC01739603,2104432,68567
CHEMBL285440,P20309,,WQILUXNQRKEYJI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1560441,KI,=,31.2,NM,,,,,,,,,,,,,,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,,"Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).",J. Med. Chem.,1992,35,7,"Leader H, Gordon RK, Baumgold J, Boyd VL, Newman AH, Smejkal RM, Chiang PK",,138701,DTCT0023280,668840,DTCC00158498,1114574,11861
CHEMBL285802,P20309,ZOTEPINE,HDOZVRUNCMBHFH-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,73,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14758080,DTCC00160409,2111215,68417
CHEMBL285898,P20309,,HXBKNTPSKWVIGR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1560441,KI,=,160,NM,,,,,,,,,,,,,,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,,"Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).",J. Med. Chem.,1992,35,7,"Leader H, Gordon RK, Baumgold J, Boyd VL, Newman AH, Smejkal RM, Chiang PK",,138701,DTCT0023280,685187,DTCC00158704,1599525,11861
CHEMBL286008,P20309,,HPHMHCRNJVKYKE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1560441,KI,=,1.7,NM,,,,,,,,,,,,,,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,,"Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).",J. Med. Chem.,1992,35,7,"Leader H, Gordon RK, Baumgold J, Boyd VL, Newman AH, Smejkal RM, Chiang PK",,138701,DTCT0023280,690258,DTCC00158692,1917096,11861
CHEMBL28607,P20309,,NNGCXJPRHBHODU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1224715,DTCC00165991,1567062,4253
CHEMBL286398,P20309,PROPYLENE GLYCOL,DNIAPMSPPWPWGF-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7372869,DTCC00167384,1798417,46191
CHEMBL286398,P20309,PROPYLENE GLYCOL,DNIAPMSPPWPWGF-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7372870,DTCC00167384,1798417,46191
CHEMBL28651,P20309,,TYDSNTMUQPPTLL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1235955,DTCC00165361,1917164,4253
CHEMBL287096,P20309,,ZUYPXJXTDJMPBJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,676248,DTCC00157809,1227524,17183
CHEMBL287096,P20309,,ZUYPXJXTDJMPBJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.84,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,676243,DTCC00157809,1227524,17183
CHEMBL287096,P20309,,ZUYPXJXTDJMPBJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.15,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,676085,DTCC00157809,1227524,17183
CHEMBL287671,P20309,,KGZWRXWYLPRJCF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1237326,DTCC00165326,143413,4253
CHEMBL287863,P20309,,IFJIIFSMZCOESI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,468810,DTCC00157808,840597,17183
CHEMBL287863,P20309,,IFJIIFSMZCOESI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,3.94,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,693823,DTCC00157808,840597,17183
CHEMBL287863,P20309,,IFJIIFSMZCOESI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,4.51,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,693822,DTCC00157808,840597,17183
CHEMBL28833,P20309,,QRQZDZPCRVUFNL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1220064,DTCC00165329,2079897,4253
CHEMBL289469,P20309,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331816,DTCC00177095,249942,46191
CHEMBL289469,P20309,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7331817,DTCC00177095,249942,46191
CHEMBL28997,P20309,,HNCAIEASLRMRKM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1210834,DTCC00165992,1373676,4253
CHEMBL29,P20309,BENZYLPENICILLIN,JGSARLDLIJGVTE-MBNYWOFBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7376190,DTCC00133537,51497,46191
CHEMBL29,P20309,BENZYLPENICILLIN,JGSARLDLIJGVTE-MBNYWOFBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7376191,DTCC00133537,51497,46191
CHEMBL290106,P20309,BITHIONOL,JFIOVJDNOJYLKP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7274253,DTCC00104360,153440,46191
CHEMBL290106,P20309,BITHIONOL,JFIOVJDNOJYLKP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7274254,DTCC00104360,153440,46191
CHEMBL290916,P20309,EDARAVONE,QELUYTUMUWHWMC-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7315346,DTCC00181825,443476,46191
CHEMBL290916,P20309,EDARAVONE,QELUYTUMUWHWMC-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7315347,DTCC00181825,443476,46191
CHEMBL291338,P20309,"3,3',4',5-TETRACHLOROSALICYLANILIDE",SJQBHPJLLIJASD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293265,DTCC00204573,1447875,46191
CHEMBL291338,P20309,"3,3',4',5-TETRACHLOROSALICYLANILIDE",SJQBHPJLLIJASD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293266,DTCC00204573,1447875,46191
CHEMBL291562,P20309,,RQPHVQRRFIQPNU-VOVZHTNUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,5011.87,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1389248,DTCC00203655,1013996,4936
CHEMBL29292,P20309,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449311,DTCC00165773,120979,46191
CHEMBL29292,P20309,UBENIMEX,VGGGPCQERPFHOB-RDBSUJKOSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449312,DTCC00165773,120979,46191
CHEMBL293492,P20309,CINNAMALDEHYDE,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7362685,DTCC00198978,1124447,46191
CHEMBL293492,P20309,CINNAMALDEHYDE,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7362686,DTCC00198978,1124447,46191
CHEMBL294199,P20309,CAPSAICIN,YKPUWZUDDOIDPM-SOFGYWHQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276175,DTCC00207211,736256,46191
CHEMBL294199,P20309,CAPSAICIN,YKPUWZUDDOIDPM-SOFGYWHQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276176,DTCC00207211,736256,46191
CHEMBL294273,P20309,,SEGNDTHRZAYKPQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9622546,KI,=,15000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,,6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.,J. Med. Chem.,1998,41,12,"Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW",,138707,DTCT0023280,1614124,DTCC00213330,140422,14670
CHEMBL294273,P20309,,SEGNDTHRZAYKPQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,15000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138710,DTCT0023280,607204,DTCC00213330,128981,15779
CHEMBL294273,P20309,,SEGNDTHRZAYKPQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,607205,DTCC00213330,128981,15779
CHEMBL294649,P20309,,ZNAPADWWBWFMCQ-HNNXBMFYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,50118.72,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1995,5,16,,,138257,DTCT0023280,898526,DTCC00199702,787483,1269
CHEMBL294663,P20309,,RQPHVQRRFIQPNU-DEPSAMCGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,3311.31,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1399012,DTCC00203710,723180,4936
CHEMBL294726,P20309,,IWGSNHPEKKRXQD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,15293.8,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,525508,DTCC00209446,140382,2697
CHEMBL295416,P20309,PIRINIXIC ACID,SZRPDCCEHVWOJX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378777,DTCC00183846,671791,46191
CHEMBL295416,P20309,PIRINIXIC ACID,SZRPDCCEHVWOJX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378778,DTCC00183846,671791,46191
CHEMBL295698,P20309,KETOCONAZOLE,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429153,DTCC00191118,51483,46191
CHEMBL295698,P20309,KETOCONAZOLE,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429154,DTCC00191118,51483,46191
CHEMBL296419,P20309,ASTEMIZOLE,GXDALQBWZGODGZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,840,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279386,DTCC00186013,413968,46191
CHEMBL296419,P20309,ASTEMIZOLE,GXDALQBWZGODGZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,178,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279387,DTCC00186013,413968,46191
CHEMBL29808,P20309,,HGWVDBLPHYBBTH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1233652,DTCC00165332,855982,4253
CHEMBL298612,P20309,,ZNAPADWWBWFMCQ-OAHLLOKOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,31622.78,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1995,5,16,,,138257,DTCT0023280,903199,DTCC00199987,464443,1269
CHEMBL3,P20309,NICOTINE,SNICXCGAKADSCV-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,Not Active,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629549,DTCC00132283,57189,56353
CHEMBL3,P20309,NICOTINE,SNICXCGAKADSCV-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396885,DTCC00132283,51492,46191
CHEMBL3,P20309,NICOTINE,SNICXCGAKADSCV-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396886,DTCC00132283,51492,46191
CHEMBL30,P20309,CIMETIDINE,AQIXAKUUQRKLND-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7358385,DTCC00133542,282997,46191
CHEMBL30,P20309,CIMETIDINE,AQIXAKUUQRKLND-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7358386,DTCC00133542,282997,46191
CHEMBL30008,P20309,FLUNARIZINE,SMANXXCATUTDDT-QPJJXVBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,1479,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7324668,DTCC00164139,542576,46191
CHEMBL30008,P20309,FLUNARIZINE,SMANXXCATUTDDT-QPJJXVBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,313,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7324669,DTCC00164139,542576,46191
CHEMBL300987,P20309,,JHBJXFJNSKBBLY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,10804.1,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,532137,DTCC00209171,1693154,2697
CHEMBL301041,P20309,,GVRIVFLIGBHYRA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,5493.9,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,533067,DTCC00209325,1629056,2697
CHEMBL301670,P20309,,FMPNFDSPHNUFOS-HAHRSARXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,1621.81,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1404026,DTCC00203555,981711,4936
CHEMBL302145,P20309,,FJIIFJMUKPRFTH-UZLBHIALSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,93,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1459151,DTCC00220924,1773649,5621
CHEMBL302720,P20309,,RPWGPUBKJDYNDR-UZLBHIALSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,650,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1450732,DTCC00221606,1132330,5621
CHEMBL302795,P20309,TENOXICAM,LZNWYQJJBLGYLT-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457014,DTCC00224436,1641854,46191
CHEMBL302795,P20309,TENOXICAM,LZNWYQJJBLGYLT-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457015,DTCC00224436,1641854,46191
CHEMBL302809,P20309,,CXCOPHKFCPOFFH-UTKZUKDTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,3.3,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1477448,DTCC00220723,1293642,5621
CHEMBL30327,P20309,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN",HGUFODBRKLSHSI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7282270,DTCC00168237,833154,46191
CHEMBL30327,P20309,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN",HGUFODBRKLSHSI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7282271,DTCC00168237,833154,46191
CHEMBL303758,P20309,,WZEWMBNWOJJFNU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,2720.9,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,518449,DTCC00209255,1564047,2697
CHEMBL3039518,P20309,BATEFENTEROL,URWYQGVSPQJGGB-DHUJRADRSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,2,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126137,DTCC01405473,558906,62168
CHEMBL3039518,P20309,BATEFENTEROL,URWYQGVSPQJGGB-DHUJRADRSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,T1/2,=,0.05,HR,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor assessed as dissociation half life,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477448,DTCT0023280,14126173,DTCC01405473,558906,62168
CHEMBL3039597,P20309,GENTAMICIN,NPEFREDMMVQEPL-RWPARATISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7308027,DTCC01405528,51474,46191
CHEMBL3039597,P20309,GENTAMICIN,NPEFREDMMVQEPL-RWPARATISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7308028,DTCC01405528,51474,46191
CHEMBL304036,P20309,,BLDNOAIVFGARLP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,2827.7,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,537955,DTCC00209354,1882018,2697
CHEMBL304142,P20309,,MMAAVQKZYQKTJY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7783150,EC50,=,620,NM,,,,,,,,,,,,,,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),,Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors.,J. Med. Chem.,1995,38,12,"Bräuner-Osborne H, Ebert B, Brann MR, Falch E, Krogsgaard-Larsen P",,138582,DTCT0023280,920934,DTCC00221915,257866,13059
CHEMBL305264,P20309,,XTTVTDWUFDGHOL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7783150,EC50,=,140,NM,,,,,,,,,,,,,,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),,Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors.,J. Med. Chem.,1995,38,12,"Bräuner-Osborne H, Ebert B, Brann MR, Falch E, Krogsgaard-Larsen P",,138582,DTCT0023280,909570,DTCC00222513,1132339,13059
CHEMBL305331,P20309,,QIQNNBXHAYSQRY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9622546,INHIBITION,=,19,%,,cell_based,,,,,,,,,,,CHO,Percentage inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,,6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.,J. Med. Chem.,1998,41,12,"Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW",,138724,DTCT0023280,1601552,DTCC00213544,1693189,14670
CHEMBL305531,P20309,,MBGKVLLSSVDNHB-CCFGZORBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,2.9,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1465376,DTCC00221149,550319,5621
CHEMBL305660,P20309,EBASTINE,MJJALKDDGIKVBE-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,647.5,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306830,DTCC00223547,1704690,46191
CHEMBL305660,P20309,EBASTINE,MJJALKDDGIKVBE-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,137.2,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306831,DTCC00223547,1704690,46191
CHEMBL306043,P20309,GOLD SODIUM THIOMALATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323239,DTCC00225368,1188067,46191
CHEMBL306043,P20309,GOLD SODIUM THIOMALATE,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323240,DTCC00225368,1188067,46191
CHEMBL306462,P20309,,QXLHEORBUDQVTH-PKNBQFBNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12747793,KI,=,1500,NM,,,,,,,,,,,,,,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,,C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.,J. Med. Chem.,2003,46,11,"Kim MG, Bodor ET, Wang C, Harden TK, Kohn H",,138704,DTCT0023280,1092233,DTCC00224799,335442,17326
CHEMBL306903,P20309,,ARNGHJQKGZGVCU-APWZRJJASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,17,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1447199,DTCC00221569,323627,5621
CHEMBL30713,P20309,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23602445,KI,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human recombinant muscarinic M3 receptor expressed in CHO cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013,23,11,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,964945,DTCT0023280,12464706,DTCC01739501,1995571,54821
CHEMBL307145,P20309,PYROGALLOL,WQGWDDDVZFFDIG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7398725,DTCC00231461,1220280,46191
CHEMBL307145,P20309,PYROGALLOL,WQGWDDDVZFFDIG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7398726,DTCC00231461,1220280,46191
CHEMBL307554,P20309,,AMOUHXSQTRSDEO-UTKZUKDTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,290,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1480041,DTCC00221607,2065356,5621
CHEMBL307810,P20309,,YQGXZPSEAUHNIN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,0.97,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1697717,DTCC00224002,1934898,3918
CHEMBL3084393,P20309,,AMCQLHFZSJNRGF-ACDBMABISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,1498,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969373,DTCC01407366,1493511,44786
CHEMBL3084394,P20309,,SUUDZYHGMLHTBK-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,134,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969374,DTCC01407367,1105406,44786
CHEMBL3084395,P20309,,YTOAEGAXGGORPZ-SUNUQKROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969375,DTCC01407368,813701,44786
CHEMBL3084396,P20309,,ZWDDMBUPVUAOHG-QDMKHBRRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969376,DTCC01407369,1875746,44786
CHEMBL3084396,P20309,,ZWDDMBUPVUAOHG-QDMKHBRRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,2.51,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969431,DTCC01407369,1875746,44786
CHEMBL3084397,P20309,,QLCVMIAFQMBVPR-RRAHESAUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,135,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969377,DTCC01407370,1875747,44786
CHEMBL3084398,P20309,,GHTUHTCNLCSPKL-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969379,DTCC01407371,1396702,44786
CHEMBL3084398,P20309,,GHTUHTCNLCSPKL-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,5.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969433,DTCC01407371,1396702,44786
CHEMBL3084399,P20309,,IXFMEOWLUAJCKR-XQJPQCLXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969380,DTCC01407372,1493512,44786
CHEMBL3084399,P20309,,IXFMEOWLUAJCKR-XQJPQCLXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,5.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969434,DTCC01407372,1493512,44786
CHEMBL3084400,P20309,,RKZSCLBPKOKXIU-XLMMQIPYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969381,DTCC01407373,361701,44786
CHEMBL3084401,P20309,,AMIGVCGDCCHKBG-JVUUFTDCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,11,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969382,DTCC01407374,2006076,44786
CHEMBL3084401,P20309,,AMIGVCGDCCHKBG-JVUUFTDCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969435,DTCC01407374,2006076,44786
CHEMBL3084402,P20309,,GVPIZWSOAYBFHB-JVUUFTDCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,25,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969383,DTCC01407375,1040197,44786
CHEMBL3084403,P20309,,NHLDYZYLWRLASL-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969384,DTCC01407376,69571,44786
CHEMBL3084404,P20309,,VNQMCUQGJOXRFO-JVUUFTDCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,74,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969385,DTCC01407377,1908078,44786
CHEMBL3084405,P20309,,KNSVMWRWDZXNMX-XLMMQIPYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,65,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969386,DTCC01407378,1622802,44786
CHEMBL3084406,P20309,,YXAIOBQXJXRRIU-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,37,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969387,DTCC01407379,427001,44786
CHEMBL3084407,P20309,,NKDNDPJSRKHLTQ-MLEGESEGSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,112,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969388,DTCC01407380,1137676,44786
CHEMBL3084408,P20309,,JIPHIAYJBAKVDF-CBROWBKPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,290,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969389,DTCC01407381,1811337,44786
CHEMBL3084409,P20309,,SKVSWEQTIJTHFX-UXDPJVGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969411,DTCC01407382,555692,44786
CHEMBL3084409,P20309,,SKVSWEQTIJTHFX-UXDPJVGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,0.126,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969446,DTCC01407382,555692,44786
CHEMBL3084410,P20309,,VKVBLOMSVSKUIE-ZIGIEQIVSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969390,DTCC01407383,1428993,44786
CHEMBL3084410,P20309,,VKVBLOMSVSKUIE-ZIGIEQIVSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,2.51,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969436,DTCC01407383,1428993,44786
CHEMBL3084411,P20309,,FBNQFIVNCJFTPB-CBROWBKPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,17,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969391,DTCC01407384,1396737,44786
CHEMBL3084412,P20309,,DCLXBTYBEJHUKR-LOLVFPEOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,65,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969392,DTCC01407385,1590229,44786
CHEMBL3084413,P20309,,BWOXSKDDWQTJRH-ZIGIEQIVSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969393,DTCC01407386,263264,44786
CHEMBL3084413,P20309,,BWOXSKDDWQTJRH-ZIGIEQIVSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,0.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969437,DTCC01407386,263264,44786
CHEMBL3084413,P20309,,BWOXSKDDWQTJRH-ZIGIEQIVSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,1,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor in human bronchus assessed as potency against carbachol-induced contraction,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750517,DTCT0023280,5969452,DTCC01407386,263264,44786
CHEMBL3084413,P20309,,BWOXSKDDWQTJRH-ZIGIEQIVSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KI,=,0.45,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750516,DTCT0023280,5969451,DTCC01407386,263264,44786
CHEMBL3084413,P20309,,BWOXSKDDWQTJRH-ZIGIEQIVSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,TIME,=,59,MIN,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor in human bronchus assessed as reversal time for 50% of carbachol-induced contraction to return to maximum relaxation at 10 nM,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750518,DTCT0023280,5969453,DTCC01407386,263264,44786
CHEMBL3084414,P20309,,XQQJNQGIQPUNDW-XQJPQCLXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969394,DTCC01407387,749410,44786
CHEMBL3084414,P20309,,XQQJNQGIQPUNDW-XQJPQCLXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,0.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969438,DTCC01407387,749410,44786
CHEMBL3084415,P20309,,VTEBGQVQOOCNPJ-RNNWOUSISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969395,DTCC01407388,1908098,44786
CHEMBL3084415,P20309,,VTEBGQVQOOCNPJ-RNNWOUSISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969439,DTCC01407388,1908098,44786
CHEMBL3084416,P20309,,MVZOBVHMXSHKRY-JCNHLJMTSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,23,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969396,DTCC01407389,1590230,44786
CHEMBL3084417,P20309,,OQWSNRLETNFLOU-ABHLOGGPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969397,DTCC01407390,1493547,44786
CHEMBL3084417,P20309,,OQWSNRLETNFLOU-ABHLOGGPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,1.58,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969440,DTCC01407390,1493547,44786
CHEMBL3084418,P20309,,UKFNTLFRHBJXNS-ANGAXHOCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969398,DTCC01407391,2038801,44786
CHEMBL3084418,P20309,,UKFNTLFRHBJXNS-ANGAXHOCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969441,DTCC01407391,2038801,44786
CHEMBL3084419,P20309,,VCNVEWKKXRXISC-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969405,DTCC01407392,684735,44786
CHEMBL3084419,P20309,,VCNVEWKKXRXISC-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,0.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969443,DTCC01407392,684735,44786
CHEMBL3084447,P20309,,PFCSPMLKJFWOCM-FVQHAEBGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,ACTIVITY,=,45,%,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor assessed as remaining activity measured as percentage of maximum response generated from 80% of saturating dose of ACh at 30 uM by calcium mobilization assay,,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815542,DTCT0023280,10458496,DTCC01407420,1767006,48012
CHEMBL3084447,P20309,,PFCSPMLKJFWOCM-FVQHAEBGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,IC50,>,10000,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor by calcium mobilization assay,,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815541,DTCT0023280,10458450,DTCC01407420,1767006,48012
CHEMBL3084449,P20309,,VZBIHFDPWCGOCN-QLPKVWCKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,EC50,,,,,,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor by calcium mobilization assay,Not Active,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815537,DTCT0023280,10456429,DTCC01407422,1961122,48012
CHEMBL3084449,P20309,,VZBIHFDPWCGOCN-QLPKVWCKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22507963,IC50,,,,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor by calcium mobilization assay,Not Active,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,2012,22,10,"Melancon BJ, Gogliotti RD, Tarr JC, Saleh SA, Chauder BA, Lebois EP, Cho HP, Utley TJ, Sheffler DJ, Bridges TM, Morrison RD, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Wood MR",,815541,DTCT0023280,10459160,DTCC01407422,1961122,48012
CHEMBL3084457,P20309,,OOJGLCRHZYMYKE-JUUNKEJTSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461688,DTCC01407430,834305,47954
CHEMBL3084457,P20309,,OOJGLCRHZYMYKE-JUUNKEJTSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.0501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461714,DTCC01407430,834305,47954
CHEMBL3084458,P20309,,HVCYVZFXLJNFAQ-XBLVWSOUSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461689,DTCC01407431,1767016,47954
CHEMBL3084458,P20309,,HVCYVZFXLJNFAQ-XBLVWSOUSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.0501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461715,DTCC01407431,1767016,47954
CHEMBL3084459,P20309,,XKRKFRNMCTYSTF-NYDKNSFHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461687,DTCC01407432,995653,47954
CHEMBL3084459,P20309,,XKRKFRNMCTYSTF-NYDKNSFHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.0501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461713,DTCC01407432,995653,47954
CHEMBL3084460,P20309,,PTQXFWGMBXUWMO-JUUNKEJTSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461690,DTCC01407433,382092,47954
CHEMBL3084460,P20309,,PTQXFWGMBXUWMO-JUUNKEJTSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.158,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461716,DTCC01407433,382092,47954
CHEMBL3084461,P20309,,SHVPEYKLIJETEN-XBLVWSOUSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461691,DTCC01407434,2090771,47954
CHEMBL3084461,P20309,,SHVPEYKLIJETEN-XBLVWSOUSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,1.26,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461717,DTCC01407434,2090771,47954
CHEMBL3084462,P20309,,XGXIQQSOZRTCPQ-XBLVWSOUSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461692,DTCC01407435,1125479,47954
CHEMBL3084462,P20309,,XGXIQQSOZRTCPQ-XBLVWSOUSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461718,DTCC01407435,1125479,47954
CHEMBL3084463,P20309,,QGTUWNJUVNJZJF-HPQGXRIXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461693,DTCC01407436,445652,47954
CHEMBL3084463,P20309,,QGTUWNJUVNJZJF-HPQGXRIXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.158,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461719,DTCC01407436,445652,47954
CHEMBL3084464,P20309,,XLYWGZFAXXMCIH-LCQKPEITSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,=,89.6,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461694,DTCC01407437,349526,47954
CHEMBL3084465,P20309,,GEVMIHRCJZWWAG-LCQKPEITSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,=,318,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461695,DTCC01407438,445653,47954
CHEMBL3084466,P20309,,JMIBSCMZPWSCFJ-PQVZWLMISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,=,109,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461696,DTCC01407439,834307,47954
CHEMBL3084467,P20309,,RUFDCRHFGITFQH-DLTGYTIASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,=,85.2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461697,DTCC01407440,931148,47954
CHEMBL3084468,P20309,,POAPXOLGFOVXQS-NLUMPWKBSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461698,DTCC01407441,963491,47954
CHEMBL3084468,P20309,,POAPXOLGFOVXQS-NLUMPWKBSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,KD,=,0.631,NM,,cell_based,,,,,,,,,,,CHO,Antagonist potency at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis relative to control,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815844,DTCT0023280,10461720,DTCC01407441,963491,47954
CHEMBL3084469,P20309,,FEBODYDOLOXAGQ-GIVLHMTPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22460029,IC50,=,64,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium mobilization by FLIPR analysis,,"Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists.",Bioorg. Med. Chem. Lett.,2012,22,9,"Lainé DI, Yan H, Xie H, Davis RS, Dufour J, Widdowson KL, Palovich MR, Wan Z, Foley JJ, Schmidt DB, Hunsberger GE, Burman M, Bacon AM, Webb EF, Luttmann MA, Salmon M, Sarau HM, Umbrecht ST, Landis PS, Peck BJ, Busch-Petersen J",,815843,DTCT0023280,10461699,DTCC01407442,672883,47954
CHEMBL3084638,P20309,,XVTZQTLXSLKPCP-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903773,DTCC01407614,1621534,35251
CHEMBL3084638,P20309,,XVTZQTLXSLKPCP-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,=,6399,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903677,DTCC01407614,1621534,35251
CHEMBL3084639,P20309,,PILDZUGYLLHLSW-KNLYZUQLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903767,DTCC01407615,683523,35251
CHEMBL3084639,P20309,,PILDZUGYLLHLSW-KNLYZUQLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,=,206,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903683,DTCC01407615,683523,35251
CHEMBL3084639,P20309,,PILDZUGYLLHLSW-KNLYZUQLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,206,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969406,DTCC01407615,684736,44786
CHEMBL3084643,P20309,,SOXXQXVGPUWVOY-XITXYIRHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903763,DTCC01407619,586596,35251
CHEMBL3084643,P20309,,SOXXQXVGPUWVOY-XITXYIRHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903687,DTCC01407619,586596,35251
CHEMBL3084643,P20309,,SOXXQXVGPUWVOY-XITXYIRHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KD,=,3.16,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by measuring ratio of acetylcholine EC50 in presence and absence of compound by FLIPR assay,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581783,DTCT0023280,2903723,DTCC01407619,586596,35251
CHEMBL3084643,P20309,,SOXXQXVGPUWVOY-XITXYIRHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KI,=,2.51,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581785,DTCT0023280,2903705,DTCC01407619,586596,35251
CHEMBL3084643,P20309,,SOXXQXVGPUWVOY-XITXYIRHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969412,DTCC01407619,587825,44786
CHEMBL3084643,P20309,,SOXXQXVGPUWVOY-XITXYIRHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,3.98,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969448,DTCC01407619,587825,44786
CHEMBL3084650,P20309,,IECFFSCULPEXHT-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903775,DTCC01407626,229667,35251
CHEMBL3084650,P20309,,IECFFSCULPEXHT-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903675,DTCC01407626,229667,35251
CHEMBL3084650,P20309,,IECFFSCULPEXHT-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KD,=,0.0631,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by measuring ratio of acetylcholine EC50 in presence and absence of compound by FLIPR assay,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581783,DTCT0023280,2903720,DTCC01407626,229667,35251
CHEMBL3084650,P20309,,IECFFSCULPEXHT-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KI,=,0.158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581785,DTCT0023280,2903702,DTCC01407626,229667,35251
CHEMBL3084650,P20309,,IECFFSCULPEXHT-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969399,DTCC01407626,230919,44786
CHEMBL3084650,P20309,,IECFFSCULPEXHT-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,0.316,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969442,DTCC01407626,230919,44786
CHEMBL3084658,P20309,,NULNJXKOSLKYAG-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903776,DTCC01407634,1200023,35251
CHEMBL3084658,P20309,,NULNJXKOSLKYAG-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903674,DTCC01407634,1200023,35251
CHEMBL3084658,P20309,,NULNJXKOSLKYAG-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KD,=,0.501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by measuring ratio of acetylcholine EC50 in presence and absence of compound by FLIPR assay,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581783,DTCT0023280,2903719,DTCC01407634,1200023,35251
CHEMBL3084658,P20309,,NULNJXKOSLKYAG-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KI,=,3.16,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581785,DTCT0023280,2903701,DTCC01407634,1200023,35251
CHEMBL3084658,P20309,,NULNJXKOSLKYAG-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969378,DTCC01407634,1201143,44786
CHEMBL3084658,P20309,,NULNJXKOSLKYAG-UXDPJVGCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,0.501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969432,DTCC01407634,1201143,44786
CHEMBL3084662,P20309,,LAOBIJDCKIAALB-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903762,DTCC01407638,1636245,35251
CHEMBL3084662,P20309,,LAOBIJDCKIAALB-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903673,DTCC01407638,1636245,35251
CHEMBL3084662,P20309,,LAOBIJDCKIAALB-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KD,=,2.51,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by measuring ratio of acetylcholine EC50 in presence and absence of compound by FLIPR assay,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581783,DTCT0023280,2903718,DTCC01407638,1636245,35251
CHEMBL3084662,P20309,,LAOBIJDCKIAALB-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KI,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581785,DTCT0023280,2903700,DTCC01407638,1636245,35251
CHEMBL3084662,P20309,,LAOBIJDCKIAALB-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969371,DTCC01407638,1718523,44786
CHEMBL3084662,P20309,,LAOBIJDCKIAALB-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,973,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969372,DTCC01407638,1718524,44786
CHEMBL3084662,P20309,,LAOBIJDCKIAALB-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,2.51,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969430,DTCC01407638,1718523,44786
CHEMBL3084663,P20309,,XSIVUDDVVOILTG-LQLSTCSOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903771,DTCC01407639,1038951,35251
CHEMBL3084663,P20309,,XSIVUDDVVOILTG-LQLSTCSOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,=,1939,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903679,DTCC01407639,1038951,35251
CHEMBL3084663,P20309,,XSIVUDDVVOILTG-LQLSTCSOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,1939,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969401,DTCC01407639,1040241,44786
CHEMBL3084670,P20309,,NDHVOPDKZALZCQ-QYEXWFEISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903768,DTCC01407646,1265203,35251
CHEMBL3084670,P20309,,NDHVOPDKZALZCQ-QYEXWFEISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,=,2732,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903682,DTCC01407646,1265203,35251
CHEMBL3084670,P20309,,NDHVOPDKZALZCQ-QYEXWFEISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,2732,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969404,DTCC01407646,1266519,44786
CHEMBL3084674,P20309,,HNHGRDMXIHUIFC-LQLSTCSOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903770,DTCC01407650,1745766,35251
CHEMBL3084674,P20309,,HNHGRDMXIHUIFC-LQLSTCSOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,=,2895,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903680,DTCC01407650,1745766,35251
CHEMBL3084674,P20309,,HNHGRDMXIHUIFC-LQLSTCSOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,2895,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969402,DTCC01407650,1747023,44786
CHEMBL3084678,P20309,,NYBGTVSENFSZOR-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903766,DTCC01407654,360428,35251
CHEMBL3084678,P20309,,NYBGTVSENFSZOR-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,=,687,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903684,DTCC01407654,360428,35251
CHEMBL3084678,P20309,,NYBGTVSENFSZOR-ZHPFXUNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,=,687,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969407,DTCC01407654,361732,44786
CHEMBL3084679,P20309,,CHLSHLSJSIBNQZ-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as effect on calcium mobilization by FLIPR,Not Active,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581798,DTCT0023280,2903764,DTCC01407655,1297730,35251
CHEMBL3084679,P20309,,CHLSHLSJSIBNQZ-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581789,DTCT0023280,2903686,DTCC01407655,1297730,35251
CHEMBL3084679,P20309,,CHLSHLSJSIBNQZ-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KD,=,3.98,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by measuring ratio of acetylcholine EC50 in presence and absence of compound by FLIPR assay,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581783,DTCT0023280,2903722,DTCC01407655,1297730,35251
CHEMBL3084679,P20309,,CHLSHLSJSIBNQZ-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19616944,KI,=,2.51,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,,"Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.",Bioorg. Med. Chem. Lett.,2009,19,16,"Wan Z, Laine DI, Yan H, Zhu C, Widdowson KL, Buckley PT, Burman M, Foley JJ, Sarau HM, Schmidt DB, Webb EF, Belmonte KE, Palovich M",,581785,DTCT0023280,2903704,DTCC01407655,1297730,35251
CHEMBL3084679,P20309,,CHLSHLSJSIBNQZ-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,IC50,<,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969408,DTCC01407655,1298974,44786
CHEMBL3084679,P20309,,CHLSHLSJSIBNQZ-FJPGZJACSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19630384,KD,=,3.98,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR,,"Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.",J. Med. Chem.,2009,52,16,"Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K",,750511,DTCT0023280,5969444,DTCC01407655,1298974,44786
CHEMBL3084803,P20309,ASTROMICIN,BIDUPMYXGFNAEJ-APGVDKLISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7260800,DTCC01407776,768473,46191
CHEMBL3084803,P20309,ASTROMICIN,BIDUPMYXGFNAEJ-APGVDKLISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7260801,DTCC01407776,768473,46191
CHEMBL3085058,P20309,,NCLBMDHPOPEBAH-XQJPQCLXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,4.6,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196875,DTCC01408031,1841299,23981
CHEMBL3085059,P20309,,CAQGYFCPPHIMEA-DIXMHULASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,2.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196946,DTCC01408032,1231022,23981
CHEMBL3085060,P20309,,FEKGKRQIFNAJIN-BWSPSPBFSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,2.8,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196945,DTCC01408033,1166330,23981
CHEMBL3085061,P20309,,LYBFOOAXDLUWHH-XQJPQCLXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,56.6,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196944,DTCC01408034,2003489,23981
CHEMBL3085062,P20309,,CXZMCRFYBOUINA-QAFRNLQFSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,154.4,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196943,DTCC01408035,811186,23981
CHEMBL3085063,P20309,,MGOZKLPZKLFEGH-XQJPQCLXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,342.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196942,DTCC01408036,1135083,23981
CHEMBL3085064,P20309,,MBYHADOWQSDZEF-RMRMZDFSSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,407.2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196941,DTCC01408037,1070146,23981
CHEMBL3085065,P20309,,ROIMAFYIRZIYQZ-QKYUOBHYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,713.9,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196940,DTCC01408038,746804,23981
CHEMBL3085066,P20309,,ONEZZACKTANODU-OUUFYCGQSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,971.7,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196939,DTCC01408039,1231023,23981
CHEMBL3085067,P20309,,ICHRMLKAANWUBU-XLMMQIPYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,21.2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196938,DTCC01408040,131537,23981
CHEMBL3085068,P20309,,WFYAISOAZNWVBA-BWSPSPBFSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,6.4,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196937,DTCC01408041,1263851,23981
CHEMBL3085069,P20309,,IPKYTDXSPOMMGW-XLMMQIPYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,16,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196936,DTCC01408042,8693,23981
CHEMBL3085070,P20309,,YUPCHOBIWKJCKG-BWSPSPBFSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,42.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196935,DTCC01408043,1426517,23981
CHEMBL3085071,P20309,,ZWMNOSGQCNJQHW-DIXMHULASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196934,DTCC01408044,1716100,23981
CHEMBL3085072,P20309,,NMIFIVWWEXIONJ-XLMMQIPYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196933,DTCC01408045,1716101,23981
CHEMBL3085073,P20309,,NGOBIYYWAZKXCP-KJEGMACNSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196932,DTCC01408046,1841300,23981
CHEMBL3085074,P20309,,JCONHUDEYZRIRK-XLMMQIPYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,11.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196931,DTCC01408047,1587628,23981
CHEMBL3085075,P20309,,SMWYZITYQGDZSF-QYESKELBSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,137.4,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196930,DTCC01408048,876510,23981
CHEMBL3085076,P20309,,BCHOSNDXBYSKLO-WKCHPHFGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,74.5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196929,DTCC01408049,1970860,23981
CHEMBL3085077,P20309,,VSHUCQXNUSYTML-BCDXTJNWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,20.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196928,DTCC01408050,195957,23981
CHEMBL3085078,P20309,,KQJQPAOCEGFVNJ-BWTSREIZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,27.5,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196927,DTCC01408051,164022,23981
CHEMBL3085079,P20309,,BURCDLIOLMBANF-WKCHPHFGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,720.7,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196926,DTCC01408052,1652499,23981
CHEMBL3085080,P20309,,CNDOHBNSSCZYEQ-XVAYZXCPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,776.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196925,DTCC01408053,1458487,23981
CHEMBL3085081,P20309,,VCHGIYMMLJTVHQ-AERCQKQUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,2310.7,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196924,DTCC01408054,1620264,23981
CHEMBL3085082,P20309,,YWQDIBGYTPAIFT-PMOLBWCYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,1143.6,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196923,DTCC01408055,8694,23981
CHEMBL3085083,P20309,,RESZDJROOFXNAI-ZBYYUNFXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,1161.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196922,DTCC01408056,66997,23981
CHEMBL3085084,P20309,,CCSZSHPNZBSEMO-VTYHHJSWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,2135.4,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196921,DTCC01408057,455448,23981
CHEMBL3085085,P20309,,FIYZCZVBIXLYNG-REPLKXPHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,261.6,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196920,DTCC01408058,1005335,23981
CHEMBL3085086,P20309,,REFOKOYWCWAHCW-BWTSREIZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,108,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196919,DTCC01408059,488823,23981
CHEMBL3085087,P20309,,RJSPORZIBKRWHU-REPLKXPHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,57.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196918,DTCC01408060,1684729,23981
CHEMBL3085088,P20309,,BGECMWFZHVFBGB-REPLKXPHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,428.3,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196917,DTCC01408061,617558,23981
CHEMBL3085089,P20309,,FMMKJMIJNXFPMS-BCDXTJNWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,22.9,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196916,DTCC01408062,1808821,23981
CHEMBL3085090,P20309,,HVRWHBXGKRCKSP-IZZQQSIFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,10.9,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196915,DTCC01408063,359065,23981
CHEMBL3085091,P20309,,NNUZSHSDIMQZLW-SCAQPMJSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,7.2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196914,DTCC01408064,1937596,23981
CHEMBL3085092,P20309,,FHNLUXLINNMPIP-DZFIZOCASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,109,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196913,DTCC01408065,1716102,23981
CHEMBL3085093,P20309,,XUDSWTHYTNINGG-RUYXUALKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17911022,IC50,=,136.9,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells by measuring calcium mobilization,,Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonists.,Bioorg. Med. Chem. Lett.,2007,17,22,"Lainé DI, Xie H, Buffet N, Foley JJ, Buckley P, Webb EF, Widdowson KL, Palovich MR, Belmonte KE",,450373,DTCT0023280,2196912,DTCC01408066,1970861,23981
CHEMBL3085495,P20309,BIPERIDEN,YSXKPIUOCJLQIE-FDGGOGDCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,5.95,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417727,DTCC01408450,1975104,54418
CHEMBL3085543,P20309,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,<,4,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1335661,DTCC01408495,1980972,15566
CHEMBL3085543,P20309,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.5,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1335662,DTCC01408495,1980972,15566
CHEMBL3085543,P20309,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1335667,DTCC01408495,1980972,15566
CHEMBL3085543,P20309,,BXTUHNWXQLWICJ-DIXMSKSGSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1335671,DTCC01408495,1980972,15566
CHEMBL308566,P20309,,JQPHWWSHVFGYHV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11055330,KI,=,3.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,,Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000,10,20,"Wang Y, Chackalamannil S, Hu Z, Clader JW, Greenlee W, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, McQuade R, Lachowicz JE",,138706,DTCT0023280,776546,DTCC00226775,1391723,3944
CHEMBL3087229,P20309,,ARCIZOABLFAJAS-OUZZWEIQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,<,0.0398,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940959,DTCC01409952,1235716,56408
CHEMBL3087230,P20309,,HNKRLZPRTHVMQJ-IDPZRHLESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.0501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940958,DTCC01409953,396523,56408
CHEMBL3087231,P20309,,QUAIUSNOIOELSW-XCCMJPSHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,<,0.0316,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940957,DTCC01409954,1074872,56408
CHEMBL3087231,P20309,,QUAIUSNOIOELSW-XCCMJPSHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,<,0.0316,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940978,DTCC01409954,1074872,56408
CHEMBL3087232,P20309,,PAEJPLSEKUTQNC-XCCMJPSHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940956,DTCC01409955,1592289,56408
CHEMBL3087233,P20309,,LVHKGMAYXOTDSE-AJXMQQCNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940955,DTCC01409956,1845676,56408
CHEMBL3087234,P20309,,LUOBQRVUQRDMPE-DZHMJCDGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940954,DTCC01409957,1975448,56408
CHEMBL3087235,P20309,,CWLNEZMBCLXHJX-BRFPSQFKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.0501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940953,DTCC01409958,103954,56408
CHEMBL3087236,P20309,,PQDTWVDWIUQDTF-MZXKRHHESA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940952,DTCC01409959,1813467,56408
CHEMBL3087237,P20309,,KHCXXQYHUVQGEE-DZHMJCDGSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940951,DTCC01409960,1009868,56408
CHEMBL3087238,P20309,,ZRHXKKPEYUNNBL-JBXYENHNSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.126,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940950,DTCC01409961,298579,56408
CHEMBL3087239,P20309,,JICFUBJEFYMWBQ-YMVPHMABSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,100,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940949,DTCC01409962,1235717,56408
CHEMBL3087240,P20309,,DLNIEWCUZWKGNF-RPVZNCQLSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,<,0.0631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940948,DTCC01409963,719171,56408
CHEMBL3087241,P20309,,BDNNTVNLAANSTK-HZCURFCSSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940947,DTCC01409964,168538,56408
CHEMBL3087242,P20309,,YRUXAAYJHYFZMZ-VONVOUFKSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940946,DTCC01409965,265470,56408
CHEMBL3087243,P20309,,FFUZDRCSLKCBGV-FWOSDDQRSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,7.94,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940945,DTCC01409966,1398886,56408
CHEMBL3087244,P20309,,YITBQWRJXLBMCT-FWOSDDQRSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.398,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940944,DTCC01409967,265471,56408
CHEMBL3087245,P20309,,OFFQLWSKACQMSD-RPVZNCQLSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,12.59,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940943,DTCC01409968,654702,56408
CHEMBL3087361,P20309,,OCLIXQDGMSAKMJ-HJODHZIISA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,10,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940942,DTCC01410085,1430931,56408
CHEMBL3087362,P20309,,UYYIYNBXGLEYLK-WITHESGTSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940941,DTCC01410086,1942497,56408
CHEMBL3087363,P20309,,UYYIYNBXGLEYLK-XLGWRGSPSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,31.62,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940940,DTCC01410087,1720460,56408
CHEMBL3087364,P20309,,GYLJMOYBAJNBSS-SLRLHWDHSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940939,DTCC01410088,168540,56408
CHEMBL3087365,P20309,,KJVFBVSHMIQWFW-SLRLHWDHSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,2.51,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940938,DTCC01410089,200289,56408
CHEMBL3087366,P20309,,BRPRLHZWCQJPSQ-NGKDMHNESA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940937,DTCC01410090,589896,56408
CHEMBL3087367,P20309,,IOSUSOFDGOYOFV-HHBNHXTQSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940936,DTCC01410091,1042355,56408
CHEMBL3087368,P20309,,ZQQBGKDGQXCFGG-HHBNHXTQSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940935,DTCC01410092,1042356,56408
CHEMBL3087369,P20309,,IQKHJOKQTJCWTF-HHBNHXTQSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,<,0.126,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940934,DTCC01410093,881136,56408
CHEMBL3087370,P20309,,NQGRLZYESHTPIU-ZITBFLLYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940933,DTCC01410094,1910111,56408
CHEMBL3087371,P20309,,ICGUPQUGQUQVJN-AKFGGTECSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940932,DTCC01410095,1495632,56408
CHEMBL3087372,P20309,,FPKBQCCSBQRMJY-ZITBFLLYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940931,DTCC01410096,654704,56408
CHEMBL3087373,P20309,,OWRPHWOPRIJNNK-AKFGGTECSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940930,DTCC01410097,945330,56408
CHEMBL3087374,P20309,,UEXOAAKEBXTLET-RLINZHSJSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,2.51,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940929,DTCC01410098,493368,56408
CHEMBL3087375,P20309,,NEUFSOXNVGTMNW-LFHVHZEISA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940928,DTCC01410099,1910112,56408
CHEMBL3087376,P20309,,CVEFEYIRGSTOIU-LMEDFRRQSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940927,DTCC01410100,1203185,56408
CHEMBL3087377,P20309,,VCQIKBRVJZPEMB-HBUOLCFLSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.398,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940926,DTCC01410101,1268642,56408
CHEMBL3087378,P20309,,FNMHYIRJZOVBNE-HBUOLCFLSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940925,DTCC01410102,1720461,56408
CHEMBL3087379,P20309,,BPQSEJGNTMGTEA-HBUOLCFLSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940924,DTCC01410103,168541,56408
CHEMBL3087945,P20309,,CBQOVSFJMFUMOJ-YXAHDSQTSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,2.51,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940923,DTCC01410674,331201,56408
CHEMBL3087946,P20309,,QHDJYQAOEYIFHE-GIVRZJQPSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940922,DTCC01410675,751437,56408
CHEMBL3087947,P20309,,HEQXYQJRXHSDHG-HBUOLCFLSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940921,DTCC01410676,525654,56408
CHEMBL3087948,P20309,,KITBYKJLSNGKPT-HBUOLCFLSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940920,DTCC01410677,298587,56408
CHEMBL3087949,P20309,,UMUGTQBISHLVAE-GIVRZJQPSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940919,DTCC01410678,1235722,56408
CHEMBL3087950,P20309,,QNSUTEZULRGESR-HSQDXKERSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940917,DTCC01410679,1592297,56408
CHEMBL3087951,P20309,,QVHVJRDRMAPDLZ-XNEHPLGMSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,6.31,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940916,DTCC01410680,1749032,56408
CHEMBL3087952,P20309,,RTDHONVBKUIQIL-NRFUFCHMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940915,DTCC01410681,429044,56408
CHEMBL3087953,P20309,,HSIJWKXHMVAASP-LAAOYOPBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940914,DTCC01410682,719180,56408
CHEMBL3087954,P20309,,XRHBTBUUJLJXQO-JUEZVXFGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940913,DTCC01410683,1009873,56408
CHEMBL3087955,P20309,,IUDARXCDKYQQGY-RZXUQNCUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.398,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940912,DTCC01410684,1813472,56408
CHEMBL3087956,P20309,,DYTKNOCAWNCBEV-BRFPSQFKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,25.12,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940911,DTCC01410685,1813473,56408
CHEMBL3087957,P20309,,BVVYJGOLLPPZJT-JUEZVXFGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.0794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940909,DTCC01410686,429045,56408
CHEMBL3087958,P20309,,YBUGOMSORKYASS-LAAOYOPBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.316,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940908,DTCC01410687,1170954,56408
CHEMBL3087959,P20309,,DVRRHBYHAIRKEY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.0316,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940974,DTCC01410688,1720468,56408
CHEMBL3087960,P20309,,YLLMZSCQYQANKC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.251,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940973,DTCC01410689,719181,56408
CHEMBL3087961,P20309,,VOWQGVADNCNFKU-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.0631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940972,DTCC01410690,848755,56408
CHEMBL3088075,P20309,,IIGOBGCDNPRZDU-INIZCTEOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.0794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940971,DTCC01410805,460260,56408
CHEMBL3088076,P20309,,LHTBYFHEOLPZFV-OZWAEMERSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,2.51,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940970,DTCC01410806,1170957,56408
CHEMBL3088077,P20309,,QCUDPWGDINBVDR-RXFKJLCSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,39.81,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940969,DTCC01410807,265479,56408
CHEMBL3088078,P20309,,LDEZNTSKWRFAHD-NRFUFCHMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,39.81,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940968,DTCC01410808,22125,56408
CHEMBL3088079,P20309,,VBESUWMOLJOGJN-JOMKWTIYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940967,DTCC01410809,2072686,56408
CHEMBL3088080,P20309,,RAJJUUJWYSNNFB-MUZWYTLNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.0794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940966,DTCC01410810,1527951,56408
CHEMBL3088081,P20309,,RBDXMLYCZKSKHX-OKBRVIPFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.0631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940965,DTCC01410811,2008271,56408
CHEMBL3088082,P20309,,NANQYNXGFGPELV-SHCORVSCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,<,0.0398,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940964,DTCC01410812,1720469,56408
CHEMBL3088083,P20309,,VDTLYHQPNZLFMJ-XCCMJPSHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,3.16,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940963,DTCC01410813,200293,56408
CHEMBL3088084,P20309,,ZQILZUIFOHLKHJ-JOMKWTIYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.158,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940962,DTCC01410814,815886,56408
CHEMBL3088085,P20309,,OMFYQFNPSPKZFA-KGBLJUBMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.126,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940961,DTCC01410815,881143,56408
CHEMBL3088086,P20309,,AKFPOKNYHMXDIT-ROTRRZJSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,=,0.0631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940960,DTCC01410816,1560007,56408
CHEMBL308924,P20309,,ONWKWAMFSRFAOY-WYMLVPIESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12747793,KI,=,37000,NM,,,,,,,,,,,,,,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,,C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.,J. Med. Chem.,2003,46,11,"Kim MG, Bodor ET, Wang C, Harden TK, Kohn H",,138704,DTCT0023280,1072789,DTCC00224414,2044967,17326
CHEMBL308924,P20309,,ONWKWAMFSRFAOY-WYMLVPIESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12747793,KI,>,100000,NM,,,,,,,,,,,,,,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,,C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.,J. Med. Chem.,2003,46,11,"Kim MG, Bodor ET, Wang C, Harden TK, Kohn H",,138704,DTCT0023280,1071672,DTCC00224414,2044966,17326
CHEMBL3091664,P20309,,KIZQHZCIECZBKQ-JNSIGTBNSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.0631,NM,,cell_based,,,,,,,,,,,,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,,,J. Med. Chem.,2013,56,21,,,1278645,DTCT0023280,12954554,DTCC01411274,739293,56523
CHEMBL3091665,P20309,,LTVBTHZVRPMPHS-JZHUCNJQSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.0501,NM,,cell_based,,,,,,,,,,,,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,,,J. Med. Chem.,2013,56,21,,,1278645,DTCT0023280,12954553,DTCC01411275,1768920,56523
CHEMBL3091666,P20309,,AJPXFRLXXJVSNX-JZHUCNJQSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1.58,NM,,cell_based,,,,,,,,,,,,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,,,J. Med. Chem.,2013,56,21,,,1278645,DTCT0023280,12954552,DTCC01411276,1930080,56523
CHEMBL3091667,P20309,,CXYRUNPLKGGUJF-ARFADGTLSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.158,NM,,cell_based,,,,,,,,,,,,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,,,J. Med. Chem.,2013,56,21,,,1278645,DTCT0023280,12954559,DTCC01411277,2092806,56523
CHEMBL3091668,P20309,,XDNVYVIYLBMMDL-QSPPWMIRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,2,NM,,cell_based,,,,,,,,,,,,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,,,J. Med. Chem.,2013,56,21,,,1278645,DTCT0023280,12954558,DTCC01411278,642771,56523
CHEMBL3091669,P20309,,BCPQEEOHCQIZRI-GPCXMOOGSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,5.01,NM,,cell_based,,,,,,,,,,,,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,,,J. Med. Chem.,2013,56,21,,,1278645,DTCT0023280,12954557,DTCC01411279,1865706,56523
CHEMBL3091670,P20309,,SZWUZKLDNSNZQH-JZHUCNJQSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.316,NM,,cell_based,,,,,,,,,,,,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,,,J. Med. Chem.,2013,56,21,,,1278645,DTCT0023280,12954555,DTCC01411280,417039,56523
CHEMBL3094311,P20309,,NHUZHVAPAIJQRS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24238903,INHIBITION,=,13.7,%,,,,,,,,,,,,,,Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279086,DTCT0023280,12962136,DTCC01413925,1127501,56656
CHEMBL3094312,P20309,,KKYAPAJUTFYVRD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24238903,INHIBITION,=,19.5,%,,,,,,,,,,,,,,Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279086,DTCT0023280,12962094,DTCC01413926,351566,56656
CHEMBL3094313,P20309,,XVKBXJCHXRLYAQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24238903,INHIBITION,=,-3.5,%,,,,,,,,,,,,,,Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279086,DTCT0023280,12962052,DTCC01413927,933254,56656
CHEMBL3094314,P20309,,NLGKYLSBSOGION-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24238903,INHIBITION,=,-6.5,%,,,,,,,,,,,,,,Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279086,DTCT0023280,12962010,DTCC01413928,901389,56656
CHEMBL3094316,P20309,,RSZFCDGHJLBYEB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24238903,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279086,DTCT0023280,12963238,DTCC01413930,1708845,56656
CHEMBL3094317,P20309,,VCEAPZBMHGKMHI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24238903,INHIBITION,=,12.7,%,,,,,,,,,,,,,,Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279086,DTCT0023280,12962305,DTCC01413931,1256448,56656
CHEMBL3094318,P20309,,CYPDLWIUOMSUJR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24238903,INHIBITION,=,-2.1,%,,,,,,,,,,,,,,Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279086,DTCT0023280,12962263,DTCC01413932,1737126,56656
CHEMBL3094319,P20309,,YYONFKYBFNEIKC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24238903,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279086,DTCT0023280,12962221,DTCC01413933,965453,56656
CHEMBL3094320,P20309,,UZVSKGBBGCJIRV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24238903,INHIBITION,=,11.9,%,,,,,,,,,,,,,,Inhibition of muscarinergic M3 receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013,21,24,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279086,DTCT0023280,12962178,DTCC01413934,1644990,56656
CHEMBL3099899,P20309,,VDWKDBPHAPPUBO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24215892,INHIBITION,=,-2,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM relative to control,,"Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs).",Bioorg. Med. Chem. Lett.,2013,23,24,"Mercer SP, Roecker AJ, Garson S, Reiss DR, Meacham Harrell C, Murphy KL, Bruno JG, Bednar RA, Lemaire W, Cui D, Cabalu TD, Tang C, Prueksaritanont T, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ",,1282922,DTCT0023280,12973602,DTCC01415896,1737150,56711
CHEMBL31,P20309,GATIFLOXACIN,XUBOMFCQGDBHNK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7320727,DTCC00133611,185553,46191
CHEMBL31,P20309,GATIFLOXACIN,XUBOMFCQGDBHNK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7320728,DTCC00133611,185553,46191
CHEMBL310016,P20309,,GDPJXHFICUEJBT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,100,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1438462,DTCC00244256,1564435,5053
CHEMBL310132,P20309,,PHXFLZQXEBYAEU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,2,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1410965,DTCC00244784,270035,5053
CHEMBL3104091,P20309,,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24365159,KI,=,3761,NM,,,,,,,,,,,,,,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283821,DTCT0023280,12984105,DTCC01417357,351604,56928
CHEMBL3104091,P20309,,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24365159,KI,=,3801.89,NM,,,,,,,,,,,,,,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283821,DTCT0023280,12984216,DTCC01417357,351604,56928
CHEMBL3104092,P20309,,RQBRUGMHSQYCNU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24365159,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283821,DTCT0023280,12984175,DTCC01417358,1030177,56928
CHEMBL3104093,P20309,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24365159,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014,24,2,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283821,DTCT0023280,12984134,DTCC01417359,577788,56928
CHEMBL3105208,P20309,,RDSYLVNSMMDBBS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24164599,IC50,>,30000,NM,,cell_based,,,,,,,,,,,,Negative allosteric modulation of human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization incubated for 150 secs prior to acetylcholine induction by Fluo-4 AM staining-based fluorescence assay,,"Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).",J. Med. Chem.,2013,56,22,"Gentry PR, Kokubo M, Bridges TM, Kett NR, Harp JM, Cho HP, Smith E, Chase P, Hodder PS, Niswender CM, Daniels JS, Conn PJ, Wood MR, Lindsley CW",,1284793,DTCT0023280,12988110,DTCC01418452,869198,56851
CHEMBL3105213,P20309,,GXBAKXRLQAPKEE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24164599,IC50,>,30000,NM,,cell_based,,,,,,,,,,,,Negative allosteric modulation of human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization incubated for 150 secs prior to acetylcholine induction by Fluo-4 AM staining-based fluorescence assay,,"Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).",J. Med. Chem.,2013,56,22,"Gentry PR, Kokubo M, Bridges TM, Kett NR, Harp JM, Cho HP, Smith E, Chase P, Hodder PS, Niswender CM, Daniels JS, Conn PJ, Wood MR, Lindsley CW",,1284793,DTCT0023280,12988109,DTCC01418458,1419209,56851
CHEMBL3105228,P20309,,GXBAKXRLQAPKEE-QHCPKHFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24164599,IC50,>,30000,NM,,cell_based,,,,,,,,,,,,Negative allosteric modulation of human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization incubated for 150 secs prior to acetylcholine induction by Fluo-4 AM staining-based fluorescence assay,,"Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).",J. Med. Chem.,2013,56,22,"Gentry PR, Kokubo M, Bridges TM, Kett NR, Harp JM, Cho HP, Smith E, Chase P, Hodder PS, Niswender CM, Daniels JS, Conn PJ, Wood MR, Lindsley CW",,1284793,DTCT0023280,12988108,DTCC01418473,1930163,56851
CHEMBL310555,P20309,OXYQUINOLINE,MCJGNVYPOGVAJF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7384585,DTCC00239255,1092347,46191
CHEMBL310555,P20309,OXYQUINOLINE,MCJGNVYPOGVAJF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7384586,DTCC00239255,1092347,46191
CHEMBL310558,P20309,,GSTSHGWHXRRCHO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,11400,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138710,DTCT0023280,596608,DTCC00243838,1132553,15779
CHEMBL310558,P20309,,GSTSHGWHXRRCHO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,596609,DTCC00243838,1132553,15779
CHEMBL310604,P20309,HOMOCYSTEINE,FFFHZYDWPBMWHY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14743994,DTCC00239847,2108578,69159
CHEMBL310852,P20309,,VHYUYQHTMPWAPK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,ACTIVITY,<,1,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138567,DTCT0023280,1108272,DTCC00231978,551951,10523
CHEMBL310852,P20309,,VHYUYQHTMPWAPK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2153827,AFFINITY,=,99,%,,cell_based,,,,,,,,,,,SK-N-SH,Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]NMS,,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,1990,33,2,"Bradbury BJ, Baumgold J, Jacobson KA",,138570,DTCT0023280,1108273,DTCC00231978,551951,10523
CHEMBL311350,P20309,PIROMIDIC ACID,RCIMBBZXSXFZBV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383111,DTCC00230394,1862718,46191
CHEMBL311350,P20309,PIROMIDIC ACID,RCIMBBZXSXFZBV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383112,DTCC00230394,1862718,46191
CHEMBL311469,P20309,2-ACETYLAMINOFLUORENE,CZIHNRWJTSTCEX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7298719,DTCC00242606,2025633,46191
CHEMBL311469,P20309,2-ACETYLAMINOFLUORENE,CZIHNRWJTSTCEX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7298720,DTCC00242606,2025633,46191
CHEMBL3115074,P20309,,FMJSLPJYTAKVLJ-CQVJSGDESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26091726,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM relative to control,,Discovery and characterization of a potent and selective EP4 receptor antagonist.,Bioorg. Med. Chem. Lett.,2015,25,16,"Schiffler MA, Chandrasekhar S, Fisher MJ, Harvey A, Kuklish SL, Wang XS, Warshawsky AM, York JS, Yu XP",,1508888,DTCT0023280,14498800,DTCC01423122,1336428,63221
CHEMBL311795,P20309,,HMBFXHIQISYDKM-RXVVDRJESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,15115380,KI,=,716,NM,,,,,,,,,,,,,,Antagonistic activity against muscarinic M3 receptor,,"Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.",J. Med. Chem.,2004,47,10,"Tagat JR, McCombie SW, Nazareno D, Labroli MA, Xiao Y, Steensma RW, Strizki JM, Baroudy BM, Cox K, Lachowicz J, Varty G, Watkins R",,138699,DTCT0023280,980067,DTCC00236802,1903029,17809
CHEMBL31184,P20309,BENZO[DEF]CHRYSENE,FMMWHPNWAFZXNH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7262775,DTCC00168186,866017,46191
CHEMBL31184,P20309,BENZO[DEF]CHRYSENE,FMMWHPNWAFZXNH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7262776,DTCC00168186,866017,46191
CHEMBL313493,P20309,METHANESULFONIC ACID METHYL ESTER,MBABOKRGFJTBAE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7415354,DTCC00245877,671790,46191
CHEMBL313493,P20309,METHANESULFONIC ACID METHYL ESTER,MBABOKRGFJTBAE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7415355,DTCC00245877,671790,46191
CHEMBL313738,P20309,,OALBGXZFCMPEGE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,3000,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138710,DTCT0023280,585074,DTCC00244028,452853,15779
CHEMBL313738,P20309,,OALBGXZFCMPEGE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,585075,DTCC00244028,452853,15779
CHEMBL313749,P20309,,OESVJCHGVUTKBW-BMRADRMJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,2,%,,cell_based,,,,,,,,,,,CHO,Inositol phosphate(PI) accumulation in CHO cells expressing Muscarinic acetylcholine receptor M3 as maximal response at 100 uM relative to carbachol,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138572,DTCT0023280,1634661,DTCC00244019,550571,14722
CHEMBL313865,P20309,,SYGSVYHTPYEUDG-QPEQYQDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,5,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,929090,DTCC00260603,401309,3355
CHEMBL313865,P20309,,SYGSVYHTPYEUDG-QPEQYQDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,39,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,929091,DTCC00260603,401309,3355
CHEMBL313918,P20309,,IVALIPSTPXYJMQ-OUKQBFOZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,14,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88024,DTCT0023280,763544,DTCC00244581,854609,316
CHEMBL313918,P20309,,IVALIPSTPXYJMQ-OUKQBFOZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,16400,NM,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity in SK-N-SH neuroblastoma cells expressing human muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88157,DTCT0023280,763545,DTCC00244581,854609,316
CHEMBL314420,P20309,,LBEPAYHAANAFQE-BMRADRMJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,10,%,,cell_based,,,,,,,,,,,CHO,Inositol phosphate(PI) accumulation in CHO cells expressing Muscarinic acetylcholine receptor M3 as maximal response at 100 uM relative to carbachol,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138572,DTCT0023280,1605524,DTCC00244012,193518,14722
CHEMBL314493,P20309,,RZSWLEFBXTVYMU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,6700,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138710,DTCT0023280,616367,DTCC00244027,1649961,15779
CHEMBL314493,P20309,,RZSWLEFBXTVYMU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,616368,DTCC00244027,1649961,15779
CHEMBL314584,P20309,,NWPXNCVKZRAFRI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,INHIBITION,<,20,%,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from membrane preparation from CHO-K1 cells for Muscarinic acetylcholine receptor M3,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138588,DTCT0023280,1413570,DTCC00244219,76029,5053
CHEMBL314737,P20309,OXADIAZOLE,XARSDFQMNNNPBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,0.269,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88024,DTCT0023280,748246,DTCC00253050,337139,316
CHEMBL314737,P20309,OXADIAZOLE,XARSDFQMNNNPBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,104000,NM,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity in SK-N-SH neuroblastoma cells expressing human muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88157,DTCT0023280,748247,DTCC00253050,337139,316
CHEMBL314831,P20309,,KROLNNVAILXBJV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,1.58,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1405262,DTCC00244207,1014444,5053
CHEMBL315127,P20309,,BDFWFCFVBOIEON-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,794.33,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1426956,DTCC00243741,1046836,5053
CHEMBL315428,P20309,,BMBATQJOKULRPS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,450,NM,,cell_based,,,,,,,,,,,CHO,The binding affinity was measured as inhibition of binding of [3H]- quinuclidinyl benzilate to m3 Muscarinic acetylcholine receptor M3 in membranes of CHO cells,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138711,DTCT0023280,606019,DTCC00243629,1002894,15779
CHEMBL315428,P20309,,BMBATQJOKULRPS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,606020,DTCC00243629,1002894,15779
CHEMBL315676,P20309,,NBYBORGTFLJPJT-MDZDMXLPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,47,%,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M2 values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol.,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,139892,DTCT0023280,1615408,DTCC00244582,452869,14722
CHEMBL315676,P20309,,NBYBORGTFLJPJT-MDZDMXLPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,51,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88024,DTCT0023280,747052,DTCC00244582,466346,316
CHEMBL315676,P20309,,NBYBORGTFLJPJT-MDZDMXLPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,8400,NM,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity in SK-N-SH neuroblastoma cells expressing human muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88157,DTCT0023280,747053,DTCC00244582,466346,316
CHEMBL315891,P20309,,LITSQTSJSLZVPA-DHDCSXOGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,6,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,927884,DTCC00259930,1435506,3355
CHEMBL315891,P20309,,LITSQTSJSLZVPA-DHDCSXOGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,46,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,927885,DTCC00259930,1435506,3355
CHEMBL316084,P20309,,QBFFXFQVLLQBOQ-XNTDXEJSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,3,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,933790,DTCC00259927,2013037,3355
CHEMBL316084,P20309,,QBFFXFQVLLQBOQ-XNTDXEJSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,18,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,933791,DTCC00259927,2013037,3355
CHEMBL316329,P20309,,VUNFWSNZRZSOAP-KGENOOAVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,31,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,907963,DTCC00259814,1882545,3355
CHEMBL316329,P20309,,VUNFWSNZRZSOAP-KGENOOAVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,37,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,907964,DTCC00259814,1882545,3355
CHEMBL316561,P20309,PROGLUMIDE,DGMKFQYCZXERLX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379143,DTCC00259031,1383781,46191
CHEMBL316561,P20309,PROGLUMIDE,DGMKFQYCZXERLX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379144,DTCC00259031,1383781,46191
CHEMBL316780,P20309,,VLRULVISHOCDFV-ZROIWOOFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,1,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,929082,DTCC00260574,303275,3355
CHEMBL316780,P20309,,VLRULVISHOCDFV-ZROIWOOFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,19,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,929083,DTCC00260574,303275,3355
CHEMBL318440,P20309,,NTGDQLIFBAUKTF-SXGWCWSVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,1,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,912631,DTCC00260589,1947316,3355
CHEMBL318440,P20309,,NTGDQLIFBAUKTF-SXGWCWSVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,26,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,912632,DTCC00260589,1947316,3355
CHEMBL3186763,P20309,,DCAMTBFFNOHDAW-DYTRJAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25244572,INHIBITION,=,3,%,,,,,,,,,,,,,,Displacement of [3H]N-Methylscopolamine from human muscarinic M3 receptor at 10 uM,,"Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.",J. Med. Chem.,2014,57,20,"Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE",,1439035,DTCT0023280,14011968,DTCC01442275,2029987,59962
CHEMBL318746,P20309,,ZEQOYITXODHWOI-ZSOIEALJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,928016,DTCC00260573,982263,3355
CHEMBL318746,P20309,,ZEQOYITXODHWOI-ZSOIEALJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,928017,DTCC00260573,982263,3355
CHEMBL318995,P20309,,ZYBBUFPKZJQNLL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,338.84,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1602660,DTCC00274894,1468030,16818
CHEMBL319081,P20309,,MARULEJWKPYSRB-NDENLUEZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,,,,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM; ND=No data,Not Determined,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139787,DTCT0023280,905586,DTCC00259773,368517,3355
CHEMBL319081,P20309,,MARULEJWKPYSRB-NDENLUEZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,,,,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM; ND=No data,Not Determined,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139792,DTCT0023280,905585,DTCC00259773,368517,3355
CHEMBL319244,P20309,CAFFEIC ACID PHENETHYL ESTER,SWUARLUWKZWEBQ-VQHVLOKHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7261931,DTCC00274084,88625,46191
CHEMBL319244,P20309,CAFFEIC ACID PHENETHYL ESTER,SWUARLUWKZWEBQ-VQHVLOKHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7261932,DTCC00274084,88625,46191
CHEMBL320465,P20309,,JCJXWNVOVZEIHE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,70.79,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1601332,DTCC00274453,1597197,16818
CHEMBL3215298,P20309,ABAMECTIN,IBSREHMXUMOFBB-JFUDTMANSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286883,DTCC01462720,2025634,46191
CHEMBL3215298,P20309,ABAMECTIN,IBSREHMXUMOFBB-JFUDTMANSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286884,DTCC01462720,2025634,46191
CHEMBL3216322,P20309,,ZKJFRHZPOHGRIM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22370270,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM,,"Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS).",Bioorg. Med. Chem. Lett.,2012,22,7,"Annedi SC, Ramnauth J, Cossette M, Maddaford SP, Dove P, Rakhit S, Andrews JS, Porreca F",,812450,DTCT0023280,10433711,DTCC01463738,2006765,47737
CHEMBL3217984,P20309,,YVENIGOVHPMTDH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329745,DTCT0023280,13584611,DTCC01464882,1030631,39761
CHEMBL3219031,P20309,,MHCLZKGUUFRJCO-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.39,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579667,DTCC01465940,1657351,39463
CHEMBL3219032,P20309,,VVZDAMSHHUSQQC-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,2.2,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579668,DTCC01465941,1625177,39463
CHEMBL3219033,P20309,,XRUGWYOIFVUFLD-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,3.7,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579669,DTCC01465942,1431177,39463
CHEMBL3219034,P20309,,HJDXDXHHUVMBAQ-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,18,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579670,DTCC01465943,557971,39463
CHEMBL3219035,P20309,,YYNSODJGHSFYEU-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,26,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579671,DTCC01465944,1268879,39463
CHEMBL3219036,P20309,,NNDJFKAXZPUHPC-UMSFTDKQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,10,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579672,DTCC01465945,1235957,39463
CHEMBL3219037,P20309,,DCLLCRKTECSOJS-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,>,73,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579673,DTCC01465946,751669,39463
CHEMBL3219038,P20309,,SKTXVMKLBITPKW-UMSFTDKQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,22,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579674,DTCC01465947,1010139,39463
CHEMBL3219039,P20309,,YDYGDSDQUGVCTL-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,76,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579675,DTCC01465948,1625178,39463
CHEMBL3219040,P20309,,UKIZSSAMRMJVHP-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,5,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579676,DTCC01465949,136467,39463
CHEMBL3219041,P20309,,PBXXNFYJZUROSJ-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,8.3,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579677,DTCC01465950,1431178,39463
CHEMBL3219042,P20309,,NLEWMFKEAMXROY-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.73,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579678,DTCC01465951,1689328,39463
CHEMBL3219042,P20309,,NLEWMFKEAMXROY-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,TIME,=,117,MIN,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as time taken to reach 50% of total [3H]-NMS,,,MedChemComm,2011,2,9,,,1328779,DTCT0023280,13581932,DTCC01465951,1689328,39463
CHEMBL3219043,P20309,,OJVPMYOYQFRHSC-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,4.8,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579679,DTCC01465952,22706,39463
CHEMBL3219044,P20309,,QUPPZULLRXQLGP-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,2,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579680,DTCC01465953,687124,39463
CHEMBL3219045,P20309,,XKANEACQXQNDQP-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,38,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579681,DTCC01465954,557972,39463
CHEMBL3219046,P20309,,ICCARDNTCOUOPW-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1.1,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579682,DTCC01465955,1878203,39463
CHEMBL3219047,P20309,,OEMARKIPGSUZKA-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,4.4,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579683,DTCC01465956,298842,39463
CHEMBL3219048,P20309,,NKHXRZSJUJKIDV-UMSFTDKQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1.1,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579684,DTCC01465957,590146,39463
CHEMBL3219049,P20309,,QKMFQEAWWXOBAM-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,2,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579685,DTCC01465958,460506,39463
CHEMBL3219050,P20309,,LVPZMNAGJCNTKS-QNGWXLTQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,4.4,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579686,DTCC01465959,848980,39463
CHEMBL3219051,P20309,,MSAQGVKTRRVSDT-YJNPBZNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,9.2,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579687,DTCC01465960,2008498,39463
CHEMBL3219052,P20309,,GHEXUPCRJJWFHU-FNNIOBQYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,4.3,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579688,DTCC01465961,914139,39463
CHEMBL3219053,P20309,,NYJDYILKQVAKDD-XQICOKAMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1.3,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579689,DTCC01465962,1010140,39463
CHEMBL3219054,P20309,,YUFFZHVXHZKZLX-SCAWEBRLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,8.9,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579690,DTCC01465963,1334006,39463
CHEMBL3219055,P20309,,ZMONBPURLAYZLL-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,36,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579691,DTCC01465964,557973,39463
CHEMBL3219056,P20309,,OLQVXOXGEMTERL-QNGWXLTQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,3.1,NM,,,,,,,,,,,,,,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,,,MedChemComm,2011,2,9,,,1328771,DTCT0023280,13579692,DTCC01465965,557974,39463
CHEMBL324712,P20309,,IOCLVUYATNHDFO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,535.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1629238,DTCC00297024,982652,15558
CHEMBL324936,P20309,,GSKLYSJVJSIEEC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,299.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1636705,DTCC00297426,1014978,15558
CHEMBL325372,P20309,METHYLPARABEN,LXCFILQKKLGQFO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7432512,DTCC00280408,315667,46191
CHEMBL325372,P20309,METHYLPARABEN,LXCFILQKKLGQFO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7432513,DTCC00280408,315667,46191
CHEMBL326450,P20309,,XQLXDIIVOCDWBZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,151.36,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1620533,DTCC00274471,530296,16818
CHEMBL326450,P20309,,XQLXDIIVOCDWBZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,151,NM,,,,,,,,,,,,,,Binding affinity to human M3 muscarinic receptor,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936428,DTCT0023280,11761584,DTCC00274471,525078,53451
CHEMBL32749,P20309,FERULIC ACID,KSEBMYQBYZTDHS-HWKANZROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7311766,DTCC00171237,1544898,46191
CHEMBL32749,P20309,FERULIC ACID,KSEBMYQBYZTDHS-HWKANZROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7311767,DTCC00171237,1544898,46191
CHEMBL327664,P20309,,GPNLQCQDIKQSIH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,17000,NM,,,,,,,,,,,,,,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),,,Bioorg. Med. Chem. Lett.,1994,4,24,,,138254,DTCT0023280,827270,DTCC00261932,820514,1026
CHEMBL327827,P20309,,IBWKUSSSMFKEDB-CVKSISIWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,88,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,907971,DTCC00259835,1947315,3355
CHEMBL327827,P20309,,IBWKUSSSMFKEDB-CVKSISIWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,98,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,907972,DTCC00259835,1947315,3355
CHEMBL327978,P20309,,CJYCHJNLSAMLSW-NTEUORMPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,905578,DTCC00259281,1785680,3355
CHEMBL327978,P20309,,CJYCHJNLSAMLSW-NTEUORMPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,905579,DTCC00259281,1785680,3355
CHEMBL328250,P20309,ADINAZOLAM,GJSLOMWRLALDCT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14747550,DTCC00257326,2109445,68567
CHEMBL328565,P20309,,OXLWKCOVWCVMRM-WPWMEQJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,76,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,906772,DTCC00260122,530131,3355
CHEMBL328565,P20309,,OXLWKCOVWCVMRM-WPWMEQJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,98,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,906773,DTCC00260122,530131,3355
CHEMBL328753,P20309,,NTGDQLIFBAUKTF-CXUHLZMHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,9,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,932680,DTCC00259955,1693702,3355
CHEMBL328753,P20309,,NTGDQLIFBAUKTF-CXUHLZMHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,31,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,932681,DTCC00259955,1693702,3355
CHEMBL3287723,P20309,,AOYJKNKRKBOUAP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24735492,INHIBITION,=,8.3,%,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor at 10 uM by radioligand displacement assay,,Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence.,J. Med. Chem.,2014,57,10,"Dhanya RP, Sheffler DJ, Dahl R, Davis M, Lee PS, Yang L, Nickols HH, Cho HP, Smith LH, D'Souza MS, Conn PJ, Der-Avakian A, Markou A, Cosford ND",,1361678,DTCT0023280,13779784,DTCC01498697,200946,59335
CHEMBL3289390,P20309,,JRRNZNSGDSFFIR-FSRHSHDFSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24844758,KI,=,2.11,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3R expressed in CHOK1 cells after 2 hrs by scintillation counting analysis,,"Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities.",Bioorg. Med. Chem.,2014,22,13,"Yamashita Y, Tanaka K, Asano T, Yamakawa N, Kobayashi D, Ishihara T, Hanaya K, Shoji M, Sugai T, Wada M, Mashimo T, Fukunishi Y, Mizushima T",,1362504,DTCT0023280,13761437,DTCC01500381,622896,59448
CHEMBL3289391,P20309,,JRRNZNSGDSFFIR-FYZYNONXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24844758,KI,=,28,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3R expressed in CHOK1 cells after 2 hrs by scintillation counting analysis,,"Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities.",Bioorg. Med. Chem.,2014,22,13,"Yamashita Y, Tanaka K, Asano T, Yamakawa N, Kobayashi D, Ishihara T, Hanaya K, Shoji M, Sugai T, Wada M, Mashimo T, Fukunishi Y, Mizushima T",,1362504,DTCT0023280,13761438,DTCC01500382,331768,59448
CHEMBL3289440,P20309,,UVXUYONHJCGLGM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24852118,EMAX,=,7,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay relative to acetylcholine,,"Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M4 muscarinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2014,24,13,"Suwa A, Konishi Y, Uruno Y, Takai K, Nakako T, Sakai M, Enomoto T, Ochi Y, Matsuda H, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1362930,DTCT0023280,13766409,DTCC01500431,221634,59418
CHEMBL3289440,P20309,,UVXUYONHJCGLGM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,=,7,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 0.3 uM by calcium mobilization assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447388,DTCT0023280,13918284,DTCC01500431,221946,60676
CHEMBL3289441,P20309,,UNZMPFNJKZPQFT-LDLYASANSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24852118,EMAX,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay relative to acetylcholine,Not Determined,"Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M4 muscarinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2014,24,13,"Suwa A, Konishi Y, Uruno Y, Takai K, Nakako T, Sakai M, Enomoto T, Ochi Y, Matsuda H, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1362930,DTCT0023280,13766427,DTCC01500432,448509,59418
CHEMBL3289442,P20309,,CPSGCDLKARETBW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24852118,EMAX,=,4,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay relative to acetylcholine,,"Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M4 muscarinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2014,24,13,"Suwa A, Konishi Y, Uruno Y, Takai K, Nakako T, Sakai M, Enomoto T, Ochi Y, Matsuda H, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1362930,DTCT0023280,13766406,DTCC01500433,1548742,59418
CHEMBL3289443,P20309,,GFUMOPVVRFRDRF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24852118,EMAX,=,1,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay relative to acetylcholine,,"Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M4 muscarinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2014,24,13,"Suwa A, Konishi Y, Uruno Y, Takai K, Nakako T, Sakai M, Enomoto T, Ochi Y, Matsuda H, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1362930,DTCT0023280,13766395,DTCC01500434,2061510,59418
CHEMBL3289444,P20309,,GKQPPHRQSZDMNP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24852118,EMAX,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay relative to acetylcholine,Not Determined,"Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M4 muscarinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2014,24,13,"Suwa A, Konishi Y, Uruno Y, Takai K, Nakako T, Sakai M, Enomoto T, Ochi Y, Matsuda H, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1362930,DTCT0023280,13766428,DTCC01500435,189319,59418
CHEMBL3289445,P20309,,PXACJECGEGYJKT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24852118,EMAX,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic acetylcholine receptor M3 expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay relative to acetylcholine,Not Determined,"Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M4 muscarinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2014,24,13,"Suwa A, Konishi Y, Uruno Y, Takai K, Nakako T, Sakai M, Enomoto T, Ochi Y, Matsuda H, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1362930,DTCT0023280,13766429,DTCC01500436,998603,59418
CHEMBL3289656,P20309,,PQVQCEDGSJVHMK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24800940,INHIBITION,<,50,%,,,,,,,,,,,,,,Displacement of [3H]QNB from human muscarinic M3 receptor by PDSP assay,,Identification of a new selective dopamine D4 receptor ligand.,Bioorg. Med. Chem.,2014,22,12,"Sampson D, Zhu XY, Eyunni SV, Etukala JR, Ofori E, Bricker B, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1365254,DTCT0023280,13768376,DTCC01500650,643587,59363
CHEMBL3290012,P20309,,GXZWKZAOGQRNTL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24805037,INHIBITION,<,40,%,,cell_based,,,,,,,,,,,,Displacement of [3H]4-DAMP from human recombinant M3 receptor expressed in CHO cells at 1 uM,,Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia.,J. Med. Chem.,2014,57,11,"Kolaczkowski M, Marcinkowska M, Bucki A, Pawlowski M, Mitka K, Jaskowska J, Kowalski P, Kazek G, Siwek A, Wasik A, Wesolowska A, Mierzejewski P, Bienkowski P",,1361022,DTCT0023280,13779837,DTCC01501009,1128279,59370
CHEMBL3290012,P20309,,GXZWKZAOGQRNTL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24805037,KI,>,1000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]4-DAMP from human recombinant M3 receptor expressed in CHO cells,,Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia.,J. Med. Chem.,2014,57,11,"Kolaczkowski M, Marcinkowska M, Bucki A, Pawlowski M, Mitka K, Jaskowska J, Kowalski P, Kazek G, Siwek A, Wasik A, Wesolowska A, Mierzejewski P, Bienkowski P",,1361018,DTCT0023280,13777719,DTCC01501009,1128279,59370
CHEMBL329740,P20309,,GXHNERMILLSZQF-YBEGLDIGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,26,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,903090,DTCC00259861,1500189,3355
CHEMBL329740,P20309,,GXHNERMILLSZQF-YBEGLDIGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,35,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,903091,DTCC00259861,1500189,3355
CHEMBL329782,P20309,,CJYCHJNLSAMLSW-ZROIWOOFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,3,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,934958,DTCC00259242,1693701,3355
CHEMBL329782,P20309,,CJYCHJNLSAMLSW-ZROIWOOFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,14,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,934959,DTCC00259242,1693701,3355
CHEMBL329815,P20309,,OLMGQTCURTUFHE-LFYBBSHMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,931333,DTCC00259342,885688,3355
CHEMBL329815,P20309,,OLMGQTCURTUFHE-LFYBBSHMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,931334,DTCC00259342,885688,3355
CHEMBL33,P20309,LEVOFLOXACIN,GSDSWSVVBLHKDQ-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429491,DTCC00133684,51486,46191
CHEMBL33,P20309,LEVOFLOXACIN,GSDSWSVVBLHKDQ-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429492,DTCC00133684,51486,46191
CHEMBL330461,P20309,,VLRULVISHOCDFV-NTEUORMPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,933970,DTCC00260597,2045330,3355
CHEMBL330461,P20309,,VLRULVISHOCDFV-NTEUORMPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,933971,DTCC00260597,2045330,3355
CHEMBL330587,P20309,,PWWIFONZRLYSFR-SFQUDFHCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,5,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,905570,DTCC00260062,1079521,3355
CHEMBL330587,P20309,,PWWIFONZRLYSFR-SFQUDFHCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,41,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,905571,DTCC00260062,1079521,3355
CHEMBL330692,P20309,,OZAISDVKJFKNET-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,>>,200,NM,,,,,,,,,,,,,,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),,,Bioorg. Med. Chem. Lett.,1994,4,24,,,138254,DTCT0023280,817103,DTCC00262413,1597058,1026
CHEMBL330885,P20309,,UCJWUWKRHRSREA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,88401.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1638081,DTCC00297473,1338974,15558
CHEMBL330892,P20309,,FZCNLBNYMINNCB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1653.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1608732,DTCC00297575,950339,15558
CHEMBL3309715,P20309,,WEEMBFSDDKDUDM-SBSPUUFOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24980056,KI,>,100000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,,"Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.",Bioorg. Med. Chem. Lett.,2014,24,15,"Del Bello F, Bonifazi A, Quaglia W, Mazzolari A, Barocelli E, Bertoni S, Matucci R, Nesi M, Piergentili A, Vistoli G",,1459949,DTCT0023280,13906761,DTCC01509971,611162,60777
CHEMBL3309717,P20309,,NYVTVOQPSVCFEJ-VTLYIQCISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24980056,KI,>,100000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,,"Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.",Bioorg. Med. Chem. Lett.,2014,24,15,"Del Bello F, Bonifazi A, Quaglia W, Mazzolari A, Barocelli E, Bertoni S, Matucci R, Nesi M, Piergentili A, Vistoli G",,1459949,DTCT0023280,13906763,DTCC01509972,385162,60777
CHEMBL3309718,P20309,,IESOTRJGGBRBNI-DDWIOCJRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24980056,KI,=,26915.35,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,,"Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.",Bioorg. Med. Chem. Lett.,2014,24,15,"Del Bello F, Bonifazi A, Quaglia W, Mazzolari A, Barocelli E, Bertoni S, Matucci R, Nesi M, Piergentili A, Vistoli G",,1459949,DTCT0023280,13906708,DTCC01509973,254190,60777
CHEMBL330999,P20309,,IUTHPKSYSZCIOF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,109.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1626838,DTCC00296989,498440,15558
CHEMBL3310035,P20309,,RQPAEAIGXOANQF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to human M3 receptor expressed in CHO Flp-In cells at 10 uM after 90 mins by microbeta counting analysis,Not Active,,J. Nat. Prod.,2014,77,5,,,1450753,DTCT0023280,13892086,DTCC01510285,655458,57486
CHEMBL3310798,P20309,,PVFVHKCDVIMZNW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,=,5,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 1 uM by calcium mobilization assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447387,DTCT0023280,13918275,DTCC01511039,1355364,60676
CHEMBL3310799,P20309,,RKFIEBSNVSQAJU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,=,4,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 1 uM by calcium mobilization assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447387,DTCT0023280,13918276,DTCC01511040,59934,60676
CHEMBL3310800,P20309,,ZIXYMMYKROQVQH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,=,8,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 0.3 uM by calcium mobilization assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447388,DTCT0023280,13918281,DTCC01511041,221945,60676
CHEMBL3310801,P20309,,DZFBYVSNFOUWIN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,=,11,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 0.3 uM by calcium mobilization assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447388,DTCT0023280,13918282,DTCC01511042,837617,60676
CHEMBL3310802,P20309,,PLIHWCCORFZAAL-WLHGVMLRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,=,2,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 0.3 uM by calcium mobilization assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447388,DTCT0023280,13918283,DTCC01511043,385195,60676
CHEMBL3310802,P20309,,PLIHWCCORFZAAL-WLHGVMLRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,INTRINSIC ACTIVITY,=,2,%,,,,,,,,,,,,,,Intrinsic activity at muscarinic M3 receptor (unknown origin) at 10 uM by calcium mobilization assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447408,DTCT0023280,13918341,DTCC01511043,385195,60676
CHEMBL3310917,P20309,,LDEWEPZWOUBQKD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 1 uM by calcium mobilization assay,Not Determined,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447387,DTCT0023280,13918277,DTCC01511157,1322549,60676
CHEMBL3310918,P20309,,ZVUHRPULMOACBY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 1 uM by calcium mobilization assay,Not Determined,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447387,DTCT0023280,13918278,DTCC01511158,514583,60676
CHEMBL3310919,P20309,,YIJJQNGJKWINFX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 1 uM by calcium mobilization assay,Not Determined,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447387,DTCT0023280,13918279,DTCC01511159,1997069,60676
CHEMBL3310920,P20309,,VUMGDEDSFXYDRS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24856064,ACTIVITY,=,6,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor (unknown origin) at 1 uM by calcium mobilization assay,,"Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.",Bioorg. Med. Chem. Lett.,2014,24,14,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,1447387,DTCT0023280,13918280,DTCC01511160,1646101,60676
CHEMBL331516,P20309,,LKTAUFSNUPYSFQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,447.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1631663,DTCC00297180,1112626,15558
CHEMBL332181,P20309,,YDWKEYWSUIOOSA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,290,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1603892,DTCC00297330,562747,15558
CHEMBL332320,P20309,,DPSJSZQSAMCEEQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,399.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1630583,DTCC00297592,1371573,15558
CHEMBL332335,P20309,,DOLFVMZEABLGEI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1689.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1638088,DTCC00297432,1533002,15558
CHEMBL332405,P20309,,OCCJPNPQQHMSPY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,6712.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1639359,DTCC00297221,1079961,15558
CHEMBL332645,P20309,,RDNBKWZNJOENSF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,16753.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1615090,DTCC00107501,1208160,15558
CHEMBL3329755,P20309,,FJPQEOQGIZSLES-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25147929,%MAX,=,67,%,,cell_based,,,,,,,,,,,,Activity at human muscarinic acetylcholine receptor subtype 3 expressed in CHO cells by calcium mobilization assay acetylcholine,,"Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380).",J. Med. Chem.,2014,57,18,"Gentry PR, Kokubo M, Bridges TM, Noetzel MJ, Cho HP, Lamsal A, Smith E, Chase P, Hodder PS, Niswender CM, Daniels JS, Conn PJ, Lindsley CW, Wood MR",,1457836,DTCT0023280,13953757,DTCC01519788,24256,59741
CHEMBL3329755,P20309,,FJPQEOQGIZSLES-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25147929,EC50,=,2100,NM,,cell_based,,,,,,,,,,,,Activity at human muscarinic acetylcholine receptor subtype 3 expressed in CHO cells by calcium mobilization assay,,"Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380).",J. Med. Chem.,2014,57,18,"Gentry PR, Kokubo M, Bridges TM, Noetzel MJ, Cho HP, Lamsal A, Smith E, Chase P, Hodder PS, Niswender CM, Daniels JS, Conn PJ, Lindsley CW, Wood MR",,1457825,DTCT0023280,13953746,DTCC01519788,24256,59741
CHEMBL332980,P20309,,SKQHCGXQTHBODB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,40.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1601129,DTCC00297241,853791,15558
CHEMBL333065,P20309,,UKZDLIRTNLHAHI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1308,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1626831,DTCC00297380,982657,15558
CHEMBL333125,P20309,,SEKPGYNINLEQAT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1842,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1613772,DTCC00297516,1240958,15558
CHEMBL3334797,P20309,,KEGBICCDHKITSP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25164761,INHIBITION,=,20.6,%,,,,,,,,,,,,,,Displacement of [3H]4-DAMP from human muscarinic M3 receptor at 10 uM relative to control,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014,86,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1457898,DTCT0023280,13968443,DTCC01521941,1996944,59781
CHEMBL333940,P20309,,RNRYJWQFMOEPCM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,983,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1619024,DTCC00297262,1208161,15558
CHEMBL334093,P20309,,QZMPWNAACGQQPV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,2046.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1601124,DTCC00107404,108873,15558
CHEMBL334194,P20309,,OZCCPRJEWJXRBF-GUTACTQSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,3175.4,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1625411,DTCC00296935,1980663,15558
CHEMBL334245,P20309,,NNZFGQZAXFFBFY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,162.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1633069,DTCC00296828,336275,15558
CHEMBL334255,P20309,CETYLPYRIDINIUM BROMIDE,DVBJBNKEBPCGSY-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,34,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7338686,DTCC00294369,510299,46191
CHEMBL334255,P20309,CETYLPYRIDINIUM BROMIDE,DVBJBNKEBPCGSY-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,7.3,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7338687,DTCC00294369,510299,46191
CHEMBL3349343,P20309,,KEULHYWQKUQHOL-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,INHIBITION,=,0,%,,,,,,,,,,,,,,Compound was evaluated for its binding affinity at human muscarinic receptor Hm3 by the displacement of [3H]NMS radioligand using membranes from transfected chinese hamster ovarian cell at 1000 nM concentration,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139788,DTCT0023280,539698,DTCC01528544,658821,2697
CHEMBL3349343,P20309,,KEULHYWQKUQHOL-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,INHIBITION,=,0,%,,,,,,,,,,,,,,Compound was evaluated for its binding affinity at human muscarinic receptor Hm3 by the displacement of [3H]NMS radioligand using membranes from transfected chinese hamster ovarian cell at 100 nM concentration,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139789,DTCT0023280,539697,DTCC01528544,658821,2697
CHEMBL3350037,P20309,,DEQANNDTNATYII-JDBXKHNRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7386600,DTCC01529235,510306,46191
CHEMBL3350037,P20309,,DEQANNDTNATYII-JDBXKHNRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7386601,DTCC01529235,510306,46191
CHEMBL3350062,P20309,,FXAMBWMILDAFOW-RVBSWOSCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904165,DTCC01529260,66478,20440
CHEMBL3350063,P20309,,FXAMBWMILDAFOW-QARKVSRYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904090,DTCC01529261,908603,20440
CHEMBL3350064,P20309,,FXAMBWMILDAFOW-MRCNFZFLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904082,DTCC01529262,260099,20440
CHEMBL3351103,P20309,,FXAMBWMILDAFOW-SKNMHBRKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904091,DTCC01530295,940245,20440
CHEMBL3351104,P20309,,FXAMBWMILDAFOW-XHGVETGHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904089,DTCC01530296,908604,20440
CHEMBL3351105,P20309,,FXAMBWMILDAFOW-LWIGBJQBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,<,100000,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904081,DTCC01530297,1361240,20440
CHEMBL3354065,P20309,,PHMGZAICAOYEAF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,1202.26,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961031,DTCC01531487,1420053,60063
CHEMBL3354066,P20309,,QTQLWKLZSPZQTO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,93.33,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961032,DTCC01531488,1031110,60063
CHEMBL3354067,P20309,,JOMFXRAREZYSMG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,4.68,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961033,DTCC01531489,157521,60063
CHEMBL3354068,P20309,,WTRLYZUEDFZGKI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,0.794,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961034,DTCC01531490,546547,60063
CHEMBL3354069,P20309,,PFSPMYHTZUFJQW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,1.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961035,DTCC01531491,772332,60063
CHEMBL3354070,P20309,,SQVWTVHVWIHOSU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,10,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961036,DTCC01531492,966320,60063
CHEMBL3354071,P20309,,FNCJWKNHUAURLL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,44.67,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961037,DTCC01531493,1548834,60063
CHEMBL3354072,P20309,,FKIOAWWWCGUPIH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,11748.98,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961038,DTCC01531494,998709,60063
CHEMBL3354073,P20309,,QKTOQRPNKITPLN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,1905.46,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961039,DTCC01531495,125034,60063
CHEMBL3354074,P20309,,WOWRXMYCLGLRFQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,630.96,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961040,DTCC01531496,1548835,60063
CHEMBL3354075,P20309,,AWEBVNCNTLOVSN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,199.53,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961041,DTCC01531497,902296,60063
CHEMBL3354076,P20309,,GKFAOGATDDYRDQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,575.44,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961042,DTCC01531498,643681,60063
CHEMBL3354077,P20309,,ZOEYTLRCDGNMCU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,338.84,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13961043,DTCC01531499,1063350,60063
CHEMBL3354078,P20309,,LOOAMMHLLVGAEL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25275964,KI,=,57.54,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,,"Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1).",J. Med. Chem.,2014,57,21,"Bonifazi A, Yano H, Del Bello F, Farande A, Quaglia W, Petrelli R, Matucci R, Nesi M, Vistoli G, Ferré S, Piergentili A",,1438415,DTCT0023280,13965497,DTCC01531500,1516808,60063
CHEMBL335542,P20309,CDD-0273,NHUURXLCGOCXHZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,ACTIVITY,,,,,cell_based,,,,,,,,,,,A9,Ability to stimulate biochemical responses in cell lines expressing muscarinic A9 L receptor sub types; no significant change from basal levels,Not Active,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138566,DTCT0023280,822686,DTCC01743215,615923,17526
CHEMBL335542,P20309,CDD-0273,NHUURXLCGOCXHZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,KI,=,5.01,NM,,cell_based,,,,,,,,,,,A9,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138831,DTCT0023280,822684,DTCC01743215,615923,17526
CHEMBL335542,P20309,CDD-0273,NHUURXLCGOCXHZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells; Not calculable due to inconsistent dose response curves from assay to assay,Not Determined,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138826,DTCT0023280,822685,DTCC01743215,615923,17526
CHEMBL3359597,P20309,,NYVTVOQPSVCFEJ-OULXEKPRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24980056,KI,>,100000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,,"Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.",Bioorg. Med. Chem. Lett.,2014,24,15,"Del Bello F, Bonifazi A, Quaglia W, Mazzolari A, Barocelli E, Bertoni S, Matucci R, Nesi M, Piergentili A, Vistoli G",,1459949,DTCT0023280,13906762,DTCC01537052,482335,60777
CHEMBL336668,P20309,,KVYFZISXHXCPGM-ROJZRYHKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,<,3.9,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1361744,DTCC00322622,1436212,15566
CHEMBL336668,P20309,,KVYFZISXHXCPGM-ROJZRYHKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.2,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1361745,DTCC00322622,1436212,15566
CHEMBL336668,P20309,,KVYFZISXHXCPGM-ROJZRYHKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1361754,DTCC00322622,1436212,15566
CHEMBL336668,P20309,,KVYFZISXHXCPGM-ROJZRYHKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1361750,DTCC00322622,1436212,15566
CHEMBL338280,P20309,,RJTFLNTYBWZYMU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,4069.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1616316,DTCC00297593,1980662,15558
CHEMBL338790,P20309,,SSMIFVHARFVINF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7280909,DTCC00302791,1512803,46191
CHEMBL338790,P20309,,SSMIFVHARFVINF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7280910,DTCC00302791,1512803,46191
CHEMBL3401640,P20309,,UMNOHXLPNDJCMM-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,15,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057443,DTCC01545059,1658146,58648
CHEMBL3401641,P20309,,ZJSWMRJWTWJORH-ZDUSSCGKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,2.2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057444,DTCC01545060,201500,58648
CHEMBL3401642,P20309,,MDSAFGBQDVEKGD-ZDUSSCGKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,110,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057445,DTCC01545061,1879036,58648
CHEMBL3401643,P20309,,SWLGIXHESZQGPK-MAUKXSAKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,1.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057446,DTCC01545062,1782095,58648
CHEMBL3401644,P20309,,WOQRTLKHUAYKIA-SFVWDYPZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,738.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057448,DTCC01545063,1108554,58648
CHEMBL3401644,P20309,,WOQRTLKHUAYKIA-SFVWDYPZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,889.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057447,DTCC01545063,1108553,58648
CHEMBL3401645,P20309,,PSFULERNVNPNAD-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,18.7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057449,DTCC01545064,1529059,58648
CHEMBL3401646,P20309,,RRBQMQSYNDZVOX-KRWDZBQOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,37.3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057450,DTCC01545065,397693,58648
CHEMBL3401647,P20309,,GZYGHLOFWVNJOI-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,172.5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057451,DTCC01545066,590931,58648
CHEMBL3401648,P20309,,ZOQNBZKVHYFHGD-XPTDNKBGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,0.7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057454,DTCC01545067,558780,58648
CHEMBL3401649,P20309,,YZCFWWYSYVLNNC-DVWUEADGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,0.7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057455,DTCC01545068,1140879,58648
CHEMBL3401650,P20309,,QTQTVZHMXYTWLO-OUIHKFQYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,0.7,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057456,DTCC01545069,623387,58648
CHEMBL3401651,P20309,,HMMFYOXCKMHKFL-JXJWEVJGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057457,DTCC01545070,1269713,58648
CHEMBL3401652,P20309,,WVXIGPWCHZXWDZ-JXJWEVJGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,33.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057458,DTCC01545071,1334899,58648
CHEMBL3401653,P20309,,OLPZDLPPXQWQNY-STNBFCITSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,130.5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057459,DTCC01545072,24480,58648
CHEMBL3401654,P20309,,RYPRTVDFRFJHLK-XDVWKIBCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,0.8,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057460,DTCC01545073,914898,58648
CHEMBL3401655,P20309,,NIHSLQJBOAEDMA-ZJKFLMFHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,64.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057461,DTCC01545074,1204211,58648
CHEMBL3401656,P20309,,XAOYXWBMNWEHTO-ODDGICHGSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,60.2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057462,DTCC01545075,1140880,58648
CHEMBL3401657,P20309,,ZJSWMRJWTWJORH-CYBMUJFWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,1069.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057463,DTCC01545076,1658147,58648
CHEMBL3401658,P20309,,HMMFYOXCKMHKFL-PIJXPWFJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,599.3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057464,DTCC01545077,1496688,58648
CHEMBL3402918,P20309,,YBKAPRVMMLAXFH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,=,18.8,%,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060841,DTCC01546350,1322655,61603
CHEMBL3402919,P20309,,GXATUVHDTBQTHZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,=,9.5,%,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060842,DTCC01546351,1549132,61603
CHEMBL3402921,P20309,,IIHVKHDHKXEXOF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,=,56.6,%,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060843,DTCC01546353,804903,61603
CHEMBL3402923,P20309,,URBUMUJCBDKJGD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,=,40.5,%,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060844,DTCC01546355,1517101,61603
CHEMBL3402924,P20309,,XHVBOXISNREGDV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,Not Determined,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060845,DTCC01546356,1866970,61603
CHEMBL3402925,P20309,,RNEKDQXWBNJZMH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,Not Determined,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060846,DTCC01546357,934418,61603
CHEMBL3402926,P20309,,HUUJHPZPWHBODS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,Not Determined,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060847,DTCC01546358,2030101,61603
CHEMBL3402927,P20309,,CGALBEKELFKTQL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,Not Determined,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060848,DTCC01546359,1738306,61603
CHEMBL3402928,P20309,,ISUDWPNYNIWYQO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,Not Determined,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060849,DTCC01546360,1581339,61603
CHEMBL340561,P20309,,LUXQPLKVKOXPTP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,356.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1605255,DTCC00297022,594972,15558
CHEMBL340780,P20309,,SIBJNEXHOAROOS-HLRBRJAUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,220.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1624066,DTCC00297267,756343,15558
CHEMBL340804,P20309,,FRRZPZBBNJYGBE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11708906,REDUCTION,=,12,%,,cell_based,,,,,,,,,,,CHO-K1,Affinity for human M3 cloned muscarinic receptor subtype expressed in CHO-K1 cells at a concentration of 10 uM,,"Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activators.",J. Med. Chem.,2001,44,24,"Melchiorre C, Bolognesi ML, Budriesi R, Ghelardini C, Chiarini A, Minarini A, Rosini M, Tumiatti V, Wade EJ",,138718,DTCT0023280,1589465,DTCC00310023,1112787,16447
CHEMBL340978,P20309,BENOXAPROFEN,MITFXPHMIHQXPI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7278285,DTCC00314414,510297,46191
CHEMBL340978,P20309,BENOXAPROFEN,MITFXPHMIHQXPI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7278286,DTCC00314414,510297,46191
CHEMBL34139,P20309,GENACONAZOLE,HFGZFHCWKKQGIS-NOZJJQNGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7333596,DTCC00173585,1416030,46191
CHEMBL34139,P20309,GENACONAZOLE,HFGZFHCWKKQGIS-NOZJJQNGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7333597,DTCC00173585,1416030,46191
CHEMBL341447,P20309,,HGVRINLIZKXTQO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9435896,IC50,=,5400,NM,,,,,,,,,,,,,,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",,"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,1997,40,26,"Bromidge SM, Brown F, Cassidy F, Clark MS, Dabbs S, Hadley MS, Hawkins J, Loudon JM, Naylor CB, Orlek BS, Riley GJ",,138586,DTCT0023280,1332157,DTCC00317759,1241221,14467
CHEMBL34259,P20309,METHOTREXATE,FBOZXECLQNJBKD-ZDUSSCGKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7436622,DTCC00173293,1351113,46191
CHEMBL34259,P20309,METHOTREXATE,FBOZXECLQNJBKD-ZDUSSCGKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7436623,DTCC00173293,1351113,46191
CHEMBL342658,P20309,,FLQDEIOQMBKPDI-LBLAZRMVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.2,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1340352,DTCC00322597,1533299,15566
CHEMBL342658,P20309,,FLQDEIOQMBKPDI-LBLAZRMVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.2,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1340351,DTCC00322597,1533299,15566
CHEMBL342658,P20309,,FLQDEIOQMBKPDI-LBLAZRMVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1340361,DTCC00322597,1533299,15566
CHEMBL342658,P20309,,FLQDEIOQMBKPDI-LBLAZRMVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1340357,DTCC00322597,1533299,15566
CHEMBL3426687,P20309,,SBRNHWWXPRISTF-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.0794,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126143,DTCC01557256,2041972,62168
CHEMBL3426688,P20309,,LOCRWCHVWSBTGW-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.2,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126142,DTCC01557257,1335039,62168
CHEMBL3426689,P20309,,VOJOFEOZEAFAIH-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,1.58,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126141,DTCC01557258,1464270,62168
CHEMBL3426690,P20309,,NUZGHPRAJRDAHI-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.2,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126140,DTCC01557259,397815,62168
CHEMBL3426691,P20309,,AYCMGWISFMUMQW-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.158,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126139,DTCC01557260,1846753,62168
CHEMBL3426692,P20309,,IHTRAWRWVJOGMS-UMSFTDKQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.631,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126138,DTCC01557261,623493,62168
CHEMBL3426693,P20309,,GDJRFZAXEHZNNO-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.0501,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126136,DTCC01557262,201604,62168
CHEMBL3426694,P20309,,JCBCQBKLQMPNJD-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,1.26,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126135,DTCC01557263,849918,62168
CHEMBL3426695,P20309,,AXDVKUKWTWDJJY-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.501,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126134,DTCC01557264,784730,62168
CHEMBL3426696,P20309,,YRUGHJXUKGKYOZ-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.316,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126133,DTCC01557265,526760,62168
CHEMBL3426697,P20309,,FUIVIZCFQUCDAW-XIFFEERXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.1,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126131,DTCC01557266,1367612,62168
CHEMBL3426698,P20309,,REUZFCAPUWZSMB-MCILPLIISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.316,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126130,DTCC01557267,526761,62168
CHEMBL3426699,P20309,,MOHLSWKFSCMURH-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.631,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126127,DTCC01557268,201605,62168
CHEMBL3426700,P20309,,KCGNECXNOLZZEK-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,6.31,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126126,DTCC01557269,1626160,62168
CHEMBL3426701,P20309,,WTMCCDLGHBYXDM-QNGWXLTQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,3.16,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126125,DTCC01557270,2041973,62168
CHEMBL3426702,P20309,,AAWDKUPZMHITDM-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.794,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126124,DTCC01557271,430157,62168
CHEMBL3426703,P20309,,HRBOQLGXZJCUQY-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.316,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126123,DTCC01557272,1846754,62168
CHEMBL3426704,P20309,,GJTYLBHZSBMEKJ-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.631,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126122,DTCC01557273,1204322,62168
CHEMBL3426705,P20309,,VIJLXHRRASBMEY-QNGWXLTQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,0.2,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126121,DTCC01557274,201606,62168
CHEMBL3426706,P20309,,DUQNZGIGZOEZHH-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,1,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126120,DTCC01557275,817039,62168
CHEMBL3426707,P20309,,IDXPBXOVSGLIJZ-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,7.94,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126119,DTCC01557276,1302333,62168
CHEMBL3426708,P20309,,SDXOZIUOFTUROS-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25629394,KI,=,2,NM,,,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,,"Discovery of (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-Biphenyl]-2-ylcarbamate (TD-5959, GSK961081, Batefenterol): First-in-Class Dual Pharmacology Multivalent Muscarinic Antagonist and ß2 Agonist (MABA) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).",J. Med. Chem.,2015,58,6,"Hughes AD, Chen Y, Hegde SS, Jasper JR, Jaw-Tsai S, Lee TW, McNamara A, Pulido-Rios MT, Steinfeld T, Mammen M",,1477237,DTCT0023280,14126118,DTCC01557277,1846755,62168
CHEMBL342810,P20309,,CTCZKABHVPGYMK-VXIAURRFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,<,4,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1325341,DTCC00322463,692200,15566
CHEMBL342810,P20309,,CTCZKABHVPGYMK-VXIAURRFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.1,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1325342,DTCC00322463,692200,15566
CHEMBL342810,P20309,,CTCZKABHVPGYMK-VXIAURRFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,365113,DTCC00322463,692200,15566
CHEMBL342810,P20309,,CTCZKABHVPGYMK-VXIAURRFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1325289,DTCC00322463,692200,15566
CHEMBL343357,P20309,BRUCINE-N-OXIDE,HHHQMKWPZAYIAE-AWRJASDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,2.8,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1340368,DTCC01743361,854121,15566
CHEMBL343357,P20309,BRUCINE-N-OXIDE,HHHQMKWPZAYIAE-AWRJASDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,2.8,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1340367,DTCC01743361,854121,15566
CHEMBL343357,P20309,BRUCINE-N-OXIDE,HHHQMKWPZAYIAE-AWRJASDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1340375,DTCC01743361,854121,15566
CHEMBL343357,P20309,BRUCINE-N-OXIDE,HHHQMKWPZAYIAE-AWRJASDASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,>,2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1340380,DTCC01743361,854121,15566
CHEMBL343449,P20309,,GLAINAZGDXQPHT-NLFFAJNJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,7.8,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1381901,DTCC00334906,1080384,16058
CHEMBL343644,P20309,,MXMXMYWNGBMDEJ-HFMPRLQTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,19,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1373074,DTCC00335362,627907,16058
CHEMBL343659,P20309,,FFERIMSSXPDFOU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,11,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1365320,DTCC00334845,788960,16058
CHEMBL343796,P20309,N-BENZYL BRUCINE IODIDE,XFMQETLKDRNYRE-QIBSSCBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.8,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1344334,DTCC01743353,336608,15566
CHEMBL343796,P20309,N-BENZYL BRUCINE IODIDE,XFMQETLKDRNYRE-QIBSSCBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,>,4,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1344333,DTCC01743353,336608,15566
CHEMBL343796,P20309,N-BENZYL BRUCINE IODIDE,XFMQETLKDRNYRE-QIBSSCBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1344341,DTCC01743353,336608,15566
CHEMBL343796,P20309,N-BENZYL BRUCINE IODIDE,XFMQETLKDRNYRE-QIBSSCBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1344346,DTCC01743353,336608,15566
CHEMBL343951,P20309,N-2-METHYLNAPHTHYL STRYCHNINE IODIDE,XGFSECKOYNLTFU-AQHLSBRRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,<,5.8,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1355368,DTCC01743358,402054,15566
CHEMBL343951,P20309,N-2-METHYLNAPHTHYL STRYCHNINE IODIDE,XGFSECKOYNLTFU-AQHLSBRRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,6,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1355369,DTCC01743358,402054,15566
CHEMBL343951,P20309,N-2-METHYLNAPHTHYL STRYCHNINE IODIDE,XGFSECKOYNLTFU-AQHLSBRRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1355016,DTCC01743358,402054,15566
CHEMBL343951,P20309,N-2-METHYLNAPHTHYL STRYCHNINE IODIDE,XGFSECKOYNLTFU-AQHLSBRRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1355374,DTCC01743358,402054,15566
CHEMBL34431,P20309,CILOSTAMIDE,UIAYVIIHMORPSJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349748,DTCC00173669,1894963,46191
CHEMBL34431,P20309,CILOSTAMIDE,UIAYVIIHMORPSJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349749,DTCC00173669,1894963,46191
CHEMBL344487,P20309,N-4-METHYLBIPHENYL STRYCHNINE IODIDE,WAQFJNKEGRGXNP-RLYXXHHQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,5.6,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1325371,DTCC01743357,821196,15566
CHEMBL344487,P20309,N-4-METHYLBIPHENYL STRYCHNINE IODIDE,WAQFJNKEGRGXNP-RLYXXHHQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,5.7,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1325372,DTCC01743357,821196,15566
CHEMBL344487,P20309,N-4-METHYLBIPHENYL STRYCHNINE IODIDE,WAQFJNKEGRGXNP-RLYXXHHQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,<,0.2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1325381,DTCC01743357,821196,15566
CHEMBL344487,P20309,N-4-METHYLBIPHENYL STRYCHNINE IODIDE,WAQFJNKEGRGXNP-RLYXXHHQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1325377,DTCC01743357,821196,15566
CHEMBL344892,P20309,,LRXMLERJAJTUBK-DHZHZOJOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9435896,IC50,=,300,NM,,,,,,,,,,,,,,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",,"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,1997,40,26,"Bromidge SM, Brown F, Cassidy F, Clark MS, Dabbs S, Hadley MS, Hawkins J, Loudon JM, Naylor CB, Orlek BS, Riley GJ",,138586,DTCT0023280,1343236,DTCC00317459,31503,14467
CHEMBL344934,P20309,,HPYWWIDPSXNWLB-HWHTXHROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.6,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1339267,DTCC00322650,205815,15566
CHEMBL344934,P20309,,HPYWWIDPSXNWLB-HWHTXHROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.6,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1339266,DTCC00322650,205815,15566
CHEMBL344934,P20309,,HPYWWIDPSXNWLB-HWHTXHROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,<,0.2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1339276,DTCC00322650,205815,15566
CHEMBL344934,P20309,,HPYWWIDPSXNWLB-HWHTXHROSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1339272,DTCC00322650,205815,15566
CHEMBL345985,P20309,,VWOTVFVXQHGUGN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,270,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1385733,DTCC00334499,983072,16058
CHEMBL346178,P20309,OSANETANT,DZOJBGLFWINFBF-UMSFTDKQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25738882,INHIBITION,>=,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]4-DAMP from recombinant human muscarinic M3 receptor expressed in CHO cells at 1 uM after 60 mins by scintillation counting analysis relative to control,,Discovery and optimization of novel antagonists to the human neurokinin-3 receptor for the treatment of sex-hormone disorders (part I).,J. Med. Chem.,2015,58,7,"Hoveyda HR, Fraser GL, Roy MO, Dutheuil G, Batt F, El Bousmaqui M, Korac J, Lenoir F, Lapin A, Noël S, Blanc S",,1475784,DTCT0023280,14114153,DTCC00342636,1710181,62080
CHEMBL346194,P20309,,IASYIMACMPYPDM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,14,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1384543,DTCC00334417,402211,16058
CHEMBL35,P20309,FUROSEMIDE,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7322857,DTCC00133917,51472,46191
CHEMBL35,P20309,FUROSEMIDE,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7322858,DTCC00133917,51472,46191
CHEMBL35057,P20309,TIOSPIRONE,ZFZPJDFBJFHYIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,1290,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14747289,DTCC00174506,2109387,68417
CHEMBL352375,P20309,,HBRHULDGKNIFGB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,2238.72,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,996781,DTCC00366463,1981498,17703
CHEMBL352375,P20309,,HBRHULDGKNIFGB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,4073.8,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1007506,DTCC00366463,1981499,17703
CHEMBL352375,P20309,,HBRHULDGKNIFGB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,20892.96,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1000333,DTCC00366463,1981500,17703
CHEMBL352404,P20309,,LILGWEMIANQXTF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,3162.28,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,990387,DTCC00366971,628283,17703
CHEMBL352723,P20309,,SOZIYETWMOLCLB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,1047.13,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1006198,DTCC00366998,174304,17703
CHEMBL352779,P20309,,BOBFJOWTOWSGDG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,23988.33,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,997915,DTCC00367807,821712,17703
CHEMBL352908,P20309,,LIYNIIYRYCYRCY-CMDGGOBGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,19,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88023,DTCT0023280,738347,DTCC00364128,1948506,316
CHEMBL352908,P20309,,LIYNIIYRYCYRCY-CMDGGOBGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,8900,NM,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity in SK-N-SH neuroblastoma cells expressing human muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88157,DTCT0023280,738348,DTCC00364128,1948506,316
CHEMBL352966,P20309,,NGALRHXIDGBNKZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,2511.89,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,982422,DTCC00366603,1948537,17703
CHEMBL353140,P20309,,YGSXHXIKDSYAGK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,46.4,NM,,,,,,,,,,,,,,Tested in vitro for the binding affinity against muscarinic receptor subtype 3 (M3),,,Bioorg. Med. Chem. Lett.,1997,7,7,,,138255,DTCT0023280,1408563,DTCC00362154,1404779,2471
CHEMBL353290,P20309,,FTTBANDCEOHFPG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,263.03,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1002713,DTCC00366609,1048230,17703
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,0.2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362677,DTCC01631599,1103267,26143
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.35,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2911772,DTCC01631599,1115565,35090
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,KI,=,0.14,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581966,DTCT0023280,2910998,DTCC01631599,1115565,35090
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,0.0501,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605544,DTCC01631599,1116814,42029
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21310610,KI,=,0.034,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,,Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.,Bioorg. Med. Chem. Lett.,2011,21,5,"Hughes AD, Chin KH, Dunham SL, Jasper JR, King KE, Lee TW, Mammen M, Martin J, Steinfeld T",,726947,DTCT0023280,5147838,DTCC01631599,1105189,34812
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.0098,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776524,DTCT0023280,7504739,DTCC01631599,1124489,46208
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.051,NM,,cell_based,,,,,,,,,,,CHO-K1,Antagonist activity at human recombinant M3 receptor expressed in CHO-K1 cells assessed as inhibition of carbamoyl choline-induced calcium currents after 4 hrs by fluorimetry,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776520,DTCT0023280,7504632,DTCC01631599,1124489,46208
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,KI,=,0.075,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776521,DTCT0023280,7504625,DTCC01631599,1124489,46208
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,PKB,=,10.2,,,,,,,,,,,,,,,Antagonist activity at M3 receptor in human bronchial ring assessed as inhibition of electrically field-stimulated contractile response after 4 hrs,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776581,DTCT0023280,7504763,DTCC01631599,1124489,46208
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,=,9.45,HR,,,,,,,,,,,,,,Displacement of radioligand from M3 receptor assessed as dissociation half life,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776591,DTCT0023280,7504792,DTCC01631599,1124489,46208
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,22.83,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 24 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776525,DTCT0023280,7504745,DTCC01631599,1124489,46208
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21870878,T1/2,>,24,HR,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells assessed as dissociation half life at 100 fold human M1 receptor binding Ki concentration after 2 hrs by dilution-offset filter binding assay,,Inhalation by design: novel tertiary amine muscarinic m(3) receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.,J. Med. Chem.,2011,54,19,"Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ",,776523,DTCT0023280,7504611,DTCC01631599,1124489,46208
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0501,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542765,DTCC01631599,1124572,46625
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,<,0.0501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940977,DTCC01631599,1107515,56408
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25800115,IC50,=,0.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.,Bioorg. Med. Chem. Lett.,2015,25,8,"Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M",,1465998,DTCT0023280,14057452,DTCC01631599,1108555,58648
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.01,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human M3 receptor expressed in CHO cells assessed as inhibition of carbachol-induced response after 30 mins by AP-1-driven luciferase reporter gene assay,,,J. Med. Chem.,2013,56,21,,,1278646,DTCT0023280,12954560,DTCC01631599,1127473,56523
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.0158,NM,,cell_based,,,,,,,,,,,,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,,,J. Med. Chem.,2013,56,21,,,1278645,DTCT0023280,12954556,DTCC01631599,1127473,56523
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,RATIO,=,67,,,,,,,,,,,,,,,"Ratio of 7-(2,2-Dithiophen-2-ylacetoxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo-[3.3.1.0(2,4)]nonane, Bromide Koff to compound Koff for wild type human M3 receptor",,,J. Med. Chem.,2013,56,21,,,1278623,DTCT0023280,12954529,DTCC01631599,1127473,56523
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,RATIO KI,=,7.5,,,,,,,,,,,,,,,"Ratio of 7-(2,2-Dithiophen-2-ylacetoxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo-[3.3.1.0(2,4)]nonane, Bromide Ki to compound Ki for human M3 receptor",,,J. Med. Chem.,2013,56,21,,,1278624,DTCT0023280,12954531,DTCC01631599,1127473,56523
CHEMBL3545181,P20309,TIOTROPIUM BROMIDE,MQLXPRBEAHBZTK-SEINRUQRSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,T1/2,=,24.5,HR,,cell_based,,,,,,,,,,,,Binding affinity to wild type human M3 receptor expressed in HEK293T cells assessed as half life by radioligand displacement assay,,,J. Med. Chem.,2013,56,21,,,1278635,DTCT0023280,12954542,DTCC01631599,1127473,56523
CHEMBL354523,P20309,,DDXKWKGIBLVYQU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,281.84,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,981199,DTCC00366870,821714,17703
CHEMBL3545252,P20309,DOCETAXEL HYDRATE,XCDIRYDKECHIPE-QHEQPUDQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7364227,DTCC01631667,51465,46191
CHEMBL3545252,P20309,DOCETAXEL HYDRATE,XCDIRYDKECHIPE-QHEQPUDQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7364228,DTCC01631667,51465,46191
CHEMBL3545990,P20309,,QTBCATBNRIYMPB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2704370,KI,=,10,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14744818,DTCC01632324,2108837,68413
CHEMBL354678,P20309,,RCPNNLKDMRCWCD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,309.03,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,983686,DTCC00367066,595778,17703
CHEMBL354738,P20309,,YZYSRFCRVIIRAE-ZHACJKMWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,49,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88021,DTCT0023280,735720,DTCC00363907,595747,316
CHEMBL354738,P20309,,YZYSRFCRVIIRAE-ZHACJKMWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,8800,NM,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity in SK-N-SH neuroblastoma cells expressing human muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88157,DTCT0023280,735721,DTCC00363907,595747,316
CHEMBL354841,P20309,,SEVOIKJSSMTXNE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,501.19,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,989202,DTCC00366934,174302,17703
CHEMBL355392,P20309,,HCFXLIDWFGBUOO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,1778.28,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,985742,DTCC00366929,1883735,17703
CHEMBL355455,P20309,,RZZNAYPGBUQODF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,1905.46,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,990392,DTCC00366492,1436745,17703
CHEMBL355560,P20309,,JRAAJCZTZLYJSP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,8128.31,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,988169,DTCC00367052,32547,17703
CHEMBL355769,P20309,,KLYUNLYWGBECRC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,1819.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1002718,DTCC00366582,1241820,17703
CHEMBL355851,P20309,,ZFMAFQYIPBPWQJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,48977.88,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,991803,DTCC00367698,1819506,17703
CHEMBL355874,P20309,,CKABNURNABKRSF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,,Tested in vitro for the binding affinity against muscarinic receptor subtype 3 (M3); not active,Not Active,,Bioorg. Med. Chem. Lett.,1997,7,7,,,138256,DTCT0023280,1302079,DTCC00361742,531304,2471
CHEMBL3559671,P20309,POLYVINYL ALCOHOL,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396069,DTCC01642718,1155684,46191
CHEMBL3559671,P20309,POLYVINYL ALCOHOL,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396070,DTCC01642718,1155684,46191
CHEMBL356181,P20309,,MGYXHBLZZIWHEY-CLOONOSVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,6.1,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1377018,DTCC00334869,498857,16058
CHEMBL356305,P20309,,HEPQZYCRJHNVCR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,3.5,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1381908,DTCC00335094,77068,16058
CHEMBL356505,P20309,,ZVVYAPAWNNSOSQ-XXBNENTESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,3.2,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1404289,DTCC00334672,1851219,16058
CHEMBL3577955,P20309,,PWDBREUBRYUEGC-BTJKTKAUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human M3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496631,DTCT0023280,14434860,DTCC01646031,903869,62611
CHEMBL3577956,P20309,,ABJWJGMTLYSISP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human M3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496631,DTCT0023280,14434861,DTCC01646032,386606,62611
CHEMBL3577957,P20309,,MRTJHEDYFUFHHQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25893048,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human M3 receptor at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015,6,4,,,1496631,DTCT0023280,14434862,DTCC01646033,1550378,62611
CHEMBL357995,P20309,BOPINDOLOL,UUOJIACWOAYWEZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7280180,DTCC00343658,510298,46191
CHEMBL357995,P20309,BOPINDOLOL,UUOJIACWOAYWEZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7280181,DTCC00343658,510298,46191
CHEMBL358193,P20309,,DUJZVZNVMYQVAM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,3.6,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1373080,DTCC00334871,1565416,16058
CHEMBL358289,P20309,,ANXXZECPSLPAFT-GJZUVCINSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,28,NM,,cell_based,,,,,,,,,,,CHO,Ability to inhibit binding of [3H]NMS was determined by receptor binding assay using membranes from chinese hamster ovary (CHO) cells expressing cloned Muscarinic acetylcholine receptor M3,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,87678,DTCT0023280,1393146,DTCC00334951,173924,16058
CHEMBL358726,P20309,,NQWKKVJOEVKIHT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,2.3,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1386948,DTCC00335000,1080383,16058
CHEMBL3589977,P20309,,QGKLLEYCXJRYRS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25936259,INHIBITION,=,94,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in CHO cells at 1 uM by scintillation counting analysis,,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,2015,23,13,"Czopek A, Kolaczkowski M, Bucki A, Byrtus H, Pawlowski M, Kazek G, Bojarski AJ, Piaskowska A, Kalinowska-Tluscik J, Partyka A, Wesolowska A",,1503774,DTCT0023280,14462446,DTCC01650889,1323949,62925
CHEMBL3589978,P20309,,KCCOADNQWWNYBT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25936259,INHIBITION,=,101,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in CHO cells at 1 uM by scintillation counting analysis,,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,2015,23,13,"Czopek A, Kolaczkowski M, Bucki A, Byrtus H, Pawlowski M, Kazek G, Bojarski AJ, Piaskowska A, Kalinowska-Tluscik J, Partyka A, Wesolowska A",,1503774,DTCT0023280,14462447,DTCC01650890,1836321,62925
CHEMBL3590089,P20309,,BUVAGKGIBHOSMY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25936259,INHIBITION,=,99,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in CHO cells at 1 uM by scintillation counting analysis,,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,2015,23,13,"Czopek A, Kolaczkowski M, Bucki A, Byrtus H, Pawlowski M, Kazek G, Bojarski AJ, Piaskowska A, Kalinowska-Tluscik J, Partyka A, Wesolowska A",,1503774,DTCT0023280,14462448,DTCC01651002,1868305,62925
CHEMBL3590090,P20309,,KGSZZVYNXYDZEW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25936259,INHIBITION,=,102,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in CHO cells at 1 uM by scintillation counting analysis,,Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.,Bioorg. Med. Chem.,2015,23,13,"Czopek A, Kolaczkowski M, Bucki A, Byrtus H, Pawlowski M, Kazek G, Bojarski AJ, Piaskowska A, Kalinowska-Tluscik J, Partyka A, Wesolowska A",,1503774,DTCT0023280,14462449,DTCC01651003,1453458,62925
CHEMBL359197,P20309,,ODALTOXTLZKACI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,190,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1377014,DTCC00334903,595394,16058
CHEMBL359220,P20309,,SCFOSBYRXXJTEX-SSPYTLHUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,18,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1401821,DTCC00333928,2013938,16058
CHEMBL3608450,P20309,,XYYAWEJOUNEPTR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26227772,INHIBITION,<,50,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015,25,17,"Kapadia N, Harding WW",,1512563,DTCT0023280,14522438,DTCC01659060,2010933,63285
CHEMBL3613642,P20309,,KORKKQLDGMHNKO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26235950,INHIBITION,=,21,%,,,,,,,,,,,,,,Binding affinity to human M3 receptor assessed as inhibition of control specific binding at 10 uM,,Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.,Bioorg. Med. Chem. Lett.,2015,25,18,"Wei ZL, Nguyen MT, O'Mahony DJ, Acevedo A, Zipfel S, Zhang Q, Liu L, Dourado M, Chi C, Yip V, DeFalco J, Gustafson A, Emerling DE, Kelly MG, Kincaid J, Vincent F, Duncton MA",,1514548,DTCT0023280,14536071,DTCC01662099,495991,63547
CHEMBL3616497,P20309,,HIAHAOIBWTWJRB-CLJLJLNGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545921,DTCC01664542,301268,63681
CHEMBL3616498,P20309,,VUHFTOXCJSJPEQ-WIVNOQECSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545926,DTCC01662575,26607,63681
CHEMBL3616499,P20309,,YMTIKNJPMOZWQC-KKCBMOPLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545927,DTCC01662576,1045013,63681
CHEMBL3616500,P20309,,KZQKEAJBBOIGDO-PGBCRKCBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545928,DTCC01662577,366440,63681
CHEMBL3616501,P20309,,KOQVBYSCBCRVQJ-SVUXJTORSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545929,DTCC01662578,1433531,63681
CHEMBL3618436,P20309,,VWFBTZBIIDESPH-DHIUTWEWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545910,DTCC01664531,1751507,63681
CHEMBL3618437,P20309,,RKNPLGSRBQTSSW-KPIJYGRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545911,DTCC01664532,1912683,63681
CHEMBL3618438,P20309,,PAXUROWAARPBFL-NHCUHLMSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545912,DTCC01664533,1012594,63681
CHEMBL3618439,P20309,,JSPXZNQFXGPDQX-DNQXCXABSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545913,DTCC01664534,74188,63681
CHEMBL3618440,P20309,,JVWDGMMGXIGYDW-DNQXCXABSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545914,DTCC01664535,268176,63681
CHEMBL3618441,P20309,,DVPVARWCVVZQGR-JWQCQUIFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545915,DTCC01664536,1751508,63681
CHEMBL3618442,P20309,,NKFACVAYGRCZLM-ILBGXUMGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545916,DTCC01664537,1012595,63681
CHEMBL3618443,P20309,,FIKHVNSOWDWIAY-JWQCQUIFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545917,DTCC01664538,301267,63681
CHEMBL3618444,P20309,,PZZSDDQQIYYRHC-DNQXCXABSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545918,DTCC01664539,462964,63681
CHEMBL3618445,P20309,,PQFYMKJLSHXJPL-DNQXCXABSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545919,DTCC01664540,1369088,63681
CHEMBL3618446,P20309,,FHYBLIBOSNBUPM-JWQCQUIFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545920,DTCC01664541,1751509,63681
CHEMBL3618447,P20309,,JHELQKNAOZSOSK-APHAHKARSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545922,DTCC01664543,1880612,63681
CHEMBL3618448,P20309,,AMCZEBWTXNDLAJ-MKFQNBQCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545923,DTCC01664544,1336517,63681
CHEMBL3618449,P20309,,QONGGTDDWIPGAU-APHAHKARSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545924,DTCC01664545,203003,63681
CHEMBL3618450,P20309,,SDRAGSOFYIVJQO-APHAHKARSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,Not Active,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545925,DTCC01664546,496016,63681
CHEMBL3627739,P20309,,SFGNFMORMGLQMU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,=,1540,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577680,DTCC01669242,1291560,64068
CHEMBL3629353,P20309,,SHHHPTFIRLSTIA-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,0.73,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573388,DTCC01669058,625061,63971
CHEMBL3629353,P20309,,SHHHPTFIRLSTIA-DHUJRADRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,=,1.95,HR,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573398,DTCC01669058,625061,63971
CHEMBL3629354,P20309,,OLVBRIDMPHNYHK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,0.34,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573390,DTCC01669059,754065,63971
CHEMBL3629354,P20309,,OLVBRIDMPHNYHK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,,,,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,Not Determined,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573400,DTCC01669059,754065,63971
CHEMBL3629355,P20309,,BCZILQQCQBJKKH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,1.1,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573391,DTCC01669060,721780,63971
CHEMBL3629355,P20309,,BCZILQQCQBJKKH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,,,,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,Not Determined,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573401,DTCC01669060,721780,63971
CHEMBL3629356,P20309,,OZJWNVOXXCSPRM-QNGWXLTQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,3.7,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573392,DTCC01669061,1238525,63971
CHEMBL3629356,P20309,,OZJWNVOXXCSPRM-QNGWXLTQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,<,0.25,HR,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573402,DTCC01669061,1238525,63971
CHEMBL3629357,P20309,,HCEFKOKLPKFQMI-LHEWISCISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,18,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573393,DTCC01669062,431678,63971
CHEMBL3629357,P20309,,HCEFKOKLPKFQMI-LHEWISCISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,,,,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,Not Determined,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573403,DTCC01669062,431678,63971
CHEMBL3629358,P20309,,JIFRXMWKDXCKDK-ZGLUAFTOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,7.7,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573394,DTCC01669063,1465796,63971
CHEMBL3629358,P20309,,JIFRXMWKDXCKDK-ZGLUAFTOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,=,8.18,HR,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573404,DTCC01669063,1465796,63971
CHEMBL3629359,P20309,,JIFRXMWKDXCKDK-IOPIWRGFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,3.7,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573395,DTCC01669064,1816219,63971
CHEMBL3629359,P20309,,JIFRXMWKDXCKDK-IOPIWRGFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,=,4.63,HR,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573405,DTCC01669064,1816219,63971
CHEMBL3629360,P20309,,OLYUOAVKDLVFLJ-PIFUBOJPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,KI,=,0.29,NM,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522863,DTCT0023280,14573396,DTCC01669065,1594999,63971
CHEMBL3629360,P20309,,OLYUOAVKDLVFLJ-PIFUBOJPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26471092,T1/2,<,1.67,HR,,,,,,,,,,,,,,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor assessed as compound dissociation half life by dilution method,,Molecular hybridization yields triazole bronchodilators for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2015,25,22,"Jones LH, Burrows J, Feeder N, Glossop P, James K, Jones RM, Kenyon AS, Patel S, Roberts DF, Selby MD, Strang RS, Stuart EF, Trevethick MA, Watson J, Wright KN, Clarke N",,1522864,DTCT0023280,14573406,DTCC01669065,1594999,63971
CHEMBL3629529,P20309,,LREPVNCKBAPXFF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,=,5260,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577673,DTCC01669235,1486280,64068
CHEMBL3629530,P20309,,OPURXCGDAMNMQI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,=,640,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577674,DTCC01669236,1421875,64068
CHEMBL3629531,P20309,,WFVHJKOXFHWPIC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577675,DTCC01669237,1453632,64068
CHEMBL3629532,P20309,,YSGQXZGDFDFWGM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,=,3290,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577676,DTCC01669238,1615508,64068
CHEMBL3629533,P20309,,YXGVPWUJZGXZLR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,=,4600,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577677,DTCC01669239,483977,64068
CHEMBL3629534,P20309,,MOXAZUHAPUILEZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,=,370,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577678,DTCC01669240,62035,64068
CHEMBL3629535,P20309,,GXZBAYCWADAORP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,>,30000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577679,DTCC01669241,1098148,64068
CHEMBL3629536,P20309,,IIMVXAUGGZVGEA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,=,4030,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577681,DTCC01669243,612768,64068
CHEMBL3629537,P20309,,IHSFSTYDYRRQHL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,=,2300,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577683,DTCC01669244,2096166,64068
CHEMBL3629538,P20309,,CWMNPHKHIXRHRR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,>,10000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577684,DTCC01669245,1868457,64068
CHEMBL3629539,P20309,,LLZBHPGNKFIHAD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26494260,KI,=,3550,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,,Muscarinic acetylcholine receptor binding affinities of pethidine analogs.,Bioorg. Med. Chem. Lett.,2015,25,22,"Lee NR, Zhang X, Darna M, Dwoskin LP, Zheng G",,1523365,DTCT0023280,14577685,DTCC01669246,1356947,64068
CHEMBL3632960,P20309,,CSAFNZNYHXCHJR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26428869,ACTIVITY,=,7,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 acetylcholine receptor expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015,25,22,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525710,DTCT0023280,14591941,DTCC01669956,1615517,64203
CHEMBL3632961,P20309,,NHYLZNQBAJTZSS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26428869,ACTIVITY,=,21,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 acetylcholine receptor expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015,25,22,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525710,DTCT0023280,14591940,DTCC01669957,1966014,64203
CHEMBL3632962,P20309,,XOXRENMGMTUADK-GOSISDBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26428869,ACTIVITY,=,2,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 acetylcholine receptor expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015,25,22,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525710,DTCT0023280,14591939,DTCC01669958,1679836,64203
CHEMBL3632963,P20309,,XOXRENMGMTUADK-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26428869,ACTIVITY,=,3,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 acetylcholine receptor expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015,25,22,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525710,DTCT0023280,14591938,DTCC01669959,1226110,64203
CHEMBL3632964,P20309,,GQDQXNDPLXGENL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26428869,ACTIVITY,=,1,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 acetylcholine receptor expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015,25,22,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525710,DTCT0023280,14591937,DTCC01669960,548282,64203
CHEMBL3633184,P20309,,BUYVTPGEWYQFCF-RSPOEFSDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26428869,ACTIVITY,=,2,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 acetylcholine receptor expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015,25,22,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525710,DTCT0023280,14591936,DTCC01670182,839209,64203
CHEMBL3633184,P20309,,BUYVTPGEWYQFCF-RSPOEFSDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26428869,ACTIVITY,=,2,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 acetylcholine receptor expressed in CHO cells assessed as calcium mobilization at 30 uM by FLIPR assay,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015,25,22,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525731,DTCT0023280,14591903,DTCC01670182,839209,64203
CHEMBL3633185,P20309,,KTKOZTNYUYYWOX-XGWQRUHWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26428869,ACTIVITY,=,1,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 acetylcholine receptor expressed in CHO cells assessed as calcium mobilization at 0.3 uM by FLIPR assay,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015,25,22,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525710,DTCT0023280,14591935,DTCC01670183,1615521,64203
CHEMBL3633650,P20309,,FRUZIJBUVKTDFU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26516782,IC50,=,27500,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor expressed in HEK293 cells assessed as inhibition of carbachol-induced inositol monophosphate accumulation after 1 hr by FRET assay,,Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.,J. Med. Chem.,2015,58,22,"Johansson H, Boesgaard MW, Nørskov-Lauritsen L, Larsen I, Kuhne S, Gloriam DE, Bräuner-Osborne H, Sejer Pedersen D",,1526363,DTCT0023280,14599360,DTCC01670653,1077572,64305
CHEMBL3633650,P20309,,FRUZIJBUVKTDFU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26516782,IC50,=,27542.29,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor expressed in HEK293 cells assessed as inhibition of carbachol-induced inositol monophosphate accumulation after 1 hr by FRET assay,,Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.,J. Med. Chem.,2015,58,22,"Johansson H, Boesgaard MW, Nørskov-Lauritsen L, Larsen I, Kuhne S, Gloriam DE, Bräuner-Osborne H, Sejer Pedersen D",,1526363,DTCT0023280,14599356,DTCC01670653,1077572,64305
CHEMBL3633656,P20309,,LRHFIHBNRRLFSM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26516782,IC50,=,4170,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor expressed in HEK293 cells assessed as inhibition of carbachol-induced inositol monophosphate accumulation after 1 hr by FRET assay,,Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.,J. Med. Chem.,2015,58,22,"Johansson H, Boesgaard MW, Nørskov-Lauritsen L, Larsen I, Kuhne S, Gloriam DE, Bräuner-Osborne H, Sejer Pedersen D",,1526363,DTCT0023280,14599362,DTCC01670659,1562527,64305
CHEMBL3633656,P20309,,LRHFIHBNRRLFSM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26516782,IC50,=,57543.99,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor expressed in HEK293 cells assessed as inhibition of carbachol-induced inositol monophosphate accumulation after 1 hr by FRET assay,,Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.,J. Med. Chem.,2015,58,22,"Johansson H, Boesgaard MW, Nørskov-Lauritsen L, Larsen I, Kuhne S, Gloriam DE, Bräuner-Osborne H, Sejer Pedersen D",,1526363,DTCT0023280,14599357,DTCC01670659,1562527,64305
CHEMBL3633663,P20309,,FKKXSOZSQAQHFN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26516782,IC50,=,4168.69,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor expressed in HEK293 cells assessed as inhibition of carbachol-induced inositol monophosphate accumulation after 1 hr by FRET assay,,Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.,J. Med. Chem.,2015,58,22,"Johansson H, Boesgaard MW, Nørskov-Lauritsen L, Larsen I, Kuhne S, Gloriam DE, Bräuner-Osborne H, Sejer Pedersen D",,1526363,DTCT0023280,14599358,DTCC01670666,560399,64305
CHEMBL3633663,P20309,,FKKXSOZSQAQHFN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26516782,IC50,=,51300,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor expressed in HEK293 cells assessed as inhibition of carbachol-induced inositol monophosphate accumulation after 1 hr by FRET assay,,Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.,J. Med. Chem.,2015,58,22,"Johansson H, Boesgaard MW, Nørskov-Lauritsen L, Larsen I, Kuhne S, Gloriam DE, Bräuner-Osborne H, Sejer Pedersen D",,1526363,DTCT0023280,14599364,DTCC01670666,560399,64305
CHEMBL3633665,P20309,,BEQQTFBHBHMGEU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26516782,IC50,=,51286.14,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor expressed in HEK293 cells assessed as inhibition of carbachol-induced inositol monophosphate accumulation after 1 hr by FRET assay,,Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.,J. Med. Chem.,2015,58,22,"Johansson H, Boesgaard MW, Nørskov-Lauritsen L, Larsen I, Kuhne S, Gloriam DE, Bräuner-Osborne H, Sejer Pedersen D",,1526363,DTCT0023280,14599359,DTCC01670668,1751577,64305
CHEMBL3633665,P20309,,BEQQTFBHBHMGEU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26516782,IC50,=,58000,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor expressed in HEK293 cells assessed as inhibition of carbachol-induced inositol monophosphate accumulation after 1 hr by FRET assay,,Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold.,J. Med. Chem.,2015,58,22,"Johansson H, Boesgaard MW, Nørskov-Lauritsen L, Larsen I, Kuhne S, Gloriam DE, Bräuner-Osborne H, Sejer Pedersen D",,1526363,DTCT0023280,14599361,DTCC01670668,1751577,64305
CHEMBL3633757,P20309,,AJIMVLSQIMXLNV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26475518,INHIBITION,<,50,%,,,,,,,,,,,,,,Displacement of [3H]-QNB from recombinant human muscarinic M3 receptor at 10 uM after 1.5 hrs by Microbeta scintillation counting analysis relative to control,,Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT2A receptor.,Bioorg. Med. Chem. Lett.,2015,25,22,"Ponnala S, Kapadia N, Madapa S, Alberts IL, Harding WW",,1527262,DTCT0023280,14599730,DTCC01670761,1077577,64247
CHEMBL3639442,P20309,,JVRDCTUOXNGKAJ-RQQNCLOISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633322,DTCC01677680,1932948,64662
CHEMBL3645274,P20309,,FLTOZNVHXUTDCB-FAIXQHPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633280,DTCC01677601,1998856,64662
CHEMBL3645275,P20309,,HITOGYOOCJOUAF-KDXMTYKHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633238,DTCC01677602,1966207,64662
CHEMBL3645276,P20309,,BORASJFEKISWCW-KDXMTYKHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633281,DTCC01677603,1932945,64662
CHEMBL3645277,P20309,,JVAHJOWFOOWVCB-RWYGWLOXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633239,DTCC01677604,1324320,64662
CHEMBL3645278,P20309,,TXPUXFKWQMYVCW-KDXMTYKHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633282,DTCC01677605,1966208,64662
CHEMBL3645279,P20309,,QSSJJHUUNHDAAS-FAIXQHPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633240,DTCC01677606,419972,64662
CHEMBL3645280,P20309,,LUGDEMWQBDECKF-DQNNLVPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633284,DTCC01677607,742253,64662
CHEMBL3645281,P20309,,TYXCVHIRUSKPFD-BGUOZTDRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633241,DTCC01677608,936160,64662
CHEMBL3645282,P20309,,TYXCVHIRUSKPFD-JQFVALKYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633285,DTCC01677609,1771811,64662
CHEMBL3645283,P20309,,AFEIULHOTSQERY-RWYGWLOXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14631289,DTCC01677610,1900879,63918
CHEMBL3645284,P20309,,JPDDQRTVCNIZBI-FAIXQHPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633286,DTCC01677611,1901021,64662
CHEMBL3645285,P20309,,WBAQVSSKMIHGAV-FAIXQHPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633243,DTCC01677612,612978,64662
CHEMBL3645286,P20309,,NVXUMSJFXXFZCY-FAIXQHPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633244,DTCC01677613,84,64662
CHEMBL3645287,P20309,,UMFKRZOYLNBDPB-RWYGWLOXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633287,DTCC01677614,1389776,64662
CHEMBL3645288,P20309,,MNNPZOILVIICPF-RWYGWLOXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633245,DTCC01677615,968294,64662
CHEMBL3645289,P20309,,PMXJNHWWGMWBNU-NHNYVTFBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633288,DTCC01677616,1161693,64662
CHEMBL3645290,P20309,,PMXJNHWWGMWBNU-OAPNFVEUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633246,DTCC01677617,1422084,64662
CHEMBL3645291,P20309,,PMXJNHWWGMWBNU-CNFIALLCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633289,DTCC01677618,450648,64662
CHEMBL3645292,P20309,,AASAEQLTIUBPQN-QLKFWGTOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633290,DTCC01677619,1453860,64662
CHEMBL3645293,P20309,,FOWOFRSRPCHWOM-QLKFWGTOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633247,DTCC01677620,85,64662
CHEMBL3645294,P20309,,YVLWWMCEDBUTKG-SJARJILFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633291,DTCC01677621,255956,64662
CHEMBL3645295,P20309,,GRKMMSVOPAFSBE-WBCKFURZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633248,DTCC01677622,321757,64662
CHEMBL3645296,P20309,,BGJCRDMNFIEHDC-SJARJILFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633292,DTCC01677623,289234,64662
CHEMBL3645297,P20309,,FZESBWXQNCWDRI-WBCKFURZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633249,DTCC01677624,1836685,64662
CHEMBL3645298,P20309,,CBBYNTQVUWUEGZ-QLKFWGTOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633293,DTCC01677625,1739989,64662
CHEMBL3645299,P20309,,FNYJMACZWQRMGE-SJARJILFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633250,DTCC01677626,742254,64662
CHEMBL3645300,P20309,,SVZCFOOBMRCIIT-QLKFWGTOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633294,DTCC01677627,1194270,64662
CHEMBL3645301,P20309,,WBXGNUCLVIJHMF-SUESPNGSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633295,DTCC01677628,62258,64662
CHEMBL3645302,P20309,,XHSXXAJXHBNTCF-JWERODGISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633251,DTCC01677629,321758,64662
CHEMBL3645303,P20309,,WBXGNUCLVIJHMF-VNIMEATCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633296,DTCC01677630,709932,64662
CHEMBL3645304,P20309,,WBXGNUCLVIJHMF-RUXKANOASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633252,DTCC01677631,677883,64662
CHEMBL3645305,P20309,,WMOXZAIHKSUWOG-SUESPNGSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633297,DTCC01677632,548474,64662
CHEMBL3645306,P20309,,CBLMSUYHFJLJAI-JWERODGISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633253,DTCC01677633,904338,64662
CHEMBL3645307,P20309,,WMOXZAIHKSUWOG-VNIMEATCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633298,DTCC01677634,1130429,64662
CHEMBL3645308,P20309,,WMOXZAIHKSUWOG-RUXKANOASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633254,DTCC01677635,742255,64662
CHEMBL3645309,P20309,,PIWWKOXFLRSQCE-JWERODGISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633299,DTCC01677636,1966209,64662
CHEMBL3645310,P20309,,AQCSPCSXGOHDCK-LYMXURKRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633255,DTCC01677637,62259,64662
CHEMBL3645311,P20309,,XJEAVZYSXGRNQI-JWERODGISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633300,DTCC01677638,1998857,64662
CHEMBL3645312,P20309,,ODECJHUQVYAWEN-LYMXURKRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633256,DTCC01677639,612979,64662
CHEMBL3645313,P20309,,XJEAVZYSXGRNQI-PWOKGZDBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633301,DTCC01677640,289235,64662
CHEMBL3645314,P20309,,XJEAVZYSXGRNQI-RKCQUONGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633257,DTCC01677641,354451,64662
CHEMBL3645315,P20309,,YTRGIOKXPCKHFY-PWOKGZDBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633302,DTCC01677642,1000818,64662
CHEMBL3645316,P20309,,YTRGIOKXPCKHFY-RKCQUONGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633258,DTCC01677643,1324321,64662
CHEMBL3645317,P20309,,WHJUYNZYDNBNOK-JWERODGISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633303,DTCC01677644,1453861,64662
CHEMBL3645318,P20309,,QGMRBUSFOGDHPR-JWERODGISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633259,DTCC01677645,1615746,64662
CHEMBL3645319,P20309,,FQCGRIQVNBFTRZ-JWERODGISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633304,DTCC01677646,2031832,64662
CHEMBL3645320,P20309,,BSQSYHBHVQTFMO-MZCJWYLYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633260,DTCC01677647,1932946,64662
CHEMBL3645321,P20309,,BSQSYHBHVQTFMO-XFTGMPDSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633305,DTCC01677648,516433,64662
CHEMBL3645322,P20309,,BODWRNBUQHEVTC-MZCJWYLYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633261,DTCC01677649,1836686,64662
CHEMBL3645323,P20309,,BODWRNBUQHEVTC-XFTGMPDSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633306,DTCC01677650,516434,64662
CHEMBL3645324,P20309,,ZLDOAEZARXOVGM-QLKFWGTOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633262,DTCC01677651,223732,64662
CHEMBL3645325,P20309,,AQXSFUIPLNARQT-GWHBCOKCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633307,DTCC01677652,1226314,64662
CHEMBL3645326,P20309,,ODARRQMRLUNWHI-QLKFWGTOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633263,DTCC01677653,1226315,64662
CHEMBL3645327,P20309,,INEVMNGPFBQIRV-SJARJILFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633308,DTCC01677654,62260,64662
CHEMBL3645328,P20309,,ICICBRGBJXHGJJ-SJARJILFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633264,DTCC01677655,516435,64662
CHEMBL3645329,P20309,,ZDJDDHHJDNXZRV-GWHBCOKCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633309,DTCC01677656,1033170,64662
CHEMBL3645330,P20309,,GGWUVFMRZFZGSA-GWHBCOKCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633265,DTCC01677657,387063,64662
CHEMBL3645331,P20309,,GTEBMPVWJKJLRG-LYMXURKRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633266,DTCC01677658,1932947,64662
CHEMBL3645331,P20309,,GTEBMPVWJKJLRG-LYMXURKRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633310,DTCC01677658,1932947,64662
CHEMBL3645332,P20309,,OSAFDYZMOUYANI-MZCJWYLYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633311,DTCC01677659,255957,64662
CHEMBL3645333,P20309,,OSAFDYZMOUYANI-XFTGMPDSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633267,DTCC01677660,1804378,64662
CHEMBL3645334,P20309,,LMLRUHCKOAVURE-PTIAPEEWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633312,DTCC01677661,62261,64662
CHEMBL3645335,P20309,,NQNXCSBZTJTNCO-DXYQNXQJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633268,DTCC01677662,255958,64662
CHEMBL3645336,P20309,,ASGGQRAVBINOEP-LYMXURKRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.4,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633313,DTCC01677663,1615747,64662
CHEMBL3645337,P20309,,VVLSTPUGOCPAEL-ISARHTMVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633269,DTCC01677664,191408,64662
CHEMBL3645338,P20309,,CSVLBRHQBBCJKT-SJARJILFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633314,DTCC01677665,548475,64662
CHEMBL3645339,P20309,,WFARSWRTMDDFJY-SJARJILFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633270,DTCC01677666,321759,64662
CHEMBL3645340,P20309,,MEJMXLXPFPMXCM-GWHBCOKCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633315,DTCC01677667,1291750,64662
CHEMBL3645341,P20309,,NFVOYFBRNSXFDY-LYMXURKRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633271,DTCC01677668,1711779,64662
CHEMBL3645342,P20309,,NFVOYFBRNSXFDY-MZCJWYLYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633316,DTCC01677669,450649,64662
CHEMBL3645343,P20309,,NFVOYFBRNSXFDY-XFTGMPDSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633272,DTCC01677670,548476,64662
CHEMBL3645344,P20309,,KJFYREGWQMVZCE-LYMXURKRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633317,DTCC01677671,1259370,64662
CHEMBL3645345,P20309,,ZPVNNQIFWZBUJY-LYMXURKRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633273,DTCC01677672,1453862,64662
CHEMBL3645346,P20309,,ZPVNNQIFWZBUJY-MZCJWYLYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633318,DTCC01677673,1739990,64662
CHEMBL3645347,P20309,,ZPVNNQIFWZBUJY-XFTGMPDSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633274,DTCC01677674,1033171,64662
CHEMBL3645348,P20309,,ODRNIPYHRVQXEY-ISARHTMVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633319,DTCC01677675,1998858,64662
CHEMBL3645349,P20309,,JROFTQQUDINWSC-PTIAPEEWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633275,DTCC01677676,289236,64662
CHEMBL3645350,P20309,,JROFTQQUDINWSC-XEWCOGJJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633320,DTCC01677677,580685,64662
CHEMBL3645351,P20309,,JVRDCTUOXNGKAJ-PTIAPEEWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633321,DTCC01677678,904339,64662
CHEMBL3645352,P20309,,JVRDCTUOXNGKAJ-XEWCOGJJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633276,DTCC01677679,86,64662
CHEMBL3645353,P20309,,RDAMMRZCHNVQKB-PTIAPEEWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633277,DTCC01677681,1901022,64662
CHEMBL3645354,P20309,,RDAMMRZCHNVQKB-RQQNCLOISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14633323,DTCC01677682,2031833,64662
CHEMBL3645355,P20309,,RDAMMRZCHNVQKB-XEWCOGJJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.8,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14631363,DTCC01677683,94567,63918
CHEMBL3645356,P20309,,FVDWCPLRNMZSNA-LYMXURKRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14631364,DTCC01677684,1421951,63918
CHEMBL3645357,P20309,,SYKGDCNCYPJCKO-ISARHTMVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14631365,DTCC01677685,321635,63918
CHEMBL3645358,P20309,,VUYIKQFKMBOBJI-GWHBCOKCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14631366,DTCC01677686,191292,63918
CHEMBL3645359,P20309,,CYMUVEHHMNKYST-FAIXQHPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14631284,DTCC01677687,742127,63918
CHEMBL3645359,P20309,,CYMUVEHHMNKYST-FAIXQHPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14644541,DTCC01677687,742127,63918
CHEMBL3645360,P20309,,PGYKQRWVVBAZQY-BMWXWXOGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14644542,DTCC01677688,321636,63918
CHEMBL3645361,P20309,,JORDOGYMROOYCP-SJARJILFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14644545,DTCC01677689,289127,63918
CHEMBL3645361,P20309,,JORDOGYMROOYCP-SJARJILFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14635448,DTCC01677689,289268,64662
CHEMBL3645362,P20309,,CSCDNAKNKBLYJF-KDXMTYKHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14644540,DTCC01677690,1739869,63918
CHEMBL3645363,P20309,,AKYUMGLGSXQSCR-FAIXQHPJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14644543,DTCC01677691,223603,63918
CHEMBL3645364,P20309,,ARCRSHGBFYOWBH-WBCKFURZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14644544,DTCC01677692,774159,63918
CHEMBL3645365,P20309,,JROFTQQUDINWSC-RQQNCLOISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using muscarinic receptors.,,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2013,,,,,1527832,DTCT0023280,14644546,DTCC01677693,806515,63918
CHEMBL364713,P20309,NOSCAPINE,AKNNEGZIBPJZJG-MSOLQXFVSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7403736,DTCC00398932,898293,46191
CHEMBL364713,P20309,NOSCAPINE,AKNNEGZIBPJZJG-MSOLQXFVSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7403737,DTCC00398932,898293,46191
CHEMBL366563,P20309,,LEVWYRKDKASIDU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14727084,DTCC00370225,2103226,69159
CHEMBL3666066,P20309,,KVMMKDMMCQUAMU-KDXMTYKHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14635443,DTCC01698603,1680113,64662
CHEMBL3666067,P20309,,HLFSCDINWNKPBL-BMWXWXOGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14635444,DTCC01698604,968314,64662
CHEMBL3666068,P20309,,VXJWGNOXAWXFSN-WBCKFURZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",,Diamide compounds having muscarinic receptor antagonist and =2 adrenergic receptor agonist activity,,2014,,,,,1528694,DTCT0023280,14635446,DTCC01698605,127,64662
CHEMBL3670825,P20309,,QFJDHDDFPKAMOX-KJLWCSGBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,0.23,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637530,DTCC01703410,2075598,64554
CHEMBL3670825,P20309,,QFJDHDDFPKAMOX-KJLWCSGBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.16,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637529,DTCC01703410,2075598,64554
CHEMBL3670826,P20309,,GIQCKBPBJOZAKR-SDVBZNEUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,0.25,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637532,DTCC01703411,74416,64554
CHEMBL3670826,P20309,,GIQCKBPBJOZAKR-SDVBZNEUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,19,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637542,DTCC01703411,74416,64554
CHEMBL3670826,P20309,,GIQCKBPBJOZAKR-SDVBZNEUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.18,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637531,DTCC01703411,74416,64554
CHEMBL3670826,P20309,,GIQCKBPBJOZAKR-SDVBZNEUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,14,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637541,DTCC01703411,74416,64554
CHEMBL3670827,P20309,,GIQCKBPBJOZAKR-KWOGNLBTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,0.25,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637534,DTCC01703412,560590,64554
CHEMBL3670827,P20309,,GIQCKBPBJOZAKR-KWOGNLBTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,36,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637544,DTCC01703412,560590,64554
CHEMBL3670827,P20309,,GIQCKBPBJOZAKR-KWOGNLBTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.18,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637533,DTCC01703412,560590,64554
CHEMBL3670827,P20309,,GIQCKBPBJOZAKR-KWOGNLBTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,26,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637543,DTCC01703412,560590,64554
CHEMBL3670828,P20309,,GIQCKBPBJOZAKR-XSNSTOHYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,0.3,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637536,DTCC01703413,1459119,64554
CHEMBL3670828,P20309,,GIQCKBPBJOZAKR-XSNSTOHYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,2.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637538,DTCC01703413,1459119,64554
CHEMBL3670828,P20309,,GIQCKBPBJOZAKR-XSNSTOHYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,2.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637540,DTCC01703413,1459119,64554
CHEMBL3670828,P20309,,GIQCKBPBJOZAKR-XSNSTOHYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.22,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637535,DTCC01703413,1459119,64554
CHEMBL3670828,P20309,,GIQCKBPBJOZAKR-XSNSTOHYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637537,DTCC01703413,1459119,64554
CHEMBL3670828,P20309,,GIQCKBPBJOZAKR-XSNSTOHYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,2.1,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",,"7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof",,2014,,,,,1527639,DTCT0023280,14637539,DTCC01703413,1459119,64554
CHEMBL36715,P20309,PIRACETAM,GMZVRMREEHBGGF-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374486,DTCC00176308,1383779,46191
CHEMBL36715,P20309,PIRACETAM,GMZVRMREEHBGGF-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374487,DTCC00176308,1383779,46191
CHEMBL3686863,P20309,,WOJKYHBOHSQZDW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,27020304,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM,,Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists.,Bioorg. Med. Chem. Lett.,2016,26,9,"Blanco MJ, Vetman T, Chandrasekhar S, Fisher MJ, Harvey A, Kuklish SL, Chambers M, Lin C, Mudra D, Oskins J, Wang XS, Yu XP, Warshawsky AM.",,1571687,DTCT0023280,229605,DTCC01719610,1045855,66780
CHEMBL369062,P20309,,KUKJOLRCPDCJAJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,2.1,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1607661,DTCC00375266,692860,11844
CHEMBL369575,P20309,,YMVKVHVILBKUBG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,2754.23,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,978856,DTCC00366465,725040,17703
CHEMBL36994,P20309,ANIRACETAM,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273368,DTCC00176277,1447877,46191
CHEMBL36994,P20309,ANIRACETAM,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273369,DTCC00176277,1447877,46191
CHEMBL370128,P20309,,OHBRURMYVYWCLY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1859424,DTCC00407469,174725,19805
CHEMBL370232,P20309,,CHFVEWGLPHGQML-GOSISDBHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.05,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879421,DTCC00411469,1598792,10048
CHEMBL370862,P20309,,WVXKZFBGVXVVRR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,4,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879418,DTCC00411483,1242322,10048
CHEMBL37161,P20309,FENBENDAZOLE,HDDSHPAODJUKPD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330885,DTCC00174892,2089748,46191
CHEMBL37161,P20309,FENBENDAZOLE,HDDSHPAODJUKPD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330886,DTCC00174892,2089748,46191
CHEMBL371734,P20309,,VBKBVALDNMYEBZ-DHIUTWEWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,3.2,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879435,DTCC00411791,1274984,10048
CHEMBL371734,P20309,,VBKBVALDNMYEBZ-DHIUTWEWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,3.98,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362686,DTCC00411791,1264231,26143
CHEMBL372453,P20309,,OGWAJJGAXANYMJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16143528,KI,>,10000,NM,,,,,,,,,,,,,,Affinity towards cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective serotonin 5-HT1B receptor ligands.,Bioorg. Med. Chem. Lett.,2005,15,21,"Huang Y, Bae SA, Roth BL, Laruelle M",,320817,DTCT0023280,1846024,DTCC00404612,435218,19805
CHEMBL372566,P20309,,ZGBSEJYQXDWFRF-YADHBBJMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,13,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879413,DTCC00411654,660974,10048
CHEMBL372795,P20309,STREPTOMYCIN,UCSJYZPVAKXKNQ-HZYVHMACSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475991,DTCC00411395,51509,46191
CHEMBL372795,P20309,STREPTOMYCIN,UCSJYZPVAKXKNQ-HZYVHMACSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475992,DTCC00411395,51509,46191
CHEMBL373256,P20309,,JHVGODZODVAJRI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,40,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879430,DTCC00411390,1819978,10048
CHEMBL373410,P20309,,YKEGMLRCDJTLEV-GICFTMHYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,7,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974215,DTCC00432404,876148,21327
CHEMBL373515,P20309,,UJXAGMVNACHDOG-RBUKOAKNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,5.25,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025487,DTCC00442257,972545,22057
CHEMBL3736156,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26565745,EC50,>,5011.87,NM,,,,,,,,,,,,,,Agonist activity at human wild-type M3 receptor expressed in CHO-K1 cells assessed as calcium level by FDSS assay,,Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example.,J. Med. Chem.,2015,58,23,"Rombouts FJ, Tovar F, Austin N, Tresadern G, Trabanco AA.",,1539160,DTCT0023280,2902,DTCC00063664,1162142,65419
CHEMBL3736156,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26565745,IC50,>,5011.87,NM,,,,,,,,,,,,,,Antagonist activity at human wild-type M3 receptor expressed in CHO-K1 cells assessed as acetylcholine-induced calcium by FDSS assay,,Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example.,J. Med. Chem.,2015,58,23,"Rombouts FJ, Tovar F, Austin N, Tresadern G, Trabanco AA.",,1539137,DTCT0023280,2833,DTCC00063664,1162142,65419
CHEMBL3736433,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26565745,EC50,>,5011.87,NM,,,,,,,,,,,,,,Agonist activity at human wild-type M3 receptor expressed in CHO-K1 cells assessed as calcium level by FDSS assay,,Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example.,J. Med. Chem.,2015,58,23,"Rombouts FJ, Tovar F, Austin N, Tresadern G, Trabanco AA.",,1539160,DTCT0023280,2901,DTCC00063663,1648350,65419
CHEMBL3736433,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26565745,IC50,>,5011.87,NM,,,,,,,,,,,,,,Antagonist activity at human wild-type M3 receptor expressed in CHO-K1 cells assessed as acetylcholine-induced calcium by FDSS assay,,Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example.,J. Med. Chem.,2015,58,23,"Rombouts FJ, Tovar F, Austin N, Tresadern G, Trabanco AA.",,1539137,DTCT0023280,2832,DTCC00063663,1648350,65419
CHEMBL37372,P20309,,WFXACEPWPCLBGC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,52.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417728,DTCC00177223,589584,54418
CHEMBL373835,P20309,,XEWJCQCEESQMLA-DHSPPMNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,28,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972904,DTCC00432049,1872903,21327
CHEMBL373888,P20309,CDD-0309A,IMKYINSUEJXTJZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,ACTIVITY,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis relative to carbachol,Not Active,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422705,DTCT0023280,2001195,DTCC00002179,272264,21638
CHEMBL373888,P20309,CDD-0309A,IMKYINSUEJXTJZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,50.12,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,2001095,DTCC00002179,272264,21638
CHEMBL373888,P20309,CDD-0309A,IMKYINSUEJXTJZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,Not Determined,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001147,DTCC00002179,272264,21638
CHEMBL373994,P20309,,RVGJKIIDOBCNAB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,4.32,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030913,DTCC00443256,1114149,22115
CHEMBL3740472,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26363507,INHIBITION,<,50,%,,,,,,,,,,,,,,Agonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as cAMP level at 10 uM after 4 hrs by luciferase reporter gene assay,,"Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.",Eur. J. Med. Chem.,2015,103,,"Nirogi R, Mohammed AR, Shinde AK, Bogaraju N, Gagginapalli SR, Ravella SR, Kota L, Bhyrapuneni G, Muddana NR, Benade V, Palacharla RC, Jayarajan P, Subramanian R, Goyal VK.",,1540922,DTCT0023280,16685,DTCC00065101,1648360,65482
CHEMBL3740472,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26363507,INHIBITION,<,50,%,,,,,,,,,,,,,,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as cAMP level at 10 uM after 4 hrs by luciferase reporter gene assay,,"Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.",Eur. J. Med. Chem.,2015,103,,"Nirogi R, Mohammed AR, Shinde AK, Bogaraju N, Gagginapalli SR, Ravella SR, Kota L, Bhyrapuneni G, Muddana NR, Benade V, Palacharla RC, Jayarajan P, Subramanian R, Goyal VK.",,1540942,DTCT0023280,16705,DTCC00065101,1648360,65482
CHEMBL374099,P20309,,SDTXFAOVLONHRG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,114,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030938,DTCC00443238,175051,22115
CHEMBL3741992,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26460788,INHIBITION,<,30,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM,,Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.,J. Med. Chem.,2015,58,21,"Lopez-Tapia F, Walker KA, Brotherton-Pleiss C, Caroon J, Nitzan D, Lowrie L, Gleason S, Zhao SH, Berger J, Cockayne D, Phippard D, Suttmann R, Fitch WL, Bourdet D, Rege P, Huang X, Broadbent S, Dvorak C, Zhu J, Wagner P, Padilla F, Loe B, Jahangir A, Alker A.",,1541650,DTCT0023280,20296,DTCC00065423,1804813,65488
CHEMBL374452,P20309,,MKNASJNZVVEVJG-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,0.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030376,DTCC00443156,1852395,22116
CHEMBL374478,P20309,RIFAMPICIN,JQXXHWHPUNPDRT-WLSIYKJHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479498,DTCC00437710,51504,46191
CHEMBL374478,P20309,RIFAMPICIN,JQXXHWHPUNPDRT-WLSIYKJHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479499,DTCC00437710,51504,46191
CHEMBL374513,P20309,,BDWGATIFULLOLF-NHYGQJMQSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,1.84,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030361,DTCC00443089,1852396,22116
CHEMBL374987,P20309,,KVBKUXNXDGXGGR-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,727,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030385,DTCC00443122,564278,22116
CHEMBL374989,P20309,,NBVYRBDIADJELP-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,1.89,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030375,DTCC00443157,175052,22116
CHEMBL375073,P20309,,UJXAGMVNACHDOG-MOPGFXCFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,2.45,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025542,DTCC00442275,1523016,22057
CHEMBL375178,P20309,,OGOJBRGMDGWIJB-ZUPGYTDKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,-7,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972906,DTCC00432051,1069801,21327
CHEMBL375180,P20309,,OQAADAQINWYEOG-DKBFFSQUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974210,DTCC00432012,972439,21327
CHEMBL375277,P20309,,PEVGVLCERDITEB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,18.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030881,DTCC00443211,1534601,22115
CHEMBL3754085,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26764191,INHIBITION,=,-13,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM,,"Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.",Bioorg. Med. Chem. Lett.,2016,26,3,"Blanco MJ, Vetman T, Chandrasekhar S, Fisher MJ, Harvey A, Chambers M, Lin C, Mudra D, Oskins J, Wang XS, Yu XP, Warshawsky AM.",,1548174,DTCT0023280,53393,DTCC00071613,1045702,65899
CHEMBL375420,P20309,,ZAACSVRUEKCICF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,1.72,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030908,DTCC00443288,142908,22115
CHEMBL375851,P20309,,JNDQWNMDDVQDNC-FDOHDBATSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,5.01,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025535,DTCC00442204,1715837,22057
CHEMBL375969,P20309,,JNDQWNMDDVQDNC-CMXBXVFLSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,0.741,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025536,DTCC00442184,2036007,22057
CHEMBL3759860,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26761776,INHIBITION,=,50,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor (unknown origin) at 1 to 2 uM by radioligand binding assay,,Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.,Eur. J. Med. Chem.,2016,109,,"Park JS, Im W, Choi S, Park SJ, Jung JM, Baek KS, Son HP, Sharma S, Kim IS, Jung YH.",,1552856,DTCT0023280,69228,DTCC00074937,432317,66015
CHEMBL376000,P20309,,QRIOHHDYJDFPEK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,1.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030882,DTCC00443194,305281,22115
CHEMBL376057,P20309,,NIWWXHZNICDGMJ-HWAJWLCKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,0.589,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025532,DTCC00442248,1808562,22057
CHEMBL376180,P20309,AMINOPTERIN,TVZGACDUOSZQKY-LBPRGKRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286009,DTCC00445374,120968,46191
CHEMBL376180,P20309,AMINOPTERIN,TVZGACDUOSZQKY-LBPRGKRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7286010,DTCC00445374,120968,46191
CHEMBL376255,P20309,,DFCLHAWGKPEFIX-XUVXKRRUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,1.7,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025538,DTCC00442153,1328764,22057
CHEMBL376295,P20309,CDD-0314A,AKPSMQSQINOOPH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,ACTIVITY,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis relative to carbachol,Not Active,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422705,DTCT0023280,2001189,DTCC00002172,725757,21638
CHEMBL376295,P20309,CDD-0314A,AKPSMQSQINOOPH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,199.53,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,2001089,DTCC00002172,725757,21638
CHEMBL376295,P20309,CDD-0314A,AKPSMQSQINOOPH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,Not Determined,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001141,DTCC00002172,725757,21638
CHEMBL3763166,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26653033,INHIBITION,<,50,%,,,,,,,,,,,,,,Inhibition of Muscarinic M3 receptor (unknown origin) at 10 uM,,"Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.",J. Med. Chem.,2016,59,1,"Lin SY, Yeh TK, Kuo CC, Song JS, Cheng MF, Liao FY, Chao MW, Huang HL, Chen YL, Yang CY, Wu MH, Hsieh CL, Hsiao W, Peng YH, Wu JS, Lin LM, Sun M, Chao YS, Shih C, Wu SY, Pan SL, Hung MS, Ueng SH.",,1553610,DTCT0023280,91886,DTCC00075195,807224,66086
CHEMBL3764557,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26786693,KI,=,1000,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor (unknown origin),,Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists.,Bioorg. Med. Chem. Lett.,2016,26,4,"Micheli F, Cremonesi S, Semeraro T, Tarsi L, Tomelleri S, Cavanni P, Oliosi B, Perdona E, Sava A, Zonzini L, Feriani A, Braggio S, Heidbreder C.",,1554006,DTCT0023280,95749,DTCC00076594,387623,66141
CHEMBL376636,P20309,,QEVOAVBRSZFZGI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,418,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030915,DTCC00443234,337923,22115
CHEMBL376781,P20309,,PZNWDUWKLZHRGR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,2.75,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030907,DTCC00443171,33995,22115
CHEMBL376870,P20309,,DFCLHAWGKPEFIX-HSALFYBXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,2.19,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025540,DTCC00442292,681931,22057
CHEMBL376897,P20309,METHYLSCOPOLAMINE,LZCOQTDXKCNBEE-IKIFYQGPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,1.1,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS radioligand using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139673,DTCT0023280,517396,DTCC00442166,140381,2697
CHEMBL376897,P20309,METHYLSCOPOLAMINE,LZCOQTDXKCNBEE-IKIFYQGPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,0.135,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025530,DTCC00442166,131263,22057
CHEMBL376897,P20309,METHYLSCOPOLAMINE,LZCOQTDXKCNBEE-IKIFYQGPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,0.135,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076866,DTCC00442166,133056,36436
CHEMBL376897,P20309,METHYLSCOPOLAMINE,LZCOQTDXKCNBEE-IKIFYQGPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,0.135,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512619,DTCC00442166,154656,48454
CHEMBL376900,P20309,,FDJOVQRCCRYZCJ-URNYMRNVSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,6.66,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030368,DTCC00443067,1884513,22116
CHEMBL376956,P20309,,HXAOFPLPOJLQNR-YAACQPLRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,5,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972903,DTCC00432019,714090,21327
CHEMBL377241,P20309,,VKAMBSPXFFZIQB-QGZVFWFLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16789729,KI,=,160,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3R,,A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic properties.,J. Med. Chem.,2006,49,13,"Dyck B, Markison S, Zhao L, Tamiya J, Grey J, Rowbottom MW, Zhang M, Vickers T, Sorensen K, Norton C, Wen J, Heise CE, Saunders J, Conlon P, Madan A, Schwarz D, Goodfellow VS",,368895,DTCT0023280,1957105,DTCC00426714,1787570,20995
CHEMBL377376,P20309,,JZVDUQABUGQWQO-VMXYRSAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,8,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972912,DTCC00432237,424169,21327
CHEMBL377377,P20309,,NAHPTJKBLQDGNZ-VBAOBBRWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,5,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972913,DTCC00432238,1905231,21327
CHEMBL377377,P20309,,NAHPTJKBLQDGNZ-VBAOBBRWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972914,DTCC00432238,1905232,21327
CHEMBL3774411,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26951894,KI,=,1096.48,NM,,,,,,,,,,,,,,Antagonist activity at recombinant human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine induced calcium mobilization preincubated for 10 mins followed by acetylcholine addition measured after 1 hr by fluo-4 AM dye-based FLIPR assay,,"1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.",Bioorg. Med. Chem.,2016,24,8,"Micheli F, Bernardelli A, Bianchi F, Braggio S, Castelletti L, Cavallini P, Cavanni P, Cremonesi S, Dal Cin M, Feriani A, Oliosi B, Semeraro T, Tarsi L, Tomelleri S, Wong A, Visentini F, Zonzini L, Heidbreder C.",,1561636,DTCT0023280,112567,DTCC00080540,1454538,66397
CHEMBL3774649,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26951894,KI,=,1445.44,NM,,,,,,,,,,,,,,Antagonist activity at recombinant human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine induced calcium mobilization preincubated for 10 mins followed by acetylcholine addition measured after 1 hr by fluo-4 AM dye-based FLIPR assay,,"1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.",Bioorg. Med. Chem.,2016,24,8,"Micheli F, Bernardelli A, Bianchi F, Braggio S, Castelletti L, Cavallini P, Cavanni P, Cremonesi S, Dal Cin M, Feriani A, Oliosi B, Semeraro T, Tarsi L, Tomelleri S, Wong A, Visentini F, Zonzini L, Heidbreder C.",,1561636,DTCT0023280,113534,DTCC00080547,1740606,66397
CHEMBL3774769,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26951894,KI,=,478.63,NM,,,,,,,,,,,,,,Antagonist activity at recombinant human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine induced calcium mobilization preincubated for 10 mins followed by acetylcholine addition measured after 1 hr by fluo-4 AM dye-based FLIPR assay,,"1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.",Bioorg. Med. Chem.,2016,24,8,"Micheli F, Bernardelli A, Bianchi F, Braggio S, Castelletti L, Cavallini P, Cavanni P, Cremonesi S, Dal Cin M, Feriani A, Oliosi B, Semeraro T, Tarsi L, Tomelleri S, Wong A, Visentini F, Zonzini L, Heidbreder C.",,1561636,DTCT0023280,112568,DTCC00080542,1131044,66397
CHEMBL3775197,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26951894,KI,=,2187.76,NM,,,,,,,,,,,,,,Antagonist activity at recombinant human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine induced calcium mobilization preincubated for 10 mins followed by acetylcholine addition measured after 1 hr by fluo-4 AM dye-based FLIPR assay,,"1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.",Bioorg. Med. Chem.,2016,24,8,"Micheli F, Bernardelli A, Bianchi F, Braggio S, Castelletti L, Cavallini P, Cavanni P, Cremonesi S, Dal Cin M, Feriani A, Oliosi B, Semeraro T, Tarsi L, Tomelleri S, Wong A, Visentini F, Zonzini L, Heidbreder C.",,1561636,DTCT0023280,111893,DTCC00080537,882,66397
CHEMBL3775226,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26951894,KI,=,245.47,NM,,,,,,,,,,,,,,Antagonist activity at recombinant human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine induced calcium mobilization preincubated for 10 mins followed by acetylcholine addition measured after 1 hr by fluo-4 AM dye-based FLIPR assay,,"1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.",Bioorg. Med. Chem.,2016,24,8,"Micheli F, Bernardelli A, Bianchi F, Braggio S, Castelletti L, Cavallini P, Cavanni P, Cremonesi S, Dal Cin M, Feriani A, Oliosi B, Semeraro T, Tarsi L, Tomelleri S, Wong A, Visentini F, Zonzini L, Heidbreder C.",,1561636,DTCT0023280,112566,DTCC00080421,1033840,66397
CHEMBL3775436,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26988801,INHIBITION,=,8.5,%,,,,,,,,,,,,,,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016,24,8,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559508,DTCT0023280,118958,DTCC00081018,517082,66408
CHEMBL3775589,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26951894,KI,=,1258.93,NM,,,,,,,,,,,,,,Antagonist activity at recombinant human muscarinic M3 receptor expressed in CHO-K1 cells assessed as inhibition of acetylcholine induced calcium mobilization preincubated for 10 mins followed by acetylcholine addition measured after 1 hr by fluo-4 AM dye-based FLIPR assay,,"1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.",Bioorg. Med. Chem.,2016,24,8,"Micheli F, Bernardelli A, Bianchi F, Braggio S, Castelletti L, Cavallini P, Cavanni P, Cremonesi S, Dal Cin M, Feriani A, Oliosi B, Semeraro T, Tarsi L, Tomelleri S, Wong A, Visentini F, Zonzini L, Heidbreder C.",,1561636,DTCT0023280,112565,DTCC00080419,322365,66397
CHEMBL3775769,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26988801,INHIBITION,=,4.4,%,,,,,,,,,,,,,,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016,24,8,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559508,DTCT0023280,119828,DTCC00081020,774921,66408
CHEMBL377728,P20309,,FJFYFTMGULTVHT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,316,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914041,DTCC00419421,1820069,20612
CHEMBL377729,P20309,,HVHXZLNPNDBEOH-IUODEOHRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,32,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914027,DTCC00419428,1916429,20612
CHEMBL37858,P20309,SARAFLOXACIN,XBHBWNFJWIASRO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479858,DTCC00180187,51508,46191
CHEMBL37858,P20309,SARAFLOXACIN,XBHBWNFJWIASRO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479859,DTCC00180187,51508,46191
CHEMBL378623,P20309,,DWDKVNQJPOUNQW-MMSQBWMUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,32,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972899,DTCC00432015,1393787,21327
CHEMBL378772,P20309,,UUQTXJMGYQWWJC-RQOYOAKWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.17,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974294,DTCC00431566,552715,21327
CHEMBL378859,P20309,,KXGAHULLQRZYOM-SXLOSVNLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,1.2,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974300,DTCC00432382,520630,21327
CHEMBL378872,P20309,,BHAUVKSALKMKRU-SLGZMBILSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.39,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974301,DTCC00432381,1198443,21327
CHEMBL378885,P20309,,NKECRNQFOBAVDC-SVSXPMSYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,3.7,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974302,DTCC00432380,1840924,21327
CHEMBL378904,P20309,,LSFXNFJHAUSTAG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,126,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914029,DTCC00419793,919207,20612
CHEMBL379055,P20309,,SIIRFLRGILJEAH-VMXYRSAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,59,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972897,DTCC00432013,1619889,21327
CHEMBL379055,P20309,,SIIRFLRGILJEAH-VMXYRSAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,150,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974222,DTCC00432013,1619889,21327
CHEMBL379104,P20309,,RLIZUHYQJBJANU-DKWWYQQMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,33,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972901,DTCC00432017,843665,21327
CHEMBL379105,P20309,,MQSDPIYSWOTIPO-DKWWYQQMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,7,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972902,DTCC00432018,1776021,21327
CHEMBL379483,P20309,,PVKKHILMTNMADV-VMXYRSAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,82,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972898,DTCC00432014,1684323,21327
CHEMBL379483,P20309,,PVKKHILMTNMADV-VMXYRSAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,49,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974223,DTCC00432014,1684323,21327
CHEMBL379990,P20309,,SGUXTVIDKWZUJV-VEGJFJAASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,7,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974216,DTCC00432403,195590,21327
CHEMBL38,P20309,TRETINOIN,SHGAZHPCJJPHSC-YCNIQYBTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7452681,DTCC00134063,51513,46191
CHEMBL38,P20309,TRETINOIN,SHGAZHPCJJPHSC-YCNIQYBTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7452682,DTCC00134063,51513,46191
CHEMBL380135,P20309,,PBODJIVKSZWLEB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,63,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914025,DTCC00419388,1820070,20612
CHEMBL380314,P20309,,FHGYVALILVFMAG-WFASDCNBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,7.9,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914015,DTCC00419754,1916430,20612
CHEMBL380477,P20309,,VDXDERZRWFVBIS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,79,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914033,DTCC00419839,887400,20612
CHEMBL380583,P20309,,CGVBUQQTPXIKLP-XMMPIXPASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,7.9,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879424,DTCC00411468,1242321,10048
CHEMBL380759,P20309,,VKZKHKWSKAJSKS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16539379,KI,=,2398.83,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,,"Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.",J. Med. Chem.,2006,49,6,"Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F",,337457,DTCT0023280,1904203,DTCC00417014,552573,20440
CHEMBL3808485,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,27185330,EC50,>,10000,NM,,,,,,,,,,,,,,Positive allosteric modulation of human M3,,"Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core.",Bioorg. Med. Chem. Lett.,2016,26,13,"Wood MR, Noetzel MJ, Engers JL, Bollinger KA, Melancon BJ, Tarr JC, Han C, West M, Gregro AR, Lamsal A, Chang S, Ajmera S, Smith E, Chase P, Hodder PS, Bubser M, Jones CK, Hopkins CR, Emmitte KA, Niswender CM, Wood MW, Duggan ME, Conn PJ, Bridges TM, Lindsley CW.",,1579477,DTCT0023280,279794,DTCC00095139,549242,67187
CHEMBL380926,P20309,,YHGJKEPHPBNDOA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,100,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1913900,DTCC00418597,1663393,20612
CHEMBL380954,P20309,,NTYZIRSXTSUBFT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,63,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914035,DTCC00419837,1016297,20612
CHEMBL381020,P20309,,URXQXNPRSDVQNH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,20,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879417,DTCC00411588,563966,10048
CHEMBL381259,P20309,,ORVIZUQZIOQNAO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,200,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914038,DTCC00419503,1081353,20612
CHEMBL381333,P20309,,CZSPDYBKOUOJCH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,25,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914051,DTCC00419229,757746,20612
CHEMBL381469,P20309,,KXTCGQZDSVQUGY-HXUWFJFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,50,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879411,DTCC00411661,1016229,10048
CHEMBL381623,P20309,,WUMIJQZPHGJALC-JOCHJYFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.13,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879403,DTCC00411742,822221,10048
CHEMBL381623,P20309,,WUMIJQZPHGJALC-JOCHJYFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,0.126,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362673,DTCC00411742,811554,26143
CHEMBL381752,P20309,,FLWJLPFBCQASMQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,50,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914046,DTCC00418598,110231,20612
CHEMBL381878,P20309,,XBHYDGIWYCSUSE-JOCHJYFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,1,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879428,DTCC00411227,822223,10048
CHEMBL382213,P20309,,RTMQZXMBCBMCJK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.79,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879409,DTCC00412024,1501945,10048
CHEMBL3823101,P20309,,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26914985,ACTIVITY,=,86,%,,,,,,,,,,,,,,Inhibition of human M3 receptor assessed as remaining activity at 10 uM,,Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor.,J. Med. Chem.,2016,59,10,"Martin LJ, Koegl M, Bader G, Cockcroft XL, Fedorov O, Fiegen D, Gerstberger T, Hofmann MH, Hohmann AF, Kessler D, Knapp S, Knesl P, Kornigg S, Muller S, Nar H, Rogers C, Rumpel K, Schaaf O, Steurer S, Tallant C, Vakoc CR, Zeeb M, Zoephel A, Pearson M, Boehmelt G, McConnell D.",,1586821,DTCT0023280,304615,DTCC00099812,1260227,67435
CHEMBL382374,P20309,,MUCYBPUWZHIVRY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,3200,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914056,DTCC00110256,1755271,20612
CHEMBL383248,P20309,,QJIZOYTUFMNZTI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,7.9,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879408,DTCC00412031,1016230,10048
CHEMBL383389,P20309,,YBHBMQZXDTYBSG-JOCHJYFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.79,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879425,DTCC00411462,2014788,10048
CHEMBL384467,P20309,DEXAMETHASONE,UREBDLICKHMUKA-CXSFZGCWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368070,DTCC00437785,639578,46191
CHEMBL384467,P20309,DEXAMETHASONE,UREBDLICKHMUKA-CXSFZGCWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368071,DTCC00437785,639578,46191
CHEMBL384599,P20309,,CERXDVAQZNCTCU-GNSKLVJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,2,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974219,DTCC00432172,1069800,21327
CHEMBL384670,P20309,,USSNTKNKIDZPTF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,13.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030925,DTCC00443189,1146505,22115
CHEMBL384773,P20309,,GHYJQAVZBFFLBM-VMXYRSAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972911,DTCC00432062,1328662,21327
CHEMBL385229,P20309,,ZUCVDMXMSJHSSK-ZAYVUINWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,91,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972900,DTCC00432016,876149,21327
CHEMBL385229,P20309,,ZUCVDMXMSJHSSK-ZAYVUINWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,23,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974224,DTCC00432016,876149,21327
CHEMBL385328,P20309,,DFCLHAWGKPEFIX-ZCNNSNEGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,0.891,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025541,DTCC00442283,358780,22057
CHEMBL385843,P20309,,XAKDAGAWIFVBTF-VBAOBBRWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,9,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972917,DTCC00432351,98846,21327
CHEMBL386059,P20309,,FECWVCGFBZKCLL-QMDRZIQZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,4,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974214,DTCC00432006,1872902,21327
CHEMBL386060,P20309,,IRIOHTRBIFPPFI-MFABWLECSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,12,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974212,DTCC00432008,2003074,21327
CHEMBL386291,P20309,,AWXUMBLMWANQON-DKBFFSQUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,-4,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974211,DTCC00432009,1458164,21327
CHEMBL386630,P20309,TESTOSTERONE,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483101,DTCC00437190,477923,46191
CHEMBL386630,P20309,TESTOSTERONE,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483102,DTCC00437190,477923,46191
CHEMBL386983,P20309,CDD-0310A,PGDYOGMNQCUWMZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,ACTIVITY,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis relative to carbachol,Not Active,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422705,DTCT0023280,2001192,DTCC00002178,1663577,21638
CHEMBL386983,P20309,CDD-0310A,PGDYOGMNQCUWMZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KD,=,63.1,NM,,,,,,,,,,,,,,Antagonist activity at human M3 receptor assessed as inhibition of carbachol binding,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422715,DTCT0023280,2001224,DTCC00002178,1663577,21638
CHEMBL386983,P20309,CDD-0310A,PGDYOGMNQCUWMZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,KI,=,1584.89,NM,,cell_based,,,,,,,,,,,A9,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422699,DTCT0023280,2001092,DTCC00002178,1663577,21638
CHEMBL386983,P20309,CDD-0310A,PGDYOGMNQCUWMZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17149881,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Agonist activity at human M3 receptor expressed in A9 L cells assessed as stimulation of phosphoinositide hydrolysis,Not Determined,"Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.",J. Med. Chem.,2006,49,25,"Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS",,422704,DTCT0023280,2001144,DTCC00002178,1663577,21638
CHEMBL38737,P20309,THIOACETAMIDE,YUKQRDCYNOVPGJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483224,DTCC00179105,88637,46191
CHEMBL38737,P20309,THIOACETAMIDE,YUKQRDCYNOVPGJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7483225,DTCC00179105,88637,46191
CHEMBL387482,P20309,,XJZRYBXCNSIJAD-XZVFQGBBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,-4,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972919,DTCC00432171,1263517,21327
CHEMBL387546,P20309,,NBVYRBDIADJELP-KZQYXEPFSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,1.04,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030365,DTCC00443080,467240,22116
CHEMBL387632,P20309,(+)-CIS-DIOXOLANE IODIDE,XFHBFOSBGWDTRO-KZYPOYLOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24980056,KI,=,13489.63,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,,"Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.",Bioorg. Med. Chem. Lett.,2014,24,15,"Del Bello F, Bonifazi A, Quaglia W, Mazzolari A, Barocelli E, Bertoni S, Matucci R, Nesi M, Piergentili A, Vistoli G",,1459949,DTCT0023280,13906714,DTCC00002589,287350,60777
CHEMBL388541,P20309,,FICJSUGPVTUXMP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,83.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030922,DTCC00443213,1982233,22115
CHEMBL388590,P20309,BENZBROMARONE,WHQCHUCQKNIQEC-UHFFFAOYSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258270,DTCC00445492,153438,46191
CHEMBL388590,P20309,BENZBROMARONE,WHQCHUCQKNIQEC-UHFFFAOYSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258271,DTCC00445492,153438,46191
CHEMBL389621,P20309,HYDROCORTISONE,JYGXADMDTFJGBT-VWUMJDOOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306419,DTCC00445397,800578,46191
CHEMBL389621,P20309,HYDROCORTISONE,JYGXADMDTFJGBT-VWUMJDOOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306420,DTCC00445397,800578,46191
CHEMBL389992,P20309,,LVEWVTVQNUIEPS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,13,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157558,DTCC00462736,336274,23370
CHEMBL390839,P20309,,ZFBFLFSZJZOBBU-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,249,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030388,DTCC00443114,33996,22116
CHEMBL390842,P20309,,KUBKWLQZGDWVNE-OULXEKPRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,EC50,=,407.38,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 receptor expressed in CHO cells,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432435,DTCT0023280,2061480,DTCC00111210,1841082,22396
CHEMBL390842,P20309,,KUBKWLQZGDWVNE-OULXEKPRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17084634,INTRINSIC ACTIVITY,=,1,,,cell_based,,,,,,,,,,,CHO,Intrinsic activity at muscarinic M3 receptor expressed in CHO cells assessed as ratio of agonist activity to activity of carbachol,,Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.,Bioorg. Med. Chem.,2007,15,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Bruni B, Buccioni M, Carrieri A, Ciattini S",,432440,DTCT0023280,2061500,DTCC00111210,1841082,22396
CHEMBL390842,P20309,,KUBKWLQZGDWVNE-OULXEKPRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18077164,KI,=,3388.44,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,,"Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.",Bioorg. Med. Chem. Lett.,2008,18,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Buccioni M, Nesi M, Matucci R",,461882,DTCT0023280,2278186,DTCC00111210,1841479,25106
CHEMBL390842,P20309,,KUBKWLQZGDWVNE-OULXEKPRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,7585.78,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164330,DTCC00111210,1854280,36765
CHEMBL390842,P20309,,KUBKWLQZGDWVNE-OULXEKPRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22243489,KI,=,7585.78,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,,"1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists.",J. Med. Chem.,2012,55,4,"Del Bello F, Barocelli E, Bertoni S, Bonifazi A, Camalli M, Campi G, Giannella M, Matucci R, Nesi M, Pigini M, Quaglia W, Piergentili A",,826080,DTCT0023280,10512632,DTCC00111210,1863835,48454
CHEMBL390842,P20309,,KUBKWLQZGDWVNE-OULXEKPRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24980056,KI,=,7585.78,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,,"Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.",Bioorg. Med. Chem. Lett.,2014,24,15,"Del Bello F, Bonifazi A, Quaglia W, Mazzolari A, Barocelli E, Bertoni S, Matucci R, Nesi M, Piergentili A, Vistoli G",,1459949,DTCT0023280,13906720,DTCC00111210,1866844,60777
CHEMBL391977,P20309,,ONSBLCCSCRKRKU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,2.9,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164138,DTCC00111779,1841177,23149
CHEMBL392045,P20309,,MREDDVDVVADTHB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,IC50,>,100,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164134,DTCC00111785,714358,23149
CHEMBL392186,P20309,,BOXRBFJLKOMZNE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,4.2,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164136,DTCC00111782,1970738,23149
CHEMBL392760,P20309,WAY-181187,RYBOXBBYCVOYNO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17948978,ACTIVITY,<,50,%,,,,,,,,,,,,,,Displacement of radio ligand from muscarinic M3 receptor at 100 nM,,"Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.",J. Med. Chem.,2007,50,23,"Cole DC, Stock JR, Lennox WJ, Bernotas RC, Ellingboe JW, Boikess S, Coupet J, Smith DL, Leung L, Zhang GM, Feng X, Kelly MF, Galante R, Huang P, Dawson LA, Marquis K, Rosenzweig-Lipson S, Beyer CE, Schechter LE",,451189,DTCT0023280,2203182,DTCC00003286,2020054,24044
CHEMBL394137,P20309,,CWHBWBZGFMIKAF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,1.5,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164143,DTCC00464048,617446,23149
CHEMBL394254,P20309,,YRAPYXYTEMMURR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,3.3,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164146,DTCC00464045,1652393,23149
CHEMBL394255,P20309,,TUWSHNPHYLLLCD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,14,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164141,DTCC00464051,66878,23149
CHEMBL394329,P20309,,UELJWCNXSZHJHU-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,5539,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193386,DTCC00473790,1491068,23951
CHEMBL395110,P20309,MEPAZINE,CBHCDHNUZWWAPP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,191,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430032,DTCC00464417,477046,46191
CHEMBL395110,P20309,MEPAZINE,CBHCDHNUZWWAPP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,40,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430033,DTCC00464417,477046,46191
CHEMBL395368,P20309,,ZYALYWXELCWDBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17127059,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity at muscarinic M3 receptor at 1 uM,Not Active,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,4,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453451,DTCT0023280,2219128,DTCC00477229,67033,24220
CHEMBL395571,P20309,,ZRPGGNHMOAWEPI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,40,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157568,DTCC00462712,1564903,23370
CHEMBL395609,P20309,,DIMAAAZZSSXDEH-DFBJGRDBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17127059,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity at muscarinic M3 receptor at 1 uM,Not Active,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,4,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453451,DTCT0023280,2219178,DTCC00477237,682203,24220
CHEMBL396761,P20309,,FTIDRMNTTJHUPO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,158.49,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157832,DTCC00462729,530499,23370
CHEMBL396761,P20309,,FTIDRMNTTJHUPO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,200,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157562,DTCC00462729,530499,23370
CHEMBL396845,P20309,,JWMOCQPZPIJACF-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,887,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193385,DTCC00473793,1587624,23951
CHEMBL397983,P20309,AMG-487,WQTKNBPCJKRYPA-OAQYLSRUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,,,,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,Not Determined,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455666,DTCC00002887,1567625,31823
CHEMBL398043,P20309,,SPJDCNFZODNKEM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,537,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193389,DTCC00473767,1873283,23951
CHEMBL398440,P20309,CHLOROXYLENOL,OSDLLIBGSJNGJE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7362480,DTCC00485552,1059329,46191
CHEMBL398440,P20309,CHLOROXYLENOL,OSDLLIBGSJNGJE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7364505,DTCC00485552,1059329,46191
CHEMBL4,P20309,OFLOXACIN,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7390913,DTCC00132314,1641850,46191
CHEMBL4,P20309,OFLOXACIN,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7390914,DTCC00132314,1641850,46191
CHEMBL40,P20309,PHENOBARBITAL,DDBREPKUVSBGFI-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7382899,DTCC00134072,51499,46191
CHEMBL40,P20309,PHENOBARBITAL,DDBREPKUVSBGFI-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7382900,DTCC00134072,51499,46191
CHEMBL402207,P20309,,DYKWWNCEKVABFK-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of basal Eu-GTP binding,Not Active,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477426,DTCT0023280,2368255,DTCC00490919,1491403,26235
CHEMBL402207,P20309,,DYKWWNCEKVABFK-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,2.69153E+15,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368175,DTCC00490919,1491403,26235
CHEMBL402207,P20309,,DYKWWNCEKVABFK-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,PKB,=,6.25,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of carbachol-induced Eu-GTP binding,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477421,DTCT0023280,2368241,DTCC00490919,1491403,26235
CHEMBL402282,P20309,,XENYNIAITLJGFI-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,1.8197E+14,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368181,DTCC00491044,650615,26235
CHEMBL402794,P20309,BIS(2-ETHYLHEXYL)PHTHALATE,BJQHLKABXJIVAM-BGYRXZFFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7265879,DTCC00499603,153439,46191
CHEMBL402794,P20309,BIS(2-ETHYLHEXYL)PHTHALATE,BJQHLKABXJIVAM-BGYRXZFFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7265880,DTCC00499603,153439,46191
CHEMBL402879,P20309,,QVMMTHPNSFHIPH-QMDRZIQZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,-2,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974217,DTCC00432402,972438,21327
CHEMBL403,P20309,SULBACTAM,FKENQMMABCRJMK-RITPCOANSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458621,DTCC00132361,671795,46191
CHEMBL403,P20309,SULBACTAM,FKENQMMABCRJMK-RITPCOANSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458622,DTCC00132361,671795,46191
CHEMBL403029,P20309,,XVRVZKJLXTWKSC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,1.41254E+13,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368184,DTCC00491080,617906,26235
CHEMBL403592,P20309,,RASOSRDDYBIKOY-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,8.12831E+13,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368177,DTCC00490964,99594,26235
CHEMBL403773,P20309,,VNPBUFXHTACLEO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of basal Eu-GTP binding,Not Active,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477426,DTCT0023280,2368256,DTCC00490965,67367,26235
CHEMBL403773,P20309,,VNPBUFXHTACLEO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,1.38038E+15,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368176,DTCC00490965,67367,26235
CHEMBL403773,P20309,,VNPBUFXHTACLEO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,PKB,=,6.14,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of carbachol-induced Eu-GTP binding,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477421,DTCT0023280,2368233,DTCC00490965,67367,26235
CHEMBL403858,P20309,PH-709829,PTGWFYYEAUFEAS-ZYHUDNBSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18490160,ACTIVITY,=,15,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]DAMP from human muscarinic M3 receptor expressed in CHO cells at 10 uM,,"Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity.",Bioorg. Med. Chem. Lett.,2008,18,12,"Acker BA, Jacobsen EJ, Rogers BN, Wishka DG, Reitz SC, Piotrowski DW, Myers JK, Wolfe ML, Groppi VE, Thornburgh BA, Tinholt PM, Walters RR, Olson BA, Fitzgerald L, Staton BA, Raub TJ, Krause M, Li KS, Hoffmann WE, Hajos M, Hurst RS, Walker DP",,479261,DTCT0023280,2375389,DTCC00004038,941160,26339
CHEMBL404,P20309,TAZOBACTAM,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470000,DTCC00132373,88636,46191
CHEMBL404,P20309,TAZOBACTAM,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470001,DTCC00132373,88636,46191
CHEMBL404520,P20309,CHLORTETRACYCLINE,CYDMQBQPVICBEU-XRNKAMNCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7341072,DTCC00502280,1027048,46191
CHEMBL404520,P20309,CHLORTETRACYCLINE,CYDMQBQPVICBEU-XRNKAMNCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7341073,DTCC00502280,1027048,46191
CHEMBL404557,P20309,,KUBKWLQZGDWVNE-VTLYIQCISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18077164,KI,=,61659.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,,"Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.",Bioorg. Med. Chem. Lett.,2008,18,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Buccioni M, Nesi M, Matucci R",,461882,DTCT0023280,2278182,DTCC00112469,876707,25106
CHEMBL404557,P20309,,KUBKWLQZGDWVNE-VTLYIQCISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,35481.34,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164354,DTCC00112469,889629,36765
CHEMBL404811,P20309,DIGITONIN,UVYVLBIGDKGWPX-YCCXZQINSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7340434,DTCC00199357,249941,46191
CHEMBL404811,P20309,DIGITONIN,UVYVLBIGDKGWPX-YCCXZQINSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7340435,DTCC00199357,249941,46191
CHEMBL404866,P20309,,ZXONLUAUCNXHRY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,1.14815E+13,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368182,DTCC00491043,2036605,26235
CHEMBL405117,P20309,,COMTUMBLKXMVJR-JGEPAZAQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,80,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972909,DTCC00432060,1037323,21327
CHEMBL405117,P20309,,COMTUMBLKXMVJR-JGEPAZAQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,48,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974227,DTCC00432060,1037323,21327
CHEMBL40554,P20309,,DDKOMKXCUXCQBS-UHFFFAOYSA-O,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,2398.83,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649044,DTCC00181310,532765,31191
CHEMBL40583,P20309,3-METHYLCHOLANTHRENE,PPQNQXQZIWHJRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7290553,DTCC00181233,1894962,46191
CHEMBL40583,P20309,3-METHYLCHOLANTHRENE,PPQNQXQZIWHJRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7290554,DTCC00181233,1894962,46191
CHEMBL406,P20309,INDAPAMIDE,NDDAHWYSQHTHNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7422351,DTCC00132717,1609547,46191
CHEMBL406,P20309,INDAPAMIDE,NDDAHWYSQHTHNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7422352,DTCC00132717,1609547,46191
CHEMBL407,P20309,FLUMAZENIL,OFBIFZUFASYYRE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7320425,DTCC00132733,1609545,46191
CHEMBL407,P20309,FLUMAZENIL,OFBIFZUFASYYRE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7320426,DTCC00132733,1609545,46191
CHEMBL407030,P20309,GAMMA-CYCLODEXTRIN,MIFVTYPADKEWAV-HGRQBIKSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7312207,DTCC00003162,88629,46191
CHEMBL407030,P20309,GAMMA-CYCLODEXTRIN,MIFVTYPADKEWAV-HGRQBIKSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7312208,DTCC00003162,88629,46191
CHEMBL407135,P20309,COLISTINE,YKQOSKADJPQZHB-YNWHQGOSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7352407,DTCC00494880,1705874,46191
CHEMBL407135,P20309,COLISTINE,YKQOSKADJPQZHB-YNWHQGOSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7352408,DTCC00494880,1705874,46191
CHEMBL40733,P20309,DESMETHYLSERTRALINE,SRPXSILJHWNFMK-ZBEGNZNMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,3500,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14738536,DTCC00177141,2106676,68567
CHEMBL408,P20309,TROGLITAZONE,GXPHKUHSUJUWKP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449210,DTCC00132763,800583,46191
CHEMBL408,P20309,TROGLITAZONE,GXPHKUHSUJUWKP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7449211,DTCC00132763,800583,46191
CHEMBL409151,P20309,,OIVUQKJVYIDTLN-DNQXCXABSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,0.316,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362685,DTCC00492516,424917,26143
CHEMBL41,P20309,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,1000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14730122,DTCC00134078,2104074,68567
CHEMBL41,P20309,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,3595,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7324785,DTCC00134078,1609546,46191
CHEMBL41,P20309,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,762,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7324786,DTCC00134078,1609546,46191
CHEMBL410061,P20309,,QUEZQOMBHXIFLS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362679,DTCC00492425,455779,26143
CHEMBL410414,P20309,DIRLOTAPIDE,TUOSYWCFRFNJBS-BHVANESWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17276061,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 1 uM,Not Active,"In vitro and in vivo profile of 5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity.",Bioorg. Med. Chem. Lett.,2007,17,7,"Li J, Bronk BS, Dirlam JP, Blize AE, Bertinato P, Jaynes BH, Hickman A, Miskell C, Pillai UA, Tibbitts JS, Haven ML, Kolosko NL, Barry CJ, Manion TB",,446935,DTCT0023280,2169185,DTCC00465113,698411,23620
CHEMBL410890,P20309,,YLJPQUAQAHVZQK-XLIONFOSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,3.7,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1462976,DTCC00221670,1326178,5621
CHEMBL411,P20309,DIETHYLSTILBESTROL,RGLYKWWBQGJZGM-ISLYRVAYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,18432,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7363834,DTCC00132930,2057648,46191
CHEMBL411,P20309,DIETHYLSTILBESTROL,RGLYKWWBQGJZGM-ISLYRVAYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,3907,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7363835,DTCC00132930,2057648,46191
CHEMBL411514,P20309,,DIYINODUENLYSI-HSZRJFAPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,10,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362681,DTCC00492470,973153,26143
CHEMBL412663,P20309,,MPSNEAHFGOEKBI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9622546,INHIBITION,=,28,%,,cell_based,,,,,,,,,,,CHO,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with rat Muscarinic acetylcholine receptor M3,,6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.,J. Med. Chem.,1998,41,12,"Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW",,138722,DTCT0023280,1634630,DTCC00213545,1722766,14670
CHEMBL412873,P20309,SPARTEINE,SLRCCWJSBJZJBV-TUVASFSCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7478052,DTCC00141609,1674150,46191
CHEMBL412873,P20309,SPARTEINE,SLRCCWJSBJZJBV-TUVASFSCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7478053,DTCC00141609,1674150,46191
CHEMBL413,P20309,SIROLIMUS,QFJCIRLUMZQUOT-HPLJOQBZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457636,DTCC00132982,477921,46191
CHEMBL413,P20309,SIROLIMUS,QFJCIRLUMZQUOT-HPLJOQBZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457637,DTCC00132982,477921,46191
CHEMBL413965,P20309,FELBINAC,QRZAKQDHEVVFRX-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7322284,DTCC00106501,1285874,46191
CHEMBL413965,P20309,FELBINAC,QRZAKQDHEVVFRX-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7322285,DTCC00106501,1285874,46191
CHEMBL414804,P20309,OXALIPLATIN,ZROHGHOFXNOHSO-BNTLRKBRSA-L,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7382340,DTCC00333435,736264,46191
CHEMBL414804,P20309,OXALIPLATIN,ZROHGHOFXNOHSO-BNTLRKBRSA-L,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7382341,DTCC00333435,736264,46191
CHEMBL415,P20309,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,170,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7369512,DTCC00133038,217576,46191
CHEMBL415,P20309,CLOMIPRAMINE,GDLIGKIOYRNHDA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,36,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7369513,DTCC00133038,217576,46191
CHEMBL415324,P20309,TRANILAST,NZHGWWWHIYHZNX-CSKARUKUSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447106,DTCC00281196,1674153,46191
CHEMBL415324,P20309,TRANILAST,NZHGWWWHIYHZNX-CSKARUKUSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7447107,DTCC00281196,1674153,46191
CHEMBL41543,P20309,,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293170,DTCC00180007,866015,46191
CHEMBL41543,P20309,,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7293171,DTCC00180007,866015,46191
CHEMBL415690,P20309,BETADEX,WHGYBXFWUBPSRW-FOUAGVGXSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7262853,DTCC00463534,249937,46191
CHEMBL415690,P20309,BETADEX,WHGYBXFWUBPSRW-FOUAGVGXSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7262854,DTCC00463534,249937,46191
CHEMBL416,P20309,METHOXSALEN,QXKHYNVANLEOEG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7406719,DTCC00133091,1765976,46191
CHEMBL416,P20309,METHOXSALEN,QXKHYNVANLEOEG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7406720,DTCC00133091,1765976,46191
CHEMBL417,P20309,EPIRUBICIN,AOJJSUZBOXZQNB-VTZDEGQISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7315467,DTCC00133135,671788,46191
CHEMBL417,P20309,EPIRUBICIN,AOJJSUZBOXZQNB-VTZDEGQISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7315468,DTCC00133135,671788,46191
CHEMBL418971,P20309,BISPHENOL A,IISBACLAFKSPIT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7271315,DTCC00260853,88624,46191
CHEMBL418971,P20309,BISPHENOL A,IISBACLAFKSPIT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7271316,DTCC00260853,88624,46191
CHEMBL419142,P20309,,VHVPHEQZIBIJKB-NTEUORMPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,917310,DTCC00259988,1500191,3355
CHEMBL419142,P20309,,VHVPHEQZIBIJKB-NTEUORMPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139793,DTCT0023280,917311,DTCC00259988,1500191,3355
CHEMBL42,P20309,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,20,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14745832,DTCC00134115,2109047,68417
CHEMBL42,P20309,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8822531,KI,=,7,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14745829,DTCC00134115,2109031,68827
CHEMBL42,P20309,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10708730,KI,=,109,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14745834,DTCC00134115,2109048,68468
CHEMBL42,P20309,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,25,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14745831,DTCC00134115,2109030,68826
CHEMBL42,P20309,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,7,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14745830,DTCC00134115,2109046,68458
CHEMBL42,P20309,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,109,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14745833,DTCC00134115,2109046,68458
CHEMBL42,P20309,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,78,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365265,DTCC00134115,51460,46191
CHEMBL42,P20309,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,17,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365266,DTCC00134115,51460,46191
CHEMBL42,P20309,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,100,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329745,DTCT0023280,13584607,DTCC00134115,58495,39761
CHEMBL420,P20309,GUANABENZ,WDZVGELJXXEGPV-YIXHJXPBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314857,DTCC00133212,1416031,46191
CHEMBL420,P20309,GUANABENZ,WDZVGELJXXEGPV-YIXHJXPBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314858,DTCC00133212,1416031,46191
CHEMBL420008,P20309,,XOZKVVSXDCLNPX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11055330,KI,=,3.4,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,,Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000,10,20,"Wang Y, Chackalamannil S, Hu Z, Clader JW, Greenlee W, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, McQuade R, Lachowicz JE",,138706,DTCT0023280,797602,DTCC00226616,1359062,3944
CHEMBL420255,P20309,,FCXGFIPSMPFKDE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,>,5000,NM,,,,,,,,,,,,,,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),,,Bioorg. Med. Chem. Lett.,1994,4,24,,,138254,DTCT0023280,846983,DTCC00261908,1629599,1026
CHEMBL420662,P20309,,HATAELBMIJKIHX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,407.38,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1601327,DTCC00274658,1882688,16818
CHEMBL420781,P20309,,QHCKLZMSWSJPAW-BMRADRMJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,0,%,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M2 values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol.,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,139892,DTCT0023280,1628327,DTCC00244081,452870,14722
CHEMBL421,P20309,SULFASALAZINE,NCEXYHBECQHGNR-QZQOTICOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7476257,DTCC00133232,2025643,46191
CHEMBL421,P20309,SULFASALAZINE,NCEXYHBECQHGNR-QZQOTICOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7476258,DTCC00133232,2025643,46191
CHEMBL421113,P20309,,PVJYTQKTDNFHQU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11055330,KI,=,10.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,,Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000,10,20,"Wang Y, Chackalamannil S, Hu Z, Clader JW, Greenlee W, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, McQuade R, Lachowicz JE",,138706,DTCT0023280,799002,DTCC00226641,225644,3944
CHEMBL422,P20309,TRIFLUOPERAZINE,ZEWQUBUPAILYHI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,1001,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14733167,DTCC00133320,2104679,68826
CHEMBL422,P20309,TRIFLUOPERAZINE,ZEWQUBUPAILYHI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440575,DTCC00133320,962453,46191
CHEMBL422,P20309,TRIFLUOPERAZINE,ZEWQUBUPAILYHI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440576,DTCC00133320,962453,46191
CHEMBL422665,P20309,,YRRVEDQQANFYHX-NLFFAJNJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,6.9,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1386952,DTCC00334943,1597925,16058
CHEMBL423192,P20309,ANISOMYCIN,YKJYKKNCCRKFSL-RDBSUJKOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279282,DTCC00329526,866016,46191
CHEMBL423192,P20309,ANISOMYCIN,YKJYKKNCCRKFSL-RDBSUJKOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279283,DTCC00329526,866016,46191
CHEMBL423831,P20309,,MPVIJPUSNDEBBO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,25.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,980016,DTCC00367062,1339842,17703
CHEMBL424,P20309,SALICYLIC ACID,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462368,DTCC00133347,51507,46191
CHEMBL424,P20309,SALICYLIC ACID,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462369,DTCC00133347,51507,46191
CHEMBL424214,P20309,,VWJYXQWEMPOSAS-SAPNQHFASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11354386,KI,=,97723.72,NM,,cell_based,,,,,,,,,,,CHO,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,,Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.,Bioorg. Med. Chem. Lett.,2001,11,9,"Böhme TM, Keim C, Dannhardt G, Mutschler E, Lambrecht G",,138827,DTCT0023280,1350695,DTCC00154276,1066575,4821
CHEMBL424286,P20309,N-AMINO BRUCINE MESITYLENESULFONATE,YEHVVXMTEUHAGT-MDJCGXDDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.8,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1348296,DTCC01743368,498720,15566
CHEMBL424286,P20309,N-AMINO BRUCINE MESITYLENESULFONATE,YEHVVXMTEUHAGT-MDJCGXDDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.9,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1348297,DTCC01743368,498720,15566
CHEMBL424286,P20309,N-AMINO BRUCINE MESITYLENESULFONATE,YEHVVXMTEUHAGT-MDJCGXDDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1348301,DTCC01743368,498720,15566
CHEMBL424286,P20309,N-AMINO BRUCINE MESITYLENESULFONATE,YEHVVXMTEUHAGT-MDJCGXDDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,>,2,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1348306,DTCC01743368,498720,15566
CHEMBL424416,P20309,,SIYFJBSSISWOBJ-QAPCUYQASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,17,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1480048,DTCC00221808,1455739,5621
CHEMBL42442,P20309,OXFENDAZOLE,BEZZFPOZAYTVHN-UHFFFAOYSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395300,DTCC00184703,282999,46191
CHEMBL42442,P20309,OXFENDAZOLE,BEZZFPOZAYTVHN-UHFFFAOYSA-N,2,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395301,DTCC00184703,282999,46191
CHEMBL426123,P20309,(-)-THALIDOMIDE,UEJJHQNACJXSKW-VIFPVBQESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7297121,DTCC00001569,1609540,46191
CHEMBL426123,P20309,(-)-THALIDOMIDE,UEJJHQNACJXSKW-VIFPVBQESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7297122,DTCC00001569,1609540,46191
CHEMBL426393,P20309,,YHMNXSIUGYBUAW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,228,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030929,DTCC00443181,757970,22115
CHEMBL426890,P20309,,VBMVFCIJGFHCCF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,2445,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030898,DTCC00443219,564277,22115
CHEMBL427013,P20309,,NHSNVFUDXZEPFP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16275087,KI,=,0.32,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,2006,16,2,"Starck JP, Talaga P, Quéré L, Collart P, Christophe B, Lo Brutto P, Jadot S, Chimmanamada D, Zanda M, Wagner A, Mioskowski C, Massingham R, Guyaux M",,327855,DTCT0023280,1879410,DTCC00411986,1405297,10048
CHEMBL42710,P20309,EUGENOL,RRAFCDWBNXTKKO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7309489,DTCC00183810,1253322,46191
CHEMBL42710,P20309,EUGENOL,RRAFCDWBNXTKKO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7309490,DTCC00183810,1253322,46191
CHEMBL427216,P20309,GLICLAZIDE,BOVGTQGAOIONJV-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7318839,DTCC00422269,800576,46191
CHEMBL427216,P20309,GLICLAZIDE,BOVGTQGAOIONJV-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7318840,DTCC00422269,800576,46191
CHEMBL427390,P20309,,FXPSOZQCBXDQGT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16439121,KI,=,100,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,,"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.",Bioorg. Med. Chem. Lett.,2006,16,7,"Provins L, Christophe B, Danhaive P, Dulieu J, Durieu V, Gillard M, Lebon F, Lengelé S, Quéré L, van Keulen B",,345379,DTCT0023280,1914044,DTCC00419415,1372930,20612
CHEMBL427526,P20309,(R)-IBUPROPHEN,HEFNNWSXXWATRW-SNVBAGLBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470659,DTCC00396930,671793,46191
CHEMBL427526,P20309,(R)-IBUPROPHEN,HEFNNWSXXWATRW-SNVBAGLBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470660,DTCC00396930,671793,46191
CHEMBL428,P20309,TROVAFLOXACIN,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442295,DTCC00133538,1577011,46191
CHEMBL428,P20309,TROVAFLOXACIN,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442296,DTCC00133538,1577011,46191
CHEMBL428647,P20309,PACLITAXEL,RCINICONZNJXQF-MZXODVADSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7393209,DTCC00138918,51496,46191
CHEMBL428647,P20309,PACLITAXEL,RCINICONZNJXQF-MZXODVADSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7393210,DTCC00138918,51496,46191
CHEMBL428880,P20309,CROMOLYN,IMZMKUWMOSJXDT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7339685,DTCC00138605,671787,46191
CHEMBL428880,P20309,CROMOLYN,IMZMKUWMOSJXDT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7339686,DTCC00138605,671787,46191
CHEMBL428916,P20309,,LDQWDYOIYCCVMX-WLHGVMLRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,4013,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193391,DTCC00473752,260583,23951
CHEMBL428962,P20309,,VBKBVALDNMYEBZ-PKTZIBPZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18359633,KI,=,0.2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,,Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.,Bioorg. Med. Chem. Lett.,2008,18,8,"Starck JP, Provins L, Christophe B, Gillard M, Jadot S, Lo Brutto P, Quéré L, Talaga P, Guyaux M",,475991,DTCT0023280,2362687,DTCC00492556,1038066,26143
CHEMBL429,P20309,LABETALOL,SGUAFYQXFOLMHL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429236,DTCC00133676,120973,46191
CHEMBL429,P20309,LABETALOL,SGUAFYQXFOLMHL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429237,DTCC00133676,120973,46191
CHEMBL429023,P20309,ROTENONE,JUVIOZPCNVVQFO-HBGVWJBISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7488103,DTCC00134556,1027058,46191
CHEMBL429023,P20309,ROTENONE,JUVIOZPCNVVQFO-HBGVWJBISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7488104,DTCC00134556,1027058,46191
CHEMBL429620,P20309,,NEJXTPAHRJINQU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,IC50,>,100,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164154,DTCC00464036,909024,23149
CHEMBL43048,P20309,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12761331,KI,=,1851,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14730560,DTCC00186878,2104160,68767
CHEMBL430587,P20309,,RQPHVQRRFIQPNU-PBEPXJRFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,10964.78,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1400457,DTCC00203604,787533,4936
CHEMBL43064,P20309,CINNARIZINE,DERZBLKQOCDDDZ-JLHYYAGUSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,762,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7367034,DTCC01738588,930078,46191
CHEMBL43064,P20309,CINNARIZINE,DERZBLKQOCDDDZ-JLHYYAGUSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,162,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7367035,DTCC01738588,930078,46191
CHEMBL431688,P20309,,UZZVATFZIVRAFI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1927.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1605220,DTCC00107406,205509,15558
CHEMBL432170,P20309,,AKVBPIBFLBXBAR-CPJSRVTESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,15115380,KI,>,5300,NM,,,,,,,,,,,,,,Antagonistic activity against muscarinic M3 receptor,,"Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.",J. Med. Chem.,2004,47,10,"Tagat JR, McCombie SW, Nazareno D, Labroli MA, Xiao Y, Steensma RW, Strizki JM, Baroudy BM, Cox K, Lachowicz J, Varty G, Watkins R",,138699,DTCT0023280,1011229,DTCC00236228,1968275,17809
CHEMBL433257,P20309,HARRINGTONINE,HAVJATCHLFRDHY-KSZYUSJVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310627,DTCC00188822,1447883,46191
CHEMBL433257,P20309,HARRINGTONINE,HAVJATCHLFRDHY-KSZYUSJVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310628,DTCC00188822,1447883,46191
CHEMBL433355,P20309,,PHMKCTAFYAPWGP-QPEQYQDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,919526,DTCC00260031,1240553,3355
CHEMBL433355,P20309,,PHMKCTAFYAPWGP-QPEQYQDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,11,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,919527,DTCC00260031,1240553,3355
CHEMBL43383,P20309,,BCUGCHZRMKTPMU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,63.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14735622,DTCC00185332,2105705,68416
CHEMBL434,P20309,ISOPROTERENOL,JWZZKOKVBUJMES-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437555,DTCC00133870,315665,46191
CHEMBL434,P20309,ISOPROTERENOL,JWZZKOKVBUJMES-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437556,DTCC00133870,315665,46191
CHEMBL434063,P20309,GW1929,QTQMRBZOBKYXCG-MHZLTWQESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327650,DTCC01743578,994594,46191
CHEMBL434063,P20309,GW1929,QTQMRBZOBKYXCG-MHZLTWQESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327651,DTCC01743578,994594,46191
CHEMBL434388,P20309,,NCOBSULCEGPDAP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,32,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157566,DTCC00462720,141259,23370
CHEMBL434684,P20309,,DMQAXIJUTYJHIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,31.62,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,1007561,DTCC00367081,1469113,17703
CHEMBL434765,P20309,,YSPSUCSBUBWFID-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,79,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157569,DTCC00462710,1915066,23370
CHEMBL434929,P20309,,PFUOHJZFGIXXQE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,101,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030933,DTCC00443277,142907,22115
CHEMBL435,P20309,HYDROCHLOROTHIAZIDE,JZUFKLXOESDKRF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336281,DTCC00133916,1285877,46191
CHEMBL435,P20309,HYDROCHLOROTHIAZIDE,JZUFKLXOESDKRF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336282,DTCC00133916,1285877,46191
CHEMBL435158,P20309,,NOVHBLUNWGORLP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,IC50,>,100,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164151,DTCC00464039,488705,23149
CHEMBL435353,P20309,,OQSIDBCKNRLVHE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17188867,KI,=,11,NM,,cell_based,,,,,,,,,,,Sf9,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,,"1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.",Bioorg. Med. Chem. Lett.,2007,17,4,"Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T",,441418,DTCT0023280,2164142,DTCC00464049,1166206,23149
CHEMBL435949,P20309,,IDBBDQXTEVOOKW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11378358,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to cloned Muscarinic acetylcholine receptor M3,,Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.,Bioorg. Med. Chem. Lett.,2001,11,11,"Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M",,138981,DTCT0023280,1212293,DTCC00165331,1788237,4253
CHEMBL436492,P20309,,JHSZRBVWJTVOGE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,25.8,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030920,DTCC00443220,435611,22115
CHEMBL436814,P20309,,IJILNSLXXDENGI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17398090,KI,=,631,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,,Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives.,Bioorg. Med. Chem. Lett.,2007,17,11,"Provins L, Christophe B, Danhaive P, Dulieu J, Gillard M, Quéré L, Stebbins K",,443515,DTCT0023280,2157561,DTCC00462731,627461,23370
CHEMBL436850,P20309,,VSOBLNMIFPVGOT-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,2.45471E+14,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368185,DTCC00491083,1971241,26235
CHEMBL437,P20309,SULFATHIAZOLE,JNMRHUJNCSQMMB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7480611,DTCC00133961,1027059,46191
CHEMBL437,P20309,SULFATHIAZOLE,JNMRHUJNCSQMMB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7480612,DTCC00133961,1027059,46191
CHEMBL437002,P20309,,LEVTWCPGXIVKEH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7294303,DTCC00473690,1734052,46191
CHEMBL437002,P20309,,LEVTWCPGXIVKEH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7294304,DTCC00473690,1734052,46191
CHEMBL437334,P20309,,FHUWBWRDUCYYKK-VMXYRSAXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,11,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1972910,DTCC00432061,1937220,21327
CHEMBL438,P20309,SULFAMERAZINE,QPPBRPIAZZHUNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484726,DTCC00133994,1798418,46191
CHEMBL438,P20309,SULFAMERAZINE,QPPBRPIAZZHUNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484727,DTCC00133994,1798418,46191
CHEMBL438243,P20309,ALAMETHICIN,LGHSQOCGTJHDIL-UTXLBGCNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352463,KI,=,619,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).",J. Med. Chem.,2007,50,7,"Peretto I, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Cerri A, Menegon S, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Bassani F, Delcanale M, Imbimbo BP",,429188,DTCT0023280,2030379,DTCC00444027,1820268,22116
CHEMBL438427,P20309,,XTFLNWJPCXKOPL-XMMPIXPASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,13.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030894,DTCC00443231,1081591,22115
CHEMBL43882,P20309,TRICHLOROETHANE,UBOXGVDOUJQMTN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7452810,DTCC00104711,1830694,46191
CHEMBL43882,P20309,TRICHLOROETHANE,UBOXGVDOUJQMTN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7452811,DTCC00104711,1830694,46191
CHEMBL438822,P20309,,DKABYCZEFMBXSO-BMSWWXRLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,KI,=,0.39,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395698,DTCT0023280,1974297,DTCC00432277,810785,21327
CHEMBL438880,P20309,,CTWROBSUHKMCTE-MFABWLECSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,12,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974218,DTCC00432401,908760,21327
CHEMBL439,P20309,SULFADIAZINE,SEEPANYCNGTZFQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7471736,DTCC00133995,1734063,46191
CHEMBL439,P20309,SULFADIAZINE,SEEPANYCNGTZFQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7471737,DTCC00133995,1734063,46191
CHEMBL439329,P20309,,CVJGFTBSHHKNRH-AJAIOKFNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16970392,INHIBITION,=,22,%,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells at 1 uM,,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,2006,49,19,"Sagara Y, Sagara T, Uchiyama M, Otsuki S, Kimura T, Fujikawa T, Noguchi K, Ohtake N",,395707,DTCT0023280,1974213,DTCC00432007,1005012,21327
CHEMBL439588,P20309,,YEWKXOVRQPTZSH-GDNBJRDFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,12,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139791,DTCT0023280,914890,DTCC00260596,853410,3355
CHEMBL439588,P20309,,YEWKXOVRQPTZSH-GDNBJRDFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,48,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,914891,DTCC00260596,853410,3355
CHEMBL44,P20309,GENISTEIN,TZBJGXHYKVUXJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7303754,DTCC00134437,2089749,46191
CHEMBL44,P20309,GENISTEIN,TZBJGXHYKVUXJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7303755,DTCC00134437,2089749,46191
CHEMBL440085,P20309,,TUTIKEIKWZZHKM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,800,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1015534,DTCC00133069,596757,8985
CHEMBL440138,P20309,,TUIVYXUOOMYSLZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,7400,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138710,DTCT0023280,595403,DTCC00243802,128982,15779
CHEMBL440138,P20309,,TUIVYXUOOMYSLZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,595404,DTCC00243802,128982,15779
CHEMBL441687,P20309,GLYCYRRHIZIN,LPLVUJXQOOQHMX-QWBHMCJMSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314731,DTCC00424760,1992805,46191
CHEMBL441687,P20309,GLYCYRRHIZIN,LPLVUJXQOOQHMX-QWBHMCJMSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314732,DTCC00424760,1992805,46191
CHEMBL441873,P20309,,BMGQVKZMTZBKLQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17352462,KI,=,13.4,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,Antagonist,"Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).",J. Med. Chem.,2007,50,7,"Peretto I, Forlani R, Fossati C, Giardina GA, Giardini A, Guala M, La Porta E, Petrillo P, Radaelli S, Radice L, Raveglia LF, Santoro E, Scudellaro R, Scarpitta F, Bigogno C, Misiano P, Dondio GM, Rizzi A, Armani E, Amari G, Civelli M, Villetti G, Patacchini R, Bergamaschi M, Delcanale M, Salcedo C, Fernández AG, Imbimbo BP",,429171,DTCT0023280,2030927,DTCC00443185,984280,22115
CHEMBL442,P20309,ERGOTAMINE,XCGSFFUVFURLIX-VFGNJEKYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330518,DTCC00134058,1027052,46191
CHEMBL442,P20309,ERGOTAMINE,XCGSFFUVFURLIX-VFGNJEKYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330519,DTCC00134058,1027052,46191
CHEMBL442494,P20309,SRIF-28,GGYTXJNZMFRSLX-OKOIUDDXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,18,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,917317,DTCC00000662,530132,3355
CHEMBL442494,P20309,SRIF-28,GGYTXJNZMFRSLX-OKOIUDDXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,50,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,917318,DTCC00000662,530132,3355
CHEMBL443,P20309,SULFAMETHOXAZOLE,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463128,DTCC00134101,315670,46191
CHEMBL443,P20309,SULFAMETHOXAZOLE,JLKIGFTWXXRPMT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463129,DTCC00134101,315670,46191
CHEMBL443267,P20309,,URMUNPDVNSULQI-GCJKJVERSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,7,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1476204,DTCC00221859,64145,5621
CHEMBL443780,P20309,,KFFUMWAFMBSHHP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1560441,KI,=,9.9,NM,,,,,,,,,,,,,,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Muscarinic acetylcholine receptor M3 subtype,,"Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).",J. Med. Chem.,1992,35,7,"Leader H, Gordon RK, Baumgold J, Boyd VL, Newman AH, Smejkal RM, Chiang PK",,138702,DTCT0023280,655432,DTCC00158664,984714,11861
CHEMBL443925,P20309,,WLYRERZDPMFDFL-GPNIZQGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460541,DTCC00566338,1745580,32581
CHEMBL444633,P20309,RIFABUTIN,ATEBXHFBFRCZMA-VXTBVIBXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475124,DTCC00465352,1092349,46191
CHEMBL444633,P20309,RIFABUTIN,ATEBXHFBFRCZMA-VXTBVIBXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7475125,DTCC00465352,1092349,46191
CHEMBL445,P20309,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,50,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14739646,DTCC00134116,2107129,68567
CHEMBL445,P20309,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,171,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7399406,DTCC00134116,1092345,46191
CHEMBL445,P20309,NORTRIPTYLINE,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,36,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7399407,DTCC00134116,1092345,46191
CHEMBL445206,P20309,ISOEUGENOL,BJIOGJUNALELMI-ARJAWSKDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429041,DTCC00115215,1830686,46191
CHEMBL445206,P20309,ISOEUGENOL,BJIOGJUNALELMI-ARJAWSKDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429042,DTCC00115215,1830686,46191
CHEMBL445332,P20309,SALVINORIN A,OBSYBRPAKCASQB-AGQYDFLVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12192085,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14728543,DTCC00395210,2103589,69286
CHEMBL446,P20309,SULFAMETHAZINE,ASWVTGNCAZCNNR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454431,DTCC00134119,574627,46191
CHEMBL446,P20309,SULFAMETHAZINE,ASWVTGNCAZCNNR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454432,DTCC00134119,574627,46191
CHEMBL44618,P20309,CHLOROFORM,HEDRZPFGACZZDS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7358179,DTCC00187868,1383774,46191
CHEMBL44618,P20309,CHLOROFORM,HEDRZPFGACZZDS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7358180,DTCC00187868,1383774,46191
CHEMBL44657,P20309,ETOPOSIDE,VJJPUSNTGOMMGY-MRVIYFEKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7335033,DTCC00188464,51468,46191
CHEMBL44657,P20309,ETOPOSIDE,VJJPUSNTGOMMGY-MRVIYFEKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7335034,DTCC00188464,51468,46191
CHEMBL447,P20309,SECOBARBITAL,KQPKPCNLIDLUMF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458113,DTCC00134177,1862719,46191
CHEMBL447,P20309,SECOBARBITAL,KQPKPCNLIDLUMF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7458114,DTCC00134177,1862719,46191
CHEMBL447566,P20309,,ISRCFEMWSXVREU-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,486000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624337,DTCC00551794,1621173,33075
CHEMBL44814,P20309,CARBON TETRACHLORIDE,VZGDMQKNWNREIO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7351349,DTCC00187852,1512806,46191
CHEMBL44814,P20309,CARBON TETRACHLORIDE,VZGDMQKNWNREIO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7351350,DTCC00187852,1512806,46191
CHEMBL44884,P20309,ETHAMBUTOL,AEUTYOVWOVBAKS-UWVGGRQHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7326320,DTCC00187691,381010,46191
CHEMBL44884,P20309,ETHAMBUTOL,AEUTYOVWOVBAKS-UWVGGRQHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7326321,DTCC00187691,381010,46191
CHEMBL448904,P20309,,BRQVGSTYYOHAJE-TXDWVUBVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,158.49,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460513,DTCC00565492,261720,32581
CHEMBL45,P20309,MELATONIN,DRLFMBDRBRZALE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7417185,DTCC00134723,50368,46191
CHEMBL45,P20309,MELATONIN,DRLFMBDRBRZALE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7417186,DTCC00134723,50368,46191
CHEMBL450093,P20309,,CVDCILQPWZQPLG-TXDWVUBVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,398.11,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460510,DTCC00565495,1427582,32581
CHEMBL450463,P20309,,NTRCVGKENRJOLL-VIFPVBQESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,33113.11,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649052,DTCC00510336,111097,31191
CHEMBL450685,P20309,,PLVJHUDIKYHLGU-ACEFPKFPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,501.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460515,DTCC00565490,68112,32581
CHEMBL450729,P20309,,KMVFIIBYOFOADI-QMMMGPOBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,52480.75,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649055,DTCC00510273,240176,31191
CHEMBL450986,P20309,NOCARDIMICIN D,CILDOHPTQUQJJM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,IC50,=,1100,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747242,DTCC00506713,1114711,29989
CHEMBL450986,P20309,NOCARDIMICIN D,CILDOHPTQUQJJM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,KI,=,230,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747248,DTCC00506713,1114711,29989
CHEMBL451,P20309,CHLORDIAZEPOXIDE,ANTSCNMPPGJYLG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7351548,DTCC00134272,574622,46191
CHEMBL451,P20309,CHLORDIAZEPOXIDE,ANTSCNMPPGJYLG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7351549,DTCC00134272,574622,46191
CHEMBL451040,P20309,,YCELWYOPQGUTDN-ACEFPKFPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,100,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460514,DTCC00565491,1492134,32581
CHEMBL451043,P20309,,WUQAXDTXXDUDGH-BTMGADRYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,100,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460518,DTCC00565291,392957,32581
CHEMBL451335,P20309,,LIFJPSLQRGQNMM-ZETCQYMHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,43651.58,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649061,DTCC00510267,920157,31191
CHEMBL452,P20309,CLONAZEPAM,DGBIGWXXNGSACT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7337226,DTCC00134302,574623,46191
CHEMBL452,P20309,CLONAZEPAM,DGBIGWXXNGSACT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7337227,DTCC00134302,574623,46191
CHEMBL45245,P20309,PHENANTHRIDIN-6(5H)-ONE,RZFVLEJOHSLEFR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283944,DTCC01739960,2057642,46191
CHEMBL45245,P20309,PHENANTHRIDIN-6(5H)-ONE,RZFVLEJOHSLEFR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283945,DTCC01739960,2057642,46191
CHEMBL452861,P20309,(-)-PROPANOLOL ,AQHHHDLHHXJYJD-AWEZNQCLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470989,DTCC00515151,1253328,46191
CHEMBL452861,P20309,(-)-PROPANOLOL ,AQHHHDLHHXJYJD-AWEZNQCLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470990,DTCC00515151,1253328,46191
CHEMBL453,P20309,SULFISOXAZOLE,NHUHCSRWZMLRLA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454573,DTCC00134318,477922,46191
CHEMBL453,P20309,SULFISOXAZOLE,NHUHCSRWZMLRLA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454574,DTCC00134318,477922,46191
CHEMBL45454,P20309,,LAWODBWCXWPBOU-VOMIJIAVSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17305327,KI,=,1.78,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,Antagonist,"Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.",J. Med. Chem.,2007,50,6,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Martini E, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,428379,DTCT0023280,2025689,DTCC00189098,228083,22057
CHEMBL456,P20309,ETHACRYNIC ACID,AVOLMBLBETYQHX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7322029,DTCC00134433,1155679,46191
CHEMBL456,P20309,ETHACRYNIC ACID,AVOLMBLBETYQHX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7322030,DTCC00134433,1155679,46191
CHEMBL456807,P20309,PHENYLHYDRAZINE,HKOOXMFOFWEVGF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404493,DTCC00514646,413975,46191
CHEMBL456807,P20309,PHENYLHYDRAZINE,HKOOXMFOFWEVGF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404494,DTCC00514646,413975,46191
CHEMBL457,P20309,GEMFIBROZIL,HEMJJKBWTPKOJG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7329330,DTCC00134705,1285875,46191
CHEMBL457,P20309,GEMFIBROZIL,HEMJJKBWTPKOJG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7329331,DTCC00134705,1285875,46191
CHEMBL457299,P20309,ETHYLENE GLYCOL,LYCAIKOWRPUZTN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7313668,DTCC00525050,1383777,46191
CHEMBL457299,P20309,ETHYLENE GLYCOL,LYCAIKOWRPUZTN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7313669,DTCC00525050,1383777,46191
CHEMBL457302,P20309,,CLKRLHFNFDDTQF-BTMGADRYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,251.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460519,DTCC00565290,456580,32581
CHEMBL458019,P20309,PARAQUAT DICHLORIDE,FIKAKWIAUPDISJ-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7376064,DTCC00549932,283000,46191
CHEMBL458019,P20309,PARAQUAT DICHLORIDE,FIKAKWIAUPDISJ-UHFFFAOYSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7376065,DTCC00549932,283000,46191
CHEMBL458105,P20309,,FHUAGMIMNACXJX-TXDWVUBVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,1000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460509,DTCC00565496,877624,32581
CHEMBL458416,P20309,,LGGXPKQFJZIICN-QMMMGPOBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,147910.84,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649058,DTCC00510270,207772,31191
CHEMBL459,P20309,METHYLDOPA,CJCSPKMFHVPWAR-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7423949,DTCC00135281,185555,46191
CHEMBL459,P20309,METHYLDOPA,CJCSPKMFHVPWAR-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7423950,DTCC00135281,185555,46191
CHEMBL459730,P20309,,OQIBXTHHXDTIBJ-OAQYLSRUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18754613,INHIBITION,<,50,%,,,,,,,,,,,,,,Displacement of [3H]QNB from human cloned muscarinic M3 receptor,,"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.",J. Med. Chem.,2008,51,18,"Donohue SR, Pike VW, Finnema SJ, Truong P, Andersson J, Gulyás B, Halldin C",,512532,DTCT0023280,2562880,DTCC00529017,2036926,31906
CHEMBL46,P20309,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7403848,DTCC00134875,315668,46191
CHEMBL46,P20309,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7403849,DTCC00134875,315668,46191
CHEMBL460,P20309,MOLINDONE,KLPWJLBORRMFGK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14741577,DTCC00135337,2107761,68826
CHEMBL460291,P20309,LACIDIPINE,GKQPCPXONLDCMU-CCEZHUSRSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433491,DTCC00514659,736260,46191
CHEMBL460291,P20309,LACIDIPINE,GKQPCPXONLDCMU-CCEZHUSRSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433492,DTCC00514659,736260,46191
CHEMBL460470,P20309,,KMVFIIBYOFOADI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,44668.36,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649057,DTCC00510271,1982807,31191
CHEMBL460499,P20309,CARMOFUR,AOCCBINRVIKJHY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7364309,DTCC00515303,51452,46191
CHEMBL460499,P20309,CARMOFUR,AOCCBINRVIKJHY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7364310,DTCC00515303,51452,46191
CHEMBL461087,P20309,2-(2-FURYL)PYRROLIDINE,LIFJPSLQRGQNMM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,11481.54,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2648998,DTCC00005281,1275893,31191
CHEMBL461088,P20309,,LIFJPSLQRGQNMM-SSDOTTSWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,25118.86,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649062,DTCC00510266,888285,31191
CHEMBL461089,P20309,,LGGXPKQFJZIICN-MRVPVSSYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,12022.64,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649059,DTCC00510269,1820901,31191
CHEMBL461502,P20309,,KMVFIIBYOFOADI-MRVPVSSYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,81283.05,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649056,DTCC00510272,338566,31191
CHEMBL461571,P20309,,DHUATBAZHILHIC-MRXNPFEDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18701276,IC50,=,1560,NM,,,,,,,,,,,,,,Displacement of radioligand from muscarinic M3 receptor,,Highly functionalized 7-azaindoles as selective PPAR gamma modulators.,Bioorg. Med. Chem. Lett.,2008,18,17,"Debenham SD, Chan A, Lau FW, Liu W, Wood HB, Lemme K, Colwell L, Habulihaz B, Akiyama TE, Einstein M, Doebber TW, Sharma N, Wang CF, Wu M, Berger JP, Meinke PT",,512432,DTCT0023280,2579222,DTCC00512123,1725965,31847
CHEMBL461709,P20309,,NTRCVGKENRJOLL-SECBINFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,28840.32,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2650090,DTCC00510275,1917293,31191
CHEMBL461727,P20309,AMYGDALIN,XUCIJNAGGSZNQT-JHSLDZJXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302638,DTCC00113956,1674140,46191
CHEMBL461727,P20309,AMYGDALIN,XUCIJNAGGSZNQT-JHSLDZJXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302639,DTCC00113956,1674140,46191
CHEMBL462547,P20309,URETHANE,JOYRKODLDBILNP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7451174,DTCC00513785,1155688,46191
CHEMBL462547,P20309,URETHANE,JOYRKODLDBILNP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7451175,DTCC00513785,1155688,46191
CHEMBL464099,P20309,N-METHYLLAUROTETANINE,ZFLRVRLYWHNAEC-AWEZNQCLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25695425,INHIBITION,<,50,%,,cell_based,,,,,,,,,,,,Displacement of [3H]QNB/[3H]]NMS from human recombinant muscarinic M3 receptor expressed in CHO cell membranes by radioligand binding assay,,Semisynthetic Studies on and Biological Evaluation of N-Methyllaurotetanine Analogues as Ligands for 5-HT Receptors.,J. Nat. Prod.,2015,78,4,"Madapa S, Harding WW",,1499656,DTCT0023280,14438741,DTCC00005857,624816,62678
CHEMBL465123,P20309,SEPROXETINE,WIQRCHMSJFFONW-HNNXBMFYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,760,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14744100,DTCC00530866,2108610,68567
CHEMBL466253,P20309,VU0238429,CKLGZXFOLMHCMC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19438238,EC50,>,30000,NM,,cell_based,,,,,,,,,,,CHO,Activation of human muscarinic M3 receptor expressed in CHO cells coexpressing Gq protein assessed as potentiation of acetylcholine-induced intracellular Ca2+ mobilization,,"Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.",J. Med. Chem.,2009,52,11,"Bridges TM, Marlo JE, Niswender CM, Jones CK, Jadhav SB, Gentry PR, Plumley HC, Weaver CD, Conn PJ, Lindsley CW",,519767,DTCT0023280,2825848,DTCC00006737,143837,33649
CHEMBL466253,P20309,VU0238429,CKLGZXFOLMHCMC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20004578,ACTIVITY,=,30,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 expressed in CHO cells assessed as stimulation of calcium mobilization at 30 uM,,"Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.",Bioorg. Med. Chem. Lett.,2010,20,2,"Bridges TM, Kennedy JP, Cho HP, Breininger ML, Gentry PR, Hopkins CR, Conn PJ, Lindsley CW",,605050,DTCT0023280,3175088,DTCC00006737,133134,36913
CHEMBL466253,P20309,VU0238429,CKLGZXFOLMHCMC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23562060,EC50,>,30000,NM,,,,,,,,,,,,,,Positive allosteric modulation of human muscarinic M3 receptor,,"Discovery of ML326: The first sub-micromolar, selective M5 PAM.",Bioorg. Med. Chem. Lett.,2013,23,10,"Gentry PR, Bridges TM, Lamsal A, Vinson PN, Smith E, Chase P, Hodder PS, Engers JL, Niswender CM, Scott Daniels J, Jeffrey Conn P, Wood MR, Lindsley CW",,960034,DTCT0023280,12436498,DTCC00006737,156255,54522
CHEMBL466271,P20309,,ABPAUEWHUKZUPD-UYCLPYRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,12.59,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460531,DTCC00582389,1492138,32581
CHEMBL467,P20309,HYDROXYUREA,VSNHCAURESNICA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319272,DTCC00136099,1155681,46191
CHEMBL467,P20309,HYDROXYUREA,VSNHCAURESNICA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319273,DTCC00136099,1155681,46191
CHEMBL467094,P20309,NANTENINE,WSVWKHTVFGTTKJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19963380,KI,>,10000,NM,,,,,,,,,,,,,,Displacement of [3H]QNB from human muscarinic M3 receptor,,Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.,Bioorg. Med. Chem. Lett.,2010,20,2,"Legendre O, Pecic S, Chaudhary S, Zimmerman SM, Fantegrossi WE, Harding WW",,604303,DTCT0023280,3169960,DTCC00115128,663129,36881
CHEMBL468,P20309,THALIDOMIDE,UEJJHQNACJXSKW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7461438,DTCC00136280,348406,46191
CHEMBL468,P20309,THALIDOMIDE,UEJJHQNACJXSKW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7461439,DTCC00136280,348406,46191
CHEMBL469,P20309,KETOROLAC,OZWKMVRBQXNZKK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437653,DTCC00136324,120972,46191
CHEMBL469,P20309,KETOROLAC,OZWKMVRBQXNZKK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437654,DTCC00136324,120972,46191
CHEMBL469178,P20309,,KHPHTCQUWNDWKK-SETFGOOZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18386916,ACTIVITY,=,5.2,NM,,,,,,,,,,,,,,Inhibition of CHRM3,,Chemical fragments as foundations for understanding target space and activity prediction.,J. Med. Chem.,2008,51,9,"Sutherland JJ, Higgs RE, Watson I, Vieth M",,532557,DTCT0023280,2414419,DTCC00115727,359904,28753
CHEMBL469912,P20309,PUROMYCIN,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7385837,DTCC00511258,477920,46191
CHEMBL469912,P20309,PUROMYCIN,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7385838,DTCC00511258,477920,46191
CHEMBL47,P20309,VITAMIN E,GVJHHUAWPYXKBD-IEOSBIPESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299365,DTCC00135004,348395,46191
CHEMBL47,P20309,VITAMIN E,GVJHHUAWPYXKBD-IEOSBIPESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299366,DTCC00135004,348395,46191
CHEMBL471,P20309,SOTALOL,ZBMZVLHSJCTVON-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7469310,DTCC00136675,88634,46191
CHEMBL471,P20309,SOTALOL,ZBMZVLHSJCTVON-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7469311,DTCC00136675,88634,46191
CHEMBL471213,P20309,,NRZIRCFWEUKUBP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor at up to 30 uM,Not Active,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492765,DTCT0023280,2600575,DTCC00566343,651316,32596
CHEMBL471214,P20309,,DPTWSDMDTMQUMF-GITCGBDTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,25.12,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460538,DTCC00566398,1842360,32581
CHEMBL471635,P20309,,FSFHENORZFDCAB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor at up to 30 uM,Not Active,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492765,DTCT0023280,2600576,DTCC00566417,1038793,32596
CHEMBL471636,P20309,,ZSFAOJRFJGSUDK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor at up to 30 uM,Not Active,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492765,DTCT0023280,2600578,DTCC00566419,1006375,32596
CHEMBL472,P20309,GLYBURIDE,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7335978,DTCC00136719,51475,46191
CHEMBL472,P20309,GLYBURIDE,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7335979,DTCC00136719,51475,46191
CHEMBL47244,P20309,PICROTOXININ,PIMZUZSSNYHVCU-YKWPQBAZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7343846,DTCC00186559,217577,46191
CHEMBL47244,P20309,PICROTOXININ,PIMZUZSSNYHVCU-YKWPQBAZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7343847,DTCC00186559,217577,46191
CHEMBL475534,P20309,NITRENDIPINE,PVHUJELLJLJGLN-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401331,DTCC00514677,88633,46191
CHEMBL475534,P20309,NITRENDIPINE,PVHUJELLJLJGLN-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401332,DTCC00514677,88633,46191
CHEMBL475965,P20309,,IFWGJAXMPXZADJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19146417,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human M3 receptor at 1 uM,,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,2009,52,3,"Wroblowski B, Wigglesworth MJ, Szekeres PG, Smith GD, Rahman SS, Nicholson NH, Muir AI, Hall A, Heer JP, Garland SL, Coates WJ",,516651,DTCT0023280,2696292,DTCC00550152,1567645,32399
CHEMBL476,P20309,DACARBAZINE,FDKXTQMXEQVLRF-ZHACJKMWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7361261,DTCC00136858,800573,46191
CHEMBL476,P20309,DACARBAZINE,FDKXTQMXEQVLRF-ZHACJKMWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7361262,DTCC00136858,800573,46191
CHEMBL476434,P20309,,XLMWLFZADLUISU-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624354,DTCC00551565,1777316,33075
CHEMBL476434,P20309,,XLMWLFZADLUISU-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624379,DTCC00551565,1777316,33075
CHEMBL476435,P20309,,IVFFUMJDPZDZRQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,6599000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624322,DTCC00551566,489669,33075
CHEMBL476436,P20309,,PZLVACJOYCSGHJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,1068000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624324,DTCC00551568,1231961,33075
CHEMBL476839,P20309,,MJKRYUCQHJLOIV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19329329,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human cloned muscarinic M3 receptor by competitive binding experiment,Not Active,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563513,DTCT0023280,2623740,DTCC00551715,1103808,33115
CHEMBL476990,P20309,,WRCIAIDMFLNHQO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689375,DTCC00544796,1178553,31355
CHEMBL477821,P20309,,AQMPTYUVSBXZPZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689379,DTCC00544728,1632367,31355
CHEMBL478034,P20309,,RCRAYIPXTHUIJR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689377,DTCC00544794,1178552,31355
CHEMBL478069,P20309,,ZHOKRBBGLIKDAT-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,122000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624327,DTCC00551665,845031,33075
CHEMBL478070,P20309,,HZQAYFMNTUFTDZ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,87000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624328,DTCC00551666,1745404,33075
CHEMBL478226,P20309,,PJRZQQXWGYRGCW-WOJBJXKFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18595721,KI,>,10000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,,"Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.",Bioorg. Med. Chem.,2008,16,15,"Minarini A, Marucci G, Bellucci C, Giorgi G, Tumiatti V, Bolognesi ML, Matera R, Rosini M, Melchiorre C",,491020,DTCT0023280,2759483,DTCC00544369,196825,30679
CHEMBL478227,P20309,,PJRZQQXWGYRGCW-VQTJNVASSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18595721,KI,>,10000,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,,"Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.",Bioorg. Med. Chem.,2008,16,15,"Minarini A, Marucci G, Bellucci C, Giorgi G, Tumiatti V, Bolognesi ML, Matera R, Rosini M, Melchiorre C",,491020,DTCT0023280,2759482,DTCC00544370,2037123,30679
CHEMBL478662,P20309,,UKCKRTPVYWRRHT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689381,DTCC00115890,1917668,31355
CHEMBL478834,P20309,,DRWJMJVERMOJBX-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18621528,INHIBITION,>,80,%,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor at 10 uM,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490859,DTCT0023280,2765715,DTCC00543783,456304,30733
CHEMBL478834,P20309,,DRWJMJVERMOJBX-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18621528,KI,=,635,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,2008,18,15,"Fish PV, Barta NS, Gray DL, Ryckmans T, Stobie A, Wakenhut F, Whitlock GA",,490863,DTCT0023280,2765719,DTCC00543783,456304,30733
CHEMBL479,P20309,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,15,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14741236,DTCC00137035,2107660,68417
CHEMBL479,P20309,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,43,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14741233,DTCC00137035,2104842,68826
CHEMBL479,P20309,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,15,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14741234,DTCC00137035,2107658,68458
CHEMBL479,P20309,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,90,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7461542,DTCC00137035,185558,46191
CHEMBL479,P20309,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,19,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7461543,DTCC00137035,185558,46191
CHEMBL479383,P20309,,IJHSPFFWIXGDBB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18588282,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488427,DTCT0023280,2775987,DTCC00525641,1756334,30579
CHEMBL479526,P20309,,ZETHWWBQKDKSDJ-NASUQTAISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,25.12,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460522,DTCC00566412,941845,32581
CHEMBL480,P20309,LANSOPRAZOLE,MJIHNNLFOKEZEW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416510,DTCC00137040,1027055,46191
CHEMBL480,P20309,LANSOPRAZOLE,MJIHNNLFOKEZEW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416511,DTCC00137040,1027055,46191
CHEMBL480299,P20309,,LJYNEMRCASTSJC-NMXAJACMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,19.95,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460547,DTCC00566229,327635,32581
CHEMBL480464,P20309,CREMASTRINE,AVBKRVFZNFJQBK-FVCCEPFGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,15844951,IC50,=,126,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in insect Sf9 cells,,"Cremastrine, a pyrrolizidine alkaloid from Cremastra appendiculata.",J. Nat. Prod.,2005,68,4,"Ikeda Y, Nonaka H, Furumai T, Igarashi Y",,525849,DTCT0023280,2757750,DTCC00538498,1103650,29840
CHEMBL480877,P20309,,NWDSKQPCBSNNRO-GPNIZQGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,7.94,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460542,DTCC00566337,1427590,32581
CHEMBL480878,P20309,,HJYMHTFRYBMHRW-GPNIZQGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460540,DTCC00566339,1777502,32581
CHEMBL481,P20309,IRINOTECAN,UWKQSNNFCGGAFS-XIFFEERXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420478,DTCC00137047,381014,46191
CHEMBL481,P20309,IRINOTECAN,UWKQSNNFCGGAFS-XIFFEERXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7420479,DTCC00137047,381014,46191
CHEMBL481153,P20309,,CJGNMVAAMQAWEF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23707254,KI,=,66,NM,,,,,,,,,,,,,,Antagonist activity at muscarinic M3 receptor (unknown origin) by PDSP assay,,Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.,Bioorg. Med. Chem. Lett.,2013,23,13,"Darvesh S, Macdonald IR, Martin E",,969170,DTCT0023280,12498998,DTCC00526518,1624676,55086
CHEMBL481280,P20309,,BUZBVOKDNAZIIM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18588282,INHIBITION,<,10,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488427,DTCT0023280,2775979,DTCC00525642,1756335,30579
CHEMBL481863,P20309,JNJ-10392980,ZIQGASWXUSSORV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18588282,INHIBITION,=,19,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488311,DTCT0023280,2775750,DTCC00006309,207957,30579
CHEMBL482496,P20309,,ZFUOLNAKPBFDIJ-VQBNBCTGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18468904,KI,>,500,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,"High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.",Bioorg. Med. Chem.,2008,16,11,"Nichols DE, Frescas SP, Chemel BR, Rehder KS, Zhong D, Lewin AH",,556756,DTCT0023280,2543051,DTCC00559644,1906611,28891
CHEMBL483253,P20309,,COGWXDUNGZOYBW-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,39000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624346,DTCC00551915,1874198,33075
CHEMBL483749,P20309,,QPUXUSUONDVIKY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19338356,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009,52,7,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497678,DTCT0023280,2727949,DTCC00569050,273669,34004
CHEMBL484475,P20309,,TUOUSRXPEXGSJA-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624343,DTCC00551912,2004413,33075
CHEMBL484475,P20309,,TUOUSRXPEXGSJA-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624371,DTCC00551912,2004413,33075
CHEMBL484476,P20309,,IABGKCOXRKFFQD-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,306000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624344,DTCC00551913,877449,33075
CHEMBL48449,P20309,CANTHARIDIN,DHZBEENLJMYSHQ-XCVPVQRUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273217,DTCC00189104,1544894,46191
CHEMBL48449,P20309,CANTHARIDIN,DHZBEENLJMYSHQ-XCVPVQRUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273218,DTCC00189104,1544894,46191
CHEMBL484952,P20309,,MTEFLXYKMHWTNG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19338356,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009,52,7,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497678,DTCT0023280,2727950,DTCC00569111,759316,34004
CHEMBL485259,P20309,EUCALYPTOL,WEEGYLXZBRQIMU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7305180,DTCC00539560,542575,46191
CHEMBL485259,P20309,EUCALYPTOL,WEEGYLXZBRQIMU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7305181,DTCC00539560,542575,46191
CHEMBL485549,P20309,NIFURSOL,XXUXXCZCUGIGPP-WLRTZDKTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375419,DTCC00563507,2057651,46191
CHEMBL485549,P20309,NIFURSOL,XXUXXCZCUGIGPP-WLRTZDKTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375420,DTCC00563507,2057651,46191
CHEMBL485755,P20309,,YYFWUVQKYICWEJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600534,DTCC00565517,910280,32596
CHEMBL485913,P20309,,RMXFQZCSLVEMPG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,ACTIVITY,=,24.1,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor relative to carbachol,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492759,DTCT0023280,2600542,DTCC00565659,2069195,32596
CHEMBL485913,P20309,,RMXFQZCSLVEMPG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,=,113,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600541,DTCC00565659,2069195,32596
CHEMBL485953,P20309,,XWZNKQSARMNAJJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600535,DTCC00565518,2037398,32596
CHEMBL486331,P20309,,CKUGQYKWEJWUKL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600532,DTCC00565359,1874377,32596
CHEMBL486758,P20309,,SZMMDBAEOIFVNU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600533,DTCC00565516,1745572,32596
CHEMBL486982,P20309,,VSIWWORCEGQUCZ-NMXAJACMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460521,DTCC00565288,456579,32581
CHEMBL486983,P20309,,XKJHWFAMUVWRDJ-NMXAJACMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460520,DTCC00565289,294987,32581
CHEMBL487557,P20309,,QSWNXPCHWZDBMP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor at up to 30 uM,Not Active,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492765,DTCT0023280,2600581,DTCC00565295,1265001,32596
CHEMBL487558,P20309,,ATABUFAIIIFSIQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor at up to 30 uM,Not Active,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492765,DTCT0023280,2600582,DTCC00565296,1427578,32596
CHEMBL487764,P20309,,LKIPSYLMJNHCQL-RXBHZZDJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460516,DTCC00565351,1136217,32581
CHEMBL487788,P20309,,GVLDTEKPXVTOGI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600538,DTCC00565596,1685751,32596
CHEMBL487894,P20309,DIPYRONE SODIUM,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7353337,DTCC00513255,1416028,46191
CHEMBL487894,P20309,DIPYRONE SODIUM,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7353338,DTCC00513255,1416028,46191
CHEMBL487984,P20309,,ZYKHMDFAAIQNQH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600537,DTCC00565595,812335,32596
CHEMBL487985,P20309,,ZCFZBUNCKXEBAK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600539,DTCC00565597,1232146,32596
CHEMBL487986,P20309,,GIWVDIDTRYDGRF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600540,DTCC00565599,197058,32596
CHEMBL488,P20309,AMINOGLUTETHIMIDE,ROBVIMPUHSLWNV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302360,DTCC00137354,477910,46191
CHEMBL488,P20309,AMINOGLUTETHIMIDE,ROBVIMPUHSLWNV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302361,DTCC00137354,477910,46191
CHEMBL488025,P20309,EXISULIND,MVGSNCBCUWPVDA-MFOYZWKCSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7467649,DTCC00113831,1674151,46191
CHEMBL488025,P20309,EXISULIND,MVGSNCBCUWPVDA-MFOYZWKCSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7467650,DTCC00113831,1674151,46191
CHEMBL489020,P20309,,BZPVZPVBVAGSJZ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,135000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624333,DTCC00551737,1621172,33075
CHEMBL489032,P20309,,PTQLWOGBUZTLRW-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,850000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624336,DTCC00551793,1491968,33075
CHEMBL489032,P20309,,PTQLWOGBUZTLRW-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.398,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624368,DTCC00551793,1491968,33075
CHEMBL489211,P20309,,SJKKJIJOXFFDLP-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624356,DTCC00552045,327476,33075
CHEMBL489211,P20309,,SJKKJIJOXFFDLP-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.0398,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624381,DTCC00552045,327476,33075
CHEMBL489212,P20309,,VLBDNNHJSKOGCJ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624351,DTCC00552046,1362695,33075
CHEMBL489212,P20309,,VLBDNNHJSKOGCJ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.0251,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624377,DTCC00552046,1362695,33075
CHEMBL489225,P20309,,WUOHKHFXIHJLCK-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,30000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624334,DTCC00551738,1653439,33075
CHEMBL489576,P20309,,BVXXXRLWEYNAGE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689369,DTCC00545514,501033,31355
CHEMBL489625,P20309,,FTFQOHPIVJFSFN-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624361,DTCC00552175,683142,33075
CHEMBL489625,P20309,,FTFQOHPIVJFSFN-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.251,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624385,DTCC00552175,683142,33075
CHEMBL489626,P20309,,CFXRBEDIYVRMIQ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,12000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624363,DTCC00552177,1809773,33075
CHEMBL49,P20309,BUSPIRONE,QWCRAEMEVRGPNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7264742,DTCC00135177,120970,46191
CHEMBL49,P20309,BUSPIRONE,QWCRAEMEVRGPNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7264743,DTCC00135177,120970,46191
CHEMBL490,P20309,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,80,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14733049,DTCC00137638,2104824,68567
CHEMBL490,P20309,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,179,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7380366,DTCC00137638,1188071,46191
CHEMBL490,P20309,PAROXETINE,AHOUBRCZNHFOSL-YOEHRIQHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,38,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7380367,DTCC00137638,1188071,46191
CHEMBL490236,P20309,,OYRRUMWUKNIZRJ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,22000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624355,DTCC00552110,261535,33075
CHEMBL490236,P20309,,OYRRUMWUKNIZRJ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,3.16,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624380,DTCC00552110,261535,33075
CHEMBL490237,P20309,,YTIXDYJVHDWDOY-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624358,DTCC00552112,1459395,33075
CHEMBL490237,P20309,,YTIXDYJVHDWDOY-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.0398,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624383,DTCC00552112,1459395,33075
CHEMBL490242,P20309,,DPRCXLFGHGSXRM-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624364,DTCC00552241,910074,33075
CHEMBL490242,P20309,,DPRCXLFGHGSXRM-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,3.16,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624386,DTCC00552241,910074,33075
CHEMBL490243,P20309,,VEXJMDRECRGFAV-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624365,DTCC00552242,651144,33075
CHEMBL490243,P20309,,VEXJMDRECRGFAV-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.398,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624387,DTCC00552242,651144,33075
CHEMBL490244,P20309,,KDPYXAKZNYGSFT-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624366,DTCC00552243,489676,33075
CHEMBL490244,P20309,,KDPYXAKZNYGSFT-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624388,DTCC00552243,489676,33075
CHEMBL490597,P20309,,UTARSHGDECSMJT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689382,DTCC00545445,1503271,31355
CHEMBL490598,P20309,,QKEUCDCLCOAHSK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689373,DTCC00545446,208181,31355
CHEMBL490632,P20309,,PPXOTGGYVKBLCQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19329329,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human cloned muscarinic M3 receptor by competitive binding experiment,Not Active,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563513,DTCT0023280,2623721,DTCC00551773,1906510,33115
CHEMBL490651,P20309,,COPKCSVWCOELAC-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,9500,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624339,DTCC00551854,779765,33075
CHEMBL490651,P20309,,COPKCSVWCOELAC-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624369,DTCC00551854,779765,33075
CHEMBL490652,P20309,,UVHOMQLWAMQBHF-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,29509000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624340,DTCC00551855,1006196,33075
CHEMBL490797,P20309,,IVSZXUDAZZHELN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689371,DTCC00545448,1696767,31355
CHEMBL49080,P20309,CLENBUTEROL,STJMRWALKKWQGH-UHFFFAOYSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7343636,DTCC00193265,1155678,46191
CHEMBL49080,P20309,CLENBUTEROL,STJMRWALKKWQGH-UHFFFAOYSA-N,1,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7343637,DTCC00193265,1155678,46191
CHEMBL490856,P20309,,MFIASLRDMJXZEN-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,829000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624341,DTCC00551856,521907,33075
CHEMBL491208,P20309,,FVBQJCJEQPAJFJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689374,DTCC00545442,143942,31355
CHEMBL491209,P20309,,VBYGBDXPFRYDEZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,ACTIVITY,=,24.1,%,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor relative to carbachol,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536134,DTCT0023280,2689344,DTCC00545444,1374237,31355
CHEMBL491209,P20309,,VBYGBDXPFRYDEZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,=,113,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2688318,DTCC00545444,1374237,31355
CHEMBL491246,P20309,,JJTVLFWIZIXSQE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,13000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624357,DTCC00551976,2069020,33075
CHEMBL491246,P20309,,JJTVLFWIZIXSQE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,3.98,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624382,DTCC00551976,2069020,33075
CHEMBL491252,P20309,,QADQSXUHFSYSAP-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,5403000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624352,DTCC00552047,910072,33075
CHEMBL491456,P20309,,XQHLIOWDLHYJHD-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,1956000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624330,DTCC00551734,2037216,33075
CHEMBL491457,P20309,,PQTQHAWSVMWEDT-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,104000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624331,DTCC00551735,164888,33075
CHEMBL491818,P20309,,VGVQNTNYOVKGPI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689368,DTCC00545515,436633,31355
CHEMBL492359,P20309,,AYOMMUGPXRFTPJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,199.53,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479380,DTCC00534826,404421,32803
CHEMBL492374,P20309,,MYLFFZKGICCWIN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,19.95,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479406,DTCC00535303,1821180,32803
CHEMBL492391,P20309,,HICIQQCYTDKJQB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,1258.93,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479414,DTCC00535364,1567466,32803
CHEMBL492437,P20309,,FTPFTSZCIOVABV-QHCPKHFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18798607,KD,=,0.158,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells assessed as acetylcholine-induced change in cytosolic calcium concentration by FLIPR assay,,Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,19,"Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI",,538749,DTCT0023280,2567771,DTCC00527246,597368,31950
CHEMBL492437,P20309,,FTPFTSZCIOVABV-QHCPKHFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.158,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479420,DTCC00527246,597446,32803
CHEMBL492701,P20309,,KGIOAIQTLWUAAN-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,39.81,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479382,DTCC00534887,1696632,32803
CHEMBL492702,P20309,,XGNSQBMWUTXLPY-KRWDZBQOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,501.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479383,DTCC00534888,273263,32803
CHEMBL492756,P20309,,AOZZHVNJTGQRRC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479381,DTCC00534827,143824,32803
CHEMBL492802,P20309,,NDAPPPXYHOQZGP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,79.43,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479395,DTCC00535112,1374087,32803
CHEMBL492978,P20309,,XETAJRIWKUYYBW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479413,DTCC00535363,175894,32803
CHEMBL492987,P20309,,GZOPBJVPTXYWRB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,630.96,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479369,DTCC00535591,1374093,32803
CHEMBL492988,P20309,,KENDXJSKWIECKF-ZEQRLZLVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,79.43,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479370,DTCC00535592,1115022,32803
CHEMBL492989,P20309,,CBXIVVZYUDSZRU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,5011.87,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479371,DTCC00535593,662186,32803
CHEMBL492997,P20309,,OQYCMIKSVDGGPQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,100,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479400,DTCC00535188,1341559,32803
CHEMBL492998,P20309,,ZLHVGKHJBXYUBJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479401,DTCC00535189,630019,32803
CHEMBL493,P20309,BROMOCRIPTINE,OZVBMTJYIDMWIL-AYFBDAFISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273013,DTCC00137993,1544893,46191
CHEMBL493,P20309,BROMOCRIPTINE,OZVBMTJYIDMWIL-AYFBDAFISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273014,DTCC00137993,1544893,46191
CHEMBL493079,P20309,,WQMYHVQXLJIIHO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18798607,IC50,=,31.62,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human cloned muscarinic M3 receptor expressed in CHO cells by FLIPR assay,,Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,19,"Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI",,538748,DTCT0023280,2567822,DTCC00528134,1049838,31950
CHEMBL493079,P20309,,WQMYHVQXLJIIHO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,31.62,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479363,DTCC00528134,1049923,32803
CHEMBL493131,P20309,,WSSGFZYQWZJJNG-LJQANCHMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,50.12,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479376,DTCC00534612,36238,32803
CHEMBL493265,P20309,,WEFKYTFPJRTGKU-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18798607,KD,=,0.0501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells assessed as acetylcholine-induced change in cytosolic calcium concentration by FLIPR assay,,Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,19,"Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI",,538749,DTCT0023280,2567774,DTCC00527243,1632174,31950
CHEMBL493266,P20309,,NAOXUXMOYDUMFJ-FQEVSTJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18798607,KD,=,0.0501,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells assessed as acetylcholine-induced change in cytosolic calcium concentration by FLIPR assay,,Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,19,"Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI",,538749,DTCT0023280,2567773,DTCC00527244,1726115,31950
CHEMBL493328,P20309,,WSSGFZYQWZJJNG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479374,DTCC00534610,1082542,32803
CHEMBL493329,P20309,,WSSGFZYQWZJJNG-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,5.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479375,DTCC00534611,1567460,32803
CHEMBL493465,P20309,,ZBEWUYNNNHETOS-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18798607,KD,=,0.251,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells assessed as acetylcholine-induced change in cytosolic calcium concentration by FLIPR assay,,Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,19,"Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI",,538749,DTCT0023280,2567772,DTCC00527245,1082450,31950
CHEMBL493795,P20309,,WKEGMVFSZKEMJV-ZJWBFHOUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,302,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2557118,DTCC00541173,100032,28855
CHEMBL493795,P20309,,WKEGMVFSZKEMJV-ZJWBFHOUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,467.74,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2557120,DTCC00541173,100031,28855
CHEMBL493939,P20309,,YYMCSLOGSPQTBK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,251.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479386,DTCC00534982,36247,32803
CHEMBL493979,P20309,,UNZBDOQVZFAUNP-IRROGDNISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,42.66,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2542464,DTCC00115666,392649,28855
CHEMBL493979,P20309,,UNZBDOQVZFAUNP-IRROGDNISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,194.98,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2557117,DTCC00115666,392648,28855
CHEMBL493980,P20309,,UNZBDOQVZFAUNP-PHTWQSKTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,18.2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541447,DTCC00115667,1777179,28855
CHEMBL493980,P20309,,UNZBDOQVZFAUNP-PHTWQSKTSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,389.05,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2557116,DTCC00115667,1777178,28855
CHEMBL494022,P20309,,PXKKBPAWILJYFB-NRFANRHFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,3.16,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479428,DTCC00535597,1821181,32803
CHEMBL494131,P20309,,JBFZFDYEPFJJLV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,3162.28,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479387,DTCC00534983,1632248,32803
CHEMBL494151,P20309,,RTCPIQVUPXWTSA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479402,DTCC00535247,1726187,32803
CHEMBL494410,P20309,,ZQCIKMSXAIZQKB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,251.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479417,DTCC00535420,436510,32803
CHEMBL494411,P20309,,LLAPHYHAXNGUCF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479418,DTCC00535421,662185,32803
CHEMBL494741,P20309,,QMQSFKXBMQSIFH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,50.12,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479403,DTCC00535248,1210604,32803
CHEMBL494742,P20309,,DMRYSONGBKCOGI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,794.33,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479405,DTCC00535250,1696641,32803
CHEMBL494749,P20309,,ZNEZHJZADNKLJX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,19.95,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479407,DTCC00535304,1503148,32803
CHEMBL494752,P20309,,DGRHYHQFIWGGSE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,199.53,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479411,DTCC00535361,175893,32803
CHEMBL494778,P20309,,DABOCKHWKVKIBT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,251.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479390,DTCC00535045,404427,32803
CHEMBL494779,P20309,,GUHFKILYEZRVAS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,6309.57,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479391,DTCC00535046,662181,32803
CHEMBL494781,P20309,,IRXIGLVYMPJWRR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,501.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479364,DTCC00535477,500930,32803
CHEMBL494836,P20309,,UKAFLVCFAOWFQE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479368,DTCC00535531,1756429,32803
CHEMBL494837,P20309,,CIASUTYANWXVKR-VWLOTQADSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479424,DTCC00535533,500931,32803
CHEMBL494950,P20309,,IFCARSQCGCULTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,199.53,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479408,DTCC00535305,1853313,32803
CHEMBL494951,P20309,,GLGLZWBBACKFGR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,1995.26,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479409,DTCC00535306,1726188,32803
CHEMBL494953,P20309,,CVKBXORXPUPUHQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,501.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479412,DTCC00535362,338861,32803
CHEMBL494962,P20309,,YXOYZWXQUSPZBK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,7943.28,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479392,DTCC00535047,2015993,32803
CHEMBL494996,P20309,,TYUJFICSPZLWGO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,1584.89,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479365,DTCC00115070,468214,32803
CHEMBL494997,P20309,,JVKWHJYNBOKMGU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,6309.57,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479366,DTCC00115071,1308968,32803
CHEMBL494998,P20309,,FMRRZXIQQGQXPV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479367,DTCC00115072,1082559,32803
CHEMBL495025,P20309,,FDUXTTJVEBRQLR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479393,DTCC00535048,1082551,32803
CHEMBL495028,P20309,,AAADPBLPXCELKR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,3.98,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479419,DTCC00535478,143828,32803
CHEMBL495102,P20309,,TZMFISJHWGELJA-HUXLDHJRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460528,DTCC00582385,392967,32581
CHEMBL495172,P20309,,CILXHEFUKPSOMO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,50.12,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479394,DTCC00535111,1178423,32803
CHEMBL495180,P20309,,MXVLGCKKMFFFAW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,79.43,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479397,DTCC00535114,1406543,32803
CHEMBL495350,P20309,,JUHGCPRCZJKVCB-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.0794,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479425,DTCC00535534,758926,32803
CHEMBL495357,P20309,,CLOOIRUHUDOLQM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479372,DTCC00535594,1950350,32803
CHEMBL495358,P20309,,RXCCIZPAGIKKKR-QHCPKHFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.126,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479426,DTCC00535595,1535523,32803
CHEMBL495360,P20309,,CMZDOILYDDDCBK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,501.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479398,DTCC00535186,338858,32803
CHEMBL495361,P20309,,CIUIHVMKWIARKD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,1000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479399,DTCC00535187,2048185,32803
CHEMBL495531,P20309,,BJFMBQBPMWUGFF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,<,1,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455704,DTCC00548056,1115197,31823
CHEMBL495531,P20309,,BJFMBQBPMWUGFF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455600,DTCC00548056,1115195,31823
CHEMBL495778,P20309,PENICILLIC ACID,YCOFRPYSZKIPBQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371932,DTCC00115404,866022,46191
CHEMBL495778,P20309,PENICILLIC ACID,YCOFRPYSZKIPBQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371933,DTCC00115404,866022,46191
CHEMBL496,P20309,HEXACHLOROPHENE,ACGUYXCXAPNIKK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314906,DTCC00138998,1765973,46191
CHEMBL496,P20309,HEXACHLOROPHENE,ACGUYXCXAPNIKK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314907,DTCC00138998,1765973,46191
CHEMBL496376,P20309,,YPIYIPYCTOJYAU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,=,11000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455701,DTCC00547955,273436,31823
CHEMBL496376,P20309,,YPIYIPYCTOJYAU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455700,DTCC00547955,273437,31823
CHEMBL496915,P20309,,UNZBDOQVZFAUNP-LCCWGKBJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,23.99,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541446,DTCC00541244,844908,28855
CHEMBL496915,P20309,,UNZBDOQVZFAUNP-LCCWGKBJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,199.53,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541444,DTCC00541244,844909,28855
CHEMBL497799,P20309,,WSPJCXDAFUSHQL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455698,DTCC00548016,791172,31823
CHEMBL497799,P20309,,WSPJCXDAFUSHQL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455699,DTCC00548016,791171,31823
CHEMBL498,P20309,CHLORPROPAMIDE,RKWGIWYCVPQPMF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371203,DTCC00139298,1253319,46191
CHEMBL498,P20309,CHLORPROPAMIDE,RKWGIWYCVPQPMF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371204,DTCC00139298,1253319,46191
CHEMBL498556,P20309,,ZZNJOZRGMRQBSR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,=,3000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455703,DTCC00547902,694594,31823
CHEMBL498556,P20309,,ZZNJOZRGMRQBSR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18922694,IC50,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.,Bioorg. Med. Chem. Lett.,2008,18,21,"Bongartz JP, Buntinx M, Coesemans E, Hermans B, Lommen GV, Wauwe JV",,496615,DTCT0023280,2455702,DTCC00547902,694595,31823
CHEMBL498770,P20309,IODOPHENPROPIT,UBHYDQAARZKHEZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8564266,KI,=,3700,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14743387,DTCC00541500,2108370,69351
CHEMBL498847,P20309,SECNIDAZOLE,KPQZUUQMTUIKBP-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7488334,DTCC00550707,1765980,46191
CHEMBL498847,P20309,SECNIDAZOLE,KPQZUUQMTUIKBP-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7488335,DTCC00550707,1765980,46191
CHEMBL499,P20309,TIMOLOL,BLJRIMJGRPQVNF-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7481299,DTCC00139310,1894976,46191
CHEMBL499,P20309,TIMOLOL,BLJRIMJGRPQVNF-JTQLQIEISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7481300,DTCC00139310,1894976,46191
CHEMBL499519,P20309,NOCARDIMICIN B,QFWVGKDFYOXTQO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,IC50,=,630,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747240,DTCC00506711,1631930,29989
CHEMBL499519,P20309,NOCARDIMICIN B,QFWVGKDFYOXTQO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,KI,=,130,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747246,DTCC00506711,1631930,29989
CHEMBL499536,P20309,,HQYLURGLNKLOQJ-XHDPSFHLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19208472,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human recombinant muscarinic M3 receptor,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009,19,5,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566273,DTCT0023280,2473422,DTCC00517855,1555907,32916
CHEMBL499815,P20309,ATRACTYLOSIDE,IUCNQFHEWLYECJ-CXCSZTQTSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7269291,DTCC00539373,1765970,46191
CHEMBL499815,P20309,ATRACTYLOSIDE,IUCNQFHEWLYECJ-CXCSZTQTSA-L,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7269292,DTCC00539373,1765970,46191
CHEMBL50,P20309,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14729961,DTCC00135230,2104025,69275
CHEMBL500,P20309,PINDOLOL,JZQKKSLKJUAGIC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387367,DTCC00139321,736265,46191
CHEMBL500,P20309,PINDOLOL,JZQKKSLKJUAGIC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387368,DTCC00139321,736265,46191
CHEMBL500306,P20309,,WNQPFBPKKQGYFX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,145000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624325,DTCC00551569,1938553,33075
CHEMBL500313,P20309,,CRTBVFNYYUEWDJ-BQBZGAKWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24128660,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.",Bioorg. Med. Chem. Lett.,2013,23,23,"Bolchi C, Valoti E, Binda M, Fasoli F, Ferrara R, Fumagalli L, Gotti C, Matucci R, Vistoli G, Pallavicini M",,990367,DTCT0023280,12629552,DTCC00532790,1995799,56353
CHEMBL501419,P20309,,VKXFSAYDXXXNGC-JKGBFCRXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,31.62,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460544,DTCC00566232,1874384,32581
CHEMBL501486,P20309,,SOORCXGGKXAUNP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,1995.26,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479416,DTCC00535419,404431,32803
CHEMBL501727,P20309,,XKCJLNBEKXPHNT-SHQCIBLASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,IC50,=,19952.62,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510508,DTCT0023280,2433204,DTCC00560172,1276468,30932
CHEMBL501756,P20309,BRUCINE,RRKTZKIUPZVBMF-IBTVXLQLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,2.9,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1348349,DTCC00571355,788825,15566
CHEMBL501756,P20309,BRUCINE,RRKTZKIUPZVBMF-IBTVXLQLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,3.5,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1348348,DTCC00571355,788825,15566
CHEMBL501756,P20309,BRUCINE,RRKTZKIUPZVBMF-IBTVXLQLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1348356,DTCC00571355,788825,15566
CHEMBL501756,P20309,BRUCINE,RRKTZKIUPZVBMF-IBTVXLQLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1348361,DTCC00571355,788825,15566
CHEMBL502000,P20309,,XKCJLNBEKXPHNT-SQHAQQRYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,IC50,=,1584.89,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510508,DTCT0023280,2433203,DTCC00560173,2016314,30932
CHEMBL502620,P20309,ACLARUBICIN,USZYSDMBJDPRIF-SVEJIMAYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7284059,DTCC00522599,1383771,46191
CHEMBL502620,P20309,ACLARUBICIN,USZYSDMBJDPRIF-SVEJIMAYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7284060,DTCC00522599,1383771,46191
CHEMBL502896,P20309,CETRAXATE HYDROCHLORIDE,USROQQUKEBHOFF-SKKCDYJJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368811,DTCC00521861,477913,46191
CHEMBL502896,P20309,CETRAXATE HYDROCHLORIDE,USROQQUKEBHOFF-SKKCDYJJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368812,DTCC00521861,477913,46191
CHEMBL503,P20309,LOVASTATIN,PCZOHLXUXFIOCF-BXMDZJJMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412632,DTCC00140133,1480347,46191
CHEMBL503,P20309,LOVASTATIN,PCZOHLXUXFIOCF-BXMDZJJMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412633,DTCC00140133,1480347,46191
CHEMBL503468,P20309,,HXPLFONFARJCJA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18507369,IC50,>,50000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor,,"Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.",J. Med. Chem.,2008,51,12,"Choi SK, Green D, Ho A, Klein U, Marquess D, Taylor R, Turner SD",,552742,DTCT0023280,2551395,DTCC00558762,1524260,28959
CHEMBL503735,P20309,,MIAQTWNDRFRVOQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19438238,%MAX,=,78,%,,cell_based,,,,,,,,,,,CHO,Activation of human muscarinic M3 receptor expressed in CHO cells coexpressing Gq protein assessed as potentiation of acetylcholine-induced intracellular Ca2+ mobilization at 30 uM relative to acetylcholine,,"Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.",J. Med. Chem.,2009,52,11,"Bridges TM, Marlo JE, Niswender CM, Jones CK, Jadhav SB, Gentry PR, Plumley HC, Weaver CD, Conn PJ, Lindsley CW",,519768,DTCT0023280,2825864,DTCC00536388,630031,33649
CHEMBL503735,P20309,,MIAQTWNDRFRVOQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19438238,EC50,=,2220,NM,,cell_based,,,,,,,,,,,CHO,Activation of human muscarinic M3 receptor expressed in CHO cells coexpressing Gq protein assessed as potentiation of acetylcholine-induced intracellular Ca2+ mobilization,,"Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.",J. Med. Chem.,2009,52,11,"Bridges TM, Marlo JE, Niswender CM, Jones CK, Jadhav SB, Gentry PR, Plumley HC, Weaver CD, Conn PJ, Lindsley CW",,519767,DTCT0023280,2825863,DTCC00536388,630031,33649
CHEMBL503735,P20309,,MIAQTWNDRFRVOQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20004578,EC50,=,2200,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 expressed in CHO cells assessed as stimulation of calcium mobilization,,"Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.",Bioorg. Med. Chem. Lett.,2010,20,2,"Bridges TM, Kennedy JP, Cho HP, Breininger ML, Gentry PR, Hopkins CR, Conn PJ, Lindsley CW",,605046,DTCT0023280,3175083,DTCC00536388,619128,36913
CHEMBL504,P20309,DIMETHYL SULFOXIDE,IAZDPXIOMUYVGZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7370627,DTCC00140586,1798409,46191
CHEMBL504,P20309,DIMETHYL SULFOXIDE,IAZDPXIOMUYVGZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7370628,DTCC00140586,1798409,46191
CHEMBL504760,P20309,CAMPHOR,DSSYKIVIOFKYAU-XCBNKYQSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7352640,DTCC00113446,217578,46191
CHEMBL504760,P20309,CAMPHOR,DSSYKIVIOFKYAU-XCBNKYQSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7352641,DTCC00113446,217578,46191
CHEMBL505086,P20309,,LGGXPKQFJZIICN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,18197.01,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649060,DTCC00510268,1664260,31191
CHEMBL505197,P20309,NOCARDIMICIN A,LGOZXNLEMXJIMS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,IC50,=,5890,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747239,DTCC00506710,1406203,29989
CHEMBL505197,P20309,NOCARDIMICIN A,LGOZXNLEMXJIMS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,KI,=,1250,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747245,DTCC00506710,1406203,29989
CHEMBL505452,P20309,,XKCJLNBEKXPHNT-WKDCXCOVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,IC50,=,19.95,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510508,DTCT0023280,2433249,DTCC00561112,920812,30932
CHEMBL505452,P20309,,XKCJLNBEKXPHNT-WKDCXCOVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,19.95,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460549,DTCC00561112,910286,32581
CHEMBL505453,P20309,,XKCJLNBEKXPHNT-RPLLCQBOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,IC50,=,3162.28,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510508,DTCT0023280,2433194,DTCC00561113,2048493,30932
CHEMBL50588,P20309,EMETINE,AUVVAXYIELKVAI-CKBKHPSWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319574,DTCC00195239,216401,46191
CHEMBL50588,P20309,EMETINE,AUVVAXYIELKVAI-CKBKHPSWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319575,DTCC00195239,216401,46191
CHEMBL506,P20309,PRIMAQUINE,INDBQLZJXZLFIT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374747,DTCC00140892,1155686,46191
CHEMBL506,P20309,PRIMAQUINE,INDBQLZJXZLFIT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7374748,DTCC00140892,1155686,46191
CHEMBL506247,P20309,TANNIC ACID,LRBQNJMCXXYXIU-PPKXGCFTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7465656,DTCC00524002,444643,46191
CHEMBL506247,P20309,TANNIC ACID,LRBQNJMCXXYXIU-PPKXGCFTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7465657,DTCC00524002,444643,46191
CHEMBL507581,P20309,,OXONULSFJHQURN-STJUJJKNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,1584.89,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460511,DTCC00565494,1136221,32581
CHEMBL507760,P20309,NOCARDIMICIN C,ZRSRFOLUVALIAN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,IC50,=,4700,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747241,DTCC00506712,35308,29989
CHEMBL507760,P20309,NOCARDIMICIN C,ZRSRFOLUVALIAN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,KI,=,1000,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747247,DTCC00506712,35308,29989
CHEMBL508097,P20309,,CKOMWFWOVNVJOL-SANMLTNESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.0631,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479422,DTCC00535480,565209,32803
CHEMBL508102,P20309,CARBIMAZOLE,CFOYWRHIYXMDOT-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7266431,DTCC00566137,1351108,46191
CHEMBL508102,P20309,CARBIMAZOLE,CFOYWRHIYXMDOT-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7266432,DTCC00566137,1351108,46191
CHEMBL508112,P20309,BENZOTHIAZYL DISULFIDE,AFZSMODLJJCVPP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7274065,DTCC00534219,606967,46191
CHEMBL508112,P20309,BENZOTHIAZYL DISULFIDE,AFZSMODLJJCVPP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7274066,DTCC00534219,606967,46191
CHEMBL508338,P20309,THIOMERSAL,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7478931,DTCC00113560,962452,46191
CHEMBL508338,P20309,THIOMERSAL,,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7478932,DTCC00113560,962452,46191
CHEMBL508556,P20309,,HOTHCRDGQDBOOH-AUPVMFHISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,501.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460512,DTCC00565493,1556494,32581
CHEMBL508807,P20309,NOCARDIMICIN F,JJWFEHNQRVSVKR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,IC50,=,6290,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747244,DTCC00506715,35309,29989
CHEMBL508807,P20309,NOCARDIMICIN F,JJWFEHNQRVSVKR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,KI,=,1330,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747250,DTCC00506715,35309,29989
CHEMBL509,P20309,MECLOFENAMIC ACID,SBDNJUWAMKYJOX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429915,DTCC00140998,510304,46191
CHEMBL509,P20309,MECLOFENAMIC ACID,SBDNJUWAMKYJOX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429916,DTCC00140998,510304,46191
CHEMBL510139,P20309,CITRININ,CQIUKKVOEOPUDV-IYSWYEEDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7362743,DTCC00525343,249940,46191
CHEMBL510139,P20309,CITRININ,CQIUKKVOEOPUDV-IYSWYEEDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7362744,DTCC00525343,249940,46191
CHEMBL510340,P20309,NOCCARDIMICIN E,PIFYJYLXAXDUEB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,IC50,=,4560,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747243,DTCC00506714,143497,29989
CHEMBL510340,P20309,NOCCARDIMICIN E,PIFYJYLXAXDUEB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16038549,KI,=,970,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,,"Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.",J. Nat. Prod.,2005,68,7,"Ikeda Y, Nonaka H, Furumai T, Onaka H, Igarashi Y",,550722,DTCT0023280,2747249,DTCC00506714,143497,29989
CHEMBL511,P20309,PYRILAMINE,YECBIJXISLIIDS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7394441,DTCC00141084,1830688,46191
CHEMBL511,P20309,PYRILAMINE,YECBIJXISLIIDS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7394442,DTCC00141084,1830688,46191
CHEMBL511833,P20309,,HTFHTKNLGFVJTQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor at up to 30 uM,Not Active,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492765,DTCT0023280,2600579,DTCC00566420,229482,32596
CHEMBL513,P20309,CARMUSTINE,DLGOEMSEDOSKAD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368722,DTCC00141242,1383773,46191
CHEMBL513,P20309,CARMUSTINE,DLGOEMSEDOSKAD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7368723,DTCC00141242,1383773,46191
CHEMBL513228,P20309,,AMISGKITNKHXTK-IAXKEJLGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,794.33,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460539,DTCC00566397,456602,32581
CHEMBL513277,P20309,,NTRCVGKENRJOLL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,22908.68,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649054,DTCC00510274,790752,31191
CHEMBL513765,P20309,,OXJXXSDOAJKXKB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor at up to 30 uM,Not Active,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492765,DTCT0023280,2600577,DTCC00566418,197066,32596
CHEMBL514,P20309,LOMUSTINE,GQYIWUVLTXOXAJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429596,DTCC00141290,1765975,46191
CHEMBL514,P20309,LOMUSTINE,GQYIWUVLTXOXAJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429597,DTCC00141290,1765975,46191
CHEMBL514689,P20309,,XRBAANKNSRDGQL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689376,DTCC00544795,920610,31355
CHEMBL515,P20309,CHLORAMBUCIL,JCKYGMPEJWAADB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7340992,DTCC00141382,477914,46191
CHEMBL515,P20309,CHLORAMBUCIL,JCKYGMPEJWAADB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7342988,DTCC00141382,477914,46191
CHEMBL515462,P20309,,PGPDYCONSZRNSF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,1104000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624323,DTCC00551567,910064,33075
CHEMBL515472,P20309,,QCFZUTYIUYQTPW-JOCHJYFZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19329329,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human cloned muscarinic M3 receptor by competitive binding experiment,Not Active,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563513,DTCT0023280,2623742,DTCC00551712,554033,33115
CHEMBL515489,P20309,,RVMQZHDDVVRTFF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689378,DTCC00544793,1788706,31355
CHEMBL515914,P20309,AZARIBINE,QQOBRRFOVWGIMD-OJAKKHQRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279634,DTCC00514747,477912,46191
CHEMBL515914,P20309,AZARIBINE,QQOBRRFOVWGIMD-OJAKKHQRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279635,DTCC00514747,477912,46191
CHEMBL516,P20309,CYPROHEPTADINE,JJCFRYNCJDLXIK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,12,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14737528,DTCC00141384,2106344,68567
CHEMBL516,P20309,CYPROHEPTADINE,JJCFRYNCJDLXIK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,46,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7369893,DTCC00141384,833160,46191
CHEMBL516,P20309,CYPROHEPTADINE,JJCFRYNCJDLXIK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,9.66,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7369894,DTCC00141384,833160,46191
CHEMBL516088,P20309,,HVJOIRMQZXEGPW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19329329,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human cloned muscarinic M3 receptor by competitive binding experiment,Not Active,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009,17,8,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563513,DTCT0023280,2623741,DTCC00551713,1264819,33115
CHEMBL516120,P20309,,MXHSHQLSKUMQJF-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,2824000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624326,DTCC00551664,1362690,33075
CHEMBL516121,P20309,,FGRNHLWRJTYTCI-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,935000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624329,DTCC00551667,1459392,33075
CHEMBL517087,P20309,,CUWQWPONTQQRRZ-NMXAJACMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,25.12,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460546,DTCC00566230,1556505,32581
CHEMBL517712,P20309,ATROPINE,RKUNBYITZUJHSG-SPUOUPEWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11831911,KI,=,0.5,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,,Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.,J. Med. Chem.,2002,45,4,"Sagara Y, Sagara T, Mase T, Kimura T, Numazawa T, Fujikawa T, Noguchi K, Ohtake N",,138703,DTCT0023280,1608875,DTCC00507754,1565905,11844
CHEMBL517712,P20309,ATROPINE,RKUNBYITZUJHSG-SPUOUPEWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,KI,=,0.9,NM,,cell_based,,,,,,,,,,,BHK-21,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659456,DTCT0023280,3460967,DTCC00507754,1557379,40772
CHEMBL517712,P20309,ATROPINE,RKUNBYITZUJHSG-SPUOUPEWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23523385,KI,=,2.18,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,,Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods.,Bioorg. Med. Chem.,2013,21,9,"Bhattacharjee AK, Pomponio JW, Evans SA, Pervitsky D, Gordon RK",,956583,DTCT0023280,12417737,DTCC00507754,1559656,54418
CHEMBL517712,P20309,ATROPINE,RKUNBYITZUJHSG-SPUOUPEWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,2.07,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7272082,DTCC00507754,1577004,46191
CHEMBL517712,P20309,ATROPINE,RKUNBYITZUJHSG-SPUOUPEWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,0.439,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7272083,DTCC00507754,1577004,46191
CHEMBL518001,P20309,,DKHZVOWFKMHNPB-WKDCXCOVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,19.95,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460548,DTCC00566154,1006373,32581
CHEMBL518747,P20309,,CRCUINALVBZFCY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689380,DTCC00544727,468337,31355
CHEMBL519240,P20309,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18983139,ACTIVITY,=,17.1,%,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor at 10 uM relative to control,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494242,DTCT0023280,2604300,DTCC00008943,1621329,32034
CHEMBL519240,P20309,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18983139,INHIBITION,=,83,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494021,DTCT0023280,2604220,DTCC00008943,1621329,32034
CHEMBL519609,P20309,,FPUKGJMTLUQGFZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23707254,KI,=,170,NM,,,,,,,,,,,,,,Antagonist activity at muscarinic M3 receptor (unknown origin) by PDSP assay,,Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems.,Bioorg. Med. Chem. Lett.,2013,23,13,"Darvesh S, Macdonald IR, Martin E",,969170,DTCT0023280,12499015,DTCC00526517,1235500,55086
CHEMBL519652,P20309,,ROCIDKGHPSNBKL-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624345,DTCC00551914,132531,33075
CHEMBL519652,P20309,,ROCIDKGHPSNBKL-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624372,DTCC00551914,132531,33075
CHEMBL519760,P20309,,FWDQHCMQPLYEEB-GPNIZQGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,50.12,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460545,DTCC00566231,1588779,32581
CHEMBL519893,P20309,,AMSLUDLIDFRROJ-GPNIZQGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,2511.89,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460517,DTCC00565292,489843,32581
CHEMBL520349,P20309,,OHOQFGDSEWQDAX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19338356,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009,52,7,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497678,DTCT0023280,2727951,DTCC00569166,1178835,34004
CHEMBL521,P20309,IBUPROFEN,HEFNNWSXXWATRW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323523,DTCC00141944,833161,46191
CHEMBL521,P20309,IBUPROFEN,HEFNNWSXXWATRW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323524,DTCC00141944,833161,46191
CHEMBL521030,P20309,,FNIWYWIHLOTVQU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,30000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600536,DTCC00565519,1809926,32596
CHEMBL521179,P20309,SR-3677,OQWZIAVXCYIZNN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18834107,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 3 uM,,Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.,J. Med. Chem.,2008,51,21,"Feng Y, Yin Y, Weiser A, Griffin E, Cameron MD, Lin L, Ruiz C, Schürer SC, Inoue T, Rao PV, Schröter T, Lograsso P",,538210,DTCT0023280,2672780,DTCC00564119,1535842,31402
CHEMBL521244,P20309,,AMWYWNMCYBNFMO-RXBHZZDJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,6.31,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460543,DTCC00566336,1038791,32581
CHEMBL521388,P20309,,AQIOZTSTCKLBDS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,ACTIVITY,,,,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor at up to 30 uM,Not Active,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492765,DTCT0023280,2600580,DTCC00565294,1938760,32596
CHEMBL521523,P20309,,ZOZCBLGQKDOWFZ-QHCPKHFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18798607,KD,=,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells assessed as acetylcholine-induced change in cytosolic calcium concentration by FLIPR assay,,Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,19,"Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI",,538749,DTCT0023280,2567769,DTCC00527294,1147400,31950
CHEMBL521523,P20309,,ZOZCBLGQKDOWFZ-QHCPKHFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18798607,KI,=,0.0316,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,,Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,19,"Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI",,539023,DTCT0023280,2567788,DTCC00527294,1147400,31950
CHEMBL521523,P20309,,ZOZCBLGQKDOWFZ-QHCPKHFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18798607,PKB,=,10.5,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells assessed as acetylcholine-induced change in cytosolic calcium concentration pretreated for 30 mins by FLIPR assay,,Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,19,"Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI",,539025,DTCT0023280,2567787,DTCC00527294,1147400,31950
CHEMBL521523,P20309,,ZOZCBLGQKDOWFZ-QHCPKHFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.01,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479434,DTCC00527294,1147476,32803
CHEMBL521589,P20309,BAMBUTEROL,ANZXOIAKUNOVQU-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7266907,DTCC00514881,1318439,46191
CHEMBL521589,P20309,BAMBUTEROL,ANZXOIAKUNOVQU-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7266908,DTCC00514881,1318439,46191
CHEMBL521696,P20309,,BNWLQLSZHBDWOI-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.0316,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479421,DTCC00535479,468212,32803
CHEMBL521781,P20309,,QYCWFUYPCMJQHQ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624347,DTCC00551974,1685577,33075
CHEMBL521781,P20309,,QYCWFUYPCMJQHQ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.0794,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624373,DTCC00551974,1685577,33075
CHEMBL521914,P20309,,YCXFJNGLJADSBQ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689370,DTCC00545449,1082679,31355
CHEMBL521921,P20309,,GYBJLQNXDYKARM-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,36000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624362,DTCC00552176,1329973,33075
CHEMBL521986,P20309,,IBKBJRQAVBTTTC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,6.31,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479384,DTCC00534889,1885434,32803
CHEMBL522020,P20309,,PQNPJCMCZTZRMH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479415,DTCC00535418,630020,32803
CHEMBL522081,P20309,,POQXKEIISDGWLM-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624359,DTCC00552113,715451,33075
CHEMBL522081,P20309,,POQXKEIISDGWLM-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.0631,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624384,DTCC00552113,715451,33075
CHEMBL522418,P20309,,GXSUPSQXDPKCBP-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624335,DTCC00551792,1874195,33075
CHEMBL522418,P20309,,GXSUPSQXDPKCBP-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.794,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624367,DTCC00551792,1874195,33075
CHEMBL522451,P20309,,NEAXZQHSZHLDPB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689372,DTCC00545447,1470972,31355
CHEMBL522460,P20309,,CWPKTBMRVATCBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689348,DTCC00545443,1374236,31355
CHEMBL522460,P20309,,CWPKTBMRVATCBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18829311,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,"Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.",Bioorg. Med. Chem. Lett.,2008,18,20,"Miller NR, Daniels RN, Bridges TM, Brady AE, Conn PJ, Lindsley CW",,492758,DTCT0023280,2600531,DTCC00545443,1362862,32596
CHEMBL522460,P20309,,CWPKTBMRVATCBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,EMAX,=,1,%,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as increase of acetylcholine-induced calcium flux at 10 uM by FLIPR assay relative to acetylcholine,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659448,DTCT0023280,3460755,DTCC00545443,1363815,40772
CHEMBL522460,P20309,,CWPKTBMRVATCBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,KI,=,430,NM,,cell_based,,,,,,,,,,,BHK-21,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659456,DTCT0023280,3460790,DTCC00545443,1363815,40772
CHEMBL522460,P20309,,CWPKTBMRVATCBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23200253,EC50,>,30000,NM,,cell_based,,,,,,,,,,,CHO,Partial agonist activity at human muscarinic M3 receptor expressed in CHO cells calcium response,,Further exploration of M1 allosteric agonists: subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism.,Bioorg. Med. Chem. Lett.,2013,23,1,"Sheffler DJ, Sevel C, Le U, Lovell KM, Tarr JC, Carrington SJ, Cho HP, Digby GJ, Niswender CM, Conn PJ, Hopkins CR, Wood MR, Lindsley CW",,937322,DTCT0023280,11770770,DTCC00545443,1365947,53186
CHEMBL522460,P20309,,CWPKTBMRVATCBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23200253,IC50,=,2300,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium response,,Further exploration of M1 allosteric agonists: subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism.,Bioorg. Med. Chem. Lett.,2013,23,1,"Sheffler DJ, Sevel C, Le U, Lovell KM, Tarr JC, Carrington SJ, Cho HP, Digby GJ, Niswender CM, Conn PJ, Hopkins CR, Wood MR, Lindsley CW",,937318,DTCT0023280,11770765,DTCC00545443,1365947,53186
CHEMBL522460,P20309,,CWPKTBMRVATCBL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23200253,IC50,=,2344.23,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of Ach-induced calcium response,,Further exploration of M1 allosteric agonists: subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism.,Bioorg. Med. Chem. Lett.,2013,23,1,"Sheffler DJ, Sevel C, Le U, Lovell KM, Tarr JC, Carrington SJ, Cho HP, Digby GJ, Niswender CM, Conn PJ, Hopkins CR, Wood MR, Lindsley CW",,937318,DTCT0023280,11770764,DTCC00545443,1365947,53186
CHEMBL522495,P20309,,TVVVKJSBUJENQR-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.631,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479427,DTCC00535596,1632252,32803
CHEMBL522632,P20309,,QMRDJZUHTBHKNW-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,208000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624332,DTCC00551736,100167,33075
CHEMBL522838,P20309,,YMLDKXCNWFTSCB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,31.62,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479385,DTCC00534890,1950343,32803
CHEMBL522992,P20309,,XHMVBARQDPSGNY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,1258.93,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479379,DTCC00534825,1082547,32803
CHEMBL523012,P20309,,WSDGMDUTHWKDMT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479373,DTCC00534609,1821174,32803
CHEMBL523044,P20309,,AJBGYCZPYITRRR-VWLOTQADSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.251,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479423,DTCC00535532,1308969,32803
CHEMBL523299,P20309,UMECLIDINIUM BROMIDE,PEJHHXHHNGORMP-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,ACTIVITY,=,145,MIN,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor assessed as offset time for 50% of carbachol-induced human bronchus contraction to return at 10 nM,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562969,DTCT0023280,2624402,DTCC00551857,1685576,33075
CHEMBL523299,P20309,UMECLIDINIUM BROMIDE,PEJHHXHHNGORMP-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as reversible inhibition of acetylcholine-induced calcium mobilization for 90 mins measured after 180 mins of washout period by FLIPR assay,Active,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562975,DTCT0023280,2624389,DTCC00551857,1685576,33075
CHEMBL523299,P20309,UMECLIDINIUM BROMIDE,PEJHHXHHNGORMP-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624342,DTCC00551857,1685576,33075
CHEMBL523299,P20309,UMECLIDINIUM BROMIDE,PEJHHXHHNGORMP-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.0316,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624370,DTCC00551857,1685576,33075
CHEMBL523299,P20309,UMECLIDINIUM BROMIDE,PEJHHXHHNGORMP-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.316,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor assessed as inhibition of carbachol-induced bronchus contraction,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562976,DTCT0023280,2624401,DTCC00551857,1685576,33075
CHEMBL523299,P20309,UMECLIDINIUM BROMIDE,PEJHHXHHNGORMP-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KI,=,0.06,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells coexpressing Gqi5 by scintillation proximity assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562973,DTCT0023280,2624400,DTCC00551857,1685576,33075
CHEMBL523474,P20309,,FPAAYJHLZCHQFL-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624348,DTCC00551975,1588598,33075
CHEMBL523474,P20309,,FPAAYJHLZCHQFL-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.0631,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624374,DTCC00551975,1588598,33075
CHEMBL523518,P20309,,WKEGMVFSZKEMJV-WEAPTXNRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,281.84,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2557119,DTCC00541172,651026,28855
CHEMBL523518,P20309,,WKEGMVFSZKEMJV-WEAPTXNRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,512.86,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541377,DTCC00541172,651025,28855
CHEMBL523598,P20309,,LEMBXLWSTKZAQB-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624350,DTCC00552044,1329971,33075
CHEMBL523598,P20309,,LEMBXLWSTKZAQB-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.398,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624376,DTCC00552044,1329971,33075
CHEMBL523657,P20309,,FLALJSHQEQFXKG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18805692,EC50,>,50000,NM,,,,,,,,,,,,,,Agonist activity at muscarinic M3 receptor,,Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.,Bioorg. Med. Chem. Lett.,2008,18,20,"Bridges TM, Brady AE, Kennedy JP, Daniels RN, Miller NR, Kim K, Breininger ML, Gentry PR, Brogan JT, Jones CK, Conn PJ, Lindsley CW",,536130,DTCT0023280,2689383,DTCC00545369,1632377,31355
CHEMBL523685,P20309,VU0119498,DELLOEULSHGYCG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19438238,%MAX,=,65.5,%,,cell_based,,,,,,,,,,,CHO,Activation of human muscarinic M3 receptor expressed in CHO cells coexpressing Gq protein assessed as potentiation of acetylcholine-induced intracellular Ca2+ mobilization at 30 uM relative to acetylcholine,,"Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.",J. Med. Chem.,2009,52,11,"Bridges TM, Marlo JE, Niswender CM, Jones CK, Jadhav SB, Gentry PR, Plumley HC, Weaver CD, Conn PJ, Lindsley CW",,519768,DTCT0023280,2825870,DTCC00006707,500934,33649
CHEMBL523685,P20309,VU0119498,DELLOEULSHGYCG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19438238,EC50,=,6380,NM,,cell_based,,,,,,,,,,,CHO,Activation of human muscarinic M3 receptor expressed in CHO cells coexpressing Gq protein assessed as potentiation of acetylcholine-induced intracellular Ca2+ mobilization,,"Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.",J. Med. Chem.,2009,52,11,"Bridges TM, Marlo JE, Niswender CM, Jones CK, Jadhav SB, Gentry PR, Plumley HC, Weaver CD, Conn PJ, Lindsley CW",,519767,DTCT0023280,2825869,DTCC00006707,500934,33649
CHEMBL523685,P20309,VU0119498,DELLOEULSHGYCG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20004578,EC50,=,6400,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human muscarinic M3 expressed in CHO cells assessed as stimulation of calcium mobilization,,"Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.",Bioorg. Med. Chem. Lett.,2010,20,2,"Bridges TM, Kennedy JP, Cho HP, Breininger ML, Gentry PR, Hopkins CR, Conn PJ, Lindsley CW",,605046,DTCT0023280,3175078,DTCC00006707,490244,36913
CHEMBL523685,P20309,VU0119498,DELLOEULSHGYCG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20801651,EC50,=,6400,NM,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulation of muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization after 1 hr by FLIPR assay,,Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,19,"Bridges TM, Kennedy JP, Hopkins CR, Conn PJ, Lindsley CW",,664708,DTCT0023280,3531392,DTCC00006707,502488,41125
CHEMBL523685,P20309,VU0119498,DELLOEULSHGYCG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22148748,EC50,=,6400,NM,,,,,,,,,,,,,,Positive allosteric modulation activity at muscarinic M3 receptor,,"Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.",J. Med. Chem.,2012,55,4,"Melancon BJ, Hopkins CR, Wood MR, Emmitte KA, Niswender CM, Christopoulos A, Conn PJ, Lindsley CW",,832793,DTCT0023280,10549715,DTCC00006707,511527,48932
CHEMBL523685,P20309,VU0119498,DELLOEULSHGYCG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22148748,EMAX,=,66,%,,,,,,,,,,,,,,Positive allosteric modulation activity at muscarinic M3 receptor relative to acetylcholine,,"Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.",J. Med. Chem.,2012,55,4,"Melancon BJ, Hopkins CR, Wood MR, Emmitte KA, Niswender CM, Christopoulos A, Conn PJ, Lindsley CW",,832794,DTCT0023280,10549716,DTCC00006707,511527,48932
CHEMBL523712,P20309,,YQWQPCDILQYXLD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,630.96,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479404,DTCC00535249,306195,32803
CHEMBL523767,P20309,,FQGXKIQQELWWLZ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,=,17000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624360,DTCC00552174,261536,33075
CHEMBL523957,P20309,,NEYGAMRQICXESO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624349,DTCC00551977,164893,33075
CHEMBL523957,P20309,,NEYGAMRQICXESO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.0398,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624375,DTCC00551977,164893,33075
CHEMBL524031,P20309,,UUUSUGOZBNBBQR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,2511.89,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479388,DTCC00534984,920466,32803
CHEMBL524032,P20309,,NENDOUAXXLHWFM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479389,DTCC00534985,1696636,32803
CHEMBL524061,P20309,,UNZBDOQVZFAUNP-SLLHVTCXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,346.74,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541443,DTCC00541245,1297249,28855
CHEMBL524061,P20309,,UNZBDOQVZFAUNP-SLLHVTCXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,691.83,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541445,DTCC00541245,1297248,28855
CHEMBL524097,P20309,,MVYUVZORWYSLPK-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,ACTIVITY,=,57,MIN,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor assessed as offset time for 50% of carbachol-induced human bronchus contraction to return at 10 nM,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562969,DTCT0023280,2624394,DTCC00551795,196901,33075
CHEMBL524097,P20309,,MVYUVZORWYSLPK-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as reversible inhibition of acetylcholine-induced calcium mobilization for 90 mins measured after 180 mins of washout period by FLIPR assay,Not Active,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562975,DTCT0023280,2624390,DTCC00551795,196901,33075
CHEMBL524097,P20309,,MVYUVZORWYSLPK-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624338,DTCC00551795,196901,33075
CHEMBL524097,P20309,,MVYUVZORWYSLPK-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,1.26,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M3 receptor assessed as inhibition of carbachol-induced bronchus contraction,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562976,DTCT0023280,2624393,DTCC00551795,196901,33075
CHEMBL524097,P20309,,MVYUVZORWYSLPK-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KI,=,0.13,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells coexpressing Gqi5 by scintillation proximity assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562973,DTCT0023280,2624321,DTCC00551795,196901,33075
CHEMBL524119,P20309,,ZZGRUJIGZVAXHU-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,IC50,<,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562970,DTCT0023280,2624353,DTCC00552111,779767,33075
CHEMBL524119,P20309,,ZZGRUJIGZVAXHU-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19317446,KD,=,0.126,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human cloned muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic based-FLIPR assay,,Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2009,52,8,"Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, Widdowson KL, Palovich MR, Blaney FE, Foley JJ, Webb EF, Luttmann MA, Burman M, Belmonte K, Salmon M",,562974,DTCT0023280,2624378,DTCC00552111,779767,33075
CHEMBL524153,P20309,,RNPCOHCWKNMBRI-QHCPKHFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18799310,ACTIVITY,=,27,%,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor at 10 uM,,"Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, a selective alpha2C adrenergic receptor antagonist.",Bioorg. Med. Chem. Lett.,2008,18,20,"Patel SD, Habeski WM, Min H, Zhang J, Roof R, Snyder B, Bora G, Campbell B, Li C, Hidayetoglu D, Johnson DS, Chaudhry A, Charlton ME, Kablaoui NM",,535932,DTCT0023280,2685296,DTCC00545284,1600091,31332
CHEMBL524168,P20309,,KAXFGZPRRJXVBS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,501.19,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479396,DTCC00535113,1726186,32803
CHEMBL52440,P20309,DEXTROMETHORPHAN,MKXZASYAUGDDCJ-NJAFHUGGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355112,DTCC00195499,315664,46191
CHEMBL52440,P20309,DEXTROMETHORPHAN,MKXZASYAUGDDCJ-NJAFHUGGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355113,DTCC00195499,315664,46191
CHEMBL526,P20309,PROPOFOL,OLBCVFGFOZPWHH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7398611,DTCC00142061,51502,46191
CHEMBL526,P20309,PROPOFOL,OLBCVFGFOZPWHH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7398612,DTCC00142061,51502,46191
CHEMBL526009,P20309,,XKCJLNBEKXPHNT-IGKIAQTJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510508,DTCT0023280,2433205,DTCC00561114,1050220,30932
CHEMBL526009,P20309,,XKCJLNBEKXPHNT-IGKIAQTJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460499,DTCC00561114,1038784,32581
CHEMBL527,P20309,PIROXICAM,QYSPLQLAKJAUJT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387469,DTCC00142164,866023,46191
CHEMBL527,P20309,PIROXICAM,QYSPLQLAKJAUJT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387470,DTCC00142164,866023,46191
CHEMBL527216,P20309,,PWOFWVFUYSXALY-UYCLPYRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460533,DTCC00582390,1232155,32581
CHEMBL527880,P20309,,ISTCTOUZRSAZGU-SBSPUUFOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,17782.79,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649050,DTCC00582388,1631972,31191
CHEMBL529,P20309,AZITHROMYCIN,MQTOSJVFKKJCRP-BICOPXKESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7272223,DTCC00142593,1512804,46191
CHEMBL529,P20309,AZITHROMYCIN,MQTOSJVFKKJCRP-BICOPXKESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7272224,DTCC00142593,1512804,46191
CHEMBL531,P20309,PERGOLIDE,YEHCICAEULNIGD-MZMPZRCHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387138,DTCC00142656,1318444,46191
CHEMBL531,P20309,PERGOLIDE,YEHCICAEULNIGD-MZMPZRCHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387139,DTCC00142656,1318444,46191
CHEMBL532,P20309,ERYTHROMYCIN,ULGZDMOVFRHVEP-RWJQBGPGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7334783,DTCC00142668,51467,46191
CHEMBL532,P20309,ERYTHROMYCIN,ULGZDMOVFRHVEP-RWJQBGPGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7334784,DTCC00142668,51467,46191
CHEMBL534,P20309,KETOTIFEN,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,2209,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407745,DTCC00142999,217580,46191
CHEMBL534,P20309,KETOTIFEN,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,468,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407746,DTCC00142999,217580,46191
CHEMBL53463,P20309,DOXORUBICIN,AOJJSUZBOXZQNB-TZSSRYMLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7325858,DTCC00196573,51466,46191
CHEMBL53463,P20309,DOXORUBICIN,AOJJSUZBOXZQNB-TZSSRYMLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7325859,DTCC00196573,51466,46191
CHEMBL538360,P20309,,FTEMNAZGUWPJAT-OCXYILCQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,KD,=,3.16,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460501,DTCC00582439,2004602,32581
CHEMBL538793,P20309,,CQGQFKBWLUBQQX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,ACTIVITY,=,200,%,,cell_based,,,,,,,,,,,A9,Ability to stimulate biochemical responses in cell lines expressing muscarinic A9 L receptor sub types,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138565,DTCT0023280,822701,DTCC00580965,551484,17526
CHEMBL538793,P20309,,CQGQFKBWLUBQQX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,EC50,=,2.51189E+13,NM,,cell_based,,,,,,,,,,,A9,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138825,DTCT0023280,822700,DTCC00580965,551484,17526
CHEMBL538793,P20309,,CQGQFKBWLUBQQX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,KI,=,125.89,NM,,cell_based,,,,,,,,,,,A9,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138831,DTCT0023280,822699,DTCC00580965,551484,17526
CHEMBL538863,P20309,,ICFWBEXJAZPKES-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,=,2511.89,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479378,DTCC00582444,1115018,32803
CHEMBL538864,P20309,,LAWOSJNSDDHWRN-UQIIZPHYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.158,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479430,DTCC00582446,694434,32803
CHEMBL539119,P20309,,CERQWVLDIIWWTD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,IC50,>,10000,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562387,DTCT0023280,2479377,DTCC00582447,1950339,32803
CHEMBL539120,P20309,,WLUMBDZYACAKKA-CHEOKKHZSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,4.17,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541435,DTCC00582449,489546,28855
CHEMBL539120,P20309,,WLUMBDZYACAKKA-CHEOKKHZSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,26.92,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541437,DTCC00582449,489544,28855
CHEMBL539121,P20309,,WLUMBDZYACAKKA-JHKFYDNRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,6.92,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541434,DTCC00582450,1135926,28855
CHEMBL539121,P20309,,WLUMBDZYACAKKA-JHKFYDNRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,162.18,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541432,DTCC00582450,1135927,28855
CHEMBL539373,P20309,,JIGQNAWNJXJZOE-VSQDCZAJSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,51.29,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541439,DTCC00582451,1491837,28855
CHEMBL539373,P20309,,JIGQNAWNJXJZOE-VSQDCZAJSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,208.93,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541441,DTCC00582451,1491836,28855
CHEMBL539421,P20309,,UPNQDHOPRXFHQY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Subtype selectivity and the cooperativity with N-methyl Scopolamine (NMS) at muscarinic acetylcholine receptor M3; Activity range is 0.2-0.8,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138577,DTCT0023280,468134,DTCC00157816,1001955,17183
CHEMBL539421,P20309,,UPNQDHOPRXFHQY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.23,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the (N-methyl Scopolamine) NMS-liganded muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138823,DTCT0023280,468129,DTCC00157816,1001955,17183
CHEMBL539421,P20309,,UPNQDHOPRXFHQY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11881995,LOG 1/M,=,5.6,,,,,,,,,,,,,,,Logarithm of affinity (log 1/M) at the muscarinic acetylcholine receptor M3 by using semiquantitative equilibrium and off-rate assay,,Substituted pentacyclic carbazolones as novel muscarinic allosteric agents: synthesis and structure-affinity and cooperativity relationships.,J. Med. Chem.,2002,45,6,"Gharagozloo P, Lazareno S, Miyauchi M, Popham A, Birdsall NJ",,138824,DTCT0023280,468128,DTCC00157816,1001955,17183
CHEMBL539885,P20309,,YJOAFZBDECYIKB-UYNZSIRJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,39.81,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460536,DTCC00582463,1971981,32581
CHEMBL539886,P20309,,SHVWXJJGDJGCGJ-JCOPYZAKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.126,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479433,DTCC00582465,856372,32803
CHEMBL539887,P20309,,MYTTVAMSBJDWCJ-GXUZKUJRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,KD,=,0.0251,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510509,DTCT0023280,2433240,DTCC00582467,1535792,30932
CHEMBL54,P20309,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14727323,DTCC00135385,2103294,68826
CHEMBL54,P20309,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14727322,DTCC00135385,2103344,68458
CHEMBL54,P20309,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25070422,KI,,,,,,,,,,,,,,,,,Displacement of [3H]QNB from human muscarinic M3 receptor by liquid scintillation counting,Not Determined,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014,24,17,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452253,DTCT0023280,13943028,DTCC00135385,59464,61087
CHEMBL54,P20309,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336191,DTCC00135385,51476,46191
CHEMBL54,P20309,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336192,DTCC00135385,51476,46191
CHEMBL540144,P20309,,MULHJPPLPOONQR-YOZJSLMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,6.31,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460497,DTCC00582475,1071257,32581
CHEMBL540145,P20309,,VCQOIIBIEPQYAA-NSZULBDUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,KD,=,0.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460503,DTCC00582476,554216,32581
CHEMBL540146,P20309,,KBJPPKSFFDIUDK-RFRXDZATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,KD,=,2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460507,DTCC00582479,2004601,32581
CHEMBL540148,P20309,,ASIDMQKXUIKLCY-ZIIGJBQBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,KD,=,0.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460505,DTCC00582485,1874380,32581
CHEMBL540251,P20309,,ZHMKFRQKXCMJTI-YCBFMBTMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.1,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479431,DTCC00582407,79156,32803
CHEMBL540316,P20309,,BIPJEVLVWPZDEX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,1244.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1631658,DTCC00580590,238003,15558
CHEMBL540359,P20309,,LJDOMRHCUJTSAI-ZBBHSQCGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,KD,=,0.126,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510509,DTCT0023280,2433190,DTCC00582395,1147805,30932
CHEMBL540359,P20309,,LJDOMRHCUJTSAI-ZBBHSQCGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,KD,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510509,DTCT0023280,2433214,DTCC00582395,1147805,30932
CHEMBL540359,P20309,,LJDOMRHCUJTSAI-ZBBHSQCGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,KI,=,31.62,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methyl Scopolamine from human muscarinic acetylcholine M3 receptor expressed in CHO cells by scintillation proximity assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510512,DTCT0023280,2433217,DTCC00582395,1147805,30932
CHEMBL540359,P20309,,LJDOMRHCUJTSAI-ZBBHSQCGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,PKB,=,10.1,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510508,DTCT0023280,2433250,DTCC00582395,1147805,30932
CHEMBL540359,P20309,,LJDOMRHCUJTSAI-ZBBHSQCGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,KD,=,0.126,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460500,DTCC00582395,1136222,32581
CHEMBL540396,P20309,,UEQNXYHNQAZVTO-WAQYZQTGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18680280,KD,=,0.0126,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic acetylcholine M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by single concentration kinetic FLIPR assay,,Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,16,"Jin J, Wang Y, Shi D, Wang F, Davis RS, Jin Q, Fu W, Foley JJ, Webb EF, Dehaas CJ, Berlanga M, Burman M, Sarau HM, Morrow DM, Rao P, Kallal LA, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,510509,DTCT0023280,2433237,DTCC00582402,1632538,30932
CHEMBL540398,P20309,,NCWPXSLFBGDOQT-NADAZAGSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,25.12,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460524,DTCC00582405,910288,32581
CHEMBL540399,P20309,,HGRMSMBCYYVCIF-TXGUGDMRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,6.31,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460537,DTCC00582410,11734,32581
CHEMBL540400,P20309,,FONAZWATUJVTNO-UYCLPYRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,7.94,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460526,DTCC00582411,845193,32581
CHEMBL540401,P20309,,MOCQHGLHASMOEA-RFRXDZATSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,KD,=,2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460506,DTCC00582413,1395232,32581
CHEMBL540445,P20309,PARTHENOLIDE,KTEXNACQROZXEV-SLXBATTESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7382669,DTCC00556195,574624,46191
CHEMBL540445,P20309,PARTHENOLIDE,KTEXNACQROZXEV-SLXBATTESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7384703,DTCC00556195,574624,46191
CHEMBL541,P20309,BENZOIC ACID,WPYMKLBDIGXBTP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7271125,DTCC00143343,833157,46191
CHEMBL541,P20309,BENZOIC ACID,WPYMKLBDIGXBTP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7271126,DTCC00143343,833157,46191
CHEMBL54126,P20309,NEOSTIGMINE BROMIDE,LULNWZDBKTWDGK-UHFFFAOYSA-M,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375293,DTCC00197200,1027056,46191
CHEMBL54126,P20309,NEOSTIGMINE BROMIDE,LULNWZDBKTWDGK-UHFFFAOYSA-M,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375294,DTCC00197200,1027056,46191
CHEMBL541584,P20309,,ILIQSFKSKTYXNT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,403.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1630588,DTCC00580542,1047421,15558
CHEMBL541671,P20309,,WLUMBDZYACAKKA-QCBZKDDCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,77.62,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541431,DTCC00582504,1103701,28855
CHEMBL541671,P20309,,WLUMBDZYACAKKA-QCBZKDDCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,323.59,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541433,DTCC00582504,1103696,28855
CHEMBL542622,P20309,WAY-132983,QAXRREHLPKHWBI-IJDFPQMLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10450949,EC50,=,3.7,NM,,,,,,,,,,,,,,In vitro functional agonism against M3 muscarinic receptor (PI),,"Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling.",Bioorg. Med. Chem. Lett.,1999,9,14,"Sabb AL, Husbands GM, Tokolics J, Stein RP, Tasse RP, Boast CA, Moyer JA, Abou-Gharbia M",,138242,DTCT0023280,715036,DTCC00022252,561756,3155
CHEMBL542622,P20309,WAY-132983,QAXRREHLPKHWBI-IJDFPQMLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10450949,KI,=,5.9,NM,,,,,,,,,,,,,,Binding affinity towards human muscarinic M3 receptor,,"Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling.",Bioorg. Med. Chem. Lett.,1999,9,14,"Sabb AL, Husbands GM, Tokolics J, Stein RP, Tasse RP, Boast CA, Moyer JA, Abou-Gharbia M",,138244,DTCT0023280,715033,DTCC00022252,561756,3155
CHEMBL542622,P20309,WAY-132983,QAXRREHLPKHWBI-IJDFPQMLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10450949,PI,=,53,%,,cell_based,,,,,,,,,,,CHO,Evaluated in vitro for its ability to stimulate phosphoinositide (PI) turnover in CHO cells transfected with CMV vector containing cDNA expressing human M3 muscarinic receptor (PI),,"Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling.",Bioorg. Med. Chem. Lett.,1999,9,14,"Sabb AL, Husbands GM, Tokolics J, Stein RP, Tasse RP, Boast CA, Moyer JA, Abou-Gharbia M",,138245,DTCT0023280,715038,DTCC00022252,561756,3155
CHEMBL543177,P20309,,HBITVWHEDYQNAJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,211.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1608725,DTCC00576121,141304,15558
CHEMBL543890,P20309,,OLJNINNFAOHHOE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,749.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1603848,DTCC00576135,1500620,15558
CHEMBL54440,P20309,MEVASTATIN,AJLFOPYRIVGYMJ-INTXDZFKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7436858,DTCC00201440,51490,46191
CHEMBL54440,P20309,MEVASTATIN,AJLFOPYRIVGYMJ-INTXDZFKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7436859,DTCC00201440,51490,46191
CHEMBL545,P20309,ALCOHOL,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330638,DTCC00143522,1416029,46191
CHEMBL545,P20309,ALCOHOL,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330639,DTCC00143522,1416029,46191
CHEMBL545077,P20309,,VUTKBVZTSXWIQM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,ACTIVITY,=,73,%,,cell_based,,,,,,,,,,,A9,Ability to stimulate biochemical responses in cell lines expressing muscarinic A9 L receptor sub types,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138565,DTCT0023280,842669,DTCC00576525,1650825,17526
CHEMBL545077,P20309,,VUTKBVZTSXWIQM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,EC50,=,1E+14,NM,,cell_based,,,,,,,,,,,A9,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138825,DTCT0023280,842668,DTCC00576525,1650825,17526
CHEMBL545077,P20309,,VUTKBVZTSXWIQM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,KI,=,79.43,NM,,cell_based,,,,,,,,,,,A9,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138831,DTCT0023280,842667,DTCC00576525,1650825,17526
CHEMBL547,P20309,ISOTRETINOIN,SHGAZHPCJJPHSC-XFYACQKRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407652,DTCC00143769,930080,46191
CHEMBL547,P20309,ISOTRETINOIN,SHGAZHPCJJPHSC-XFYACQKRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7407653,DTCC00143769,930080,46191
CHEMBL54720,P20309,,QYWDOJXSLBBWLE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8642566,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibitory activity against Muscarinic acetylcholine receptor M3 using [3H]NMS at 10e5 (M),,Novel selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines.,J. Med. Chem.,1996,39,10,"Rault S, Lancelot JC, Prunier H, Robba M, Renard P, Delagrange P, Pfeiffer B, Caignard DH, Guardiola-Lemaitre B, Hamon M",,138983,DTCT0023280,1149486,DTCC00197722,237043,13585
CHEMBL549,P20309,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7354115,DTCC00144121,444637,46191
CHEMBL549,P20309,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7354116,DTCC00144121,444637,46191
CHEMBL54943,P20309,CYSTEINE,XUJNEKJLAYXESH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14732639,DTCC00201307,2103464,69159
CHEMBL549577,P20309,,DAIWBMZPSVQRCH-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.76,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910945,DTCC00588156,208592,35090
CHEMBL549784,P20309,,OEKSMYDGWZJQDC-VQRHYKMASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.39,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910958,DTCC00588163,694965,35090
CHEMBL549986,P20309,,QYOYLHDCZNMWNQ-XIVHMJBLSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,1.62,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910968,DTCC00588167,144346,35090
CHEMBL55,P20309,PENTAMIDINE,XDRYMKDFEDOLFX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378466,DTCC00135468,51498,46191
CHEMBL55,P20309,PENTAMIDINE,XDRYMKDFEDOLFX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378467,DTCC00135468,51498,46191
CHEMBL550,P20309,PILOCARPINE,QCHFTSOMWOSFHM-WPRPVWTQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,=,76.5,%,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060852,DTCC00144150,482461,61603
CHEMBL550885,P20309,,ZFUPVYYWJGARQW-OLODFECESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,KD,=,0.631,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460502,DTCC00582394,165063,32581
CHEMBL551063,P20309,,QKBNQVVTYRQENH-QTQXQZBYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.37,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910971,DTCC00589758,2048698,35090
CHEMBL551113,P20309,,JHAHGWMPINVXDP-OGEVYIQJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,1258.93,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460523,DTCC00582414,11735,32581
CHEMBL551327,P20309,,ODLGHDZATGHICB-MSZWFKHVSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.24,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910972,DTCC00591236,1017978,35090
CHEMBL551466,P20309,ACLIDINIUM BROMIDE,XLAKJQPTOJHYDR-QTQXQZBYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.17,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910962,DTCC00589774,791508,35090
CHEMBL551466,P20309,ACLIDINIUM BROMIDE,XLAKJQPTOJHYDR-QTQXQZBYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,KI,=,0.07,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581966,DTCT0023280,2910996,DTCC00589774,791508,35090
CHEMBL551466,P20309,ACLIDINIUM BROMIDE,XLAKJQPTOJHYDR-QTQXQZBYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,21036043,IC50,=,0.126,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,,The discovery of new spirocyclic muscarinic M3 antagonists.,Bioorg. Med. Chem. Lett.,2010,20,24,"Stocks MJ, Alcaraz L, Bailey A, Bowers K, Donald D, Edwards H, Hunt F, Kindon N, Pairaudeau G, Theaker J, Warner DJ",,687865,DTCT0023280,3605546,DTCC00589774,792743,42029
CHEMBL551466,P20309,ACLIDINIUM BROMIDE,XLAKJQPTOJHYDR-QTQXQZBYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22047691,IC50,<,0.0501,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,,"The discovery of AZD9164, a novel muscarinic M3 antagonist.",Bioorg. Med. Chem. Lett.,2011,21,24,"Mete A, Bowers K, Chevalier E, Donald DK, Edwards H, Escott KJ, Ford R, Grime K, Millichip I, Teobald B, Russell V",,789189,DTCT0023280,7542764,DTCC00589774,800668,46625
CHEMBL551466,P20309,ACLIDINIUM BROMIDE,XLAKJQPTOJHYDR-QTQXQZBYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24144851,IC50,<,0.0501,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,,"The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.",Bioorg. Med. Chem. Lett.,2013,23,23,"Mete A, Bowers K, Bull RJ, Coope H, Donald DK, Escott KJ, Ford R, Grime K, Mather A, Ray NC, Russell V",,1274564,DTCT0023280,12940975,DTCC00589774,783569,56408
CHEMBL551525,P20309,,DYANBEYXYZKCOS-NRFANRHFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,94,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910946,DTCC00591242,144345,35090
CHEMBL551563,P20309,,KYIQLEVPUSNDHE-PPHPATTJSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,2691.53,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649046,DTCC00582482,1788368,31191
CHEMBL551729,P20309,,GYDFTKNRHZMENP-ZDUSSCGKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.23,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910948,DTCC00591244,111846,35090
CHEMBL551729,P20309,,GYDFTKNRHZMENP-ZDUSSCGKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,RATIO IC50,=,1.5,,,,,,,,,,,,,,,Ratio of tiotropium bromide IC50 to compound IC50 for human muscarinic M3 receptor,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581963,DTCT0023280,2911794,DTCC00591244,111846,35090
CHEMBL551729,P20309,,GYDFTKNRHZMENP-ZDUSSCGKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,RATIO IC50,=,9,,,,,,,,,,,,,,,Ratio of ipratropium bromide IC50 to compound IC50 for human muscarinic M3 receptor,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581964,DTCT0023280,2911795,DTCC00591244,111846,35090
CHEMBL551731,P20309,,SMCLERNDEYAHHL-WJOQIKPCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.61,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910966,DTCC00591247,1276688,35090
CHEMBL553025,P20309,VINORELBINE BASE,GBABOYUKABKIAF-IELIFDKJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445830,DTCC00587683,1027061,46191
CHEMBL553025,P20309,VINORELBINE BASE,GBABOYUKABKIAF-IELIFDKJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445831,DTCC00587683,1027061,46191
CHEMBL553058,P20309,,QFEZMJMPOGYHNM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,ACTIVITY,,,,,cell_based,,,,,,,,,,,A9,Ability to stimulate biochemical responses in cell lines expressing muscarinic A9 L receptor sub types; no significant change from basal levels,Not Active,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138566,DTCT0023280,843882,DTCC00576648,129870,17526
CHEMBL553058,P20309,,QFEZMJMPOGYHNM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,KI,=,25.12,NM,,cell_based,,,,,,,,,,,A9,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138831,DTCT0023280,843880,DTCC00576648,129870,17526
CHEMBL553058,P20309,,QFEZMJMPOGYHNM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13678406,LOG EC50,,,,,cell_based,,,,,,,,,,,L cells,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells; Not calculable due to inconsistent dose response curves from assay to assay,Not Determined,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,2003,46,20,"Cao Y, Zhang M, Wu C, Lee S, Wroblewski ME, Whipple T, Nagy PI, Takács-Novák K, Balázs A, Torös S, Messer WS",,138826,DTCT0023280,843881,DTCC00576648,129870,17526
CHEMBL553155,P20309,,ISTCTOUZRSAZGU-FVGYRXGTSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,21379.62,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649049,DTCC00582383,467918,31191
CHEMBL553431,P20309,,IFADQYXYNMCYQZ-UYCLPYRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460535,DTCC00582466,132741,32581
CHEMBL553433,P20309,,DSNRGNKZNJTMAH-JXPUCNARSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,50.12,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460530,DTCC00582470,392966,32581
CHEMBL553434,P20309,,KYIQLEVPUSNDHE-HNCPQSOCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,7762.47,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649047,DTCC00582471,1788367,31191
CHEMBL553446,P20309,,NWSGPQHVYDPULS-VVBGAXOOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,125.89,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460525,DTCC00582408,425615,32581
CHEMBL553448,P20309,,VQDKKGYTYDGCOQ-SDOHQYEBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,KD,=,0.02,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460504,DTCC00582412,1265003,32581
CHEMBL554532,P20309,,ISTCTOUZRSAZGU-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,2754.23,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649051,DTCC00582435,2015730,31191
CHEMBL554632,P20309,,HALIFDFRLAPODA-NCSZJGHKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460534,DTCC00582431,165069,32581
CHEMBL554699,P20309,,RBDHPXXRYPWNOU-YJBOKZPZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.7,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910953,DTCC00588160,1885939,35090
CHEMBL554706,P20309,,HCWDCKCUMMSAAH-CZCBIWLKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,0.0794,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479432,DTCC00582392,143823,32803
CHEMBL554725,P20309,,BGOFOSMLNNTRNP-ZWBOZGNMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.45,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910961,DTCC00588166,1983580,35090
CHEMBL554916,P20309,,WLUMBDZYACAKKA-YYHZLDICSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,288.4,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541438,DTCC00582460,1716850,28855
CHEMBL554916,P20309,,WLUMBDZYACAKKA-YYHZLDICSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,323.59,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541436,DTCC00582460,1716852,28855
CHEMBL554918,P20309,,LVEKZLJAWFLJNQ-BRNFCIBVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,12.59,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460527,DTCC00582478,651317,32581
CHEMBL555019,P20309,,QOWCZPCRIOUVQI-UYCLPYRZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,10,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460532,DTCC00122951,1938773,32581
CHEMBL555146,P20309,,VGSYEFOBFMUWGO-OAHLLOKOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22313227,KI,=,204,NM,,,,,,,,,,,,,,Binding affinity to human recombinant M3 receptor,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012,55,5,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818805,DTCT0023280,10474239,DTCC00380469,1106159,48153
CHEMBL555471,P20309,,ZOFOGPUYUZALRN-IRZMNIQFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,6.31,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460498,DTCC00582400,165064,32581
CHEMBL555474,P20309,,BLEOSRYRMWBYNE-GBUJFNHDSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,2,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460496,DTCC00582477,1653616,32581
CHEMBL555475,P20309,,KYIQLEVPUSNDHE-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,6918.31,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649048,DTCC00582480,111098,31191
CHEMBL555476,P20309,,YBEYGDJWJWOQAQ-UQIIZPHYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18798607,RATIO,=,9.8,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at cloned muscarinic M3 receptor expressed in CHO cells assessed as acetylcholine-induced change in cytosolic calcium concentration by FLIPR assay,,Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.,J. Med. Chem.,2008,51,19,"Jin J, Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Webb EF, Berlanga M, Burman M, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Lainé DI",,538749,DTCT0023280,2567770,DTCC00582483,1821091,31950
CHEMBL555706,P20309,,LGMGQBHYUNQXHA-RVMAVJEGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,KD,=,0.631,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460508,DTCC00582486,1103986,32581
CHEMBL555707,P20309,,YEVPWEXYCSXNFL-VNOCRLHUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18818072,IC50,=,31.62,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced intracellular Ca2+ mobilization by FLIPR assay,,Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.,Bioorg. Med. Chem. Lett.,2008,18,20,"Jin J, Wang Y, Shi D, Wang F, Fu W, Davis RS, Jin Q, Foley JJ, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Busch-Petersen J",,496878,DTCT0023280,2460529,DTCC00122949,197065,32581
CHEMBL556221,P20309,,NASJAUNCFRWKJI-NTHLUGJQSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.24,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910969,DTCC00592844,1821686,35090
CHEMBL556222,P20309,,WVSLILWGBHCSMD-SVUMUAINSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.25,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910974,DTCC00592845,2048699,35090
CHEMBL556390,P20309,,JIGQNAWNJXJZOE-NJBVFQRPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,263.03,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541442,DTCC00582448,1459262,28855
CHEMBL556390,P20309,,JIGQNAWNJXJZOE-NJBVFQRPSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,416.87,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2541440,DTCC00582448,1459265,28855
CHEMBL556426,P20309,,MYLRUMTYZFICQR-LPHOPBHVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.42,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910951,DTCC00592857,791507,35090
CHEMBL556634,P20309,,ZPZZUKPXBVIULS-VQRHYKMASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,200,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910959,DTCC00592860,565730,35090
CHEMBL556635,P20309,,QYOYLHDCZNMWNQ-GHFJOUEHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.18,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910967,DTCC00592864,240967,35090
CHEMBL556635,P20309,,QYOYLHDCZNMWNQ-GHFJOUEHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,KI,=,0.07,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581966,DTCT0023280,2910995,DTCC00592864,240967,35090
CHEMBL556798,P20309,,LRAMPPKCUBOSQB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,16821774,IC50,=,2070,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,"Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonists.",J. Med. Chem.,2006,49,14,"Habashita H, Kokubo M, Hamano S, Hamanaka N, Toda M, Shibayama S, Tada H, Sagawa K, Fukushima D, Maeda K, Mitsuya H",,373792,DTCT0023280,1953442,DTCC00581632,1937179,21051
CHEMBL55698,P20309,,FMPNFDSPHNUFOS-IKYUPOPPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,1949.84,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1399008,DTCC00203631,755362,4936
CHEMBL557555,P20309,CIPROFIBRATE,KPSRODZRAIWAKH-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371432,DTCC00590844,1447879,46191
CHEMBL557555,P20309,CIPROFIBRATE,KPSRODZRAIWAKH-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7371433,DTCC00590844,1447879,46191
CHEMBL557808,P20309,,ATAVXNXZRACOBD-XUFGBYFOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18455407,KI,=,34.67,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,,"Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.",Bioorg. Med. Chem.,2008,16,10,"Dei S, Bellucci C, Buccioni M, Ferraroni M, Guandalini L, Manetti D, Marucci G, Matucci R, Nesi M, Romanelli MN, Scapecchi S, Teodori E",,556679,DTCT0023280,2557257,DTCC00582304,229161,28855
CHEMBL558,P20309,MEXILETINE,VLPIATFUUWWMKC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7406959,DTCC00145505,1351114,46191
CHEMBL558,P20309,MEXILETINE,VLPIATFUUWWMKC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7406960,DTCC00145505,1351114,46191
CHEMBL558551,P20309,(R)-THALIDOMIDE,UEJJHQNACJXSKW-SECBINFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302740,DTCC00022784,1220271,46191
CHEMBL558551,P20309,(R)-THALIDOMIDE,UEJJHQNACJXSKW-SECBINFHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302741,DTCC00022784,1220271,46191
CHEMBL558605,P20309,,IDJFABFFZZDIIM-JIDHJSLPSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19243945,KD,=,3.16,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human recombinant muscarinic M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPR based single concentration kinetic assay,,M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.,Bioorg. Med. Chem. Lett.,2009,19,6,"Budzik B, Wang Y, Shi D, Wang F, Xie H, Wan Z, Zhu C, Foley JJ, Nuthulaganti P, Kallal LA, Sarau HM, Morrow DM, Moore ML, Rivero RA, Palovich M, Salmon M, Belmonte KE, Laine DI, Jin J",,562388,DTCT0023280,2479429,DTCC00582445,1308963,32803
CHEMBL558910,P20309,,HGMITUYOCPPQLE-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.9,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910949,DTCC00594467,565729,35090
CHEMBL559106,P20309,,PGRIFQFOBQZFTR-BCGUBYTQSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.31,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910963,DTCC00594471,1567952,35090
CHEMBL559147,P20309,Y-27632,IYOZTVGMEWJPKR-IJLUTSLNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7451414,DTCC00589732,1798420,46191
CHEMBL559147,P20309,Y-27632,IYOZTVGMEWJPKR-IJLUTSLNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7451415,DTCC00589732,1798420,46191
CHEMBL559931,P20309,,KVAQGLGKAIWEJG-NTHLUGJQSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.96,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910970,DTCC00585007,1342071,35090
CHEMBL560177,P20309,,TZQRQWWAQZCVET-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19560918,ACTIVITY,<,50,%,,,,,,,,,,,,,,Binding affinity to human recombinant muscarinic M3 receptor at 1 uM by radioligand binding assay,,Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identification.,Bioorg. Med. Chem. Lett.,2009,19,16,"Holmes IP, Micheli F, Gaines S, Lorthioir O, Watson SP, Fabio RD, Gentile G, Heidbreder C, Savoia C, Worby A",,582211,DTCT0023280,2912204,DTCC00586238,694967,35180
CHEMBL560327,P20309,,LLORSFIKGQRFSL-QQEZHUOCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910957,DTCC00585020,1211139,35090
CHEMBL561,P20309,LOMEFLOXACIN,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425298,DTCC00145731,1480346,46191
CHEMBL561,P20309,LOMEFLOXACIN,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425299,DTCC00145731,1480346,46191
CHEMBL561187,P20309,,SNHZRZADGXRVTE-YSJJPGTISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.59,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910973,DTCC00586519,436989,35090
CHEMBL561870,P20309,,YFMPQZSMJXCXNI-IJADKNTHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.71,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910956,DTCC00583532,662669,35090
CHEMBL562,P20309,GRISEOFULVIN,DDUHZTYCFQRHIY-RBHXEPJQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306252,DTCC00145751,800577,46191
CHEMBL562,P20309,GRISEOFULVIN,DDUHZTYCFQRHIY-RBHXEPJQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306253,DTCC00145751,800577,46191
CHEMBL562642,P20309,,RBDHPXXRYPWNOU-MAUKXSAKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.39,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910952,DTCC00594468,306718,35090
CHEMBL562655,P20309,,SVLMOWSUKMWKRN-BCGUBYTQSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,1.04,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910955,DTCC00594469,1017979,35090
CHEMBL56275,P20309,,FMPNFDSPHNUFOS-YOUYAXGRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,676.08,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1365029,DTCC00203557,1596405,4936
CHEMBL562890,P20309,,OWSMBRZAWZLSGI-IJADKNTHSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,1.04,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910965,DTCC00589777,436990,35090
CHEMBL563,P20309,FLURBIPROFEN,SYTBZMRGLBWNTM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7335593,DTCC00145756,1447882,46191
CHEMBL563,P20309,FLURBIPROFEN,SYTBZMRGLBWNTM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7335594,DTCC00145756,1447882,46191
CHEMBL56337,P20309,EPALRESTAT,CHNUOJQWGUIOLD-NFZZJPOKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336715,DTCC00204779,2025636,46191
CHEMBL56337,P20309,EPALRESTAT,CHNUOJQWGUIOLD-NFZZJPOKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336716,DTCC00204779,2025636,46191
CHEMBL56367,P20309,NIMESULIDE,HYWYRSMBCFDLJT-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379731,DTCC00201992,736262,46191
CHEMBL56367,P20309,NIMESULIDE,HYWYRSMBCFDLJT-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379732,DTCC00201992,736262,46191
CHEMBL563887,P20309,,VJOYACFUOINUHV-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.92,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910947,DTCC00589769,889089,35090
CHEMBL563920,P20309,,HILDNLJIJXAVHA-AWEZNQCLSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19663387,KI,=,76,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO Flp-In cells by liquid scintillation counting,,Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.,J. Med. Chem.,2009,52,17,"Moree WJ, Li BF, Jovic F, Coon T, Yu J, Gross RS, Tucci F, Marinkovic D, Zamani-Kord S, Malany S, Bradbury MJ, Hernandez LM, O'Brien Z, Wen J, Wang H, Hoare SR, Petroski RE, Sacaan A, Madan A, Crowe PD, Beaton G",,582992,DTCT0023280,2905903,DTCC00123531,229682,35288
CHEMBL563996,P20309,,RAJBLHVEYWFZKO-SUXARLGOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,1.68,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910954,DTCC00583531,2080873,35090
CHEMBL564,P20309,PROMAZINE,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,416,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7381435,DTCC00145816,413977,46191
CHEMBL564,P20309,PROMAZINE,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,88,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7381436,DTCC00145816,413977,46191
CHEMBL564057,P20309,,MVEPXAZDSUKBQJ-VDVBFHQISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.2,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910960,DTCC00589772,468732,35090
CHEMBL564057,P20309,,MVEPXAZDSUKBQJ-VDVBFHQISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,KI,=,0.08,NM,,,,,,,,,,,,,,Binding affinity to muscarinic M3 receptor,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581966,DTCT0023280,2910994,DTCC00589772,468732,35090
CHEMBL564201,P20309,6-AZAURIDINE,WYXSYVWAUAUWLD-SHUUEZRQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7269419,DTCC00485142,768474,46191
CHEMBL564201,P20309,6-AZAURIDINE,WYXSYVWAUAUWLD-SHUUEZRQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7269420,DTCC00485142,768474,46191
CHEMBL564226,P20309,(S)-(+)-DIMETHINDENE,MVMQESMQSYOVGV-HNNXBMFYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12593665,KI,=,3388.44,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,2003,46,5,"Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G",,138830,DTCT0023280,979966,DTCC00591566,238798,17703
CHEMBL564515,P20309,,WSJPAAOJWAKGSF-BCGUBYTQSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.28,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910964,DTCC00585023,37760,35090
CHEMBL564747,P20309,,MYLRUMTYZFICQR-QFBILLFUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.31,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910950,DTCC00592856,111847,35090
CHEMBL564765,P20309,,WVSLILWGBHCSMD-RRVPVRNKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19653626,IC50,=,0.48,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,,Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).,J. Med. Chem.,2009,52,16,"Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H",,581962,DTCT0023280,2910975,DTCC00594458,1697142,35090
CHEMBL565,P20309,CLOFIBRATE,KNHUKKLJHYUCFP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356510,DTCC00145838,1641847,46191
CHEMBL565,P20309,CLOFIBRATE,KNHUKKLJHYUCFP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7356511,DTCC00145838,1641847,46191
CHEMBL565547,P20309,,QGJVXXSJZAPJME-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19646865,KI,=,8200,NM,,,,,,,,,,,,,,Inhibition of muscarinic receptor 3,,Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.,Bioorg. Med. Chem. Lett.,2009,19,17,"Brennan PE, Whitlock GA, Ho DK, Conlon K, McMurray G",,599286,DTCT0023280,3109453,DTCC00602399,208957,36131
CHEMBL56564,P20309,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440691,DTCC00204705,736266,46191
CHEMBL56564,P20309,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440692,DTCC00204705,736266,46191
CHEMBL566534,P20309,ARTEMETHER,SXYIRMFQILZOAM-HVNFFKDJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7267897,DTCC00600123,736254,46191
CHEMBL566534,P20309,ARTEMETHER,SXYIRMFQILZOAM-HVNFFKDJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7267898,DTCC00600123,736254,46191
CHEMBL567,P20309,PERPHENAZINE,RGCVKNLCSQQDEP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,1848,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14759315,DTCC00145901,2107208,68826
CHEMBL567,P20309,PERPHENAZINE,RGCVKNLCSQQDEP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,1848,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14759964,DTCC00145901,2107208,68826
CHEMBL567,P20309,PERPHENAZINE,RGCVKNLCSQQDEP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395707,DTCC00145901,1798415,46191
CHEMBL567,P20309,PERPHENAZINE,RGCVKNLCSQQDEP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395708,DTCC00145901,1798415,46191
CHEMBL567292,P20309,GSK554418A,VARGWBUXBMFVJN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19743867,ACTIVITY,<,10,%,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor at 1 uM,,"Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain.",J. Med. Chem.,2009,52,19,"Giblin GM, Billinton A, Briggs M, Brown AJ, Chessell IP, Clayton NM, Eatherton AJ, Goldsmith P, Haslam C, Johnson MR, Mitchell WL, Naylor A, Perboni A, Slingsby BP, Wilson AW",,597183,DTCT0023280,3106186,DTCC00023379,791885,36268
CHEMBL567597,P20309,ARTEMISININ,BLUAFEHZUWYNDE-DKGJTOOQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7270554,DTCC00601707,1960072,46191
CHEMBL567597,P20309,ARTEMISININ,BLUAFEHZUWYNDE-DKGJTOOQSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7270555,DTCC00601707,1960072,46191
CHEMBL567713,P20309,,MWCLCGKVMLYVJI-RUZDIDTESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19731961,INHIBITION,=,55,%,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor at 10 uM,,Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.,J. Med. Chem.,2009,52,23,"Lawson EC, Luci DK, Ghosh S, Kinney WA, Reynolds CH, Qi J, Smith CE, Wang Y, Minor LK, Haertlein BJ, Parry TJ, Damiano BP, Maryanoff BE",,596676,DTCT0023280,3103299,DTCC00606822,1524723,36254
CHEMBL568237,P20309,,XIFVRPRCVBESLU-GFCCVEGCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19692241,ACTIVITY,=,1000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor,,Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.,Bioorg. Med. Chem. Lett.,2009,19,18,"Andrews MD, Green MP, Allerton CM, Batchelor DV, Blagg J, Brown AD, Gordon DW, McMurray G, Millns DJ, Nichols CL, Watson L",,598096,DTCT0023280,3109950,DTCC00602574,715911,36208
CHEMBL568775,P20309,,BEZNQWHLSZMASN-KFWGXXPESA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,154.88,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076862,DTCC00605672,974234,36436
CHEMBL568870,P20309,,BEZNQWHLSZMASN-WCRWPNQISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,9.33,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076861,DTCC00605668,1071592,36436
CHEMBL569,P20309,PROCAINE,MFDFERRIHVXMIY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396334,DTCC00145963,930084,46191
CHEMBL569,P20309,PROCAINE,MFDFERRIHVXMIY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396335,DTCC00145963,930084,46191
CHEMBL569089,P20309,,BEZNQWHLSZMASN-UULHHVIKSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,512.86,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076863,DTCC00605576,1492441,36436
CHEMBL569212,P20309,,MVNBPMNELMRFMU-DENIHFKCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,323.59,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076854,DTCC00605644,1810274,36436
CHEMBL569270,P20309,,UTPGRZGMQVAYAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24147864,KI,>,10000,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor by PDSP assay,,Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1).,J. Med. Chem.,2013,56,22,"Xu R, Zanotti-Fregonara P, Zoghbi SS, Gladding RL, Woock AE, Innis RB, Pike VW",,1274772,DTCT0023280,12941173,DTCC00606473,1333771,56413
CHEMBL569307,P20309,,BEZNQWHLSZMASN-ZOLWKPHLSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,1.51,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076860,DTCC00605614,12635,36436
CHEMBL569712,P20309,,FZOPTRUFUOFHSM-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,8.91,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076865,DTCC00605592,1104326,36436
CHEMBL569729,P20309,,KVJBFFFRSBLVFJ-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,36.31,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076858,DTCC00605685,1907014,36436
CHEMBL569760,P20309,,BEZNQWHLSZMASN-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,7.24,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076859,DTCC00605613,229801,36436
CHEMBL569953,P20309,,MVNBPMNELMRFMU-SIKLNZKXSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,1659.59,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076855,DTCC00605645,522451,36436
CHEMBL57,P20309,NEVIRAPINE,NQDJXKOVJZTUJA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383955,DTCC00135799,51491,46191
CHEMBL57,P20309,NEVIRAPINE,NQDJXKOVJZTUJA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383956,DTCC00135799,51491,46191
CHEMBL571,P20309,KETOPROFEN,DKYWVDODHFEZIM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433415,DTCC00145969,2025638,46191
CHEMBL571,P20309,KETOPROFEN,DKYWVDODHFEZIM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433416,DTCC00145969,2025638,46191
CHEMBL571121,P20309,,MVNBPMNELMRFMU-KNQAVFIVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,1.66,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076852,DTCC00605622,1492442,36436
CHEMBL571123,P20309,,GTXZQPRWWKNJQL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,85.11,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076856,DTCC00605667,1200147,36436
CHEMBL571341,P20309,,MVNBPMNELMRFMU-UGKGYDQZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,23.44,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076853,DTCC00605623,812644,36436
CHEMBL571758,P20309,,JFIOFXPCIFBCIW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19743867,ACTIVITY,<,10,%,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor at 1 uM,,"Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain.",J. Med. Chem.,2009,52,19,"Giblin GM, Billinton A, Briggs M, Brown AJ, Chessell IP, Clayton NM, Eatherton AJ, Goldsmith P, Haslam C, Johnson MR, Mitchell WL, Naylor A, Perboni A, Slingsby BP, Wilson AW",,597183,DTCT0023280,3106210,DTCC00608289,372332,36268
CHEMBL572,P20309,NITROFURANTOIN,NXFQHRVNIOXGAQ-YCRREMRBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7405681,DTCC00145970,1927018,46191
CHEMBL572,P20309,NITROFURANTOIN,NXFQHRVNIOXGAQ-YCRREMRBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7405682,DTCC00145970,1927018,46191
CHEMBL573,P20309,NIACIN,PVNIIMVLHYAWGP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388317,DTCC00146015,381015,46191
CHEMBL573,P20309,NIACIN,PVNIIMVLHYAWGP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388318,DTCC00146015,381015,46191
CHEMBL57485,P20309,,FMPNFDSPHNUFOS-YOASDKSVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,2089.3,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1386628,DTCC00203556,1628991,4936
CHEMBL576663,P20309,,CHXGLJOIUDBPTI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,95.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076198,DTCC00605596,715942,36436
CHEMBL576707,P20309,,WHZBQLWHOPDIPC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,33.88,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076857,DTCC00123817,1232470,36436
CHEMBL578,P20309,ENALAPRIL,GBXSMTUPTTWBMN-XIRDDKMYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323827,DTCC00146157,49658,46191
CHEMBL578,P20309,ENALAPRIL,GBXSMTUPTTWBMN-XIRDDKMYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323828,DTCC00146157,49658,46191
CHEMBL578171,P20309,BENZYLIC ACID,UKXSKSHDVLQNKG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,0.088,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14739266,DTCC00601715,2106977,68417
CHEMBL578171,P20309,BENZYLIC ACID,UKXSKSHDVLQNKG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,0.08,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14739267,DTCC00601715,2106978,68567
CHEMBL58,P20309,MITOXANTRONE,KKZJGLLVHKMTCM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7439136,DTCC00103487,1092344,46191
CHEMBL58,P20309,MITOXANTRONE,KKZJGLLVHKMTCM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7439137,DTCC00103487,1092344,46191
CHEMBL580,P20309,LORAZEPAM,DIWRORZWFLOCLC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440343,DTCC00146251,1285879,46191
CHEMBL580,P20309,LORAZEPAM,DIWRORZWFLOCLC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440344,DTCC00146251,1285879,46191
CHEMBL58228,P20309,,ZGWVRJWWDJNRNP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,1616.4,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,532142,DTCC00209172,400757,2697
CHEMBL583,P20309,GREPAFLOXACIN,AIJTTZAVMXIJGM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336111,DTCC00146380,542577,46191
CHEMBL583,P20309,GREPAFLOXACIN,AIJTTZAVMXIJGM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336112,DTCC00146380,542577,46191
CHEMBL583027,P20309,,QCMYAVMNHSOOKW-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,23.44,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076864,DTCC00605577,845538,36436
CHEMBL583051,P20309,,MVNBPMNELMRFMU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19928767,KI,=,7.76,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,,"Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.",J. Med. Chem.,2010,53,1,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martelli C, Martini E, Marucci G, Orlandi F, Romanelli MN, Teodori E, Cirilli R",,596257,DTCT0023280,3076199,DTCC00605602,1330484,36436
CHEMBL584,P20309,NELFINAVIR,QAGYKUNXZHXKMR-HKWSIXNMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401087,DTCC01738575,1798414,46191
CHEMBL584,P20309,NELFINAVIR,QAGYKUNXZHXKMR-HKWSIXNMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7401088,DTCC01738575,1798414,46191
CHEMBL585,P20309,TRIAMTERENE,FNYLWPVRPXGIIP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445359,DTCC00146599,1674154,46191
CHEMBL585,P20309,TRIAMTERENE,FNYLWPVRPXGIIP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445360,DTCC00146599,1674154,46191
CHEMBL588119,P20309,SULOCTIDIL,BFCDFTHTSVTWOG-YLJYHZDGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,4623.8,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7471999,DTCC00123899,2057654,46191
CHEMBL588119,P20309,SULOCTIDIL,BFCDFTHTSVTWOG-YLJYHZDGSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,980,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7472000,DTCC00123899,2057654,46191
CHEMBL58824,P20309,,FMPNFDSPHNUFOS-LYTIHPTOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12113806,KI,=,794.33,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,,Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2002,12,15,"Gao LJ, Waelbroeck M, Hofman S, Van Haver D, Milanesio M, Viterbo D, De Clercq PJ",,139829,DTCT0023280,1383008,DTCC00203500,236924,4936
CHEMBL593443,P20309,,MMFSFQDCALVVNK-OULXEKPRSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,44668.36,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164327,DTCC00613437,1244650,36765
CHEMBL59347,P20309,,KPZUVZJSQLBQHD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,32589.6,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,517401,DTCC00209282,1014075,2697
CHEMBL593620,P20309,,ARKMSPVEHZPKKM-BAUSSPIASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,10471.29,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164365,DTCC00613547,1727020,36765
CHEMBL593685,P20309,,ARKMSPVEHZPKKM-DHTOPLTISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,16218.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164352,DTCC00613546,631048,36765
CHEMBL593861,P20309,,HHQWGXVMIJSVBU-HNCPQSOCSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,40738.03,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164366,DTCC00613548,1633291,36765
CHEMBL593864,P20309,,SENFHXUCIWUEOP-HHDYSPPTSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164317,DTCC00613440,1727019,36765
CHEMBL593871,P20309,,SENFHXUCIWUEOP-RWDYHCJXSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164320,DTCC00613439,631046,36765
CHEMBL594376,P20309,,MMFSFQDCALVVNK-VTLYIQCISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,66069.34,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164339,DTCC00613661,1854281,36765
CHEMBL594801,P20309,,YYKQDBAAANMOGS-SBSPUUFOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,21379.62,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164332,DTCC00613509,38596,36765
CHEMBL594802,P20309,,IAMLKTAMOFMTDP-SBSPUUFOSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,77624.71,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164331,DTCC00613510,1697635,36765
CHEMBL594803,P20309,,QEMZFYRAGKOYMF-BAUSSPIASA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,32359.37,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164353,DTCC00613511,1375166,36765
CHEMBL595,P20309,PIOGLITAZONE,HYAFETHFCAUJAY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391668,DTCC00148462,1318445,46191
CHEMBL595,P20309,PIOGLITAZONE,HYAFETHFCAUJAY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391669,DTCC00148462,1318445,46191
CHEMBL595022,P20309,,QEMZFYRAGKOYMF-DHTOPLTISA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,46773.51,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164367,DTCC00613545,534043,36765
CHEMBL595265,P20309,,SENFHXUCIWUEOP-OAINAWNSSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,10964.78,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164329,DTCC00613438,209146,36765
CHEMBL595449,P20309,,ILPANLYEJQKXKY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19646882,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.,Bioorg. Med. Chem.,2009,17,17,"Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S, Wannemacher KM, Howells RD, Welsh WJ",,601716,DTCT0023280,3163182,DTCC00612138,1136637,36541
CHEMBL597,P20309,PHENTOLAMINE,MRBDMNSDAVCSSF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395830,DTCC00148793,1641852,46191
CHEMBL597,P20309,PHENTOLAMINE,MRBDMNSDAVCSSF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395831,DTCC00148793,1641852,46191
CHEMBL59836,P20309,,YECZUVJTDYORCB-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10450976,KI,=,4.2,NM,,,,,,,,,,,,,,Binding affinity for human cloned Muscarinic M3 receptors,,"Stereoselective synthesis of a new muscarinic M3 receptor antagonist, J-104129.",Bioorg. Med. Chem. Lett.,1999,9,14,"Mitsuya M, Kawakami K, Ogino Y, Miura K, Mase T",,138243,DTCT0023280,507470,DTCC00211623,2000562,3234
CHEMBL59836,P20309,,YECZUVJTDYORCB-DEOSSOPVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,4.2,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1394337,DTCC00211623,2013937,16058
CHEMBL59898,P20309,PD-102807,VDDUJINYXKGZLV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,950,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,534959,DTCC01740612,29369,2697
CHEMBL59898,P20309,PD-102807,VDDUJINYXKGZLV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12086495,KI,=,257.04,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,,Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.,J. Med. Chem.,2002,45,14,"Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD",,138832,DTCT0023280,1612711,DTCC01740612,30644,16818
CHEMBL59898,P20309,PD-102807,VDDUJINYXKGZLV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of basal Eu-GTP binding,Not Active,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477426,DTCT0023280,2368248,DTCC01740612,9469,26235
CHEMBL59898,P20309,PD-102807,VDDUJINYXKGZLV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,KI,=,1.38038E+15,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477412,DTCT0023280,2368224,DTCC01740612,9469,26235
CHEMBL59898,P20309,PD-102807,VDDUJINYXKGZLV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18395442,PKB,=,5.63,,,cell_based,,,,,,,,,,,CHO,Antagonist activity at human muscarinic M3 receptor expressed in CHO cells assessed as inhibition of carbachol-induced Eu-GTP binding,,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008,18,9,"Varoli L, Andreani A, Burnelli S, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Bedini A, Fazio N, Spampinato S",,477421,DTCT0023280,2368240,DTCC01740612,9469,26235
CHEMBL599,P20309,MELOXICAM,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421480,DTCC00149080,638767,46191
CHEMBL599,P20309,MELOXICAM,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421481,DTCC00149080,638767,46191
CHEMBL59939,P20309,,CFROMQQFSYBIHZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,3394,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,539705,DTCC00209277,885146,2697
CHEMBL599760,P20309,RO-85,WLMBSKSEPQCRJV-OAHLLOKOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20045645,ACTIVITY,>,50,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells at 10 uM after 60 mins by scintillation counting,,"Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.",Bioorg. Med. Chem. Lett.,2010,20,3,"Brotherton-Pleiss CE, Dillon MP, Ford AP, Gever JR, Carter DS, Gleason SK, Lin CJ, Moore AG, Thompson AW, Villa M, Zhai Y",,612472,DTCT0023280,3188533,DTCC00030157,1918622,37451
CHEMBL6,P20309,INDOMETHACIN,CGIGDMFJXJATDK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430917,DTCC00132340,51479,46191
CHEMBL6,P20309,INDOMETHACIN,CGIGDMFJXJATDK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430918,DTCC00132340,51479,46191
CHEMBL600325,P20309,PROSCILLARIDIN,MYEJFUXQJGHEQK-ALRJYLEOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7381487,DTCC00486948,1705878,46191
CHEMBL600325,P20309,PROSCILLARIDIN,MYEJFUXQJGHEQK-ALRJYLEOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7381488,DTCC00486948,1705878,46191
CHEMBL60142,P20309,,ZFQPOANUZSLNNR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,3704.2,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,521567,DTCC00209198,1817666,2697
CHEMBL602850,P20309,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11474345,DTCC00609826,1300183,51935
CHEMBL602850,P20309,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12598964,DTCC00609826,1301031,55935
CHEMBL603,P20309,ZAFIRLUKAST,YEEZWCHGZNKEEK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7441833,DTCC00150003,1830696,46191
CHEMBL603,P20309,ZAFIRLUKAST,YEEZWCHGZNKEEK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7441834,DTCC00150003,1830696,46191
CHEMBL604482,P20309,,HRSJEMJKLHWGLF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23562060,EC50,>,30000,NM,,,,,,,,,,,,,,Positive allosteric modulation of human muscarinic M3 receptor,,"Discovery of ML326: The first sub-micromolar, selective M5 PAM.",Bioorg. Med. Chem. Lett.,2013,23,10,"Gentry PR, Bridges TM, Lamsal A, Vinson PN, Smith E, Chase P, Hodder PS, Engers JL, Niswender CM, Scott Daniels J, Jeffrey Conn P, Wood MR, Lindsley CW",,960034,DTCT0023280,12436497,DTCC00610615,1450580,54522
CHEMBL604798,P20309,CP-810123,BSNKYWSMUAGMDO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20043678,KI,=,8300,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010,53,3,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611817,DTCT0023280,3182708,DTCC00030113,1039298,37429
CHEMBL608,P20309,PROBUCOL,FYPMFJGVHOHGLL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387742,DTCC00150969,962450,46191
CHEMBL608,P20309,PROBUCOL,FYPMFJGVHOHGLL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7387743,DTCC00150969,962450,46191
CHEMBL608151,P20309,,IBZJKEOJOGAMGJ-COPLHBTASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20170186,KI,=,63.1,NM,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor,,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,2010,53,6,"Micheli F, Cavanni P, Arban R, Benedetti R, Bertani B, Bettati M, Bettelini L, Bonanomi G, Braggio S, Checchia A, Davalli S, Di Fabio R, Fazzolari E, Fontana S, Marchioro C, Minick D, Negri M, Oliosi B, Read KD, Sartori I, Tedesco G, Tarsi L, Terreni S, Visentini F, Zocchi A, Zonzini L",,613769,DTCT0023280,3213879,DTCC00615202,437543,37197
CHEMBL608560,P20309,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22959245,KI,,,,,,,,,,,,,,,,,Binding affinity to M3 muscarinic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012,22,19,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884093,DTCT0023280,11474373,DTCC00609825,1780158,51935
CHEMBL608560,P20309,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23981939,KI,,,,,,,,,,,,,,,,,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013,21,19,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985408,DTCT0023280,12600255,DTCC00609825,1780917,55935
CHEMBL60889,P20309,MOSAPRIDE,YPELFRMCRYSPKZ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7426444,DTCC00208987,217581,46191
CHEMBL60889,P20309,MOSAPRIDE,YPELFRMCRYSPKZ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7426445,DTCC00208987,217581,46191
CHEMBL608985,P20309,,SENFHXUCIWUEOP-YMQJAAJZSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,>,100000,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164318,DTCC00613508,1211676,36765
CHEMBL609602,P20309,,OBGQXKXUFQHOCB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20303264,ACTIVITY,,,,,cell_based,,,,,,,,,,,CHO,Positive allosteric modulator activity at human muscarinic M3 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium mobilization by FLIPR assay,Not Active,Heterocyclic fused pyridone carboxylic acid M(1) positive allosteric modulators.,Bioorg. Med. Chem. Lett.,2010,20,8,"Kuduk SD, Di Marco CN, Chang RK, Ray WJ, Ma L, Wittmann M, Seager MA, Koeplinger KA, Thompson CD, Hartman GD, Bilodeau MT",,626611,DTCT0023280,3297960,DTCC00610307,889846,38385
CHEMBL609720,P20309,N-3-NITROBENZYL STRYCHNINE BROMIDE,JXHNSEBJWRYIJS-ZUQDKBMMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,<,4.7,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1335645,DTCC00030333,788823,15566
CHEMBL609720,P20309,N-3-NITROBENZYL STRYCHNINE BROMIDE,JXHNSEBJWRYIJS-ZUQDKBMMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.8,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1335646,DTCC00030333,788823,15566
CHEMBL609720,P20309,N-3-NITROBENZYL STRYCHNINE BROMIDE,JXHNSEBJWRYIJS-ZUQDKBMMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1335655,DTCC00030333,788823,15566
CHEMBL609720,P20309,N-3-NITROBENZYL STRYCHNINE BROMIDE,JXHNSEBJWRYIJS-ZUQDKBMMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,2,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1335651,DTCC00030333,788823,15566
CHEMBL609721,P20309,N-4-NITROBENZYL STRYCHNINE BROMIDE,FTMSGOSVHZODOL-ZUQDKBMMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.6,,,,,,,,,,,,,,,Binding affinity at the NMS liganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138568,DTCT0023280,1355353,DTCC00030334,402055,15566
CHEMBL609721,P20309,N-4-NITROBENZYL STRYCHNINE BROMIDE,FTMSGOSVHZODOL-ZUQDKBMMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,AFFINITY,=,4.6,,,,,,,,,,,,,,,Binding affinity at the unliganded human muscarinic acetylcholine receptor M3 was estimated as log affinity (log1/M),,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138569,DTCT0023280,1355352,DTCC00030334,402055,15566
CHEMBL609721,P20309,N-4-NITROBENZYL STRYCHNINE BROMIDE,FTMSGOSVHZODOL-ZUQDKBMMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,0.8,,,,,,,,,,,,,,,Cooperativity with acetylcholine at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138575,DTCT0023280,1355362,DTCC00030334,402055,15566
CHEMBL609721,P20309,N-4-NITROBENZYL STRYCHNINE BROMIDE,FTMSGOSVHZODOL-ZUQDKBMMSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986715,COOPERATIVITY,=,1.19,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M3,,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,1999,42,3,"Gharagozloo P, Lazareno S, Popham A, Birdsall NJ",,138574,DTCT0023280,1355358,DTCC00030334,402055,15566
CHEMBL61,P20309,PODOFILOX,YJGVMLPVUAXIQN-XVVDYKMHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391771,DTCC00136120,51501,46191
CHEMBL61,P20309,PODOFILOX,YJGVMLPVUAXIQN-XVVDYKMHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391772,DTCC00136120,51501,46191
CHEMBL611,P20309,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7461369,DTCC00103842,2025644,46191
CHEMBL611,P20309,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7461370,DTCC00103842,2025644,46191
CHEMBL614,P20309,PYRAZINAMIDE,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7390162,DTCC00151678,898296,46191
CHEMBL614,P20309,PYRAZINAMIDE,IPEHBUMCGVEMRF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7390163,DTCC00151678,898296,46191
CHEMBL61412,P20309,,PPAUYLKOXHOIRK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,1482.3,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,528414,DTCC00209199,1979657,2697
CHEMBL61494,P20309,,WENKIEOMTSYROD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,10315.1,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,519486,DTCC00209230,1629057,2697
CHEMBL61700,P20309,,QELYJMWPIJVOGA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,3067.8,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,527457,DTCC00209355,1046475,2697
CHEMBL61774,P20309,,QCKRJTMYXCHUDG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,12612.2,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,538823,DTCC00209412,1849759,2697
CHEMBL621,P20309,TRAZODONE,PHLBKPHSAVXXEF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14759109,DTCC00154041,2111442,68567
CHEMBL621,P20309,TRAZODONE,PHLBKPHSAVXXEF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14759758,DTCC00154041,2111442,68567
CHEMBL621,P20309,TRAZODONE,PHLBKPHSAVXXEF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7450829,DTCC00154041,51512,46191
CHEMBL621,P20309,TRAZODONE,PHLBKPHSAVXXEF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7450830,DTCC00154041,51512,46191
CHEMBL62193,P20309,SULFADIMETHOXINE,ZZORFUFYDOWNEF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7476110,DTCC00208934,703987,46191
CHEMBL62193,P20309,SULFADIMETHOXINE,ZZORFUFYDOWNEF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7476111,DTCC00208934,703987,46191
CHEMBL622,P20309,ETODOLAC,NNYBQONXHNTVIJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330749,DTCC00154070,153443,46191
CHEMBL622,P20309,ETODOLAC,NNYBQONXHNTVIJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7330750,DTCC00154070,153443,46191
CHEMBL62247,P20309,,BDIZCMDNZUBLMP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,2629,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,522589,DTCC00209254,497505,2697
CHEMBL62251,P20309,,QPMSDLVPDBQHOL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9873472,IC50,=,2817,NM,,,,,,,,,,,,,,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,,Identification and characterization of m4 selective muscarinic antagonists.,Bioorg. Med. Chem. Lett.,1998,8,15,"Augelli-Szafran CE, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD",,139672,DTCT0023280,526411,DTCC00209445,497506,2697
CHEMBL625,P20309,THIABENDAZOLE,WJCNZQLZVWNLKY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470200,DTCC00154204,217588,46191
CHEMBL625,P20309,THIABENDAZOLE,WJCNZQLZVWNLKY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7470201,DTCC00154204,217588,46191
CHEMBL6273,P20309,FLEROXACIN,XBJBPGROQZJDOJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7328854,DTCC00132376,1220277,46191
CHEMBL6273,P20309,FLEROXACIN,XBJBPGROQZJDOJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7328855,DTCC00132376,1220277,46191
CHEMBL628,P20309,PENTOXIFYLLINE,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7382794,DTCC00154570,1641851,46191
CHEMBL628,P20309,PENTOXIFYLLINE,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7382795,DTCC00154570,1641851,46191
CHEMBL629,P20309,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,12.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14727524,DTCC00154602,2103407,68567
CHEMBL629,P20309,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10227113,KI,=,39,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14727523,DTCC00154602,2103406,68459
CHEMBL629,P20309,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,26,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7298217,DTCC00154602,477911,46191
CHEMBL629,P20309,AMITRIPTYLINE,KRMDCWKBEZIMAB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,5.44,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7298218,DTCC00154602,477911,46191
CHEMBL631,P20309,PROPAFENONE,JWHAUXFOSRPERK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7390046,DTCC00154637,1927020,46191
CHEMBL631,P20309,PROPAFENONE,JWHAUXFOSRPERK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7390047,DTCC00154637,1927020,46191
CHEMBL632,P20309,BETAMETHASONE,UREBDLICKHMUKA-DVTGEIKXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7277096,DTCC00154673,1188064,46191
CHEMBL632,P20309,BETAMETHASONE,UREBDLICKHMUKA-DVTGEIKXSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7277097,DTCC00154673,1188064,46191
CHEMBL633,P20309,AMIODARONE,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,3201,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7292716,DTCC00154700,768472,46191
CHEMBL633,P20309,AMIODARONE,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,679,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7292717,DTCC00154700,768472,46191
CHEMBL63323,P20309,NIFLUMIC ACID,JZFPYUNJRRFVQU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7405563,DTCC00211494,639583,46191
CHEMBL63323,P20309,NIFLUMIC ACID,JZFPYUNJRRFVQU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7405564,DTCC00211494,639583,46191
CHEMBL63354,P20309,AMENTOFLAVONE,YUSWMAULDXZHPY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14753797,DTCC00216407,2103540,69275
CHEMBL635,P20309,PREDNISONE,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396193,DTCC00154731,381016,46191
CHEMBL635,P20309,PREDNISONE,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396194,DTCC00154731,381016,46191
CHEMBL63560,P20309,(R)-BICALUTAMIDE,LKJPYSCBVHEWIU-KRWDZBQOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283441,DTCC00216573,833153,46191
CHEMBL63560,P20309,(R)-BICALUTAMIDE,LKJPYSCBVHEWIU-KRWDZBQOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283442,DTCC00216573,833153,46191
CHEMBL637,P20309,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14728916,DTCC00154763,2103731,68567
CHEMBL637,P20309,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7451307,DTCC00154763,1512820,46191
CHEMBL637,P20309,VENLAFAXINE,PNVNVHUZROJLTJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7451308,DTCC00154763,1512820,46191
CHEMBL6373,P20309,,SFAVNCAJEGVFMX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,>,50000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1036442,DTCC00132985,1599271,8985
CHEMBL6375,P20309,,AAKMJFSTMUYOCW-SQQVDAMQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,>,50000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1040571,DTCC00133081,1787934,8985
CHEMBL63756,P20309,FLUPERLAPINE,OBWGMKKHCLHVIE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,41,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14734578,DTCC00217180,2105307,68417
CHEMBL6377,P20309,,ASLGIQYPFOFVJA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,>,50000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1039137,DTCC00133082,661472,8985
CHEMBL64,P20309,ISONIAZID,QRXWMOHMRWLFEY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433317,DTCC00136222,51480,46191
CHEMBL64,P20309,ISONIAZID,QRXWMOHMRWLFEY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433318,DTCC00136222,51480,46191
CHEMBL640,P20309,PROCAINAMIDE,REQCZEXYDRLIBE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392036,DTCC00154806,1577009,46191
CHEMBL640,P20309,PROCAINAMIDE,REQCZEXYDRLIBE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392037,DTCC00154806,1577009,46191
CHEMBL64000,P20309,,HHXDJDWQQPSWHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9622546,KI,=,680,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,,6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.,J. Med. Chem.,1998,41,12,"Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW",,138707,DTCT0023280,1639731,DTCC00213284,1143978,14670
CHEMBL64000,P20309,,HHXDJDWQQPSWHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,680,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138710,DTCT0023280,457971,DTCC00213284,1143450,15779
CHEMBL64000,P20309,,HHXDJDWQQPSWHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,457972,DTCC00213284,1143450,15779
CHEMBL642,P20309,ACEBUTOLOL,GOEMGAFJFRBGGG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7292108,DTCC00154812,1798405,46191
CHEMBL642,P20309,ACEBUTOLOL,GOEMGAFJFRBGGG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7292109,DTCC00154812,1798405,46191
CHEMBL643,P20309,PROMETHAZINE,PWWVAXIEGOYWEE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,20,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7385748,DTCC00154825,1188074,46191
CHEMBL643,P20309,PROMETHAZINE,PWWVAXIEGOYWEE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,4.15,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7385749,DTCC00154825,1188074,46191
CHEMBL6437,P20309,MIANSERIN,UEQUQVLFIPOEMF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,1405,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411257,DTCC00132673,1383778,46191
CHEMBL6437,P20309,MIANSERIN,UEQUQVLFIPOEMF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,298,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411258,DTCC00132673,1383778,46191
CHEMBL6451,P20309,,SCPYRRZFPGLILV-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,1800,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1052997,DTCC00133084,2015279,8985
CHEMBL6466,P20309,COUMARIN,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7369794,DTCC00133265,833159,46191
CHEMBL6466,P20309,COUMARIN,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7369795,DTCC00133265,833159,46191
CHEMBL64788,P20309,,UQNMBYYNYGZWBK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9622546,KI,=,18000,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,,6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.,J. Med. Chem.,1998,41,12,"Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW",,138707,DTCT0023280,1616667,DTCC00213105,1979710,14670
CHEMBL648,P20309,CYCLIZINE,UVKZSORBKUEBAZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,748,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7352540,DTCC00154967,381007,46191
CHEMBL648,P20309,CYCLIZINE,UVKZSORBKUEBAZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,159,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7352541,DTCC00154967,381007,46191
CHEMBL64894,P20309,GENTIAN VIOLET,ZXJXZNDDNMQXFV-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,4330,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310309,DTCC00212699,703981,46191
CHEMBL64894,P20309,GENTIAN VIOLET,ZXJXZNDDNMQXFV-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,918,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310310,DTCC00212699,703981,46191
CHEMBL649,P20309,NADOLOL,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430871,DTCC00154988,2057650,46191
CHEMBL649,P20309,NADOLOL,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7430872,DTCC00154988,2057650,46191
CHEMBL65,P20309,CAMPTOTHECIN,VSJKWCGYPAHWDS-FQEVSTJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7267756,DTCC00136347,51451,46191
CHEMBL65,P20309,CAMPTOTHECIN,VSJKWCGYPAHWDS-FQEVSTJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7267757,DTCC00136347,51451,46191
CHEMBL650,P20309,METHYLPREDNISOLONE,VHRSUDSXCMQTMA-PJHHCJLFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7436744,DTCC00154993,1447885,46191
CHEMBL650,P20309,METHYLPREDNISOLONE,VHRSUDSXCMQTMA-PJHHCJLFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7436745,DTCC00154993,1447885,46191
CHEMBL653,P20309,NIZATIDINE,SGXXNSQHWDMGGP-IZZDOVSWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375538,DTCC00155018,866021,46191
CHEMBL653,P20309,NIZATIDINE,SGXXNSQHWDMGGP-IZZDOVSWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375539,DTCC00155018,866021,46191
CHEMBL6568,P20309,,NXWHMHNUXVMTKI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,20000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1018010,DTCC00103434,1437724,8985
CHEMBL657,P20309,DIPHENHYDRAMINE,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,229,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14746471,DTCC00155038,2109185,68417
CHEMBL657,P20309,DIPHENHYDRAMINE,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,647,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7340500,DTCC00155038,1285873,46191
CHEMBL657,P20309,DIPHENHYDRAMINE,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,137,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7340501,DTCC00155038,1285873,46191
CHEMBL6587,P20309,,KNQQDOUAUHGRHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,>,50000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1049230,DTCC00103433,855651,8985
CHEMBL659,P20309,GALANTAMINE,ASUTZQLVASHGKV-JDFRZJQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7335733,DTCC00155049,994592,46191
CHEMBL659,P20309,GALANTAMINE,ASUTZQLVASHGKV-JDFRZJQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7303619,DTCC00155049,994592,46191
CHEMBL660,P20309,AMANTADINE,DKNWSYNQZKUICI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7285882,DTCC00155056,1285872,46191
CHEMBL660,P20309,AMANTADINE,DKNWSYNQZKUICI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7285883,DTCC00155056,1285872,46191
CHEMBL661,P20309,ALPRAZOLAM,VREFGVBLTWBCJP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302236,DTCC00155057,994588,46191
CHEMBL661,P20309,ALPRAZOLAM,VREFGVBLTWBCJP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7302237,DTCC00155057,994588,46191
CHEMBL66322,P20309,,ZUHDKSXKMLQBAW-APWZRJJASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,11,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1465380,DTCC00221697,356342,5621
CHEMBL66400,P20309,,OWDSSIDYHAEOHU-IBGZPJMESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,1.7,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1481249,DTCC00221039,1002665,5621
CHEMBL666,P20309,FOSCARNET,ZJAOAACCNHFJAH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314348,DTCC00155151,1765971,46191
CHEMBL666,P20309,FOSCARNET,ZJAOAACCNHFJAH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7314349,DTCC00155151,1765971,46191
CHEMBL667,P20309,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12235229,KI,=,4200,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14737050,DTCC00103957,2106176,68470
CHEMBL667,P20309,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18077164,KI,=,7079.46,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,,"Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.",Bioorg. Med. Chem. Lett.,2008,18,2,"Piergentili A, Quaglia W, Giannella M, Del Bello F, Buccioni M, Nesi M, Matucci R",,461882,DTCT0023280,2278180,DTCC00103957,1776535,25106
CHEMBL667,P20309,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,EC50,=,3.2,NM,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as increase of acetylcholine-induced calcium flux by FLIPR assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659446,DTCT0023280,3460749,DTCC00103957,1778423,40772
CHEMBL667,P20309,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22677319,EC50,=,3.2,NM,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as calcium mobilization for 6 mins by Calcium4-based staining,,Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential.,Bioorg. Med. Chem. Lett.,2012,22,15,"Sams AG, Larsen K, Mikkelsen GK, Hentzer M, Christoffersen CT, Jensen KG, Frederiksen K, Bang-Andersen B",,829280,DTCT0023280,10536786,DTCC00103957,1799570,48886
CHEMBL667,P20309,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,22677319,EMAX,=,100,%,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as calcium mobilization atb 10 uM for 6 mins by Calcium4-based staining relative to acetylcholine,,Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential.,Bioorg. Med. Chem. Lett.,2012,22,15,"Sams AG, Larsen K, Mikkelsen GK, Hentzer M, Christoffersen CT, Jensen KG, Frederiksen K, Bang-Andersen B",,829279,DTCT0023280,10537473,DTCC00103957,1799570,48886
CHEMBL667,P20309,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,=,100,%,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060853,DTCC00103957,1802691,61603
CHEMBL667,P20309,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EC50,=,205,NM,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay,,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517986,DTCT0023280,14545930,DTCC00103957,1783650,63681
CHEMBL667,P20309,ACETYLCHOLINE,OIPILFWXSMYKGL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26299349,EFFICACY,=,117,%,,cell_based,,,,,,,,,,,,Agonist activity at human muscarinic M3 receptor expressed in CHO cells after 30 mins by GTPgamma35S binding assay relative to acetylcholine,,Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.,Bioorg. Med. Chem. Lett.,2015,25,19,"Liu B, Croy CH, Hitchcock SA, Allen JR, Rao Z, Evans D, Bures MG, McKinzie DL, Watt ML, Stuart Gregory G, Hansen MM, Hoogestraat PJ, Jamison JA, Okha-Mokube FM, Stratford RE, Turner W, Bymaster F, Felder CC",,1517987,DTCT0023280,14545933,DTCC00103957,1783650,63681
CHEMBL6680,P20309,,DGMPKWQBFSQOEW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,3400,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1020606,DTCC00133118,1114329,8985
CHEMBL66820,P20309,,GEUKFRPGSOAJHW-NQIIRXRSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,47,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1462986,DTCC00221694,614848,5621
CHEMBL6702,P20309,,MLYAUOKINLUHRK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,>,50000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1021731,DTCC00133109,272530,8985
CHEMBL672,P20309,FENOFIBRATE,YMTINGFKWWXKFG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7335163,DTCC01738591,1220276,46191
CHEMBL672,P20309,FENOFIBRATE,YMTINGFKWWXKFG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7335164,DTCC01738591,1220276,46191
CHEMBL6767,P20309,,VEOVHJYFYPNTIP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,1200,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1025511,DTCC00133079,1242832,8985
CHEMBL67814,P20309,,XSIRNWJXBZIYEQ-PBHICJAKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,50,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1480044,DTCC00221146,1488309,5621
CHEMBL67873,P20309,,YDUYOCIXWLWORE-XLIONFOSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,89,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1471244,DTCC00221570,1617561,5621
CHEMBL679,P20309,EPINEPHRINE,UCTWMZQNUQWSLP-VIFPVBQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7311193,DTCC00156188,1512808,46191
CHEMBL679,P20309,EPINEPHRINE,UCTWMZQNUQWSLP-VIFPVBQESA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7311194,DTCC00156188,1512808,46191
CHEMBL6807,P20309,,OHKWDPCVXYOQLZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,>,50000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1041810,DTCC00133078,758176,8985
CHEMBL683,P20309,CLOFIBRIC ACID,TXCGAZHTZHNUAI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7360830,DTCC00156551,1894964,46191
CHEMBL683,P20309,CLOFIBRIC ACID,TXCGAZHTZHNUAI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7360831,DTCC00156551,1894964,46191
CHEMBL68384,P20309,,FUMDHGFBMAYXOX-XLIONFOSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,1.2,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1478783,DTCC00220960,550320,5621
CHEMBL685,P20309,MEBENDAZOLE,OPXLLQIJSORQAM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425626,DTCC00156769,800580,46191
CHEMBL685,P20309,MEBENDAZOLE,OPXLLQIJSORQAM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425627,DTCC00156769,800580,46191
CHEMBL68584,P20309,,JBVFPTKZYNRPII-KDOFPFPSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,5.1,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1455592,DTCC00221150,1132331,5621
CHEMBL6859,P20309,,VWGWXSCTVZCITH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,>,50000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1036447,DTCC00133108,1373348,8985
CHEMBL686,P20309,MEFENAMIC ACID,HYYBABOKPJLUIN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408533,DTCC00157071,1416034,46191
CHEMBL686,P20309,MEFENAMIC ACID,HYYBABOKPJLUIN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408534,DTCC00157071,1416034,46191
CHEMBL6860,P20309,,VBPWSRUTFRJWCK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,>,50000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1030498,DTCC00133117,661473,8985
CHEMBL68609,P20309,,WVAXSPFXHVXZHT-BEFAXECRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,8.3,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1481246,DTCC00220744,2033624,5621
CHEMBL689,P20309,MANNITOL,FBPFZTCFMRRESA-KVTDHHQDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7438319,DTCC00157212,1960078,46191
CHEMBL689,P20309,MANNITOL,FBPFZTCFMRRESA-KVTDHHQDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7438320,DTCC00157212,1960078,46191
CHEMBL691,P20309,ETHINYL ESTRADIOL,BFPYWIDHMRZLRN-SLHNCBLASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7334911,DTCC00158050,2089747,46191
CHEMBL691,P20309,ETHINYL ESTRADIOL,BFPYWIDHMRZLRN-SLHNCBLASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7334912,DTCC00158050,2089747,46191
CHEMBL69305,P20309,,JGSYDDJSPMMTRM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7783150,EC50,=,500,NM,,,,,,,,,,,,,,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),,Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors.,J. Med. Chem.,1995,38,12,"Bräuner-Osborne H, Ebert B, Brann MR, Falch E, Krogsgaard-Larsen P",,138582,DTCT0023280,919866,DTCC00222444,808466,13059
CHEMBL69306,P20309,,VBFXRCFWGDRJKA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7783150,EC50,=,130,NM,,,,,,,,,,,,,,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),,Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors.,J. Med. Chem.,1995,38,12,"Bräuner-Osborne H, Ebert B, Brann MR, Falch E, Krogsgaard-Larsen P",,138582,DTCT0023280,898795,DTCC00222445,1584849,13059
CHEMBL69383,P20309,,JQRGZCIIOMPAEJ-KDOFPFPSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,320,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1465372,DTCC00221142,614847,5621
CHEMBL69402,P20309,,UKMOUADRKGHLMZ-BEFAXECRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,16,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1449532,DTCC00221151,938001,5621
CHEMBL69452,P20309,,QIXOXAUNCKVBGL-HTXNQAPBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12747793,KI,=,840,NM,,,,,,,,,,,,,,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,,C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.,J. Med. Chem.,2003,46,11,"Kim MG, Bodor ET, Wang C, Harden TK, Kohn H",,138704,DTCT0023280,1065795,DTCC00224359,529752,17326
CHEMBL69452,P20309,,QIXOXAUNCKVBGL-HTXNQAPBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12747793,KI,=,7500,NM,,,,,,,,,,,,,,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,,C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.,J. Med. Chem.,2003,46,11,"Kim MG, Bodor ET, Wang C, Harden TK, Kohn H",,138704,DTCT0023280,1083424,DTCC00224359,529753,17326
CHEMBL695,P20309,TRIMETHADIONE,IRYJRGCIQBGHIV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445482,DTCC00158510,1830695,46191
CHEMBL695,P20309,TRIMETHADIONE,IRYJRGCIQBGHIV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445483,DTCC00158510,1830695,46191
CHEMBL69582,P20309,,ODAGWGUCKWUZTJ-APWZRJJASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,9.6,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1461795,DTCC00221119,1488310,5621
CHEMBL69595,P20309,,QDDPQJCCXUPHKY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,,,,,,,,,,,,,,,,,The compound was tested for the binding affinity against Muscarinic acetylcholine receptor M3; not tested,Not Determined,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138713,DTCT0023280,1702808,DTCC00223276,1391687,3918
CHEMBL696,P20309,ETHOSUXIMIDE,HAPOVYFOVVWLRS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7309358,DTCC00158516,88627,46191
CHEMBL696,P20309,ETHOSUXIMIDE,HAPOVYFOVVWLRS-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7309359,DTCC00158516,88627,46191
CHEMBL69648,P20309,,GQDOZDXWIPGDGI-FQEVSTJZSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,1.1,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1456706,DTCC00221113,1455738,5621
CHEMBL6966,P20309,VERAPAMIL,SGTNSNPWRIOYBX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7453170,DTCC00133226,51515,46191
CHEMBL6966,P20309,VERAPAMIL,SGTNSNPWRIOYBX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7453171,DTCC00133226,51515,46191
CHEMBL69678,P20309,,HQRSMNLSFMUJPL-KOSHJBKYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11150173,KI,=,2.8,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,,"A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.",J. Med. Chem.,2000,43,26,"Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T",,138696,DTCT0023280,1385726,DTCC00221112,238412,16058
CHEMBL69678,P20309,,HQRSMNLSFMUJPL-KOSHJBKYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,2.8,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1451997,DTCC00221112,225579,5621
CHEMBL69733,P20309,RS-100235,UVOCSZKGWJOKNN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1995.26,NM,,,,,,,,,,,,,,Compound was evaluated for binding affinity against Muscarinic M3 receptor using radioligand binding assay,,,Bioorg. Med. Chem. Lett.,1995,5,18,,,138258,DTCT0023280,768649,DTCC01740815,1753132,1312
CHEMBL69765,P20309,,JRTMAXYLOBYIGG-KNQAVFIVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,930,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1462990,DTCC00220872,96540,5621
CHEMBL698,P20309,TETRACAINE,GKCBAIGFKIBETG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487327,DTCC00158693,866024,46191
CHEMBL698,P20309,TETRACAINE,GKCBAIGFKIBETG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487328,DTCC00158693,866024,46191
CHEMBL69904,P20309,,BXSCQQSXYILOPY-RDGATRHJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,2400,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1478787,DTCC00220871,1035024,5621
CHEMBL7002,P20309,CIGLITAZONE,YZFWTZACSRHJQD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,14947,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7345481,DTCC00133474,413970,46191
CHEMBL7002,P20309,CIGLITAZONE,YZFWTZACSRHJQD-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,3168,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7345482,DTCC00133474,413970,46191
CHEMBL701,P20309,BACLOFEN,KPYSYYIEGFHWSV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7261063,DTCC00159319,1318438,46191
CHEMBL701,P20309,BACLOFEN,KPYSYYIEGFHWSV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7261064,DTCC00159319,1318438,46191
CHEMBL7018,P20309,,FFSBYSXQVCTLTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,4500,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1047817,DTCC00133070,758175,8985
CHEMBL702,P20309,PIPERACILLIN,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400245,DTCC00159449,962449,46191
CHEMBL702,P20309,PIPERACILLIN,IVBHGBMCVLDMKU-GXNBUGAJSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400246,DTCC00159449,962449,46191
CHEMBL70586,P20309,SPIRADOLINE,NYKCGQQJNVPOLU-ONTIZHBOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7486589,DTCC00226650,1318446,46191
CHEMBL70586,P20309,SPIRADOLINE,NYKCGQQJNVPOLU-ONTIZHBOSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7486590,DTCC00226650,1318446,46191
CHEMBL707,P20309,DOXAZOSIN,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7344962,DTCC00159683,1992804,46191
CHEMBL707,P20309,DOXAZOSIN,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7344963,DTCC00159683,1992804,46191
CHEMBL708,P20309,ZIPRASIDONE,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14716063,DTCC00159929,2100303,68826
CHEMBL708,P20309,ZIPRASIDONE,MVWVFYHBGMAFLY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,1300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14716065,DTCC00159929,2100306,68458
CHEMBL70828,P20309,,VBBBAIRVFNYIBU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,,,,,,,,,,,,,,,,,The compound was tested for the binding affinity against Muscarinic acetylcholine receptor M3; not tested,Not Determined,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138713,DTCT0023280,1685213,DTCC00105673,96580,3918
CHEMBL70927,P20309,DEFERIPRONE,TZXKOCQBRNJULO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7350719,DTCC00224426,348396,46191
CHEMBL70927,P20309,DEFERIPRONE,TZXKOCQBRNJULO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7350720,DTCC00224426,348396,46191
CHEMBL71,P20309,CHLORPROMAZINE,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,67,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14715843,DTCC00137262,2100222,68417
CHEMBL71,P20309,CHLORPROMAZINE,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,47,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14715841,DTCC00137262,2100181,68826
CHEMBL71,P20309,CHLORPROMAZINE,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,67,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14715845,DTCC00137262,2100225,68458
CHEMBL71,P20309,CHLORPROMAZINE,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,206,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7366805,DTCC00137262,51456,46191
CHEMBL71,P20309,CHLORPROMAZINE,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,44,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7366806,DTCC00137262,51456,46191
CHEMBL710,P20309,FINASTERIDE,DBEPLOCGEIEOCV-WSBQPABSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7320282,DTCC00159940,348402,46191
CHEMBL710,P20309,FINASTERIDE,DBEPLOCGEIEOCV-WSBQPABSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7320283,DTCC00159940,348402,46191
CHEMBL711,P20309,PHENINDIONE,NFBAXHOPROOJAW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378565,DTCC00159969,185556,46191
CHEMBL711,P20309,PHENINDIONE,NFBAXHOPROOJAW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378566,DTCC00159969,185556,46191
CHEMBL71124,P20309,,NDXFHBBFUCQHAL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,0.16,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1694035,DTCC00223652,1681901,3918
CHEMBL71147,P20309,,OFTJLQGRWRVUFL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,0.48,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1712175,DTCC00223716,1100227,3918
CHEMBL71147,P20309,,OFTJLQGRWRVUFL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11055330,KI,=,0.48,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,,Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000,10,20,"Wang Y, Chackalamannil S, Hu Z, Clader JW, Greenlee W, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, McQuade R, Lachowicz JE",,138706,DTCT0023280,779343,DTCC00223716,1100263,3944
CHEMBL712,P20309,ANISINDIONE,XRCFXMGQEVUZFC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276326,DTCC00160027,574619,46191
CHEMBL712,P20309,ANISINDIONE,XRCFXMGQEVUZFC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7276327,DTCC00160027,574619,46191
CHEMBL714,P20309,ALBUTEROL,NDAUXUAQIAJITI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7488219,DTCC00160256,962451,46191
CHEMBL714,P20309,ALBUTEROL,NDAUXUAQIAJITI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7488220,DTCC00160256,962451,46191
CHEMBL71431,P20309,,INNRKNITHWITSQ-SFHVURJKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,1.4,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1457980,DTCC00221809,1968103,5621
CHEMBL71483,P20309,,KWJMMMDBONQOQA-GCJKJVERSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,26,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1472534,DTCC00221810,2033623,5621
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8822531,KI,=,13,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14757640,DTCC00160346,2111149,68827
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10227113,KI,=,13,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14757637,DTCC00160346,2111166,68459
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10708730,KI,=,132,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14757641,DTCC00160346,2111162,68468
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,105,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14757635,DTCC00160346,2111148,68826
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,13,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14757638,DTCC00160346,2111150,68458
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,126,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14757636,DTCC00160346,2111150,68458
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,132,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14757642,DTCC00160346,2111150,68458
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,392,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395193,DTCC00160346,1512814,46191
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,83,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7395194,DTCC00160346,1512814,46191
CHEMBL715,P20309,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,100,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329745,DTCT0023280,13584606,DTCC00160346,1516359,39761
CHEMBL71531,P20309,,RINSDLXTLQIMOU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,13.76,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1720457,DTCC00223562,1520647,3918
CHEMBL716,P20309,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8822531,KI,=,705,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14715539,DTCC00160380,2100070,68827
CHEMBL716,P20309,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14715544,DTCC00160380,2100067,68826
CHEMBL716,P20309,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,1320,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14715541,DTCC00160380,2100125,68458
CHEMBL716,P20309,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7403068,DTCC00160380,1734062,46191
CHEMBL716,P20309,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329745,DTCT0023280,13584608,DTCC00160380,1737586,39761
CHEMBL716,P20309,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7403069,DTCC00160380,1734062,46191
CHEMBL717,P20309,MEDROXYPROGESTERONE ACETATE,PSGAAPLEWMOORI-PEINSRQWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434187,DTCC00160710,1188069,46191
CHEMBL717,P20309,MEDROXYPROGESTERONE ACETATE,PSGAAPLEWMOORI-PEINSRQWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7438417,DTCC00160710,1188070,46191
CHEMBL717,P20309,MEDROXYPROGESTERONE ACETATE,PSGAAPLEWMOORI-PEINSRQWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7434188,DTCC00160710,1188069,46191
CHEMBL717,P20309,MEDROXYPROGESTERONE ACETATE,PSGAAPLEWMOORI-PEINSRQWSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7438418,DTCC00160710,1188070,46191
CHEMBL71799,P20309,,PPZSYYWPALHGHI-KRJOACHSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,100,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1448303,DTCC00220891,1520613,5621
CHEMBL71933,P20309,,KXVFQXVLMGMAOA-NQIIRXRSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12798328,KI,=,120,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,,"Muscarinic M(3) receptor antagonists with (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2.",Bioorg. Med. Chem. Lett.,2003,13,13,"Ogino Y, Ohtake N, Kobayashi K, Kimura T, Fujikawa T, Hasegawa T, Noguchi K, Mase T",,138705,DTCT0023280,1451993,DTCC00220959,1520612,5621
CHEMBL71971,P20309,,SEXKJERBKVAFLC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11012031,KI,=,6.8,NM,,,,,,,,,,,,,,Binding affinity against Muscarinic acetylcholine receptor M3,,Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.,Bioorg. Med. Chem. Lett.,2000,10,19,"Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW",,138712,DTCT0023280,1720451,DTCC00223687,291145,3918
CHEMBL72,P20309,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,210,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14715263,DTCC00137288,2100027,68567
CHEMBL72,P20309,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355032,DTCC00137288,1124448,46191
CHEMBL72,P20309,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7355033,DTCC00137288,1124448,46191
CHEMBL720,P20309,BENZYL ALCOHOL,WVDDGKGOMKODPV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279972,DTCC00161432,1641844,46191
CHEMBL720,P20309,BENZYL ALCOHOL,WVDDGKGOMKODPV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7279973,DTCC00161432,1641844,46191
CHEMBL723,P20309,CARVEDILOL,OGHNVEJMJSYVRP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7338573,DTCC00162415,993764,46191
CHEMBL723,P20309,CARVEDILOL,OGHNVEJMJSYVRP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7338574,DTCC00162415,993764,46191
CHEMBL72551,P20309,,LNNRXCJKYSSUPF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11055330,KI,=,121.6,NM,,cell_based,,,,,,,,,,,CHO-K1,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,,Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000,10,20,"Wang Y, Chackalamannil S, Hu Z, Clader JW, Greenlee W, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, McQuade R, Lachowicz JE",,138706,DTCT0023280,785185,DTCC00226613,873866,3944
CHEMBL726,P20309,FLUPHENAZINE,PLDUPXSUYLZYBN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,1441,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14715006,DTCC00162562,2099865,68826
CHEMBL726,P20309,FLUPHENAZINE,PLDUPXSUYLZYBN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,4728,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7329050,DTCC00162562,1734056,46191
CHEMBL726,P20309,FLUPHENAZINE,PLDUPXSUYLZYBN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1002,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7329051,DTCC00162562,1734056,46191
CHEMBL727,P20309,THIOGUANINE,WYWHKKSPHMUBEB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457204,DTCC00162578,120978,46191
CHEMBL727,P20309,THIOGUANINE,WYWHKKSPHMUBEB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457205,DTCC00162578,120978,46191
CHEMBL728,P20309,PROCHLORPERAZINE,WIKYUJGCLQQFNW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,1514,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404983,DTCC00162902,1512815,46191
CHEMBL728,P20309,PROCHLORPERAZINE,WIKYUJGCLQQFNW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,321,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404984,DTCC00162902,1512815,46191
CHEMBL7303,P20309,ARECOLINE,HJJPJSXJAXAIPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,=,100,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1034017,DTCC00133059,1209921,8985
CHEMBL7303,P20309,ARECOLINE,HJJPJSXJAXAIPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7783150,EC50,=,340,NM,,,,,,,,,,,,,,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),,Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors.,J. Med. Chem.,1995,38,12,"Bräuner-Osborne H, Ebert B, Brann MR, Falch E, Krogsgaard-Larsen P",,138582,DTCT0023280,934191,DTCC00133059,1196089,13059
CHEMBL7303,P20309,ARECOLINE,HJJPJSXJAXAIPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9435896,IC50,=,11000,NM,,,,,,,,,,,,,,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",,"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,1997,40,26,"Bromidge SM, Brown F, Cassidy F, Clark MS, Dabbs S, Hadley MS, Hawkins J, Loudon JM, Naylor CB, Orlek BS, Riley GJ",,138586,DTCT0023280,1343248,DTCC00133059,1208408,14467
CHEMBL7303,P20309,ARECOLINE,HJJPJSXJAXAIPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9438027,IC50,=,58000,NM,,cell_based,,,,,,,,,,,CHO,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,,"Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.",J. Med. Chem.,1998,41,1,"Sauerberg P, Olesen PH, Sheardown MJ, Rimvall K, Thøgersen H, Shannon HE, Sawyer BD, Ward JS, Bymaster FP, DeLapp NW, Calligaro DO, Swedberg MD",,138982,DTCT0023280,1589800,DTCC00133059,1195317,14608
CHEMBL7303,P20309,ARECOLINE,HJJPJSXJAXAIPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9622546,KI,=,5700,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,,6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.,J. Med. Chem.,1998,41,12,"Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW",,138707,DTCT0023280,1600249,DTCC00133059,1207290,14670
CHEMBL7303,P20309,ARECOLINE,HJJPJSXJAXAIPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,INHIBITION (AT 100UM),=,42,%,,cell_based,,,,,,,,,,,CHO,The binding affinity was measured as inhibition of binding of [3H]- quinuclidinyl benzilate to m3 Muscarinic acetylcholine receptor M3 in membranes of CHO cells,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138822,DTCT0023280,582735,DTCC00133059,1196324,15779
CHEMBL7303,P20309,ARECOLINE,HJJPJSXJAXAIPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,582736,DTCC00133059,1196324,15779
CHEMBL7303,P20309,ARECOLINE,HJJPJSXJAXAIPN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12747793,KI,=,43000,NM,,,,,,,,,,,,,,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,,C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.,J. Med. Chem.,2003,46,11,"Kim MG, Bodor ET, Wang C, Harden TK, Kohn H",,138704,DTCT0023280,1076268,DTCC00133059,1207410,17326
CHEMBL741,P20309,LAMOTRIGINE,PYZRQGJRPPTADH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412142,DTCC00164108,1512811,46191
CHEMBL741,P20309,LAMOTRIGINE,PYZRQGJRPPTADH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7412143,DTCC00164108,1512811,46191
CHEMBL742,P20309,KETAMINE,YQEZLKZALYSWHR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7424869,DTCC00164207,1862716,46191
CHEMBL742,P20309,KETAMINE,YQEZLKZALYSWHR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7424870,DTCC00164207,1862716,46191
CHEMBL74300,P20309,,CXFZFEJJLNLOTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,19896386,KI,=,2398.83,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,,"Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.",Bioorg. Med. Chem.,2009,17,24,"Piergentili A, Quaglia W, Del Bello F, Giannella M, Pigini M, Barocelli E, Bertoni S, Matucci R, Nesi M, Bruni B, Di Vaira M",,605174,DTCT0023280,3164351,DTCC00229398,1244652,36765
CHEMBL74300,P20309,,CXFZFEJJLNLOTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24980056,KI,=,2398.83,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,,"Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.",Bioorg. Med. Chem. Lett.,2014,24,15,"Del Bello F, Bonifazi A, Quaglia W, Mazzolari A, Barocelli E, Bertoni S, Matucci R, Nesi M, Piergentili A, Vistoli G",,1459949,DTCT0023280,13906733,DTCC00229398,1257526,60777
CHEMBL74300,P20309,,CXFZFEJJLNLOTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,3,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88021,DTCT0023280,755935,DTCC00229398,1241787,316
CHEMBL74300,P20309,,CXFZFEJJLNLOTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,,,,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor; ND=Not determined,Not Determined,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88158,DTCT0023280,755936,DTCC00229398,1241787,316
CHEMBL74300,P20309,,CXFZFEJJLNLOTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,7,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in forskolin-stimulated cAMP accumulation using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222746,DTCT0023280,1048061,DTCC00229398,1229935,319
CHEMBL74300,P20309,,CXFZFEJJLNLOTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,7,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in phosphoinositides (PI) hydrolysis using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222891,DTCT0023280,1048059,DTCC00229398,1229935,319
CHEMBL74300,P20309,,CXFZFEJJLNLOTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,=,13,%,,cell_based,,,,,,,,,,,CHO,"Percent increase in Arachidonic acid (AA) release using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR)",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222745,DTCT0023280,1048060,DTCC00229398,1229935,319
CHEMBL74300,P20309,,CXFZFEJJLNLOTA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,INCREASE,,,,,cell_based,,,,,,,,,,,CHO,"Percent increase in intracellular calcium ion concentration ([Ca2+]i) using CHO cells, stably transfected with human muscarinic m3 acetylcholine receptor (AChR); nd=Not determined",Not Determined,,Bioorg. Med. Chem. Lett.,1992,2,8,,,222748,DTCT0023280,1048062,DTCC00229398,1229935,319
CHEMBL744,P20309,RILUZOLE,FTALBRSUTCGOEG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487995,DTCC00164269,348405,46191
CHEMBL744,P20309,RILUZOLE,FTALBRSUTCGOEG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7487996,DTCC00164269,348405,46191
CHEMBL748,P20309,PRALIDOXIME CHLORIDE,HIGSLXSBYYMVKI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404738,DTCC00164888,1798416,46191
CHEMBL748,P20309,PRALIDOXIME CHLORIDE,HIGSLXSBYYMVKI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7404739,DTCC00164888,1798416,46191
CHEMBL7482,P20309,,VDZUHIZCJRYPOR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,3712371,EC50,>,50000,NM,,tissue,,,,,,,,,,,,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",,A novel class of conformationally restricted heterocyclic muscarinic agonists.,J. Med. Chem.,1986,29,6,"Sauerberg P, Larsen JJ, Falch E, Krogsgaard-Larsen P",,138367,DTCT0023280,1026849,DTCC00133248,1982412,8985
CHEMBL75435,P20309,DEXKETOPROFEN,DKYWVDODHFEZIM-NSHDSACASA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7350799,DTCC00229147,1447880,46191
CHEMBL75435,P20309,DEXKETOPROFEN,DKYWVDODHFEZIM-NSHDSACASA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7350800,DTCC00229147,1447880,46191
CHEMBL7568,P20309,QUINACRINE,GPKJTRJOBQGKQK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,1255,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7405358,DTCC00134204,2089751,46191
CHEMBL7568,P20309,QUINACRINE,GPKJTRJOBQGKQK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,266,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7405359,DTCC00134204,2089751,46191
CHEMBL757,P20309,NANDROLONE,NPAGDVCDWIYMMC-IZPLOLCNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388203,DTCC00166843,930082,46191
CHEMBL757,P20309,NANDROLONE,NPAGDVCDWIYMMC-IZPLOLCNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7388204,DTCC00166843,930082,46191
CHEMBL75880,P20309,PERHEXILINE,CYXKNKQEMFBLER-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,3118.6,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391423,DTCC00230384,1124453,46191
CHEMBL75880,P20309,PERHEXILINE,CYXKNKQEMFBLER-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,661,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391424,DTCC00230384,1124453,46191
CHEMBL762,P20309,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375931,DTCC00167236,2025641,46191
CHEMBL762,P20309,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7375932,DTCC00167236,2025641,46191
CHEMBL7634,P20309,OXOTREMORINE,RSDOPYMFZBJHRL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,7783150,EC50,=,210,NM,,,,,,,,,,,,,,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),,Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors.,J. Med. Chem.,1995,38,12,"Bräuner-Osborne H, Ebert B, Brann MR, Falch E, Krogsgaard-Larsen P",,138582,DTCT0023280,905987,DTCC00133945,1228203,13059
CHEMBL7634,P20309,OXOTREMORINE,RSDOPYMFZBJHRL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9438027,IC50,=,17000,NM,,cell_based,,,,,,,,,,,CHO,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,,"Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activity.",J. Med. Chem.,1998,41,1,"Sauerberg P, Olesen PH, Sheardown MJ, Rimvall K, Thøgersen H, Shannon HE, Sawyer BD, Ward JS, Bymaster FP, DeLapp NW, Calligaro DO, Swedberg MD",,138982,DTCT0023280,1583531,DTCC00133945,1227414,14608
CHEMBL7634,P20309,OXOTREMORINE,RSDOPYMFZBJHRL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,INHIBITION,=,28,%,,cell_based,,,,,,,,,,,CHO,Inhibition of binding of [3H]- quinuclidinyl benzilate to Muscarinic acetylcholine receptor M3 in membranes of CHO cells at 100 uM compound concentration,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138590,DTCT0023280,601261,DTCC00133945,1228434,15779
CHEMBL7634,P20309,OXOTREMORINE,RSDOPYMFZBJHRL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,INHIBITION,,,,,cell_based,,,,,,,,,,,CHO,The binding affinity was measured as inhibition of binding of [3H]- oxotremorine-M to Muscarinic acetylcholine receptor M3 in membranes of CHO cells; ND means no data,No data,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138714,DTCT0023280,601262,DTCC00133945,1228434,15779
CHEMBL7634,P20309,OXOTREMORINE,RSDOPYMFZBJHRL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,25765911,EFFICACY,=,88.8,%,,cell_based,,,,,,,,,,,,Agonist activity at human m3 muscarinic acetylcholine receptor expressed in HEK293 cells by calcium mobilization assay at 10 microM by FLIPR assay relative to 100 nM acetylcholine response,,Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2015,25,7,"Huang M, Suk DH, Cho NC, Bhattarai D, Kang SB, Kim Y, Pae AN, Rhim H, Keum G",,1465083,DTCT0023280,14060851,DTCC00133945,1257669,61603
CHEMBL765,P20309,GUANETHIDINE,ACGDKVXYNVEAGU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319099,DTCC00167701,2089750,46191
CHEMBL765,P20309,GUANETHIDINE,ACGDKVXYNVEAGU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7319100,DTCC00167701,2089750,46191
CHEMBL768,P20309,ESMOLOL,AQNDDEOPVVGCPG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7309249,DTCC00167907,1253321,46191
CHEMBL768,P20309,ESMOLOL,AQNDDEOPVVGCPG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7309250,DTCC00167907,1253321,46191
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,17889543,KI,=,0.68,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,,Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.,Bioorg. Med. Chem.,2007,15,24,"Dallanoce C, De Amici M, Barocelli E, Bertoni S, Roth BL, Ernsberger P, De Micheli C",,450047,DTCT0023280,2193384,DTCC00231986,553086,23951
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18588282,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008,51,14,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488283,DTCT0023280,2775803,DTCC00231986,565128,30579
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18983139,IC50,=,0.59,NM,,,,,,,,,,,,,,Displacement of radiolabeled 4DAMP from human muscarinic M3 receptor,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494460,DTCT0023280,2584094,DTCC00231986,555295,32034
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18983139,KI,=,0.42,NM,,,,,,,,,,,,,,Displacement of radiolabeled 4DAMP from human muscarinic M3 receptor,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008,51,22,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494460,DTCT0023280,2584118,DTCC00231986,555295,32034
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20875743,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of human muscarinic M3 receptor,,"Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships.",Bioorg. Med. Chem.,2010,18,21,"Hayashi S, Nakata E, Morita A, Mizuno K, Yamamura K, Kato A, Ohashi K",,714795,DTCT0023280,5075515,DTCC00231986,555383,43117
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23403082,IC50,=,5.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHOK1 cells after 2 hrs,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013,23,6,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965447,DTCT0023280,12469513,DTCC00231986,577393,54795
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23403082,INHIBITION,=,-4,%,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHOK1 cells at 10 uM after 2 hrs relative to control,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013,23,6,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965652,DTCT0023280,12469581,DTCC00231986,577393,54795
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23403082,KI,=,2.5,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHOK1 cells after 2 hrs,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013,23,6,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965447,DTCT0023280,12469446,DTCC00231986,577393,54795
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23466604,IC50,=,0.56,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor by radioligand displacement assay,,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,2013,63,,"Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F",,966179,DTCT0023280,12471254,DTCC00231986,577397,54801
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23466604,KI,=,0.4,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor by radioligand displacement assay,,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,2013,63,,"Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F",,966179,DTCT0023280,12471180,DTCC00231986,577397,54801
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23582449,IC50,=,0.43,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M3 receptor by radioligand displacement assay,,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,2013,21,10,"Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M",,964192,DTCT0023280,12465335,DTCC00231986,577388,54817
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,24805037,KI,=,0.44,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]4-DAMP from human recombinant M3 receptor expressed in CHO cells,,Novel Arylsulfonamide Derivatives with 5-HT6/5-HT7 Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia.,J. Med. Chem.,2014,57,11,"Kolaczkowski M, Marcinkowska M, Bucki A, Pawlowski M, Mitka K, Jaskowska J, Kowalski P, Kazek G, Siwek A, Wasik A, Wesolowska A, Mierzejewski P, Bienkowski P",,1361018,DTCT0023280,13779854,DTCC00231986,578613,59370
CHEMBL76897,P20309,4-DAMP,WWJHRSCUAQPFQO-UHFFFAOYSA-M,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,26988801,IC50,=,0.41,NM,,,,,,,,,,,,,,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016,24,8,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559773,DTCT0023280,117221,DTCC00231986,549102,66408
CHEMBL76904,P20309,TYRPHOSTIN 23,VTJXFTPMFYAJJU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445599,DTCC00233094,1765983,46191
CHEMBL76904,P20309,TYRPHOSTIN 23,VTJXFTPMFYAJJU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445600,DTCC00233094,1765983,46191
CHEMBL772,P20309,RESERPINE,QEVHRUUCFGRFIF-MDEJGZGSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462005,DTCC00168399,1992810,46191
CHEMBL772,P20309,RESERPINE,QEVHRUUCFGRFIF-MDEJGZGSSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462006,DTCC00168399,1992810,46191
CHEMBL773,P20309,GLYCINE,DHMQDGOQFOQNFH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306118,DTCC00168448,1544900,46191
CHEMBL773,P20309,GLYCINE,DHMQDGOQFOQNFH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7306119,DTCC00168448,1544900,46191
CHEMBL77675,P20309,"N,N'-DIPHENYL-GUANIDINE",OWRCNXZUPFZXOS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7290458,DTCC01741294,1155675,46191
CHEMBL77675,P20309,"N,N'-DIPHENYL-GUANIDINE",OWRCNXZUPFZXOS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7290459,DTCC01741294,1155675,46191
CHEMBL783,P20309,NATEGLINIDE,OELFLUMRDSZNSF-BRWVUGGUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396767,DTCC00170640,1512813,46191
CHEMBL783,P20309,NATEGLINIDE,OELFLUMRDSZNSF-BRWVUGGUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7396768,DTCC00170640,1512813,46191
CHEMBL787,P20309,MONTELUKAST,UCHDWCPVSPXUMX-TZIWLTJVSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,6626,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7422179,DTCC00171266,1798413,46191
CHEMBL787,P20309,MONTELUKAST,UCHDWCPVSPXUMX-TZIWLTJVSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1404,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7422180,DTCC00171266,1798413,46191
CHEMBL788,P20309,IDOXURIDINE,XQFRJNBWHJMXHO-RRKCRQDMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336409,DTCC00171444,510301,46191
CHEMBL788,P20309,IDOXURIDINE,XQFRJNBWHJMXHO-RRKCRQDMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7336410,DTCC00171444,510301,46191
CHEMBL79,P20309,LIDOCAINE,NNJVILVZKWQKPM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437994,DTCC00137707,1609550,46191
CHEMBL79,P20309,LIDOCAINE,NNJVILVZKWQKPM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7437995,DTCC00137707,1609550,46191
CHEMBL79061,P20309,,IOAZQBRQOPSGMR-IADCTJSHSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,15115380,KI,>,5300,NM,,,,,,,,,,,,,,Antagonistic activity against muscarinic M3 receptor,,"Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.",J. Med. Chem.,2004,47,10,"Tagat JR, McCombie SW, Nazareno D, Labroli MA, Xiao Y, Steensma RW, Strizki JM, Baroudy BM, Cox K, Lachowicz J, Varty G, Watkins R",,138699,DTCT0023280,990468,DTCC00236717,291286,17809
CHEMBL799,P20309,CILOSTAZOL,RRGUKTPIGVIEKM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7354052,DTCC00173670,2057647,46191
CHEMBL799,P20309,CILOSTAZOL,RRGUKTPIGVIEKM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7354053,DTCC00173670,2057647,46191
CHEMBL8,P20309,CIPROFLOXACIN,MYSWGUAQZAJSOK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7341300,DTCC00103423,51457,46191
CHEMBL8,P20309,CIPROFLOXACIN,MYSWGUAQZAJSOK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7341301,DTCC00103423,51457,46191
CHEMBL80,P20309,NALOXONE,UZHSEJADLWPNLE-GRGSLBFTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416005,DTCC00137855,1155683,46191
CHEMBL80,P20309,NALOXONE,UZHSEJADLWPNLE-GRGSLBFTSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7416006,DTCC00137855,1155683,46191
CHEMBL802,P20309,MINOXIDIL,ZFMITUMMTDLWHR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7426349,DTCC00174151,1641849,46191
CHEMBL802,P20309,MINOXIDIL,ZFMITUMMTDLWHR-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7426350,DTCC00174151,1641849,46191
CHEMBL803,P20309,CYTARABINE,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7348338,DTCC00174264,51462,46191
CHEMBL803,P20309,CYTARABINE,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7348339,DTCC00174264,51462,46191
CHEMBL806,P20309,FLUTAMIDE,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7305739,DTCC00175006,1253324,46191
CHEMBL806,P20309,FLUTAMIDE,MKXKFYHWDHIYRV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7305740,DTCC00175006,1253324,46191
CHEMBL808,P20309,ECONAZOLE,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,1789,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7311088,DTCC00175675,1764791,46191
CHEMBL808,P20309,ECONAZOLE,LEZWWPYKPKIXLL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,379,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7311089,DTCC00175675,1764791,46191
CHEMBL809,P20309,SERTRALINE,VGKDLMBJGBXTGI-SJCJKPOMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7469186,DTCC00176302,1414866,46191
CHEMBL809,P20309,SERTRALINE,VGKDLMBJGBXTGI-SJCJKPOMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7469187,DTCC00176302,1414866,46191
CHEMBL81,P20309,RALOXIFENE,GZUITABIAKMVPG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479380,DTCC01738582,1960080,46191
CHEMBL81,P20309,RALOXIFENE,GZUITABIAKMVPG-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7479381,DTCC01738582,1960080,46191
CHEMBL817,P20309,TOLAZAMIDE,OUDSBRTVNLOZBN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7468345,DTCC00178466,1285883,46191
CHEMBL817,P20309,TOLAZAMIDE,OUDSBRTVNLOZBN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7468346,DTCC00178466,1285883,46191
CHEMBL81878,P20309,PD-151832,FXBXWJPMXQHOGD-WUKNDPDISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,6,%,,cell_based,,,,,,,,,,,CHO,Inositol phosphate(PI) accumulation in CHO cells expressing Muscarinic acetylcholine receptor M3 as maximal response at 100 uM relative to carbachol,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138572,DTCT0023280,1620701,DTCC01741456,1585105,14722
CHEMBL81878,P20309,PD-151832,FXBXWJPMXQHOGD-WUKNDPDISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,93,%,,,,,,,,,,,,,,Maximal response obtained for each drug normalized to effect of carbachol in Muscarinic acetylcholine receptor M3,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138571,DTCT0023280,1620707,DTCC01741456,1585105,14722
CHEMBL81878,P20309,PD-151832,FXBXWJPMXQHOGD-WUKNDPDISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,ED50,=,3857,NM,,cell_based,,,,,,,,,,,NIH3T3,Amplification of transfected NIH3T3 cells was measured in Muscarinic acetylcholine receptor M3 required to produce half maximal effect,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138583,DTCT0023280,1620706,DTCC01741456,1585105,14722
CHEMBL81878,P20309,PD-151832,FXBXWJPMXQHOGD-WUKNDPDISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,PI,=,6,%,,cell_based,,,,,,,,,,,CHO,Ability to stimulate inositol phosphate(PI) accumulation in CHO cells expressing human m3 receptor (max. concentration. 100 uM),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,139790,DTCT0023280,1512775,DTCC01741456,1598118,1549
CHEMBL81895,P20309,,DLIJXWKSKPMWKN-BMRADRMJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,4,%,,cell_based,,,,,,,,,,,CHO,Inositol phosphate(PI) accumulation in CHO cells expressing Muscarinic acetylcholine receptor M3 as maximal response at 100 uM relative to carbachol,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138572,DTCT0023280,1638458,DTCC00243594,1035299,14722
CHEMBL81977,P20309,3-AMINOBENZAMIDE,GSCPDZHWVNUUFI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288017,DTCC00237769,1798404,46191
CHEMBL81977,P20309,3-AMINOBENZAMIDE,GSCPDZHWVNUUFI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7288018,DTCC00237769,1798404,46191
CHEMBL820,P20309,BUSULFAN,COVZYZSDYWQREU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7267655,DTCC00178870,898285,46191
CHEMBL820,P20309,BUSULFAN,COVZYZSDYWQREU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7267656,DTCC00178870,898285,46191
CHEMBL822,P20309,TERBINAFINE,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7465780,DTCC00179021,833164,46191
CHEMBL822,P20309,TERBINAFINE,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7465781,DTCC00179021,833164,46191
CHEMBL82512,P20309,,MMFZKXHXJMXHLL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,2,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1422071,DTCC00244788,1046840,5053
CHEMBL826,P20309,ENOXACIN,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7328147,DTCC00179302,1219085,46191
CHEMBL826,P20309,ENOXACIN,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7328148,DTCC00179302,1219085,46191
CHEMBL82754,P20309,,MITFBVJTVLMZJU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,7500,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138710,DTCT0023280,617763,DTCC00243702,1870722,15779
CHEMBL82754,P20309,,MITFBVJTVLMZJU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,617764,DTCC00243702,1870722,15779
CHEMBL828,P20309,PHENOTHIAZINE,WJFKNYWRSNBZNX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391556,DTCC00179549,1734060,46191
CHEMBL828,P20309,PHENOTHIAZINE,WJFKNYWRSNBZNX-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7391557,DTCC00179549,1734060,46191
CHEMBL82850,P20309,,SQVDABXKZMOOSK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,158.49,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1406578,DTCC00244206,401118,5053
CHEMBL82859,P20309,,KFLSUTLOMIEDAI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,3.98,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1409915,DTCC00244020,108310,5053
CHEMBL83,P20309,TAMOXIFEN,NKANXQFJJICGDU-QPLCGJKRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,2974,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463334,DTCC00137911,51510,46191
CHEMBL83,P20309,TAMOXIFEN,NKANXQFJJICGDU-QPLCGJKRSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,630,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463335,DTCC00137911,51510,46191
CHEMBL83074,P20309,,ARTPBFFTEWVQHK-FOCLMDBBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,0,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88023,DTCT0023280,743343,DTCC00244427,337140,316
CHEMBL83074,P20309,,ARTPBFFTEWVQHK-FOCLMDBBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,,,,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor; ND=Not determined,Not Determined,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88158,DTCT0023280,743344,DTCC00244427,337140,316
CHEMBL831,P20309,LOXAPINE,XJGVXQDUIWGIRW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,390,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14712244,DTCC00181137,2098631,68417
CHEMBL831,P20309,LOXAPINE,XJGVXQDUIWGIRW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,122,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14712190,DTCC00181137,2098610,68826
CHEMBL832,P20309,SULFINPYRAZONE,MBGGBVCUIVRRBF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484866,DTCC00181706,1124456,46191
CHEMBL832,P20309,SULFINPYRAZONE,MBGGBVCUIVRRBF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484867,DTCC00181706,1124456,46191
CHEMBL833,P20309,TICLOPIDINE,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7472597,DTCC00181784,1285882,46191
CHEMBL833,P20309,TICLOPIDINE,PHWBOXQYWZNQIN-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7472598,DTCC00181784,1285882,46191
CHEMBL83363,P20309,,DSJSFUZSKADELN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,15.85,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1414803,DTCC00244208,1596837,5053
CHEMBL83459,P20309,,JOPXNGPVIWEQPF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,7.94,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1420710,DTCC00244200,820320,5053
CHEMBL83668,P20309,TOLNAFTATE,FUSNMLFNXJSCDI-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7477095,DTCC00242570,1124458,46191
CHEMBL83668,P20309,TOLNAFTATE,FUSNMLFNXJSCDI-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7477096,DTCC00242570,1124458,46191
CHEMBL838,P20309,BENAZEPRIL,XPCFTKFZXHTYIP-PMACEKPBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7275325,DTCC00182957,574621,46191
CHEMBL838,P20309,BENAZEPRIL,XPCFTKFZXHTYIP-PMACEKPBSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7275326,DTCC00182957,574621,46191
CHEMBL83982,P20309,,GUQRTYIJUZWIBN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,2.51,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1410960,DTCC00244785,172943,5053
CHEMBL84,P20309,TOPOTECAN,UCFGDBYHRUNTLO-QHCPKHFHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7485660,DTCC00138393,315672,46191
CHEMBL84,P20309,TOPOTECAN,UCFGDBYHRUNTLO-QHCPKHFHSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7485661,DTCC00138393,315672,46191
CHEMBL841,P20309,LOPERAMIDE,RDOIQAHITMMDAJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433851,DTCC00183381,1092343,46191
CHEMBL841,P20309,LOPERAMIDE,RDOIQAHITMMDAJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7433852,DTCC00183381,1092343,46191
CHEMBL84113,P20309,,AKLGENRCHBXEKW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,1300,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138710,DTCT0023280,594261,DTCC00243236,550560,15779
CHEMBL84113,P20309,,AKLGENRCHBXEKW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,594262,DTCC00243236,550560,15779
CHEMBL84158,P20309,TIAPRIDE,JTVPZMFULRWINT-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463874,DTCC00241707,1734065,46191
CHEMBL84158,P20309,TIAPRIDE,JTVPZMFULRWINT-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7463875,DTCC00241707,1734065,46191
CHEMBL844,P20309,BRIMONIDINE,XYLJNLCSTIOKRM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258789,DTCC00183812,2057645,46191
CHEMBL844,P20309,BRIMONIDINE,XYLJNLCSTIOKRM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7258790,DTCC00183812,2057645,46191
CHEMBL845,P20309,N-DESMETHYLCLOZAPINE,JNNOSTQEZICQQP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,EMAX,=,10,%,,cell_based,,,,,,,,,,,BHK-21,Agonist activity at human muscarinic M3 receptor expressed in BHK-21 cells assessed as increase of acetylcholine-induced calcium flux at 10 uM by FLIPR assay relative to acetylcholine,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659448,DTCT0023280,3460754,DTCC00183895,393957,40772
CHEMBL845,P20309,N-DESMETHYLCLOZAPINE,JNNOSTQEZICQQP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,20684563,KI,=,90,NM,,cell_based,,,,,,,,,,,BHK-21,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010,53,17,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659456,DTCT0023280,3460789,DTCC00183895,393957,40772
CHEMBL84893,P20309,,PXNORIDOJLRDSM-FOCLMDBBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,STIMULATIONS,=,8,%,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M3 values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol.,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138721,DTCT0023280,1634652,DTCC00244392,291376,14722
CHEMBL84893,P20309,,PXNORIDOJLRDSM-FOCLMDBBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,11,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88024,DTCT0023280,735730,DTCC00244392,304504,316
CHEMBL84893,P20309,,PXNORIDOJLRDSM-FOCLMDBBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,,,,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor; ND=Not determined,Not Determined,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88158,DTCT0023280,735731,DTCC00244392,304504,316
CHEMBL84893,P20309,,PXNORIDOJLRDSM-FOCLMDBBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,PI,=,8,%,,cell_based,,,,,,,,,,,CHO,Ability to stimulate inositol phosphate(PI) accumulation in CHO cells expressing human m3 receptor (max. concentration. 100 uM),,,Bioorg. Med. Chem. Lett.,1995,5,6,,,139790,DTCT0023280,1489266,DTCC00244392,304309,1549
CHEMBL84919,P20309,,DMFYILRTMAAJKX-WUKNDPDISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,2,%,,cell_based,,,,,,,,,,,CHO,Inositol phosphate(PI) accumulation in CHO cells expressing Muscarinic acetylcholine receptor M3 as maximal response at 100 uM relative to carbachol,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138572,DTCT0023280,1619394,DTCC00244033,1228446,14722
CHEMBL84993,P20309,,XJOWNNNBRMDSFK-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,1.26,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1426951,DTCC00244294,1175441,5053
CHEMBL85,P20309,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14711815,DTCC00138594,2098505,68417
CHEMBL85,P20309,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12629531,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14711817,DTCC00138594,2098475,68826
CHEMBL85,P20309,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14711813,DTCC00138594,2098487,68458
CHEMBL85,P20309,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466521,DTCC00138594,1383782,46191
CHEMBL85,P20309,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,>,1000,NM,,,,,,,,,,,,,,Binding affinity to M3 receptor (unknown origin) by PDSP assay,,,MedChemComm,2012,3,5,,,1329745,DTCT0023280,13584610,DTCC00138594,1387256,39761
CHEMBL85,P20309,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7466522,DTCC00138594,1383782,46191
CHEMBL850,P20309,SPARFLOXACIN,DZZWHBIBMUVIIW-DTORHVGOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7473673,DTCC00185794,1124454,46191
CHEMBL850,P20309,SPARFLOXACIN,DZZWHBIBMUVIIW-DTORHVGOSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7473674,DTCC00185794,1124454,46191
CHEMBL85190,P20309,,ARWACDLWRNGONO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,=,3200,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138710,DTCT0023280,607218,DTCC00243968,1326430,15779
CHEMBL85190,P20309,,ARWACDLWRNGONO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10891110,KI,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]- oxotremorine-M binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,Not Determined,6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.,J. Med. Chem.,2000,43,13,"Daly JW, Gupta TH, Padgett WL, Pei XF",,138709,DTCT0023280,607219,DTCC00243968,1326430,15779
CHEMBL852,P20309,MELPHALAN,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425749,DTCC00185853,249079,46191
CHEMBL852,P20309,MELPHALAN,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7425750,DTCC00185853,249079,46191
CHEMBL85264,P20309,,QVQXOEJQGXTXJX-BMRADRMJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,6,%,,cell_based,,,,,,,,,,,CHO,Inositol phosphate(PI) accumulation in CHO cells expressing Muscarinic acetylcholine receptor M3 as maximal response at 100 uM relative to carbachol,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138572,DTCT0023280,1632122,DTCC00244243,1585106,14722
CHEMBL85391,P20309,,JFUYPMPSSHRFOG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,3.98,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1429500,DTCC00244273,1014445,5053
CHEMBL85460,P20309,,IGNCXXVRIFRQNM-BMRADRMJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,12,%,,cell_based,,,,,,,,,,,CHO,Inositol phosphate(PI) accumulation in CHO cells expressing Muscarinic acetylcholine receptor M3 as maximal response at 100 uM relative to carbachol,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138572,DTCT0023280,1615415,DTCC00244011,874064,14722
CHEMBL85511,P20309,,CJLABAFJLFSHBB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,1000,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1413572,DTCC00244179,1046839,5053
CHEMBL85568,P20309,,HJOOQUSWJJHORA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,158.49,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1407607,DTCC00244120,1014443,5053
CHEMBL856,P20309,PRIMIDONE,DQMZLTXERSFNPB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379045,DTCC00186106,1674147,46191
CHEMBL856,P20309,PRIMIDONE,DQMZLTXERSFNPB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379046,DTCC00186106,1674147,46191
CHEMBL85645,P20309,,HDDBXIZSHYNAEQ-BUHFOSPRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,=,19,%,,cell_based,,,,,,,,,,,CHO,Inositol phosphate(PI) accumulation in CHO cells expressing Muscarinic acetylcholine receptor M3 as maximal response at 100 uM relative to carbachol,,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138572,DTCT0023280,1625751,DTCC00243643,582706,14722
CHEMBL85658,P20309,,KTIJCZACSJLVCJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,INHIBITION,=,20,%,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine from membrane preparation from CHO-K1 cells for Muscarinic acetylcholine receptor M3; value given as 20-50%,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138589,DTCT0023280,1414801,DTCC00244755,659177,5053
CHEMBL85678,P20309,,JFFWZDZAUYUZOI-BQYQJAHWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,CCH,=,53,%,,cell_based,,,,,,,,,,,SK-N-SH,"Evaluated for its MIPA (muscarinic-stimulated inositol phosphate accumulation) activity measured in SK-N-SH neuroblastoma cells expressing human muscarinic m3 receptor, compound run at 100 uM;100 uM of carbachol was used",,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88023,DTCT0023280,762273,DTCC00244583,1915880,316
CHEMBL85678,P20309,,JFFWZDZAUYUZOI-BQYQJAHWSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,EC50,=,14600,NM,,cell_based,,,,,,,,,,,SK-N-SH,Effective concentration for MIPA (muscarinic-stimulated inositol phosphate accumulation) activity in SK-N-SH neuroblastoma cells expressing human muscarinic M3 receptor,,,Bioorg. Med. Chem. Lett.,1992,2,8,,,88157,DTCT0023280,762274,DTCC00244583,1915880,316
CHEMBL85728,P20309,"4,4'-METHYLENEDIANILINE",YBRVSVVVWCFQMG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7294707,DTCC00242937,1318436,46191
CHEMBL85728,P20309,"4,4'-METHYLENEDIANILINE",YBRVSVVVWCFQMG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7294708,DTCC00242937,1318436,46191
CHEMBL85892,P20309,,CHMIKIFFWBMPHB-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,1,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1406561,DTCC00244295,1629412,5053
CHEMBL85936,P20309,,CXODJKKXKWTUIZ-BUHFOSPRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,,,,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M3. values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol; Not tested,Not Determined,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138573,DTCT0023280,1635888,DTCC00243644,323893,14722
CHEMBL85950,P20309,,LHSWHRHCIOMFRZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,79.43,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1426958,DTCC00244121,368348,5053
CHEMBL85996,P20309,,PMQYZWMILDAHGO-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,0.794,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1414805,DTCC00243742,204923,5053
CHEMBL86,P20309,METOCLOPRAMIDE,TTWJBBZEZQICBI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411129,DTCC00138614,51488,46191
CHEMBL86,P20309,METOCLOPRAMIDE,TTWJBBZEZQICBI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411130,DTCC00138614,51488,46191
CHEMBL86012,P20309,,FRBGIYHCCJKHFJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,25.12,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1407605,DTCC00244220,723641,5053
CHEMBL86150,P20309,,WUUNJWKXMYQQPX-BMRADRMJSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,,,,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M3. values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol; Not tested,Not Determined,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138573,DTCT0023280,1620721,DTCC00244008,1132560,14722
CHEMBL86197,P20309,,CWNABBKUCKBPHJ-FOCLMDBBSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,,,,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M3. values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol; Not tested,Not Determined,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138573,DTCT0023280,1619403,DTCC00244216,1163790,14722
CHEMBL862,P20309,GUANFACINE,INJOMKTZOLKMBF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323352,DTCC00186365,1351111,46191
CHEMBL862,P20309,GUANFACINE,INJOMKTZOLKMBF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7323353,DTCC00186365,1351111,46191
CHEMBL86288,P20309,,IYOSOYKZMYVRLK-WUKNDPDISA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9651157,CCH,,,,,cell_based,,,,,,,,,,,CHO,Stimulations of inositol phosphate(PI) accumulation in transfected CHO cells in Muscarinic acetylcholine receptor M3. values are the maximal response obtained from the compound tested at 100 uM normalized to the effect of carbachol; Not tested,Not Determined,"Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist.",J. Med. Chem.,1998,41,14,"Tecle H, Barrett SD, Lauffer DJ, Augelli-Szafran C, Brann MR, Callahan MJ, Caprathe BW, Davis RE, Doyle PD, Eubanks D, Lipiniski W, Mirzadegan T, Moos WH, Moreland DW, Nelson CB, Pavia MR, Raby C, Schwarz RD, Spencer CJ, Thomas AJ, Jaen JC",,138573,DTCT0023280,1606707,DTCC00244241,1935125,14722
CHEMBL86304,P20309,MOCLOBEMIDE,YHXISWVBGDMDLQ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7409259,DTCC00246764,833162,46191
CHEMBL86304,P20309,MOCLOBEMIDE,YHXISWVBGDMDLQ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7409260,DTCC00246764,833162,46191
CHEMBL86309,P20309,,SOTPKNTZHGXCSJ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,25.12,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1419444,DTCC00244199,1079343,5053
CHEMBL865,P20309,VALDECOXIB,LNPDTQAFDNKSHK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440805,DTCC00187234,866025,46191
CHEMBL865,P20309,VALDECOXIB,LNPDTQAFDNKSHK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7440806,DTCC00187234,866025,46191
CHEMBL866,P20309,MYCOPHENOLIC ACID,HPNSFSBZBAHARI-RUDMXATFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7439234,DTCC00188298,120975,46191
CHEMBL866,P20309,MYCOPHENOLIC ACID,HPNSFSBZBAHARI-RUDMXATFSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7439235,DTCC00188298,120975,46191
CHEMBL86715,P20309,PROCYCLIDINE,WYDUSKDSKCASEF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,12.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14711085,DTCC00246880,2098343,68417
CHEMBL86754,P20309,IODOQUINOL,UXZFQZANDVDGMM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7439417,DTCC00246886,1220278,46191
CHEMBL86754,P20309,IODOQUINOL,UXZFQZANDVDGMM-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7439418,DTCC00246886,1220278,46191
CHEMBL870,P20309,ALENDRONIC ACID,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299275,DTCC00190086,800568,46191
CHEMBL870,P20309,ALENDRONIC ACID,OGSPWJRAVKPPFI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7299276,DTCC00190086,800568,46191
CHEMBL871,P20309,ETIDRONIC ACID,DBVJJBKOTRCVKF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7326430,DTCC00190087,542574,46191
CHEMBL871,P20309,ETIDRONIC ACID,DBVJJBKOTRCVKF-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7326431,DTCC00190087,542574,46191
CHEMBL87132,P20309,,DWNCOSUKQGWVJL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,31.62,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1422078,DTCC00244222,594365,5053
CHEMBL87285,P20309,ANDROSTERONE,QGXBDMJGAMFCBF-HLUDHZFRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283341,DTCC00245174,930075,46191
CHEMBL87285,P20309,ANDROSTERONE,QGXBDMJGAMFCBF-HLUDHZFRSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7283342,DTCC00245174,930075,46191
CHEMBL87302,P20309,,TVPYSIMEYHFHLN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,25.12,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1415981,DTCC00243988,820319,5053
CHEMBL877,P20309,TRANEXAMIC ACID,GYDJEQRTZSCIOI-LJGSYFOKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445247,DTCC00192310,1544904,46191
CHEMBL877,P20309,TRANEXAMIC ACID,GYDJEQRTZSCIOI-LJGSYFOKSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7445248,DTCC00192310,1544904,46191
CHEMBL87708,P20309,LOFEPRAMINE,SAPNXPWPAUFAJU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,130,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14710936,DTCC00246941,2098305,68567
CHEMBL878,P20309,METOLAZONE,AQCHWTWZEMGIFD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7415451,DTCC00192311,1253327,46191
CHEMBL878,P20309,METOLAZONE,AQCHWTWZEMGIFD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7415452,DTCC00192311,1253327,46191
CHEMBL88,P20309,CYCLOPHOSPHAMIDE,CMSMOCZEIVJLDB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7361159,DTCC00139205,994590,46191
CHEMBL88,P20309,CYCLOPHOSPHAMIDE,CMSMOCZEIVJLDB-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7361160,DTCC00139205,994590,46191
CHEMBL880,P20309,FAMCICLOVIR,GGXKWVWZWMLJEH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7313799,DTCC00192933,444642,46191
CHEMBL880,P20309,FAMCICLOVIR,GGXKWVWZWMLJEH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7313800,DTCC00192933,444642,46191
CHEMBL88078,P20309,,USJBKAJGBOUZJY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12182854,KI,=,25.12,NM,,,,,,,,,,,,,,In vitro affinity for muscarinic M3 receptor.,,A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.,Bioorg. Med. Chem. Lett.,2002,12,18,"Diouf O, Gadeau S, Chellé F, Gelbcke M, Talaga P, Christophe B, Gillard M, Massingham R, Guyaux M",,138828,DTCT0023280,1434699,DTCC00244223,1403357,5053
CHEMBL888,P20309,GEMCITABINE,SDUQYLNIPVEERB-QPPQHZFASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7325007,DTCC00194280,51473,46191
CHEMBL888,P20309,GEMCITABINE,SDUQYLNIPVEERB-QPPQHZFASA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7325008,DTCC00194280,51473,46191
CHEMBL891,P20309,CLOXACILLIN,LQOLIRLGBULYKD-JKIFEVAISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7360937,DTCC00194952,2089744,46191
CHEMBL891,P20309,CLOXACILLIN,LQOLIRLGBULYKD-JKIFEVAISA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7360938,DTCC00194952,2089744,46191
CHEMBL894,P20309,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14710666,DTCC00195238,2098249,68567
CHEMBL894,P20309,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7261835,DTCC00195238,800571,46191
CHEMBL894,P20309,BUPROPION,SNPPWIUOZRMYNY-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7261836,DTCC00195238,800571,46191
CHEMBL895,P20309,NALBUPHINE,NETZHAKZCGBWSS-CEDHKZHLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7439369,DTCC00195307,413972,46191
CHEMBL895,P20309,NALBUPHINE,NETZHAKZCGBWSS-CEDHKZHLSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7439370,DTCC00195307,413972,46191
CHEMBL897,P20309,PROBENECID,DBABZHXKTCFAPX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383377,DTCC00195516,1188073,46191
CHEMBL897,P20309,PROBENECID,DBABZHXKTCFAPX-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383378,DTCC00195516,1188073,46191
CHEMBL898,P20309,DIFLUNISAL,HUPFGZXOMWLGNK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7370560,DTCC00195664,477917,46191
CHEMBL898,P20309,DIFLUNISAL,HUPFGZXOMWLGNK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7370561,DTCC00195664,477917,46191
CHEMBL9,P20309,NORFLOXACIN,OGJPXUAPXNRGGI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392813,DTCC00132409,51494,46191
CHEMBL9,P20309,NORFLOXACIN,OGJPXUAPXNRGGI-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7392814,DTCC00132409,51494,46191
CHEMBL900,P20309,ORPHENADRINE,QVYRGXJJSLMXQH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,120,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14709610,DTCC00195771,2098036,68567
CHEMBL900,P20309,ORPHENADRINE,QVYRGXJJSLMXQH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,175,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7373725,DTCC00195771,217582,46191
CHEMBL900,P20309,ORPHENADRINE,QVYRGXJJSLMXQH-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,37,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7373726,DTCC00195771,217582,46191
CHEMBL90125,P20309,,WSPOMRSOLSGNFJ-VGOFMYFVSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,22,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14709593,DTCC00254041,2098021,68417
CHEMBL902,P20309,FAMOTIDINE,XUFQPHANEAPEMJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7318047,DTCC00196201,1155680,46191
CHEMBL902,P20309,FAMOTIDINE,XUFQPHANEAPEMJ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7318048,DTCC00196201,1155680,46191
CHEMBL90555,P20309,VINCRISTINE,OGWKCGZFUXNPDA-XQKSVPLYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442531,DTCC00249955,51516,46191
CHEMBL90555,P20309,VINCRISTINE,OGWKCGZFUXNPDA-XQKSVPLYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7442532,DTCC00249955,51516,46191
CHEMBL91,P20309,MICONAZOLE,BYBLEWFAAKGYCD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,3154,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7415532,DTCC00139665,1317286,46191
CHEMBL91,P20309,MICONAZOLE,BYBLEWFAAKGYCD-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,668,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7415533,DTCC00139665,1317286,46191
CHEMBL914,P20309,FEXOFENADINE,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7316044,DTCC00198847,413971,46191
CHEMBL914,P20309,FEXOFENADINE,RWTNPBWLLIMQHL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7316045,DTCC00198847,413971,46191
CHEMBL917,P20309,FLOXURIDINE,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7297559,DTCC00199915,1609542,46191
CHEMBL917,P20309,FLOXURIDINE,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7297560,DTCC00199915,1609542,46191
CHEMBL918,P20309,PHENACEMIDE,XPFRXWCVYUEORT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400034,DTCC00199924,1577008,46191
CHEMBL918,P20309,PHENACEMIDE,XPFRXWCVYUEORT-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7400035,DTCC00199924,1577008,46191
CHEMBL92278,P20309,,OLMGQTCURTUFHE-XGICHPGQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,928991,DTCC00259341,30343,3355
CHEMBL92278,P20309,,OLMGQTCURTUFHE-XGICHPGQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,928992,DTCC00259341,30343,3355
CHEMBL923,P20309,RISEDRONIC ACID,IIDJRNMFWXDHID-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462142,DTCC00200598,1927022,46191
CHEMBL923,P20309,RISEDRONIC ACID,IIDJRNMFWXDHID-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462143,DTCC00200598,1927022,46191
CHEMBL92387,P20309,5-METHYLFURMETHIDE,KOWVJDFMEZKDDT-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18543900,KI,=,6165.95,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,,Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.,J. Med. Chem.,2008,51,13,"Scapecchi S, Nesi M, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Manetti D, Martini E, Marucci G, Romanelli MN, Teodori E, Cirilli R",,491218,DTCT0023280,2649043,DTCC01741645,597191,31191
CHEMBL92401,P20309,IPRONIAZID,NYMGNSNKLVNMIA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411830,DTCC00256735,1992806,46191
CHEMBL92401,P20309,IPRONIAZID,NYMGNSNKLVNMIA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7411831,DTCC00256735,1992806,46191
CHEMBL926,P20309,DOBUTAMINE,JRWZLRBJNMZMFE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7359932,DTCC00105095,1383776,46191
CHEMBL926,P20309,DOBUTAMINE,JRWZLRBJNMZMFE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7359933,DTCC00105095,1383776,46191
CHEMBL93,P20309,ZILEUTON,MWLSOWXNZPKENC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7448746,DTCC00139913,51518,46191
CHEMBL93,P20309,ZILEUTON,MWLSOWXNZPKENC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7448747,DTCC00139913,51518,46191
CHEMBL932,P20309,DIPYRIDAMOLE,IZEKFCXSFNUWAM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349032,DTCC00202383,444640,46191
CHEMBL932,P20309,DIPYRIDAMOLE,IZEKFCXSFNUWAM-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7349033,DTCC00202383,444640,46191
CHEMBL93258,P20309,,LITSQTSJSLZVPA-OQLLNIDSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,927877,DTCC00259953,237537,3355
CHEMBL93258,P20309,,LITSQTSJSLZVPA-OQLLNIDSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,7,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,927824,DTCC00259953,237537,3355
CHEMBL934,P20309,METYRAPONE,FJLBFSROUSIWMA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7428345,DTCC00202598,1992807,46191
CHEMBL934,P20309,METYRAPONE,FJLBFSROUSIWMA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7428346,DTCC00202598,1992807,46191
CHEMBL936,P20309,DIPHENIDOL,OGAKLTJNUQRZJU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,245,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7344771,DTCC00202761,1416027,46191
CHEMBL936,P20309,DIPHENIDOL,OGAKLTJNUQRZJU-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,52,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7344772,DTCC00202761,1416027,46191
CHEMBL93645,P20309,ACECLOFENAC,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7294821,DTCC00256586,1285871,46191
CHEMBL93645,P20309,ACECLOFENAC,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7294822,DTCC00256586,1285871,46191
CHEMBL93709,P20309,,FOFLCCPWXLOSCY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,2000,NM,,,,,,,,,,,,,,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),,,Bioorg. Med. Chem. Lett.,1994,4,24,,,138254,DTCT0023280,855849,DTCC00262414,433618,1026
CHEMBL93819,P20309,,YEWKXOVRQPTZSH-XNTDXEJSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,5,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,904289,DTCC00259923,1014593,3355
CHEMBL93819,P20309,,YEWKXOVRQPTZSH-XNTDXEJSSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,17,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,904290,DTCC00259923,1014593,3355
CHEMBL93876,P20309,,IBWKUSSSMFKEDB-YSMPRRRNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,9,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,906780,DTCC00259884,885686,3355
CHEMBL93876,P20309,,IBWKUSSSMFKEDB-YSMPRRRNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,82,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,906781,DTCC00259884,885686,3355
CHEMBL94,P20309,PHYSOSTIGMINE,PIJVFDBKTWXHHD-HIFRSBDPSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378677,DTCC00139956,1862717,46191
CHEMBL94,P20309,PHYSOSTIGMINE,PIJVFDBKTWXHHD-HIFRSBDPSA-N,3,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7378678,DTCC00139956,1862717,46191
CHEMBL940,P20309,GABAPENTIN,UGJMXCAKCUNAIE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327164,DTCC00204291,2025637,46191
CHEMBL940,P20309,GABAPENTIN,UGJMXCAKCUNAIE-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7327165,DTCC00204291,2025637,46191
CHEMBL941,P20309,IMATINIB,KTUFNOKKBVMGRW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7313027,DTCC01738580,51477,46191
CHEMBL941,P20309,IMATINIB,KTUFNOKKBVMGRW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7313028,DTCC01738580,51477,46191
CHEMBL9419,P20309,METACETAMOL,QLNWXBAGRTUKKI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7285221,DTCC00136686,477909,46191
CHEMBL9419,P20309,METACETAMOL,QLNWXBAGRTUKKI-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7285222,DTCC00136686,477909,46191
CHEMBL942,P20309,BISACODYL,KHOITXIGCFIULA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7268662,DTCC00204742,736255,46191
CHEMBL942,P20309,BISACODYL,KHOITXIGCFIULA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7268663,DTCC00204742,736255,46191
CHEMBL94349,P20309,,ZEQOYITXODHWOI-RIYZIHGNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,909323,DTCC00260566,982262,3355
CHEMBL94349,P20309,,ZEQOYITXODHWOI-RIYZIHGNSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,2,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,909324,DTCC00260566,982262,3355
CHEMBL945,P20309,AMILORIDE,XSDQTOBWRPYKKA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296673,DTCC00205274,2057644,46191
CHEMBL945,P20309,AMILORIDE,XSDQTOBWRPYKKA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7296674,DTCC00205274,2057644,46191
CHEMBL94601,P20309,,OXLWKCOVWCVMRM-PKAZHMFMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,44,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,916155,DTCC00259309,562357,3355
CHEMBL94601,P20309,,OXLWKCOVWCVMRM-PKAZHMFMSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,94,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,916156,DTCC00259309,562357,3355
CHEMBL94704,P20309,,SYGSVYHTPYEUDG-NTUHNPAUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,935071,DTCC00260604,108473,3355
CHEMBL94704,P20309,,SYGSVYHTPYEUDG-NTUHNPAUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,935072,DTCC00260604,108473,3355
CHEMBL94739,P20309,FEMOXETINE,OJSFTALXCYKKFQ-YLJYHZDGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,220,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708786,DTCC00259432,2097831,68567
CHEMBL94772,P20309,,ZHHAFUJWPPGPNL-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,6900,NM,,,,,,,,,,,,,,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),,,Bioorg. Med. Chem. Lett.,1994,4,24,,,138254,DTCT0023280,822205,DTCC00261907,885702,1026
CHEMBL94858,P20309,,GXHNERMILLSZQF-MHWRWJLKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,919519,DTCC00259837,76217,3355
CHEMBL94858,P20309,,GXHNERMILLSZQF-MHWRWJLKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,53,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,919520,DTCC00259837,76217,3355
CHEMBL94921,P20309,,UEPTUEJDVFQHBN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,2600,NM,,,,,,,,,,,,,,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),,,Bioorg. Med. Chem. Lett.,1994,4,24,,,138254,DTCT0023280,827275,DTCC00262343,1435525,1026
CHEMBL95,P20309,TACRINE,YLJREFDVOIBQDA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454662,DTCC00140002,283001,46191
CHEMBL95,P20309,TACRINE,YLJREFDVOIBQDA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7454663,DTCC00140002,283001,46191
CHEMBL9514,P20309,NOCODAZOLE,KYRVNWMVYQXFEU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379852,DTCC00136712,2025640,46191
CHEMBL9514,P20309,NOCODAZOLE,KYRVNWMVYQXFEU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7379853,DTCC00136712,2025640,46191
CHEMBL954,P20309,ENCLOMIPHENE,GKIRPKYJQBWNGO-OCEACIFDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,=,2071,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365144,DTCC00208231,1383775,46191
CHEMBL954,P20309,ENCLOMIPHENE,GKIRPKYJQBWNGO-OCEACIFDSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,439,NM,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7365145,DTCC00208231,1383775,46191
CHEMBL95764,P20309,GLYPHOSATE,XDDAORKBJWWYJS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7318982,DTCC00263189,1894968,46191
CHEMBL95764,P20309,GLYPHOSATE,XDDAORKBJWWYJS-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7318983,DTCC00263189,1894968,46191
CHEMBL959,P20309,RIMANTADINE,UBCHPRBFMUDMNC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457769,DTCC00208870,574626,46191
CHEMBL959,P20309,RIMANTADINE,UBCHPRBFMUDMNC-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7457770,DTCC00208870,574626,46191
CHEMBL960,P20309,LEFLUNOMIDE,VHOGYURTWQBHIL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429357,DTCC00208904,249943,46191
CHEMBL960,P20309,LEFLUNOMIDE,VHOGYURTWQBHIL-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7429358,DTCC00208904,249943,46191
CHEMBL96042,P20309,,ZTQPUWZQTBIPIH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,=,1500,NM,,,,,,,,,,,,,,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),,,Bioorg. Med. Chem. Lett.,1994,4,24,,,138254,DTCT0023280,842096,DTCC00262375,1240581,1026
CHEMBL96083,P20309,,VHVPHEQZIBIJKB-ZROIWOOFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,,,,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM; ND=No data,Not Determined,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139785,DTCT0023280,352977,DTCC00259954,530133,3355
CHEMBL96083,P20309,,VHVPHEQZIBIJKB-ZROIWOOFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,,,,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM; ND=No data,Not Determined,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139787,DTCT0023280,352978,DTCC00259954,530133,3355
CHEMBL96135,P20309,,MARULEJWKPYSRB-UDWIEESQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,,,,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM; ND=No data,Not Determined,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139787,DTCT0023280,931460,DTCC00260567,1240555,3355
CHEMBL96135,P20309,,MARULEJWKPYSRB-UDWIEESQSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,,,,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM; ND=No data,Not Determined,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139792,DTCT0023280,931459,DTCC00260567,1240555,3355
CHEMBL96290,P20309,,VUNFWSNZRZSOAP-STZFKDTASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,22,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,905562,DTCC00259813,1047024,3355
CHEMBL96290,P20309,,VUNFWSNZRZSOAP-STZFKDTASA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,52,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,905563,DTCC00259813,1047024,3355
CHEMBL96397,P20309,,PHMKCTAFYAPWGP-NTUHNPAUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,924115,DTCC00260032,1500190,3355
CHEMBL96397,P20309,,PHMKCTAFYAPWGP-NTUHNPAUSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,20,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,924116,DTCC00260032,1500190,3355
CHEMBL964,P20309,DISULFIRAM,AUZONCFQVSMFAP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7357654,DTCC00209451,1318441,46191
CHEMBL964,P20309,DISULFIRAM,AUZONCFQVSMFAP-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7357655,DTCC00209451,1318441,46191
CHEMBL965,P20309,CARBACHOL CHLORIDE,VPJXQGSRWJZDOB-UHFFFAOYSA-O,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12235229,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708348,DTCC00209635,2097691,68470
CHEMBL96579,P20309,,BEURYPRTOCSHLD-QPEQYQDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,903097,DTCC00259371,1532601,3355
CHEMBL96579,P20309,,BEURYPRTOCSHLD-QPEQYQDCSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,10,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,903098,DTCC00259371,1532601,3355
CHEMBL96779,P20309,,ZRQTXCLHQAFFSA-MHWRWJLKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,925433,DTCC00260591,1240554,3355
CHEMBL96779,P20309,,ZRQTXCLHQAFFSA-MHWRWJLKSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,925434,DTCC00260591,1240554,3355
CHEMBL96939,P20309,,ZRQTXCLHQAFFSA-YBEGLDIGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,3,%,,cell_based,,,,,,,,,,,CHO,Aability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139674,DTCT0023280,901843,DTCC00260590,820493,3355
CHEMBL96939,P20309,,ZRQTXCLHQAFFSA-YBEGLDIGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,15,%,,cell_based,,,,,,,,,,,CHO,Aability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139675,DTCT0023280,901844,DTCC00260590,820493,3355
CHEMBL972,P20309,SELEGILINE,MEZLKOACVSPNER-GFCCVEGCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462480,DTCC00210689,51433,46191
CHEMBL972,P20309,SELEGILINE,MEZLKOACVSPNER-GFCCVEGCSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7462481,DTCC00210689,51433,46191
CHEMBL97414,P20309,,QBFFXFQVLLQBOQ-GDNBJRDFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,14,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139784,DTCT0023280,903083,DTCC00259897,1914693,3355
CHEMBL97414,P20309,,QBFFXFQVLLQBOQ-GDNBJRDFSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,63,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,903084,DTCC00259897,1914693,3355
CHEMBL97468,P20309,,PWWIFONZRLYSFR-ATVHPVEESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,31,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 1 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139791,DTCT0023280,932688,DTCC00260061,433597,3355
CHEMBL97468,P20309,,PWWIFONZRLYSFR-ATVHPVEESA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10522693,INHIBITION,=,87,%,,cell_based,,,,,,,,,,,CHO,Ability to displace [3H]N-methylscopolamine binding to M3 human recombinant muscarinic receptor in CHO cells at concentration 10 uM,,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY",,139786,DTCT0023280,932689,DTCC00260061,433597,3355
CHEMBL975,P20309,MESNA,XOGTZOOQQBDUSI-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408646,DTCC00211154,1960079,46191
CHEMBL975,P20309,MESNA,XOGTZOOQQBDUSI-UHFFFAOYSA-M,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7408647,DTCC00211154,1960079,46191
CHEMBL9751,P20309,,RKUNBYITZUJHSG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,1.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708085,DTCC00137289,2097610,68417
CHEMBL9751,P20309,,RKUNBYITZUJHSG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2704370,KI,=,0.15,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708137,DTCC00137289,2097635,68413
CHEMBL9751,P20309,,RKUNBYITZUJHSG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10227113,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708088,DTCC00137289,2097612,68459
CHEMBL9751,P20309,,RKUNBYITZUJHSG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,10708730,KI,=,0.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708146,DTCC00137289,2097634,68468
CHEMBL9751,P20309,,RKUNBYITZUJHSG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11303071,KI,=,0.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708142,DTCC00137289,2097618,68460
CHEMBL9751,P20309,,RKUNBYITZUJHSG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,0.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708087,DTCC00137289,2097611,68458
CHEMBL9751,P20309,,RKUNBYITZUJHSG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,0.2,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708141,DTCC00137289,2097611,68458
CHEMBL9751,P20309,,RKUNBYITZUJHSG-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,14642972,KI,=,0.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14708147,DTCC00137289,2097611,68458
CHEMBL976,P20309,PRAZIQUANTEL,FSVJFNAIGNNGKK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383253,DTCC00213280,1383780,46191
CHEMBL976,P20309,PRAZIQUANTEL,FSVJFNAIGNNGKK-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7383254,DTCC00213280,1383780,46191
CHEMBL978,P20309,METHACHOLINE,NZWOPGCLSHLLPA-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9622546,INHIBITION,=,34,%,,cell_based,,,,,,,,,,,CHO,Percentage inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,,6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.,J. Med. Chem.,1998,41,12,"Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW",,138695,DTCT0023280,1634633,DTCC00213543,172643,14670
CHEMBL980,P20309,GUAIFENESIN,HSRJKNPTNIJEKV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310579,DTCC00214269,994593,46191
CHEMBL980,P20309,GUAIFENESIN,HSRJKNPTNIJEKV-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7310580,DTCC00214269,994593,46191
CHEMBL983,P20309,SUCCINYLCHOLINE CHLORIDE,YOEWQQVKRJEPAE-UHFFFAOYSA-L,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484956,DTCC00215702,1674152,46191
CHEMBL983,P20309,SUCCINYLCHOLINE CHLORIDE,YOEWQQVKRJEPAE-UHFFFAOYSA-L,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7484957,DTCC00215702,1674152,46191
CHEMBL98350,P20309,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421274,DTCC00262208,1960077,46191
CHEMBL98350,P20309,LY-294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7421275,DTCC00262208,1960077,46191
CHEMBL989,P20309,FLUOCINOLONE ACETONIDE,FEBLZLNTKCEFIT-VSXGLTOVSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7303416,DTCC00218597,1351110,46191
CHEMBL989,P20309,FLUOCINOLONE ACETONIDE,FEBLZLNTKCEFIT-VSXGLTOVSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7303417,DTCC00218597,1351110,46191
CHEMBL990,P20309,BUTENAFINE,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273123,DTCC00218762,1862713,46191
CHEMBL990,P20309,BUTENAFINE,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7273124,DTCC00218762,1862713,46191
CHEMBL991,P20309,STAVUDINE,XNKLLVCARDGLGL-JGVFFNPUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7471618,DTCC00220129,1927023,46191
CHEMBL991,P20309,STAVUDINE,XNKLLVCARDGLGL-JGVFFNPUSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7471619,DTCC00220129,1927023,46191
CHEMBL99521,P20309,,SNSMIIQEKVYNOH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11504829,KI,=,77.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14707931,DTCC00265386,2097559,68432
CHEMBL9967,P20309,PIRENZEPINE,RMHMFHUVIITRHF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,150,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14707863,DTCC00137744,2097534,68417
CHEMBL9967,P20309,PIRENZEPINE,RMHMFHUVIITRHF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,138.04,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14707865,DTCC00137744,2097533,68416
CHEMBL9967,P20309,PIRENZEPINE,RMHMFHUVIITRHF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2704370,KI,=,180,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14707861,DTCC00137744,2097530,68413
CHEMBL9967,P20309,PIRENZEPINE,RMHMFHUVIITRHF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,9986705,IC50,=,955.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,,Identification and characterization of m1 selective muscarinic receptor antagonists1.,J. Med. Chem.,1999,42,3,"Augelli-Szafran CE, Blankley CJ, Jaen JC, Moreland DW, Nelson CB, Penvose-Yi JR, Schwarz RD, Thomas AJ",,138585,DTCT0023280,1606374,DTCC00137744,1371574,15558
CHEMBL9967,P20309,PIRENZEPINE,RMHMFHUVIITRHF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,18595721,KI,=,47.86,NM,,cell_based,,,,,,,,,,,CHO-K1,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,,"Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.",Bioorg. Med. Chem.,2008,16,15,"Minarini A, Marucci G, Bellucci C, Giorgi G, Tumiatti V, Bolognesi ML, Matera R, Rosini M, Melchiorre C",,491020,DTCT0023280,2759488,DTCC00137744,1362609,30679
CHEMBL9967,P20309,PIRENZEPINE,RMHMFHUVIITRHF-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,23379472,KI,=,158,NM,,,,,,,,,,,,,,Binding affinity to human M3 muscarinic receptor,,Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.,J. Med. Chem.,2013,56,4,"Zheng G, Smith AM, Huang X, Subramanian KL, Siripurapu KB, Deaciuc A, Zhan CG, Dwoskin LP",,936428,DTCT0023280,11761588,DTCC00137744,1365920,53451
CHEMBL998,P20309,LORATADINE,JCCNYMKQOSZNPW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,IC50,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7436096,DTCC00223343,1253325,46191
CHEMBL998,P20309,LORATADINE,JCCNYMKQOSZNPW-UHFFFAOYSA-N,4,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,,KI,,,,,,,,,,,,,,,,CHO-K1,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774651,DTCT0023280,7436097,DTCC00223343,1253325,46191
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,15.49,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14754053,DTCC01744004,2109708,68416
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,93.33,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14749063,DTCC01744004,2109708,68416
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,8100134,KI,=,5.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14752357,DTCC01744004,2109759,68567
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14746987,DTCC01744004,2109188,69275
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12110997,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14749651,DTCC01744004,2109188,69275
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14754388,DTCC01744004,2110075,69159
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13679167,KI,=,2.51,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14749285,DTCC01744004,2109640,68421
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13679167,KI,=,6.31,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14755047,DTCC01744004,2109640,68421
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13679167,KI,=,16.98,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14748966,DTCC01744004,2109640,68421
,P20309,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13679167,KI,=,102.33,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14748703,DTCC01744004,2109640,68421
,P20309,1-CYCLOHEXYL-1-PHENYL-4-PIPERIDIN-1-YL-BUT-2-YN-1-OL,IXXCPZGOFVCPCH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,2.18,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14750883,DTCC01746439,2109990,68416
,P20309,1-CYCLOHEXYL-1-PHENYL-4-PIPERIDIN-1-YL-BUT-2-YN-1-OL,IXXCPZGOFVCPCH-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1994002,KI,=,45.71,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14750884,DTCC01746439,2109990,68416
,P20309,AC1N3NBH,XBSQTYHEGZTYJE-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12235229,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14747689,DTCC01746148,2109467,68470
,P20309,D-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-GSVOUGTGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14755096,DTCC01745877,2104421,69159
,P20309,D-HOMOCYSTEINE SULFINIC ACID,PDNJLMZEGXHSCU-GSVOUGTGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14753003,DTCC01746621,2110340,69159
,P20309,D-HOMOCYSTEINE THIOLACTONE,KIWQWJKWBHZMDT-GSVOUGTGSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14751356,DTCC01746491,2110074,69159
,P20309,DL-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12649361,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14755134,DTCC01745876,2104415,69159
,P20309,HEXAHYDRODIFENIDOL,ILHSFCNKNNNPRN-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2704370,KI,=,16,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14753025,DTCC01746626,2110348,68413
,P20309,LITHOCHOLYLCHOLINE,KWEWGNPMETZMTR-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12235229,KI,=,1100,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14751525,DTCC01746500,2110086,68470
,P20309,LITHOCHOLYLTAURINE,QBYUNVOYXHFVKC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,12235229,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14726909,DTCC01745711,2103224,68470
,P20309,MDL 100907,HXTGXYRHXAGCFP-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,15999145,KI,=,10000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14750501,DTCC01745097,2109914,69464
,P20309,NNC 11-1585,ROEXPZFFOZZHOY-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11504829,KI,=,4.68,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14728694,DTCC01745773,2103684,68432
,P20309,NNC 11-1607,TYLFZULSDOOCRC-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,11504829,KI,=,8.13,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14730093,DTCC01745835,2104070,68432
,P20309,PDSP1_001335,AILVCKQCTVDJPU-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,13679167,KI,=,75.86,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14746811,DTCC01746115,2109263,68421
,P20309,SURECN11079699,RVQVUMIXBGFJLZ-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,1346637,KI,=,530,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14754029,DTCC01745795,2110507,68417
,P20309,SURECN9660473,NPNXPJMTHYXCHW-UHFFFAOYSA-N,0,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,GPCR,,,2704370,KI,=,1.2,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023280,14752352,DTCC01746570,2110247,68413
